
<html lang="en"     class="pb-page"  data-request-id="ad6ccb7b-073b-4aff-9fc7-43d43e38260c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.0c01704;issue:issue:10.1021/jmcmar.2021.64.issue-1;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Reactive Oxygen Species (ROS)-Responsive Prodrugs, Probes, and Theranostic Prodrugs: Applications in the ROS-Related Diseases" /></meta><meta name="dc.Creator" content="Pengfei  Wang" /></meta><meta name="dc.Creator" content="Qijie  Gong" /></meta><meta name="dc.Creator" content="Jiabao  Hu" /></meta><meta name="dc.Creator" content="Xiang  Li" /></meta><meta name="dc.Creator" content="Xiaojin  Zhang" /></meta><meta name="dc.Description" content="Elevated levels of reactive oxygen species (ROS) have commonly been implicated in a variety of diseases, including cancer, inflammation, and neurodegenerative diseases. In light of significant diff..." /></meta><meta name="Description" content="Elevated levels of reactive oxygen species (ROS) have commonly been implicated in a variety of diseases, including cancer, inflammation, and neurodegenerative diseases. In light of significant diff..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 23, 2020" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01704" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01704" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01704" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01704" /></link>
        
    
    

<title>Reactive Oxygen Species (ROS)-Responsive Prodrugs, Probes, and Theranostic Prodrugs: Applications in the ROS-Related Diseases | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01704" /></meta><meta property="og:title" content="Reactive Oxygen Species (ROS)-Responsive Prodrugs, Probes, and Theranostic Prodrugs: Applications in the ROS-Related Diseases" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0032.jpeg" /></meta><meta property="og:description" content="Elevated levels of reactive oxygen species (ROS) have commonly been implicated in a variety of diseases, including cancer, inflammation, and neurodegenerative diseases. In light of significant differences in ROS levels between the nonpathogenic and pathological tissues, an increasing number of ROS-responsive prodrugs, probes, and theranostic prodrugs have been developed for the targeted treatment and precise diagnosis of ROS-related diseases. This review will summarize and provide insight into recent advances in ROS-responsive prodrugs, fluorescent probes, and theranostic prodrugs, with applications to different ROS-related diseases and various subcellular organelle-targetable and disease-targetable features. The ROS-responsive moieties, the self-immolative linkers, and the typical activation mechanism for the ROS-responsive release are also summarized and discussed." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01704"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01704">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01704&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01704&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01704&amp;href=/doi/10.1021/acs.jmedchem.0c01704" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 298-325</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01664" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.0c01518" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Reactive Oxygen Species (ROS)-Responsive Prodrugs, Probes, and Theranostic Prodrugs: Applications in the ROS-Related Diseases</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Pengfei Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pengfei Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Jiangsu Key Laboratory of Drug Design and Optimization, and Department of Chemistry, China Pharmaceutical University, Nanjing 211198, China</div><div class="loa-info-affiliations-info">Department of Pharmaceutical Engineering, China Pharmaceutical University, Nanjing 211198, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pengfei++Wang">Pengfei Wang</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qijie Gong</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qijie Gong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Jiangsu Key Laboratory of Drug Design and Optimization, and Department of Chemistry, China Pharmaceutical University, Nanjing 211198, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qijie++Gong">Qijie Gong</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jiabao Hu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jiabao Hu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Jiangsu Key Laboratory of Drug Design and Optimization, and Department of Chemistry, China Pharmaceutical University, Nanjing 211198, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jiabao++Hu">Jiabao Hu</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xiang Li</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiang Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Engineering, China Pharmaceutical University, Nanjing 211198, China</div></div><span class="conrtib-corresp"><strong>*</strong>X.L.: phone, +86-25-86185754; email, <a href="/cdn-cgi/l/email-protection#dcb0b5a4b5bdb2bb9cbfaca9f2b9b8a9f2bfb2"><span class="__cf_email__" data-cfemail="563a3f2e3f3738311635262378333223783538">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiang++Li">Xiang Li</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4061-7115" title="Orcid link">http://orcid.org/0000-0002-4061-7115</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Xiaojin Zhang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiaojin Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Jiangsu Key Laboratory of Drug Design and Optimization, and Department of Chemistry, China Pharmaceutical University, Nanjing 211198, China</div></div><span class="conrtib-corresp"><strong>*</strong>X.Z.: phone, +86-13913007140; email, <a href="/cdn-cgi/l/email-protection#a9d3d1c3e9cad9dc87cccddc87cac7"><span class="__cf_email__" data-cfemail="dda7a5b79dbeada8f3b8b9a8f3beb3">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiaojin++Zhang">Xiaojin Zhang</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath5">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1898-3071" title="Orcid link">http://orcid.org/0000-0002-1898-3071</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01704&amp;href=/doi/10.1021%2Facs.jmedchem.0c01704" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 298–325</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 23, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>28 September 2020</li><li><span class="item_label"><b>Published</b> online</span>23 December 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 January 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01704" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01704</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D298%26pageCount%3D28%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPengfei%2BWang%252C%2BQijie%2BGong%252C%2BJiabao%2BHu%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D1%26contentID%3Dacs.jmedchem.0c01704%26title%3DReactive%2BOxygen%2BSpecies%2B%2528ROS%2529-Responsive%2BProdrugs%252C%2BProbes%252C%2Band%2BTheranostic%2BProdrugs%253A%2BApplications%2Bin%2Bthe%2BROS-Related%2BDiseases%26numPages%3D28%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D325%26publicationDate%3DJanuary%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01704"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3189</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">5</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01704" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Reactive Oxygen Species (ROS)-Responsive Prodrugs, Probes, and Theranostic Prodrugs: Applications in the ROS-Related Diseases&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Pengfei&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Qijie&quot;,&quot;last_name&quot;:&quot;Gong&quot;},{&quot;first_name&quot;:&quot;Jiabao&quot;,&quot;last_name&quot;:&quot;Hu&quot;},{&quot;first_name&quot;:&quot;Xiang&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Xiaojin&quot;,&quot;last_name&quot;:&quot;Zhang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;298-325&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01704&quot;},&quot;abstract&quot;:&quot;Elevated levels of reactive oxygen species (ROS) have commonly been implicated in a variety of diseases, including cancer, inflammation, and neurodegenerative diseases. In light of significant differences in ROS levels between the nonpathogenic and pathological tissues, an increasing number of ROS-responsive prodrugs, probes, and theranostic prodrugs have been developed for the targeted treatment and precise diagnosis of ROS-related diseases. This review will summarize and provide insight into recent advances in ROS-responsive prodrugs, fluorescent probes, and theranostic prodrugs, with applications to different ROS-related diseases and various subcellular organelle-targetable and disease-targetable features. The ROS-responsive moieties, the self-immolative linkers, and the typical activation mechanism for the ROS-responsive release are also summarized and discussed.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01704&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01704" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01704&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01704" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01704&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01704" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01704&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01704&amp;href=/doi/10.1021/acs.jmedchem.0c01704" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01704" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01704" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01704%26sid%3Dliteratum%253Aachs%26pmid%3D33356214%26genre%3Darticle%26aulast%3DWang%26date%3D2021%26atitle%3DReactive%2BOxygen%2BSpecies%2B%2528ROS%2529-Responsive%2BProdrugs%252C%2BProbes%252C%2Band%2BTheranostic%2BProdrugs%253A%2BApplications%2Bin%2Bthe%2BROS-Related%2BDiseases%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D1%26spage%3D298%26epage%3D325%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291876" title="Drug release">Drug release</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=290808" title="Toxicity">Toxicity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/jmcmar.2021.64.issue-1/20210114/jmcmar.2021.64.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0032.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Elevated levels of reactive oxygen species (ROS) have commonly been implicated in a variety of diseases, including cancer, inflammation, and neurodegenerative diseases. In light of significant differences in ROS levels between the nonpathogenic and pathological tissues, an increasing number of ROS-responsive prodrugs, probes, and theranostic prodrugs have been developed for the targeted treatment and precise diagnosis of ROS-related diseases. This review will summarize and provide insight into recent advances in ROS-responsive prodrugs, fluorescent probes, and theranostic prodrugs, with applications to different ROS-related diseases and various subcellular organelle-targetable and disease-targetable features. The ROS-responsive moieties, the self-immolative linkers, and the typical activation mechanism for the ROS-responsive release are also summarized and discussed.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53880" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53880" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Reactive oxygen species (ROS) are a series of chemically reactive oxygen-containing molecules, such as hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), superoxide (O<sub>2</sub><sup>–</sup>), superoxide radical anion (O<sub>2</sub>̇<sup>•–</sup>), and hydroxyl radical (·OH), which play an indispensable physiological role in cell signal transduction, acting as secondary messengers.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1−4)</a> ROS homeostasis is critical for maintaining normal cell metabolism, proliferation, and differentiation.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> However, abnormally elevated ROS levels in cells may cause oxidative stress due to their high chemical reactivity, which can lead to cellular dysfunction, induce pathological changes,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and contribute to the progression of diseases, such as cancer,<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> inflammation,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and neurodegenerative diseases including Alzheimer’s disease (AD) and Parkinson’s disease (PD).<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11−13)</a></div><div class="NLM_p">Cellular ROS production primarily occurs in the mitochondria.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Both NADH ubiquitin reductase (complex I) and ubiquitin cytochrome <i>c</i> reductase (complex III) of the mitochondrial electron transport chain are involved in the univalent reduction of O<sub>2</sub> to O<sub>2</sub>̇<sup>•–</sup>.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Among them, mitochondrial proteins such as E2 subunits of pyruvate dehydrogenase are the main targets of oxidative stress.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Previous studies have demonstrated that arsenic trioxide, an approved drug for the treatment of acute promyelocytic leukemia, can elevate the production of H<sub>2</sub>O<sub>2</sub> in mitochondria and produce hydroxyl radicals through the Fenton reaction, leading to oxidative damage of pyruvate dehydrogenase.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a> The disruption of such mitochondrial enzyme activities by arsenic trioxide will reduce the ability of cancer cells to meet energy requirements, thus causing cancer cell death.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a> Additionally, enzymes such as NADPH oxidases (NOXs), nitric oxide synthase, and xanthine oxidase will also contribute to the generation of ROS with superoxide and hydrogen peroxide as byproducts of their catalytic processes.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19,20)</a> The NOXs family of enzymes are composed of a flavoprotein, cytochrome <i>b</i>, and regulatory subunits specific to the family member and are considered to be crucial for ROS production. When activated, NOXs assemble in the cell membrane and reduce oxygen to superoxide.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19,20)</a> Physiologically, the endogenous ROS levels are stably maintained at a low level of approximately 20 × 10<sup>–3</sup> μM in normal cells owing to the cellular redox homeostasis.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> However, it has been suggested that ROS levels in the pathological tissue of certain ROS-related diseases, such as cancer and inflammation, could reach significantly higher concentrations of up to 100 μM.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Those diseased cells could adapt to significantly increased levels of ROS.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> Thus, ROS have been selected as a starting point or target for diagnosis and therapy of various ROS-related diseases.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a> In light of the significant differences in ROS levels between nonpathogenic and pathological tissues, an increasing number of ROS-responsive prodrugs, probes, and theranostic prodrugs have been developed for the targeted treatment and precise diagnosis of the ROS-related diseases.</div><div class="NLM_p">Of the endogenous ROS, H<sub>2</sub>O<sub>2</sub> has been regarded as the most crucial member with a relatively weaker reactivity in the cells and relatively higher concentrations compared to other ROS.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The mitochondrion is the primary site of H<sub>2</sub>O<sub>2</sub> production, and the cell respiratory rate determines the level of H<sub>2</sub>O<sub>2</sub> in the cytoplasm and other intracellular compartments.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> H<sub>2</sub>O<sub>2</sub> plays a variety of physiological functions <i>in vivo</i>, including immune response,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> cell signaling,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and regulation of oxidative stress.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> In particular, the responses of cell signaling to H<sub>2</sub>O<sub>2</sub> are dose-dependent and cell-type-specific.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> An increase in H<sub>2</sub>O<sub>2</sub> concentration may lead to oxidative cell damage through the loss of protein function.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The determination of H<sub>2</sub>O<sub>2</sub> levels in living cells is a crucial factor in understanding the mechanism of disease development and pharmacodynamics; the distribution of H<sub>2</sub>O<sub>2</sub> in living cells may differ in subcellular organelles. In this case, fluorescent probes can make a specific and sensitive response to changes in H<sub>2</sub>O<sub>2</sub> concentrations in cells, enabling the monitoring and detection of H<sub>2</sub>O<sub>2</sub> levels within living cells and even in subcellular organelles, thus providing useful tools for exploring the process of drug action, the function of H<sub>2</sub>O<sub>2</sub> in living cells, and clinical physiological diagnosis.<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34,35)</a></div><div class="NLM_p last">In recent decades, significant progress in ROS-responsive prodrugs, probes, and theranostic prodrugs has occurred. This review will summarize and provide insight into recent advances in ROS-responsive prodrugs, fluorescent probes, and theranostic prodrugs, in particular their application to different ROS-related diseases and various subcellular organelle-targetable and disease-targetable features. The ROS-responsive prodrugs have been classified according to the ROS-responsive moieties, such as the typical arylboronates, thiazolidinone, and selenium- or sulfur-containing classes. Additionally, the self-immolative linkers and typical activation mechanisms related to the ROS-responsive release will also be summarized and discussed.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  Activation Mechanisms of the ROS-Responsive Prodrugs</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83715" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83715" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Boronates, including boronate esters and boronic acids, are important chemical functional groups responsive to ROS in cells.<a onclick="showRef(event, 'ref36 ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38 ref39">(36−39)</a> Structurally, the boron atom in boronates contains an empty p-orbital that is susceptible to attack by nucleophiles such as H<sub>2</sub>O<sub>2</sub>, a major member of the ROS family. In the case of phenylboronate, a subsequent Baeyer–Villiger oxidation-like rearrangement, followed by hydrolysis, will lead to the formation of a phenolic hydroxyl group, which may initiate the bond breaking of a typical cleavable linker and subsequent release of an active parent drug under physiological conditions.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Thus, phenylboronate is the most common “ROS trigger group” to be introduced in a ROS-responsive prodrug.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> As illustrated in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, H<sub>2</sub>O<sub>2</sub> or its dissociated anionic form is prone to attacking the electrophilic boron center of the arylboronate-containing prodrug (<b>1a</b>) to form a tetrahedral boronate intermediate (<b>1b</b>). Then, the phenyl group migrates from the boron (B) atom to the adjacent oxygen (O) atom through a 1,2-rearrangement reaction to give the borate (<b>1c</b>). Compared with the structure of <b>1a</b>, <b>1c</b> has an oxygen atom inserted within the original carbon–boron bond. Subsequently, the borate <b>1c</b> is easily hydrolyzed under physiological conditions, converting into a boric acid/ester and the corresponding phenolic intermediate <b>1d</b>. Generally, the rate of reaction between H<sub>2</sub>O<sub>2</sub> and the boronate moiety as in <b>1a</b> to form <b>1d</b> is quite fast, with most of prodrug <b>1a</b> completely converted to <b>1d</b> in 15 min.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42,43)</a> Following a 1,6-elimination reaction, the methylphenyloxy linker in <b>1d</b> is spontaneously cleaved, leading to the release of the parent drug (<b>1e</b>) and <i>para</i>-benzoquinone methide (<i>p</i>-QM) (<b>1f</b>). The latter will then convert into <b>1g</b> or <b>1h</b> upon reaction with H<sub>2</sub>O or glutathione (GSH), respectively, in cells. The final 1,6-elimination step is considered to be the rate-limiting step of the ROS-responsive drug release.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Drug release mechanism for arylboronate-containing ROS-responsive prodrugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Structurally, a ROS-responsive prodrug should include two independent functional domains, a ROS acceptor (trigger) and a pharmacodynamic agent (effector), which are usually connected by a self-cleavable “linker system” (linker).<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, we have summarized various linking strategies for designing the arylboronate-containing ROS-responsive prodrugs based on parent drugs with different functional groups. In the case of parent drugs with an aromatic hydroxyl group, their corresponding prodrugs could be designed by using an ether-type cleavable linker (type A) or a carbonate ester-type cleavable linker (type B) or by replacing the hydroxyl with its boronate precursor, directly linked to the parent scaffold via a carbon–boron bond (type C). It is worth noting that the chemical types of linkers affect the rates of self-cleavage and drug release. Jourden et al. investigated different self-immolative linkers (types A–C) on the releasing rates of the parent drug; the results suggested that the carbonate ester-type cleavable linkage (type B) was the most efficient and fastest linkage for drug release. It can be postulated that this is because the hydrolysis process of boronate ester and the linker cleaving process could be accelerated by the thermodynamics of CO<sub>2</sub> release.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Prodrugs with the self-immolative ether linker (type A) can release parent drugs upon ROS-responsive oxidation and hydrolysis, followed by the 1,6-elimination cleavage. Prodrugs without a self-immolative linker, as in type C, possessed a similar boronate moiety to that in type A. The drug-releasing rate of type C was found to be approximately 2 orders of magnitude slower than that of type A or type B, indicating that self-immolative linkers were more advantageous for converting prodrugs into the active parent drugs upon ROS stimulation.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Various linking strategies for designing the arylboronate-containing ROS-responsive prodrugs based on parent drugs with different functional groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For parent drugs containing the functional group of either hydroxamic acid or amine, similar self-immolative linkers, shown as type D and type E in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, could be utilized to construct the ROS-responsive prodrugs.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44,45)</a> Importantly, the carbamate self-immolative linker (type E) may still be the first choice for the development of prodrugs based on the structures with an amine group because carbamate is relatively chemically stable and the thermodynamic property of CO<sub>2</sub> release is favorable for drug release.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> As seen, self-immolative linkers are widely used and play critical roles in the design and development of the boronate-containing ROS-responsive prodrugs.</div><div class="NLM_p">Apart from the typical arylboronates, the heterocycle thiazolidinone could also be used as a “ROS trigger” group for designing prodrugs based on the parent drugs with a carboxyl pharmacophore (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> The carbonyl group in prodrug (<b>2a</b>) is susceptible to attack by the nucleophilic H<sub>2</sub>O<sub>2</sub> to form <b>2b</b>. Subsequently, <b>2b</b> converts rapidly into <b>2c</b>, where the thiazolidinone moiety acts as a robust leaving group. The formed peroxy acid <b>2c</b> is easily hydrolyzed under physiological pH conditions, leading to the release of the parent drug with a carboxyl pharmacophore (<b>2e</b>).<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Drug release mechanism for the thiazolidinone-containing ROS-responsive prodrugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recently, selenium and sulfur atoms have been utilized as “ROS trigger” groups in some types of ROS-responsive prodrugs as they are prone to be oxidated in the presence of high levels of ROS in cells. As shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, following a ROS-mediated oxidation reaction in cells, the selenium-containing prodrug <b>3a</b> converted into <b>3b</b>; the latter underwent a <i>syn</i>-elimination reaction to form a double bond between the C5 and C6 sites and gave <b>3c</b>. The intermediate <b>3c</b> was extremely unstable, undergoing a cheletropic/retro-Diels–Alder reaction to release parent drug CO spontaneously under very mild conditions (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> This is an interesting prodrug strategy that uses an inter- and intramolecular Diels–Alder cycloaddition to trigger the release of CO caged in a cyclopentadienone moiety.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Additionally, sulfur-containing thioketal (TK) linkers are prone to be oxidized to sulfoxides or sulfones upon exposure to ROS through oxidation; the methylene sulfones may be rapidly cleaved by hydrolysis under physiological conditions to release active drugs, <b>4c</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Such sulfur-containing cleavable linkers have been commonly used in polymeric prodrugs. For example, polymeric prodrug <b>4a</b> formed micelles by self-assembly in aqueous solutions. In cancer cells, the elevated levels of ROS initiated the oxidation reaction to give <b>4b</b> and subsequent hydrolysis triggered the TK linker to break, leading to the selective release of the corresponding active drug <b>4c</b> in cancer cells (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51,52)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Drug release mechanism for the selenium- or sulfur-containing ROS-responsive prodrugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Aryl oxalate esters,<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> thioethers,<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> and tellurium<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> have also been reported as ROS-responsive moieties with similar release mechanisms to the above-mentioned moieties, thiazolidinone and thioketal. Additionally, polypeptide chains containing multiple proline, histidine, lysine, and arginine residues were found to be susceptible to oxidative cleavage.<a onclick="showRef(event, 'ref56 ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref56 ref57 ref58">(56−58)</a> Among them, a proline oligomer was commonly utilized as the ROS-responsive moiety in biomedical materials.<a onclick="showRef(event, 'ref56 ref58'); return false;" href="javascript:void(0);" class="ref ref56 ref58">(56,58)</a> However, it has rarely been applied in the design of small-molecule ROS-responsive prodrugs. A summary of all the reported ROS-responsive structures is listed in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, outlining the different types of ROS-responsive sites, moieties, and release mechanisms.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Brief Summary of the ROS-Responsive Structures</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0031.gif" alt="" id="fx1" /></img><div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">3.  ROS-Responsive Prodrugs</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33351" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33351" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">3.1.  ROS-Responsive Anticancer Prodrugs</h3><div class="NLM_p">Considering that cancer cells commonly exhibit significantly higher levels of ROS than normal cells, modification of anticancer agents into prodrugs by introducing ROS-responsive groups to mask the critical cytotoxic pharmacophore moiety is a promising strategy to improve the safety profiles of nonselective antitumor agents.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p">DNA interstrand cross-link (ICL)-inducing agents have been widely used in cancer chemotherapy, mediating their clinical outcomes through interruption of DNA replication and transcription.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> However, these drugs usually incur severe side effects due to their poor selectivity to affect only cancer cells. In 2011, Peng et al. reported the H<sub>2</sub>O<sub>2</sub>-activated anticancer prodrugs <b>5</b> and <b>6</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>), based on the structures of nitrogen mustards.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> The positive charge generated by the quaternary nitrogen in <b>5</b> and <b>6</b> significantly decreased the electron density of mustard nitrogens that induces chemical alkylation, thus masking the cytotoxicity of these compounds. In cancer cells, the reaction of phenylboronate or phenylboronic acid (trigger) with ROS led to a significant increase in cytotoxicity of nitrogen mustards (effector), while the prodrugs <b>5</b> and <b>6</b> showed a significantly reduced intrinsic toxicity. In cell-based assays, the cancer cells were usually treated with additional H<sub>2</sub>O<sub>2</sub> to mimic the high oxidative stress level of tumor tissues. When the ratio of prodrug <b>5</b> or <b>6</b> to H<sub>2</sub>O<sub>2</sub> was 2:1, the observed rate constant of induced ICL formation was 4.6 × 10<sup>–5</sup> s<sup>–1</sup> or 4.7 × 10<sup>–5</sup> s<sup>–1</sup>, respectively. The cross-linking efficiency of <b>5</b> and <b>6</b> was 43%, which is comparable to that of nitrogen mustard alone (47% ICLs). The growth-inhibitory rates of <b>5</b> and <b>6</b> toward SR cells (leukemia cells), NCI-H460 (non-small-cell lung cancer cells), CAKI-1, and SN12C (renal cancer cells) at 10 μM were 90%, 85%, 66%, and 57%, respectively. Under the same cell conditions, <b>5</b> and <b>6</b> did not cause apoptosis in normal lymphocytes, demonstrating good preliminary safety profiles <i>in vitro</i>.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> In 2014, Peng et al. further investigated various electron-withdrawing linkers and identified an effective anticancer prodrug <b>7</b> with a carbamate linker (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a><i>In vitro</i> cytotoxicity assays revealed that <b>7</b> possessed potent inhibitory activity toward a variety of cancer cell lines, including leukemia, lung cancer, breast cancer, and renal cancer, with GI<sub>50</sub> values below 1 μM.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Additionally, Peng et al. reported another neutral type of ROS-activated prodrug <b>8</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Compared with the charged prodrugs <b>5</b> and <b>6</b>, the neutral prodrug <b>8</b> was proposed to more easily penetrate cell membranes. <i>In vitro</i> cytotoxicity assays demonstrated that <b>8</b> induced 40–80% apoptosis in primary leukemic lymphocytes isolated from chronic lymphocytic leukemia (CLL) patients. In comparison, <b>8</b> was less toxic to normal lymphocytes from healthy donors (less than 25% cell death).<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> These results suggested that ROS-responsive prodrugs could potentially be a useful strategy for reducing the side effects of the nitrogen mustard-type antitumor drugs.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structures of ICL-inducing prodrugs <b>5</b>–<b>8</b> and mechanisms of ICL formation induced by H<sub>2</sub>O<sub>2</sub> activation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Camptothecin (CPT), a potent anticancer drug derived from natural products, may suppress DNA replication and RNA synthesis by directly binding to topoisomerase I (TopoI).<a onclick="showRef(event, 'ref63 ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref63 ref64 ref65">(63−65)</a> SN-38 (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>), a derivative of CPT, has a pharmacophore predominantly composed of a phenolic hydroxyl group, which can be used as a starting point for designing prodrugs to be selectively activated by ROS, such as H<sub>2</sub>O<sub>2</sub>. SN-38 could be released at a concentration of H<sub>2</sub>O<sub>2</sub> as low as 0.5 mM in a concentration-dependent manner.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Compared with SN-38, prodrug <b>9</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) displayed comparable cytotoxic activity toward MCF-7 and U251 cells and enhanced activity toward HT-29 cells.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Further, <b>9</b> was evaluated in the xenograft model to assess its antitumor activity <i>in vivo</i>. Following a dose of 2.0 mg/kg (ip), prodrug <b>9</b> exhibited significant antitumor activity with a ratio of tumor volume in treated versus control mice (<i>T</i>/<i>C</i> ratio) of 28.1%, which is comparable to that achieved with irinotecan, a reference drug, at a dose of 15 mg/kg (<i>T</i>/<i>C</i> = 8.39%); notably, no obvious toxicity or any anaphylactic reactions were observed, suggesting an improved safety profile for <b>9</b><i>in vivo</i>.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Similarly, a new evodiamine prodrug <b>10</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) was designed using an arylboronate functional group as the initiator (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Potentially, it may induce apoptosis of HCT116 colon cancer cells in a dose-dependent manner and arrest the growth of HCT116 cells in the G2 phase. The <i>in vitro</i> assessment of antitumor effects revealed that <b>10</b> had good antiproliferative activity toward HCT116, MCF-7, and A549 cancer cells with IC<sub>50</sub> values ranging from 16 μM to 37 μM. Notably, the cytotoxic activity of <b>10</b> against HCT116 cells (IC<sub>50</sub> = 16 μM) was slightly more potent than the lead compound 3-fluoro-10-hydroxyevodiamine (IC<sub>50</sub> = 27 μM).<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures of ROS-responsive anticancer prodrugs <b>9</b>–<b>17</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Histone deacetylase (HDAC) is a crucial enzyme in cellular regulation of the acetylation levels of histones and non-histones to affect the dense structure of chromatin to achieve epigenetic regulation. Abnormal overexpression of many HDAC isoforms was found to be related to cancer development. Thus, HDAC inhibitors (HDACi) could be developed for the treatment of cancer.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Hydroxamic acid derivatives are the most investigated chemotype for HDACi because the hydroxamic acid moiety is an excellent chelator for binding to the Zn<sup>2+</sup> cation in the active site of HDACs. Vorinostat (SAHA) and belinostat, representative HDAC inhibitors, were used for the treatment of cutaneous T-cell lymphoma (CTCL) and relapsed/refractory peripheral T-cell lymphoma (PTCL), respectively.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> However, their poor selectivity to cancer cells resulted in a series of unwanted side effects. Vascular calcification was a common side effect of the hydroxamic acid-containing HDACi.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Additionally, the hydroxamic acid moiety was unstable <i>in vivo</i>, leading to a decrease in the therapeutic effects.<a onclick="showRef(event, 'ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref71 ref72">(71,72)</a> Although acyl and carbamate derivatives of hydroxamate-based HDACi were developed to improve the cell permeability, hydrolysis stability, and pharmacokinetic properties, these molecules still lacked the desired specificity for cancer cells.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Srivastava et al. capped the hydroxamic acid residue of SAHA with a ROS-responsive group, 4-hydroxymethylboronic pinacol ester, resulting in the SAHA prodrug <b>11a</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> The carbonate ester-type prodrug <b>11a</b> was found to be relatively stable in serum, while the phenylboronate may be reactive with H<sub>2</sub>O<sub>2</sub> and rapidly generate the parent drug form with the hydroxamic acid. <i>In vivo</i> assays revealed that <b>11a</b> showed an improved selectivity toward the ROS-sufficient cancer cells; the cytotoxicity of <b>11a</b> toward the ROS-deficient HEK-293T normal cells was significantly reduced (EC<sub>50</sub> > 1 μM) when compared with SAHA (EC<sub>50</sub> = 100 nM). Also, the lipophilicity of <b>11a</b> increased dramatically with a cLogP value of 4.337, compared to the cLogP value for SAHA of 0.989. The cellular drug uptake of <b>11a</b> was greatly accelerated, presumably due to increased lipophilicity in a multicellular tumor spheroid model.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Compared with SAHA, <b>11a</b> was more efficient in reducing tumor spheroids size; <b>11a</b> reduced tumor volume by 80%, while SAHA only reduced tumor volume by 50%.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Prodrug <b>11b</b>, structurally similar to <b>11a</b>, could be activated upon exposure to cellular H<sub>2</sub>O<sub>2</sub>, and consequently, the active HDACi released intracellularly then led to the suppression of viable acute myeloid leukemia (AML) cells.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Prodrug <b>11b</b> was also used in combination with conventional chemotherapy drugs, such as cytarabine, and other “targeted” anti-AML drugs to improve anticancer efficacy.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> The same design strategy was employed to produce the belinostat prodrug <b>12</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Wang et al. developed a ROS-responsive prodrug with therapeutic potential for the treatment of solid tumors, such as metastatic breast cancer, by introducing a phenylboronate moiety into the hydroxamic acid pharmacophore of belinostat. <i>In vitro</i> assays showed that <b>12</b> was active toward human breast adenocarcinoma MCF-7 cells with an IC<sub>50</sub> value of 1.46 μM. Although it was less potent than belinostat (IC<sub>50</sub> = 0.096 μM), no obvious cytotoxicity was observed for <b>12</b> toward normal mammary epithelial MCF-10A cells even at a relatively high concentration of 10 μM. Importantly, prodrug <b>12</b> showed 85.4% inhibition of tumor growth (TGI) in an MCF-7 tumor xenograft model, which was more efficacious than belinostat <i>in vivo</i> (TGI = 77.7%<i>)</i>. This may be attributed to the superior bioavailability of <b>12</b> within ROS-elevated tumor tissues; the drug concentration in tumor tissue in the <b>12</b>-treated group was found to be more than 2-fold higher than in the belinostat-treated group.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></div><div class="NLM_p">Gemcitabine (GEM), a first-line drug for treating pancreatic cancer, was the primary adjuvant chemotherapy after radical surgery for pancreatic ductal adenocarcinoma (PDAC).<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> However, its clinical application was limited due to severe side effects, such as myelosuppression. To improve the safety profile, a novel type of boronate clathrate prodrug, <b>13</b>, was designed (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Prodrug <b>13</b> was found to be selectively activated by high levels of ROS in cancer cells, releasing GEM to induce the antitumor effects. Prodrug <b>13</b> exhibited a comparable potency to that of GEM in an immunodeficient xenograft mouse model <i>in vivo</i>. Notably, owing to its selective activation in cancer cells, the myelosuppression side effect of GEM was significantly reduced when administered with prodrug <b>13</b><i>in vivo</i>.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></div><div class="NLM_p">Doxorubicin (DOX) is an effective and broad-spectrum antitumor drug; however, its therapeutic application is significantly limited due to severe cardiotoxicity. Prodrug <b>14</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) was designed by branching the amino group of DOX with a ROS-responsive arylboronate-based self-immolative linker.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Prodrug <b>14</b> manifested potent <i>in vitro</i> cytotoxicity toward several cancer cells, which was comparable with DOX. Significantly, the IC<sub>50</sub> for <b>14</b> against the pancreatic MiPaCa-2 cells was 0.3 μM. Additionally, prodrug <b>14</b> was found to efficiently release DOX in tumor tissues on a MiaPaca-2 tumor model, inferring promising therapeutic outcomes of such ROS-responsive prodrugs in the treatment of pancreatic cancer.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a></div><div class="NLM_p">5-Fluorouracil (5-FU) has been used alone or in combination with other chemotherapy drugs for the treatment of various solid tumors. As an antimetabolic agent, 5-FU also inhibits the growth of normal cells and causes significant side effects.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> Xue et al. designed ROS-responsive prodrugs of 5-FU, such as <b>15</b> and <b>16</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>), by introducing a phenylboronate group to 5-FU to mask its cytotoxicity toward normal cells.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> Upon exposure to H<sub>2</sub>O<sub>2</sub>, 5-FU was efficiently released from the boronate ester prodrug <b>15</b>, while the boronic acid prodrug showed a much slower 5-FU release. <i>In vitro</i> assays showed that prodrug <b>15</b> manifested highly selective cytotoxicity toward a variety of cancer cells, with no obvious cytotoxicity observed for <b>15</b> in normal MEC1 cells even at the high concentration of 100 μM.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> The acute toxicity of prodrug <b>15</b> was tested in C57BL/6 male mice, with no death or any other abnormalities observed in the prodrug <b>15</b>-treated group at a high dose of 100 mg/kg throughout a 2-week treatment. All mice died on the 12th day in the 5-FU-treated group at the same dose. The results indicate that prodrug <b>15</b> possessed a significantly superior safety profile than the parent 5-FU and may reduce the side effects experienced with 5-FU, such as myelosuppression, central neurotoxicity, and gastrointestinal toxicity.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a></div><div class="NLM_p">Melatonin (MLT), a tryptophan-derived hormone, has been shown to inhibit the growth of several types of cancers both <i>in vitro</i> and <i>in vivo</i>, although its mode of action remains controversial.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Recently, Bedini et al. reported an MLT prodrug (<b>17</b>) (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) with a ROS-responsive phenylboronate trigger inserted at the nitrogen of the indole scaffold within MLT.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Prodrug <b>17</b> could be selectively activated under the high H<sub>2</sub>O<sub>2</sub> concentrations in cancer cells, releasing both the MLT and cytotoxic <i>p</i>-QM intermediate to exert synergistic antitumor effects. When treated with 50 μM <b>17</b>, the cytotoxic activity was evident in Hela cells; in contrast, no obvious cell death was observed in normal cells, suggesting that prodrug <b>17</b> was preferentially bioactivated by the elevated levels of ROS in cancer cells.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div><div class="NLM_p">Perturbation of redox homeostasis by further inducing ROS production or GSH depletion to push the ROS levels in cancer cells to exceed the “toxicity threshold” has been a promising strategy for cancer therapy.<a onclick="showRef(event, 'ref82 ref83'); return false;" href="javascript:void(0);" class="ref ref82 ref83">(82,83)</a> 5,8-Dihydroxy-1,4-naphthoquinone, also known as naphthazarin (Nap), is a naturally occurring anticancer agent. The cytotoxicity of Nap is due to the adjacent carbonyl and hydroxy moieties acting as potential Cu(II) ionophores.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Recently, Zhou et al. reported a ROS-responsive prodrug of Nap, PNap (<b>18</b>) (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>), where the two hydroxy groups are masked with a phenylboronate ROS trigger.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Anticancer mechanism of the ROS-responsive prodrug <b>18</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition to small molecule-based prodrugs, the ROS-responsive prodrug approach was also applied to modify proteins for target cancer therapy. RNase is a protein drug that has entered clinical trials for cancer treatment; it is capable of cleaving RNA and inducing cytotoxicity in cancer cells.<a onclick="showRef(event, 'ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref85 ref86">(85,86)</a> Wang et al. introduced an arylboronate ROS-responsive trigger onto a critical lysine residue of RNase A, which was essential for its activity, thus generating a ROS-responsive RNase, RNase A-NBC (<b>19</b>) (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). This modification led to a temporary inactivation of RNase, with prodrug <b>19</b> becoming reactivated by high levels of ROS in cancer cells.<a onclick="showRef(event, 'ref46 ref87'); return false;" href="javascript:void(0);" class="ref ref46 ref87">(46,87)</a> Consequently, prodrug <b>19</b> manifested cytotoxicity selective to cancer cells, such as B16F10, PC-3, HeLa, and MDA-MB-231 cancer cells, and the cytotoxicity to normal cells was significantly reduced, leading to a considerable increase in tolerated dosages of RNase A to generate improved therapeutic outcomes in clinical use.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. ROS-responsive prodrug (<b>19</b>) of an anticancer protein RNase A and its ROS-triggered drug release.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Mokhir et al. reported a novel group of aminoferrocene-based prodrugs, for example, <b>20</b> shown in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>, where the parent aminoferrocene moieties are caged by phenylboronate ester-type ROS triggers. Prodrug <b>20</b> may be activated upon exposure to high levels of ROS in cancer cells to form a quinone methide (<i>p</i>-QM) and the parent drug aminoferrocenes.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> The former could inhibit the antioxidant system of cancer cells, while the latter could induce rapid ROS generation in cancer cells, thus producing anticancer effects through a synergistic manner. The mechanism of the ROS-responsive drug release for <b>20</b> was illustrated in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>. Upon exposure to high levels of H<sub>2</sub>O<sub>2</sub>, the boron–carbon bond of <b>20</b> was cleaved to form phenol (<b>20a</b>), which existed in equilibrium with phenolate (<b>20b</b>) (p<i>K</i><sub>a</sub> ≈ 9) in an aqueous solution. Compound <b>20b</b> then experienced a spontaneous 1,6-elimination reaction to produce <b>20c</b> and <i>p</i>-QM.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Intermediate <b>20c</b> was unstable in aqueous solution, resulting in rapid hydrolysis, leading to the release of the <i>N</i>-alkylaminoferrocene <b>20e</b> together with a molecule of CO<sub>2</sub>. Compound <b>20e</b> can be further oxidized by O<sub>2</sub> or H<sub>2</sub>O<sub>2</sub> to form aminoferrocene cation (<b>20f</b>) and generate HO· or O<sub>2</sub><sup>–</sup>, which are more active ROS. In addition, <b>20f</b> may decompose to release iron ions, which catalyze the generation of more toxic ROS from less reactive H<sub>2</sub>O<sub>2</sub> or O<sub>2</sub>.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Moreover, <i>p</i>-QM consumes ROS scavengers such as GSH, resulting in the inhibition of the antioxidant system in cancer cells (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>).<a onclick="showRef(event, 'ref88 ref90'); return false;" href="javascript:void(0);" class="ref ref88 ref90">(88,90)</a> It has been suggested that these pathways explained the induced synergistic effects on cancer cell growth inhibition.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. <i>N</i>-Alkylaminoferrocene prodrugs (<b>20</b>) and the mechanism of the ROS-responsive drug release for <b>20</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Structural modifications on the aminoferrocene-based prodrugs were explored by the Mokhir group to improve selectivity and potency toward cancer cells and drug-like properties, such as cell membrane permeability and water solubility.<a onclick="showRef(event, 'ref90 ref91 ref92 ref93 ref94'); return false;" href="javascript:void(0);" class="ref ref90 ref91 ref92 ref93 ref94">(90−94)</a> Benzylation of the amino group on the ferrocene scaffold resulted in a series of N-substituted prodrugs, as represented by <b>21</b> (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>). Prodrug <b>21</b> was found to be more cytotoxic toward many cancer cells such as HL-60, RAJI, BL-2, JVM-2, and LNCap cells, in comparison to its amino counterpart (<b>20</b>, R = H).<a onclick="showRef(event, 'ref90 ref91'); return false;" href="javascript:void(0);" class="ref ref90 ref91">(90,91)</a> For instance, <b>21</b> manifested an IC<sub>50</sub> of approximately 11 μM on the growth of HL-60 leukemia cells.<a onclick="showRef(event, 'ref90 ref92'); return false;" href="javascript:void(0);" class="ref ref90 ref92">(90,92)</a> Substituents on the benzyl of <b>21</b> with electron-donating or -accepting moieties, such as fluoro, methoxy, and acetoxy functional groups, had little effect on its cytotoxicity. <i>Ex vivo</i> and <i>in vivo</i> safety profiles of prodrug <b>21</b> were evaluated using rat cut liver slices at concentrations of up to 10 μM and hybrid male BDF1 mice at doses of up to 6 mg/kg with no obvious toxicity observed in either experiment.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> The survival of BDF1 mice with L1210 leukemia was extended from 13.7 days to 17.5 days when prodrug <b>21</b> was administrated via iv six times daily at a low dose of 26 μg/kg.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> Prodrug <b>21</b> showed good antitumor potency and preferable safety profiles; however, high lipophilicity led to difficulties in administering prodrug <b>21</b> and potentially caused poor reproducibility of therapeutic effects in clinical trials. Consequently, prodrug <b>22</b> (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>), where the <i>N</i>-benzyl fragment was replaced with <i>N</i>-propargyl, led to a decrease in lipophilicity compared to <b>21</b> (<b>22</b>, log <i>P</i> = 3.78; <b>21</b>, log <i>P</i> = 4.51).<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> Prodrug <b>22</b> was markedly more water-soluble, resulting in a significant increase in its ROS-generation properties, which was approximately 7-fold more efficient than <b>21</b> in ROS generation in BL-2 cancer cells. Prodrug <b>22</b> was active toward a series of cancer cells with IC<sub>50</sub> values ranging from 15 to 31 μM, while it was found to be nontoxic toward normal cells up to 50 μM.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> Notably, <b>22</b> significantly inhibited Guerin’s carcinoma (T8) growth with <i>in vivo</i> dosing at 30 mg/kg.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a></div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Monophenylboronate- or bisphenylboronate-containing ROS-responsive prodrugs (<b>22</b>–<b>24</b>) of aminoferrocene with various substituents at the amino group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Interestingly, prodrug <b>23</b> was designed by inserting two phenylboronate-type ROS-responsive triggers onto the aminoferrocene scaffold.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> Prodrug <b>23</b> manifested increased cytotoxicity toward HL-60 cells with an IC<sub>50</sub> of 12 μM, which was more potent than the monoboronate prodrug <b>21</b> (IC<sub>50</sub> = 52 μM). This may be due to increased levels of the toxic <i>p</i>-QM, thus causing more robust suppression of the intracellular antioxidant system.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> Considering that lysosomes contained a higher level of ROS and iron ions responsible for producing highly toxic HO·, Mokhir et al. further designed ROS-responsive prodrug <b>24</b> with a piperidine moiety introduced onto the benzyl group to make it lysosome-specific targeting.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> The piperidine moiety is predicted to be protonated in the acidic environment of lysosomes, facilitating prodrug <b>24</b> to be captured within lysosomes. Prodrug <b>24</b> was more sensitive to relatively higher levels of ROS in lysosomes and released the parent drug more efficiently than in the cytoplasm. It was found that <b>24</b> was 6- to 7-fold more cytotoxic than its counterpart <b>21</b> toward a variety of cancer cells, including BL-2, Jurkat, and DU-145 cancer cells, with IC<sub>50</sub> values ranging between 3.5 and 7.2 μM. Notably, <b>24</b> was shown to be weakly toxic against noncancer human dermal fibroblast adult (HDFa) cells (IC<sub>50</sub> = 30 μM). The murine Nemeth–Kellner lymphoma model revealed that <b>24</b> significantly inhibited tumor growth <i>in vivo</i> at a dose of 40 mg/kg.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a></div><div class="NLM_p">Platinum-based drugs such as carboplatin, cisplatin, and oxaliplatin have been successfully used clinically for the treatment of several cancers, including testicular cancer, ovarian cancer, and colorectal cancer.<a onclick="showRef(event, 'ref95 ref96'); return false;" href="javascript:void(0);" class="ref ref95 ref96">(95,96)</a> However, it is challenging for platinum-based drugs to be selectively uptaken by cancer cells so that sufficient concentration for therapeutic effects can be achieved.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> Clinical use of platinum-based drugs is significantly limited due to the dose-limiting and severe side effects.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> Mokhir et al. reported a novel conjugate (<b>25</b>) of a clinically used platinum-based drug carboplatin with the ROS-responsive aminoferrocene moiety mentioned above which targets cancer cell mitochondria (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>).<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> In the cancer microenvironment with elevated levels of ROS, the ROS-sensitive phenylboronate moiety in <b>25</b> could be cleaved to generate ferrocenium-based delocalized lipophilic cations (DLCs). Given that cancer cells showed a much more negative mitochondrial transmembrane potential than normal cells, the resultant carboplatin linked with DLCs could be taken up selectively by cancer cells.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> It was found that <b>25</b> could deliver a 5.7-fold increased amount of platinum to the mitochondria of A2780 human ovarian cancer cells than the parent drug carboplatin. As a consequence, <b>25</b> manifested a significantly higher anticancer potency (IC<sub>50</sub> = 35 μM) than the parent drug carboplatin (IC<sub>50</sub> > 200 μM) toward A2780 cancer cells with a 24 h incubation. Notably, <b>25</b> was nontoxic toward normal human dermal fibroblasts (NHDF) cells, showing substantially higher anticancer activity and selectivity.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> A similar ROS-responsive prodrug (<b>26</b>) based on cisplatin was reported by the Mokhir group, which contains two ROS-responsive aminoferrocene fragments (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>).<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> Prodrug <b>26</b> was first activated due to high levels of ROS in tumor cells. The two aminoferrocene fragments behave as electronic donors, providing two electrons to rapidly and effectively attack an electronic receptor Pt(IV), thus releasing the parent drug cisplatin. Prodrug <b>26</b> showed potent inhibitory activity toward A2780 cancer cells and cisplatin-resistant A2780cis cancer cells with IC<sub>50</sub> values of 2.5 and 6 μM, respectively, while remaining nontoxic to HDFa normal cells (IC<sub>50</sub> > 25 μM).<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> In 2018, Mokhir et al. further reported a ROS-responsive prodrug (<b>27</b>) based on oxaliplatin with a similar release mechanism to that of <b>26</b>.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> Prodrug <b>27</b> was more potent than <b>26</b> toward both A2780 and A2780cis cancer cells with IC<sub>50</sub> values of 0.4 and 0.7 μM, respectively. Prodrug <b>27</b> showed a 45-fold reduced activity toward normal HDFa cells, suggesting that the ROS-responsive prodrug strategy should result in reducing the side effects of platinum-based chemotherapeutic drugs in cancer therapy.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a></div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. ROS-responsive platinum-based prodrugs (<b>25</b>–<b>27</b>) and the possible mechanism of activation responsive to ROS in cancer cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition to the boronate moiety, selenium (Se), tellurium (Te), and sulfur atoms have been explored as ROS-responsive trigger groups. Carbon monoxide (CO) has been considered as a potential therapeutic agent for cancer therapy,<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> and its controlled release in cancer cells is of great importance. In 2017, Wang et al. reported a novel series of selenium-containing organic CO prodrugs, as represented by <b>28</b> and <b>29</b> (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>),<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> where the phenylselenyl group acts as an effective ROS trigger group. The selenium group is prone to be oxidized by elevated levels of ROS in cancer cells, such as hypochlorite (ClO<sup>–</sup>), singlet oxygen (<sup>1</sup>O<sub>2</sub>), and superoxide (O<sup>2–</sup>). The formed selenoxide analog then undergoes <i>syn</i>-elimination (selenoxide elimination) to form a double bond between the C5 and C6 site, ready for the subsequent cheletropic reaction to rapidly release CO under physiological conditions (as shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). It is worth noting that the phenylselenyl group is finally converted to a nontoxic byproduct, phenylselenenic acid, with an LD<sub>50</sub> value of 1200 μmol/kg in mice.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The selective release of CO by prodrug <b>29</b> in cancer cells resulted in a significant synergistic effect when combined with DOX, an anticancer drug. Treatment with 2 μM DOX alone showed a 20% growth inhibition on HeLa cells, while DOX used in combination with prodrug <b>29</b> (12.5 μM) resulted in a considerably raised inhibitory rate, up to 80%.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Structures of ROS-responsive anticancer prodrugs <b>28</b>–<b>32</b> with Se, Te, or S atoms as the ROS-responsive trigger groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As Te shares similar chemical properties to that of Se, Xu et al. designed a γ radiation-responsive Te-containing side-chain polymer PEG-b-PAA-g-Te (<b>30</b>) for cancer therapy.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> The currently used chemotherapeutic drug cisplatin is coordinated with the polymer, which then self-assembles in an aqueous solution with cisplatin in the hydrophobic core of the nanoparticles. As a consequence, the cytotoxicity of cisplatin is temporarily reduced in structure <b>30</b> due to the coordination effects, which reduces the side effects of the nanomedicine. Low doses of γ radiation cause the Te-containing moiety of the nanoparticles to be oxidized due to the enhanced ROS levels. Such oxidation leads to increased hydrophilicity of the nanoparticles and weakens the coordination between cisplatin and Te, facilitating the release of cisplatin from the nanoparticles and subsequent return of the cisplatin cytotoxicity. Also, Te in the nanoparticles increases the concentration of intracellular ROS to induce apoptosis in MDA-MB-231 cells. The synergistic mechanisms of chemotherapy and radiotherapy reduce both the required radiation and chemotherapy doses for treatment on the premise of ensuring the therapeutic effect.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></div><div class="NLM_p">Sun et al. designed a ROS-triggered prodrug (<b>31</b>), thioether-linked linoleic acid–paclitaxel conjugate (PTX-S-LA), which was used in the design and preparation of self-strengthened bioactivating prodrug-based nanoparticles that consist of PTX-S-LA and β-lapachone (LAP).<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> In cancer cells, oxidation-responsive self-strengthened prodrug-based polymeric micelles (LAP/PTX-S-LA PMs) release LAP, which can elevate the cellular ROS levels. Consequently, LAP-induced ROS combined with endogenous ROS can contribute to the oxidization of the thioether bond, leading to the release of the active cytotoxic agent PTX. When the molar ratio of prodrug <b>31</b> to LAP in PMS is 1:3, the IC<sub>50</sub> of PTX-S-LA PMs treated 4T1 and A549 cancer cells were 126.7 nM and 176.2 nM, respectively. Furthermore, the LAP/PTX-S-LA PMs showed similar cancer cell killing ability compared with paclitaxel (Taxol). In NIH 3T3 normal cells, the IC<sub>50</sub> of PTX-S-LA PMs was similar to that of LAP/PTX-S-LA PMs, implying that LAP/PTX-S-LA PMs are less toxic for normal cells. Additionally, the AUC (area under the curve) of LAP/PTX-S-LA PMs was 11-fold that of PTX, indicating that LAP/PTX-S-LA PMs prolong systemic circulation and enhance tumor accumulation. LCP/PTX-S-LA-PMs exhibited better <i>in vivo</i> anticancer efficacy in 4T1 xenograft mice than PTX.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></div><div class="NLM_p last">Melphalan (MPH), an alkylating anticancer agent, can be used for the treatment of glioblastoma (GBM), the most common and invasive primary brain tumor.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> However, low water solubility (0.1 μg/mL) and poor selectivity toward cancer cells of MPH result in limited clinical use.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> In 2020, Duskey et al. reported a prodrug of MPH, mPEGTK-MPH (<b>32</b>), by introducing a ROS-responsive group thioketal (TK) together with water-soluble polyethylene glycol (PEG) (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>).<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> It was found that <b>32</b> possessed both a hydrophilic portion (PEG) and a hydrophobic component (MPH), which results in self-association in aqueous solutions. Nanosized micelles of <b>32</b> could be selectively uptaken by GBM cells; the sulfur-containing TK linker is sensitive to the high levels of ROS in GBM cancer cells (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), leading to the cancer-cell-selective release of the cytotoxic parent drug MPH.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">3.2.  ROS-Responsive Anti-Inflammatory Prodrugs</h3><div class="NLM_p">Oxidative stress has been considered as one of the specific features in the pathogenesis of inflammation.<a onclick="showRef(event, 'ref105 ref106'); return false;" href="javascript:void(0);" class="ref ref105 ref106">(105,106)</a> Under pathological inflammatory conditions, the extracellular levels of H<sub>2</sub>O<sub>2</sub> in the inflammatory site were found to be over 100 times more than in the healthy tissue, reaching a concentration as high as 1.0 mM.<a onclick="showRef(event, 'ref107 ref108'); return false;" href="javascript:void(0);" class="ref ref107 ref108">(107,108)</a> Thus, high levels of H<sub>2</sub>O<sub>2</sub> could be used as the stimulant for prodrug activation, making it reasonable for modifying anti-inflammatory drugs into ROS-responsive prodrugs. A variety of clinical anti-inflammatory agents have been modified into prodrugs by introducing ROS-responsive groups, such as thiazolidinone or arylboronate, resulting in reduced toxicity to normal cells, enhanced anti-inflammatory efficiency, and improved metabolic stability.<a onclick="showRef(event, 'ref109 ref110 ref111 ref112 ref113 ref114 ref115 ref116 ref117 ref118 ref119 ref120 ref121 ref122'); return false;" href="javascript:void(0);" class="ref ref109 ref110 ref111 ref112 ref113 ref114 ref115 ref116 ref117 ref118 ref119 ref120 ref121 ref122">(109−122)</a></div><div class="NLM_p">Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease that can cause severe joint injury and other extra-articular changes.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Low-dose methotrexate (LD-MTX, <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>) is the standard treatment for RA;<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> however, its clinical application is limited due to serious adverse effects, low efficacy, and pharmacokinetic inadequacies. Thus, more effective and safer therapies for RA are needed.<a onclick="showRef(event, 'ref112 ref113'); return false;" href="javascript:void(0);" class="ref ref112 ref113">(112,113)</a> The carboxyl functional group of MTX (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>) is a common prodrug modification target. Carboxylic acids can be esterified to improve pharmacokinetic profiles, but this strategy is not disease-targeting.<a onclick="showRef(event, 'ref114 ref115'); return false;" href="javascript:void(0);" class="ref ref114 ref115">(114,115)</a> Clausen et al. suggested a thiazolidinone-based H<sub>2</sub>O<sub>2</sub>-responsive MTX prodrug <b>33</b> (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>) for the selective delivery of MTX to inflammatory tissues, assuming that inflammation is related to elevated levels of ROS, such as H<sub>2</sub>O<sub>2</sub>.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Prodrug <b>33</b> was metabolically stable and water-soluble and could be activated by pathophysiological levels of ROS, reverting to MTX by converting the thiazolidinone moiety back to the carboxyl group.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> In the collagen-induced arthritis (CIA) mouse model, <b>33</b> manifested promising potency comparable to MTX and exhibited improved safety profiles. The mice treated with <b>33</b> experienced a more stable body weight as compared to the MTX-treated group.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Additionally, the Clausen group reported two more phenylboronate ROS-responsive prodrugs (<b>34</b> and <b>35</b>) (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>) based on the MTX structure.<a onclick="showRef(event, 'ref109 ref116'); return false;" href="javascript:void(0);" class="ref ref109 ref116">(109,116)</a> Both of these prodrugs showed acceptable chemical and metabolic stability in various physiological conditions of blood (pH = 7.4), under simulated gastric fluid (SGF) acidic conditions, under simulated intestinal fluid (SIF) basic conditions, and in liver microsomes.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> Treated with equimolar doses of prodrug <b>34</b> (9.7 mg/kg) and <b>35</b> (8.8 mg/kg) once daily for 2 weeks in the CIA DBA/1J mice model, the incidence of arthritis was reduced, with a similar response to those treated with MTX (7.0 mg/kg). Notably, no obvious side effects were observed for the groups treated with <b>34</b> and <b>35</b>, while the MTX-treated group showed a significant body-weight loss.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> These results suggested that the ROS-responsive prodrug strategy, as exemplified by prodrugs <b>34</b> and <b>35</b>, is useful for modifying anti-inflammatory agents to their corresponding prodrugs with sustained efficacy in controlling the development of arthritis disease and improved safety profiles. Interestingly, prodrugs <b>34</b> and <b>35</b> with phenylboronates as the ROS-trigger groups were found to be more effective in RA therapy than prodrug <b>33</b> using a thiazolidinone as the ROS-trigger moiety.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a></div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Structures of MTX and its prodrugs <b>33</b>–<b>35</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the inflammatory response induced by ischemia, matrix metalloproteinases (MMPs), a family of Zn(II) dependent hydrolytic enzymes, can be activated by ROS, resulting in the disruption of the blood–brain barrier (BBB), leading to cell death. Therefore, MMP inhibitors (MMPi) are considered to have therapeutic potential for treating neurological disorders, including stroke or neuroinflammation by ameliorating BBB dysfunction.<a onclick="showRef(event, 'ref117 ref118'); return false;" href="javascript:void(0);" class="ref ref117 ref118">(117,118)</a> However, poor selectivity and dose-limiting side effects significantly hindered the clinical application of MMPi.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> Cohen et al. reported the first ROS-responsive prodrug approach for MMPi, utilizing targets such as 1,2-HOPO-2 and PY-2 (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>), by masking the key hydroxy group responsible for the zinc-binding with a phenylboronate moiety, generating the corresponding prodrugs, <b>36</b> and <b>37</b> (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>).<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> Prodrugs <b>36</b> and <b>37</b> manifested poor inhibition against MMP-9 with IC<sub>50</sub> values of >1 mM, representing a >100-fold increase compared with the parent active counterparts. Following exposure to a high concentration of H<sub>2</sub>O<sub>2</sub> (100 μM), the MMP-9 inhibition by prodrug <b>36</b> and <b>37</b> recovered to a level similar to the parent active inhibitor 1,2-HOPO-2 and PY-2. Interestingly, these prodrugs were thought to have a dual-action mechanism to prevent reperfusion injury by cleaving elevated ROS and generating a potent MMPi, inferring a potential to reduce the side effects of the BBB disruption caused by stroke.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a></div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Structures of anti-inflammatory prodrugs <b>36</b>–<b>40</b> and their corresponding parent agents.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) regulates cellular oxidative stress by enhancing the antioxidant system.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> The Kelch-like ECH-associated protein 1 (Keap1) is a negative regulator of Nrf2; thus, inhibitors of the Keak1-Nrf2 protein–protein interaction (PPI) could be developed as anti-inflammatory agents.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> In 2020, Jiang et al. reported a new Keap1-Nrf2 inhibitor (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>) with an IC<sub>50</sub> of 96.7 nM. Subsequently, the carboxyl pharmacophoric moiety was masked using a ROS-responsive thiazolidinone group to generate the first ROS-responsive prodrug (<b>36</b>) (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>) for Keap1-Nrf2 inhibition. Prodrug <b>37</b> remained inactive and was chemically and metabolically stable in various physiological conditions. When exposed to H<sub>2</sub>O<sub>2</sub> or inflammatory cells, it efficiently converted into the carboxyl parent agent to activate the Nrf2 pathway. Additionally, prodrug <b>36</b> was more permeable to cross cell membranes (Pe = 6.35 × 10<sup>–6</sup> cm/s) compared to the parent compound (Pe = 0.80 × 10<sup>–6</sup> cm/s) and showed a significantly increased activity of Nrf induction with an EC<sub>50</sub> of 0.32 μM in lipopolysaccharide (LPS)-treated HepG2-ARE-C8 cells when compared to the parent compound (EC<sub>50</sub> = 13.14 μM).<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> Importantly, prodrug <b>36</b> showed preferable pharmacokinetic properties for oral administration with a bioavailability of 68.1%. LPS-induced inflammatory C57BL/6 mice model showed <b>36</b> to have significant anti-inflammatory effects comparable to dexamethasone orally dosed at 10 mg/kg, which was much more potent than its parent compound even at a higher dose (40 mg/kg).<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a></div><div class="NLM_p last">Ischemia–reperfusion (I/R) injury has been observed in various clinical conditions, such as acute coronary syndrome, hepatic and renal ischemic insults, cardiopulmonary bypass surgery, and vascular thromboembolic events.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> ROS accumulation and oxidative damage have both been associated with I/R injury.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> Therefore, H<sub>2</sub>O<sub>2</sub> presents a strategic target for therapy directed at the site of I/R injury. Following the induction of intracellular oxidative stress by ROS, a large number of unfolded proteins accumulate in the endoplasmic reticulum (ER) and induce an unfolded protein response (UPR). ATF6 is a key stress protein in UPR, and activation of ATF6 helps to regulate ER stress responses and maintain the activity of antioxidant enzymes by scavenging ROS.<a onclick="showRef(event, 'ref123 ref124'); return false;" href="javascript:void(0);" class="ref ref123 ref124">(123,124)</a> Cooley et al. designed and synthesized an ATF6 activator prodrug (<b>39</b>).<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> In a simulated I/R injury model, the mediator level of lactate dehydrogenase (LDH) (a marker of cell necrosis) in the <b>39</b>-treated group was approximately half of the control group, and prodrug <b>39</b> significantly improved the survival rate of myocardial tissue.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Kang et al. developed the H<sub>2</sub>O<sub>2</sub>-activatable I/R targeted prodrug (<b>40</b>).<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> On one hand, prodrug <b>40</b> uses the protective group, self-immolative boronic ester, to scavenge cellular H<sub>2</sub>O<sub>2</sub>. On the other hand, upon reaction with H<sub>2</sub>O<sub>2</sub>, it releases HBA (<i>p</i>-hydroxybenzyl alcohol) which inhibits the expression of the proinflammatory cytokine TNF-α (tumor necrosis factor α) and exerts potent antioxidant and anti-inflammatory activities. Prodrug <b>40</b> showed a significant protective effect on hepatic and cardiac I/R injury at a dose of less than 5 mg/kg, while a dosage of at least 25 mg/kg was required for HBA to exert sufficient therapeutic effects. No obvious abnormalities in renal or hepatic function were observed in mice after administering prodrug <b>40</b> (1.5 (mg/kg)/day) daily for 7 continuous days. These results infer that prodrug <b>40</b> has significant therapeutic benefits in the treatment of I/R injury due to its low effective dose and high therapeutic activity.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">4.  ROS-Responsive Probes</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21246" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21246" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Small-molecule probe-based fluorescence imaging technology has become an indispensable method in the field of biology and medicine. To achieve ROS-specific imaging, probes based on arylboronates have attracted researchers’ interest due to their high specificity for the main ROS in cells, H<sub>2</sub>O<sub>2</sub>, under physiological conditions.<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34,35)</a> In 2004, Chang et al. first reported a new class of boronate-based fluorescent probes, represented by peroxyfluor-1 (<b>41</b>) (<a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>), for intracellular imaging of H<sub>2</sub>O<sub>2</sub> in living biological samples.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> Compound <b>41</b> represents a 10- to 100-fold increase in H<sub>2</sub>O<sub>2</sub> selectivity compared to previously reported probes. Subsequently, peroxyresorufin-1 (<b>42</b>) and peroxyxanthone-1 (<b>43</b>) were developed and they both also showed excellent selectivity for intracellular H<sub>2</sub>O<sub>2</sub>.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> Using this strategy, the Chang group further developed peroxy green 1 (PO1) (<b>44</b>) and peroxy crimson 1 (PC1) (<b>45</b>) for visualizing endogenous H<sub>2</sub>O<sub>2</sub> in living cells after growth factor stimulation, including the first direct imaging of H<sub>2</sub>O<sub>2</sub> involvement in brain cell signaling. These probes facilitate a novel mechanism for exploring the rapidly expanding role of H<sub>2</sub>O<sub>2</sub> in cellular signal transduction.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> Boronate deprotection has become a general, chemoselective strategy for developing fluorescent probes with unprecedented selectivity for H<sub>2</sub>O<sub>2</sub> relative to cellular ROS.</div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Structures of the H<sub>2</sub>O<sub>2</sub>-targeting fluorescent ROS probes <b>41</b>–<b>45</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To date, various ROS-responsive fluorescent probes have been developed specifically for targeting different subcellular organelles, such as mitochondria, lysosomes, and nuclei, as well as for pathological tissues. The ROS-responsive fluorescence probes allow visualization of the localized production and accumulation of intracellular H<sub>2</sub>O<sub>2</sub> in cells or animals, which is potentially useful for the clinical diagnosis of ROS-related diseases, including cancer, inflammation, and neurodegenerative diseases such as AD and PD.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11−13)</a></div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">4.1.  Subcellular Organelle-Targetable ROS Probes</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10">4.1.1.  Mitochondrial-Targeting ROS Probes</h4><div class="NLM_p">The mitochondrion, as the main site for cell respiration, is the primary source of ROS. H<sub>2</sub>O<sub>2</sub>, as the main ROS in the mitochondrion, is critical for cell survival, growth, and differentiation. Changes in cell levels of H<sub>2</sub>O<sub>2</sub> are closely related to the development of various diseases, including cancer.<a onclick="showRef(event, 'ref129 ref130'); return false;" href="javascript:void(0);" class="ref ref129 ref130">(129,130)</a> A variety of probes were designed and synthesized to monitor changes of endogenous H<sub>2</sub>O<sub>2</sub> in mitochondria. The negatively charged mitochondrial membrane (−180 mV)<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> has been used for developing mitochondrial-targeting probes by introducing positively charged groups, such as triphenylphosphonium salt (TPP). In 2008, Chang et al. designed and synthesized a mitochondrial-targeting fluorescence probe (<b>46)</b> (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>) for imaging H<sub>2</sub>O<sub>2</sub>. Prodrug <b>46</b> consisted of a dihydrorhodamine (DHR) moiety as the fluorescent reporter, an arylboronate moiety as the ROS-responsive group, and a positive-charged TPP moiety as the mitochondrial-targeting group.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> Upon exposure to high levels of H<sub>2</sub>O<sub>2</sub>, probe <b>46</b> could stimulate considerably enhanced fluorescence emission (λ<sub>em</sub> = 528 nm), enabling the visualization of endogenous H<sub>2</sub>O<sub>2</sub> formation in the mitochondria of living cells. Notably, <b>46</b> was capable of detecting changes in the H<sub>2</sub>O<sub>2</sub> elevations in a PD model with oxidative stress.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> In 2012, Kim et al. developed a two-photon fluorescence probe <b>47</b> (<a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>), with a TPP moiety as the mitochondrial-targeting group, a phenylboronate as the ROS-responsive group, and an aminonaphthenyl benzothiazole fragment as the reporter.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> Probe <b>47</b> showed a remarkable emission color change from blue to yellow in response to H<sub>2</sub>O<sub>2</sub>, excellent selectivity to mitochondrial H<sub>2</sub>O<sub>2</sub>, good safety profiles, and good stability in a range of physiological conditions. One-photon fluorescence probes generally have limitations in deep tissue imaging due to their relatively shallow penetration depth (<80 μm).<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> Notably, probe <b>47</b> as a two-photon fluorescence probe was more suitable for quantitative imaging of H<sub>2</sub>O<sub>2</sub> in living tissues at an increased penetration depth of 100–180 μm.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a></div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Structures of the mitochondrial-targeting fluorescent ROS probes <b>46</b>–<b>53</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2016, Peng et al. reported a mitochondrial-targeting near-infrared (NIR) fluorescence probe (<b>48</b>) (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>) for imaging H<sub>2</sub>O<sub>2</sub> in living animals.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> It employed a positive quaternary amine for mitochondria targeting and an arylboronate moiety for H<sub>2</sub>O<sub>2</sub> sensing. Importantly, probe <b>48</b> was successfully applied for the first time for in vivo imaging H<sub>2</sub>O<sub>2</sub> related to an autophagy process.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> Similarly, in 2017, Tang et al. reported another mitochondrial-targeting NIR fluorescent probe (<b>49</b>) (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>) for H<sub>2</sub>O<sub>2</sub>, where a positive methylpyridine was used as the mitochondrial-targeting group and a classic phenylboronate as the ROS-sensitive group.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> Prodrug <b>49</b> showed a weak emission band at 539 nm; upon exposure to H<sub>2</sub>O<sub>2</sub>, a new emission band turned up at 669 nm along with the disappearance of the 539 nm band, resulting in the efficient detection and imaging of H<sub>2</sub>O<sub>2</sub> in living A549 cells.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> In 2018, Zhang et al. studied a new mitochondrial-targeting ratiometric fluorescent probe (<b>50</b>) (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>) for imaging H<sub>2</sub>O<sub>2</sub> in living cells,<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> in which a coumarin scaffold was used as the fluorescent reporter, a positive alkylated pyridine for mitochondrial-targeting, and phenylboronate as the H<sub>2</sub>O<sub>2</sub> responsive group. The strong electron-withdrawing effect of the pyridine cation led to a remarkable intermolecular charge transfer (ICT) process. As a consequence, probe <b>50</b> itself showed an intense red fluorescence emission at 640 nm. Upon exposure to H<sub>2</sub>O<sub>2</sub>, the phenylboronate moiety was cleaved through a 1,6-elimination reaction to weaken the electron-withdrawing effect, resulting in a remarkable blue-shift emission of probe <b>50</b> from 640 to 535 nm. Probe <b>50</b> can be used for quantitative and selective detection of cellular H<sub>2</sub>O<sub>2</sub>.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> In 2018, Song et al. reported a mitochondrial-targeting fluorescent probe (<b>51</b>) (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>) for imaging H<sub>2</sub>O<sub>2</sub> in living cells, with a similar mechanism based on the ICT process in prodrug <b>50</b>, using a different fluorescent reporter.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a></div><div class="NLM_p">Recently, in 2019, Zhao et al. reported a mitochondrial-targeting fluorescent probe (<b>52</b>) (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>) for detecting H<sub>2</sub>O<sub>2</sub> in living cancer cells with low background fluorescence, utilizing a double-quenching strategy.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>, the 4-dimethylaminoazobenzene-4′-carboxylic acid (DABCYL) moiety in <b>52</b> acts as a fluorescence quencher, resulting in a significant decrease in the background fluorescence intensity for <b>52</b>. Upon exposure to H<sub>2</sub>O<sub>2</sub>, the conversion of the ROS-responsive phenylboronate group to a hydroxy group rapidly triggers a 1,6-elimination reaction of the self-cleavable linker to release the DABCYL quencher moiety, leading to a rapid and efficient release of the rhodamine fluorophore to give a strong fluorescence (<a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>). This so-called double-quenching strategy resulted in a fluorescence enhancement of over 50-fold. As a consequence, probe <b>52</b> was capable of sensitively determining the concentration of H<sub>2</sub>O<sub>2</sub> in mitochondria of living cells with a detection limit of 0.025 μM.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a></div><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Mechanism of the ROS-responsive and mitochondrial-targeting probe <b>52</b> by a double-quenching strategy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In 2020, Zhang et al. synthesized a mitochondrial-targeted fluorescent probe (<b>53</b>) (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>) for the detection of ONOO<sup>–</sup>.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> Probe <b>53</b> exhibits rapid response (<1 min), high selectivity, and also high sensitivity (detection limit = 16 nM). The fluorescence intensity at 569 nm is linearly related to ONOO<sup>–</sup> levels (0–10 μM). Probe <b>53</b> has been successfully used to monitor the fluctuation of endogenous ONOO<sup>–</sup> concentrations and to observe H<sub>2</sub>S-induced ONOO<sup>–</sup> scavenging in HeLa cells.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a></div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11">4.1.2.  Lysosomes-Targeting ROS Probes</h4><div class="NLM_p">Lysosomes are acidic (pH 4.5–5.0), single membrane coated, sac-like organelles responsible for the recycling and degradation of cell components.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> Lysosomal disruption caused by elevated ROS levels can result in a significant amount of peroxidized proteins and lipids to be accumulated in lysosomes and has been considered to be closely related to a number of diseases, including cancer and aging-associated neurodegenerative disorders.<a onclick="showRef(event, 'ref140 ref141'); return false;" href="javascript:void(0);" class="ref ref140 ref141">(140,141)</a> Thus, it is of great importance to develop assays for monitoring and detecting the levels of ROS in lysosomes.</div><div class="NLM_p">Given that lysosomes are much more acidic compared to other subcellular organelles, an alkaline moiety, such as morpholine, has commonly been used as a lysosome-locating group to enable the accumulation of probes or drugs within lysosomes.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> Yoon et al. reported a lysosome-targeting fluorescent probe (<b>54</b>) (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>) for visualizing H<sub>2</sub>O<sub>2</sub> in cells, which incorporated naphthalimide as the fluorescent reporter, a morpholine moiety for lysosome targeting, and a ROS-responsive and cleavable phenylboronate group (<a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>). Probe <b>54</b> manifested a high selectivity and sensitivity toward H<sub>2</sub>O<sub>2</sub> compared with other ROS and displayed good water solubility, enabling its use in living cells.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> Probe <b>54</b> itself showed very weak red emission in HeLa cells; however, once the HeLa cells were incubated with H<sub>2</sub>O<sub>2</sub> (100 mM), an increase of red emission (λ<sub>em</sub>= 528 nm) was observed.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> Similarly, employing morpholine as the lysosome-locating moiety, Zhao et al. developed a lysosome-targeting and pH-sensitive fluorescence probe (<b>55</b>) for effectively visualizing endogenous H<sub>2</sub>O<sub>2</sub> in lysosomes, without external stimulations, in HeLa cells, while negligible signal interference was observed from the cytoplasm and other subcellular organelles.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a></div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Structures of the lysosome-targeting fluorescent ROS probes <b>54</b>–<b>56</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0019.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Mechanism of the lysosome-targeting H<sub>2</sub>O<sub>2</sub> probe <b>54</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2016, Zhao et al. developed a pH-switchable and ROS-responsive probe (<b>56</b>) (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>) for imaging intracellular H<sub>2</sub>O<sub>2</sub> in acidic lysosomes in living cells.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> Probe <b>56</b> itself only exhibited a weak fluorescence signal in the presence of the attached boronate quenching group. Upon exposure to H<sub>2</sub>O<sub>2</sub>, the boronate group was removed rapidly by H<sub>2</sub>O<sub>2</sub>-mediated oxidation, triggering the considerable enhancement of fluorescence signals. At low pH, the protonated form manifested remarkably stronger fluorescence emission; however, the corresponding deprotonated form showed weak fluorescence response, thus proving a high selectivity of the probe toward acidic lysosomes in cells (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>).<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a></div><figure id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0020.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Mechanism of fluorescence response of <b>56</b> to H<sub>2</sub>O<sub>2</sub> at different pH conditions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12">4.1.3.  Nucleus-Targeting ROS Probes</h4><div class="NLM_p">The nucleus contains the majority of the genetic material of the cell, such as DNA, where the ROS levels have a significant influence on nuclear functions and gene transcription. Elevated ROS concentrations in the nucleus have been revealed to be related to various diseases, including cancer. Modifications of DNA oxidized by excessive ROS have been proved to exist in cancer tissues.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> Thus, it is of great importance to develop probes for ROS imaging and detection specifically in the nucleus, thus helping us to more deeply understand the relationships between different levels of ROS in the nucleus and related diseases. However, relatively few numbers of the nucleus-targeting fluorescent probes have been reported to date.</div><div class="NLM_p">Reported strategies for designing nucleus-targeting ROS probes rely on attaching a DAN-binding or a nucleus-locating moiety onto a ROS-responsive fluorescent probe. Zhang et al. first developed the ROS-responsive fluorescent probe <b>57</b> (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>) with a so-called SNAP-Tag, which was capable of modifying biomolecules via a nucleophilic substitution mediated by a Cys residue.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> Histone H2B, a small protein containing 126 amino acids, is full of positively charged amino acid side chains at a physiological pH, allowing it to selectively and strongly interact in the nucleus with DNA, which has many negatively charged phosphate groups.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> In light of this, Zhang et al. further applied the SNAP-Tag to covalently link with the histone H2B protein, generating an H2B-labeled ROS-responsive fluorescent probe <b>58</b> (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>) for nuclear localization.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> Additionally, Yi et al. reported a nucleus-targeting fluorescent probe (<b>59</b>) (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>) for the highly sensitive detection of nuclear H<sub>2</sub>O<sub>2</sub>.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> Probe <b>59</b> consisted of an arylboronate fluorescent moiety for ROS-targeting and fluorescent lighting and a peptide with a sequence VQRKRQKLMP-NH<sub>2</sub>, derived from the transcript factor NF-κB, for guiding nuclear localization of the probe.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> Once localized in the nucleus and exposed to ROS, probe <b>59</b> could be selectively activated with the maximum emission wavelength of 551 nm, enabling the nucleus-targeting detection of ROS in living cells.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a></div><figure id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0021.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Structures of the nucleus-targeting fluorescent ROS probes <b>58</b> and <b>59</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13">4.2.  Cancer-Cell-Targetable Fluorescent Probes</h3><div class="NLM_p">In 2010, Chang et al. reported a viable bioluminescent probe <b>60</b> (<a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>) for detecting fluctuations in H<sub>2</sub>O<sub>2</sub> levels produced in living animals and the endogenous H<sub>2</sub>O<sub>2</sub> levels in prostate tumor models.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> On the basis of the expectations of increased H<sub>2</sub>O<sub>2</sub> levels in cancer cells, probe <b>60</b> is activated by selectively cleavage of the H<sub>2</sub>O<sub>2</sub>-sensitive boronic acid group to generate firefly luciferin. Firefly luciferin then reacts with firefly luciferase enzyme to produce a bioluminescent readout and a 612 nm emission, which enables deep tissue signal penetration with an optical readout.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> In 2017, Liang et al. developed a bioluminescence turn-on probe <b>61</b> by modification of the luciferin moiety for the highly selective detection of ClO<sup>–</sup><i>in vitro</i> and imaging of ClO<sup>–</sup> in tumors of living mice.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> ClO<sup>–</sup> can oxidize benzoyl hydrazine to generate water-unstable dibenzoyl diimide, followed by hydrolyzation to generate luciferin which fluoresces following the catalysis with the luciferase enzyme. <i>In vitro</i> experiments showed that <b>61</b> could be used in a highly selective detection method of ClO<sup>–</sup> levels within the range of 0–62.5 μM, with a lower limit of detection of 0.705 μM.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a></div><figure id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0022.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Structures of cancer-cell-targetable fluorescent probes <b>60</b>–<b>62</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To achieve cancer-selective imaging for ROS, in 2019, Shin et al. reported a NIR fluorescence probe (<b>62</b>) based on a triple targeting strategy (<a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>).<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> This strategy employed three typical features that are highly elevated in cancer cells as targets for improving the cancer specificity, namely, somatostatin receptors (SSTRs), lysosomal protease cathepsin B, and ROS. Structurally, the designed triple-targeting probe <b>62</b> consists of (a) octreotide that binds to SSTRs, (b) a phenylboronic acid that is responsive to H<sub>2</sub>O<sub>2</sub>, (c) a dipeptide fragment that is a substrate for cathepsin B, and (d) a NIR fluorescence reporter for imaging.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> Probe <b>62</b> itself was considered to be considerably weakly fluorescent as the NIR reporter was masked by an ether linker. Upon approaching the cancer cells, <b>62</b> would first be sensed by the SSTRs (first target) on the cellular membrane and be transported into the cancer cells via receptor-associated endocytosis. Second, the phenylboronate group attached to the lysine moiety with a carbamate linker would be self-immolatively cleaved through a 1,6-elimination upon exposure to high levels of H<sub>2</sub>O<sub>2</sub> (second target) in cancer cells. Finally, the resultant uncaged dipeptide moiety in the probe is removed due to catalysis by cathepsin B which is overexpressed in cancer cells (third target), leading to the release of the strong fluorescent NIR reporter for imaging. Probe <b>62</b> was reported as being successful for selective imaging of cancer cells, including HeLa and A549 cells, without any interference from normal cells.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14">4.3.  ROS-Responsive Probes for the Detection of Inflammatory Cells</h3><div class="NLM_p">Liu et al. reported a ROS-responsive fluorescent probe (<b>63</b>) using 9<i>H</i>-1,3-dichloro-7-hydroxy-9,9-dimethylacridine-2-one (DDAO) as the fluorescent reporter (<a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>).<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> Probe <b>63</b> exhibited dual modes of NIR fluorescence turn-on and ratiometric detection upon exposure to H<sub>2</sub>O<sub>2</sub>, making it useful for imaging of endogenous H<sub>2</sub>O<sub>2</sub> generated in the inflammatory regions of mice induced by LPS.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> Probe <b>63</b> showed an orange fluorescence emission (λ<sub>em</sub> = 620 nm), which upon exposure to H<sub>2</sub>O<sub>2</sub> shifted to a dark color (fluorescence emission peak at λ<sub>em</sub> = 660 nm), resulting in the fluorescent color change of orange to red (<a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>). Thus probe <b>63</b> could be used to quantitatively detect tissue concentrations of H<sub>2</sub>O<sub>2</sub> utilizing the ratio of <i>F</i><sub>660</sub>/<i>F</i><sub>620</sub>. Over the range of 1 mM and 100 mM, the fluorescence intensity has an excellent linear correlation (<i>R</i><sup>2</sup> = 0.998) with the concentration of H<sub>2</sub>O<sub>2</sub>.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> These results suggested that probe <b>63</b> has great potential for efficient and selective determination of the levels of ROS related to inflammation both <i>in vitro</i> and <i>in vivo</i>.</div><figure id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0023.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Mechanism of probe <b>63</b> responsiveness to H<sub>2</sub>O<sub>2</sub> in an animal model of acute inflammation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15">4.4.  ROS-Responsive Probes for the Detection of Neurodegenerative Diseases</h3><div class="NLM_p">As mentioned previously, neurodegenerative diseases, including AD and PD, have been shown to be related to oxidative stress caused by high levels of ROS. Thus, it is of significant importance to monitor the variation of H<sub>2</sub>O<sub>2</sub> levels in the brains of patients with neurodegenerative diseases for both disease diagnosis and drug development. Substantial evidence suggested that the amyloid-β protein (Aβ) in brain regions responsible for cognition and memory could be regarded as a biological mark of the earliest symptoms of AD.<a onclick="showRef(event, 'ref153 ref154'); return false;" href="javascript:void(0);" class="ref ref153 ref154">(153,154)</a> In 2006, Ran et al. designed a ROS-responsive probe <b>64</b> (<a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>), CRANAD-88, that can pass through the BBB, producing a three-level cascade that amplifies near-infrared fluorescence (NIRF) signals upon exposure to elevated H<sub>2</sub>O<sub>2</sub> levels in AD brains.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> Curcumin analogs (Aβ binding moiety) and boronates (H<sub>2</sub>O<sub>2</sub> responsive moiety) were linked by a carbamate group, where the electron-withdrawing effect of carbamate significantly shortened the excitation/emission wavelength of <b>64</b> (Ex = 580 nm, Em = 690 nm), making it invisible for the near-infrared imaging. Upon exposure to high levels of H<sub>2</sub>O<sub>2</sub> in AD brain cells (first fluorescence amplification), the phenylboronate moiety and carbamate linker could be self-immolatively eliminated, leading to a significant shift in the excitation/emission spectrum (Ex = 630 nm, Em = 730 nm) with a 3-fold enhancement of the fluorescence intensity.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> Subsequently, the resultant part of the probe could bind to Aβs (second fluorescence amplification), causing a further 4-fold enhancement of the fluorescence intensity and a red-shift to produce a “visible” NIRF signal (third amplification). Probe <b>64</b> was used during NIRF imaging on a transgenic AD mice model and revealed evidence for elevated levels of H<sub>2</sub>O<sub>2</sub> in the AD mouse brains compared to the normal age-matched wild type mice.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> These results suggested that the ROS-responsive probe <b>64</b> can be employed to monitor the H<sub>2</sub>O<sub>2</sub> changes in brains of AD mice and provide a critical biological tool for the development of AD drugs.</div><figure id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0024.jpeg" id="gr24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Structure of the AD-targetable fluorescent probe <b>64</b> (CRANAD-88).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Additionally, in 2019, Huang et al. reported a deep-red H<sub>2</sub>O<sub>2</sub> fluorescent probe <b>65</b> for detecting H<sub>2</sub>O<sub>2</sub> levels in the brains of the PD Drosophila model (<a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">25</a></a>).<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> Probe <b>65</b> was composed of a pyrimidine-based fluorescent reporter and a ROS-responsive phenylboronate with an ether linker. Upon exposure to ROS, especially H<sub>2</sub>O<sub>2</sub>, the deep-red fluorescence emission could be newly formed at 640 nm mediated by an ICT effect. The confocal laser scanning fluorescence imaging revealed that when treated with probe <b>65</b>, the PD Drosophila brain showed significantly higher fluorescence intensity than the wild-type Drosophila brain, indicating that probe <b>65</b> has great potential in the study of the relationship between H<sub>2</sub>O<sub>2</sub> overexpression and PD development.<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a></div><figure id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0025.jpeg" id="gr25" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Structure of the PD-targetable fluorescent probe <b>65</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">5.  ROS-Responsive Theranostic Prodrugs</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51267" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51267" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Theranostic drugs, as the name suggests, is a combination of both “therapy” and “diagnosis” functionalities within a single compound. Theranostic prodrugs are an emerging and exciting prodrug strategy, capable of diagnosing early stage diseases while simultaneously delivering therapeutic drugs to the lesion site, monitoring the drug release kinetics, and visualizing the disease development stage. This one-step approach can then lead to accurate, effective, and rapid therapies for patients.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> Currently, the theranostic prodrug strategy is mainly applied in the field of cancer detection and treatment so far, so studies have relied on the overexpression of specific enzymes, elevated ROS, and redox imbalance in cancers to trigger the activation of diagnostic and deliver therapeutic drugs.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a></div><div class="NLM_p">In 2014, Kim et al. reported a ROS-responsive and mitochondrial-targeting anticancer theranostic prodrug <b>66</b> (<a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">26</a></a>) capable of effective cancer treatment and precise diagnosis <i>in vivo</i>.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> Structurally, theranostic prodrug <b>66</b> is composed of four functional groups, as illustrated in <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">25</a></a>. The first is a cancer-targeting moiety, biotin, which guides <b>66</b> to cancer tissues. The second is a mitochondrial-targeting fluorescent reporter, ethidium, which shows a weak fluorescent signal in physiological aqueous environments; however, upon interaction with double-stranded DNA or RNA, it becomes strongly fluorescent. The third is an inactive drug, 5′-deoxy-5-fluorouridine (5′-DFUR), which is converted into the active form, 5-fluorouracil (5-FU), upon the hydrolysis catalyzed by highly expressed thymidine phosphorylase in cancer cells. The fourth is a ROS-responsive phenylboronate moiety connected to a self-immolative linker. Upon exposure to elevated ROS in cancer tissues, the phenylboronate moiety is oxidized and hydrolyzed to release the parent antitumor drug 5′-DFUR, followed by cleavage of the self-immolative linker to release the activated fluorescent reporter with a strong signal at 590 nm. <i>In vitro</i> cell-based assays revealed that <b>66</b> showed a significantly enhanced anticancer effect and a high selectivity toward cancer cells with overexpressed biotin receptors and elevated ROS levels, while no obvious cytotoxicity was observed toward normal cells. <i>In vivo</i> assays in a xenograft mouse model inoculated with human A549 lung cancer cells revealed that theranostic prodrug <b>66</b> could be selectively distributed in the tumor tissue, showing a fluorescence intensity approximately 7-fold higher than that of other normal tissues, including the lung, liver, heart, kidney, and spleen. Notably, <b>66</b> showed a significant inhibitory effect on tumor growth after an 8-weeks treatment <i>in vivo</i>.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a></div><figure id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0026.jpeg" id="gr26" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Structure of the ROS-responsive theranostic prodrug <b>66</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Additionally, in 2014, Kim et al. reported a second ROS-responsive theranostic prodrug <b>67</b> for the selective treatment of metastatic cancers.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> Prodrug <b>67</b> consists of three parts, a boronate moiety as a ROS trigger group, an effective anticancer drug, SN-38, which as a derivative of CPT, and a coumarin moiety that acts as both a self-cleavable linker and a fluorescent reporter for monitoring the release of SN-38 (<a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">27</a></a> and <a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">28</a></a>).<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> Prodrug <b>67</b> can be activated by elevated H<sub>2</sub>O<sub>2</sub> levels in cancer cells, resulting in the rapid release of the parent anticancer drug SN-38. The drug release process can be detected and monitored through the simultaneous release of the fluorophore with a strong fluorescence intensity at λ<sub>max</sub> = 456 nm (<a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">28</a></a>).<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> Prodrug <b>67</b> showed considerable cytotoxicity toward cancer cells, such as B16F10 and HeLa cells in the presence of H<sub>2</sub>O<sub>2</sub>, a condition mimetic for the tumor microenvironment with high levels of ROS, while it remained nontoxic toward cells under normal conditions. The metastatic lung tumor model induced by injection of B16F10 cancer cells revealed that theranostic prodrug <b>67</b>, administrated at a low dose of 0.25 mg/kg, could be selectively distributed in metastasized lung tumor tissues, where it released the parent drug SN-38, showing an efficient and selective therapeutic activity <i>in vivo</i>.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a></div><figure id="fig27" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0027.jpeg" id="gr27" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. Structures of the ROS-responsive theranostic prodrugs <b>67</b>–<b>69</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig28" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0028.jpeg" id="gr28" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. Activation mechanism of the theranostic prodrug <b>67</b> to release the parent drug SN-38 and fluorophore in cancer cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2017, Toshima et al. reported a novel H<sub>2</sub>O<sub>2</sub>-responsive and photoactivatable theranostic prodrug <b>68</b> (<a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">27</a></a>), targeting live cancer cells with elevated H<sub>2</sub>O<sub>2</sub> levels.<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> Prodrug <b>68</b> consists of three different functional structures. The first is a pro-fluorophore moiety composed of the protected resorufin with low cytotoxicity and preferable water solubility. The second is a photoactivatable moiety (photosensitizer), anthracene (AC), which can degrade biological macromolecules such as DNA, protein, and oligosaccharides by generating ROS under UV light irradiation. The third is a ROS-responsive arylboronate moiety. Upon exposure to elevated ROS in cancer cells, the boronate moiety underwent an oxidation reaction with H<sub>2</sub>O<sub>2</sub>, followed by hydrolysis to give a phenol, then undergoes a 1,6-elimination-based linker cleavage that results in the release of the photosensitizer moiety and the resorufin-based fluorescent reporter. This sequence of activation steps resulted in a 9-fold enhancement in the emission of red fluorescence at 590 nm (λ<sub>ex</sub> = 530 nm).<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> Further cell-based assays showed that <b>68</b> not only produced fluorescence selectively in cancer cells, including HeLa cells, B16F10 cells, and A431 cells, with high levels of H<sub>2</sub>O<sub>2</sub> but also induced cytotoxicity within the tested cancer cells under light irradiation.<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a></div><div class="NLM_p">In 2017, Chakrapani et al. developed an H<sub>2</sub>O<sub>2</sub>-responsive theranostic prodrug <b>69</b> (<a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">27</a></a>) using nitric oxide (NO) as the anticancer agent to which a coupled fluorescence signal can track the release of NO in living cells.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> A coumarin moiety, the same one used in prodrug <b>67</b>, was inserted to be both a self-cleavable linker and a fluorescent reporter for monitoring the release of NO in <b>69</b>.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a></div><div class="NLM_p">In 2020, Cao et al. reported a ROS-responsive theranostic prodrug <b>70</b> (<a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">29</a></a>) that was capable of delivering the anticancer agent, CPT, to the lysosomal matrix specifically by introducing a folate moiety as the cancer-targeting unit, which enabled the cellular penetration of <b>70</b> via endocytosis mechanisms.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a> The drug release was monitored by fluorescence in real time, relying on the LHX-OH fluorophore formed by H<sub>2</sub>O<sub>2</sub> stimulation.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a> Prodrug <b>70</b> showed excellent selectivity between KB cancer cells (folate receptor-positive) and WI38 normal cells (folate receptor-negative). When treated with 5 μM prodrug <b>70</b>, the cell viability of KB cells was 70%, while the cell viability of WI38 cells was close to 100%. This is in direct contrast to CPT which is toxic to both the KB cells and WI38 cells with cell viability less than 30% at 5 μM.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a></div><figure id="fig29" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Figure 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0029.jpeg" id="gr29" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 29. Structure of the ROS-responsive theranostic prodrug <b>70</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig29"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Liu et al. designed a ROS-responsive and self-luminescing theranostic nanosystem POCl (<b>71</b>) (<a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">30</a></a>) under the inspiration of an intraparticle relayed resonance energy transfer strategy.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Upon exposure to H<sub>2</sub>O<sub>2</sub>, bis[3,4,6-trichloro-2-(pentyloxycarbonyl)phenyl]oxalate (CPPO) in <b>71</b> gave rise to a high-energy intermediate, 1,2-dixetanedione. The cascade energy was then transferred to poly[(9,9′-dioctyl-2,7-divinylenefluorenylene)-<i>alt</i>-2-methoxy-5-(2-ethylhexyloxy)-1,4-phenylene] (PFPV) and finally received by the photosensitizer tetraphenylporphyrin (TPP). As a result, tumor tissue was converted to a “light on” state by TPP, facilitating the fluorescence imaging of tumor tissues. Meanwhile, the generated <sup>1</sup>O<sub>2</sub> caused oxidative damage to cancer cells, exerting antitumor effects (<a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">30</a></a>). <i>In vitro</i> assays revealed that <b>71</b> significantly inhibited the growth of HeLa cancer cells in the presence of PFPV and H<sub>2</sub>O<sub>2</sub>, whereas <b>71</b> itself was confirmed as nontoxic toward normal liver LO2 cells. <i>In vivo</i> antitumor evaluation of <b>71</b> in mice bearing subdermal HeLa xenografts revealed that the tumor weights in the POCL group were significantly reduced by 85% compared with the control group following a 3-week treatment.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> This ROS-responsive nanosystem triggered by the enhanced ROS levels in the tumor microenvironment provides an inner light source to excite <sup>1</sup>O<sub>2</sub> generation from TPP for cancer imaging and treatment, breaking through the limitations on penetration depth experienced when exploring with an external light source.</div><figure id="fig30" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Figure 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0030.jpeg" id="gr30" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 30. Anticancer mechanism of the ROS-responsive theranostic prodrug <b>71</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig30"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">6.  Perspectives</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70514" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70514" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Given that significant differences exist in ROS levels between the nonpathogenic and pathological tissues, an increasing number of ROS-responsive prodrugs, probes, and theranostic prodrugs have been developed for the targeting treatment and precise diagnosis of ROS-related diseases. Indeed, the ROS-responsive prodrug strategy has been successfully applied to modify drugs used in clinical settings, showing improved therapeutic potency together with reduced side effects. This has been achieved by increasing the accumulation of active drugs within disease tissues, reducing doses required, and selectively releasing the active drug in disease sites. Many challenges concerning the ROS-responsive prodrugs remain to be solved, resulting in few ROS-responsive prodrugs having entered into clinical trials or been approved to date. As discussed, the phenylboronate moiety is the most commonly used ROS-trigger group for designing ROS-responsive prodrugs, which is composed of a boronate as the ROS trigger and a self-cleavable linker, benzyl, for 1–6 elimination. On the one hand, the introduction of this kind of ROS-responsive group leads to a significant increase in lipophilicity compared to the parent drug. Further addition of a disease-targetable structural functionality, such as cancer-targetable or subcellular organelle-targetable moiety, results in compounds with increased molecular sizes that would no longer meet the requirements of an approved drug. The increased lipophilicity and enlarged molecular sizes and weights would make the prodrug non-drug-like, according to Lipinski’s “rule of five” concerning drug-likeness.<a onclick="showRef(event, 'ref163 ref164'); return false;" href="javascript:void(0);" class="ref ref163 ref164">(163,164)</a> On the other hand, drug release is usually accompanied by the release of the cytotoxic quinone-like fragment, such as <i>p</i>-QM, from the cleavable linker.<a onclick="showRef(event, 'ref84 ref88 ref92'); return false;" href="javascript:void(0);" class="ref ref84 ref88 ref92">(84,88,92)</a> As <i>p</i>-QM is cytotoxic, its co-delivery may contribute to synergistic effects in the case of anticancer drugs. However, when released as a byproduct of delivery, <i>p</i>-QM would be toxic to both targeted and normal tissues and cause potential side effects when this prodrug strategy was applied in therapeutic agents for the treatment of inflammation and neurodegenerative diseases. As a result, the following two types of ROS-responsive groups, the boronate directly attached to an aryl scaffold of the parent drug without a cleavable linker and the thiazolidinone, would be the optimal choice for masking a pharmacophoric phenol and a carboxylic acid, respectively, in parent drugs to improve efficacy and reduce side effects while maintaining preferable drug-like properties. Nevertheless, the boronate group singularly as the ROS trigger is probably less efficient in converting to parent drugs upon exposure to ROS,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> compared to those linked with a self-immolative linker fragment. Thus, the development of new efficient ROS-responsive groups or hydrophilic self-immolative linkers would be a significant improvement. Due to the increasing interest and research in the field, we are confident that the ROS-responsive prodrugs will enter into and be successful in clinical trials in the near future.</div><div class="NLM_p last">Finally, ROS-responsive theranostic prodrugs have the advantage of functioning to both diagnose and treat diseases, as well as being important tools for investigating the physiological and pathological mechanism of diseases. Although currently theranostic prodrugs are used mostly for the treatment of cancer, the research of theranostic prodrugs for other ROS-related diseases still has great application potential and development value.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01704" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10176" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10176" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiang Li</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Engineering, China Pharmaceutical
University, Nanjing 211198, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4061-7115" title="Orcid link">http://orcid.org/0000-0002-4061-7115</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#9cf0f5e4f5fdf2fbdcffece9b2f9f8e9b2fff2"><span class="__cf_email__" data-cfemail="8de1e4f5e4ece3eacdeefdf8a3e8e9f8a3eee3">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaojin Zhang</span> - <span class="hlFld-Affiliation affiliation">Jiangsu
Key Laboratory of Drug Design and Optimization, and Department of
Chemistry, China Pharmaceutical University, Nanjing 211198, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1898-3071" title="Orcid link">http://orcid.org/0000-0002-1898-3071</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ccb6b4a68cafbcb9e2a9a8b9e2afa2"><span class="__cf_email__" data-cfemail="aed4d6c4eecddedb80cbcadb80cdc0">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pengfei Wang</span> - <span class="hlFld-Affiliation affiliation">Jiangsu
Key Laboratory of Drug Design and Optimization, and Department of
Chemistry, China Pharmaceutical University, Nanjing 211198, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Engineering, China Pharmaceutical
University, Nanjing 211198, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qijie Gong</span> - <span class="hlFld-Affiliation affiliation">Jiangsu
Key Laboratory of Drug Design and Optimization, and Department of
Chemistry, China Pharmaceutical University, Nanjing 211198, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiabao Hu</span> - <span class="hlFld-Affiliation affiliation">Jiangsu
Key Laboratory of Drug Design and Optimization, and Department of
Chemistry, China Pharmaceutical University, Nanjing 211198, China</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07488" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07488" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Pengfei Wang</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=BIO-d7e3712-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Pengfei Wang</b> received his Bachelor’s degree in Pharmaceutical Engineering from Shenyang Pharmaceutical University in 2019. Currently, he is a Master student majoring in Pharmaceutical Engineering under the supervision of Associate Professor Xiang Li, China Pharmaceutical University. His research topic focuses on the rational design and synthesis of ROS-responsive prodrugs for cancer treatment.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Qijie Gong</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=BIO-d7e3717-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Qijie Gong</b> received his Bachelor’s degree in Pharmacy from China Pharmaceutical University in 2016. Currently, he is a Master student majoring in Medicinal Chemistry under the supervision of Associate Professor Xiaojin Zhang, China Pharmaceutical University. His research topic focuses on the rational design and synthesis of ROS-responsive prodrugs for cancer treatment.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Jiabao Hu</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=BIO-d7e3722-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Jiabao Hu</b> received his Bachelor’s degree in Medicinal Chemistry from China Pharmaceutical University in 2018. Currently, he is a Master student majoring in Medicinal Chemistry under the supervision of Associate Professor Xiaojin Zhang, China Pharmaceutical University. His research topic focuses on the rational design and synthesis of ROS-targeting antitumor agents.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="34" class="article__inlineFigure"><h2 class="fig-label">Xiang Li</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=BIO-d7e3727-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Xiang Li</b> received her Bachelor’s degree from China Pharmaceutical University, where she also earned her Ph.D. in Pharmaceutical Engineering in 2012 and worked as a visiting scholar in the Department of Chemistry at the University of Oxford from 2019 to 2020. She is currently an Associate Professor of Pharmaceutical Engineering in the Department of Pharmaceutical Engineering at China Pharmaceutical University. Her main research interests lie in the rational design, discovery, and chemical biology studies of ROS-responsive prodrugs and ROS-targeting antitumor agents.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="35" class="article__inlineFigure"><h2 class="fig-label">Xiaojin Zhang</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=BIO-d7e3732-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Xiaojin Zhang</b> received his Bachelor’s degree from China Pharmaceutical University, where he also earned his Ph.D. in Medicinal Chemistry in 2012, and worked as a visiting scholar in the Department of Chemistry at the University of Oxford from 2019 to 2020. He is currently an Associate Professor of Medicinal Chemistry and serves as the Deputy Director of the Department of Chemistry at China Pharmaceutical University. His main research interests lie in the rational drug design and discovery of small-molecule modulators that target cell redox systems and oxygen-sensing systems. He has devoted to the design and discovery of a drug candidate in clinical trials for the treatment of anemia.</p></figure></div><div class="ack" id="ACK-d7e3740-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63807" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63807" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by grants from the National Natural Science Foundation of China (Grants 81773571 and 81973173), Jiangsu Province Funds for Excellent Young Scientists (Grant BK20170088), and the Fundamental Research Funds for the Central Universities (Grant 2632019ZD14).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">AMT</td><td class="NLM_def"><p class="first last">aminopterin</p></td></tr><tr><td class="NLM_term">ATX</td><td class="NLM_def"><p class="first last">autotaxin</p></td></tr><tr><td class="NLM_term">AC</td><td class="NLM_def"><p class="first last">anthracene</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under curve</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">CPPO</td><td class="NLM_def"><p class="first last">bis[3,4,6-trichloro-2-(pentyloxycarbonyl)phenyl] oxalate</p></td></tr><tr><td class="NLM_term">CI</td><td class="NLM_def"><p class="first last">combination index</p></td></tr><tr><td class="NLM_term">CIA</td><td class="NLM_def"><p class="first last">mouse collagen induced arthritis model</p></td></tr><tr><td class="NLM_term">CLL</td><td class="NLM_def"><p class="first last">chronic lymphocytic leukemia</p></td></tr><tr><td class="NLM_term">CPT</td><td class="NLM_def"><p class="first last">camptothecin</p></td></tr><tr><td class="NLM_term">CTCL</td><td class="NLM_def"><p class="first last">cutaneous T-cell lymphoma</p></td></tr><tr><td class="NLM_term">DABCYL</td><td class="NLM_def"><p class="first last">4-dimethylaminoazobenzene-4′-carboxylic acid</p></td></tr><tr><td class="NLM_term">DDAO</td><td class="NLM_def"><p class="first last">9<i>H</i>-1,3-dichloro-7-hydroxy-9,9-dimethylacridine-2-one</p></td></tr><tr><td class="NLM_term">5′-DFUR</td><td class="NLM_def"><p class="first last">5′-deoxy-5-fluorouridine</p></td></tr><tr><td class="NLM_term">DOX</td><td class="NLM_def"><p class="first last">doxorubicin</p></td></tr><tr><td class="NLM_term">DLC</td><td class="NLM_def"><p class="first last">nonlocalized lipophilic cation</p></td></tr><tr><td class="NLM_term">DHR</td><td class="NLM_def"><p class="first last">dihydrorhodamine</p></td></tr><tr><td class="NLM_term">EGF</td><td class="NLM_def"><p class="first last">epidermal growth factor</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">endoplasmic reticulum</p></td></tr><tr><td class="NLM_term">FITC</td><td class="NLM_def"><p class="first last">fluorescein isothiocyanate</p></td></tr><tr><td class="NLM_term">5-FU</td><td class="NLM_def"><p class="first last">5-fluorouracil</p></td></tr><tr><td class="NLM_term">GEM</td><td class="NLM_def"><p class="first last">gemcitabine</p></td></tr><tr><td class="NLM_term">GSH</td><td class="NLM_def"><p class="first last">glutathione</p></td></tr><tr><td class="NLM_term">HBA</td><td class="NLM_def"><p class="first last"><i>p</i>-hydroxybenzyl alcohol</p></td></tr><tr><td class="NLM_term">HDAC</td><td class="NLM_def"><p class="first last">histone deacetylase</p></td></tr><tr><td class="NLM_term">HDACi</td><td class="NLM_def"><p class="first last">histone deacetylase inhibitors</p></td></tr><tr><td class="NLM_term">ICL</td><td class="NLM_def"><p class="first last">interstrand cross-link</p></td></tr><tr><td class="NLM_term">Keap1</td><td class="NLM_def"><p class="first last">Kelch-like ECH-associated protein 1</p></td></tr><tr><td class="NLM_term">LDH</td><td class="NLM_def"><p class="first last">lactate dehydrogenase</p></td></tr><tr><td class="NLM_term">LD-MTX</td><td class="NLM_def"><p class="first last">low-dose methotrexate</p></td></tr><tr><td class="NLM_term">LAP</td><td class="NLM_def"><p class="first last">β-lapachone</p></td></tr><tr><td class="NLM_term">LPC</td><td class="NLM_def"><p class="first last">lysophosphatidylcholine</p></td></tr><tr><td class="NLM_term">LPS</td><td class="NLM_def"><p class="first last">lipopolysaccharide</p></td></tr><tr><td class="NLM_term">MLT</td><td class="NLM_def"><p class="first last">melatonin</p></td></tr><tr><td class="NLM_term">MMP</td><td class="NLM_def"><p class="first last">matrix metalloproteinase</p></td></tr><tr><td class="NLM_term">MMPi</td><td class="NLM_def"><p class="first last">MMP inhibitor</p></td></tr><tr><td class="NLM_term">MTX</td><td class="NLM_def"><p class="first last">methotrexate</p></td></tr><tr><td class="NLM_term">Nap</td><td class="NLM_def"><p class="first last">naphthazarin</p></td></tr><tr><td class="NLM_term">Nrf2</td><td class="NLM_def"><p class="first last">nuclear factor erythroid 2-related factor 2</p></td></tr><tr><td class="NLM_term">NLS</td><td class="NLM_def"><p class="first last">nuclear localization signal peptide</p></td></tr><tr><td class="NLM_term">NIRF</td><td class="NLM_def"><p class="first last">near-infrared fluorescence</p></td></tr><tr><td class="NLM_term">NO</td><td class="NLM_def"><p class="first last">nitric oxide</p></td></tr><tr><td class="NLM_term">NBC</td><td class="NLM_def"><p class="first last">4-nitrophenyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl carbonate</p></td></tr><tr><td class="NLM_term">OBP</td><td class="NLM_def"><p class="first last">4-hydroxymethyl boronic pinacol ester</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">Parkinson’s disease</p></td></tr><tr><td class="NLM_term"><i>p</i>-QM</td><td class="NLM_def"><p class="first last"><i>para</i>-benzoquinone methide</p></td></tr><tr><td class="NLM_term">PDAC</td><td class="NLM_def"><p class="first last">pancreatic ductal adenocarcinoma</p></td></tr><tr><td class="NLM_term">PFPV</td><td class="NLM_def"><p class="first last">poly[(9,9′-dioctyl-2,7-divinylene-fluorenylene)-<i>alt</i>-2-methoxy-5-(2-ethylhexyloxy)-1,4-phenylene]</p></td></tr><tr><td class="NLM_term">PPI</td><td class="NLM_def"><p class="first last">protein–protein interaction</p></td></tr><tr><td class="NLM_term">PTCL</td><td class="NLM_def"><p class="first last">relapsed/refractory peripheral T-cell lymphoma</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">RA</td><td class="NLM_def"><p class="first last">rheumatoid arthritis</p></td></tr><tr><td class="NLM_term">SAHA</td><td class="NLM_def"><p class="first last">vorinostat</p></td></tr><tr><td class="NLM_term">SNAP-PG</td><td class="NLM_def"><p class="first last">SNAP-Peroxy-Green</p></td></tr><tr><td class="NLM_term">SSTR</td><td class="NLM_def"><p class="first last">somatostatin receptor</p></td></tr><tr><td class="NLM_term"><i>T</i>/<i>C</i></td><td class="NLM_def"><p class="first last">ratio of tumor volume in treated versus control mice</p></td></tr><tr><td class="NLM_term">TK</td><td class="NLM_def"><p class="first last">thioketal</p></td></tr><tr><td class="NLM_term">Topo I</td><td class="NLM_def"><p class="first last">topoisomerase I</p></td></tr><tr><td class="NLM_term">TNF-α</td><td class="NLM_def"><p class="first last">tumor necrosis factor α</p></td></tr><tr><td class="NLM_term">TPP</td><td class="NLM_def"><p class="first last">triphenylphosphonium salt</p></td></tr><tr><td class="NLM_term">UPR</td><td class="NLM_def"><p class="first last">unfolded protein response</p></td></tr><tr><td class="NLM_term">WT</td><td class="NLM_def"><p class="first last">wild type</p></td></tr><tr><td class="NLM_term">ZBG</td><td class="NLM_def"><p class="first last">zinc binding group</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10223" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10223" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 164 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmgren, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, N.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halliwell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalyanaraman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhee, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornalley, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Partridge, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gems, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyström, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belousov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacker, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winterbourn, C. C.</span></span> <span> </span><span class="NLM_article-title">Unraveling the biological roles of reactive oxygen species</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">361</span>– <span class="NLM_lpage">366</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2011.03.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.cmet.2011.03.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=21459321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktF2nsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=361-366&author=M.+P.+Murphyauthor=A.+Holmgrenauthor=N.-G.+Larssonauthor=B.+Halliwellauthor=C.+J.+Changauthor=B.+Kalyanaramanauthor=S.+G.+Rheeauthor=P.+J.+Thornalleyauthor=L.+Partridgeauthor=D.+Gemsauthor=T.+Nystr%C3%B6mauthor=V.+Belousovauthor=P.+T.+Schumackerauthor=C.+C.+Winterbourn&title=Unraveling+the+biological+roles+of+reactive+oxygen+species&doi=10.1016%2Fj.cmet.2011.03.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Unraveling the Biological Roles of Reactive Oxygen Species</span></div><div class="casAuthors">Murphy, Michael P.; Holmgren, Arne; Larsson, Nils-Goeran; Halliwell, Barry; Chang, Christopher J.; Kalyanaraman, Balaraman; Rhee, Sue Goo; Thornalley, Paul J.; Partridge, Linda; Gems, David; Nystroem, Thomas; Belousov, Vsevolod; Schumacker, Paul T.; Winterbourn, Christine C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">361-366</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Reactive oxygen species are not only harmful agents that cause oxidative damage in pathologies, they also have important roles as regulatory agents in a range of biol. phenomena.  The relatively recent development of this more nuanced view presents a challenge to the biomedical research community on how best to assess the significance of reactive oxygen species and oxidative damage in biol. systems.  Considerable progress is being made in addressing these issues, and here we survey some recent developments for those contemplating research in this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKbT56CVsbG7Vg90H21EOLACvtfcHk0liyxenRCgGdhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktF2nsL4%253D&md5=f08569bc26aee0e8093983bfde841211</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2011.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2011.03.010%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26aulast%3DHolmgren%26aufirst%3DA.%26aulast%3DLarsson%26aufirst%3DN.-G.%26aulast%3DHalliwell%26aufirst%3DB.%26aulast%3DChang%26aufirst%3DC.%2BJ.%26aulast%3DKalyanaraman%26aufirst%3DB.%26aulast%3DRhee%26aufirst%3DS.%2BG.%26aulast%3DThornalley%26aufirst%3DP.%2BJ.%26aulast%3DPartridge%26aufirst%3DL.%26aulast%3DGems%26aufirst%3DD.%26aulast%3DNystr%25C3%25B6m%26aufirst%3DT.%26aulast%3DBelousov%26aufirst%3DV.%26aulast%3DSchumacker%26aufirst%3DP.%2BT.%26aulast%3DWinterbourn%26aufirst%3DC.%2BC.%26atitle%3DUnraveling%2520the%2520biological%2520roles%2520of%2520reactive%2520oxygen%2520species%26jtitle%3DCell%2520Metab.%26date%3D2011%26volume%3D13%26spage%3D361%26epage%3D366%26doi%3D10.1016%2Fj.cmet.2011.03.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finkel, T.</span></span> <span> </span><span class="NLM_article-title">Oxidant signals and oxidative stress</span>. <i>Curr. Opin. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1016/S0955-0674(03)00002-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2FS0955-0674%2803%2900002-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=12648682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitV2msLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2003&pages=247-254&author=T.+Finkel&title=Oxidant+signals+and+oxidative+stress&doi=10.1016%2FS0955-0674%2803%2900002-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidant signals and oxidative stress</span></div><div class="casAuthors">Finkel, Toren</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">247-254</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Although oxidants clearly possess the capacity to behave in a random and destructive fashion, growing evidence suggests that in many instances the prodn. of reactive oxygen species is tightly regulated and their downstream targets exquisitely specific.  This past year, several notable advances have been made in defining the specific redox-dependent targets of intracellular oxidants, as well as the myriad pathways that appear to employ oxidants as effector mols.  These new studies have significantly altered our understanding of how reactive oxygen species participate in diverse processes from tumorigenesis to aging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAh8RKELmCErVg90H21EOLACvtfcHk0liyxenRCgGdhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitV2msLo%253D&md5=89ef7bdb5b3f4f99d22e2239cbe2c9a7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0955-0674%2803%2900002-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0955-0674%252803%252900002-4%26sid%3Dliteratum%253Aachs%26aulast%3DFinkel%26aufirst%3DT.%26atitle%3DOxidant%2520signals%2520and%2520oxidative%2520stress%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2003%26volume%3D15%26spage%3D247%26epage%3D254%26doi%3D10.1016%2FS0955-0674%2803%2900002-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rhee, S. G.</span></span> <span> </span><span class="NLM_article-title">Cell signaling. H<sub>2</sub>O<sub>2</sub>, a necessary evil for cell signaling</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>312</i></span>,  <span class="NLM_fpage">1882</span>– <span class="NLM_lpage">1883</span>, <span class="refDoi"> DOI: 10.1126/science.1130481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1126%2Fscience.1130481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=16809515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A280%3ADC%252BD28zpt1Oiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=2006&pages=1882-1883&author=S.+G.+Rhee&title=Cell+signaling.+H2O2%2C+a+necessary+evil+for+cell+signaling&doi=10.1126%2Fscience.1130481"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Cell signaling. H2O2, a necessary evil for cell signaling</span></div><div class="casAuthors">Rhee Sue Goo</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">312</span>
        (<span class="NLM_cas:issue">5782</span>),
    <span class="NLM_cas:pages">1882-3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT5jW4yY2PH7u98rul4nhSdfW6udTcc2eYeCnWOwgMU-7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28zpt1Oiug%253D%253D&md5=2942e179a4630f55507999873367c240</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscience.1130481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1130481%26sid%3Dliteratum%253Aachs%26aulast%3DRhee%26aufirst%3DS.%2BG.%26atitle%3DCell%2520signaling.%2520H2O2%252C%2520a%2520necessary%2520evil%2520for%2520cell%2520signaling%26jtitle%3DScience%26date%3D2006%26volume%3D312%26spage%3D1882%26epage%3D1883%26doi%3D10.1126%2Fscience.1130481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, J.</span></span> <span> </span><span class="NLM_article-title">Fluorescent and luminescent probes for detection of reactive oxygen and nitrogen species</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">4783</span>– <span class="NLM_lpage">4804</span>, <span class="refDoi"> DOI: 10.1039/c1cs15037e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1039%2Fc1cs15037e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=21629957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVeitbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2011&pages=4783-4804&author=X.+Chenauthor=X.+Tianauthor=I.+Shinauthor=J.+Yoon&title=Fluorescent+and+luminescent+probes+for+detection+of+reactive+oxygen+and+nitrogen+species&doi=10.1039%2Fc1cs15037e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescent and luminescent probes for detection of reactive oxygen and nitrogen species</span></div><div class="casAuthors">Chen, Xiaoqiang; Tian, Xizhe; Shin, Injae; Yoon, Juyoung</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4783-4804</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Oxidative and nitrosative stress induced by ROS/RNS play crucial roles in a wide range of physiol. processes and are also implicated in various diseases, including cancer and neurodegenerative disorders.  Sensitive and selective methods for the detection of ROS/RNS based on fluorescent and luminescent probes are of great use in monitoring the in vivo prodn. of these species and elucidating their biol. functions.  This crit. review highlights recent advances that were made in the development of fluorescent and luminescent probes employed to monitor various ROS/RNS (132 refs.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQZZWhDY-Sl7Vg90H21EOLACvtfcHk0lhofqHNeudByg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVeitbfN&md5=c5d039ab805a21f3845f6b3919039a42</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1039%2Fc1cs15037e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1cs15037e%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DShin%26aufirst%3DI.%26aulast%3DYoon%26aufirst%3DJ.%26atitle%3DFluorescent%2520and%2520luminescent%2520probes%2520for%2520detection%2520of%2520reactive%2520oxygen%2520and%2520nitrogen%2520species%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2011%26volume%3D40%26spage%3D4783%26epage%3D4804%26doi%3D10.1039%2Fc1cs15037e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trachootham, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span> <span> </span><span class="NLM_article-title">Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">579</span>– <span class="NLM_lpage">591</span>, <span class="refDoi"> DOI: 10.1038/nrd2803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1038%2Fnrd2803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=19478820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsFWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=579-591&author=D.+Trachoothamauthor=J.+Alexandreauthor=P.+Huang&title=Targeting+cancer+cells+by+ROS-mediated+mechanisms%3A+a+radical+therapeutic+approach%3F&doi=10.1038%2Fnrd2803"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?</span></div><div class="casAuthors">Trachootham, Dunyaporn; Alexandre, Jerome; Huang, Peng</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">579-591</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Increased generation of reactive oxygen species (ROS) and an altered redox status have long been obsd. in cancer cells, and recent studies suggest that this biochem. property of cancer cells can be exploited for therapeutic benefits.  Cancer cells in advanced stage tumors frequently exhibit multiple genetic alterations and high oxidative stress, suggesting that it might be possible to preferentially eliminate these cells by pharmacol. ROS insults.  However, the upregulation of antioxidant capacity in adaptation to intrinsic oxidative stress in cancer cells can confer drug resistance.  Abrogation of such drug-resistant mechanisms by redox modulation could have significant therapeutic implications.  We argue that modulating the unique redox regulatory mechanisms of cancer cells might be an effective strategy to eliminate these cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobgIa2fgBPBrVg90H21EOLACvtfcHk0lhofqHNeudByg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsFWqsLk%253D&md5=d50931b8de8bcab62d376becc768a71c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd2803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2803%26sid%3Dliteratum%253Aachs%26aulast%3DTrachootham%26aufirst%3DD.%26aulast%3DAlexandre%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DP.%26atitle%3DTargeting%2520cancer%2520cells%2520by%2520ROS-mediated%2520mechanisms%253A%2520a%2520radical%2520therapeutic%2520approach%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D579%26epage%3D591%26doi%3D10.1038%2Fnrd2803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">D’Autreaux, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toledano, M. B.</span></span> <span> </span><span class="NLM_article-title">ROS as signaling molecules: mechanisms that generate specificity in ROS homeostasis</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">813</span>– <span class="NLM_lpage">824</span>, <span class="refDoi"> DOI: 10.1038/nrm2256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1038%2Fnrm2256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=17848967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKmt7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=813-824&author=B.+D%E2%80%99Autreauxauthor=M.+B.+Toledano&title=ROS+as+signaling+molecules%3A+mechanisms+that+generate+specificity+in+ROS+homeostasis&doi=10.1038%2Fnrm2256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">ROS as signaling molecules: mechanisms that generate specificity in ROS homeostasis</span></div><div class="casAuthors">D'Autreaux, Benoit; Toledano, Michel B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">813-824</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Reactive O species (ROS) have been shown to be toxic but also to function as signaling mols.  This biol. paradox underlies mechanisms that are important for the integrity and fitness of living organisms and their aging.  The pathways that regulate ROS homeostasis are crucial for mitigating the toxicity of ROS and provide strong evidence about specificity in ROS signaling.  By taking advantage of the chem. of ROS, highly specific mechanisms have evolved that form the basis of oxidant scavenging and ROS signaling systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR5hZl87z2WLVg90H21EOLACvtfcHk0lhofqHNeudByg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKmt7rF&md5=5302fd59fdfaf8636793ea768f188219</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrm2256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2256%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Autreaux%26aufirst%3DB.%26aulast%3DToledano%26aufirst%3DM.%2BB.%26atitle%3DROS%2520as%2520signaling%2520molecules%253A%2520mechanisms%2520that%2520generate%2520specificity%2520in%2520ROS%2520homeostasis%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2007%26volume%3D8%26spage%3D813%26epage%3D824%26doi%3D10.1038%2Fnrm2256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schumacker, P. T.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species in cancer cells: live by the sword, die by the sword</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">175</span>– <span class="NLM_lpage">176</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2006.08.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.ccr.2006.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=16959608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVSlu73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=175-176&author=P.+T.+Schumacker&title=Reactive+oxygen+species+in+cancer+cells%3A+live+by+the+sword%2C+die+by+the+sword&doi=10.1016%2Fj.ccr.2006.08.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species in cancer cells: live by the sword, die by the sword</span></div><div class="casAuthors">Schumacker, Paul T.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">175-176</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Reactive oxygen species and tumor biol. are intertwined in a complex web, making it difficult to understand which came first, whether oxidants are required for tumor cell growth, and whether oxidant stress can be exploited therapeutically.  Evidence suggests that transformed cells use ROS signals to drive proliferation and other events required for tumor progression.  This confers a state of increased basal oxidative stress, making them vulnerable to chemotherapeutic agents that further augment ROS generation or that weaken antioxidant defenses of the cell.  In this respect, it appears that tumor cells may die by the same systems they require.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE87Ik9Nnb2bVg90H21EOLACvtfcHk0ljWzW_rl4fRYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVSlu73M&md5=aa7c8ed4524ce0392d478c53090925d1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2006.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2006.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DSchumacker%26aufirst%3DP.%2BT.%26atitle%3DReactive%2520oxygen%2520species%2520in%2520cancer%2520cells%253A%2520live%2520by%2520the%2520sword%252C%2520die%2520by%2520the%2520sword%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D10%26spage%3D175%26epage%3D176%26doi%3D10.1016%2Fj.ccr.2006.08.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suh, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lassegue, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorescu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griendling, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambeth, J. D.</span></span> <span> </span><span class="NLM_article-title">Cell transformation by the superoxide-generating oxidase Mox1</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>401</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">82</span>, <span class="refDoi"> DOI: 10.1038/43459</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1038%2F43459" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10485709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADyaK1MXlvVGmsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=401&publication_year=1999&pages=79-82&author=Y.+A.+Suhauthor=R.+S.+Arnoldauthor=B.+Lassegueauthor=J.+Shiauthor=X.+Xuauthor=D.+Sorescuauthor=A.+B.+Chungauthor=K.+K.+Griendlingauthor=J.+D.+Lambeth&title=Cell+transformation+by+the+superoxide-generating+oxidase+Mox1&doi=10.1038%2F43459"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cell transformation by the superoxide-generating oxidase Mox1</span></div><div class="casAuthors">Suh, Young-Ah; Arnold, Rebecca S.; Lassegue, Bernard; Shi, Jing; Xu, Xlangxi; Sorescu, Dan; Chung, Andrew B.; Griendling, Kathy K.; Lambeth, J. David</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">401</span>
        (<span class="NLM_cas:issue">6748</span>),
    <span class="NLM_cas:pages">79-82</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS) generated in some non-phagocytic cells are implicated in mitogenic signaling and cancer.  Many cancer cells show increased prodn. of ROS, and normal cells exposed to hydrogen peroxide or superoxide show increased proliferation and express growth-related genes.  ROS are generated in response to growth factors, and may affect cell growth, for example in vascular smooth-muscle cells.  Increased ROS in Ras-transformed fibroblasts correlates with increased mitogenic rate.  Here the authors describe the cloning of mox1, which encodes a homolog of the catalytic subunit of the superoxide-generating NADPH oxidase of phagocytes, gp91phox.  Mox1 mRNA is expressed in colon, prostate, uterus and vascular smooth muscle, but not in peripheral blood leukocytes.  In smooth-muscle cells, platelet-derived growth factor induces mox1 mRNA prodn., while antisense mox1 mRNA decreases superoxide generation and serum-stimulated growth.  Overexpression of mox1 in NIH3T3 cells increases superoxide generation and cell growth.  Cells expressing mox1 have a transformed appearance, show anchorage-independent growth and produce tumors in athymic mice.  These data link ROS prodn. by Mox1 to growth control in non-phagocytic cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbUPMilVZ4P7Vg90H21EOLACvtfcHk0ljWzW_rl4fRYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvVGmsbg%253D&md5=6e25d37a6cfc28f9c53e798fa928382e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F43459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F43459%26sid%3Dliteratum%253Aachs%26aulast%3DSuh%26aufirst%3DY.%2BA.%26aulast%3DArnold%26aufirst%3DR.%2BS.%26aulast%3DLassegue%26aufirst%3DB.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DSorescu%26aufirst%3DD.%26aulast%3DChung%26aufirst%3DA.%2BB.%26aulast%3DGriendling%26aufirst%3DK.%2BK.%26aulast%3DLambeth%26aufirst%3DJ.%2BD.%26atitle%3DCell%2520transformation%2520by%2520the%2520superoxide-generating%2520oxidase%2520Mox1%26jtitle%3DNature%26date%3D1999%26volume%3D401%26spage%3D79%26epage%3D82%26doi%3D10.1038%2F43459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koh, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halliwell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenner, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laughton, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beart, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, N. S.</span></span> <span> </span><span class="NLM_article-title">Chronic exposure to U18666A is associated with oxidative stress in cultured murine cortical neurons</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">1278</span>– <span class="NLM_lpage">1289</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2006.03958.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1111%2Fj.1471-4159.2006.03958.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=16771828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFemu7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2006&pages=1278-1289&author=C.+H.+Kohauthor=M.+Whitemanauthor=Q.+X.+Liauthor=B.+Halliwellauthor=A.+M.+Jennerauthor=B.+S.+Wongauthor=K.+M.+Laughtonauthor=M.+Wenkauthor=C.+L.+Mastersauthor=P.+M.+Beartauthor=O.+Bernardauthor=N.+S.+Cheung&title=Chronic+exposure+to+U18666A+is+associated+with+oxidative+stress+in+cultured+murine+cortical+neurons&doi=10.1111%2Fj.1471-4159.2006.03958.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic exposure to U18666A is associated with oxidative stress in cultured murine cortical neurons</span></div><div class="casAuthors">Koh, Chor Hui Vivien; Whiteman, Matthew; Li, Qiao-Xin; Halliwell, Barry; Jenner, Andrew M.; Wong, Boon Seng; Laughton, Katrina M.; Wenk, Markus; Masters, Colin L.; Beart, Philip M.; Bernard, Ora; Cheung, Nam Sang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1278-1289</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Findings that antioxidant treatment may be beneficial in Alzheimer's disease indicate that oxidative stress is an important factor in its pathogenesis.  Studies have also suggested that cholesterol imbalance in the brain might be related to the development of neurol. disorders.  Previously, we have reported that U18666A, a cholesterol transport-inhibiting agent, leads to apoptosis and intracellular cholesterol accumulation in primary cortical neurons.  In this study, we found that neuronal apoptosis mediated by U18666A is assocd. with oxidative stress in the treated cortical neurons.  Cortical neurons treated with U18666A also showed decreased secretion and increased intraneuronal accumulation of β-amyloid.  The assocn. of neuronal apoptosis with oxidative stress and Aβ accumulation may provide clues to the pathogenesis of Alzheimer's disease, as well as the role oxidative stress plays in other neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSmp0_cKwoA7Vg90H21EOLACvtfcHk0ljWzW_rl4fRYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFemu7bK&md5=9f460d08ee51c0d1ac1fb1f1a0ccc4d1</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.03958.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.03958.x%26sid%3Dliteratum%253Aachs%26aulast%3DKoh%26aufirst%3DC.%2BH.%26aulast%3DWhiteman%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DQ.%2BX.%26aulast%3DHalliwell%26aufirst%3DB.%26aulast%3DJenner%26aufirst%3DA.%2BM.%26aulast%3DWong%26aufirst%3DB.%2BS.%26aulast%3DLaughton%26aufirst%3DK.%2BM.%26aulast%3DWenk%26aufirst%3DM.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DBeart%26aufirst%3DP.%2BM.%26aulast%3DBernard%26aufirst%3DO.%26aulast%3DCheung%26aufirst%3DN.%2BS.%26atitle%3DChronic%2520exposure%2520to%2520U18666A%2520is%2520associated%2520with%2520oxidative%2520stress%2520in%2520cultured%2520murine%2520cortical%2520neurons%26jtitle%3DJ.%2520Neurochem.%26date%3D2006%26volume%3D98%26spage%3D1278%26epage%3D1289%26doi%3D10.1111%2Fj.1471-4159.2006.03958.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mittal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malik, A. B.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species in inflammation and tissue injury</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1126</span>– <span class="NLM_lpage">1167</span>, <span class="refDoi"> DOI: 10.1089/ars.2012.5149</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1089%2Fars.2012.5149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=23991888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2cXit12qtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=1126-1167&author=M.+Mittalauthor=M.+R.+Siddiquiauthor=K.+Tranauthor=S.+P.+Reddyauthor=A.+B.+Malik&title=Reactive+oxygen+species+in+inflammation+and+tissue+injury&doi=10.1089%2Fars.2012.5149"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive Oxygen Species in Inflammation and Tissue Injury</span></div><div class="casAuthors">Mittal, Manish; Siddiqui, Mohammad Rizwan; Tran, Khiem; Reddy, Sekhar P.; Malik, Asrar B.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1126-1167</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Reactive oxygen species (ROS) are key signaling mols. that play an important role in the progression of inflammatory disorders.  An enhanced ROS generation by polymorphonuclear neutrophils (PMNs) at the site of inflammation causes endothelial dysfunction and tissue injury.  The vascular endothelium plays an important role in passage of macromols. and inflammatory cells from the blood to tissue.  Under the inflammatory conditions, oxidative stress produced by PMNs leads to the opening of inter-endothelial junctions and promotes the migration of inflammatory cells across the endothelial barrier.  The migrated inflammatory cells not only help in the clearance of pathogens and foreign particles but also lead to tissue injury.  The current review compiles the past and current research in the area of inflammation with particular emphasis on oxidative stress-mediated signaling mechanisms that are involved in inflammation and tissue injury.  Antioxid. Redox Signal. 20, 1126-1167.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot8O-h45Zi6LVg90H21EOLACvtfcHk0lhC4Xay_qy50Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXit12qtbg%253D&md5=324f08a1e66b88576526690cb6583cf5</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1089%2Fars.2012.5149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2012.5149%26sid%3Dliteratum%253Aachs%26aulast%3DMittal%26aufirst%3DM.%26aulast%3DSiddiqui%26aufirst%3DM.%2BR.%26aulast%3DTran%26aufirst%3DK.%26aulast%3DReddy%26aufirst%3DS.%2BP.%26aulast%3DMalik%26aufirst%3DA.%2BB.%26atitle%3DReactive%2520oxygen%2520species%2520in%2520inflammation%2520and%2520tissue%2520injury%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2014%26volume%3D20%26spage%3D1126%26epage%3D1167%26doi%3D10.1089%2Fars.2012.5149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barnham, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, A. I.</span></span> <span> </span><span class="NLM_article-title">Neurodegenerative diseases and oxidative stress</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">214</span>, <span class="refDoi"> DOI: 10.1038/nrd1330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1038%2Fnrd1330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=15031734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD2cXit12nsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=205-214&author=K.+J.+Barnhamauthor=C.+L.+Mastersauthor=A.+I.+Bush&title=Neurodegenerative+diseases+and+oxidative+stress&doi=10.1038%2Fnrd1330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Neurodegenerative diseases and oxidative stress</span></div><div class="casAuthors">Barnham, Kevin J.; Masters, Colin L.; Bush, Ashley I.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">205-214</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Oxidative stress has been implicated in the progression of Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.  Oxygen is vital for life but is also potentially dangerous, and a complex system of checks and balances exists for utilizing this essential element.  Oxidative stress is the result of an imbalance in pro-oxidant/antioxidant homeostasis that leads to the generation of toxic reactive oxygen species.  The systems in place to cope with the biochem. of oxygen are complex, and many questions about the mechanisms of oxygen regulation remain unanswered.  However, this same complexity provides a no. of therapeutic targets, and different strategies, including novel metal-protein attenuating compds., aimed at a variety of targets have shown promise in clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPqGR8Vlz1hLVg90H21EOLACvtfcHk0lhC4Xay_qy50Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXit12nsL4%253D&md5=73a09223923e8b895ebee89405e5c7fd</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnrd1330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1330%26sid%3Dliteratum%253Aachs%26aulast%3DBarnham%26aufirst%3DK.%2BJ.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DBush%26aufirst%3DA.%2BI.%26atitle%3DNeurodegenerative%2520diseases%2520and%2520oxidative%2520stress%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D205%26epage%3D214%26doi%3D10.1038%2Fnrd1330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, M. P.</span></span> <span> </span><span class="NLM_article-title">Pathways towards and away from Alzheimer’s disease</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>430</i></span>,  <span class="NLM_fpage">631</span>– <span class="NLM_lpage">639</span>, <span class="refDoi"> DOI: 10.1038/nature02621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1038%2Fnature02621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=15295589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmt1Gis7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=430&publication_year=2004&pages=631-639&author=M.+P.+Mattson&title=Pathways+towards+and+away+from+Alzheimer%E2%80%99s+disease&doi=10.1038%2Fnature02621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Pathways towards and away from Alzheimer's disease</span></div><div class="casAuthors">Mattson, Mark P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">430</span>
        (<span class="NLM_cas:issue">7000</span>),
    <span class="NLM_cas:pages">631-639</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Slowly but surely, Alzheimer's disease (AD) patients lose their memory and their cognitive abilities, and even their personalities may change dramatically.  These changes are due to the progressive dysfunction and death of nerve cells that are responsible for the storage and processing of information.  Although drugs can temporarily improve memory, at present there are no treatments that can stop or reverse the inexorable neurodegenerative process.  But rapid progress towards understanding the cellular and mol. alterations that are responsible for the neuron's demise may soon help in developing effective preventative and therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQHWKtbjr0cLVg90H21EOLACvtfcHk0lhC4Xay_qy50Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmt1Gis7o%253D&md5=796c7f13ce37cf041c62266bad2f7218</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnature02621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02621%26sid%3Dliteratum%253Aachs%26aulast%3DMattson%26aufirst%3DM.%2BP.%26atitle%3DPathways%2520towards%2520and%2520away%2520from%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D2004%26volume%3D430%26spage%3D631%26epage%3D639%26doi%3D10.1038%2Fnature02621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wersinger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidhu, A.</span></span> <span> </span><span class="NLM_article-title">Differential cytotoxicity of dopamine and H<sub>2</sub>O<sub>2</sub> in a human neuroblastoma divided cell line transfected with α-synuclein and its familial Parkinson’s disease-linked mutants</span>. <i>Neurosci. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>342</i></span>,  <span class="NLM_fpage">124</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1016/S0304-3940(03)00212-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2FS0304-3940%2803%2900212-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=12727333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjt1Ohsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2003&pages=124-128&author=C.+Wersingerauthor=A.+Sidhu&title=Differential+cytotoxicity+of+dopamine+and+H2O2+in+a+human+neuroblastoma+divided+cell+line+transfected+with+%CE%B1-synuclein+and+its+familial+Parkinson%E2%80%99s+disease-linked+mutants&doi=10.1016%2FS0304-3940%2803%2900212-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Differential cytotoxicity of dopamine and H2O2 in a human neuroblastoma divided cell line transfected with α-synuclein and its familial Parkinson's disease-linked mutants</span></div><div class="casAuthors">Wersinger, Christophe; Sidhu, Anita</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">342</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">124-128</span>CODEN:
                <span class="NLM_cas:coden">NELED5</span>;
        ISSN:<span class="NLM_cas:issn">0304-3940</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">α-Synuclein accumulates in Lewy bodies and two missense mutations, A30P and A53T, have been linked to familial Parkinson's disease.  Neither the normal function of α-synuclein nor the pathomechanism of α-synuclein-induced neuropathy are known.  SK-N-MC neuroblastoma cells were transiently transfected with either wt α-synuclein, or its mutants, and their abilities to protect against oxidative stress were assessed.  At low expression levels (1 μg cDNA/105 cells), all three synuclein variants were devoid of any effect on dopamine-induced cytotoxicity and nitrite prodn., whereas at higher expression (5 μg cDNA/105 cells), the variants enhanced dopamine-mediated effects.  Low levels of wt α-synuclein blocked H2O2-induced cytotoxicity and nitrite prodn., a protective effect that was partly decreased upon higher expression.  Both A30P and A53T increased in a dose-dependent manner H2O2-induced nitrite prodn. and cell death.  These results show an absence of protective effects for the A30P/A53T mutants, and a differential cytoprotective role of α-synuclein against oxidants, which varies according to expression levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzzgw5lWoTMbVg90H21EOLACvtfcHk0lhC4Xay_qy50Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjt1Ohsbk%253D&md5=4355895cf8a1ba0ba6542e9f68f4e03a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0304-3940%2803%2900212-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3940%252803%252900212-X%26sid%3Dliteratum%253Aachs%26aulast%3DWersinger%26aufirst%3DC.%26aulast%3DSidhu%26aufirst%3DA.%26atitle%3DDifferential%2520cytotoxicity%2520of%2520dopamine%2520and%2520H2O2%2520in%2520a%2520human%2520neuroblastoma%2520divided%2520cell%2520line%2520transfected%2520with%2520%25CE%25B1-synuclein%2520and%2520its%2520familial%2520Parkinson%25E2%2580%2599s%2520disease-linked%2520mutants%26jtitle%3DNeurosci.%2520Lett.%26date%3D2003%26volume%3D342%26spage%3D124%26epage%3D128%26doi%3D10.1016%2FS0304-3940%2803%2900212-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Serrano, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feito, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Mayorga, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diez-Orejas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matesanz, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portolés, M. T.</span></span> <span> </span><span class="NLM_article-title">Response of macrophages and neural cells in contact with reduced graphene oxide microfibers</span>. <i>Biomater. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">2987</span>– <span class="NLM_lpage">2997</span>, <span class="refDoi"> DOI: 10.1039/C8BM00902C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1039%2FC8BM00902C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=30255874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslGnu7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2018&pages=2987-2997&author=M.+C.+Serranoauthor=M.+J.+Feitoauthor=A.+Gonz%C3%A1lez-Mayorgaauthor=R.+Diez-Orejasauthor=M.+C.+Matesanzauthor=M.+T.+Portol%C3%A9s&title=Response+of+macrophages+and+neural+cells+in+contact+with+reduced+graphene+oxide+microfibers&doi=10.1039%2FC8BM00902C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Response of macrophages and neural cells in contact with reduced graphene oxide microfibers</span></div><div class="casAuthors">Serrano, M. C.; Feito, M. J.; Gonzalez-Mayorga, A.; Diez-Orejas, R.; Matesanz, M. C.; Portoles, M. T.</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2987-2997</span>CODEN:
                <span class="NLM_cas:coden">BSICCH</span>;
        ISSN:<span class="NLM_cas:issn">2047-4849</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Graphene-based materials are revealing a great promise for biomedical applications and demonstrating attractiveness for neural repair.  In the context of neural tissue damage, the dialogue between neural and immune cells appears crit. for driving regeneration, thus making the understanding of their relations pivotal.  Herein, the acute response of RAW-264.7 macrophages on nanostructured reduced graphene oxide (rGO) microfibers has been evaluated through the anal. of cell parameters including proliferation, viability, intracellular content of reactive oxygen species, cell cycle, apoptosis, and cell size and complexity.  The influence of the direct contact of rGO microfibers on their polarization towards M1 and M2 phenotypes has been studied by analyses of both M1 (CD80) and M2 (CD163) markers and the secretion of the inflammatory cytokines TNF-α and IL-6.  Finally, the capability of these rGO microfibers to regulate neural stem cell differentiation has been also evaluated.  Findings reveal that rGO microfibers inhibit the proliferation of RAW-264.7 macrophages without affecting their viability and cell cycle profiles.  The presence of M1 and M2 macrophages on these microfibers was confirmed after 24 and 48 h, resp., accompanied by a decrease in TNF-α and an increase in IL-6 cytokine secretion.  These rGO microfibers were also able to support the formation of a highly interconnected neural culture composed of both neurons (map2+ cells) and glial cells (vimentin+ cells).  These findings encourage further investigation of these microfibers as attractive biomaterials to interact with immune and neural cells, attempting to support wound healing and tissue repair after implantation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrihdOMvYqE5rVg90H21EOLACvtfcHk0liaTIK5ZHzfwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslGnu7zO&md5=8a2a3f27337d2e75299e0e8f49cf6cda</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1039%2FC8BM00902C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8BM00902C%26sid%3Dliteratum%253Aachs%26aulast%3DSerrano%26aufirst%3DM.%2BC.%26aulast%3DFeito%26aufirst%3DM.%2BJ.%26aulast%3DGonz%25C3%25A1lez-Mayorga%26aufirst%3DA.%26aulast%3DDiez-Orejas%26aufirst%3DR.%26aulast%3DMatesanz%26aufirst%3DM.%2BC.%26aulast%3DPortol%25C3%25A9s%26aufirst%3DM.%2BT.%26atitle%3DResponse%2520of%2520macrophages%2520and%2520neural%2520cells%2520in%2520contact%2520with%2520reduced%2520graphene%2520oxide%2520microfibers%26jtitle%3DBiomater.%2520Sci.%26date%3D2018%26volume%3D6%26spage%3D2987%26epage%3D2997%26doi%3D10.1039%2FC8BM00902C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turrens, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boveris, A.</span></span> <span> </span><span class="NLM_article-title">Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>191</i></span>,  <span class="NLM_fpage">421</span>– <span class="NLM_lpage">427</span>, <span class="refDoi"> DOI: 10.1042/bj1910421</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1042%2Fbj1910421" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=6263247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADyaL3MXlvF2mtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=1980&pages=421-427&author=J.+F.+Turrensauthor=A.+Boveris&title=Generation+of+superoxide+anion+by+the+NADH+dehydrogenase+of+bovine+heart+mitochondria&doi=10.1042%2Fbj1910421"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria</span></div><div class="casAuthors">Turrens, Julio F.; Boveris, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">421-7</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    </div><div class="casAbstract">Submitochondrial particles from bovine heart in which NADH dehydrogenase (I) was reduced by addn. of NADH and rotenone or by reversed electron transfer generated ∼0.9 nmol O2-/min/mg protein at pH 7.4 and 30°.  With NADH as substrate, rotenone, antimycin, and cyanide increased O2- prodn.  In NADH- and antimycin-supplemented submitochondrial particles, rotenone had a biphasic effect: it stimulated and inhibited O2- prodn. at the I and the ubiquinone-cytochrome b (II) sites, resp.  Generation of O2- by I supported by reversed electron transfer was inhibited by rotenone, an uncoupler, and oligomycin at concns. inhibitory to energy-dependent succinate-NAD reductase.  Cyanide did not affect and inhibited O2- generation at I and the II site, resp.  Prodn. of O2- at I was ∼50% of that at the II area.  Activity of these 2 O2--producing sites occurred over the pH range 7.0-8.8.  An O2--dependent autocatalytic process requiring NADH, submitochondrial particles, and adrenaline is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPMJIBopl-ZrVg90H21EOLACvtfcHk0liaTIK5ZHzfwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXlvF2mtg%253D%253D&md5=c2afbcbafe1c4a3e951e7bc67660a112</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1042%2Fbj1910421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj1910421%26sid%3Dliteratum%253Aachs%26aulast%3DTurrens%26aufirst%3DJ.%2BF.%26aulast%3DBoveris%26aufirst%3DA.%26atitle%3DGeneration%2520of%2520superoxide%2520anion%2520by%2520the%2520NADH%2520dehydrogenase%2520of%2520bovine%2520heart%2520mitochondria%26jtitle%3DBiochem.%2520J.%26date%3D1980%26volume%3D191%26spage%3D421%26epage%3D427%26doi%3D10.1042%2Fbj1910421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cullen, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinfeld, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, X. C.</span></span> <span> </span><span class="NLM_article-title">Arsenic binding to proteins</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">7769</span>– <span class="NLM_lpage">7792</span>, <span class="refDoi"> DOI: 10.1021/cr300015c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr300015c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVals7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2013&pages=7769-7792&author=S.+Shenauthor=X.-F.+Liauthor=W.+R.+Cullenauthor=M.+Weinfeldauthor=X.+C.+Le&title=Arsenic+binding+to+proteins&doi=10.1021%2Fcr300015c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Arsenic binding to proteins</span></div><div class="casAuthors">Shen, Shengwen; Li, Xing-Fang; Cullen, William R.; Weinfeld, Michael; Le, X. Chris</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">7769-7792</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The chem. basis and biol. implications and consequences of As binding to proteins are discussed.  Anal. techniques and the characteristics of As binding, including binding affinity, kinetics, and speciation are also described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCuo8emKPDRrVg90H21EOLACvtfcHk0lie5-fSxS4LVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVals7fO&md5=e7b8feb6cfc2faa2cf0e9c68666a04d4</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fcr300015c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr300015c%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.-F.%26aulast%3DCullen%26aufirst%3DW.%2BR.%26aulast%3DWeinfeld%26aufirst%3DM.%26aulast%3DLe%26aufirst%3DX.%2BC.%26atitle%3DArsenic%2520binding%2520to%2520proteins%26jtitle%3DChem.%2520Rev.%26date%3D2013%26volume%3D113%26spage%3D7769%26epage%3D7792%26doi%3D10.1021%2Fcr300015c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woods, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolthoff, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meehan, E. J.</span></span> <span> </span><span class="NLM_article-title">Arsenic (IV) as an intermediate in the induced oxidation of arsenic (III) by the iron (II)-hydrogen peroxide reaction</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1964</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">1698</span>– <span class="NLM_lpage">1700</span>, <span class="refDoi"> DOI: 10.1021/ja01063a011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01063a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADyaF2cXovVehtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1964&pages=1698-1700&author=R.+Woodsauthor=I.+M.+Kolthoffauthor=E.+J.+Meehan&title=Arsenic+%28IV%29+as+an+intermediate+in+the+induced+oxidation+of+arsenic+%28III%29+by+the+iron+%28II%29-hydrogen+peroxide+reaction&doi=10.1021%2Fja01063a011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Arsenic(IV) as an intermediate in the induced oxidation of arsenic(III) by the iron(II)-hydrogen peroxide reaction</span></div><div class="casAuthors">Woods, R.; Kolthoff, I. M.; Meehan, E. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1964</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1698-1700</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The Fe(II)-H2O2 couple induces the oxidn. of As(III).  The mechanism involving the intermediate formation of As(IV), is similar to that in the induced oxidn. of As (III) by the Fe(II)- peroxydisulfate couple and the photoredn. of Fe(III).  From a study of the induced oxidn. of As(III) at 25° the ratio of the rate consts. of the reactions of the hydroxyl free radical with As(III) and Fe(II) was calcd. to be 4, in satisfactory agreement with a value of 2 from the photoinduced oxidn. of As(III) by Fe(III).  This ratio for the active intermediate formed in the peroxydisulfate-Fe(II) reaction is 21.  In the Fe(II)-peroxydisulfate inducing reaction, SO4•- oxidizes As(III) to As(IV).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlhlq7XC-AmbVg90H21EOLACvtfcHk0liM4NLaE4BnFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2cXovVehtA%253D%253D&md5=28433794fae19f2059143db86b8e7b96</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fja01063a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01063a011%26sid%3Dliteratum%253Aachs%26aulast%3DWoods%26aufirst%3DR.%26aulast%3DKolthoff%26aufirst%3DI.%2BM.%26aulast%3DMeehan%26aufirst%3DE.%2BJ.%26atitle%3DArsenic%2520%2528IV%2529%2520as%2520an%2520intermediate%2520in%2520the%2520induced%2520oxidation%2520of%2520arsenic%2520%2528III%2529%2520by%2520the%2520iron%2520%2528II%2529-hydrogen%2520peroxide%2520reaction%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1964%26volume%3D86%26spage%3D1698%26epage%3D1700%26doi%3D10.1021%2Fja01063a011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Samikkannu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yih, L.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A. S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jan, K.-Y.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species are involved in arsenic trioxide inhibition of pyruvate dehydrogenase activity</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">409</span>– <span class="NLM_lpage">414</span>, <span class="refDoi"> DOI: 10.1021/tx025615j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx025615j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD3sXht1Snsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2003&pages=409-414&author=T.+Samikkannuauthor=C.-H.+Chenauthor=L.-H.+Yihauthor=A.+S.+S.+Wangauthor=S.-Y.+Linauthor=T.-C.+Chenauthor=K.-Y.+Jan&title=Reactive+oxygen+species+are+involved+in+arsenic+trioxide+inhibition+of+pyruvate+dehydrogenase+activity&doi=10.1021%2Ftx025615j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive Oxygen Species Are Involved in Arsenic Trioxide Inhibition of Pyruvate Dehydrogenase Activity</span></div><div class="casAuthors">Samikkannu, Thangavel; Chen, Chien-Hung; Yih, Ling-Huei; Wang, Alexander S. S.; Lin, Shu-Yu; Chen, Tsen-Chien; Jan, Kun-Yan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">409-414</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Arsenite was shown to inhibit pyruvate dehydrogenase (PDH) activity through binding to vicinal dithiols in pure enzyme and tissue ext. However, no data are available on how arsenite inhibits PDH activity in human cells.  The IC50 values for arsenic trioxide (As2O3) to inhibit the PDH activity in porcine heart pure enzyme prepn. and in human leukemia cell line HL60 cells were estd. to be 182 and 2 μM, resp.  Thus, As2O3 inactivation of PDH activity was about 90 times more potent in HL60 cells than in purified enzyme prepn.  The IC50 values for As2O3 and phenylarsine oxide to reduce the vicinal thiol content in HL60 cells were estd. to be 81.7 and 1.9 μM, resp.  Thus, As2O3 is a potent PDH inhibitor but a weak vicinal thiol reacting agent in HL60 cells.  Antioxidants but not dithiol compds. suppressed As2O3 inhibition of PDH activity in HL60 cells.  Conversely, dithiol compds. but not antioxidants suppressed the inhibition of PDH activity by phenylarsine oxide.  As2O3 increased H2O2 level in HL60 cells, but this was not obsd. for phenylarsine oxide.  Mitochondrial respiration inhibitors suppressed the As2O3-induced H2O2 prodn. and As2O3 inhibition of PDH activity.  Moreover, metal chelators ameliorated whereas Fenton metals aggravated As2O3 inhibition of PDH activity.  Treatment with H2O2 plus Fenton metals also decreased the PDH activity in HL60 cells. Therefore, it seems that As2O3 elevates H2O2 prodn. in mitochondria and this may produce hydroxyl through the Fenton reaction and result in oxidative damage to the protein of PDH.  The present results suggest that arsenite may cause protein oxidn. to inactivate an enzyme and this can occur at a much lower concn. than arsenite binding directly to the crit. thiols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3WDxekjR7SbVg90H21EOLACvtfcHk0liM4NLaE4BnFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXht1Snsbc%253D&md5=acc83a4bbd5f02152132470230736a3d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Ftx025615j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx025615j%26sid%3Dliteratum%253Aachs%26aulast%3DSamikkannu%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DC.-H.%26aulast%3DYih%26aufirst%3DL.-H.%26aulast%3DWang%26aufirst%3DA.%2BS.%2BS.%26aulast%3DLin%26aufirst%3DS.-Y.%26aulast%3DChen%26aufirst%3DT.-C.%26aulast%3DJan%26aufirst%3DK.-Y.%26atitle%3DReactive%2520oxygen%2520species%2520are%2520involved%2520in%2520arsenic%2520trioxide%2520inhibition%2520of%2520pyruvate%2520dehydrogenase%2520activity%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2003%26volume%3D16%26spage%3D409%26epage%3D414%26doi%3D10.1021%2Ftx025615j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imlay, J. A.</span></span> <span> </span><span class="NLM_article-title">The molecular mechanisms and physiological consequences of oxidative stress: lessons from a model bacterium</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">443</span>– <span class="NLM_lpage">454</span>, <span class="refDoi"> DOI: 10.1038/nrmicro3032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1038%2Fnrmicro3032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=23712352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3sXot1Cntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=443-454&author=J.+A.+Imlay&title=The+molecular+mechanisms+and+physiological+consequences+of+oxidative+stress%3A+lessons+from+a+model+bacterium&doi=10.1038%2Fnrmicro3032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular mechanisms and physiological consequences of oxidative stress: lessons from a model bacterium</span></div><div class="casAuthors">Imlay, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">443-454</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Oxic environments are hazardous.  Mol. oxygen adventitiously abstrs. electrons from many redox enzymes, continuously forming intracellular superoxide and hydrogen peroxide.  These species can destroy the activities of metalloenzymes and the integrity of DNA, forcing organisms to protect themselves with scavenging enzymes and repair systems.  Nevertheless, elevated levels of oxidants quickly poison bacteria, and both microbial competitors and hostile eukaryotic hosts exploit this vulnerability by assaulting these bacteria with peroxides or superoxide-forming antibiotics.  In response, bacteria activate elegant adaptive strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9r4YH3uuc_7Vg90H21EOLACvtfcHk0liM4NLaE4BnFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXot1Cntbw%253D&md5=781f5ceb7a2ffc72b902952df5f2c39e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro3032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro3032%26sid%3Dliteratum%253Aachs%26aulast%3DImlay%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520molecular%2520mechanisms%2520and%2520physiological%2520consequences%2520of%2520oxidative%2520stress%253A%2520lessons%2520from%2520a%2520model%2520bacterium%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2013%26volume%3D11%26spage%3D443%26epage%3D454%26doi%3D10.1038%2Fnrmicro3032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winterbourn, C. C.</span></span> <span> </span><span class="NLM_article-title">Reconciling the chemistry and biology of reactive oxygen species</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">278</span>– <span class="NLM_lpage">286</span>, <span class="refDoi"> DOI: 10.1038/nchembio.85</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1038%2Fnchembio.85" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=18421291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvVSmtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=278-286&author=C.+C.+Winterbourn&title=Reconciling+the+chemistry+and+biology+of+reactive+oxygen+species&doi=10.1038%2Fnchembio.85"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Reconciling the chemistry and biology of reactive oxygen species</span></div><div class="casAuthors">Winterbourn, Christine C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">278-286</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There is a vast literature on the generation and effects of reactive oxygen species in biol. systems, both in relation to damage they cause and their involvement in cell regulatory and signaling pathways.  The biol. chem. of different oxidants is becoming well understood, but it is often unclear how this translates into cellular mechanisms where redox changes have been demonstrated.  This review addresses this gap.  It examines how target selectivity and antioxidant effectiveness vary for different oxidants.  Kinetic considerations of reactivity are used to assess likely targets in cells and how reactions might be influenced by restricted diffusion and compartmentalization.  It also highlights areas where greater understanding is required on the fate of oxidants generated by cellular NADPH oxidases and on the identification of oxidant sensors in cell signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwwgXqt-zxS7Vg90H21EOLACvtfcHk0ljJJNgqjtwyVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvVSmtLo%253D&md5=c3752b90c8da55d7144dce6cfabbf836</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.85&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.85%26sid%3Dliteratum%253Aachs%26aulast%3DWinterbourn%26aufirst%3DC.%2BC.%26atitle%3DReconciling%2520the%2520chemistry%2520and%2520biology%2520of%2520reactive%2520oxygen%2520species%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D4%26spage%3D278%26epage%3D286%26doi%3D10.1038%2Fnchembio.85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Szatrowski, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nathan, C. F.</span></span> <span> </span><span class="NLM_article-title">Production of large amounts of hydrogen peroxide by human tumor cells</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">794</span>– <span class="NLM_lpage">798</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1846317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADyaK3MXpvFagsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1991&pages=794-798&author=T.+P.+Szatrowskiauthor=C.+F.+Nathan&title=Production+of+large+amounts+of+hydrogen+peroxide+by+human+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Production of large amounts of hydrogen peroxide by human tumor cells</span></div><div class="casAuthors">Szatrowski, Ted P.; Nathan, Carl F.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">794-8</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">Few nonphagocytic cells are known to generate reactive oxygen intermediates.  Based on horseradish peroxidase-dependent, catalase-inhibitable oxidn. of fluorescent scopoletin, seven human tumor cell lines constitutively elaborated H2O2 at rates (up to 0.5 nmol/104) cells/h) large enough that cumulative amts. at 4 h were comparable to the amt. of H2O2 produced by phorbol ester-triggered neutrophils.  Superoxide dismutase-inhibitable ferricytochrome c redn. was detectable at much lower rates.  H2O2 prodn. was inhibited by diphenyleneiodonium, a flavoprotein binder (concn. producing 50% inhibition, 0.3 μM), and diethyldithiocarbamate, a divalent cation chelator (concn. producing 50% inhibition, 3 μM), but not by cyanide or azide, inhibitors of electron transport, or by agents that inhibit xanthine oxidase, polyamine oxidase, or cytochrome P 450.  Cytochrome b559, present in human phagocytes and lymphocytes, was undetectable in these tumor cells by a sensitive spectrophotometric method.  Mouse fibroblasts transfected with human tyrosinase cDNA made melanin, but not H2O2.  Constitutive generation of large amts. of reactive oxygen intermediates, if it occurs in vivo, might contribute to the ability of some tumors to mutate, inhibit antiproteases, injure local tissues, and therefore promote tumor heterogeneity, invasion, and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_BGOBNQut4bVg90H21EOLACvtfcHk0ljJJNgqjtwyVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXpvFagsw%253D%253D&md5=d3efc9540319fa746cbafcef8fd4a2d5</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSzatrowski%26aufirst%3DT.%2BP.%26aulast%3DNathan%26aufirst%3DC.%2BF.%26atitle%3DProduction%2520of%2520large%2520amounts%2520of%2520hydrogen%2520peroxide%2520by%2520human%2520tumor%2520cells%26jtitle%3DCancer%2520Res.%26date%3D1991%26volume%3D51%26spage%3D794%26epage%3D798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of nonquinone substrates for NAD(P)H: quinone oxidoreductase 1 (NQO1) as Effective Intracellular ROS generators for the treatment of drug-resistant non-small-cell lung cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">11280</span>– <span class="NLM_lpage">11297</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01424</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01424" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVSgs7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=11280-11297&author=X.+Wuauthor=X.+Liauthor=Z.+Liauthor=Y.+Yuauthor=Q.+Youauthor=X.+Zhang&title=Discovery+of+nonquinone+substrates+for+NAD%28P%29H%3A+quinone+oxidoreductase+1+%28NQO1%29+as+Effective+Intracellular+ROS+generators+for+the+treatment+of+drug-resistant+non-small-cell+lung+cancer&doi=10.1021%2Facs.jmedchem.8b01424"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Nonquinone Substrates for NAD(P)H: Quinone Oxidoreductase 1 (NQO1) as Effective Intracellular ROS Generators for the Treatment of Drug-Resistant Non-Small-Cell Lung Cancer</span></div><div class="casAuthors">Wu, Xingsen; Li, Xiang; Li, Zhihong; Yu, Yancheng; You, Qidong; Zhang, Xiaojin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11280-11297</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The elevation of oxidative stress preferentially in cancer cells by efficient NQO1 substrates, which promote ROS generation through redox cycling, has emerged as an effective strategy for cancer therapy, even for treating drug-resistant cancers.  Here, we described the identification and structural optimization studies of the hit compd. 1, a new chemotype of nonquinone substrate for NQO1 as an efficient ROS generator.  Further structure-activity relationship studies resulted in the most active compd. 20k, a tricyclic 2,3-dicyano indenopyrazinone, which selectively inhibited the proliferation of NQO1-overexpressing A549 and A549/Taxol cancer cells.  Furthermore, 20k dramatically elevated the intracellular ROS levels through NQO1-catalyzed redox cycling and induced PARP-1-mediated cell apoptosis in A549/Taxol cells.  In addn., 20k significantly suppressed the growth of A549/Taxol xenograft tumors in mice with no apparent toxicity obsd. in vivo.  Together, 20k acts as an efficient NQO1 substrate and may be a new option for the treatment of NQO1-overexpresssing drug-resistant NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2n_XSHF05XLVg90H21EOLACvtfcHk0lh2HTkjn_0e8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVSgs7rJ&md5=2d7ed264c0d24f7ac7e6ea3a474f3601</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01424%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520nonquinone%2520substrates%2520for%2520NAD%2528P%2529H%253A%2520quinone%2520oxidoreductase%25201%2520%2528NQO1%2529%2520as%2520Effective%2520Intracellular%2520ROS%2520generators%2520for%2520the%2520treatment%2520of%2520drug-resistant%2520non-small-cell%2520lung%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D11280%26epage%3D11297%26doi%3D10.1021%2Facs.jmedchem.8b01424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dharmaraja, A. T.</span></span> <span> </span><span class="NLM_article-title">Role of reactive oxygen species (ROS) in therapeutics and drug resistance in cancer and bacteria</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3221</span>– <span class="NLM_lpage">3240</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01243</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01243" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVSjsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3221-3240&author=A.+T.+Dharmaraja&title=Role+of+reactive+oxygen+species+%28ROS%29+in+therapeutics+and+drug+resistance+in+cancer+and+bacteria&doi=10.1021%2Facs.jmedchem.6b01243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Reactive Oxygen Species (ROS) in Therapeutics and Drug Resistance in Cancer and Bacteria</span></div><div class="casAuthors">Dharmaraja, Allimuthu T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3221-3240</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Evading persistent drug resistance in cancer and bacteria to most of the com. used drugs is necessary to restore the human health settings.  A distinct property of cancer phenotype is enhanced glucose metab. and oxidative stress from normal cells.  Reactive oxygen species (ROS) are metabolic byproducts of aerobic respiration and are responsible for maintaining redox homeostasis in cells.  Maintaining the redox balance in cancerous cells are found to be crit. for their survival, which is modulated by reduced thiols and reducing cofactors NAD(P)H.  Thus altering the levels reducing equiv. were found to enhance intracellular ROS and sensitize cancer cells to therapeutics.  Similarly, Escherichia coli and life threatening infectious pathogens such as Staphylococcus aureus and Mycobacterium tuberculosis were found to be more sensitive to modulation of intracellular oxidative environment.  Combination drug strategies were successfully employed in attenuating the effects of drug resistant cancer and bacterial.  Here, a collection of some ROS modulation based cancer and bacterial therapeutics is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoshDBtCrwl5LVg90H21EOLACvtfcHk0lh2HTkjn_0e8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVSjsrY%253D&md5=71bfb8f37ab75364fedcb07de262fc2c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01243%26sid%3Dliteratum%253Aachs%26aulast%3DDharmaraja%26aufirst%3DA.%2BT.%26atitle%3DRole%2520of%2520reactive%2520oxygen%2520species%2520%2528ROS%2529%2520in%2520therapeutics%2520and%2520drug%2520resistance%2520in%2520cancer%2520and%2520bacteria%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3221%26epage%3D3240%26doi%3D10.1021%2Facs.jmedchem.6b01243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Current development of ROS-modulating agents as novel antitumor therapy</span>. <i>Curr. Cancer Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">122</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.2174/1568009616666160216125833</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.2174%2F1568009616666160216125833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=26881931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1eksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=122-136&author=N.+Wangauthor=Y.+Wuauthor=J.+Bianauthor=X.+Qianauthor=H.+Linauthor=H.+Sunauthor=Q.+Youauthor=X.+Zhang&title=Current+development+of+ROS-modulating+agents+as+novel+antitumor+therapy&doi=10.2174%2F1568009616666160216125833"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Current Development of ROS-Modulating Agents as Novel Antitumor Therapy</span></div><div class="casAuthors">Wang, Nan; Wu, Yue; Bian, Jinlei; Qian, Xue; Lin, Hongzhi; Sun, Haopeng; You, Qidong; Zhang, Xiaojin</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">122-136</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Compared to normal cells, usually cancer cells are under higher oxidative stress.  Elevating intracellular levels of reactive oxygen species (ROS) by introducing excessive ROS or inhibiting antioxidant system may enhance selectively of cancer cell killing by ROS-modulating agents through stress sensitization or stress overload.  Meanwhile due to the adaptive response, normal cells may be capable of maintaining redox homeostasis under exogenous ROS.  Here we review ROS-modulating agents in different mechanisms and classify them into groups by various targets for illustrating more clearly.  At last, we discuss their side effects and the potential troubles of developing these agents and argue that might be an effective strategy for further exploring to modulate the unique redox regulatory mechanisms of cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGiT3Tj48T9bVg90H21EOLACvtfcHk0lh2HTkjn_0e8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1eksbo%253D&md5=02ac2a93c914054fad81a62f98d6214f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2174%2F1568009616666160216125833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009616666160216125833%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DCurrent%2520development%2520of%2520ROS-modulating%2520agents%2520as%2520novel%2520antitumor%2520therapy%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2017%26volume%3D17%26spage%3D122%26epage%3D136%26doi%3D10.2174%2F1568009616666160216125833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span> <span> </span><span class="NLM_article-title">Bioinspired polydopamine-coated hemoglobin as potential oxygen carrier with antioxidant properties</span>. <i>Biomacromolecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1333</span>– <span class="NLM_lpage">1341</span>, <span class="refDoi"> DOI: 10.1021/acs.biomac.7b00077</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biomac.7b00077" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXksFalu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=1333-1341&author=Q.+Wangauthor=R.+Zhangauthor=M.+Luauthor=G.+Youauthor=Y.+Wangauthor=G.+Chenauthor=C.+Zhaoauthor=Z.+Wangauthor=X.+Songauthor=Y.+Wuauthor=L.+Zhaoauthor=H.+Zhou&title=Bioinspired+polydopamine-coated+hemoglobin+as+potential+oxygen+carrier+with+antioxidant+properties&doi=10.1021%2Facs.biomac.7b00077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Bioinspired Polydopamine-Coated Hemoglobin as Potential Oxygen Carrier with Antioxidant Properties</span></div><div class="casAuthors">Wang, Quan; Zhang, Ruirui; Lu, Mingzi; You, Guoxing; Wang, Ying; Chen, Gan; Zhao, Caiyan; Wang, Zhen; Song, Xiang; Wu, Yan; Zhao, Lian; Zhou, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Biomacromolecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1333-1341</span>CODEN:
                <span class="NLM_cas:coden">BOMAF6</span>;
        ISSN:<span class="NLM_cas:issn">1525-7797</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oxidative side reaction is one of the major factors hindering the development of Hb-based oxygen carriers (HBOCs).  To avoid the oxidative toxicity, we designed and synthesized polydopamine-coated Hb (Hb-PDA) nanoparticles via simple one-step assemblage without any toxic reagent.  Hb-PDA nanoparticles showed oxidative protection of Hb by inhibiting the generation of metHb (MetHb) and ferryl (Fe IV) Hb, as well as excellent antioxidant properties by scavenging free radicals and reactive oxygen species (ROS).  Interestingly, the scavenging rate of Hb-PDA nanoparticles for ABTS+ radical is at most 89%, while for DPPH radical it reaches 49%.  In addn., Hb-PDA efficiently reduced the intracellular H2O2-induced ROS generation.  Moreover, Hb-PDA nanoparticles exhibited high oxygen affinity, low effect on blood constituents, and low cytotoxicity.  The results indicate that polydopamine-coated Hb might be a promising approach for constructing novel oxygen carriers with the capacity to reduce oxidative side reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBO_fIOaqWdbVg90H21EOLACvtfcHk0ljsm3K-5Da-dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXksFalu70%253D&md5=72e546fc6d5cead2fa95fde72bac5926</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.biomac.7b00077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biomac.7b00077%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DYou%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DH.%26atitle%3DBioinspired%2520polydopamine-coated%2520hemoglobin%2520as%2520potential%2520oxygen%2520carrier%2520with%2520antioxidant%2520properties%26jtitle%3DBiomacromolecules%26date%3D2017%26volume%3D18%26spage%3D1333%26epage%3D1341%26doi%3D10.1021%2Facs.biomac.7b00077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giorgio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trinei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Migliaccio, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelicci, P. G.</span></span> <span> </span><span class="NLM_article-title">Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals?</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">722</span>– <span class="NLM_lpage">728</span>, <span class="refDoi"> DOI: 10.1038/nrm2240</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1038%2Fnrm2240" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=17700625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsVartbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=722-728&author=M.+Giorgioauthor=M.+Trineiauthor=E.+Migliaccioauthor=P.+G.+Pelicci&title=Hydrogen+peroxide%3A+a+metabolic+by-product+or+a+common+mediator+of+ageing+signals%3F&doi=10.1038%2Fnrm2240"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals?</span></div><div class="casAuthors">Giorgio, Marco; Trinei, Mirella; Migliaccio, Enrica; Pelicci, Pier Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">722-728</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The reactive oxygen species that are generated by mitochondrial respiration, including hydrogen peroxide (H2O2), are potent inducers of oxidative damage and mediators of aging.  It is not clear, however, whether oxidative stress is the result of a genetic program or the byproduct of physiol. processes.  Recent findings demonstrate that a fraction of mitochondrial H2O2, produced by a specialized enzyme as a signaling mol. in the pathway of apoptosis, induces intracellular oxidative stress and accelerates aging.  We propose that genes that control H2O2 prodn. are selected determinants of lifespan.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDrDSwJY70j7Vg90H21EOLACvtfcHk0ljsm3K-5Da-dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsVartbw%253D&md5=73d82a630334210de966bd03a2efe428</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnrm2240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2240%26sid%3Dliteratum%253Aachs%26aulast%3DGiorgio%26aufirst%3DM.%26aulast%3DTrinei%26aufirst%3DM.%26aulast%3DMigliaccio%26aufirst%3DE.%26aulast%3DPelicci%26aufirst%3DP.%2BG.%26atitle%3DHydrogen%2520peroxide%253A%2520a%2520metabolic%2520by-product%2520or%2520a%2520common%2520mediator%2520of%2520ageing%2520signals%253F%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2007%26volume%3D8%26spage%3D722%26epage%3D728%26doi%3D10.1038%2Fnrm2240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nohl, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gille, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staniek, K.</span></span> <span> </span><span class="NLM_article-title">Intracellular generation of reactive oxygen species by mitochondria</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">719</span>– <span class="NLM_lpage">723</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2004.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.bcp.2004.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=15710349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlCrsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2005&pages=719-723&author=H.+Nohlauthor=L.+Gilleauthor=K.+Staniek&title=Intracellular+generation+of+reactive+oxygen+species+by+mitochondria&doi=10.1016%2Fj.bcp.2004.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular generation of reactive oxygen species by mitochondria</span></div><div class="casAuthors">Nohl, Hans; Gille, Lars; Staniek, Katrin</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">719-723</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Mitochondria have bioenergetic properties that strongly suggest their involvement in the cellular formation of reactive oxygen species (ROS).  Apparent confirmation of this process has come from work with isolated mitochondria, which have been shown to produce H2O2 from dismutating superoxide radicals.  Two different sites were reported to shuttle single electrons to oxygen out of the normal respiratory sequence.  However, the mechanisms for ROS formation at these two sites are controversial.  Arguments against mitochondrial ROS formation in the living cell are based on the fact that bioenergetic alterations may result from the mech. removal of mitochondria from their natural environment.  Furthermore, the invasive detection methods that are generally used may be inappropriate because of the possible interaction of the detection system with mitochondrial constituents.  The use of non-invasive detection methods has proved that ROS formation does not occur unless changes in the phys. state of the membrane are established.  The aim of this commentary is to discuss critically the arguments in favor of mitochondria as the main intracellular source of ROS.  The pros and cons of working with isolated mitochondria, as well as the detection methodol. are carefully analyzed to judge whether or not the above assumption is correct.  The conclusion that mitochondria are the main ROS generators in the cell contradicts the fact that ROS release was not obsd.  However, if electron flow from ubiquinol to the bc1 complex is hindered due to changes in lipid fluidity, single electrons may transfer to dioxygen and produce H2O2 via superoxide radicals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsr722uOiHHbVg90H21EOLACvtfcHk0lgo7uybFgl_EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlCrsLo%253D&md5=c914297a48790bf23147bf21793a1049</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2004.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2004.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DNohl%26aufirst%3DH.%26aulast%3DGille%26aufirst%3DL.%26aulast%3DStaniek%26aufirst%3DK.%26atitle%3DIntracellular%2520generation%2520of%2520reactive%2520oxygen%2520species%2520by%2520mitochondria%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2005%26volume%3D69%26spage%3D719%26epage%3D723%26doi%3D10.1016%2Fj.bcp.2004.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Veal, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, B.</span></span> <span> </span><span class="NLM_article-title">Hydrogen peroxide sensing and signaling</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2007.03.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.molcel.2007.03.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=17434122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkvFSrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=1-14&author=E.+Vealauthor=A.+Dayauthor=B.+Morgan&title=Hydrogen+peroxide+sensing+and+signaling&doi=10.1016%2Fj.molcel.2007.03.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrogen peroxide sensing and signaling</span></div><div class="casAuthors">Veal, Elizabeth A.; Day, Alison M.; Morgan, Brian A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-14</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  It is well established that oxidative stress is an important cause of cell damage assocd. with the initiation and progression of many diseases.  Consequently, all air-living organisms contain antioxidant enzymes that limit oxidative stress by detoxifying reactive oxygen species, including hydrogen peroxide.  However, in eukaryotes, hydrogen peroxide also has important roles as a signaling mol. in the regulation of a variety of biol. processes.  Here, we will discuss the mol. mechanisms by which hydrogen peroxide is sensed and the increasing evidence that antioxidant enzymes play multiple, key roles as sensors and regulators of signal transduction in response to hydrogen peroxide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWVi5MYuUMYrVg90H21EOLACvtfcHk0lgo7uybFgl_EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkvFSrtr4%253D&md5=de089e276a6cbd7e58d3e92279eeae1d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2007.03.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2007.03.016%26sid%3Dliteratum%253Aachs%26aulast%3DVeal%26aufirst%3DE.%26aulast%3DDay%26aufirst%3DA.%26aulast%3DMorgan%26aufirst%3DB.%26atitle%3DHydrogen%2520peroxide%2520sensing%2520and%2520signaling%26jtitle%3DMol.%2520Cell%26date%3D2007%26volume%3D26%26spage%3D1%26epage%3D14%26doi%3D10.1016%2Fj.molcel.2007.03.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minakami, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamiya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumimoto, H.</span></span> <span> </span><span class="NLM_article-title">Visualization of phagosomal hydrogen peroxide production by a novel fluorescent probe that is localized via SNAP-Tag labeling</span>. <i>Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">5983</span>– <span class="NLM_lpage">5990</span>, <span class="refDoi"> DOI: 10.1021/ac501041w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ac501041w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2cXos1Wru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=5983-5990&author=M.+Aboauthor=R.+Minakamiauthor=K.+Miyanoauthor=M.+Kamiyaauthor=T.+Naganoauthor=Y.+Uranoauthor=H.+Sumimoto&title=Visualization+of+phagosomal+hydrogen+peroxide+production+by+a+novel+fluorescent+probe+that+is+localized+via+SNAP-Tag+labeling&doi=10.1021%2Fac501041w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Visualization of Phagosomal Hydrogen Peroxide Production by a Novel Fluorescent Probe That Is Localized via SNAP-tag Labeling</span></div><div class="casAuthors">Abo, Masahiro; Minakami, Reiko; Miyano, Kei; Kamiya, Mako; Nagano, Tetsuo; Urano, Yasuteru; Sumimoto, Hideki</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5983-5990</span>CODEN:
                <span class="NLM_cas:coden">ANCHAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2700</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hydrogen peroxide (H2O2), a member of reactive oxygen species (ROS), plays diverse physiol. roles including host defense and cellular signal transduction.  During ingestion of invading microorganisms, professional phagocytes such as macrophages release H2O2 specifically into the phagosome to direct toxic ROS toward engulfed microbes.  Although H2O2 is considered to exert discrete effects in living systems depending on location of its prodn., accumulation, and consumption, there have been limitations of techniques for probing this oxygen metabolite with high mol. specificity at the subcellular resoln.  Here the authors describe the development of an O6-benzylguanine deriv. of 5-(4-nitrobenzoyl)carbonylfluorescein (NBzF-BG), a novel H2O2-specific fluorescent probe; NBzF-BG is covalently and selectively conjugated with the SNAP-tag protein, giving the fluorophore-protein conjugate (SNAP-NBzF).  SNAP-NBzF rapidly reacts with H2O2 and thereby shows a 9-fold enhancement in fluorescence.  When SNAP-tag is expressed in HEK293T cells and RAW264.7 macrophages as a protein C-terminally fused to the transmembrane domain of platelet-derived growth factor receptor (PDGFR), the tag is presented on the outside of the plasma membrane; conjugation of NBzF-BG with the cell surface SNAP-tag enables detection of H2O2 added exogenously.  The authors also demonstrate mol. imaging of H2O2 that is endogenously produced in phagosomes of macrophages ingesting IgG-coated latex beads.  Thus, NBzF-BG, combined with the SNAP-tag technol., should be useful as a tool to measure local prodn. of H2O2 in living cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-cSshzkJ8gLVg90H21EOLACvtfcHk0lgo7uybFgl_EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXos1Wru74%253D&md5=981c12edf0a5379d8be7ebd818be2902</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fac501041w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fac501041w%26sid%3Dliteratum%253Aachs%26aulast%3DAbo%26aufirst%3DM.%26aulast%3DMinakami%26aufirst%3DR.%26aulast%3DMiyano%26aufirst%3DK.%26aulast%3DKamiya%26aufirst%3DM.%26aulast%3DNagano%26aufirst%3DT.%26aulast%3DUrano%26aufirst%3DY.%26aulast%3DSumimoto%26aufirst%3DH.%26atitle%3DVisualization%2520of%2520phagosomal%2520hydrogen%2520peroxide%2520production%2520by%2520a%2520novel%2520fluorescent%2520probe%2520that%2520is%2520localized%2520via%2520SNAP-Tag%2520labeling%26jtitle%3DAnal.%2520Chem.%26date%3D2014%26volume%3D86%26spage%3D5983%26epage%3D5990%26doi%3D10.1021%2Fac501041w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lippert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van de Bittner, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span> <span> </span><span class="NLM_article-title">Boronate oxidation as a bioorthogonal reaction approach for studying the chemistry of hydrogen peroxide in living systems</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">793</span>– <span class="NLM_lpage">804</span>, <span class="refDoi"> DOI: 10.1021/ar200126t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ar200126t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVWhu7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2011&pages=793-804&author=A.+Lippertauthor=G.+Van+de+Bittnerauthor=C.+Chang&title=Boronate+oxidation+as+a+bioorthogonal+reaction+approach+for+studying+the+chemistry+of+hydrogen+peroxide+in+living+systems&doi=10.1021%2Far200126t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Boronate Oxidation as a Bioorthogonal Reaction Approach for Studying the Chemistry of Hydrogen Peroxide in Living Systems</span></div><div class="casAuthors">Lippert, Alexander R.; Van de Bittner, Genevieve C.; Chang, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">793-804</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Reactive oxygen species (ROS), such as hydrogen peroxide, are important products of oxygen metab. that, when misregulated, can accumulate and cause oxidative stress inside cells.  Accordingly, organisms have evolved mol. systems, including antioxidant metalloenzymes (such as superoxide dismutase and catalase) and an array of thiol-based redox couples, to neutralize this threat to the cell when it occurs.  On the other hand, emerging evidence shows that the controlled generation of ROS, particularly H2O2, is necessary to maintain cellular fitness.  The identification of NADPH oxidase enzymes, which generate specific ROS and reside in virtually all cell types throughout the body, is a prime example.  Indeed, a growing body of work shows that H2O2 and other ROS have essential functions in healthy physiol. signaling pathways.  The signal-stress dichotomy of H2O2 serves as a source of motivation for disentangling its beneficial from its detrimental effects on living systems.  Mol. imaging of this oxygen metabolite with reaction-based probes is a powerful approach for real-time, noninvasive monitoring of H2O2 chem. in biol. specimens, but two key challenges to studying H2O2 in this way are chemoselectivity and bioorthogonality of probe mols.  Chemoselectivity is problematic because traditional methods for ROS detection suffer from nonspecific reactivity with other ROS.  Moreover, some methods require enzymic additives not compatible with live-cell or live-animal specimens.  Addnl., bioorthogonality requires that the reactions must not compete with or disturb intrinsic cellular chem.; this requirement is particularly crit. with thiol- or metal-based couples mediating the major redox events within the cell.  Chemoselective bioorthogonal reactions, such as alkyne-azide cycloaddns. and related click reactions, the Staudinger-Bertozzi ligation, and the transformations used in various reaction-based mol. probes, have found widespread application in the modification, labeling, and detection of biol. mols. and processes.  In this Account, we summarize H2O2 studies from our lab. using the H2O2-mediated oxidn. of aryl boronates to phenols as a bioorthogonal approach to detect fluxes of this important ROS in living systems.  We have installed this versatile switch onto org. and inorg. scaffolds to serve as "turn-on" probes for visible and near-IR (NIR) fluorescence, ratiometric fluorescence, time-gated lanthanide luminescence, and in vivo bioluminescence detection of H2O2 in living cells and animals.  Further chem. and genetic manipulations target these probes to specific organelles and other subcellular locales and can also allow them to be trapped intracellularly, enhancing their sensitivity.  These novel chem. tools have revealed fundamental new biol. insights into the prodn., localization, trafficking, and in vivo roles of H2O2 in a wide variety of living systems, including immune, cancer, stem, and neural cell models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphrbStUZBTbLVg90H21EOLACvtfcHk0lhjMwW65HENOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVWhu7rL&md5=4a9adb2c4dc443679cb4ea4ee0eee648</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Far200126t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far200126t%26sid%3Dliteratum%253Aachs%26aulast%3DLippert%26aufirst%3DA.%26aulast%3DVan%2Bde%2BBittner%26aufirst%3DG.%26aulast%3DChang%26aufirst%3DC.%26atitle%3DBoronate%2520oxidation%2520as%2520a%2520bioorthogonal%2520reaction%2520approach%2520for%2520studying%2520the%2520chemistry%2520of%2520hydrogen%2520peroxide%2520in%2520living%2520systems%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2011%26volume%3D44%26spage%3D793%26epage%3D804%26doi%3D10.1021%2Far200126t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dickinson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span> <span> </span><span class="NLM_article-title">Chemistry and biology of reactive oxygen species in signaling or stress responses</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">504</span>– <span class="NLM_lpage">511</span>, <span class="refDoi"> DOI: 10.1038/nchembio.607</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1038%2Fnchembio.607" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=21769097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFyhsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=504-511&author=B.+Dickinsonauthor=C.+Chang&title=Chemistry+and+biology+of+reactive+oxygen+species+in+signaling+or+stress+responses&doi=10.1038%2Fnchembio.607"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry and biology of reactive oxygen species in signaling or stress responses</span></div><div class="casAuthors">Dickinson, Bryan C.; Chang, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">504-511</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Reactive O species (ROS) are a family of mols. that are continuously generated, transformed and consumed in all living organisms as a consequence of aerobic life.  The traditional view of these reactive O metabolites is one of oxidative stress and damage that leads to decline of tissue and organ systems in aging and disease.  However, emerging data show that ROS produced in certain situations can also contribute to physiol. and increased fitness.  Here, the authors provide a focused discussion on what factors lead ROS mols. to become signal and/or stress agents, highlighting how increasing knowledge of the underlying chem. of ROS can lead to advances in understanding their disparate contributions to biol.  An important facet of this emerging area at the chem.-biol. interface is the development of new tools to study these small mols. and their reactivity in complex biol. systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8yowqTyr7O7Vg90H21EOLACvtfcHk0lhjMwW65HENOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFyhsL4%253D&md5=320823c1c7f9013a7c8f3d6c2f3f6952</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.607%26sid%3Dliteratum%253Aachs%26aulast%3DDickinson%26aufirst%3DB.%26aulast%3DChang%26aufirst%3DC.%26atitle%3DChemistry%2520and%2520biology%2520of%2520reactive%2520oxygen%2520species%2520in%2520signaling%2520or%2520stress%2520responses%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D504%26epage%3D511%26doi%3D10.1038%2Fnchembio.607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishna, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corpe, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buettner, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shacter, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, M.</span></span> <span> </span><span class="NLM_article-title">Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">13604</span>– <span class="NLM_lpage">13609</span>, <span class="refDoi"> DOI: 10.1073/pnas.0506390102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1073%2Fpnas.0506390102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=16157892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVygtr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=13604-13609&author=Q.+Chenauthor=M.+Espeyauthor=M.+Krishnaauthor=J.+Mitchellauthor=C.+Corpeauthor=G.+Buettnerauthor=E.+Shacterauthor=M.+Levine&title=Pharmacologic+ascorbic+acid+concentrations+selectively+kill+cancer+cells%3A+action+as+a+pro-drug+to+deliver+hydrogen+peroxide+to+tissues&doi=10.1073%2Fpnas.0506390102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues</span></div><div class="casAuthors">Chen, Qi; Espey, Michael Graham; Krishna, Murali C.; Mitchell, James B.; Corpe, Christopher P.; Buettner, Garry R.; Shacter, Emily; Levine, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">13604-13609</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Human pharmacokinetics data indicate that i.v. ascorbic acid (ascorbate) in pharmacol. concns. could have an unanticipated role in cancer treatment.  Our goals here were to test whether ascorbate killed cancer cells selectively, and if so, to det. mechanisms, using clin. relevant conditions.  Cell death in 10 cancer and 4 normal cell types was measured by using 1-h exposures.  Normal cells were unaffected by 20 mM ascorbate, whereas 5 cancer lines had EC50 values of <4 mM, a concn. easily achievable i.v.  Human lymphoma cells were studied in detail because of their sensitivity to ascorbate (EC50 of 0.5 mM) and suitability for addressing mechanisms.  Extracellular but not intracellular ascorbate mediated cell death, which occurred by apoptosis and pyknosis/necrosis.  Cell death was independent of metal chelators and absolutely dependent on H2O2 formation.  Cell death from H2O2 added to cells was identical to that found when H2O2 was generated by ascorbate treatment.  H2O2 generation was dependent on ascorbate concn., incubation time, and the presence of 0.5-10% serum, and displayed a linear relationship with ascorbate radical formation.  Although ascorbate addn. to medium generated H2O2, ascorbate addn. to blood generated no detectable H2O2 and only trace detectable ascorbate radical.  Taken together, these data indicate that ascorbate at concns. achieved only by i.v. administration may be a pro-drug for formation of H2O2, and that blood can be a delivery system of the pro-drug to tissues.  These findings give plausibility to i.v. ascorbic acid in cancer treatment, and have unexpected implications for treatment of infections where H2O2 may be beneficial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEa-_5UqwnK7Vg90H21EOLACvtfcHk0lgtm7AZO9fNPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVygtr%252FP&md5=3cbc688e2cc0df9dc3357f47b87a16f9</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0506390102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0506390102%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DEspey%26aufirst%3DM.%26aulast%3DKrishna%26aufirst%3DM.%26aulast%3DMitchell%26aufirst%3DJ.%26aulast%3DCorpe%26aufirst%3DC.%26aulast%3DBuettner%26aufirst%3DG.%26aulast%3DShacter%26aufirst%3DE.%26aulast%3DLevine%26aufirst%3DM.%26atitle%3DPharmacologic%2520ascorbic%2520acid%2520concentrations%2520selectively%2520kill%2520cancer%2520cells%253A%2520action%2520as%2520a%2520pro-drug%2520to%2520deliver%2520hydrogen%2520peroxide%2520to%2520tissues%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D13604%26epage%3D13609%26doi%3D10.1073%2Fpnas.0506390102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beal, M. F.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>443</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">795</span>, <span class="refDoi"> DOI: 10.1038/nature05292</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1038%2Fnature05292" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=17051205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVyktbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=443&publication_year=2006&pages=787-795&author=M.+T.+Linauthor=M.+F.+Beal&title=Mitochondrial+dysfunction+and+oxidative+stress+in+neurodegenerative+diseases&doi=10.1038%2Fnature05292"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases</span></div><div class="casAuthors">Lin, Michael T.; Beal, M. Flint</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">443</span>
        (<span class="NLM_cas:issue">7113</span>),
    <span class="NLM_cas:pages">787-795</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Many lines of evidence suggest that mitochondria have a central role in aging-related neurodegenerative diseases.  Mitochondria are crit. regulators of cell death, a key feature of neurodegeneration.  Mutations in mitochondrial DNA and oxidative stress both contribute to aging, which is the greatest risk factor for neurodegenerative diseases.  In all major examples of these diseases there is strong evidence that mitochondrial dysfunction occurs early and acts causally in disease pathogenesis.  Moreover, an impressive no. of disease-specific proteins interact with mitochondria.  Thus, therapies targeting basic mitochondrial processes, such as energy metab. or free-radical generation, or specific interactions of disease-related proteins with mitochondria, hold great promise.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ_a_kJVRRZbVg90H21EOLACvtfcHk0lgtm7AZO9fNPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVyktbbO&md5=f1f1e0773f62373232ff10156e630cae</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnature05292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05292%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DM.%2BT.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26atitle%3DMitochondrial%2520dysfunction%2520and%2520oxidative%2520stress%2520in%2520neurodegenerative%2520diseases%26jtitle%3DNature%26date%3D2006%26volume%3D443%26spage%3D787%26epage%3D795%26doi%3D10.1038%2Fnature05292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenmoku, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, T.</span></span> <span> </span><span class="NLM_article-title">Development of a highly specific rhodamine-based fluorescence probe for hypochlorous acid and its application to real-time imaging of phagocytosis</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">7313</span>– <span class="NLM_lpage">7318</span>, <span class="refDoi"> DOI: 10.1021/ja068740g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja068740g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1yktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=7313-7318&author=S.+Kenmokuauthor=Y.+Uranoauthor=H.+Kojimaauthor=T.+Nagano&title=Development+of+a+highly+specific+rhodamine-based+fluorescence+probe+for+hypochlorous+acid+and+its+application+to+real-time+imaging+of+phagocytosis&doi=10.1021%2Fja068740g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Highly Specific Rhodamine-Based Fluorescence Probe for Hypochlorous Acid and Its Application to Real-Time Imaging of Phagocytosis</span></div><div class="casAuthors">Kenmoku, Suguru; Urano, Yasuteru; Kojima, Hirotatsu; Nagano, Tetsuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7313-7318</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The tetramethylrhodamine (TMR) fluorophore is a useful platform for fluorescence probes, being applicable, for example, to biol. investigations utilizing fluorescence microscopy, owing to its excellent photochem. properties in aq. media.  The authors have developed new TMR derivs. that show different dependences of their behavior upon the environment.  Among them, HMTMR showed unique characteristics, and its putative spirocyclic structure was confirmed by x-ray crystallog.  Utilizing this discovery, the authors have established a strategy to modulate the fluorescence of TMR by regulating the spirocyclization, and the authors have obtained a new fluorescence probe that can detect hypochlorous acid specifically.  This probe, HySOx, can work in 99.9% aq. soln. at pH 7.4 and was confirmed to be able to detect hypochlorous acid being generated inside phagosomes in real time.  HySOx is tolerant to autoxidn. and photobleaching under bioimaging conditions.  Regulation of the spirocyclization of rhodamines, as the authors describe here, provides a new approach to the rational development of novel fluorescence probes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAmmqQG_GeaLVg90H21EOLACvtfcHk0lj-m6ydwX1q-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1yktro%253D&md5=eef6ccd5811ebb92f459e8c3e33a65af</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fja068740g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja068740g%26sid%3Dliteratum%253Aachs%26aulast%3DKenmoku%26aufirst%3DS.%26aulast%3DUrano%26aufirst%3DY.%26aulast%3DKojima%26aufirst%3DH.%26aulast%3DNagano%26aufirst%3DT.%26atitle%3DDevelopment%2520of%2520a%2520highly%2520specific%2520rhodamine-based%2520fluorescence%2520probe%2520for%2520hypochlorous%2520acid%2520and%2520its%2520application%2520to%2520real-time%2520imaging%2520of%2520phagocytosis%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D7313%26epage%3D7318%26doi%3D10.1021%2Fja068740g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hyman, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franz, K. J.</span></span> <span> </span><span class="NLM_article-title">Probing oxidative stress: Small molecule fluorescent sensors of metal ions, reactive oxygen species, and thiols</span>. <i>Coord. Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>256</i></span>,  <span class="NLM_fpage">2333</span>– <span class="NLM_lpage">2356</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2012.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.ccr.2012.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=23440254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVyiurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=2012&pages=2333-2356&author=L.+M.+Hymanauthor=K.+J.+Franz&title=Probing+oxidative+stress%3A+Small+molecule+fluorescent+sensors+of+metal+ions%2C+reactive+oxygen+species%2C+and+thiols&doi=10.1016%2Fj.ccr.2012.03.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Probing oxidative stress: Small molecule fluorescent sensors of metal ions, reactive oxygen species, and thiols</span></div><div class="casAuthors">Hyman, Lynne M.; Franz, Katherine J.</div><div class="citationInfo"><span class="NLM_cas:title">Coordination Chemistry Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">256</span>
        (<span class="NLM_cas:issue">19-20</span>),
    <span class="NLM_cas:pages">2333-2356</span>CODEN:
                <span class="NLM_cas:coden">CCHRAM</span>;
        ISSN:<span class="NLM_cas:issn">0010-8545</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Oxidative stress is a common feature shared by many diseases, including neurodegenerative diseases.  Factors that contribute to cellular oxidative stress include elevated levels of reactive oxygen species, diminished availability of detoxifying thiols, and the misregulation of metal ions (both redox-active iron and copper as well as non-redox active calcium and zinc).  Deciphering how each of these components interacts to contribute to oxidative stress presents an interesting challenge.  Fluorescent sensors can be powerful tools for detecting specific analytes within a complicated cellular environment.  Reviewed here are several classes of small mol. fluorescent sensors designed to detect several mol. participants of oxidative stress.  The authors focus the review on describing the design, function and application of probes to detect metal cations, reactive oxygen species, and intracellular thiol-contg. compds.  In addn., the authors highlight the intricacies and complications that are often faced in sensor design and implementation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx4daU-JzbsrVg90H21EOLACvtfcHk0lj-m6ydwX1q-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVyiurs%253D&md5=3b2603a7f2fb5946e36c1c61645c7dd4</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2012.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2012.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DHyman%26aufirst%3DL.%2BM.%26aulast%3DFranz%26aufirst%3DK.%2BJ.%26atitle%3DProbing%2520oxidative%2520stress%253A%2520Small%2520molecule%2520fluorescent%2520sensors%2520of%2520metal%2520ions%252C%2520reactive%2520oxygen%2520species%252C%2520and%2520thiols%26jtitle%3DCoord.%2520Chem.%2520Rev.%26date%3D2012%26volume%3D256%26spage%3D2333%26epage%3D2356%26doi%3D10.1016%2Fj.ccr.2012.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farfán-García, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo-Mendieta, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciprés-Flores, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padilla-Martínez, I. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trujillo-Ferrara, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soriano-Ursúa, M. A.</span></span> <span> </span><span class="NLM_article-title">Current data regarding the structure-toxicity relationship of boron-containing compounds</span>. <i>Toxicol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>258</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1016/j.toxlet.2016.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.toxlet.2016.06.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=27329537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtV2msLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=2016&pages=115-125&author=E.+D.+Farf%C3%A1n-Garc%C3%ADaauthor=N.+T.+Castillo-Mendietaauthor=F.+J.+Cipr%C3%A9s-Floresauthor=I.+I.+Padilla-Mart%C3%ADnezauthor=J.+G.+Trujillo-Ferraraauthor=M.+A.+Soriano-Urs%C3%BAa&title=Current+data+regarding+the+structure-toxicity+relationship+of+boron-containing+compounds&doi=10.1016%2Fj.toxlet.2016.06.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Current data regarding the structure-toxicity relationship of boron-containing compounds</span></div><div class="casAuthors">Farfan-Garcia, E. D.; Castillo-Mendieta, N. T.; Cipres-Flores, F. J.; Padilla-Martinez, I. I.; Trujillo-Ferrara, J. G.; Soriano-Ursua, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">258</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">115-125</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Boron is ubiquitous in nature, being an essential element of diverse cells.  As a result, humans have had contact with boron contg. compds. (BCCs) for a long time.  During the 20th century, BCCs were developed as antiseptics, antibiotics, cosmetics and insecticides.  Boric acid was freely used in the nosocomial environment as an antiseptic and sedative salt, leading to the death of patients and an important discovery about its crit. toxicol. for humans.  Since then the many toxicol. studies done in relation to BCCs have helped to establish the proper limits of their use.  During the last 15 years, there has been a boom of research on the design and use of new, potent and efficient boron contg. drugs, finding that the addn. of boron to some known drugs increases their affinity and selectivity.  This mini-review summarizes two aspects of BCCs: toxicol. data found with exptl. models, and the scarce but increasing data about the structure-activity relationship for toxicity and therapeutic use.  As is the case with boron-free compds., the biol. activity of BCCs is related to their chem. structure.  The authors discuss the use of new technol. to discover potent and efficient BCCs for medicinal therapy by avoiding toxic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCkpve6O1MabVg90H21EOLACvtfcHk0lj-m6ydwX1q-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtV2msLrM&md5=448678512af76a1bd04f1d157a462b3e</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.toxlet.2016.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxlet.2016.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DFarf%25C3%25A1n-Garc%25C3%25ADa%26aufirst%3DE.%2BD.%26aulast%3DCastillo-Mendieta%26aufirst%3DN.%2BT.%26aulast%3DCipr%25C3%25A9s-Flores%26aufirst%3DF.%2BJ.%26aulast%3DPadilla-Mart%25C3%25ADnez%26aufirst%3DI.%2BI.%26aulast%3DTrujillo-Ferrara%26aufirst%3DJ.%2BG.%26aulast%3DSoriano-Urs%25C3%25BAa%26aufirst%3DM.%2BA.%26atitle%3DCurrent%2520data%2520regarding%2520the%2520structure-toxicity%2520relationship%2520of%2520boron-containing%2520compounds%26jtitle%3DToxicol.%2520Lett.%26date%3D2016%26volume%3D258%26spage%3D115%26epage%3D125%26doi%3D10.1016%2Fj.toxlet.2016.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis of biologically active boron-containing compounds</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">201</span>– <span class="NLM_lpage">211</span>, <span class="refDoi"> DOI: 10.1039/C7MD00552K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1039%2FC7MD00552K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=30108914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVOrt7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=201-211&author=F.+Yangauthor=M.+Zhuauthor=J.+Zhangauthor=H.+Zhou&title=Synthesis+of+biologically+active+boron-containing+compounds&doi=10.1039%2FC7MD00552K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of biologically active boron-containing compounds</span></div><div class="casAuthors">Yang, Fei; Zhu, Mingyan; Zhang, Jinyi; Zhou, Huchen</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">201-211</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Boron-contg. compds. which possess unique and attractive properties have received increasing attention from the pharmaceutical industry and academia recently.  They have shown interesting and useful biol. activities, including antibacterial, antifungal, antiparasitic, antiviral, and anti-inflammatory activities.  In this review, the synthetic strategies for various boron-contg. compds., including peptidyl boronic acids, benzoxaboroles, benzoxaborines, benzodiazaborines, amine carboxyboranes, and amine cyanoboranes are summarized.  Representative structures of each structural class and recently developed biol. active boron-contg. compds. are used as examples in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoknvFRHlSSVbVg90H21EOLACvtfcHk0ljNfdfeyaxtsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVOrt7jN&md5=11018b19779619600cdb63d60ae07407</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1039%2FC7MD00552K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7MD00552K%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DF.%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DH.%26atitle%3DSynthesis%2520of%2520biologically%2520active%2520boron-containing%2520compounds%26jtitle%3DMedChemComm%26date%3D2018%26volume%3D9%26spage%3D201%26epage%3D211%26doi%3D10.1039%2FC7MD00552K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ban, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, H.</span></span> <span> </span><span class="NLM_article-title">Boron-based drug design</span>. <i>Chem. Rec.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">616</span>– <span class="NLM_lpage">635</span>, <span class="refDoi"> DOI: 10.1002/tcr.201402100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2Ftcr.201402100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=25800654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltFWisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=616-635&author=H.+S.+Banauthor=H.+Nakamura&title=Boron-based+drug+design&doi=10.1002%2Ftcr.201402100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Boron-Based Drug Design</span></div><div class="casAuthors">Ban, Hyun Seung; Nakamura, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Record</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">616-635</span>CODEN:
                <span class="NLM_cas:coden">CRHEAK</span>;
        ISSN:<span class="NLM_cas:issn">1528-0691</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The use of the element boron, which is not generally obsd. in a living body, possesses a high potential for the discovery of new biol. activity in pharmaceutical drug design.  In this account, the authors describe the recent developments in boron-based drug design, including boronic acid contg. protein tyrosine kinase inhibitors, proteasome inhibitors, and tubulin polymn. inhibitors, and ortho-carborane-contg. proteasome activators, hypoxia-inducible factor 1 inhibitors, and topoisomerase inhibitors.  Furthermore, the authors applied a closo-dodecaborate as a water-sol. moiety as well as a boron-10 source for the design of boron carriers in boron neutron capture therapy, such as boronated porphyrins and boron lipids for a liposomal boron delivery system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaf96EHiagY7Vg90H21EOLACvtfcHk0ljNfdfeyaxtsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltFWisrY%253D&md5=2274f1fbd3ec933c9874fe38834e41dd</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2Ftcr.201402100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Ftcr.201402100%26sid%3Dliteratum%253Aachs%26aulast%3DBan%26aufirst%3DH.%2BS.%26aulast%3DNakamura%26aufirst%3DH.%26atitle%3DBoron-based%2520drug%2520design%26jtitle%3DChem.%2520Rec.%26date%3D2015%26volume%3D15%26spage%3D616%26epage%3D635%26doi%3D10.1002%2Ftcr.201402100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stubelius, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almutairi, A.</span></span> <span> </span><span class="NLM_article-title">The chemistry of boronic acids in nanomaterials for drug delivery</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">3108</span>– <span class="NLM_lpage">3119</span>, <span class="refDoi"> DOI: 10.1021/acs.accounts.9b00292</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.accounts.9b00292" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFarsrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2019&pages=3108-3119&author=A.+Stubeliusauthor=S.+Leeauthor=A.+Almutairi&title=The+chemistry+of+boronic+acids+in+nanomaterials+for+drug+delivery&doi=10.1021%2Facs.accounts.9b00292"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The Chemistry of Boronic Acids in Nanomaterials for Drug Delivery</span></div><div class="casAuthors">Stubelius, Alexandra; Lee, Sangeun; Almutairi, Adah</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3108-3119</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Conspectus: Interest in increasing drug delivery efficiency has risen over the past decade both as a means to improve efficacy of already clin. available drugs and due to the increased difficulties of approving new drugs.  As a functional group for targeted drug delivery, boronic acids (BAs) have been incorporated in polymeric particles both as a stimuli-responsive functional group and as a targeting ligand.  Here, BA chem. presents a wealth of opportunities for biol. applications.  It not only reacts with several chem. markers of disease such as reactive oxygen species (ROS), ATP (ATP), glucose, and reduced pH, but it also acts as ligands for diols such as sialic acid.  These stimuli-responsive drug delivery systems optimize delivery of therapeutics based on rational design and precise mol. engineering.  When designing materials contg. BA, the unique chem. properties are important to take into consideration such as its vacant p-orbital, its mol. geometry, and the designed acid's pKa.  Instead of behaving as most carboxylic acids that donate protons, BAs instead primarily act as Lewis acids that accept electrons.  In aq. soln., most polymers contg. BA exist in an equil. between their triangular hydrophobic form and a tetrahedral hydrophilic form.  The most common pKa's are in the nonphysiol. range of 8-10, and much ongoing research focuses on modifying BAs into materials sensitive to a more physiol. relevant pH range.  So far, BA moieties have been incorporated into a stunning array of materials, ranging from small mols. that can self-assemble into higher order structures such as micelles and polymeric micelles, via larger polymeric assemblies, to large scale hydrogels.  With the abundance of biol. mols. contg. diols and polyhydroxy motifs, BA-contg. materials have proven valuable in several biomedical applications such as treatment of cancer, diabetes, obesity, and bacterial infections.  Both materials functionalized with BA and boronic esters display good safety profiles in vitro and in vivo; thus, BA-contg. materials represent promising carriers for responsive delivery systems with great potential for clin. translation.  The intention of this Account is to showcase the versatility of BA for biomedical applications.  We first discuss the chem. of BA and what to consider when designing BA-contg. materials.  Further, we review how its chem. recently has been applied to nanomaterials for enhanced delivery efficiency, both as a stimuli-responsive group and as a targeting ligand.  Lastly, we discuss the current limitations and further perspectives of BA in biomaterials, based on the great benefits that can come from utilizing the unique BA chem. to enhance drug delivery efficiency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFV0Gj9y1rcLVg90H21EOLACvtfcHk0ljNfdfeyaxtsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFarsrnK&md5=751da858ff3ee4ce67f87ed261c1f3f7</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facs.accounts.9b00292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.accounts.9b00292%26sid%3Dliteratum%253Aachs%26aulast%3DStubelius%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DAlmutairi%26aufirst%3DA.%26atitle%3DThe%2520chemistry%2520of%2520boronic%2520acids%2520in%2520nanomaterials%2520for%2520drug%2520delivery%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2019%26volume%3D52%26spage%3D3108%26epage%3D3119%26doi%3D10.1021%2Facs.accounts.9b00292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span> <span> </span><span class="NLM_article-title">Boronic acid compounds as potential pharmaceutical agents</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">346</span>– <span class="NLM_lpage">368</span>, <span class="refDoi"> DOI: 10.1002/med.10043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2Fmed.10043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=12647314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjsVWitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=346-368&author=W.+Yangauthor=X.+Gaoauthor=B.+Wang&title=Boronic+acid+compounds+as+potential+pharmaceutical+agents&doi=10.1002%2Fmed.10043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Boronic acid compounds as potential pharmaceutical agents</span></div><div class="casAuthors">Yang, Wenqian; Gao, Xingming; Wang, Binghe</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">346-368</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Boronic acid compds. have been used, because of their unique structural features, for the development of potent enzyme inhibitors, boron neutron capture agents for cancer therapy, and as antibody mimics that recognize biol. important saccharides.  Consequently, there has been a surge of interests in boronic acid compds.  This study reviews the recent development in this area during the last six years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB0CvJjV10BbVg90H21EOLACvtfcHk0liZZ4rohBj0lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjsVWitb8%253D&md5=0b841477e2113218d55991e23133bd60</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fmed.10043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.10043%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DB.%26atitle%3DBoronic%2520acid%2520compounds%2520as%2520potential%2520pharmaceutical%2520agents%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2003%26volume%3D23%26spage%3D346%26epage%3D368%26doi%3D10.1002%2Fmed.10043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, G. F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dos Santos, J. L.</span></span> <span> </span><span class="NLM_article-title">Boron in drug design: recent advances in the development of new therapeutic agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>179</i></span>,  <span class="NLM_fpage">791</span>– <span class="NLM_lpage">804</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.06.092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.ejmech.2019.06.092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=31288128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtleju7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2019&pages=791-804&author=G.+F.+S.+Fernandesauthor=W.+A.+Dennyauthor=J.+L.+Dos+Santos&title=Boron+in+drug+design%3A+recent+advances+in+the+development+of+new+therapeutic+agents&doi=10.1016%2Fj.ejmech.2019.06.092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Boron in drug design: Recent advances in the development of new therapeutic agents</span></div><div class="casAuthors">Fernandes, Guilherme Felipe Santos; Denny, William Alexander; Dos Santos, Jean Leandro</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">791-804</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Advances in the field of boron chem. have expanded the application of this element in Medicinal Chem.  Boron-contg. compds. represent a new class for medicinal chemists to use in their drug designs.  Bortezomib, a dipeptide boronic acid approved by the FDA in 2003 for treatment of multiple myeloma, paved the way for the discovery of new boron-contg. compds. After its approval, two other boron-contg. compds. have been approved, tavaborole for the treatment of onychomycosis and crisaborole for the treatment of mild to moderate atopic dermatitis.  A no. of boron-contg. compds. have been described and evaluated for a plethora of therapeutic applications.  The present review is intended to highlight the recent advances related to boron-contg. compds. and their therapeutic applications.  Here, we focused only in those most biol. active compds. with proven in vitro and/or in vivo efficacy in the therapeutic area published in the last years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNneApZtw8C7Vg90H21EOLACvtfcHk0liZZ4rohBj0lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtleju7fE&md5=52c7677a4b6213be8a03b48c3981bba4</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.06.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.06.092%26sid%3Dliteratum%253Aachs%26aulast%3DFernandes%26aufirst%3DG.%2BF.%2BS.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DDos%2BSantos%26aufirst%3DJ.%2BL.%26atitle%3DBoron%2520in%2520drug%2520design%253A%2520recent%2520advances%2520in%2520the%2520development%2520of%2520new%2520therapeutic%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D179%26spage%3D791%26epage%3D804%26doi%3D10.1016%2Fj.ejmech.2019.06.092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biswas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao Pinninti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maiti, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N. D. P.</span></span> <span> </span><span class="NLM_article-title">Environment activatable nanoprodrug: two-step surveillance in the anticancer drug release</span>. <i>ACS Appl. Mater. Interfaces</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">28180</span>– <span class="NLM_lpage">28184</span>, <span class="refDoi"> DOI: 10.1021/acsami.7b05132</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsami.7b05132" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht12mt7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=28180-28184&author=S.+Biswasauthor=J.+Dasauthor=S.+Barmanauthor=B.+Rao+Pinnintiauthor=T.+K.+Maitiauthor=N.+D.+P.+Singh&title=Environment+activatable+nanoprodrug%3A+two-step+surveillance+in+the+anticancer+drug+release&doi=10.1021%2Facsami.7b05132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Environment Activatable Nanoprodrug: Two-Step Surveillance in the Anticancer Drug Release</span></div><div class="casAuthors">Biswas, Sandipan; Das, Joyjyoti; Barman, Shrabani; Rao Pinninti, Bhaskara; K. Maiti, Tapas; Singh, N. D. Pradeep</div><div class="citationInfo"><span class="NLM_cas:title">ACS Applied Materials & Interfaces</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">28180-28184</span>CODEN:
                <span class="NLM_cas:coden">AAMICK</span>;
        ISSN:<span class="NLM_cas:issn">1944-8244</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Remedial cancer therapy deals with a large no. of theranostic applications.  However, systems, so far known, are only capable of single surveillance for both diagnostic and therapeutic modes of action.  A nanosystem, which can be localized to the cancer and deliver the chemotherapeutic agent on demand, will provide effective therapeutic activity.  Herein, we designed a single component nanoprodrug ANPD-X (Activatable Nano Pro-Drug-X) which identified the tumor sites by fluorescent color change (signal 1, blue to green fluorescence) using H2O2-mediated oxidn. of boronate fluorophore.  In the next step, precise spatiotemporal irradn. of light only on identified tumor sites resulted in the release of anticancer drug chlorambucil.  The real time information on drug release was achieved by a second fluorescence color change (signal 2, green to blue fluorescence).  Thus, nanoprodrug ANPD-X provided overall two-step surveillance in the anticancer drug delivery.  Activation of the ANPD-X after addn. of H2O2 and drug release upon photoirradn. was investigated in vitro by monitoring its fluorescence in the HeLa cell line.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJb4u4U95f6rVg90H21EOLACvtfcHk0liZZ4rohBj0lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht12mt7nF&md5=ae616cc6d9ff68288b597b8186fd5459</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facsami.7b05132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsami.7b05132%26sid%3Dliteratum%253Aachs%26aulast%3DBiswas%26aufirst%3DS.%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DBarman%26aufirst%3DS.%26aulast%3DRao%2BPinninti%26aufirst%3DB.%26aulast%3DMaiti%26aufirst%3DT.%2BK.%26aulast%3DSingh%26aufirst%3DN.%2BD.%2BP.%26atitle%3DEnvironment%2520activatable%2520nanoprodrug%253A%2520two-step%2520surveillance%2520in%2520the%2520anticancer%2520drug%2520release%26jtitle%3DACS%2520Appl.%2520Mater.%2520Interfaces%26date%3D2017%26volume%3D9%26spage%3D28180%26epage%3D28184%26doi%3D10.1021%2Facsami.7b05132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bedini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraternale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crinelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolucci, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarantini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spadoni, G.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological activity of hydrogen peroxide responsive arylboronate melatonin hybrids</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">100</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrestox.8b00216</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrestox.8b00216" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFehurbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2019&pages=100-112&author=A.+Bediniauthor=A.+Fraternaleauthor=R.+Crinelliauthor=M.+Mariauthor=S.+Bartolucciauthor=L.+Chiarantiniauthor=G.+Spadoni&title=Design%2C+synthesis%2C+and+biological+activity+of+hydrogen+peroxide+responsive+arylboronate+melatonin+hybrids&doi=10.1021%2Facs.chemrestox.8b00216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Activity of Hydrogen Peroxide Responsive Arylboronate Melatonin Hybrids</span></div><div class="casAuthors">Bedini, Annalida; Fraternale, Alessandra; Crinelli, Rita; Mari, Michele; Bartolucci, Silvia; Chiarantini, Laura; Spadoni, Gilberto</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">100-112</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Stimulus-responsive cleavage reactions have found broad use to direct drug release at a particular target disease area.  Increased levels of reactive oxygen species (ROS) have been assocd. with the development and progression of cancer and several other disease states, motivating the development of drug conjugates that can undergo a chemoselective ROS-triggered release.  Melatonin (MLT) and the reactive electrophile p-benzoquinone methide (p-QM) have evidenced either cytoprotective or cytotoxic effects in biol. systems, depending on the dose, cellular targets, and time of exposure.  In this study, the authors report the synthesis and biol. activity of two MLT derivs. linked to ROS-responsive arylboronate triggers (P1 and P2), which can be activated by endogenously generated hydrogen peroxide (H2O2) to release MLT, or 5-methoxytryptamine (5-MeOT), and p-QM-intermediates.  Their H2O2-induced activation mechanism was studied by HPLC-DAD-MS.  P1, which rapidly releases MLT and p-QM, was able to strongly induce the Nrf2 antioxidant signaling pathway, but was ineffective to provide protection against H2O2-mediated oxidative damage.  By contrast, P1 exhibited strong toxic effects in HeLa cancer cells, without causing significant toxicity to normal NCTC-2544 cells.  Similar, although more limited, effects were exerted by P2.  In both cases, cytotoxicity was accompanied by depletion of cellular glutathione (GSH), probably as a consequence of p-QM release, and increased ROS levels.  A role for MLT in toxicity was also obsd., suggesting that the P1 released products, MLT and p-QM, contributed additively to promote cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAvVcvY9LON7Vg90H21EOLACvtfcHk0liZZ4rohBj0lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFehurbF&md5=dd2fe6ed6ea40a9334fec58a3ea47f7d</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrestox.8b00216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrestox.8b00216%26sid%3Dliteratum%253Aachs%26aulast%3DBedini%26aufirst%3DA.%26aulast%3DFraternale%26aufirst%3DA.%26aulast%3DCrinelli%26aufirst%3DR.%26aulast%3DMari%26aufirst%3DM.%26aulast%3DBartolucci%26aufirst%3DS.%26aulast%3DChiarantini%26aufirst%3DL.%26aulast%3DSpadoni%26aufirst%3DG.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520activity%2520of%2520hydrogen%2520peroxide%2520responsive%2520arylboronate%2520melatonin%2520hybrids%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2019%26volume%3D32%26spage%3D100%26epage%3D112%26doi%3D10.1021%2Facs.chemrestox.8b00216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span> <span> </span><span class="NLM_article-title">Biocompatible boron-containing prodrugs of belinostat for the potential treatment of solid tumors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">149</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00504</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00504" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlvVertg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=149-154&author=S.+Zhengauthor=S.+Guoauthor=Q.+Zhongauthor=C.+Zhangauthor=J.+Liuauthor=L.+Yangauthor=Q.+Zhangauthor=G.+Wang&title=Biocompatible+boron-containing+prodrugs+of+belinostat+for+the+potential+treatment+of+solid+tumors&doi=10.1021%2Facsmedchemlett.7b00504"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Biocompatible Boron-Containing Prodrugs of Belinostat for the Potential Treatment of Solid Tumors</span></div><div class="casAuthors">Zheng, Shilong; Guo, Shanchun; Zhong, Qiu; Zhang, Changde; Liu, Jiawang; Yang, Lin; Zhang, Qiang; Wang, Guangdi</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">149-154</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Despite promising therapeutic utilities for treatment of hematol. malignancies, histone deacetylase inhibitor (HDACi) drugs have not proven as effective in the treatment of solid tumors.  To expand the clin. indications of HDACi drugs, we developed novel boron-contg. prodrugs of belinostat (2), one of which efficiently releases active 2 through a cascade of reactions in cell culture and demonstrates activities comparable to 2 against a panel of cancer cell lines.  Importantly, prodrug I is more efficacious than belinostat in vivo, not only inhibiting the growth of tumor but also reducing tumor vols. in an MCF-7 xenograft tumor model owing to its superior biocompatibility, which suggests its clin. potential in the treatment of solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjIOQIgps2KrVg90H21EOLACvtfcHk0liUdhX9O_USFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlvVertg%253D%253D&md5=96d56396fbcd0a6192f277ffb13fb423</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00504%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DS.%26aulast%3DZhong%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DG.%26atitle%3DBiocompatible%2520boron-containing%2520prodrugs%2520of%2520belinostat%2520for%2520the%2520potential%2520treatment%2520of%2520solid%2520tumors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D149%26epage%3D154%26doi%3D10.1021%2Facsmedchemlett.7b00504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jourden, J. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniel, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S. M.</span></span> <span> </span><span class="NLM_article-title">Investigation of self-immolative linkers in the design of hydrogen peroxide activated metalloprotein inhibitors</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">7968</span>– <span class="NLM_lpage">7970</span>, <span class="refDoi"> DOI: 10.1039/c1cc12526e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1039%2Fc1cc12526e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=21677985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotl2jsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2011&pages=7968-7970&author=J.+L.+M.+Jourdenauthor=K.+B.+Danielauthor=S.+M.+Cohen&title=Investigation+of+self-immolative+linkers+in+the+design+of+hydrogen+peroxide+activated+metalloprotein+inhibitors&doi=10.1039%2Fc1cc12526e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of self-immolative linkers in the design of hydrogen peroxide activated metalloprotein inhibitors</span></div><div class="casAuthors">Jourden, Jody L. Major; Daniel, Kevin B.; Cohen, Seth M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">7968-7970</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A series of self-immolative boronic ester protected Me salicylates and metal-binding groups with various linking strategies have been investigated for their use in the design of matrix metalloproteinase proinhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvVE1PCZf15rVg90H21EOLACvtfcHk0liUdhX9O_USFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotl2jsbY%253D&md5=8857bc5ca7ac12b8ee5eb419892a6a2c</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1039%2Fc1cc12526e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1cc12526e%26sid%3Dliteratum%253Aachs%26aulast%3DJourden%26aufirst%3DJ.%2BL.%2BM.%26aulast%3DDaniel%26aufirst%3DK.%2BB.%26aulast%3DCohen%26aufirst%3DS.%2BM.%26atitle%3DInvestigation%2520of%2520self-immolative%2520linkers%2520in%2520the%2520design%2520of%2520hydrogen%2520peroxide%2520activated%2520metalloprotein%2520inhibitors%26jtitle%3DChem.%2520Commun.%26date%3D2011%26volume%3D47%26spage%3D7968%26epage%3D7970%26doi%3D10.1039%2Fc1cc12526e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neufeld, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Ramirez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species-responsive protein modification and its intracellular delivery for targeted cancer therapy</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">13444</span>– <span class="NLM_lpage">13448</span>, <span class="refDoi"> DOI: 10.1002/anie.201407234</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2Fanie.201407234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVCit73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=13444-13448&author=M.+Wangauthor=S.+Sunauthor=C.+I.+Neufeldauthor=B.+Perez-Ramirezauthor=Q.+Xu&title=Reactive+oxygen+species-responsive+protein+modification+and+its+intracellular+delivery+for+targeted+cancer+therapy&doi=10.1002%2Fanie.201407234"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive Oxygen Species-Responsive Protein Modification and Its Intracellular Delivery for Targeted Cancer Therapy</span></div><div class="casAuthors">Wang, Ming; Sun, Shuo; Neufeld, Caleb I.; Perez-Ramirez, Bernardo; Xu, Qiaobing</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">13444-13448</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Herein we report a convenient chem. approach to reversibly modulate protein (RNase A) function and develop a protein that is responsive to reactive oxygen species (ROS) for targeted cancer therapy.  The conjugation of RNase A with 4-nitrophenyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) benzyl carbonate (NBC) blocks protein lysine and temporarily deactivates the protein.  However, the treatment of RNase A-NBC with hydrogen peroxide (one major intracellular ROS) efficiently cleaves the NBC conjugation and restores the RNase A activity.  Thus, RNase A-NBC can be reactivated inside tumor cells by high levels of intracellular ROS, thereby restoring the cytotoxicity of RNase A for cancer therapy.  Due to higher ROS levels inside tumor cells compared to healthy cells, and the resulting different levels of RNase A-NBC reactivation, RNase A-NBC shows a significant specific cytotoxicity against tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3uxwUOg3LNrVg90H21EOLACvtfcHk0liUdhX9O_USFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVCit73F&md5=d0e6ebdc36e6915f5cbd851544914e70</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2Fanie.201407234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201407234%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DNeufeld%26aufirst%3DC.%2BI.%26aulast%3DPerez-Ramirez%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DQ.%26atitle%3DReactive%2520oxygen%2520species-responsive%2520protein%2520modification%2520and%2520its%2520intracellular%2520delivery%2520for%2520targeted%2520cancer%2520therapy%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D13444%26epage%3D13448%26doi%3D10.1002%2Fanie.201407234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peiró Cadahía, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Previtali, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bondebjerg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andresen, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clausen, M. H.</span></span> <span> </span><span class="NLM_article-title">Methotrexate prodrugs sensitive to reactive oxygen species for the improved treatment of rheumatoid arthritis</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">738</span>– <span class="NLM_lpage">746</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.07.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.ejmech.2018.07.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=30048923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlOit7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2018&pages=738-746&author=N.+S.+Andersenauthor=J.+Peir%C3%B3+Cadah%C3%ADaauthor=V.+Previtaliauthor=J.+Bondebjergauthor=C.+A.+Hansenauthor=A.+E.+Hansenauthor=T.+L.+Andresenauthor=M.+H.+Clausen&title=Methotrexate+prodrugs+sensitive+to+reactive+oxygen+species+for+the+improved+treatment+of+rheumatoid+arthritis&doi=10.1016%2Fj.ejmech.2018.07.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Methotrexate prodrugs sensitive to reactive oxygen species for the improved treatment of rheumatoid arthritis</span></div><div class="casAuthors">Andersen, Nikolaj S.; Peiro Cadahia, Jorge; Previtali, Viola; Bondebjerg, Jon; Hansen, Christian A.; Hansen, Anders E.; Andresen, Thomas L.; Clausen, Mads H.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">738-746</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Methotrexate (MTX) is the std. of care in the treatment of rheumatoid arthritis (RA), a common autoimmune disease that is characterized by chronic inflammation in the synovial membrane of joints.  Unfortunately, MTX suffers from high discontinuation rates due to a large variability in efficacy and, in particular, adverse effects.  As inflammation is assocd. with elevated levels of reactive oxygen species (ROS) like H2O2, we propose to improve treatment through site-selective delivery of MTX to inflammatory tissue by use of a H2O2 sensitive MTX prodrug.  To establish proof proof-of-concept, two novel H2O2 sensitive, thiazolidinone-based MTX prodrugs were synthesized and evaluated for this purpose.  MTX-γ-thiazolidinone (MTX-γ-TZ) exhibited the most promising properties - good to high chem. and metabolic stability, excellent aq. soly., while being activated when subjected to patho-physiol. concns. of H2O2.  In vivo, MTX-γ-TZ exhibited comparable efficacy to MTX in a murine collagen type II-induced arthritis (CIA) model while treated mice showed indications of reduced toxicity as their body wt. decreased less towards the end of the study, compared to the MTX-treated group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe-StPKO8IgLVg90H21EOLACvtfcHk0licqgmMSt--zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlOit7vM&md5=82b56b143cf51ce9b1441b5e2fbf41af</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.07.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.07.045%26sid%3Dliteratum%253Aachs%26aulast%3DAndersen%26aufirst%3DN.%2BS.%26aulast%3DPeir%25C3%25B3%2BCadah%25C3%25ADa%26aufirst%3DJ.%26aulast%3DPrevitali%26aufirst%3DV.%26aulast%3DBondebjerg%26aufirst%3DJ.%26aulast%3DHansen%26aufirst%3DC.%2BA.%26aulast%3DHansen%26aufirst%3DA.%2BE.%26aulast%3DAndresen%26aufirst%3DT.%2BL.%26aulast%3DClausen%26aufirst%3DM.%2BH.%26atitle%3DMethotrexate%2520prodrugs%2520sensitive%2520to%2520reactive%2520oxygen%2520species%2520for%2520the%2520improved%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D156%26spage%3D738%26epage%3D746%26doi%3D10.1016%2Fj.ejmech.2018.07.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monserrat, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S. M.</span></span> <span> </span><span class="NLM_article-title">Exploring hydrogen peroxide responsive thiazolidinone-based prodrugs</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">7116</span>– <span class="NLM_lpage">7119</span>, <span class="refDoi"> DOI: 10.1039/C4CC09921D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1039%2FC4CC09921D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=25811298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltFWjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2015&pages=7116-7119&author=C.+Perezauthor=J.-P.+Monserratauthor=Y.+Chenauthor=S.+M.+Cohen&title=Exploring+hydrogen+peroxide+responsive+thiazolidinone-based+prodrugs&doi=10.1039%2FC4CC09921D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring hydrogen peroxide responsive thiazolidinone-based prodrugs</span></div><div class="casAuthors">Perez, Christian; Monserrat, Jean-Philippe; Chen, Yao; Cohen, Seth M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">7116-7119</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A novel approach for developing prodrugs based on masked carboxylic acids is described.  Rather than using conventional esterase-based activation, thiazolidinone protecting groups have been identified that can reveal carboxylic acid groups upon activation by hydrogen peroxide.  This may prove valuable in the continuing development of prodrug strategies that rely on reactive oxygen species as a trigger.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtp4dvzuXJCbVg90H21EOLACvtfcHk0licqgmMSt--zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltFWjtrs%253D&md5=47fae789e2adf3691d3a2fc840e76d62</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1039%2FC4CC09921D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4CC09921D%26sid%3Dliteratum%253Aachs%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DMonserrat%26aufirst%3DJ.-P.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DCohen%26aufirst%3DS.%2BM.%26atitle%3DExploring%2520hydrogen%2520peroxide%2520responsive%2520thiazolidinone-based%2520prodrugs%26jtitle%3DChem.%2520Commun.%26date%3D2015%26volume%3D51%26spage%3D7116%26epage%3D7119%26doi%3D10.1039%2FC4CC09921D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chittavong, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span> <span> </span><span class="NLM_article-title">Organic CO prodrugs activated by endogenous ROS</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">8</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.7b02775</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.7b02775" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslKltLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2018&pages=8-11&author=Z.+Panauthor=J.+Zhangauthor=K.+Jiauthor=V.+Chittavongauthor=X.+Jiauthor=B.+Wang&title=Organic+CO+prodrugs+activated+by+endogenous+ROS&doi=10.1021%2Facs.orglett.7b02775"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Organic CO Prodrugs Activated by Endogenous ROS</span></div><div class="casAuthors">Pan, Zhixiang; Zhang, Jun; Ji, Kaili; Chittavong, Vayou; Ji, Xingyue; Wang, Binghe</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8-11</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CO prodrugs with triggered release mechanisms are highly desirable for targeted delivery.  Herein described are org. CO prodrugs that are activated by ROS and thus can be used to selectively deliver CO to cells with elevated ROS levels.  Such CO prodrugs can serve as powerful tools for targeted delivery to disease sites with elevated ROS levels and to explore the therapeutic applications of CO.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSFhtEB9mJwbVg90H21EOLACvtfcHk0licqgmMSt--zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslKltLfL&md5=daba27bc927026160ad549b5288f573a</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.7b02775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.7b02775%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DK.%26aulast%3DChittavong%26aufirst%3DV.%26aulast%3DJi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DB.%26atitle%3DOrganic%2520CO%2520prodrugs%2520activated%2520by%2520endogenous%2520ROS%26jtitle%3DOrg.%2520Lett.%26date%3D2018%26volume%3D20%26spage%3D8%26epage%3D11%26doi%3D10.1021%2Facs.orglett.7b02775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oddone, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pederzoli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duskey, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Benedictis, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabrucker, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angela Vandelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruozi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tosi, G.</span></span> <span> </span><span class="NLM_article-title">ROS-responsive “smart” polymeric conjugate: synthesis, characterization and proof-of-concept study</span>. <i>Int. J. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>570</i></span>,  <span class="NLM_fpage">118655</span>, <span class="refDoi"> DOI: 10.1016/j.ijpharm.2019.118655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.ijpharm.2019.118655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=31479731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs12qs7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=570&publication_year=2019&pages=118655&author=N.+Oddoneauthor=F.+Pederzoliauthor=J.+T.+Duskeyauthor=C.+A.+De+Benedictisauthor=A.+M.+Grabruckerauthor=F.+Forniauthor=M.+Angela+Vandelliauthor=B.+Ruoziauthor=G.+Tosi&title=ROS-responsive+%E2%80%9Csmart%E2%80%9D+polymeric+conjugate%3A+synthesis%2C+characterization+and+proof-of-concept+study&doi=10.1016%2Fj.ijpharm.2019.118655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">ROS-responsive "smart" polymeric conjugate: Synthesis, characterization and proof-of-concept study</span></div><div class="casAuthors">Oddone, Natalia; Pederzoli, Francesca; Duskey, Jason T.; De Benedictis, Chiara A.; Grabrucker, Andreas M.; Forni, Flavio; Vandelli, Maria Angela; Ruozi, Barbara; Tosi, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">570</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">118655</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">New approaches integrating stimuli-responsive linkers into prodrugs are currently emerging.  These "smart" prodrugs can enhance the effectivity of conventional prodrugs with promising clin. applicability.  Oxidative stress is central to several diseases, including cancer.  Therefore, the design of prodrugs that respond to ROS stimulus, allowing a selective drug release in this condition, is fairly encouraging.  Aiming to investigate the ROS-responsiveness of prodrugs contg. the ROS-cleavable moiety, Thioketal (TK), we performed proof-of-concept studies by synthesizing ROS-responsive conjugate, namely mPEG-TK-Cy5, through exploiting Cy5 fluorescent dye.  We demonstrated that, differently to non-ROS-responsive control conjugate (mPEG-Cy5), mPEG-TK-Cy5 shows a selective release of Cy5 in response to ROS in both, ROS-simulated conditions and in vitro on glioblastoma cells.  Our results confirm the applicability of TK-technol. in the design of ROS-responsive prodrugs, which constitutes a promising approach in cancer treatment.  The translatability of this technol. for other diseases treatment makes this a highly relevant and promising approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLVScAWaLeErVg90H21EOLACvtfcHk0ljD5Izb8rJRfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs12qs7%252FL&md5=5d0d5f9f96f01b80efde2b8ff7c6ee34</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2019.118655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2019.118655%26sid%3Dliteratum%253Aachs%26aulast%3DOddone%26aufirst%3DN.%26aulast%3DPederzoli%26aufirst%3DF.%26aulast%3DDuskey%26aufirst%3DJ.%2BT.%26aulast%3DDe%2BBenedictis%26aufirst%3DC.%2BA.%26aulast%3DGrabrucker%26aufirst%3DA.%2BM.%26aulast%3DForni%26aufirst%3DF.%26aulast%3DAngela%2BVandelli%26aufirst%3DM.%26aulast%3DRuozi%26aufirst%3DB.%26aulast%3DTosi%26aufirst%3DG.%26atitle%3DROS-responsive%2520%25E2%2580%259Csmart%25E2%2580%259D%2520polymeric%2520conjugate%253A%2520synthesis%252C%2520characterization%2520and%2520proof-of-concept%2520study%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2019%26volume%3D570%26spage%3D118655%26doi%3D10.1016%2Fj.ijpharm.2019.118655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, D. A.</span>; <span class="NLM_string-name">Najera, C.</span></span> <span> </span><span class="NLM_article-title">Desulfonylation reactions</span>. In  <i>Organic Reactions</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denmark, S. E.</span></span>, Ed.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2009</span>; Vol.  <span class="NLM_volume">72</span>, pp  <span class="NLM_fpage">367</span>– <span class="NLM_lpage">656</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2F0471264180.or072.02" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=367-656&author=D.+A.+Alonso&author=C.+Najeraauthor=S.+E.+Denmark&title=Organic+Reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1002%2F0471264180.or072.02&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0471264180.or072.02%26sid%3Dliteratum%253Aachs%26aulast%3DAlonso%26aufirst%3DD.%2BA.%26atitle%3DDesulfonylation%2520reactions%26btitle%3DOrganic%2520Reactions%26aulast%3DDenmark%26aufirst%3DS.%2BE.%26pub%3DWiley%26date%3D2009%26volume%3D72%26spage%3D367%26epage%3D656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oddone, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boury, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcion, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabrucker, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da Ros, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janaszewska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandelli, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tosi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruozi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duskey, J. T.</span></span> <span> </span><span class="NLM_article-title">Synthesis, characterization, and in vitro studies of an reactive oxygen species (ROS)-responsive methoxy polyethylene glycol-thioketal-melphalan prodrug for glioblastoma treatment</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">574</span>, <span class="refDoi"> DOI: 10.3389/fphar.2020.00574</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.3389%2Ffphar.2020.00574" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=32425795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvFKksbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=574&author=N.+Oddoneauthor=F.+Bouryauthor=E.+Garcionauthor=A.+M.+Grabruckerauthor=M.+C.+Martinezauthor=F.+Da+Rosauthor=A.+Janaszewskaauthor=F.+Forniauthor=M.+A.+Vandelliauthor=G.+Tosiauthor=B.+Ruoziauthor=J.+T.+Duskey&title=Synthesis%2C+characterization%2C+and+in+vitro+studies+of+an+reactive+oxygen+species+%28ROS%29-responsive+methoxy+polyethylene+glycol-thioketal-melphalan+prodrug+for+glioblastoma+treatment&doi=10.3389%2Ffphar.2020.00574"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, characterization, and in vitro studies of an reactive oxygen species (ROS)-responsive methoxy polyethylene glycol-thioketal-melphalan prodrug for glioblastoma treatment</span></div><div class="casAuthors">Oddone, Natalia; Boury, Frank; Garcion, Emmanuel; Grabrucker, Andreas M.; Martinez, M. Carmen; Da Ros, Federica; Janaszewska, Anna; Forni, Flavio; Vandelli, Maria Angela; Tosi, Giovanni; Ruozi, Barbara; Duskey, Jason T.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">574</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Glioblastoma (GBM) is the most frequent and aggressive primary tumor of the brain and avs. a life expectancy in diagnosed patients of only 15 mo.  Hence, more effective therapies against this malignancy are urgently needed.  Several diseases, including cancer, are featured by high levels of reactive oxygen species (ROS), which are possible GBM hallmarks to target or benefit from.  Therefore, the covalent linkage of drugs to ROS-responsive mols. can be exploited aiming for a selective drug release within relevant pathol. environments.  In this work, we designed a new ROS-responsive prodrug by using Melphalan (MPH) covalently coupled with methoxy polyethylene glycol (mPEG) through a ROS-cleavable group thioketal (TK), demonstrating the capacity to self-assembly into nanosized micelles.  Full chem.-phys. characterization was conducted on the polymeric-prodrug and proper controls, along with in vitro cytotoxicity assayed on different GBM cell lines and "healthy" astrocyte cells confirming the absence of any cytotoxicity of the prodrug on healthy cells (i.e. astrocytes).  These results were compared with the non-ROS responsive counterpart, underlining the anti-tumoral activity of ROS-responsive compared to the non-ROS-responsive prodrug on GBM cells expressing high levels of ROS.  On the other hand, the combination treatment with this ROS-responsive prodrug and X-ray irradn. on human GBM cells resulted in an increase of the antitumoral effect, and this might be connected to radiotherapy.  Hence, these results represent a starting point for a rationale design of innovative and tailored ROS-responsive prodrugs to be used in GBM therapy and in combination with radiotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpICDqYbD3ndLVg90H21EOLACvtfcHk0ljD5Izb8rJRfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvFKksbbF&md5=c4b662c914a47331ddc2873113c8580b</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2020.00574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2020.00574%26sid%3Dliteratum%253Aachs%26aulast%3DOddone%26aufirst%3DN.%26aulast%3DBoury%26aufirst%3DF.%26aulast%3DGarcion%26aufirst%3DE.%26aulast%3DGrabrucker%26aufirst%3DA.%2BM.%26aulast%3DMartinez%26aufirst%3DM.%2BC.%26aulast%3DDa%2BRos%26aufirst%3DF.%26aulast%3DJanaszewska%26aufirst%3DA.%26aulast%3DForni%26aufirst%3DF.%26aulast%3DVandelli%26aufirst%3DM.%2BA.%26aulast%3DTosi%26aufirst%3DG.%26aulast%3DRuozi%26aufirst%3DB.%26aulast%3DDuskey%26aufirst%3DJ.%2BT.%26atitle%3DSynthesis%252C%2520characterization%252C%2520and%2520in%2520vitro%2520studies%2520of%2520an%2520reactive%2520oxygen%2520species%2520%2528ROS%2529-responsive%2520methoxy%2520polyethylene%2520glycol-thioketal-melphalan%2520prodrug%2520for%2520glioblastoma%2520treatment%26jtitle%3DFront.%2520Pharmacol.%26date%3D2020%26volume%3D11%26spage%3D574%26doi%3D10.3389%2Ffphar.2020.00574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span> <span> </span><span class="NLM_article-title">Self-luminescing theranostic nanoreactors with intraparticle relayed energy transfer for tumor microenvironment activated imaging and photodynamic therapy</span>. <i>Theranostics</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">20</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.7150/thno.28857</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.7150%2Fthno.28857" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=30662551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtV2nsbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=20-33&author=M.+Wuauthor=L.+Wuauthor=J.+Liauthor=D.+Zhangauthor=S.+Lanauthor=X.+Zhangauthor=X.+Linauthor=G.+Liuauthor=X.+Liuauthor=J.+Liu&title=Self-luminescing+theranostic+nanoreactors+with+intraparticle+relayed+energy+transfer+for+tumor+microenvironment+activated+imaging+and+photodynamic+therapy&doi=10.7150%2Fthno.28857"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Self-luminescing theranostic nanoreactors with intraparticle relayed energy transfer for tumor microenvironment activated imaging and photodynamic therapy</span></div><div class="casAuthors">Wu, Ming; Wu, Lingjie; Li, Jiong; Zhang, Da; Lan, Shanyou; Zhang, Xiaolong; Lin, Xinyi; Liu, Gang; Liu, Xiaolong; Liu, Jingfeng</div><div class="citationInfo"><span class="NLM_cas:title">Theranostics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">20-33</span>CODEN:
                <span class="NLM_cas:coden">THERDS</span>;
        ISSN:<span class="NLM_cas:issn">1838-7640</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">The low tissue penetration depth of external excitation light severely hinders the sensitivity of fluorescence imaging (FL) and the efficacy of photodynamic therapy (PDT) in vivo; thus, rational theranostic platforms that overcome the light penetration depth limit are urgently needed.  To overcome this crucial problem, we designed a self-luminescing nanosystem (denoted POCL) with near-IR (NIR) light emission and singlet oxygen (1O2) generation abilities utilizing an intraparticle relayed resonance energy transfer strategy.  Bis[3,4,6-trichloro-2-(pentyloxycarbonyl) phenyl] oxalate (CPPO) as a chem. energy source with high reactivity toward H2O2, poly[(9,9'-dioctyl-2,7-divinylene-fluorenylene)-alt-2-methoxy-5-(2-ethyl-hexyloxy)-1,4-phenylene] (PFPV) as a highly efficient chemiluminescence converter, and tetraphenylporphyrin (TPP) as a photosensitizer with NIR emission and 1O2 generation abilities were coencapsulated by self-assembly with poly(ethyleneglycol)-co-poly(caprolactone) (PEG-PCL) and folate-PEG-cholesterol to form the POCL nanoreactor, with folate as the targeting group.  A series of in vitro and in vivo analyses, including phys. and chem. characterizations, tumor targeting ability, tumor microenvironment activated imaging and photodynamic therapy, as well as biosafety, were systematically investigated to characterize the POCL.  The POCL displayed excellent NIR luminescence and 1O2 generation abilities in response to H2O2.  Therefore, it could serve as a specific H2O2 probe to identify tumors through chemiluminescence imaging and as a chemiluminescence-driven PDT agent for inducing tumor cell apoptosis to inhibit tumor growth due to the abnormal overprodn. of H2O2 in the tumor microenvironment.  Moreover, the folate ligand on the POCL surface can further improve the accumulation at the tumor site via a receptor-mediated mechanism, thus enhancing tumor imaging and the therapeutic effects both in vitro and in vivo but without any observable systemic toxicity.  The nanosystem reported here might serve as a targeted, smart, precise, and noninvasive strategy triggered by the tumor microenvironment rather than by an outside light source for cancer NIR imaging and PDT treatment without limitations on penetration depth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoybC75JFkvsrVg90H21EOLACvtfcHk0ljD5Izb8rJRfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtV2nsbbP&md5=3315fc09a7d9d552aaf3b446934c9cd8</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.7150%2Fthno.28857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.28857%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DLan%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DJ.%26atitle%3DSelf-luminescing%2520theranostic%2520nanoreactors%2520with%2520intraparticle%2520relayed%2520energy%2520transfer%2520for%2520tumor%2520microenvironment%2520activated%2520imaging%2520and%2520photodynamic%2520therapy%26jtitle%3DTheranostics%26date%3D2019%26volume%3D9%26spage%3D20%26epage%3D33%26doi%3D10.7150%2Fthno.28857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span> <span> </span><span class="NLM_article-title">Self-strengthened oxidation-responsive bioactivating prodrug nanosystem with sequential and synergistically facilitated drug release for treatment of breast cancer</span>. <i>ACS Appl. Mater. Interfaces</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">18914</span>– <span class="NLM_lpage">18922</span>, <span class="refDoi"> DOI: 10.1021/acsami.9b03056</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsami.9b03056" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1MXovVKgtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=18914-18922&author=K.+Wangauthor=B.+Yangauthor=H.+Yeauthor=X.+Zhangauthor=H.+Songauthor=X.+Wangauthor=N.+Liauthor=L.+Weiauthor=Y.+Wangauthor=H.+Zhangauthor=Q.+Kanauthor=Z.+Heauthor=D.+Wangauthor=J.+Sun&title=Self-strengthened+oxidation-responsive+bioactivating+prodrug+nanosystem+with+sequential+and+synergistically+facilitated+drug+release+for+treatment+of+breast+cancer&doi=10.1021%2Facsami.9b03056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Self-Strengthened Oxidation-Responsive Bioactivating Prodrug Nanosystem with Sequential and Synergistically Facilitated Drug Release for Treatment of Breast Cancer</span></div><div class="casAuthors">Wang, Kaiyuan; Yang, Bin; Ye, Hao; Zhang, Xuanbo; Song, Hang; Wang, Xia; Li, Na; Wei, Lin; Wang, Yu; Zhang, Haotian; Kan, Qiming; He, Zhonggui; Wang, Dun; Sun, Jin</div><div class="citationInfo"><span class="NLM_cas:title">ACS Applied Materials & Interfaces</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">18914-18922</span>CODEN:
                <span class="NLM_cas:coden">AAMICK</span>;
        ISSN:<span class="NLM_cas:issn">1944-8244</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Although environment-sensitive prodrug-based nanoparticles (NPs) have developed rapidly, lots of prodrug NPs still show poor selectivity and efficiency of parent drug bioactivation because of tumor heterogeneity.  Herein, self-strengthened bioactivating prodrug-based NPs are fabricated via co-encapsulation of oxidn.-responsive thioether-linked linoleic acid-paclitaxel conjugates (PTX-S-LA) and β-lapachone (LPC) into polymeric micelles (PMs).  Following cellular uptake, PMs first release LPC to significantly elevate the reactive oxidative species (ROS) level through NAD(P)H: quinone oxidoreductase-1 (NQO1) catalysis.  Then, NQO1-generated ROS in combination with endogenous high ROS levels in tumor cells could synergistically facilitate PTX-S-LA to release the active cytotoxic agent PTX.  Such a novel prodrug nanosystem exhibits self-strengthened prodrug bioactivation, ultraselective release, and cytotoxicity between cancer and normal cells, prolonged circulation time, and enhanced tumor accumulation, leading to high antitumor efficiency and superior biosafety.  Our findings pave the new way for the rational design of oxidn.-responsive prodrug NPs for high-efficacy cancer chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2h6AMn7XRQbVg90H21EOLACvtfcHk0lgXXbloQLzBYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXovVKgtL4%253D&md5=3814c1236dd14cf44643ffa59a723ca0</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Facsami.9b03056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsami.9b03056%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DSong%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DWei%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DKan%26aufirst%3DQ.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DJ.%26atitle%3DSelf-strengthened%2520oxidation-responsive%2520bioactivating%2520prodrug%2520nanosystem%2520with%2520sequential%2520and%2520synergistically%2520facilitated%2520drug%2520release%2520for%2520treatment%2520of%2520breast%2520cancer%26jtitle%3DACS%2520Appl.%2520Mater.%2520Interfaces%26date%3D2019%26volume%3D11%26spage%3D18914%26epage%3D18922%26doi%3D10.1021%2Facsami.9b03056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span> <span> </span><span class="NLM_article-title">Gamma radiation-responsive side-chain tellurium-containing polymer for cancer therapy</span>. <i>Mater. Chem. Front.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">2109</span>– <span class="NLM_lpage">2115</span>, <span class="refDoi"> DOI: 10.1039/C8QM00321A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1039%2FC8QM00321A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslequ7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2018&pages=2109-2115&author=F.+Fanauthor=S.+Gaoauthor=S.+Jiauthor=Y.+Fuauthor=P.+Zhangauthor=H.+Xu&title=Gamma+radiation-responsive+side-chain+tellurium-containing+polymer+for+cancer+therapy&doi=10.1039%2FC8QM00321A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Gamma radiation-responsive side-chain tellurium-containing polymer for cancer therapy</span></div><div class="casAuthors">Fan, Fuqiang; Gao, Shiqian; Ji, Shaobo; Fu, Yu; Zhang, Pengpeng; Xu, Huaping</div><div class="citationInfo"><span class="NLM_cas:title">Materials Chemistry Frontiers</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2109-2115</span>CODEN:
                <span class="NLM_cas:coden">MCFAC5</span>;
        ISSN:<span class="NLM_cas:issn">2052-1537</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The combination of chemotherapy and radiotherapy could not only enhance cancer treatment efficacy, but also shorten the period of the overall treatment and relieve the anxiety of the patients during the remedy.  Herein, we present a novel strategy for coordinating the chemotherapy drug CDDP with a tellurium-contg. polymer, which restrained the tumor cytotoxicity of these two portions.  After a low dose of gamma radiation, CDDP departed from the coordination complexes, and the tumor cytotoxicity of both was restored.  In contrast to conventional chemotherapy, this radiation responsive system possesses specific anticancer effects and less toxicity in the non-radiation therapy.  In addn., with regard to the premise of therapeutic efficiency, this system effectively lowered the radiated dosage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOVvS00MHEc7Vg90H21EOLACvtfcHk0lgXXbloQLzBYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslequ7vO&md5=7961bc9f0d455be65b00620847ca8036</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1039%2FC8QM00321A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8QM00321A%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DF.%26aulast%3DGao%26aufirst%3DS.%26aulast%3DJi%26aufirst%3DS.%26aulast%3DFu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DXu%26aufirst%3DH.%26atitle%3DGamma%2520radiation-responsive%2520side-chain%2520tellurium-containing%2520polymer%2520for%2520cancer%2520therapy%26jtitle%3DMater.%2520Chem.%2520Front.%26date%3D2018%26volume%3D2%26spage%3D2109%26epage%3D2115%26doi%3D10.1039%2FC8QM00321A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boire, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zachman, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rath, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sung, H.-J.</span></span> <span> </span><span class="NLM_article-title">ROS-cleavable proline oligomer crosslinking of polycaprolactone for pro-angiogenic host response</span>. <i>J. Mater. Chem. B</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">7109</span>– <span class="NLM_lpage">7113</span>, <span class="refDoi"> DOI: 10.1039/C4TB01094A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1039%2FC4TB01094A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=25343029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Siu7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=7109-7113&author=S.+H.+Leeauthor=T.+C.+Boireauthor=J.+B.+Leeauthor=M.+K.+Guptaauthor=A.+L.+Zachmanauthor=R.+Rathauthor=H.-J.+Sung&title=ROS-cleavable+proline+oligomer+crosslinking+of+polycaprolactone+for+pro-angiogenic+host+response&doi=10.1039%2FC4TB01094A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">ROS-cleavable proline oligomer crosslinking of polycaprolactone for pro-angiogenic host response</span></div><div class="casAuthors">Lee, Sue Hyun; Boire, Timothy C.; Lee, Jung Bok; Gupta, Mukesh K.; Zachman, Angela L.; Rath, Rutwik; Sung, Hak-Joon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Materials Chemistry B: Materials for Biology and Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">7109-7113</span>CODEN:
                <span class="NLM_cas:coden">JMCBDV</span>;
        ISSN:<span class="NLM_cas:issn">2050-7518</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A reactive oxygen species (ROS)-degradable scaffold is fabricated by crosslinking biocompatible, hydrolytically-degradable poly(ε-caprolactone) (PCL) with a ROS-degradable oligoproline peptide, KP7K.  The ROS-mediated degradability triggers favorable host responses of the scaffold including improved cell infiltration and angiogenesis in vivo, indicating its unique advantages for tissue engineering applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKHHa70ibZzbVg90H21EOLACvtfcHk0lgXXbloQLzBYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Siu7%252FF&md5=27047a2b4a51a0a1662a7b7122711f0a</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1039%2FC4TB01094A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4TB01094A%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DBoire%26aufirst%3DT.%2BC.%26aulast%3DLee%26aufirst%3DJ.%2BB.%26aulast%3DGupta%26aufirst%3DM.%2BK.%26aulast%3DZachman%26aufirst%3DA.%2BL.%26aulast%3DRath%26aufirst%3DR.%26aulast%3DSung%26aufirst%3DH.-J.%26atitle%3DROS-cleavable%2520proline%2520oligomer%2520crosslinking%2520of%2520polycaprolactone%2520for%2520pro-angiogenic%2520host%2520response%26jtitle%3DJ.%2520Mater.%2520Chem.%2520B%26date%3D2014%26volume%3D2%26spage%3D7109%26epage%3D7113%26doi%3D10.1039%2FC4TB01094A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amici, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stadtman, E. R.</span></span> <span> </span><span class="NLM_article-title">Conversion of amino acid residues in proteins and amino acid homopolymers to carbonyl derivatives by metal-catalyzed oxidation reactions</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>264</i></span>,  <span class="NLM_fpage">3341</span>– <span class="NLM_lpage">3346</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2FS0021-9258%2818%2994071-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=2563380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADyaL1MXhvVygsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=1989&pages=3341-3346&author=A.+Amiciauthor=R.+L.+Levineauthor=L.+Tsaiauthor=E.+R.+Stadtman&title=Conversion+of+amino+acid+residues+in+proteins+and+amino+acid+homopolymers+to+carbonyl+derivatives+by+metal-catalyzed+oxidation+reactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Conversion of amino acid residues in proteins and amino acid homopolymers to carbonyl derivatives by metal-catalyzed oxidation reactions</span></div><div class="casAuthors">Amici, Adolfo; Levine, Rodney L.; Tsai, Lin; Stadtman, Earl R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">264</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3341-6</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">A no. of metal-catalyzed oxidn. (MCO) systems mediate the oxidative inactivation of enzymes.  This oxidn. is accompanied by conversion of the side chains of some amino acid residues to carbonyl derivs.  To identify the amino acid residues which are sensitive to MCO oxidn., several enzymes/proteins and amino acid homopolymers were exposed to various MCO systems.  The carbonyl groups which were formed were converted to their corresponding 3H-labeled hydroxy derivs.  After acid hydrolysis, the labeled free amino acids were sepd. by ion-exchange chromatog.  Each protein or polymer gave rise to several different labeled amino acids.  The elution profiles of labeled amino acid obtained from prepns. of Escherichia coli glutamine synthetase which had been oxidized by MCO systems comprised of either Fe(II)/O2 or ascorbate/Fe(II)O2 both in the presence and absence of EDTA were qual. the same.  From a comparison of the elution profiles of labeled amino acids from various proteins with those obtained from homopolymers, it is evident that the side chains of histidine, arginine, lysine, and proline are particularly sensitive to oxidn. by the MCO systems.  This conclusion is supported also by direct amino acid anal. of acid hydrolyzates which shows that the oxidn. of glutamine synthetase, enolase, and phosphoglycerate kinase is assocd. with the loss of ≥1 histidine residue per subunit.  From the results of studies with homopolymers, it is apparent that glutamic semialdehyde is a major product of both proline and arginine residues.  In addn., hydroxyproline and unlabeled glutamic acid were identified among the hydrolysis products of oxidized poly-L-proline, and unlabeled aspartic acid was identified as a product of poly-L-histidine oxidn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlOhx7IIfor7Vg90H21EOLACvtfcHk0ljRIJypbj4AtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhvVygsbk%253D&md5=fc4ef7de0901f164e7c82328288bcc8f</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2994071-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252994071-8%26sid%3Dliteratum%253Aachs%26aulast%3DAmici%26aufirst%3DA.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DTsai%26aufirst%3DL.%26aulast%3DStadtman%26aufirst%3DE.%2BR.%26atitle%3DConversion%2520of%2520amino%2520acid%2520residues%2520in%2520proteins%2520and%2520amino%2520acid%2520homopolymers%2520to%2520carbonyl%2520derivatives%2520by%2520metal-catalyzed%2520oxidation%2520reactions%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1989%26volume%3D264%26spage%3D3341%26epage%3D3346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koblin, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zachman, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrien, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmeister, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giorgio, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sung, H.-J.</span></span> <span> </span><span class="NLM_article-title">Physiologically relevant oxidative degradation of oligo (proline) cross-linked polymeric scaffolds</span>. <i>Biomacromolecules</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">4357</span>– <span class="NLM_lpage">4366</span>, <span class="refDoi"> DOI: 10.1021/bm201328k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bm201328k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlGjtrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=4357-4366&author=S.+S.+Yuauthor=R.+L.+Koblinauthor=A.+L.+Zachmanauthor=D.+S.+Perrienauthor=L.+H.+Hofmeisterauthor=T.+D.+Giorgioauthor=H.-J.+Sung&title=Physiologically+relevant+oxidative+degradation+of+oligo+%28proline%29+cross-linked+polymeric+scaffolds&doi=10.1021%2Fbm201328k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Physiologically Relevant Oxidative Degradation of Oligo(proline) Cross-Linked Polymeric Scaffolds</span></div><div class="casAuthors">Yu, Shann S.; Koblin, Rachel L.; Zacherman, Angela L.; Perrien, Daniel S.; Hofmeister, Lucas H.; Giorgio, Todd D.; Sung, Hak-Joon</div><div class="citationInfo"><span class="NLM_cas:title">Biomacromolecules</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4357-4366</span>CODEN:
                <span class="NLM_cas:coden">BOMAF6</span>;
        ISSN:<span class="NLM_cas:issn">1525-7797</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chronic inflammation-mediated oxidative stress is a common mechanism of implant rejection and failure.  Therefore, polymer scaffolds that can degrade slowly in response to this environment may provide a viable platform for implant site-specific, sustained release of immunomodulatory agents over a long time period.  In this work, proline oligomers of varying lengths (Pn) were synthesized and exposed to oxidative environments, and their accelerated degrdn. under oxidative conditions was verified via high performance liq. chromatog. and gel permeation chromatog.  Next, diblock copolymers of poly(ethylene glycol) (PEG) and poly(ε-caprolactone) (PCL) were carboxylated to form 100 kDa terpolymers of 4%PEG-86%PCL-10%cPCL (cPCL = poly(carboxyl-ε-caprolactone); i% indicates molar ratio).  The polymers were then crosslinked with biaminated PEG-Pn-PEG chains, where Pn indicates the length of the proline oligomer flanked by PEG chains.  Salt-leaching of the polymeric matrixes created scaffolds of macroporous and microporous architecture, as obsd. by SEM.  The degrdn. of scaffolds was accelerated under oxidative conditions, as evidenced by mass loss and differential scanning calorimetry measurements.  Immortalized murine bone-marrow-derived macrophages were then seeded on the scaffolds and activated through the addn. of γ-interferon and lipopolysaccharide throughout the 9-day study period.  This treatment promoted the release of H2O2 by the macrophages and the degrdn. of proline-contg. scaffolds compared to the control scaffolds.  The accelerated degrdn. was evidenced by increased scaffold porosity, as visualized through SEM and X-ray microtomog. imaging.  The current study provides insight into the development of scaffolds that respond to oxidative environments through gradual degrdn. for the controlled release of therapeutics targeted to diseases that feature chronic inflammation and oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq46vPmOWHuN7Vg90H21EOLACvtfcHk0ljRIJypbj4AtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlGjtrfP&md5=789c136f7146937cb70a53643f2a53af</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fbm201328k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbm201328k%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DS.%2BS.%26aulast%3DKoblin%26aufirst%3DR.%2BL.%26aulast%3DZachman%26aufirst%3DA.%2BL.%26aulast%3DPerrien%26aufirst%3DD.%2BS.%26aulast%3DHofmeister%26aufirst%3DL.%2BH.%26aulast%3DGiorgio%26aufirst%3DT.%2BD.%26aulast%3DSung%26aufirst%3DH.-J.%26atitle%3DPhysiologically%2520relevant%2520oxidative%2520degradation%2520of%2520oligo%2520%2528proline%2529%2520cross-linked%2520polymeric%2520scaffolds%26jtitle%3DBiomacromolecules%26date%3D2011%26volume%3D12%26spage%3D4357%26epage%3D4366%26doi%3D10.1021%2Fbm201328k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Noll, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, P. S.</span></span> <span> </span><span class="NLM_article-title">Formation and repair of interstrand cross-links in DNA</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">301</span>, <span class="refDoi"> DOI: 10.1021/cr040478b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr040478b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlars73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2006&pages=277-301&author=D.+M.+Nollauthor=T.+M.+Masonauthor=P.+S.+Miller&title=Formation+and+repair+of+interstrand+cross-links+in+DNA&doi=10.1021%2Fcr040478b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Formation and Repair of Interstrand Cross-Links in DNA</span></div><div class="casAuthors">Noll, David M.; McGregor Mason, Tracey; Miller, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">277-301</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This review will focus primarily on DNA interstrand crosslinks for which there is a substantial body of information about their repair.  These include interstrand crosslinks produced by nitrogen mustards, mitomycin C, platinum compds. and psoralen.  The formation and structures of these crosslinks will first be briefly reviewed.  The mechanism of repair of these crosslinks as derived from both genetic studies and expts. in cellfree systems will then be described as they occur in both prokaryotic and eukaryotic organisms.  It will become apparent from the following discussion that the understanding of interstrand crosslink repair is at best incomplete both at the genetic and certainly at the mol. levels.  Nevertheless, an examn. of the literature from the past decade suggests that a consensus is emerging on the broader if not the detailed mechanistic aspects of the process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_YwWKX2eI9rVg90H21EOLACvtfcHk0ljRIJypbj4AtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlars73L&md5=78f3f6f9c3634d6e9e67cba3b9ee9386</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fcr040478b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr040478b%26sid%3Dliteratum%253Aachs%26aulast%3DNoll%26aufirst%3DD.%2BM.%26aulast%3DMason%26aufirst%3DT.%2BM.%26aulast%3DMiller%26aufirst%3DP.%2BS.%26atitle%3DFormation%2520and%2520repair%2520of%2520interstrand%2520cross-links%2520in%2520DNA%26jtitle%3DChem.%2520Rev.%26date%3D2006%26volume%3D106%26spage%3D277%26epage%3D301%26doi%3D10.1021%2Fcr040478b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balakrishnan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandhi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span> <span> </span><span class="NLM_article-title">Hydrogen peroxide inducible DNA cross-linking agents: targeted anticancer prodrugs</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">19278</span>– <span class="NLM_lpage">19281</span>, <span class="refDoi"> DOI: 10.1021/ja2073824</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja2073824" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyqsLvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=19278-19281&author=Y.+Kuangauthor=K.+Balakrishnanauthor=V.+Gandhiauthor=X.+Peng&title=Hydrogen+peroxide+inducible+DNA+cross-linking+agents%3A+targeted+anticancer+prodrugs&doi=10.1021%2Fja2073824"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrogen Peroxide Inducible DNA Cross-Linking Agents: Targeted Anticancer Prodrugs</span></div><div class="casAuthors">Kuang, Yunyan; Balakrishnan, Kumudha; Gandhi, Varsha; Peng, Xiaohua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">19278-19281</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The major concern for anticancer chemotherapeutic agents is the host toxicity.  The development of anticancer prodrugs targeting the unique biochem. alterations in cancer cells is an attractive approach to achieve therapeutic activity and selectivity.  We designed and synthesized a new type of nitrogen mustard prodrug that can be activated by high level of reactive oxygen species (ROS) found in cancer cells to release the active chemotherapy agent.  The activation mechanism was detd. by NMR anal.  The activity and selectivity of these prodrugs toward ROS was detd. by measuring DNA interstrand cross-links and/or DNA alkylations.  These compds. showed 60-90% inhibition toward various cancer cells, while normal lymphocytes were not affected.  To the best of our knowledge, this is the first example of H2O2-activated anticancer prodrugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY5EVvl5gaabVg90H21EOLACvtfcHk0liCkxgvxf5EBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyqsLvE&md5=d907a75fa0e9c33185187cdfb85fda29</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fja2073824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja2073824%26sid%3Dliteratum%253Aachs%26aulast%3DKuang%26aufirst%3DY.%26aulast%3DBalakrishnan%26aufirst%3DK.%26aulast%3DGandhi%26aufirst%3DV.%26aulast%3DPeng%26aufirst%3DX.%26atitle%3DHydrogen%2520peroxide%2520inducible%2520DNA%2520cross-linking%2520agents%253A%2520targeted%2520anticancer%2520prodrugs%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D19278%26epage%3D19281%26doi%3D10.1021%2Fja2073824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span> <span> </span><span class="NLM_article-title">Aromatic nitrogen mustard-based prodrugs: activity, selectivity, and the mechanism of DNA cross-linking</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">7410</span>– <span class="NLM_lpage">7418</span>, <span class="refDoi"> DOI: 10.1002/chem.201400090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2Fchem.201400090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=24806710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnslWlu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=7410-7418&author=W.+Chenauthor=Y.+Hanauthor=X.+Peng&title=Aromatic+nitrogen+mustard-based+prodrugs%3A+activity%2C+selectivity%2C+and+the+mechanism+of+DNA+cross-linking&doi=10.1002%2Fchem.201400090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Aromatic Nitrogen Mustard-Based Prodrugs: Activity, Selectivity, and the Mechanism of DNA Cross-Linking</span></div><div class="casAuthors">Chen, Wenbing; Han, Yanyan; Peng, Xiaohua</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7410-7418</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Three novel H2O2-activated arom. nitrogen mustard prodrugs (6-8) are reported.  These compds. contain a DNA alkylating agent connected to a H2O2-responsive trigger by different electron-withdrawing linkers so that they are inactive towards DNA but can be triggered by H2O2 to release active species.  The activity and selectivity of these compds. towards DNA were investigated by measuring DNA interstrand cross-link (ICL) formation in the presence or absence of H2O2.  An electron-withdrawing linker unit, such as a quaternary ammonia salt (6), a carboxyamide (7), and a carbonate group (8), is sufficient to deactivate the arom. nitrogen mustard resulting in less than 1.5 % crosslinking formation.  However, H2O2 can restore the activity of the effectors by converting a withdrawing group to a donating group, therefore increasing the crosslinking efficiency (>20 %).  The stability and reaction sites of the ICL products were detd., which revealed that alkylation induced by 7 and 8 not only occurred at the purine sites but also at the pyrimidine site.  For the first time, we isolated and characterized the monomer adducts formed between the canonical nucleosides and the arom. nitrogen mustard (15) which supported that nitrogen mustards reacted with dG, dA, and dC.  The activation mechanism was studied by NMR spectroscopic anal.  An in vitro cytotoxicity assay demonstrated that compd. 7 with a carboxyamide linker dramatically inhibited the growth of various cancer cells with a GI50 of less than 1 μM, whereas compd. 6 with a charged linker did not show any obvious toxicity in all cell lines tested.  These data indicated that a neutral carboxyamide linker is preferable for developing nitrogen mustard prodrugs.  Our results showed that 7 is a potent anticancer prodrug that can serve as a model compd. for further development.  We believe these novel arom. nitrogen mustards will inspire further and effective applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM6P1tNGeK57Vg90H21EOLACvtfcHk0liCkxgvxf5EBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnslWlu7Y%253D&md5=64c7a2f00767b697da1a635be060e49a</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1002%2Fchem.201400090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201400090%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DX.%26atitle%3DAromatic%2520nitrogen%2520mustard-based%2520prodrugs%253A%2520activity%252C%2520selectivity%252C%2520and%2520the%2520mechanism%2520of%2520DNA%2520cross-linking%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2014%26volume%3D20%26spage%3D7410%26epage%3D7418%26doi%3D10.1002%2Fchem.201400090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balakrishnan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandhi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species (ROS) inducible DNA cross-linking agents and their effect on cancer cells and normal lymphocytes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4498</span>– <span class="NLM_lpage">4510</span>, <span class="refDoi"> DOI: 10.1021/jm401349g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401349g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2cXns1Ciu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4498-4510&author=W.+Chenauthor=K.+Balakrishnanauthor=Y.+Kuangauthor=Y.+Hanauthor=M.+Fuauthor=V.+Gandhiauthor=X.+Peng&title=Reactive+oxygen+species+%28ROS%29+inducible+DNA+cross-linking+agents+and+their+effect+on+cancer+cells+and+normal+lymphocytes&doi=10.1021%2Fjm401349g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive Oxygen Species (ROS) Inducible DNA Cross-Linking Agents and Their Effect on Cancer Cells and Normal Lymphocytes</span></div><div class="casAuthors">Chen, Wenbing; Balakrishnan, Kumudha; Kuang, Yunyan; Han, Yanyan; Fu, Min; Gandhi, Varsha; Peng, Xiaohua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4498-4510</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Reducing host toxicity is one of the main challenges of cancer chemotherapy.  Many tumor cells contain high levels of ROS that make them distinctively different from normal cells.  The authors report a series of ROS-activated arom. nitrogen mustards that selectively kill chronic lymphocytic leukemia (CLL) over normal lymphocytes.  These agents showed powerful DNA crosslinking abilities when coupled with H2O2, one of the most common ROS in cancer cells, whereas little DNA crosslinking was detected without H2O2.  Consistent with chem. observation, in vitro cytotoxicity assay demonstrated that these agents induced 40-80% apoptosis in primary leukemic lymphocytes isolated from CLL patients but less than 25% cell death to normal lymphocytes from healthy donors.  The IC50 for the most potent compd. (2) was ∼5 μM in CLL cells, while the IC50 was not achieved in normal lymphocytes.  Collectively, these data provide utility and selectivity of these agents that will inspire further and effective applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmV7B5XHuPHbVg90H21EOLACvtfcHk0liCkxgvxf5EBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXns1Ciu7k%253D&md5=a5871a2d6b2909c485b4dd7c9e1cf5fe</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjm401349g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401349g%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DBalakrishnan%26aufirst%3DK.%26aulast%3DKuang%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DFu%26aufirst%3DM.%26aulast%3DGandhi%26aufirst%3DV.%26aulast%3DPeng%26aufirst%3DX.%26atitle%3DReactive%2520oxygen%2520species%2520%2528ROS%2529%2520inducible%2520DNA%2520cross-linking%2520agents%2520and%2520their%2520effect%2520on%2520cancer%2520cells%2520and%2520normal%2520lymphocytes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4498%26epage%3D4510%26doi%3D10.1021%2Fjm401349g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zu, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span> <span> </span><span class="NLM_article-title">Cytotoxicity and topo I targeting activity of substituted 10--nitrogenous heterocyclic aromatic group derivatives of SN-38</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">3200</span>– <span class="NLM_lpage">3206</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2010.03.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.ejmech.2010.03.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=20392545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtF2jtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=3200-3206&author=Q.+Y.+Liauthor=X.+Q.+Dengauthor=Y.+G.+Zuauthor=H.+Lvauthor=L.+Suauthor=L.+Yaoauthor=Y.+Zhangauthor=L.+Li&title=Cytotoxicity+and+topo+I+targeting+activity+of+substituted+10%2D%2Dnitrogenous+heterocyclic+aromatic+group+derivatives+of+SN-38&doi=10.1016%2Fj.ejmech.2010.03.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxicity and Topo I targeting activity of substituted 10--nitrogenous heterocyclic aromatic group derivatives of SN-38</span></div><div class="casAuthors">Li, Qing-yong; Deng, Xiao-qiu; Zu, Yuan-gang; Lv, Hongyan; Su, Lin; Yao, Liping; Zhang, Yu; Li, Lei</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3200-3206</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of nitrogenous heterocyclic arom. group-substituted derivs. of SN-38 were prepd.  The SN-38 derivs. were evaluated for cytotoxic activity in three cancer cell lines with many of the compds., e.g. I, displaying potency similar to topotecan.  All of the pyridine salt derivs., e.g. II, revealed comparable or superior topoisomerase I inhibitory activity compared to camptothecin (CPT).  Compared to the corresponding CPT derivs., e.g., III, the SN-38 pyridine salts, which possess an addnl. Et group, demonstrate increased cytotoxicity and topoisomerase I inhibition and good water soly.  These results are consistent with the structure activity relationship of CPT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh9ou--4j4j7Vg90H21EOLACvtfcHk0lhUFEb7a9xLQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtF2jtrg%253D&md5=fea1f37ba6f3989b7da35e77987e5140</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2010.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2010.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DQ.%2BY.%26aulast%3DDeng%26aufirst%3DX.%2BQ.%26aulast%3DZu%26aufirst%3DY.%2BG.%26aulast%3DLv%26aufirst%3DH.%26aulast%3DSu%26aufirst%3DL.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26atitle%3DCytotoxicity%2520and%2520topo%2520I%2520targeting%2520activity%2520of%2520substituted%252010--nitrogenous%2520heterocyclic%2520aromatic%2520group%2520derivatives%2520of%2520SN-38%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D3200%26epage%3D3206%26doi%3D10.1016%2Fj.ejmech.2010.03.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">A new strategy to improve the metabolic stability of lactone: discovery of (20S,21S)-21-fluorocamptothecins as novel, hydrolytically stable topoisomerase I inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">7902</span>– <span class="NLM_lpage">7910</span>, <span class="refDoi"> DOI: 10.1021/jm400906z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400906z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFarsrzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7902-7910&author=Z.+Miaoauthor=L.+Zhuauthor=G.+Dongauthor=C.+Zhuangauthor=Y.+Wuauthor=S.+Wangauthor=Z.+Guoauthor=Y.+Liuauthor=S.+Wuauthor=S.+Zhuauthor=K.+Fangauthor=J.+Yaoauthor=J.+Liauthor=C.+Shengauthor=W.+Zhang&title=A+new+strategy+to+improve+the+metabolic+stability+of+lactone%3A+discovery+of+%2820S%2C21S%29-21-fluorocamptothecins+as+novel%2C+hydrolytically+stable+topoisomerase+I+inhibitors&doi=10.1021%2Fjm400906z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">A New Strategy To Improve the Metabolic Stability of Lactone: Discovery of (20S,21S) 21-Fluorocamptothecins as Novel, Hydrolytically Stable Topoisomerase I Inhibitors</span></div><div class="casAuthors">Miao, Zhenyuan; Zhu, Lingjian; Dong, Guoqiang; Zhuang, Chunlin; Wu, Yuelin; Wang, Shengzheng; Guo, Zizao; Liu, Yang; Wu, Shanchao; Zhu, Shiping; Fang, Kun; Yao, Jianzhong; Li, Jian; Sheng, Chunquan; Zhang, Wannian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7902-7910</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lactone is a common structural motif in biol. active natural products.  However, the metabolic instability of lactone significantly reduces their in vivo potency.  In the present investigation, a new strategy to improve the metabolic stability of lactone was provided by the design of α-fluoro ether as a novel bioisostere of lactone.  The effectiveness of the α-fluoro ether/lactone replacement was validated by the discovery of (20S,21S)-21-fluorocamptothecins as hydrolytically stable topoisomerase I inhibitors.  A highly potent camptothecin deriv., (20S,21S)-7-Cyclohexyluorocamptothecin, was successfully identified, which showed excellent in vitro and in vivo antitumor activities and represents a promising lead for the discovery of novel antitumor agents.  Interestingly, this study also provided a new structure-activity relationship for the C21-carbonyl group of camptothecin, which has been regarded as an essential pharmacophore.  The authors' results revealed that the conserved C21-carbonyl group can be replaced by a fluorine substituent. α-Fluoro ether may have general application in improving the metabolic stability of lactone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvIv8t6UZLVbVg90H21EOLACvtfcHk0lhUFEb7a9xLQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFarsrzE&md5=c99ef47778bdea1041e131efdb8fdbfa</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjm400906z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400906z%26sid%3Dliteratum%253Aachs%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DZhuang%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DK.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DA%2520new%2520strategy%2520to%2520improve%2520the%2520metabolic%2520stability%2520of%2520lactone%253A%2520discovery%2520of%2520%252820S%252C21S%2529-21-fluorocamptothecins%2520as%2520novel%252C%2520hydrolytically%2520stable%2520topoisomerase%2520I%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7902%26epage%3D7910%26doi%3D10.1021%2Fjm400906z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhuniya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maiti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. S.</span></span> <span> </span><span class="NLM_article-title">An activatable prodrug for the treatment of metastatic tumors</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">13888</span>– <span class="NLM_lpage">13894</span>, <span class="refDoi"> DOI: 10.1021/ja5077684</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja5077684" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFamsL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=13888-13894&author=E.+J.+Kimauthor=S.+Bhuniyaauthor=H.+Leeauthor=H.+M.+Kimauthor=C.+Cheongauthor=S.+Maitiauthor=K.+S.+Hongauthor=J.+S.+Kim&title=An+activatable+prodrug+for+the+treatment+of+metastatic+tumors&doi=10.1021%2Fja5077684"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">An Activatable Prodrug for the Treatment of Metastatic Tumors</span></div><div class="casAuthors">Kim, Eun-Joong; Bhuniya, Sankarprasad; Lee, Hyunseung; Kim, Hyun Min; Cheong, Chaejoon; Maiti, Sukhendu; Hong, Kwan Soo; Kim, Jong Seung</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">13888-13894</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Metastatic cancers have historically been difficult to treat.  However, metastatic tumors have been found to have high levels of reactive oxygen species such as hydrogen peroxide (H2O2), supporting the hypothesis that a prodrug could be activated by intracellular H2O2 and lead to a potential antimetastatic therapy.  In this study, prodrug 7 was designed to be activated by H2O2-mediated boronate oxidn., resulting in activation of the fluorophore for detection and release of the therapeutic agent, SN-38.  Drug release from prodrug 7 was investigated by monitoring fluorescence after addn. of H2O2 to the cancer cells.  Prodrug 7 activated by H2O2, selectively inhibited tumor cell growth.  Furthermore, intratracheally administered prodrug 7 showed effective antitumor activity in a mouse model of metastatic lung disease.  Thus, this H2O2-responsive prodrug has therapeutic potential as a novel treatment for metastatic cancer via cellular imaging with fluorescence as well as selective release of the anticancer drug, SN-38.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX5gk0YqDa5rVg90H21EOLACvtfcHk0lhUFEb7a9xLQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFamsL%252FK&md5=35fc515aa6940c7b7946bb5638ed4e19</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fja5077684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja5077684%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DE.%2BJ.%26aulast%3DBhuniya%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DH.%2BM.%26aulast%3DCheong%26aufirst%3DC.%26aulast%3DMaiti%26aufirst%3DS.%26aulast%3DHong%26aufirst%3DK.%2BS.%26aulast%3DKim%26aufirst%3DJ.%2BS.%26atitle%3DAn%2520activatable%2520prodrug%2520for%2520the%2520treatment%2520of%2520metastatic%2520tumors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D13888%26epage%3D13894%26doi%3D10.1021%2Fja5077684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span> <span> </span><span class="NLM_article-title">10-Boronic acid substituted camptothecin as prodrug of SN-38</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">84</span>– <span class="NLM_lpage">89</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.03.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.ejmech.2016.03.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=27060760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlsl2htbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=84-89&author=L.+Wangauthor=S.+Xieauthor=L.+Maauthor=Y.+Chenauthor=W.+Lu&title=10-Boronic+acid+substituted+camptothecin+as+prodrug+of+SN-38&doi=10.1016%2Fj.ejmech.2016.03.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">10-Boronic acid substituted camptothecin as prodrug of SN-38</span></div><div class="casAuthors">Wang, Lei; Xie, Shao; Ma, Longjun; Chen, Yi; Lu, Wei</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">84-89</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Malignant tumor cells have been found to have high levels of reactive oxygen species such as hydrogen peroxide (H2O2), supporting the hypothesis that a prodrug could be activated by intracellular H2O2 and lead to a potential antitumor therapy.  In this study, the 7-ethyl-10-boronic acid camptothecin (B1) was synthesized for the first time as prodrug of SN-38, by linking a cleavable aryl carbon-boron bond to the SN-38.  Prodrug B1 selectively activated by H2O2, converted rapidly to the active form SN-38 under favorable oxidative conditions in cancer cells with elevated levels of H2O2.  The cell survival assay showed that prodrug B1 was equally or more effective in inhibiting the growth of six different cancer cells, as compared to SN-38.  Unexpectedly, prodrug B1 displayed even more potent Topo I inhibitory activity than SN-38, suggesting that it was not only a prodrug of SN-38 but also a typical Topo I inhibitor.  Prodrug B1 also demonstrated a significant antitumor activity at 2.0 mg/kg in a xenograft model using human brain star glioblastoma cell lines U87MG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbS7sNf3ZRmbVg90H21EOLACvtfcHk0ljX1u4sw7x06A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlsl2htbo%253D&md5=39c3592513770a0017e7a80993848eaf</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.03.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.03.063%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DXie%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DW.%26atitle%3D10-Boronic%2520acid%2520substituted%2520camptothecin%2520as%2520prodrug%2520of%2520SN-38%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D116%26spage%3D84%26epage%3D89%26doi%3D10.1016%2Fj.ejmech.2016.03.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Natural product evodiamine with borate trigger unit: discovery of potent antitumor agents against colon cancer</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">439</span>– <span class="NLM_lpage">444</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.9b00513</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.9b00513" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BB3cXktlOhtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=439-444&author=X.+Liauthor=S.+Wuauthor=G.+Dongauthor=S.+Chenauthor=Z.+Maauthor=D.+Liuauthor=C.+Sheng&title=Natural+product+evodiamine+with+borate+trigger+unit%3A+discovery+of+potent+antitumor+agents+against+colon+cancer&doi=10.1021%2Facsmedchemlett.9b00513"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Product Evodiamine with Borate Trigger Unit: Discovery of Potent Antitumor Agents against Colon Cancer</span></div><div class="casAuthors">Li, Xinglin; Wu, Shanchao; Dong, Guoqiang; Chen, Shuqiang; Ma, Zonglin; Liu, Dan; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">439-444</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In order to improve the antitumor potency of the natural product evodiamine, novel boron-contg. evodiamine derivs. were designed by incorporating boronic acid and boronate as trigger units.  Boronate deriv. 13a could be triggered by reactive oxygen species (ROS) in the HCT116 colon cancer cell line and showed excellent antitumor activity in vitro and in vivo.  It induced apoptosis in HCT116 cancer cells in a dose-dependent manner and cell growth arrest at the G2 phase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkwOrWtBZTF7Vg90H21EOLACvtfcHk0lg23V8QEARlkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXktlOhtr4%253D&md5=2bd0bc1c240bcb2faab29458ae230195</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.9b00513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.9b00513%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DNatural%2520product%2520evodiamine%2520with%2520borate%2520trigger%2520unit%253A%2520discovery%2520of%2520potent%2520antitumor%2520agents%2520against%2520colon%2520cancer%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26volume%3D11%26spage%3D439%26epage%3D444%26doi%3D10.1021%2Facsmedchemlett.9b00513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barneda-Zahonero, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parra, M.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylases and cancer</span>. <i>Mol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">579</span>– <span class="NLM_lpage">589</span>, <span class="refDoi"> DOI: 10.1016/j.molonc.2012.07.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.molonc.2012.07.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=22963873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs12gt7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2012&pages=579-589&author=B.+Barneda-Zahoneroauthor=M.+Parra&title=Histone+deacetylases+and+cancer&doi=10.1016%2Fj.molonc.2012.07.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylases and cancer</span></div><div class="casAuthors">Barneda-Zahonero, Bruna; Parra, Maribel</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Oncology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">579-589</span>CODEN:
                <span class="NLM_cas:coden">MOONC3</span>;
        ISSN:<span class="NLM_cas:issn">1574-7891</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Reversible acetylation of histone and non-histone proteins is one of the most abundant post-translational modifications in eukaryotic cells.  Protein acetylation and deacetylation are achieved by the antagonistic actions of two families of enzymes, histone acetyltransferases (HATs) and histone deacetylases (HDACs).  Aberrant protein acetylation, particularly on histones, has been related to cancer while abnormal expression of HDACs has been found in a broad range of cancer types.  Therefore, HDACs have emerged as promising targets in cancer therapeutics, and the development of HDAC inhibitors (HDIs), a rapidly evolving area of clin. research.  However, the contributions of specific HDACs to a given cancer type remain incompletely understood.  The aim of this review is to summarize the current knowledge concerning the role of HDACs in cancer with special emphasis on what we have learned from the anal. of patient samples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOl-qXEsP2IrVg90H21EOLACvtfcHk0lg23V8QEARlkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs12gt7%252FK&md5=7c294b40669bf079b1319391ee456642</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.molonc.2012.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molonc.2012.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DBarneda-Zahonero%26aufirst%3DB.%26aulast%3DParra%26aufirst%3DM.%26atitle%3DHistone%2520deacetylases%2520and%2520cancer%26jtitle%3DMol.%2520Oncol.%26date%3D2012%26volume%3D6%26spage%3D579%26epage%3D589%26doi%3D10.1016%2Fj.molonc.2012.07.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moskowitz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horwitz, S.</span></span> <span> </span><span class="NLM_article-title">Targeting histone deacetylases in T-cell lymphoma</span>. <i>Leuk. Lymphoma</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1306</span>– <span class="NLM_lpage">1319</span>, <span class="refDoi"> DOI: 10.1080/10428194.2016.1247956</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1080%2F10428194.2016.1247956" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=27813438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVCjur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2017&pages=1306-1319&author=A.+Moskowitzauthor=S.+Horwitz&title=Targeting+histone+deacetylases+in+T-cell+lymphoma&doi=10.1080%2F10428194.2016.1247956"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting histone deacetylases in T-cell lymphoma</span></div><div class="casAuthors">Moskowitz, Alison J.; Horwitz, Steven M.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia & Lymphoma</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1306-1319</span>CODEN:
                <span class="NLM_cas:coden">LELYEA</span>;
        ISSN:<span class="NLM_cas:issn">1029-2403</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Histone deacetylase inhibitors (HDACi) are epigenetic modifiers with single-agent activity in patients with cutaneous and peripheral T-cell lymphoma (CTCL, PTCL).  The mechanisms for this preferential activity remain unclear, and although some would term this as 'class effect,' there are differences in efficacy and safety, likely a result of the varying chem. structures/classes, histone and non-histone targets, potencies, and clin. dosing for each.  Three HDACi have single-agent approval in relapsed/refractory TCL in the United States: romidepsin in CTCL and PTCL, vorinostat in CTCL, and belinostat in PTCL.  Although comparison of these agents is difficult due to differences in patient populations, through this review we aimed to provide a detailed overview of the clin. data for HDACi in TCL and their use in clin. practice.  Despite early concerns, data demonstrate the cardiac safety of HDACi, while highlighting the need to maintain electrolytes in the normal range and monitor QT interval when initially co-administering antiemetics or other drugs that prolong QT.  To further improve response rates and durability of responses, HDACi are under clin. investigation in combination with chemotherapy regimens and various novel agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriCACWFrwWGLVg90H21EOLACvtfcHk0lg23V8QEARlkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVCjur3O&md5=bf630a355f4521ac0246ec9470aaca92</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1080%2F10428194.2016.1247956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10428194.2016.1247956%26sid%3Dliteratum%253Aachs%26aulast%3DMoskowitz%26aufirst%3DA.%26aulast%3DHorwitz%26aufirst%3DS.%26atitle%3DTargeting%2520histone%2520deacetylases%2520in%2520T-cell%2520lymphoma%26jtitle%3DLeuk.%2520Lymphoma%26date%3D2017%26volume%3D58%26spage%3D1306%26epage%3D1319%26doi%3D10.1080%2F10428194.2016.1247956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eom, G.</span></span> <span> </span><span class="NLM_article-title">HDAC and HDAC inhibitor: from cancer to cardiovascular diseases</span>. <i>Chonnam Med. J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.4068/cmj.2016.52.1.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.4068%2Fcmj.2016.52.1.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=26865995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmtFKms70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2016&pages=1-11&author=S.+Yoonauthor=G.+Eom&title=HDAC+and+HDAC+inhibitor%3A+from+cancer+to+cardiovascular+diseases&doi=10.4068%2Fcmj.2016.52.1.1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC and HDAC inhibitor: from cancer to cardiovascular diseases</span></div><div class="casAuthors">Yoon, Somy; Eom, Gwang Hyeon</div><div class="citationInfo"><span class="NLM_cas:title">Chonnam Medical Journal</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">CMJHA4</span>;
        ISSN:<span class="NLM_cas:issn">2233-7385</span>.
    
            (<span class="NLM_cas:orgname">Chonnam National University Medical School</span>)
        </div><div class="casAbstract">A review.  Histone deacetylases (HDACs) are epigenetic regulators that regulate the histone tail, chromatin conformation, protein-DNA interaction, and even transcription.  HDACs are also post-transcriptional modifiers that regulate the protein acetylation implicated in several pathophysiol. states.  HDAC inhibitors have been highlighted as a novel category of anti-cancer drugs.  To date, four HDAC inhibitors, Vorinostat, Romidepsin, Panobinostat, and Belinostat, have been approved by the United States Food and Drug Administration.  Principally, these HDAC inhibitors are used for hematol. cancers in clinic with less severe side effects.  Clin. trials are continuously expanding to address other types of cancer and also nonmalignant diseases.  HDAC inhibition also results in beneficial outcomes in various types of neurodegenerative diseases, inflammation disorders, and cardiovascular diseases.  In this review, we will briefly discuss 1) the roles of HDACs in the acquisition of a cancer's phenotype and the general outcome of the HDAC inhibitors in cancer, 2) the functional relevance of HDACs in cardiovascular diseases and the possible therapeutic implications of HDAC inhibitors in cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSsxE7tiGIdbVg90H21EOLACvtfcHk0libzCFEpAt3_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmtFKms70%253D&md5=fb9a3b8c88dcf36789b7813d458eb139</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.4068%2Fcmj.2016.52.1.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4068%252Fcmj.2016.52.1.1%26sid%3Dliteratum%253Aachs%26aulast%3DYoon%26aufirst%3DS.%26aulast%3DEom%26aufirst%3DG.%26atitle%3DHDAC%2520and%2520HDAC%2520inhibitor%253A%2520from%2520cancer%2520to%2520cardiovascular%2520diseases%26jtitle%3DChonnam%2520Med.%2520J.%26date%3D2016%26volume%3D52%26spage%3D1%26epage%3D11%26doi%3D10.4068%2Fcmj.2016.52.1.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balliet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallagher, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dellinger, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazarus, P.</span></span> <span> </span><span class="NLM_article-title">Characterization of UGTs active against SAHA and association between SAHA glucuronidation activity phenotype with UGT genotype</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">2981</span>– <span class="NLM_lpage">2989</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-4143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1158%2F0008-5472.CAN-08-4143" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=19318555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvVWisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=2981-2989&author=R.+Ballietauthor=G.+Chenauthor=C.+Gallagherauthor=R.+Dellingerauthor=D.+Sunauthor=P.+Lazarus&title=Characterization+of+UGTs+active+against+SAHA+and+association+between+SAHA+glucuronidation+activity+phenotype+with+UGT+genotype&doi=10.1158%2F0008-5472.CAN-08-4143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of UGTs Active against SAHA and Association between SAHA Glucuronidation Activity Phenotype with UGT Genotype</span></div><div class="casAuthors">Balliet, Renee M.; Chen, Gang; Gallagher, Carla J.; Dellinger, Ryan W.; Sun, Dongxiao; Lazarus, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2981-2989</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Suberoylanilide hydroxamic acid (SAHA) is a histone deacetylase inhibitor used in the treatment of cutaneous T-cell lymphoma and in clin. trials for treatment of multiple other cancers.  A major mode of SAHA metab. is by glucuronidation via the UDP-glucuronosyltransferase (UGT) family of enzymes.  To characterize the UGTs active against SAHA, homogenates from HEK293 cell lines overexpressing UGT wild-type or variant UGT were used.  The hepatic UGTs 2B17 and 1A9 and the extrahepatic UGTs 1A8 and 1A10 exhibited the highest overall activity against SAHA as detd. by Vmax/KM (16 ± 6.5, 7.1 ± 2.2, 33 ± 6.3, and 24 ± 2.4 nL/min-1/μg UGT protein-1, resp.), with UGT2B17 exhibiting the lowest KM (300 μmol/L) against SAHA of any UGT in vitro.  Whereas the UGT1A8p.Ala173Gly variant exhibited a 3-fold (P < 0.005) decrease in glucuronidation activity against SAHA compared with wild-type UGT1A8, the UGT1A8p.Cys277Tyr variant exhibited no detectable glucuronidation activity; a similar lack of detectable glucuronidation activity was obsd. for the UGT1A10p.Gly139Lys variant.  To analyze the effects of the UGT2B17 gene deletion variant (UGT2B17*2) on SAHA glucuronidation phenotype, human liver microsomes (HLM) were analyzed for glucuronidation activity against SAHA and compared with UGT2B17 genotype.  HLM from subjects homozygous for UGT2B17*2 exhibited a 45% (P < 0.01) decrease in glucuronidation activity and a 75% (P < 0.002) increase in KM compared with HLMs from subjects homozygous for the wild-type UGT2B17*1 allele.  Overall, these results suggest that several UGTs play an important role in the metab. of SAHA and that UGT2B17-null individuals could potentially exhibit altered SAHA clearance rates with differences in overall response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYTm-1gtyYyrVg90H21EOLACvtfcHk0libzCFEpAt3_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvVWisb4%253D&md5=de9beb1be7a46b1dfdf1a338f12c77dd</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-4143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-4143%26sid%3Dliteratum%253Aachs%26aulast%3DBalliet%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DGallagher%26aufirst%3DC.%26aulast%3DDellinger%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DLazarus%26aufirst%3DP.%26atitle%3DCharacterization%2520of%2520UGTs%2520active%2520against%2520SAHA%2520and%2520association%2520between%2520SAHA%2520glucuronidation%2520activity%2520phenotype%2520with%2520UGT%2520genotype%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D2981%26epage%3D2989%26doi%3D10.1158%2F0008-5472.CAN-08-4143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flipo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocine, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dassonneville, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Déprez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deprez-Poulain, R.</span></span> <span> </span><span class="NLM_article-title">Hydroxamates: relationships between structure and plasma stability</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">6790</span>– <span class="NLM_lpage">6802</span>, <span class="refDoi"> DOI: 10.1021/jm900648x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900648x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GgsbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6790-6802&author=M.+Flipoauthor=J.+Chartonauthor=A.+Hocineauthor=S.+Dassonnevilleauthor=B.+D%C3%A9prezauthor=R.+Deprez-Poulain&title=Hydroxamates%3A+relationships+between+structure+and+plasma+stability&doi=10.1021%2Fjm900648x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroxamates: Relationships between Structure and Plasma Stability</span></div><div class="casAuthors">Flipo, Marion; Charton, Julie; Hocine, Akila; Dassonneville, Sandrine; Deprez, Benoit; Deprez-Poulain, Rebecca</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6790-6802</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hydroxamates are valuable tools for chem. biol. as well as interesting leads for medicinal chem.  Although many hydroxamates display nanomolar activities against metalloproteases, only three hydroxamates have reached the market, among which is the HDAC inhibitor vorinostat.  Failures in development are generally attributed to lack of selectivity, toxicity, or poor stability.  To help medicinal chemists with respect to plasma stability, the authors have performed the first and preliminary study on structure-plasma stability for hydroxamates.  The authors define some structural rules to predict or improve the plasma stability in the preclin. stage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk66ooWU1NhbVg90H21EOLACvtfcHk0libzCFEpAt3_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GgsbnJ&md5=069a87988fbeb68a248d006c7f6307a0</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm900648x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900648x%26sid%3Dliteratum%253Aachs%26aulast%3DFlipo%26aufirst%3DM.%26aulast%3DCharton%26aufirst%3DJ.%26aulast%3DHocine%26aufirst%3DA.%26aulast%3DDassonneville%26aufirst%3DS.%26aulast%3DD%25C3%25A9prez%26aufirst%3DB.%26aulast%3DDeprez-Poulain%26aufirst%3DR.%26atitle%3DHydroxamates%253A%2520relationships%2520between%2520structure%2520and%2520plasma%2520stability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6790%26epage%3D6802%26doi%3D10.1021%2Fjm900648x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schlimme, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauser, A.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carafa, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kannan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stolfa, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cellamare, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altucci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sippl, W.</span></span> <span> </span><span class="NLM_article-title">Carbamate prodrug concept for hydroxamate HDAC inhibitors</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1193</span>– <span class="NLM_lpage">1198</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201100007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2Fcmdc.201100007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=21416613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotVCnsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1193-1198&author=S.+Schlimmeauthor=A.-T.+Hauserauthor=V.+Carafaauthor=R.+Heinkeauthor=S.+Kannanauthor=D.+A.+Stolfaauthor=S.+Cellamareauthor=A.+Carottiauthor=L.+Altucciauthor=M.+Jungauthor=W.+Sippl&title=Carbamate+prodrug+concept+for+hydroxamate+HDAC+inhibitors&doi=10.1002%2Fcmdc.201100007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Carbamate Prodrug Concept for Hydroxamate HDAC Inhibitors</span></div><div class="casAuthors">Schlimme, Sonja; Hauser, Alexander-Thomas; Carafa, Vincenzo; Heinke, Ralf; Kannan, Srinivasaraghavan; Stolfa, Diana A.; Cellamare, Saverio; Carotti, Angelo; Altucci, Lucia; Jung, Manfred; Sippl, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1193-1198</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Virtual screening against a HDAC6 homol. model has led to the indentification of a new HDAC6-selective inhibitor I and a carbamate deriv. that acts as a prodrug in cell culture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5mxc5jtnXe7Vg90H21EOLACvtfcHk0lhvhyFVEm-Z0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotVCnsbs%253D&md5=21fdb2c7de1ca402e9cf370cd3607eeb</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100007%26sid%3Dliteratum%253Aachs%26aulast%3DSchlimme%26aufirst%3DS.%26aulast%3DHauser%26aufirst%3DA.-T.%26aulast%3DCarafa%26aufirst%3DV.%26aulast%3DHeinke%26aufirst%3DR.%26aulast%3DKannan%26aufirst%3DS.%26aulast%3DStolfa%26aufirst%3DD.%2BA.%26aulast%3DCellamare%26aufirst%3DS.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DAltucci%26aufirst%3DL.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DSippl%26aufirst%3DW.%26atitle%3DCarbamate%2520prodrug%2520concept%2520for%2520hydroxamate%2520HDAC%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D1193%26epage%3D1198%26doi%3D10.1002%2Fcmdc.201100007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhagat, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, A.</span></span> <span> </span><span class="NLM_article-title">An endogenous reactive oxygen species (ROS)-activated histone deacetylase inhibitor prodrug for cancer chemotherapy</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2073</span>– <span class="NLM_lpage">2079</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201800367</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2Fcmdc.201800367" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=30070768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFKqu7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=2073-2079&author=S.+D.+Bhagatauthor=U.+Singhauthor=R.+K.+Mishraauthor=A.+Srivastava&title=An+endogenous+reactive+oxygen+species+%28ROS%29-activated+histone+deacetylase+inhibitor+prodrug+for+cancer+chemotherapy&doi=10.1002%2Fcmdc.201800367"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">An Endogenous Reactive Oxygen Species (ROS)-Activated Histone Deacetylase Inhibitor Prodrug for Cancer Chemotherapy</span></div><div class="casAuthors">Bhagat, Somnath D.; Singh, Usha; Mishra, Ram Kumar; Srivastava, Aasheesh</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2073-2079</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Suberoylanilide hydroxamic acid (SAHA, vorinostat) is a potent small-mol. pan-inhibitor of histone deacetylases (HDACs) approved for treatment of cutaneous T-cell lymphoma (CTCL).  However, SAHA exhibits poor selectivity for cancer cells over noncancer cells.  With an aim to improving its selectivity for cancer cells, the authors generated a novel SAHA prodrug (SAHA-OBP) that is activated in the presence of hydrogen peroxide, a reactive oxygen species (ROS) known to be overexpressed in cancer cells.  The high endogenous ROS content in cancer cells triggers rapid removal of the 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl carbonyl (OBP) cap to release active SAHA.  The SAHA-OBP prodrug demonstrates selective activity against multiple cancer cell lines such as HeLa, MCF-7, MDA-MB-231, and B16-F10, while remaining benign toward noncancer cells.  The downstream effects of SAHA released from SAHA-OBP in cancer cells is the induction of apoptosis.  SAHA-OBP was also found to be effective on multicellular tumor spheroids (MCTS).  The SAHA prodrug designed in this study undergoes rapid ROS-dependent activation and imparts much-needed selectivity to SAHA for cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQpWFPXO5SS7Vg90H21EOLACvtfcHk0lhvhyFVEm-Z0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFKqu7%252FJ&md5=194b433548a5ca7806ead22ac9a8b7a9</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201800367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201800367%26sid%3Dliteratum%253Aachs%26aulast%3DBhagat%26aufirst%3DS.%2BD.%26aulast%3DSingh%26aufirst%3DU.%26aulast%3DMishra%26aufirst%3DR.%2BK.%26aulast%3DSrivastava%26aufirst%3DA.%26atitle%3DAn%2520endogenous%2520reactive%2520oxygen%2520species%2520%2528ROS%2529-activated%2520histone%2520deacetylase%2520inhibitor%2520prodrug%2520for%2520cancer%2520chemotherapy%26jtitle%3DChemMedChem%26date%3D2018%26volume%3D13%26spage%3D2073%26epage%3D2079%26doi%3D10.1002%2Fcmdc.201800367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Z.</span></span> <span> </span><span class="NLM_article-title">H<sub>2</sub>O<sub>2</sub>/peroxynitrite-activated hydroxamic acid HDAC inhibitor prodrugs show antileukemic activities against AML cells</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">635</span>– <span class="NLM_lpage">640</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.8b00057</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00057" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFentbjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=635-640&author=Y.+Liaoauthor=L.+Xuauthor=S.+Ouauthor=H.+Edwardsauthor=D.+Luedtkeauthor=Y.+Geauthor=Z.+Qin&title=H2O2%2Fperoxynitrite-activated+hydroxamic+acid+HDAC+inhibitor+prodrugs+show+antileukemic+activities+against+AML+cells&doi=10.1021%2Facsmedchemlett.8b00057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">H2O2/Peroxynitrite-Activated Hydroxamic Acid HDAC Inhibitor Prodrugs Show Antileukemic Activities against AML Cells</span></div><div class="casAuthors">Liao, Yi; Xu, Liping; Ou, Siyu; Edwards, Holly; Luedtke, Daniel; Ge, Yubin; Qin, Zhihui</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">635-640</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Occurrence of acute myeloid leukemia (AML) results in abundant endogenous reactive oxygen species (ROS)/reactive nitrogen species (RNS) in AML cells and in disease-relevant microenvironments.  Histone deacetylase inhibitor (HDACi) prodrug approach was designed accordingly by masking the hydroxamic acid zinc binding group with hydrogen peroxide (H2O2)/peroxynitrite (PNT)-sensitive, self-immolative aryl boronic acid moiety.  Model prodrugs 5-82 (I) and 5-23 (II) were activated in AML cells to release cytotoxic HDACis, evidenced by inducing acetylation markers and reducing viability of AML cells.  Intracellular activation and antileukemic activities of prodrug were increased or decreased by ROS/PNT inducers and scavengers, resp.  Prodrugs 5-82 (I) and 5-23 (II) also enhanced the potency of chemotherapy drug cytarabine, supporting the potentials of this prodrug class in combinatorial treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtVLyTA7Ynr7Vg90H21EOLACvtfcHk0lhvhyFVEm-Z0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFentbjK&md5=923d6234d9827e3abf1c729969221ce1</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00057%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DOu%26aufirst%3DS.%26aulast%3DEdwards%26aufirst%3DH.%26aulast%3DLuedtke%26aufirst%3DD.%26aulast%3DGe%26aufirst%3DY.%26aulast%3DQin%26aufirst%3DZ.%26atitle%3DH2O2%252Fperoxynitrite-activated%2520hydroxamic%2520acid%2520HDAC%2520inhibitor%2520prodrugs%2520show%2520antileukemic%2520activities%2520against%2520AML%2520cells%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D635%26epage%3D640%26doi%3D10.1021%2Facsmedchemlett.8b00057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span> <span> </span><span class="NLM_article-title">Biocompatible boron-containing prodrugs of belinostat for the potential treatment of solid tumors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">149</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00504</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00504" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlvVertg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=149-154&author=S.+Zhengauthor=S.+Guoauthor=Q.+Zhongauthor=C.+Zhangauthor=J.+Liuauthor=L.+Yangauthor=Q.+Zhangauthor=G.+Wang&title=Biocompatible+boron-containing+prodrugs+of+belinostat+for+the+potential+treatment+of+solid+tumors&doi=10.1021%2Facsmedchemlett.7b00504"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Biocompatible Boron-Containing Prodrugs of Belinostat for the Potential Treatment of Solid Tumors</span></div><div class="casAuthors">Zheng, Shilong; Guo, Shanchun; Zhong, Qiu; Zhang, Changde; Liu, Jiawang; Yang, Lin; Zhang, Qiang; Wang, Guangdi</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">149-154</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Despite promising therapeutic utilities for treatment of hematol. malignancies, histone deacetylase inhibitor (HDACi) drugs have not proven as effective in the treatment of solid tumors.  To expand the clin. indications of HDACi drugs, we developed novel boron-contg. prodrugs of belinostat (2), one of which efficiently releases active 2 through a cascade of reactions in cell culture and demonstrates activities comparable to 2 against a panel of cancer cell lines.  Importantly, prodrug I is more efficacious than belinostat in vivo, not only inhibiting the growth of tumor but also reducing tumor vols. in an MCF-7 xenograft tumor model owing to its superior biocompatibility, which suggests its clin. potential in the treatment of solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjIOQIgps2KrVg90H21EOLACvtfcHk0ljz7VPTTpQvOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlvVertg%253D%253D&md5=96d56396fbcd0a6192f277ffb13fb423</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00504%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DS.%26aulast%3DZhong%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DG.%26atitle%3DBiocompatible%2520boron-containing%2520prodrugs%2520of%2520belinostat%2520for%2520the%2520potential%2520treatment%2520of%2520solid%2520tumors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D149%26epage%3D154%26doi%3D10.1021%2Facsmedchemlett.7b00504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geller, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barzily-Rokni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonas, O. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shental, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nejman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavert, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thaiss, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reuben, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avraham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederick, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligorio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosher, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuks, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurbatri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gopalakrishnan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurd, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skalak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaud, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trauger, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barshack, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandbank, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flaherty, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandinova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrett, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thayer, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrone, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huttenhower, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhatia, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gevers, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wargo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straussman, R.</span></span> <span> </span><span class="NLM_article-title">Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>357</i></span>,  <span class="NLM_fpage">1156</span>– <span class="NLM_lpage">1160</span>, <span class="refDoi"> DOI: 10.1126/science.aah5043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1126%2Fscience.aah5043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=28912244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVOitbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2017&pages=1156-1160&author=L.+T.+Gellerauthor=M.+Barzily-Rokniauthor=T.+Daninoauthor=O.+H.+Jonasauthor=N.+Shentalauthor=D.+Nejmanauthor=N.+Gavertauthor=Y.+Zwangauthor=Z.+A.+Cooperauthor=K.+Sheeauthor=C.+A.+Thaissauthor=A.+Reubenauthor=J.+Livnyauthor=R.+Avrahamauthor=D.+T.+Frederickauthor=M.+Ligorioauthor=K.+Chatmanauthor=S.+E.+Johnstonauthor=C.+M.+Mosherauthor=A.+Brandisauthor=G.+Fuksauthor=C.+Gurbatriauthor=V.+Gopalakrishnanauthor=M.+Kimauthor=M.+W.+Hurdauthor=M.+Katzauthor=J.+Flemingauthor=A.+Maitraauthor=D.+A.+Smithauthor=M.+Skalakauthor=J.+Buauthor=M.+Michaudauthor=S.+A.+Traugerauthor=I.+Barshackauthor=T.+Golanauthor=J.+Sandbankauthor=K.+T.+Flahertyauthor=A.+Mandinovaauthor=W.+S.+Garrettauthor=S.+P.+Thayerauthor=C.+R.+Ferroneauthor=C.+Huttenhowerauthor=S.+N.+Bhatiaauthor=D.+Geversauthor=J.+A.+Wargoauthor=T.+R.+Golubauthor=R.+Straussman&title=Potential+role+of+intratumor+bacteria+in+mediating+tumor+resistance+to+the+chemotherapeutic+drug+gemcitabine&doi=10.1126%2Fscience.aah5043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine</span></div><div class="casAuthors">Geller, Leore T.; Barzily-Rokni, Michal; Danino, Tal; Jonas, Oliver H.; Shental, Noam; Nejman, Deborah; Gavert, Nancy; Zwang, Yaara; Cooper, Zachary A.; Shee, Kevin; Thaiss, Christoph A.; Reuben, Alexandre; Livny, Jonathan; Avraham, Roi; Frederick, Dennie T.; Ligorio, Matteo; Chatman, Kelly; Johnston, Stephen E.; Mosher, Carrie M.; Brandis, Alexander; Fuks, Garold; Gurbatri, Candice; Gopalakrishnan, Vancheswaran; Kim, Michael; Hurd, Mark W.; Katz, Matthew; Fleming, Jason; Maitra, Anirban; Smith, David A.; Skalak, Matt; Bu, Jeffrey; Michaud, Monia; Trauger, Sunia A.; Barshack, Iris; Golan, Talia; Sandbank, Judith; Flaherty, Keith T.; Mandinova, Anna; Garrett, Wendy S.; Thayer, Sarah P.; Ferrone, Cristina R.; Huttenhower, Curtis; Bhatia, Sangeeta N.; Gevers, Dirk; Wargo, Jennifer A.; Golub, Todd R.; Straussman, Ravid</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">6356</span>),
    <span class="NLM_cas:pages">1156-1160</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Growing evidence suggests that microbes can influence the efficacy of cancer therapies.  By studying colon cancer models, we found that bacteria can metabolize the chemotherapeutic drug gemcitabine (2',2'-difluorodeoxycytidine) into its inactive form, 2',2'-difluorodeoxyuridine.  Metab. was dependent on the expression of a long isoform of the bacterial enzyme cytidine deaminase (CDDL), seen primarily in Gammaproteobacteria.  In a colon cancer mouse model, gemcitabine resistance was induced by intratumor Gammaproteobacteria, dependent on bacterial CDDL expression, and abrogated by cotreatment with the antibiotic ciprofloxacin.  Gemcitabine is commonly used to treat pancreatic ductal adenocarcinoma (PDAC), and we hypothesized that intratumor bacteria might contribute to drug resistance of these tumors.  Consistent with this possibility, we found that of the 113 human PDACs that were tested, 86 (76%) were pos. for bacteria, mainly Gammaproteobacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosNU1tWwuHBrVg90H21EOLACvtfcHk0ljz7VPTTpQvOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVOitbfM&md5=c362091ae8c56c0cc5dead46b4f6c96e</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1126%2Fscience.aah5043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aah5043%26sid%3Dliteratum%253Aachs%26aulast%3DGeller%26aufirst%3DL.%2BT.%26aulast%3DBarzily-Rokni%26aufirst%3DM.%26aulast%3DDanino%26aufirst%3DT.%26aulast%3DJonas%26aufirst%3DO.%2BH.%26aulast%3DShental%26aufirst%3DN.%26aulast%3DNejman%26aufirst%3DD.%26aulast%3DGavert%26aufirst%3DN.%26aulast%3DZwang%26aufirst%3DY.%26aulast%3DCooper%26aufirst%3DZ.%2BA.%26aulast%3DShee%26aufirst%3DK.%26aulast%3DThaiss%26aufirst%3DC.%2BA.%26aulast%3DReuben%26aufirst%3DA.%26aulast%3DLivny%26aufirst%3DJ.%26aulast%3DAvraham%26aufirst%3DR.%26aulast%3DFrederick%26aufirst%3DD.%2BT.%26aulast%3DLigorio%26aufirst%3DM.%26aulast%3DChatman%26aufirst%3DK.%26aulast%3DJohnston%26aufirst%3DS.%2BE.%26aulast%3DMosher%26aufirst%3DC.%2BM.%26aulast%3DBrandis%26aufirst%3DA.%26aulast%3DFuks%26aufirst%3DG.%26aulast%3DGurbatri%26aufirst%3DC.%26aulast%3DGopalakrishnan%26aufirst%3DV.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DHurd%26aufirst%3DM.%2BW.%26aulast%3DKatz%26aufirst%3DM.%26aulast%3DFleming%26aufirst%3DJ.%26aulast%3DMaitra%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DSkalak%26aufirst%3DM.%26aulast%3DBu%26aufirst%3DJ.%26aulast%3DMichaud%26aufirst%3DM.%26aulast%3DTrauger%26aufirst%3DS.%2BA.%26aulast%3DBarshack%26aufirst%3DI.%26aulast%3DGolan%26aufirst%3DT.%26aulast%3DSandbank%26aufirst%3DJ.%26aulast%3DFlaherty%26aufirst%3DK.%2BT.%26aulast%3DMandinova%26aufirst%3DA.%26aulast%3DGarrett%26aufirst%3DW.%2BS.%26aulast%3DThayer%26aufirst%3DS.%2BP.%26aulast%3DFerrone%26aufirst%3DC.%2BR.%26aulast%3DHuttenhower%26aufirst%3DC.%26aulast%3DBhatia%26aufirst%3DS.%2BN.%26aulast%3DGevers%26aufirst%3DD.%26aulast%3DWargo%26aufirst%3DJ.%2BA.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DStraussman%26aufirst%3DR.%26atitle%3DPotential%2520role%2520of%2520intratumor%2520bacteria%2520in%2520mediating%2520tumor%2520resistance%2520to%2520the%2520chemotherapeutic%2520drug%2520gemcitabine%26jtitle%3DScience%26date%3D2017%26volume%3D357%26spage%3D1156%26epage%3D1160%26doi%3D10.1126%2Fscience.aah5043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsushita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eguchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koseki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwagami, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asaoka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasahara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morihiro, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satoh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obika, S.</span></span> <span> </span><span class="NLM_article-title">A hydrogen peroxide activatable gemcitabine prodrug for the selective treatment of pancreatic ductal adenocarcinoma</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1384</span>– <span class="NLM_lpage">1391</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201900324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2Fcmdc.201900324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=31207139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlSmtb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&pages=1384-1391&author=K.+Matsushitaauthor=T.+Okudaauthor=S.+Moriauthor=M.+Konnoauthor=H.+Eguchiauthor=A.+Asaiauthor=J.+Kosekiauthor=Y.+Iwagamiauthor=D.+Yamadaauthor=H.+Akitaauthor=T.+Asaokaauthor=T.+Nodaauthor=K.+Kawamotoauthor=K.+Gotohauthor=S.+Kobayashiauthor=Y.+Kasaharaauthor=K.+Morihiroauthor=T.+Satohauthor=Y.+Dokiauthor=M.+Moriauthor=H.+Ishiiauthor=S.+Obika&title=A+hydrogen+peroxide+activatable+gemcitabine+prodrug+for+the+selective+treatment+of+pancreatic+ductal+adenocarcinoma&doi=10.1002%2Fcmdc.201900324"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">A Hydrogen Peroxide Activatable Gemcitabine Prodrug for the Selective Treatment of Pancreatic Ductal Adenocarcinoma</span></div><div class="casAuthors">Matsushita, Katsunori; Okuda, Takumi; Mori, Shohei; Konno, Masamitsu; Eguchi, Hidetoshi; Asai, Ayumu; Koseki, Jun; Iwagami, Yoshifumi; Yamada, Daisaku; Akita, Hirofumi; Asaoka, Tadafumi; Noda, Takehiro; Kawamoto, Koichi; Gotoh, Kunihito; Kobayashi, Shogo; Kasahara, Yuuya; Morihiro, Kunihiko; Satoh, Taroh; Doki, Yuichiro; Mori, Masaki; Ishii, Hideshi; Obika, Satoshi</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1384-1391</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The main concern in the use of anticancer chemotherapeutic drugs is host toxicity.  Patients need to interrupt or change chemotherapy due to adverse effects.  In this study, we aimed to decrease adverse events with gemcitabine (GEM) in the treatment of pancreatic ductal adenocarcinoma and focused on the difference of hydrogen peroxide levels in normal vs. cancer cells.  We designed and synthesized a novel boronate-ester-caged prodrug that is activated by the high H2O2 concns. found in cancer cells to release GEM.  An H2O2-activatable GEM (A-GEM) has higher selectivity for H2O2 over other reactive oxygen species (ROS) and cytotoxic effects corresponding to the H2O2 concn. in vitro.  A xenograft model of immunodeficient mice indicated that the effect of A-GEM was not inferior to that of GEM when administered in vivo.  In particular, myelosuppression was significantly decreased following A-GEM treatment compared with that following GEM treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg1DX6Qb4J5LVg90H21EOLACvtfcHk0li8LEx7ew1tXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlSmtb3N&md5=d923b63f507752e11d1a96b5481adaab</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201900324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201900324%26sid%3Dliteratum%253Aachs%26aulast%3DMatsushita%26aufirst%3DK.%26aulast%3DOkuda%26aufirst%3DT.%26aulast%3DMori%26aufirst%3DS.%26aulast%3DKonno%26aufirst%3DM.%26aulast%3DEguchi%26aufirst%3DH.%26aulast%3DAsai%26aufirst%3DA.%26aulast%3DKoseki%26aufirst%3DJ.%26aulast%3DIwagami%26aufirst%3DY.%26aulast%3DYamada%26aufirst%3DD.%26aulast%3DAkita%26aufirst%3DH.%26aulast%3DAsaoka%26aufirst%3DT.%26aulast%3DNoda%26aufirst%3DT.%26aulast%3DKawamoto%26aufirst%3DK.%26aulast%3DGotoh%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DKasahara%26aufirst%3DY.%26aulast%3DMorihiro%26aufirst%3DK.%26aulast%3DSatoh%26aufirst%3DT.%26aulast%3DDoki%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DM.%26aulast%3DIshii%26aufirst%3DH.%26aulast%3DObika%26aufirst%3DS.%26atitle%3DA%2520hydrogen%2520peroxide%2520activatable%2520gemcitabine%2520prodrug%2520for%2520the%2520selective%2520treatment%2520of%2520pancreatic%2520ductal%2520adenocarcinoma%26jtitle%3DChemMedChem%26date%3D2019%26volume%3D14%26spage%3D1384%26epage%3D1391%26doi%3D10.1002%2Fcmdc.201900324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skarbek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maslah, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rascol, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labruère, R.</span></span> <span> </span><span class="NLM_article-title">Arylboronate prodrugs of doxorubicin as promising chemotherapy for pancreatic cancer</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">103158</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2019.103158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.bioorg.2019.103158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=31376782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFWmtL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2019&pages=103158&author=C.+Skarbekauthor=S.+Serraauthor=H.+Maslahauthor=E.+Rascolauthor=R.+Labru%C3%A8re&title=Arylboronate+prodrugs+of+doxorubicin+as+promising+chemotherapy+for+pancreatic+cancer&doi=10.1016%2Fj.bioorg.2019.103158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Arylboronate prodrugs of doxorubicin as promising chemotherapy for pancreatic cancer</span></div><div class="casAuthors">Skarbek, Charles; Serra, Silvia; Maslah, Hichem; Rascol, Estelle; Labruere, Raphael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103158</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This study describes the synthesis of arylboronate-based ROS-responsive prodrugs of doxorubicin and their biol. evaluation as anticancer agents.  The detn. of the most sensitive cancer type toward arylboronate prodrugs is crucial for further consideration of these mols. in clin. phase.  To address this goal, an arylboronate-based profluorescent probe was used to compare the capacity of various cancer cell lines to efficiently convert the precursor into the free fluorophore.  On the selected MiaPaCa-2 pancreatic cancer cells, a benzeneboronate prodrug exhibited 67% of the cytotoxicity obtained with the free doxorubicin.  The prodrug was also able to induce tumor regression on MiaPaCa-2 pancreatic tumor model in ovo.  Using this model, the amt. of free doxorubicin liberated from this prodrug into the tumor was equiv. to the quantity measured after direct intratumoral injection of the same concn. of doxorubicin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYPZWNykgG4LVg90H21EOLACvtfcHk0li8LEx7ew1tXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFWmtL%252FE&md5=b5da3a39022df3cb3ddcf9a93669d5bb</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2019.103158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2019.103158%26sid%3Dliteratum%253Aachs%26aulast%3DSkarbek%26aufirst%3DC.%26aulast%3DSerra%26aufirst%3DS.%26aulast%3DMaslah%26aufirst%3DH.%26aulast%3DRascol%26aufirst%3DE.%26aulast%3DLabru%25C3%25A8re%26aufirst%3DR.%26atitle%3DArylboronate%2520prodrugs%2520of%2520doxorubicin%2520as%2520promising%2520chemotherapy%2520for%2520pancreatic%2520cancer%26jtitle%3DBioorg.%2520Chem.%26date%3D2019%26volume%3D91%26spage%3D103158%26doi%3D10.1016%2Fj.bioorg.2019.103158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obianom, O. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, F.</span></span> <span> </span><span class="NLM_article-title">Enhanced tumor selectivity of 5-fluorouracil using a reactive oxygen species-activated prodrug approach</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">131</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.8b00539</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00539" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVSgsL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=127-131&author=Y.+Aiauthor=O.+N.+Obianomauthor=M.+Kuserauthor=Y.+Liauthor=Y.+Shuauthor=F.+Xue&title=Enhanced+tumor+selectivity+of+5-fluorouracil+using+a+reactive+oxygen+species-activated+prodrug+approach&doi=10.1021%2Facsmedchemlett.8b00539"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced tumor selectivity of 5-fluorouracil using a reactive oxygen species-activated prodrug approach</span></div><div class="casAuthors">Ai, Yong; Obianom, Obinna N.; Kuser, Meredith; Li, Yue; Shu, Yan; Xue, Fengtian</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-131</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the design, synthesis, and evaluation of novel 5-fluorouracil (5FU) prodrugs 1a, 1b that are efficiently activated by the high level of reactive oxygen species (ROS) in cancer cells.  Prodrugs 1a, 1b selectively kill cancer cells over normal cells and are well-tolerated in mice.  The strategy described herein can extend application of chemotherapeutic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGVNAPjFsTbLVg90H21EOLACvtfcHk0li8LEx7ew1tXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVSgsL7P&md5=7c4d13a40d52838bbaddcc9f4d4c5537</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00539%26sid%3Dliteratum%253Aachs%26aulast%3DAi%26aufirst%3DY.%26aulast%3DObianom%26aufirst%3DO.%2BN.%26aulast%3DKuser%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DShu%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DF.%26atitle%3DEnhanced%2520tumor%2520selectivity%2520of%25205-fluorouracil%2520using%2520a%2520reactive%2520oxygen%2520species-activated%2520prodrug%2520approach%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D10%26spage%3D127%26epage%3D131%26doi%3D10.1021%2Facsmedchemlett.8b00539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gatti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dugnani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calastretti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spadoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scaglione, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bevilacqua, A.</span></span> <span> </span><span class="NLM_article-title">Antiproliferative and pro-apoptotic activity of melatonin analogues on melanoma and breast cancer cells</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">68338</span>– <span class="NLM_lpage">68353</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.20124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.18632%2Foncotarget.20124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=28978121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A280%3ADC%252BC1M%252FltlWlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=68338-68353&author=G.+Gattiauthor=V.+Luciniauthor=S.+Dugnaniauthor=A.+Calastrettiauthor=G.+Spadoniauthor=A.+Bediniauthor=S.+Rivaraauthor=M.+Morauthor=G.+Cantiauthor=F.+Scaglioneauthor=A.+Bevilacqua&title=Antiproliferative+and+pro-apoptotic+activity+of+melatonin+analogues+on+melanoma+and+breast+cancer+cells&doi=10.18632%2Foncotarget.20124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Antiproliferative and pro-apoptotic activity of melatonin analogues on melanoma and breast cancer cells</span></div><div class="casAuthors">Gatti Giuliana; Calastretti Angela; Canti Gianfranco; Bevilacqua Annamaria; Lucini Valeria; Dugnani Silvana; Scaglione Francesco; Spadoni Gilberto; Bedini Annalida; Rivara Silvia; Mor Marco</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">68338-68353</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Melatonin plays different physiological functions ranging from the regulation of circadian rhythms to tumor inhibition, owing to its antioxidant, immunomodulatory and anti-aging properties.  Due to its pleiotropic functions, melatonin has been shown to elicit cytoprotective processes in normal cells and trigger pro-apoptotic signals in cancer cells.  The therapeutic potential of melatonin analogues prompted us to investigate the in vitro and in vivo antitumor activity of new melatonin derivatives and explore the underlying molecular mechanisms.  The experiments revealed that the new melatonin analogues inhibited the growth of melanoma and breast cancer cells in a dose- and time-dependent manner.  In addition, our results indicated that melatonin derivative UCM 1037 could induce apoptosis in melanoma and breast cancer cells, as well as cell necrosis, in MCF-7.  Together, apoptosis and necrosis could be two possible mechanisms to explain the cytotoxic effect of the melatonin analogue against cancer cells.  The suppression of tumor growth by the melatonin analogues was further demonstrated in vivo in a xenograft mice model.  A decrease in the activation of MAPK pathway was observed in all cancer cells following UCM 1037 treatment.  Overall, this study describes a promising antitumor compound showing antiproliferative and cytotoxic activity in melanoma and breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRLwCRKT7Pe3b0AGQpJZWpJfW6udTcc2eaAg2vqVDCKabntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M%252FltlWlsw%253D%253D&md5=985a60350efbda8d1c366dd07f5d2f94</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.20124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.20124%26sid%3Dliteratum%253Aachs%26aulast%3DGatti%26aufirst%3DG.%26aulast%3DLucini%26aufirst%3DV.%26aulast%3DDugnani%26aufirst%3DS.%26aulast%3DCalastretti%26aufirst%3DA.%26aulast%3DSpadoni%26aufirst%3DG.%26aulast%3DBedini%26aufirst%3DA.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DCanti%26aufirst%3DG.%26aulast%3DScaglione%26aufirst%3DF.%26aulast%3DBevilacqua%26aufirst%3DA.%26atitle%3DAntiproliferative%2520and%2520pro-apoptotic%2520activity%2520of%2520melatonin%2520analogues%2520on%2520melanoma%2520and%2520breast%2520cancer%2520cells%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D68338%26epage%3D68353%26doi%3D10.18632%2Foncotarget.20124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daum, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reshetnikov, M. S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sisa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumych, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lootsik, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilyy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bila, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janko, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexiou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellner, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokhir, A.</span></span> <span> </span><span class="NLM_article-title">Lysosome-targeting amplifiers of reactive oxygen species as anticancer prodrugs</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">15545</span>– <span class="NLM_lpage">15549</span>, <span class="refDoi"> DOI: 10.1002/anie.201706585</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2Fanie.201706585" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslygtb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=15545-15549&author=S.+Daumauthor=M.+S.+V.+Reshetnikovauthor=M.+Sisaauthor=T.+Dumychauthor=M.+D.+Lootsikauthor=R.+Bilyyauthor=E.+Bilaauthor=C.+Jankoauthor=C.+Alexiouauthor=M.+Herrmannauthor=L.+Sellnerauthor=A.+Mokhir&title=Lysosome-targeting+amplifiers+of+reactive+oxygen+species+as+anticancer+prodrugs&doi=10.1002%2Fanie.201706585"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosome-Targeting Amplifiers of Reactive Oxygen Species as Anticancer Prodrugs</span></div><div class="casAuthors">Daum, Steffen; Reshetnikov, M. S. Viktor; Sisa, Miroslav; Dumych, Tetyana; Lootsik, Maxim D.; Bilyy, Rostyslav; Bila, Evgenia; Janko, Christina; Alexiou, Christoph; Herrmann, Martin; Sellner, Leopold; Mokhir, Andriy</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">15545-15549</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Cancer cells produce elevated levels of reactive oxygen species, which has been used to design cancer specific prodrugs.  Their activation relies on at least a bimol. process, in which a prodrug reacts with ROS.  However, at low micromolar concns. of the prodrugs and ROS, the activation is usually inefficient.  Herein, the authors propose and validate a potentially general approach for solving this intrinsic problem of ROS-dependent prodrugs.  In particular, known prodrug 4-(N-ferrocenyl-N-benzylaminocarbonyloxymethyl)phenylboronic acid pinacol ester was converted into its lysosome-specific analog.  Since lysosomes contain a higher concn. of active ROS than the cytoplasm, activation of the prodrug was facilitated with respect to the parent compd.  Moreover, it was found to exhibit high anticancer activity in a variety of cancer cell lines (IC50=3.5-7.2 μM) and in vivo (40 mg kg-1, NK/Ly murine model) but remained weakly toxic towards non-malignant cells (IC50=15-30 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwRXSpEQwuabVg90H21EOLACvtfcHk0ljDlZcISu6R_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslygtb3N&md5=6e9cfccec2f511cf647cff6e72044dfe</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1002%2Fanie.201706585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201706585%26sid%3Dliteratum%253Aachs%26aulast%3DDaum%26aufirst%3DS.%26aulast%3DReshetnikov%26aufirst%3DM.%2BS.%2BV.%26aulast%3DSisa%26aufirst%3DM.%26aulast%3DDumych%26aufirst%3DT.%26aulast%3DLootsik%26aufirst%3DM.%2BD.%26aulast%3DBilyy%26aufirst%3DR.%26aulast%3DBila%26aufirst%3DE.%26aulast%3DJanko%26aufirst%3DC.%26aulast%3DAlexiou%26aufirst%3DC.%26aulast%3DHerrmann%26aufirst%3DM.%26aulast%3DSellner%26aufirst%3DL.%26aulast%3DMokhir%26aufirst%3DA.%26atitle%3DLysosome-targeting%2520amplifiers%2520of%2520reactive%2520oxygen%2520species%2520as%2520anticancer%2520prodrugs%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2017%26volume%3D56%26spage%3D15545%26epage%3D15549%26doi%3D10.1002%2Fanie.201706585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bair, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palchaudhuri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hergenrother, P. J.</span></span> <span> </span><span class="NLM_article-title">Chemistry and biology of deoxynyboquinone, a potent inducer of cancer cell death</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">5469</span>– <span class="NLM_lpage">5478</span>, <span class="refDoi"> DOI: 10.1021/ja100610m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja100610m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvFKjsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=5469-5478&author=J.+S.+Bairauthor=R.+Palchaudhuriauthor=P.+J.+Hergenrother&title=Chemistry+and+biology+of+deoxynyboquinone%2C+a+potent+inducer+of+cancer+cell+death&doi=10.1021%2Fja100610m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry and Biology of Deoxynyboquinone, a Potent Inducer of Cancer Cell Death</span></div><div class="casAuthors">Bair, Joseph S.; Palchaudhuri, Rahul; Hergenrother, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5469-5478</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Deoxynyboquinone (DNQ)(I) is a potent antineoplastic agent with an unknown mechanism of action.  Here we describe a facile synthetic route to this anthraquinone, and we use this material to det. the mechanism by which DNQ induces death in cancer cells.  DNQ was synthesized in seven linear steps through a route employing three palladium-mediated coupling reactions.  Expts. performed on cancer cells grown in hypoxia and normoxia strongly suggest that DNQ undergoes bioredn. to its semiquinone, which then is re-oxidized by mol. oxygen, forming superoxide that induces cell death.  Furthermore, global transcript profiling of cells treated with DNQ shows elevation of transcripts related to oxidative stress, a result confirmed at the protein level by Western blotting.  In contrast to most other antineoplastic agents that generate reactive oxygen species (ROS), DNQ potently induces death of cancer cells in culture, with IC50 values between 16 and 210 nM.  In addn., unlike the exptl. therapeutic elesclomol, DNQ is still able to induce cancer cell death under hypoxic conditions.  This mechanistic understanding of DNQ will allow for a more comprehensive evaluation of the potential of direct ROS generation as an anticancer strategy, and DNQ itself has potential as a novel anticancer agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZNDU7HSiqTrVg90H21EOLACvtfcHk0ljDlZcISu6R_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvFKjsbg%253D&md5=743039ba174407d5bdff005502830d81</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fja100610m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja100610m%26sid%3Dliteratum%253Aachs%26aulast%3DBair%26aufirst%3DJ.%2BS.%26aulast%3DPalchaudhuri%26aufirst%3DR.%26aulast%3DHergenrother%26aufirst%3DP.%2BJ.%26atitle%3DChemistry%2520and%2520biology%2520of%2520deoxynyboquinone%252C%2520a%2520potent%2520inducer%2520of%2520cancer%2520cell%2520death%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D5469%26epage%3D5478%26doi%3D10.1021%2Fja100610m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bao, X.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, X.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, B.</span></span> <span> </span><span class="NLM_article-title">A hydrogen peroxide-activated Cu (II) pro-ionophore strategy for modifying naphthazarin as a promising anticancer agent with high selectivity for generating ROS in HepG2 cells over in L02 cells</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>152</i></span>,  <span class="NLM_fpage">597</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2019.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.freeradbiomed.2019.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=31805398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVSlu7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2020&pages=597-608&author=X.-Z.+Baoauthor=Q.+Wangauthor=X.-R.+Renauthor=F.+Daiauthor=B.+Zhou&title=A+hydrogen+peroxide-activated+Cu+%28II%29+pro-ionophore+strategy+for+modifying+naphthazarin+as+a+promising+anticancer+agent+with+high+selectivity+for+generating+ROS+in+HepG2+cells+over+in+L02+cells&doi=10.1016%2Fj.freeradbiomed.2019.12.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">A hydrogen peroxide-activated Cu(II) pro-ionophore strategy for modifying naphthazarin as a promising anticancer agent with high selectivity for generating ROS in HepG2 cells over in L02 cells</span></div><div class="casAuthors">Bao, Xia-Zhen; Wang, Qi; Ren, Xiao-Rong; Dai, Fang; Zhou, Bo</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">597-608</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Targeting redox vulnerability of cancer cells by pro-oxidants capable of generating reactive oxygen species (ROS) has surfaced as an important anticancer strategy.  Due to the intrinsic narrow therapeutic window and other dangerous side effects of ROS generation, it is highly needed and challenging to develop pro-oxidative anticancer agents (PAAs) with high selectivity for generating ROS in cancer cells.  Herein we report a hydrogen peroxide (H2O2)-activated Cu(II) pro-ionophore strategy to develop naphthazarin (Nap) as such type of PAAs based on the H2O2-mediated conversion of boronate to free phenol.  The boronate-protected Nap (PNap) can exploit increased levels of H2O2 in HepG2 cells to in situ release Nap followed by its efflux via conjugation with reduced glutathione (GSH), allowing that the Nap-GSH adduct works as a Cu(II) ionophore to induce continuously GSH depletion via a redn.-dependent releasing of Cu(I) by GSH.  This strategy endows PNap with the unprecedented ability to hit multi-redox characteristics (increased levels of H2O2, GSH and copper) of HepG2 cells, leading to ROS generation preferentially in HepG2 cells along with their selective death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnW5zVYLJv7LVg90H21EOLACvtfcHk0lguvkPJy7ml7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVSlu7zO&md5=88be6b75365195744ab7de1d474d97df</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2019.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2019.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DBao%26aufirst%3DX.-Z.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DRen%26aufirst%3DX.-R.%26aulast%3DDai%26aufirst%3DF.%26aulast%3DZhou%26aufirst%3DB.%26atitle%3DA%2520hydrogen%2520peroxide-activated%2520Cu%2520%2528II%2529%2520pro-ionophore%2520strategy%2520for%2520modifying%2520naphthazarin%2520as%2520a%2520promising%2520anticancer%2520agent%2520with%2520high%2520selectivity%2520for%2520generating%2520ROS%2520in%2520HepG2%2520cells%2520over%2520in%2520L02%2520cells%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2020%26volume%3D152%26spage%3D597%26epage%3D608%26doi%3D10.1016%2Fj.freeradbiomed.2019.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shlyakhovenko, V. O.</span></span> <span> </span><span class="NLM_article-title">Ribonucleases. Possible new approach in cancer therapy</span>. <i>Exp. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">2</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.31768/2312-8852.2016.38(1):2-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.31768%2F2312-8852.2016.38%281%29%3A2-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=27031711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A280%3ADC%252BC28flslGrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2016&pages=2-8&author=V.+O.+Shlyakhovenko&title=Ribonucleases.+Possible+new+approach+in+cancer+therapy&doi=10.31768%2F2312-8852.2016.38%281%29%3A2-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Ribonucleases. Possible new approach in cancer therapy</span></div><div class="casAuthors">Shlyakhovenko V O</div><div class="citationInfo"><span class="NLM_cas:title">Experimental oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-8</span>
        ISSN:<span class="NLM_cas:issn">1812-9269</span>.
    </div><div class="casAbstract">In the review, the use of the ribonucleases for cancer therapy is discussed.  Using of epigenetic mechanisms of regulation--blocking protein synthesis without affecting the DNA structure--is a promising direction in the therapy.  The ribonucleases isolated from different sources, despite of similar mechanism of enzymatic reactions, have different biological effects.  The use of enzymes isolated from new sources, particularly from plants and fungi, shows promising results.  In this article we discuss the new approach for the use of enzymes resistant to inhibitors and ribozymes, that is aimed at the destruction of the oncogene specific mRNA and the induction of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQQNPQZtOWPYJggzHGM8X5CfW6udTcc2eZpBxMArWxEDbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28flslGrsA%253D%253D&md5=3967f02f02f497e53593099f2364ba92</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.31768%2F2312-8852.2016.38%281%29%3A2-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.31768%252F2312-8852.2016.38%25281%2529%253A2-8%26sid%3Dliteratum%253Aachs%26aulast%3DShlyakhovenko%26aufirst%3DV.%2BO.%26atitle%3DRibonucleases.%2520Possible%2520new%2520approach%2520in%2520cancer%2520therapy%26jtitle%3DExp.%2520Oncol.%26date%3D2016%26volume%3D38%26spage%3D2%26epage%3D8%26doi%3D10.31768%2F2312-8852.2016.38%281%29%3A2-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raines, R. T.</span></span> <span> </span><span class="NLM_article-title">Ribonucleases as novel chemotherapeutics: the ranpirnase example</span>. <i>BioDrugs</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">53</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.2165/00063030-200822010-00006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.2165%2F00063030-200822010-00006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=18215091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltl2rtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=53-58&author=J.+E.+Leeauthor=R.+T.+Raines&title=Ribonucleases+as+novel+chemotherapeutics%3A+the+ranpirnase+example&doi=10.2165%2F00063030-200822010-00006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Ribonucleases as novel chemotherapeutics: the ranpirnase example</span></div><div class="casAuthors">Lee, J. Eugene; Raines, Ronald T.</div><div class="citationInfo"><span class="NLM_cas:title">BioDrugs</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-58</span>CODEN:
                <span class="NLM_cas:coden">BIDRF4</span>;
        ISSN:<span class="NLM_cas:issn">1173-8804</span>.
    
            (<span class="NLM_cas:orgname">Wolters Kluwer Health</span>)
        </div><div class="casAbstract">A review.  Ranpirnase, a cytotoxic RNase from the frog Rana pipiens, is the archetype of a novel class of cancer chemotherapeutic agents based on homologs and variants of bovine pancreatic RNase (RNase A).  Ranpirnase in combination with doxorubicin is in clin. trials for the treatment of unresectable malignant mesothelioma and other cancers.  The putative mechanism for ranpirnase-mediated cytotoxicity involves binding to anionic components of the extracellular membrane, cytosolic internalization, and degrdn. of tRNA leading to apoptosis.  The maintenance of ribonucleolytic activity in the presence of the cytosolic RNase inhibitor protein is a key aspect of the cytotoxic activity of ranpirnase.  The basis for its specific toxicity for cancer cells is not known.  This review describes the development of ranpirnase as a cancer chemotherapeutic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3VOenFh_EXrVg90H21EOLACvtfcHk0lguvkPJy7ml7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltl2rtrY%253D&md5=5ccb8937c9ca9e96fa1a08a9aaed7ffd</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.2165%2F00063030-200822010-00006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00063030-200822010-00006%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BE.%26aulast%3DRaines%26aufirst%3DR.%2BT.%26atitle%3DRibonucleases%2520as%2520novel%2520chemotherapeutics%253A%2520the%2520ranpirnase%2520example%26jtitle%3DBioDrugs%26date%3D2008%26volume%3D22%26spage%3D53%26epage%3D58%26doi%3D10.2165%2F00063030-200822010-00006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palte, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raines, R. T.</span></span> <span> </span><span class="NLM_article-title">Boronate-mediated biologic delivery</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">3631</span>– <span class="NLM_lpage">3634</span>, <span class="refDoi"> DOI: 10.1021/ja210719s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja210719s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhslals7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=3631-3634&author=G.+A.+Ellisauthor=M.+J.+Palteauthor=R.+T.+Raines&title=Boronate-mediated+biologic+delivery&doi=10.1021%2Fja210719s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Boronate-Mediated Biologic Delivery</span></div><div class="casAuthors">Ellis, Gregory A.; Palte, Michael J.; Raines, Ronald T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3631-3634</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inefficient cellular delivery limits the landscape of macromol. drugs.  Boronic acids readily form boronate esters with the 1,2- and 1,3-diols of saccharides, such as those that coat the surface of mammalian cells.  Here pendant boronic acids are shown to enhance the cytosolic delivery of a protein toxin.  Thus, boronates are a noncationic carrier that can deliver a polar macromol. into mammalian cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUQ1xdHeMzLbVg90H21EOLACvtfcHk0liLqr9muX1gHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhslals7k%253D&md5=9c17b7d03edf5a28a0bb226ef8035e7f</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1021%2Fja210719s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja210719s%26sid%3Dliteratum%253Aachs%26aulast%3DEllis%26aufirst%3DG.%2BA.%26aulast%3DPalte%26aufirst%3DM.%2BJ.%26aulast%3DRaines%26aufirst%3DR.%2BT.%26atitle%3DBoronate-mediated%2520biologic%2520delivery%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D3631%26epage%3D3634%26doi%3D10.1021%2Fja210719s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hagen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzenell, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jentzsch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veldwijk, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokhir, A.</span></span> <span> </span><span class="NLM_article-title">Aminoferrocene-based prodrugs activated by reactive oxygen species</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">924</span>– <span class="NLM_lpage">934</span>, <span class="refDoi"> DOI: 10.1021/jm2014937</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2014937" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ers7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=924-934&author=H.+Hagenauthor=P.+Marzenellauthor=E.+Jentzschauthor=F.+Wenzauthor=M.+R.+Veldwijkauthor=A.+Mokhir&title=Aminoferrocene-based+prodrugs+activated+by+reactive+oxygen+species&doi=10.1021%2Fjm2014937"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Aminoferrocene-Based Prodrugs Activated by Reactive Oxygen Species</span></div><div class="casAuthors">Hagen, Helen; Marzenell, Paul; Jentzsch, Elmar; Wenz, Frederik; Veldwijk, Marlon R.; Mokhir, Andriy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">924-934</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cancer cells generally generate higher amts. of reactive oxygen species than normal cells.  On the basis of this difference, prodrugs have been developed (e.g., hydroxyferrocifen), which remain inactive in normal cells, but become activated in cancer cells.  In this work we describe novel aminoferrocene-based prodrugs, which, in contrast to hydroxyferrocifen, after activation form not only quinone methides (QMs), but also catalysts (iron or ferrocenium ions).  The released products act in a concerted fashion.  In particular, QMs alkylate glutathione, thereby inhibiting the antioxidative system of the cell, whereas the iron species induce catalytic generation of hydroxyl radicals.  Since the catalysts are formed as products of the activation reaction, it proceeds autocatalytically.  The most potent prodrug described here is toxic toward cancer cells (human promyelocytic leukemia (HL-60), IC50 = 9 μM, and human glioblastoma-astrocytoma (U373), IC50 = 25 μM), but not toxic (up to 100 μM) toward representative nonmalignant cells (fibroblasts).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXZLxLfss0RrVg90H21EOLACvtfcHk0liLqr9muX1gHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ers7bI&md5=28894e8a8006c8b0ef91455aee76139d</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1021%2Fjm2014937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2014937%26sid%3Dliteratum%253Aachs%26aulast%3DHagen%26aufirst%3DH.%26aulast%3DMarzenell%26aufirst%3DP.%26aulast%3DJentzsch%26aufirst%3DE.%26aulast%3DWenz%26aufirst%3DF.%26aulast%3DVeldwijk%26aufirst%3DM.%2BR.%26aulast%3DMokhir%26aufirst%3DA.%26atitle%3DAminoferrocene-based%2520prodrugs%2520activated%2520by%2520reactive%2520oxygen%2520species%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D924%26epage%3D934%26doi%3D10.1021%2Fjm2014937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pigeon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Top, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vessieres, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huche, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gormen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Arbi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plamont, M.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGlinchey, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaouen, G.</span></span> <span> </span><span class="NLM_article-title">A new series of ferrocifen derivatives, bearing two aminoalkyl chains, with strong antiproliferative effects on breast cancer cells</span>. <i>New J. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">2212</span>– <span class="NLM_lpage">2218</span>, <span class="refDoi"> DOI: 10.1039/c1nj20192a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1039%2Fc1nj20192a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1ags7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2011&pages=2212-2218&author=P.+Pigeonauthor=S.+Topauthor=A.+Vessieresauthor=M.+Hucheauthor=M.+Gormenauthor=M.+El+Arbiauthor=M.-A.+Plamontauthor=M.+J.+McGlincheyauthor=G.+Jaouen&title=A+new+series+of+ferrocifen+derivatives%2C+bearing+two+aminoalkyl+chains%2C+with+strong+antiproliferative+effects+on+breast+cancer+cells&doi=10.1039%2Fc1nj20192a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">A new series of ferrocifen derivatives, bearing two aminoalkyl chains, with strong antiproliferative effects on breast cancer cells</span></div><div class="casAuthors">Pigeon, Pascal; Top, Siden; Vessieres, Anne; Huche, Michel; Goermen, Meral; El Arbi, Mehdi; Plamont, Marie-Aude; McGlinchey, Michael J.; Jaouen, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">New Journal of Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2212-2218</span>CODEN:
                <span class="NLM_cas:coden">NJCHE5</span>;
        ISSN:<span class="NLM_cas:issn">1144-0546</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">We have prepd. several organometallic systems whose structures are closely analogous to that of tamoxifen, the drug used in the treatment of hormone-dependent breast cancers, but which now possess two basic aminoalkyl chains: O(CH2)3NMe2.  Despite the absence of a phenolic functionality, these ferrocenyl compds. 3, 4 and their org. analog 5 recognize the estrogen receptor but in addn. exhibit strong antiproliferative effects on hormone-dependent breast cancer cells (MCF-7), and also on hormone-independent ones (MDA-MB-231) with, in this case, an IC50 value of about 0.4 μM.  The ferrocenyl moiety does not create a major effect here compared to a purely org. arom. group.  On the other hand, the presence within the mol. of two vicinal basic entities, potentially allowing complexation to metal ions such as Zn2+, could perhaps be the key to the antiproliferative effectiveness of this series which operates via a different mechanism to that of hydroxytamoxifen 1 and hydroxyferrocifen 2.  The behavior of these new species is discussed.  They possess the distinctive feature of combining a strong antiproliferative effect with intense antibacterial and antifungal activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppafGULcD4wbVg90H21EOLACvtfcHk0liLqr9muX1gHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1ags7fK&md5=16ee20ca7e95f9c5a3aa7e1f7a10c7da</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1039%2Fc1nj20192a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1nj20192a%26sid%3Dliteratum%253Aachs%26aulast%3DPigeon%26aufirst%3DP.%26aulast%3DTop%26aufirst%3DS.%26aulast%3DVessieres%26aufirst%3DA.%26aulast%3DHuche%26aufirst%3DM.%26aulast%3DGormen%26aufirst%3DM.%26aulast%3DEl%2BArbi%26aufirst%3DM.%26aulast%3DPlamont%26aufirst%3DM.-A.%26aulast%3DMcGlinchey%26aufirst%3DM.%2BJ.%26aulast%3DJaouen%26aufirst%3DG.%26atitle%3DA%2520new%2520series%2520of%2520ferrocifen%2520derivatives%252C%2520bearing%2520two%2520aminoalkyl%2520chains%252C%2520with%2520strong%2520antiproliferative%2520effects%2520on%2520breast%2520cancer%2520cells%26jtitle%3DNew%2520J.%2520Chem.%26date%3D2011%26volume%3D35%26spage%3D2212%26epage%3D2218%26doi%3D10.1039%2Fc1nj20192a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daum, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chekhun, V. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todor, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukianova, N. Yu.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shvets, Y. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellner, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Putzker, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Graaf, I. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groothuis, G. M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zozulia, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hampel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokhir, A.</span></span> <span> </span><span class="NLM_article-title">Improved synthesis of <i>N</i>-benzylaminoferrocene-based prodrugs and evaluation of their toxicity and antileukemic activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2015</span>– <span class="NLM_lpage">2024</span>, <span class="refDoi"> DOI: 10.1021/jm5019548</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5019548" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs12ltrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2015-2024&author=S.+Daumauthor=V.+F.+Chekhunauthor=I.+N.+Todorauthor=N.+Yu.+Lukianovaauthor=Y.+V.+Shvetsauthor=L.+Sellnerauthor=K.+Putzkerauthor=J.+Lewisauthor=T.+Zenzauthor=I.+A.+M.+de+Graafauthor=G.+M.+M.+Groothuisauthor=A.+Casiniauthor=O.+Zozuliaauthor=F.+Hampelauthor=A.+Mokhir&title=Improved+synthesis+of+N-benzylaminoferrocene-based+prodrugs+and+evaluation+of+their+toxicity+and+antileukemic+activity&doi=10.1021%2Fjm5019548"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Improved synthesis of N-benzylaminoferrocene-based prodrugs and evaluation of their toxicity and antileukemic activity</span></div><div class="casAuthors">Daum, Steffen; Chekhun, Vasiliy F.; Todor, Igor N.; Lukianova, Natalia Yu.; Shvets, Yulia V.; Sellner, Leopold; Putzker, Kerstin; Lewis, Joe; Zenz, Thorsten; de Graaf, Inge A. M.; Groothuis, Geny M. M.; Casini, Angela; Zozulia, Oleksii; Hampel, Frank; Mokhir, Andriy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2015-2024</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report on an improved method of synthesis of N-benzylaminoferrocene-based prodrugs and demonstrate its applicability by prepg. nine new aminoferrocenes.  Their effect on the viability of selected cancer cells having different p53 status was studied.  The obtained data are in agreement with the hypothesis that the toxicity of aminoferrocenes is not dependent upon p53 status.  Subsequently the toxicity of a selected prodrug (4) was investigated ex vivo using rat precision cut liver slices and in vivo on hybrid male mice BDF1.  In both expts. no toxicity was obsd.: ex vivo, up to 10 μM; in vivo, up to 6 mg/kg.  Finally, prodrug 4 was shown to extend the survival of BDF1 mice carrying L1210 leukemia from 13.7 ± 0.6 days to 17.5 ± 0.7 days when injected daily 6 times at a dose of 26 μg/kg starting from the second day after injection of L1210 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLDu6senrhSrVg90H21EOLACvtfcHk0lgjPxs2C0Ed_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs12ltrk%253D&md5=3ef143641864bf0c859a5edc63d49c8f</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Fjm5019548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5019548%26sid%3Dliteratum%253Aachs%26aulast%3DDaum%26aufirst%3DS.%26aulast%3DChekhun%26aufirst%3DV.%2BF.%26aulast%3DTodor%26aufirst%3DI.%2BN.%26aulast%3DLukianova%26aufirst%3DN.%2BYu.%26aulast%3DShvets%26aufirst%3DY.%2BV.%26aulast%3DSellner%26aufirst%3DL.%26aulast%3DPutzker%26aufirst%3DK.%26aulast%3DLewis%26aufirst%3DJ.%26aulast%3DZenz%26aufirst%3DT.%26aulast%3Dde%2BGraaf%26aufirst%3DI.%2BA.%2BM.%26aulast%3DGroothuis%26aufirst%3DG.%2BM.%2BM.%26aulast%3DCasini%26aufirst%3DA.%26aulast%3DZozulia%26aufirst%3DO.%26aulast%3DHampel%26aufirst%3DF.%26aulast%3DMokhir%26aufirst%3DA.%26atitle%3DImproved%2520synthesis%2520of%2520N-benzylaminoferrocene-based%2520prodrugs%2520and%2520evaluation%2520of%2520their%2520toxicity%2520and%2520antileukemic%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2015%26epage%3D2024%26doi%3D10.1021%2Fjm5019548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schikora, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reznikov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaykovskaya, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sachinska, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polyakova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokhir, A.</span></span> <span> </span><span class="NLM_article-title">Activity of aminoferrocene-based prodrugs against prostate cancer</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3447</span>– <span class="NLM_lpage">3450</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.07.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.bmcl.2015.07.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=26206503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFOmur3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=3447-3450&author=M.+Schikoraauthor=A.+Reznikovauthor=L.+Chaykovskayaauthor=O.+Sachinskaauthor=L.+Polyakovaauthor=A.+Mokhir&title=Activity+of+aminoferrocene-based+prodrugs+against+prostate+cancer&doi=10.1016%2Fj.bmcl.2015.07.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Activity of aminoferrocene-based prodrugs against prostate cancer</span></div><div class="casAuthors">Schikora, Margot; Reznikov, Alexander; Chaykovskaya, Liudmila; Sachinska, Olga; Polyakova, Lubov; Mokhir, Andriy</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3447-3450</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We tested cytotoxicity of aminoferrocene-based prodrugs towards human androgen-responsive and unresponsive prostate cancer cell lines LNCaP and DU-145 correspondingly.  Two prodrugs were selected, which are both activated at elevated concns. of ROS with generation of quinone methide (antioxidant system inhibitor) and iron-contg. compds. (N-benzylaminoferrocene (prodrug 1) and Fe salts (2)).  We obsd. that only prodrug 1 is active against the selected prostate cancer cells (IC50 = 11-27 μM) and its activity correlates with the high cell-membrane permeability and increased prodn. of intracellular ROS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGDdMGEI6tTbVg90H21EOLACvtfcHk0lgjPxs2C0Ed_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFOmur3J&md5=70400acb3f6622c5abeae6330efdfb0a</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.07.013%26sid%3Dliteratum%253Aachs%26aulast%3DSchikora%26aufirst%3DM.%26aulast%3DReznikov%26aufirst%3DA.%26aulast%3DChaykovskaya%26aufirst%3DL.%26aulast%3DSachinska%26aufirst%3DO.%26aulast%3DPolyakova%26aufirst%3DL.%26aulast%3DMokhir%26aufirst%3DA.%26atitle%3DActivity%2520of%2520aminoferrocene-based%2520prodrugs%2520against%2520prostate%2520cancer%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D3447%26epage%3D3450%26doi%3D10.1016%2Fj.bmcl.2015.07.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marzenell, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellner, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grinyte, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavlov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daum, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokhir, A.</span></span> <span> </span><span class="NLM_article-title">Aminoferrocene-based prodrugs and their effects on human normal and cancer cells as well as bacterial cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">6935</span>– <span class="NLM_lpage">6944</span>, <span class="refDoi"> DOI: 10.1021/jm400754c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400754c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1CltLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6935-6944&author=P.+Marzenellauthor=H.+Hagenauthor=L.+Sellnerauthor=T.+Zenzauthor=R.+Grinyteauthor=V.+Pavlovauthor=S.+Daumauthor=A.+Mokhir&title=Aminoferrocene-based+prodrugs+and+their+effects+on+human+normal+and+cancer+cells+as+well+as+bacterial+cells&doi=10.1021%2Fjm400754c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Aminoferrocene-Based Prodrugs and Their Effects on Human Normal and Cancer Cells as Well as Bacterial Cells</span></div><div class="casAuthors">Marzenell, Paul; Hagen, Helen; Sellner, Leopold; Zenz, Thorsten; Grinyte, Ruta; Pavlov, Valeri; Daum, Steffen; Mokhir, Andriy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6935-6944</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aminoferrocene-based prodrugs are activated under cancer-specific conditions (high concn. of reactive oxygen species, ROS) with the formation of glutathione scavengers (p-quinone methide) and ROS-generating iron complexes.  Herein, the authors explored three structural modifications of these prodrugs to improve their properties: (a) the attachment of a -COOH function to the ferrocene fragment leads to the improvement of water soly. and reactivity in vitro but also decreases cell-membrane permeability and biol. activity, (b) the alkylation of the N-benzyl residue does not show any significant affect, and (c) the attachment of the second arylboronic acid fragment improves the toxicity (IC50) of the prodrugs toward human promyelocytic leukemia cells (HL-60) from 52 to 12 μM.  Finally, the authors demonstrated that the prodrugs are active against primary chronic lymphocytic leukemia (CLL) cells, with the best compds. exhibiting an IC50 value of 1.5 μM.  The most active compds. were found to not affect mononuclear cells and representative bacterial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5D_up23GkYrVg90H21EOLACvtfcHk0lgjPxs2C0Ed_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1CltLrF&md5=cf2da987bcc5ba84d67d2827e73eff53</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1021%2Fjm400754c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400754c%26sid%3Dliteratum%253Aachs%26aulast%3DMarzenell%26aufirst%3DP.%26aulast%3DHagen%26aufirst%3DH.%26aulast%3DSellner%26aufirst%3DL.%26aulast%3DZenz%26aufirst%3DT.%26aulast%3DGrinyte%26aufirst%3DR.%26aulast%3DPavlov%26aufirst%3DV.%26aulast%3DDaum%26aufirst%3DS.%26aulast%3DMokhir%26aufirst%3DA.%26atitle%3DAminoferrocene-based%2520prodrugs%2520and%2520their%2520effects%2520on%2520human%2520normal%2520and%2520cancer%2520cells%2520as%2520well%2520as%2520bacterial%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6935%26epage%3D6944%26doi%3D10.1021%2Fjm400754c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daum, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babiy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konovalova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shtemenko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shtemenko, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janko, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexiou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokhir, A.</span></span> <span> </span><span class="NLM_article-title">Tuning the structure of aminoferrocene-based anticancer prodrugs to prevent their aggregation in aqueous solution</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>178</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2017.08.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.jinorgbio.2017.08.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=29028541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1elurzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2018&pages=9-17&author=S.+Daumauthor=S.+Babiyauthor=H.+Konovalovaauthor=W.+Hoferauthor=A.+Shtemenkoauthor=N.+Shtemenkoauthor=C.+Jankoauthor=C.+Alexiouauthor=A.+Mokhir&title=Tuning+the+structure+of+aminoferrocene-based+anticancer+prodrugs+to+prevent+their+aggregation+in+aqueous+solution&doi=10.1016%2Fj.jinorgbio.2017.08.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Tuning the structure of aminoferrocene-based anticancer prodrugs to prevent their aggregation in aqueous solution</span></div><div class="casAuthors">Daum, Steffen; Babiy, Svetlana; Konovalova, Helen; Hofer, Walter; Shtemenko, Alexander; Shtemenko, Natalia; Janko, Christina; Alexiou, Christoph; Mokhir, Andriy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9-17</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Aminoferrocene-based prodrugs are activated in cancer cells by reactive oxygen species (ROS).  They were shown to exhibit high cytotoxicity towards a variety of cancer cell lines and primary cancer cells, but remain not toxic towards non-malignant cells.  However, these prodrugs have rather high lipophilicity leading to relatively low water soly.  In particular, an n-octanol/water partition coeff. for the best aminoferrocene-based prodrug (2) was found to be 4.51 ± 0.03.  Though the approaches for decreasing lipophilicity are straightforward and include the addn. of polar residues to the drug structure, these modifications also lead to dramatic decrease of cell permeability and, correspondingly, lower the activity of the drug.  Therefore, a delicate balance of polar and unpolar groups should be found to reduce lipophilicity without compromising the useful drug properties.  In this study we optimized an N-alkyl substituent, which is a key element responsible for the stabilization of the aminoferrocene drug released in cancer cells from prodrug 2.  We found that an N-propargyl residue is an optimal replacement for the N-benzyl fragment.  In particular, such a substitution (prodrug 7a) leads to redn. of prodrug lipophilicity down to logP = 3.78 ± 0.05, improvement of its water soly., decrease of its propensity towards aggregation and dramatic increase of its ROS-generating properties.  Finally, we demonstrated that the optimized prodrug strongly suppresses growth of Guerin's carcinoma (T8) in vivo at the dose of 30 mg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuMK18Z4OtL7Vg90H21EOLACvtfcHk0liPsFTqvWkFRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1elurzJ&md5=2450b73a50c1d8340ee2e5aabd062772</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2017.08.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2017.08.038%26sid%3Dliteratum%253Aachs%26aulast%3DDaum%26aufirst%3DS.%26aulast%3DBabiy%26aufirst%3DS.%26aulast%3DKonovalova%26aufirst%3DH.%26aulast%3DHofer%26aufirst%3DW.%26aulast%3DShtemenko%26aufirst%3DA.%26aulast%3DShtemenko%26aufirst%3DN.%26aulast%3DJanko%26aufirst%3DC.%26aulast%3DAlexiou%26aufirst%3DC.%26aulast%3DMokhir%26aufirst%3DA.%26atitle%3DTuning%2520the%2520structure%2520of%2520aminoferrocene-based%2520anticancer%2520prodrugs%2520to%2520prevent%2520their%2520aggregation%2520in%2520aqueous%2520solution%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2018%26volume%3D178%26spage%3D9%26epage%3D17%26doi%3D10.1016%2Fj.jinorgbio.2017.08.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daum, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reshetnikov, M. S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sisa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumych, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lootsik, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilyy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bila, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janko, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexiou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellner, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokhir, A.</span></span> <span> </span><span class="NLM_article-title">Lysosome-targeting amplifiers of reactive oxygen species as anticancer prodrugs</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">15545</span>– <span class="NLM_lpage">15549</span>, <span class="refDoi"> DOI: 10.1002/anie.201706585</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2Fanie.201706585" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslygtb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=15545-15549&author=S.+Daumauthor=M.+S.+V.+Reshetnikovauthor=M.+Sisaauthor=T.+Dumychauthor=M.+D.+Lootsikauthor=R.+Bilyyauthor=E.+Bilaauthor=C.+Jankoauthor=C.+Alexiouauthor=M.+Herrmannauthor=L.+Sellnerauthor=A.+Mokhir&title=Lysosome-targeting+amplifiers+of+reactive+oxygen+species+as+anticancer+prodrugs&doi=10.1002%2Fanie.201706585"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosome-Targeting Amplifiers of Reactive Oxygen Species as Anticancer Prodrugs</span></div><div class="casAuthors">Daum, Steffen; Reshetnikov, M. S. Viktor; Sisa, Miroslav; Dumych, Tetyana; Lootsik, Maxim D.; Bilyy, Rostyslav; Bila, Evgenia; Janko, Christina; Alexiou, Christoph; Herrmann, Martin; Sellner, Leopold; Mokhir, Andriy</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">15545-15549</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Cancer cells produce elevated levels of reactive oxygen species, which has been used to design cancer specific prodrugs.  Their activation relies on at least a bimol. process, in which a prodrug reacts with ROS.  However, at low micromolar concns. of the prodrugs and ROS, the activation is usually inefficient.  Herein, the authors propose and validate a potentially general approach for solving this intrinsic problem of ROS-dependent prodrugs.  In particular, known prodrug 4-(N-ferrocenyl-N-benzylaminocarbonyloxymethyl)phenylboronic acid pinacol ester was converted into its lysosome-specific analog.  Since lysosomes contain a higher concn. of active ROS than the cytoplasm, activation of the prodrug was facilitated with respect to the parent compd.  Moreover, it was found to exhibit high anticancer activity in a variety of cancer cell lines (IC50=3.5-7.2 μM) and in vivo (40 mg kg-1, NK/Ly murine model) but remained weakly toxic towards non-malignant cells (IC50=15-30 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwRXSpEQwuabVg90H21EOLACvtfcHk0liPsFTqvWkFRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslygtb3N&md5=6e9cfccec2f511cf647cff6e72044dfe</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1002%2Fanie.201706585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201706585%26sid%3Dliteratum%253Aachs%26aulast%3DDaum%26aufirst%3DS.%26aulast%3DReshetnikov%26aufirst%3DM.%2BS.%2BV.%26aulast%3DSisa%26aufirst%3DM.%26aulast%3DDumych%26aufirst%3DT.%26aulast%3DLootsik%26aufirst%3DM.%2BD.%26aulast%3DBilyy%26aufirst%3DR.%26aulast%3DBila%26aufirst%3DE.%26aulast%3DJanko%26aufirst%3DC.%26aulast%3DAlexiou%26aufirst%3DC.%26aulast%3DHerrmann%26aufirst%3DM.%26aulast%3DSellner%26aufirst%3DL.%26aulast%3DMokhir%26aufirst%3DA.%26atitle%3DLysosome-targeting%2520amplifiers%2520of%2520reactive%2520oxygen%2520species%2520as%2520anticancer%2520prodrugs%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2017%26volume%3D56%26spage%3D15545%26epage%3D15549%26doi%3D10.1002%2Fanie.201706585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dilruba, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalayda, G. V.</span></span> <span> </span><span class="NLM_article-title">Platinum-based drugs: past, present and future</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">1103</span>– <span class="NLM_lpage">1124</span>, <span class="refDoi"> DOI: 10.1007/s00280-016-2976-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1007%2Fs00280-016-2976-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=26886018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC28XivFOqs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2016&pages=1103-1124&author=S.+Dilrubaauthor=G.+V.+Kalayda&title=Platinum-based+drugs%3A+past%2C+present+and+future&doi=10.1007%2Fs00280-016-2976-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Platinum-based drugs: past, present and future</span></div><div class="casAuthors">Dilruba, Shahana; Kalayda, Ganna V.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1103-1124</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Platinum-based drugs cisplatin, carboplatin and oxaliplatin are widely used in the therapy of human neoplasms.  Their clin. success is, however, limited due to severe side effects and intrinsic or acquired resistance to the treatment.  Much effort has been put into the development of new platinum anticancer complexes, but none of them has reached worldwide clin. application so far.  Nedaplatin, lobaplatin and heptaplatin received only regional approval.  Some new platinum complexes and platinum drug formulations are undergoing clin. trials.  Here, we review the main classes of new platinum drug candidates, such as sterically hindered complexes, monofunctional platinum drugs, complexes with biol. active ligands, trans-configured and polynuclear platinum complexes, platinum(IV) prodrugs and platinum-based drug delivery systems.  For each class of compds., a detailed overview of the mechanism of action is given, the cytotoxicity is compared to that of the clin. used platinum drugs, and the clin. perspectives are discussed.  A crit. anal. of lessons to be learned is presented.  Finally, a general outlook regarding future directions in the field of new platinum drugs is given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfV4v-5JjduLVg90H21EOLACvtfcHk0liPsFTqvWkFRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivFOqs7k%253D&md5=1e1882f631ad56ef1a07b2075b1faa5e</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1007%2Fs00280-016-2976-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-016-2976-z%26sid%3Dliteratum%253Aachs%26aulast%3DDilruba%26aufirst%3DS.%26aulast%3DKalayda%26aufirst%3DG.%2BV.%26atitle%3DPlatinum-based%2520drugs%253A%2520past%252C%2520present%2520and%2520future%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2016%26volume%3D77%26spage%3D1103%26epage%3D1124%26doi%3D10.1007%2Fs00280-016-2976-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wheate, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craig, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oun, R.</span></span> <span> </span><span class="NLM_article-title">The status of platinum anticancer drugs in the clinic and in clinical trials</span>. <i>Dalton Trans. Camb. Engl.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">8113</span>– <span class="NLM_lpage">8127</span>, <span class="refDoi"> DOI: 10.1039/c0dt00292e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1039%2Fc0dt00292e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=20593091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A280%3ADC%252BC3cjntVOhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2010&pages=8113-8127&author=N.+Wheateauthor=S.+Walkerauthor=G.+Craigauthor=R.+Oun&title=The+status+of+platinum+anticancer+drugs+in+the+clinic+and+in+clinical+trials&doi=10.1039%2Fc0dt00292e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">The status of platinum anticancer drugs in the clinic and in clinical trials</span></div><div class="casAuthors">Wheate Nial J; Walker Shonagh; Craig Gemma E; Oun Rabbab</div><div class="citationInfo"><span class="NLM_cas:title">Dalton transactions (Cambridge, England : 2003)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">8113-27</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Since its approval in 1979 cisplatin has become an important component in chemotherapy regimes for the treatment of ovarian, testicular, lung and bladder cancers, as well as lymphomas, myelomas and melanoma.  Unfortunately its continued use is greatly limited by severe dose limiting side effects and intrinsic or acquired drug resistance.  Over the last 30 years, 23 other platinum-based drugs have entered clinical trials with only two (carboplatin and oxaliplatin) of these gaining international marketing approval, and another three (nedaplatin, lobaplatin and heptaplatin) gaining approval in individual nations.  During this time there have been more failures than successes with the development of 14 drugs being halted during clinical trials.  Currently there are four drugs in the various phases of clinical trial (satraplatin, picoplatin, Lipoplatin and ProLindac).  No new small molecule platinum drug has entered clinical trials since 1999 which is representative of a shift in focus away from drug design and towards drug delivery in the last decade.  In this perspective article we update the status of platinum anticancer drugs currently approved for use, those undergoing clinical trials and those discontinued during clinical trials, and discuss the results in the context of where we believe the field will develop over the next decade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSA_Z4lAike1oxhnOQkIHOxfW6udTcc2ebL6QiE58r4Trntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjntVOhtQ%253D%253D&md5=7831999d7abf759476cc49a4cdaecb6f</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1039%2Fc0dt00292e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0dt00292e%26sid%3Dliteratum%253Aachs%26aulast%3DWheate%26aufirst%3DN.%26aulast%3DWalker%26aufirst%3DS.%26aulast%3DCraig%26aufirst%3DG.%26aulast%3DOun%26aufirst%3DR.%26atitle%3DThe%2520status%2520of%2520platinum%2520anticancer%2520drugs%2520in%2520the%2520clinic%2520and%2520in%2520clinical%2520trials%26jtitle%3DDalton%2520Trans.%2520Camb.%2520Engl.%26date%3D2010%26volume%3D39%26spage%3D8113%26epage%3D8127%26doi%3D10.1039%2Fc0dt00292e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loos, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eechoute, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verweij, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathijssen, R. H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiemer, E. A. C.</span></span> <span> </span><span class="NLM_article-title">Drug transporters of platinum-based anticancer agents and their clinical significance</span>. <i>Drug Resist. Updates</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1016/j.drup.2010.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.drup.2010.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=21251871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitFGgs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=22-34&author=H.+Burgerauthor=W.+J.+Loosauthor=K.+Eechouteauthor=J.+Verweijauthor=R.+H.+J.+Mathijssenauthor=E.+A.+C.+Wiemer&title=Drug+transporters+of+platinum-based+anticancer+agents+and+their+clinical+significance&doi=10.1016%2Fj.drup.2010.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Drug transporters of platinum-based anticancer agents and their clinical significance</span></div><div class="casAuthors">Burger, Herman; Loos, Walter J.; Eechoute, Karel; Verweij, Jaap; Mathijssen, Ron H. J.; Wiemer, Erik A. C.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Resistance Updates</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-34</span>CODEN:
                <span class="NLM_cas:coden">DRUPFW</span>;
        ISSN:<span class="NLM_cas:issn">1368-7646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Platinum-based drugs are among the most active anticancer agents and are successfully used in a wide variety of human malignancies.  However, acquired and/or intrinsic resistance still represent a major limitation.  Lately, in particular mechanisms leading to impaired uptake and/or decreased cellular accumulation of platinum compds. have attracted attention.  In this review, we focus on the role of active platinum uptake and efflux systems as determinants of platinum sensitivity and -resistance and their contribution to platinum pharmacokinetics (PK) and pharmacodynamics (PD).  First, the three mostly used platinum-based anticancer agents as well as the most promising novel platinum compds. in development are put into clin. perspective.  Next, we describe the presently known potential platinum transporters - with special emphasis on org. cation transporters (OCTs) - and discuss their role on clin. outcome (i.e. efficacy and adverse events) of platinum-based chemotherapy.  In addn., transporter-mediated tumor resistance, the impact of potential platinum transporter-mediated drug-drug interactions, and the role of drug transporters in the renal elimination of platinum compds. are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpSV0_w_vYMLVg90H21EOLACvtfcHk0ljIuO-HZBip9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXitFGgs70%253D&md5=7c061553cd5b29e46af482de08442fb3</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2010.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2010.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DBurger%26aufirst%3DH.%26aulast%3DLoos%26aufirst%3DW.%2BJ.%26aulast%3DEechoute%26aufirst%3DK.%26aulast%3DVerweij%26aufirst%3DJ.%26aulast%3DMathijssen%26aufirst%3DR.%2BH.%2BJ.%26aulast%3DWiemer%26aufirst%3DE.%2BA.%2BC.%26atitle%3DDrug%2520transporters%2520of%2520platinum-based%2520anticancer%2520agents%2520and%2520their%2520clinical%2520significance%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2011%26volume%3D14%26spage%3D22%26epage%3D34%26doi%3D10.1016%2Fj.drup.2010.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moussa, Y. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheate, N. J.</span></span> <span> </span><span class="NLM_article-title">The side effects of platinum-based chemotherapy drugs: a review for chemists</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">6645</span>– <span class="NLM_lpage">6653</span>, <span class="refDoi"> DOI: 10.1039/C8DT00838H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1039%2FC8DT00838H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=29632935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmsF2gtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2018&pages=6645-6653&author=R.+Ounauthor=Y.+E.+Moussaauthor=N.+J.+Wheate&title=The+side+effects+of+platinum-based+chemotherapy+drugs%3A+a+review+for+chemists&doi=10.1039%2FC8DT00838H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">The side effects of platinum-based chemotherapy drugs: a review for chemists</span></div><div class="casAuthors">Oun, Rabbab; Moussa, Yvonne E.; Wheate, Nial J.</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6645-6653</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The platinum-based drugs cisplatin, carboplatin and oxaliplatin are regularly prescribed in the treatment of cancer and while they are effective, their use is limited by their severe, dose-limiting side effects (also referred to as adverse effects/events).  In total, a cancer patient can experience any combination of around 40 specific side effects.  The dose-limiting side effect for cisplatin is nephrotoxicity, for carboplatin it is myelosuppression, and for oxaliplatin it is neurotoxicity.  Other common side effects include anaphylaxis, cytopenias (including leukopenia and neutropenia, thrombocytopenia, and anemia), hepatotoxicity, ototoxicity, cardiotoxicity, nausea and vomiting, diarrhea, mucositis, stomatitis, pain, alopecia, anorexia, cachexia, and asthenia.  The side effects may require patients to be prescribed dose redns. in their platinum drugs of between 25 and 100%.  Furthermore, patients require extensive monitoring of their biochemistries, kidney and liver function, and depending on the drug, hearing tests.  Finally, patients are commonly co-prescribed addnl. non-chemotherapy based drugs to treat the side effects which can include antiemetics, antibiotics and myeloid growth factors, mannitol, propafenone, saline hyperhydration, magnesium supplements, monoclonal antibody cytokine blockers and antioxidants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ8seL8Vc3g7Vg90H21EOLACvtfcHk0ljIuO-HZBip9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmsF2gtL0%253D&md5=7e23105fd5f01cd16855b01187ef3356</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1039%2FC8DT00838H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8DT00838H%26sid%3Dliteratum%253Aachs%26aulast%3DOun%26aufirst%3DR.%26aulast%3DMoussa%26aufirst%3DY.%2BE.%26aulast%3DWheate%26aufirst%3DN.%2BJ.%26atitle%3DThe%2520side%2520effects%2520of%2520platinum-based%2520chemotherapy%2520drugs%253A%2520a%2520review%2520for%2520chemists%26jtitle%3DDalton%2520Trans.%26date%3D2018%26volume%3D47%26spage%3D6645%26epage%3D6653%26doi%3D10.1039%2FC8DT00838H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reshetnikov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daum, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janko, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karawacka, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tietze, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexiou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paryzhak, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumych, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilyy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmisano, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokhir, A.</span></span> <span> </span><span class="NLM_article-title">ROS-responsive <i>N</i>-alkylaminoferrocenes for cancer-cell-specific targeting of mitochondria</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">11943</span>– <span class="NLM_lpage">11946</span>, <span class="refDoi"> DOI: 10.1002/anie.201805955</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2Fanie.201805955" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFCkt7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=11943-11946&author=V.+Reshetnikovauthor=S.+Daumauthor=C.+Jankoauthor=W.+Karawackaauthor=R.+Tietzeauthor=C.+Alexiouauthor=S.+Paryzhakauthor=T.+Dumychauthor=R.+Bilyyauthor=P.+Tripalauthor=B.+Schmidauthor=R.+Palmisanoauthor=A.+Mokhir&title=ROS-responsive+N-alkylaminoferrocenes+for+cancer-cell-specific+targeting+of+mitochondria&doi=10.1002%2Fanie.201805955"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">ROS-responsive N-alkylaminoferrocenes for cancer-cell-specific targeting of mitochondria</span></div><div class="casAuthors">Reshetnikov, Viktor; Daum, Steffen; Janko, Christina; Karawacka, Weronika; Tietze, Rainer; Alexiou, Christoph; Paryzhak, Solomiya; Dumych, Tetiana; Bilyy, Rostyslav; Tripal, Philipp; Schmid, Benjamin; Palmisano, Ralf; Mokhir, Andriy</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">11943-11946</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Mitochondrial membrane potential is more neg. in cancer cells than in normal cells, allowing cancer targeting by delocalized lipophilic cations (DLCs).  However, as the difference is rather small, these drugs affect also normal cells.  Now a concept of pro-DLCs is proposed based on an N-alkylaminoferrocene structure.  These prodrugs are activated by the reaction with reactive oxygen species (ROS) forming ferrocenium-based DLCs.  Since ROS are overproduced in cancer, the high-efficiency cancer-cell-specific targeting of mitochondria could be achieved as demonstrated by fluorescence microscopy in combination with two fluorogenic pro-DLCs in vitro and in vivo.  We prepd. a conjugate of another pro-DLC with a clin. approved drug carboplatin and confirmed that its accumulation in mitochondria was higher than that of the free drug.  This was reflected in the substantially higher anticancer effect of the conjugate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH3EjM-JLwJ7Vg90H21EOLACvtfcHk0lj6QEXNk32OAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFCkt7nP&md5=e19713f6a491ebb650a4c14774365707</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1002%2Fanie.201805955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201805955%26sid%3Dliteratum%253Aachs%26aulast%3DReshetnikov%26aufirst%3DV.%26aulast%3DDaum%26aufirst%3DS.%26aulast%3DJanko%26aufirst%3DC.%26aulast%3DKarawacka%26aufirst%3DW.%26aulast%3DTietze%26aufirst%3DR.%26aulast%3DAlexiou%26aufirst%3DC.%26aulast%3DParyzhak%26aufirst%3DS.%26aulast%3DDumych%26aufirst%3DT.%26aulast%3DBilyy%26aufirst%3DR.%26aulast%3DTripal%26aufirst%3DP.%26aulast%3DSchmid%26aufirst%3DB.%26aulast%3DPalmisano%26aufirst%3DR.%26aulast%3DMokhir%26aufirst%3DA.%26atitle%3DROS-responsive%2520N-alkylaminoferrocenes%2520for%2520cancer-cell-specific%2520targeting%2520of%2520mitochondria%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2018%26volume%3D57%26spage%3D11943%26epage%3D11946%26doi%3D10.1002%2Fanie.201805955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reshetnikov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daum, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokhir, A.</span></span> <span> </span><span class="NLM_article-title">Cancer-specific, intracellular, reductive activation of anticancer Pt (IV) prodrugs</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5678</span>– <span class="NLM_lpage">5681</span>, <span class="refDoi"> DOI: 10.1002/chem.201701192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2Fchem.201701192" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=28319647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsFSgtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=5678-5681&author=V.+Reshetnikovauthor=S.+Daumauthor=A.+Mokhir&title=Cancer-specific%2C+intracellular%2C+reductive+activation+of+anticancer+Pt+%28IV%29+prodrugs&doi=10.1002%2Fchem.201701192"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer-Specific, Intracellular, Reductive Activation of Anticancer PtIV Prodrugs</span></div><div class="casAuthors">Reshetnikov, Viktor; Daum, Steffen; Mokhir, Andriy</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5678-5681</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Because cellular uptake of anticancer PtII and PtIV drugs occurs by different mechanisms, the latter ones can exhibit substantial activity towards cells, which have either intrinsic or acquired resistance towards PtII drugs.  However, this pos. effect is diminished due to reductive activation of PtIV drugs in extracellular space that can be one of the reasons why they have not yet been approved for clin. use despite over 60 clin. trials conducted worldwide.  Herein, we suggest a soln. to this problem by achieving highly specific intracellular vs. extracellular prodrug redn.  In particular, we prepd. a hybrid PtIV prodrug contg. two pro-reductants.  This hybrid was uptaken by cells, the pro-reductants were activated in the cancer-specific microenvironment (high H2O2), and reduced PtIV by two one-electron transfers.  The drug formed in this way induced cell death both in cisplatin-sensitive and resistant cell lines, but remained nontoxic to normal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolk4Q2uk2fg7Vg90H21EOLACvtfcHk0lj6QEXNk32OAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsFSgtrw%253D&md5=ccc504f05d43ba419c208a57175a562e</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1002%2Fchem.201701192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201701192%26sid%3Dliteratum%253Aachs%26aulast%3DReshetnikov%26aufirst%3DV.%26aulast%3DDaum%26aufirst%3DS.%26aulast%3DMokhir%26aufirst%3DA.%26atitle%3DCancer-specific%252C%2520intracellular%252C%2520reductive%2520activation%2520of%2520anticancer%2520Pt%2520%2528IV%2529%2520prodrugs%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2017%26volume%3D23%26spage%3D5678%26epage%3D5681%26doi%3D10.1002%2Fchem.201701192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reshetnikov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkhypov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Julakanti, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokhir, A.</span></span> <span> </span><span class="NLM_article-title">A cancer specific oxaliplatin-releasing Pt (IV)-prodrug</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">6679</span>– <span class="NLM_lpage">6682</span>, <span class="refDoi"> DOI: 10.1039/C8DT01458B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1039%2FC8DT01458B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=29708261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotF2mur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2018&pages=6679-6682&author=V.+Reshetnikovauthor=A.+Arkhypovauthor=P.+R.+Julakantiauthor=A.+Mokhir&title=A+cancer+specific+oxaliplatin-releasing+Pt+%28IV%29-prodrug&doi=10.1039%2FC8DT01458B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">A cancer specific oxaliplatin-releasing Pt(IV)-prodrug</span></div><div class="casAuthors">Reshetnikov, Viktor; Arkhypov, Anton; Julakanti, Purushottam Reddy; Mokhir, Andriy</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6679-6682</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">We prepd. a Pt(IV)-prodrug, which under cancer specific conditions (elevated concn. of reactive oxygen species, ROS) releases a DNA-binding drug oxaliplatin as well as ROS-amplifying drugs p-quinone methide and N-alkylferrocenium.  Due to the concerted action of these components, an excellent anticancer effect was achieved: IC50 = 0.4 ± 0.1 μM for human ovarian carcinoma A2780 cells.  Importantly, the prodrug was found to be 45-fold less toxic to normal cells (HDFa).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUp2kLqbFK4rVg90H21EOLACvtfcHk0lj6QEXNk32OAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotF2mur4%253D&md5=b83ed431a5e3cdcd34f51bbec7f366da</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1039%2FC8DT01458B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8DT01458B%26sid%3Dliteratum%253Aachs%26aulast%3DReshetnikov%26aufirst%3DV.%26aulast%3DArkhypov%26aufirst%3DA.%26aulast%3DJulakanti%26aufirst%3DP.%2BR.%26aulast%3DMokhir%26aufirst%3DA.%26atitle%3DA%2520cancer%2520specific%2520oxaliplatin-releasing%2520Pt%2520%2528IV%2529-prodrug%26jtitle%3DDalton%2520Trans.%26date%3D2018%26volume%3D47%26spage%3D6679%26epage%3D6682%26doi%3D10.1039%2FC8DT01458B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wegiel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csizmadia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belcher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vercellotti, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penacho, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sukhatme, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandolfi, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helczynski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjartell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Persson, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otterbein, L. E.</span></span> <span> </span><span class="NLM_article-title">Carbon monoxide expedites metabolic exhaustion to inhibit tumor growth</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">7009</span>– <span class="NLM_lpage">7021</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-13-1075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1158%2F0008-5472.CAN-13-1075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=24121491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVKhu77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=7009-7021&author=B.+Wegielauthor=D.+Galloauthor=E.+Csizmadiaauthor=C.+Harrisauthor=J.+Belcherauthor=G.+M.+Vercellottiauthor=N.+Penachoauthor=P.+Sethauthor=V.+Sukhatmeauthor=A.+Ahmedauthor=P.+P.+Pandolfiauthor=L.+Helczynskiauthor=A.+Bjartellauthor=J.+L.+Perssonauthor=L.+E.+Otterbein&title=Carbon+monoxide+expedites+metabolic+exhaustion+to+inhibit+tumor+growth&doi=10.1158%2F0008-5472.CAN-13-1075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Carbon Monoxide Expedites Metabolic Exhaustion to Inhibit Tumor Growth</span></div><div class="casAuthors">Wegiel, Barbara; Gallo, David; Csizmadia, Eva; Harris, Clair; Belcher, John; Vercellotti, Gregory M.; Penacho, Nuno; Seth, Pankaj; Sukhatme, Vikas; Ahmed, Asif; Pandolfi, Pier Paolo; Helczynski, Leszek; Bjartell, Anders; Persson, Jenny Liao; Otterbein, Leo E.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7009-7021</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">One classical feature of cancer cells is their metabolic acquisition of a highly glycolytic phenotype.  Carbon monoxide (CO), one of the products of the cytoprotective mol. heme oxygenase-1 (HO-1) in cancer cells, has been implicated in carcinogenesis and therapeutic resistance.  However, the functional contributions of CO and HO-1 to these processes are poorly defined.  In human prostate cancers, we found that HO-1 was nuclear localized in malignant cells, with low enzymic activity in moderately differentiated tumors correlating with relatively worse clin. outcomes.  Exposure to CO sensitized prostate cancer cells but not normal cells to chemotherapy, with growth arrest and apoptosis induced in vivo in part through mitotic catastrophe.  CO targeted mitochondria activity in cancer cells as evidenced by higher oxygen consumption, free radical generation, and mitochondrial collapse.  Collectively, our findings indicated that CO transiently induces an anti-Warburg effect by rapidly fueling cancer cell bioenergetics, ultimately resulting in metabolic exhaustion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAf7Bqzr9K27Vg90H21EOLACvtfcHk0ljbOz8GF_bXUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVKhu77I&md5=8af0a258c4388ec6fdd6c017a00d3a58</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-13-1075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-13-1075%26sid%3Dliteratum%253Aachs%26aulast%3DWegiel%26aufirst%3DB.%26aulast%3DGallo%26aufirst%3DD.%26aulast%3DCsizmadia%26aufirst%3DE.%26aulast%3DHarris%26aufirst%3DC.%26aulast%3DBelcher%26aufirst%3DJ.%26aulast%3DVercellotti%26aufirst%3DG.%2BM.%26aulast%3DPenacho%26aufirst%3DN.%26aulast%3DSeth%26aufirst%3DP.%26aulast%3DSukhatme%26aufirst%3DV.%26aulast%3DAhmed%26aufirst%3DA.%26aulast%3DPandolfi%26aufirst%3DP.%2BP.%26aulast%3DHelczynski%26aufirst%3DL.%26aulast%3DBjartell%26aufirst%3DA.%26aulast%3DPersson%26aufirst%3DJ.%2BL.%26aulast%3DOtterbein%26aufirst%3DL.%2BE.%26atitle%3DCarbon%2520monoxide%2520expedites%2520metabolic%2520exhaustion%2520to%2520inhibit%2520tumor%2520growth%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D7009%26epage%3D7021%26doi%3D10.1158%2F0008-5472.CAN-13-1075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Majewska, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioannidis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raza, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanna, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulbeck, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, M.</span></span> <span> </span><span class="NLM_article-title">Postprogression survival in patients with glioblastoma treated with concurrent chemoradiotherapy: a routine care cohort study</span>. <i>CNS Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">307</span>– <span class="NLM_lpage">313</span>, <span class="refDoi"> DOI: 10.2217/cns-2017-0001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.2217%2Fcns-2017-0001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=28990795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVars77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2017&pages=307-313&author=P.+Majewskaauthor=S.+Ioannidisauthor=M.+H.+Razaauthor=N.+Tannaauthor=H.+Bulbeckauthor=M.+Williams&title=Postprogression+survival+in+patients+with+glioblastoma+treated+with+concurrent+chemoradiotherapy%3A+a+routine+care+cohort+study&doi=10.2217%2Fcns-2017-0001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Postprogression survival in patients with glioblastoma treated with concurrent chemoradiotherapy: a routine care cohort study</span></div><div class="casAuthors">Majewska, Paulina; Ioannidis, Stefanos; Raza, Muhammad Hasan; Tanna, Nikhil; Bulbeck, Helen; Williams, Mathew</div><div class="citationInfo"><span class="NLM_cas:title">CNS Oncology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-313</span>CODEN:
                <span class="NLM_cas:coden">CONNCO</span>;
        ISSN:<span class="NLM_cas:issn">2045-0915</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">Glioblastoma is the commonest malignant brain tumor in adults.  Most patients develop progressive disease before they die.  However, survival after developing progressive disease is infrequently reported.  We identified patients with histol. proven disease who were treated with concurrent chemoradiotherapy during 2006-2013.  We analyzed overall survival (OS), progression-free survival and postprogression survival (PPS) in relation to age, O6-methylguanine-DNA methyltransferase promoter methylation and extent of surgical resection.  We identified 166 patients.  Median survival was 13.5 mo; 2-yr OS was 21.7%.  Median progression-free survival and PPS were 7.03 and 4.53 mo, resp.  Age and extent of surgical resection were correlated with OS.  Only the extent of surgical resection was assocd. with PPS.  Our work suggests that the established prognostic factors for glioblastoma do not appear to help predict PPS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0ceDwZob_IbVg90H21EOLACvtfcHk0ljbOz8GF_bXUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVars77K&md5=f6b3b39a98a1ae78381d0298a07f5984</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.2217%2Fcns-2017-0001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Fcns-2017-0001%26sid%3Dliteratum%253Aachs%26aulast%3DMajewska%26aufirst%3DP.%26aulast%3DIoannidis%26aufirst%3DS.%26aulast%3DRaza%26aufirst%3DM.%2BH.%26aulast%3DTanna%26aufirst%3DN.%26aulast%3DBulbeck%26aufirst%3DH.%26aulast%3DWilliams%26aufirst%3DM.%26atitle%3DPostprogression%2520survival%2520in%2520patients%2520with%2520glioblastoma%2520treated%2520with%2520concurrent%2520chemoradiotherapy%253A%2520a%2520routine%2520care%2520cohort%2520study%26jtitle%3DCNS%2520Oncol.%26date%3D2017%26volume%3D6%26spage%3D307%26epage%3D313%26doi%3D10.2217%2Fcns-2017-0001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ajazuddin</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amarji, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanaujia, P.</span></span> <span> </span><span class="NLM_article-title">Synthesis, characterization and in vitro studies of pegylated melphalan conjugates</span>. <i>Drug Dev. Ind. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1053</span>– <span class="NLM_lpage">1062</span>, <span class="refDoi"> DOI: 10.3109/03639045.2012.702346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.3109%2F03639045.2012.702346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=22779444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosl2lu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2013&pages=1053-1062&author=+Ajazuddinauthor=A.+Alexanderauthor=B.+Amarjiauthor=P.+Kanaujia&title=Synthesis%2C+characterization+and+in+vitro+studies+of+pegylated+melphalan+conjugates&doi=10.3109%2F03639045.2012.702346"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, characterization and in vitro studies of pegylated melphalan conjugates</span></div><div class="casAuthors">Ajazuddin; Alexander, Amit; Amarji, Basant; Kanaujia, Parijat</div><div class="citationInfo"><span class="NLM_cas:title">Drug Development and Industrial Pharmacy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1053-1062</span>CODEN:
                <span class="NLM_cas:coden">DDIPD8</span>;
        ISSN:<span class="NLM_cas:issn">0363-9045</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Melphalan, a drug used for the treatment of breast, ovaries and a certain type of cancer in the bone marrow, was conjugated to linear methoxy poly (ethylene glycol) (M-PEG) of 2000 and 5000, Da.  An ester linkage between polymer and drug was used in the coupling to yield a polymeric prodrug.  Purified esters were characterized by Maldi-Tof and IR spectroscopy methods.  The modification allowed overcoming the known melphalan aq. soly. problem (0.1 μg/mL) leading us to obtain a polymer-drug bioconjugate more suitable for oral and parenteral administration.  It was found that mol. wt. of M-PEG is crit. for the conjugates stability, aq. soly. (80 times and 123 times higher aq. soly. for M-PEG 2000 and M-PEG 5000, resp.), and hemolytic activity.  The melphalan caused 100% hemolysis above the concn. 3.5 μg/mL in 1 h. whereas conjugate of M-PEG 2000 and M-PEG 5000 shows 81.3 ± 0.5% and 48.8 ± 1.5% hemolysis, resp. at 32 μg/mL after 1 h.  Further in vitro anticancer activity of melphalan and its conjugates was performed with breast cancer MCF-7 cell lines.  It shows that LD50 concn. was higher 1.14 and 2 μm for M-PEG 2000 and M-PEG 5000, resp. in comparison to pure melphalan (0.74 μm).  Above studies revealed improved pharmacokinetics properties upon conjugation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYn9sQY9K0r7Vg90H21EOLACvtfcHk0ljbOz8GF_bXUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosl2lu7s%253D&md5=60c398a129b56ef9a04162a92eefccf0</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.3109%2F03639045.2012.702346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F03639045.2012.702346%26sid%3Dliteratum%253Aachs%26aulast%3DAjazuddin%26aulast%3DAlexander%26aufirst%3DA.%26aulast%3DAmarji%26aufirst%3DB.%26aulast%3DKanaujia%26aufirst%3DP.%26atitle%3DSynthesis%252C%2520characterization%2520and%2520in%2520vitro%2520studies%2520of%2520pegylated%2520melphalan%2520conjugates%26jtitle%3DDrug%2520Dev.%2520Ind.%2520Pharm.%26date%3D2013%26volume%3D39%26spage%3D1053%26epage%3D1062%26doi%3D10.3109%2F03639045.2012.702346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gutowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowalczyk, S.</span></span> <span> </span><span class="NLM_article-title">A study of free radical chemistry: their role and pathophysiological significance</span>. <i>Acta Biochim. Polym.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.18388/abp.2013_1944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.18388%2Fabp.2013_1944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=23513192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntFaku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2013&pages=1-16&author=M.+Gutowskiauthor=S.+Kowalczyk&title=A+study+of+free+radical+chemistry%3A+their+role+and+pathophysiological+significance&doi=10.18388%2Fabp.2013_1944"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">A study of free radical chemistry: their role and pathophysiological significance</span></div><div class="casAuthors">Gutowski, Mariusz; Kowalczyk, Slawomir</div><div class="citationInfo"><span class="NLM_cas:title">Acta Biochimica Polonica</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-16</span>CODEN:
                <span class="NLM_cas:coden">ABPLAF</span>;
        ISSN:<span class="NLM_cas:issn">1734-154X</span>.
    
            (<span class="NLM_cas:orgname">Polish Biochemical Society</span>)
        </div><div class="casAbstract">A review.  Oxygen is one of the most important mols. on Earth mainly because of the biochem. symmetry of oxygenic photosynthesis and aerobic respiration that can maintain homeostasis within our planet's biosphere.  Oxygen can also produce toxic mols., reactive oxygen species (ROS).  ROS play a dual role in biol. systems, since they can be either harmful or beneficial to living systems.  They can be considered a double-edged sword because at moderate concns., nitric oxide (NO•), superoxide anion, and related reactive oxygen species play an important role as regulatory mediators in signalling processes.  Many of the ROS-mediated responses actually protect the cells against oxidative stress and reestablish "redox homeostasis".  On the other hand, overprodn. of ROS has the potential to cause damage.  In the recent decades, ROS has become a focus of interest in most biomedical disciplines and many types of clin. research.  Increasing evidence from research on several diseases shows that oxidative stress is assocd. with the pathogenesis of diabetes mellitus, obesity, cancer, cardiovascular diseases, inflammation, ischemia/reperfusion injury, obstructive sleep apnea, neurodegenerative disorders, hypertension and ageing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkALfxIGCV6bVg90H21EOLACvtfcHk0liBAuXoshlmMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntFaku7c%253D&md5=a678b12e3a6f92a39c5875068053b79b</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.18388%2Fabp.2013_1944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18388%252Fabp.2013_1944%26sid%3Dliteratum%253Aachs%26aulast%3DGutowski%26aufirst%3DM.%26aulast%3DKowalczyk%26aufirst%3DS.%26atitle%3DA%2520study%2520of%2520free%2520radical%2520chemistry%253A%2520their%2520role%2520and%2520pathophysiological%2520significance%26jtitle%3DActa%2520Biochim.%2520Polym.%26date%3D2013%26volume%3D60%26spage%3D1%26epage%3D16%26doi%3D10.18388%2Fabp.2013_1944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wruck, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fragoulis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurzynski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandenburg, L.-O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassenpflug, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freitag-Wolf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varoga, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pufe, T.</span></span> <span> </span><span class="NLM_article-title">Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-Knockout mice</span>. <i>Ann. Rheum. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">844</span>– <span class="NLM_lpage">850</span>, <span class="refDoi"> DOI: 10.1136/ard.2010.132720</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1136%2Fard.2010.132720" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=21173018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnt1egsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2011&pages=844-850&author=C.+Wruckauthor=A.+Fragoulisauthor=A.+Gurzynskiauthor=L.-O.+Brandenburgauthor=Y.+Kanauthor=K.+Chanauthor=J.+Hassenpflugauthor=S.+Freitag-Wolfauthor=D.+Varogaauthor=S.+Lipprossauthor=T.+Pufe&title=Role+of+oxidative+stress+in+rheumatoid+arthritis%3A+insights+from+the+Nrf2-Knockout+mice&doi=10.1136%2Fard.2010.132720"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-knockout mice</span></div><div class="casAuthors">Wruck, Christoph Jan; Fragoulis, Athanassios; Gurzynski, Agata; Brandenburg, Lars-Ove; Kan, Yuet Wai; Chan, Kaimin; Hassenpflug, Joachim; Freitag-Wolf, Sandra; Varoga, Deike; Lippross, Sebastian; Pufe, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the Rheumatic Diseases</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">844-850</span>CODEN:
                <span class="NLM_cas:coden">ARDIAO</span>;
        ISSN:<span class="NLM_cas:issn">0003-4967</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Increasing evidence suggests that oxidative stress may play a key role in joint destruction due to rheumatoid arthritis (RA).  The aim of this study was to elucidate the role of nuclear factor erythroid 2-related factor 2 (Nrf2), a transcription factor that maintains the cellular defense against oxidative stress, in RA.  The activation status of Nrf2 was assessed in synovial tissue from patients with RA using immunohistochem.  Antibody-induced arthritis (AIA) was induced in Nrf2-knockout and Nrf2-wild-type control mice.  The severity of cartilage destruction was evaluated using a damage score.  The extent of oxidative stress, the activation state of Nrf2 and the expression level of Nrf2 target genes were analyzed by immunhistol. staining.  The expression of vascular endothelial growth factor (VEGF)-A was examd. on mRNA and protein using the Luminex technique.  A Xenogen imaging system was used to measure Nrf2 activity in an antioxidant response element-luciferase transgenic mouse during AIA.  Results Nrf2 was activated in the joints of arthritic mice and of patients with RA.  Nrf2-knockout mice had more severe cartilage injuries and more oxidative damage, and the expression of Nrf2 target genes was enhanced in Nrf2-wild-type but not in knockout mice during AIA.  Both VEGF-A mRNA and protein expression was upregulated in Nrf2-knockout mice during AIA.  An unexpected finding was the no. of spontaneously fractured bones in Nrf2-knockout mice with AIA.  These results provide strong evidence that oxidative stress is significantly involved in cartilage degrdn. in exptl. arthritis, and indicate that the presence of a functional Nrf2 gene is a major requirement for limiting cartilage destruction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVA53-Yyb-qLVg90H21EOLACvtfcHk0liBAuXoshlmMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnt1egsbk%253D&md5=a68710cc4197ac967802fd1d0631aef2</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1136%2Fard.2010.132720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fard.2010.132720%26sid%3Dliteratum%253Aachs%26aulast%3DWruck%26aufirst%3DC.%26aulast%3DFragoulis%26aufirst%3DA.%26aulast%3DGurzynski%26aufirst%3DA.%26aulast%3DBrandenburg%26aufirst%3DL.-O.%26aulast%3DKan%26aufirst%3DY.%26aulast%3DChan%26aufirst%3DK.%26aulast%3DHassenpflug%26aufirst%3DJ.%26aulast%3DFreitag-Wolf%26aufirst%3DS.%26aulast%3DVaroga%26aufirst%3DD.%26aulast%3DLippross%26aufirst%3DS.%26aulast%3DPufe%26aufirst%3DT.%26atitle%3DRole%2520of%2520oxidative%2520stress%2520in%2520rheumatoid%2520arthritis%253A%2520insights%2520from%2520the%2520Nrf2-Knockout%2520mice%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2011%26volume%3D70%26spage%3D844%26epage%3D850%26doi%3D10.1136%2Fard.2010.132720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weinstain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savariar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felsen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsien, R.</span></span> <span> </span><span class="NLM_article-title"><i>In vivo</i> targeting of hydrogen peroxide by activatable cell-penetrating peptides</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">874</span>– <span class="NLM_lpage">877</span>, <span class="refDoi"> DOI: 10.1021/ja411547j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja411547j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2cXksVGr" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=874-877&author=R.+Weinstainauthor=E.+Savariarauthor=C.+Felsenauthor=R.+Tsien&title=In+vivo+targeting+of+hydrogen+peroxide+by+activatable+cell-penetrating+peptides&doi=10.1021%2Fja411547j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">In Vivo Targeting of Hydrogen Peroxide by Activatable Cell-Penetrating Peptides</span></div><div class="casAuthors">Weinstain, Roy; Savariar, Elamprakash N.; Felsen, Csilla N.; Tsien, Roger Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">874-877</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A hydrogen peroxide (H2O2)-activated cell-penetrating peptide was developed through incorporation of a boronic acid-contg. cleavable linker between polycationic cell-penetrating peptide and polyanionic fragments.  Fluorescence labeling of the two ends of the mol. enabled monitoring its reaction with H2O2 through release of the highly adhesive cell-penetrating peptide and disruption of fluorescence resonance energy transfer.  The H2O2 sensor selectively reacts with endogenous H2O2 in cell culture to monitor the oxidative burst of promyelocytes and in vivo to image lung inflammation.  Targeting H2O2 has potential applications in imaging and therapy of diseases related to oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZU1pQtHtIALVg90H21EOLACvtfcHk0liBAuXoshlmMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXksVGr&md5=4a5fed53a10efd855720e6c83a7e0fbf</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1021%2Fja411547j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja411547j%26sid%3Dliteratum%253Aachs%26aulast%3DWeinstain%26aufirst%3DR.%26aulast%3DSavariar%26aufirst%3DE.%26aulast%3DFelsen%26aufirst%3DC.%26aulast%3DTsien%26aufirst%3DR.%26atitle%3DIn%2520vivo%2520targeting%2520of%2520hydrogen%2520peroxide%2520by%2520activatable%2520cell-penetrating%2520peptides%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D874%26epage%3D877%26doi%3D10.1021%2Fja411547j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial induced and self-monitored intrinsic apoptosis by antitumor theranostic prodrug: <i>in vivo</i> imaging and precise cancer treatment</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">17836</span>– <span class="NLM_lpage">17843</span>, <span class="refDoi"> DOI: 10.1021/ja510421q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja510421q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFOjsL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=17836-17843&author=R.+Kumarauthor=J.+Hanauthor=H.-J.+Limauthor=W.+Renauthor=J.-Y.+Limauthor=J.-H.+Kimauthor=J.+Kim&title=Mitochondrial+induced+and+self-monitored+intrinsic+apoptosis+by+antitumor+theranostic+prodrug%3A+in+vivo+imaging+and+precise+cancer+treatment&doi=10.1021%2Fja510421q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial Induced and Self-Monitored Intrinsic Apoptosis by Antitumor Theranostic Prodrug: In Vivo Imaging and Precise Cancer Treatment</span></div><div class="casAuthors">Kumar, Rajesh; Han, Jiyou; Lim, Hee-Joung; Ren, Wen Xiu; Lim, Ja-Yun; Kim, Jong-Hoon; Kim, Jong Seung</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">17836-17843</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activation of apoptosis, the cell death machinery, in tumor cells by organelle-specific delivery of antitumor theranostic agent is the utmost challenge in cancer therapy.  Herein, we developed a highly efficient mitochondria-targeting antitumor theranostic prodrug 7 that contained two mols. of drug 5'-deoxy-5-fluorouridine and an apoptotic marker ethidium for self-monitoring intrinsic (mitochondrial) apoptosis after its activation in tumor cells.  Theranostic 7 was activated by endogenously produced mitochondrial-overexpressed H2O2 and released drug 5'-deoxy-5-fluorouridine and apoptotic marker ethidium to the tumor cells.  The in vitro and in vivo drug release was monitored by observing the fluorescence changes of ethidium.  Theranostic 7 exhibited an enhanced cytotoxicity over com. 5-fluorouracil (an active drug of 5'-deoxy-5-fluorouridine) leading to intrinsic apoptosis monitored by in situ generated ethidium.  Enhanced expression of mitochondria-mediated apoptotic genes (NOXA, PUMA, BID, BAX, and BAK), Cyt C, Caspase-3 and -9, and cell surface death receptors was obsd. after theranostic 7 activation in tumor cells.  In vivo and ex vivo xenografts revealed that theranostic 7 significantly inhibited tumor progression and cured the tumor-bearing mice.  Such organelle-specific theranostic strategies have great potential for the early diagnosis and precise treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdxDp1xuNvfLVg90H21EOLACvtfcHk0liBAuXoshlmMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFOjsL3O&md5=0e80b2f99a1054f9da8570c3ceb84783</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1021%2Fja510421q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja510421q%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DH.-J.%26aulast%3DRen%26aufirst%3DW.%26aulast%3DLim%26aufirst%3DJ.-Y.%26aulast%3DKim%26aufirst%3DJ.-H.%26aulast%3DKim%26aufirst%3DJ.%26atitle%3DMitochondrial%2520induced%2520and%2520self-monitored%2520intrinsic%2520apoptosis%2520by%2520antitumor%2520theranostic%2520prodrug%253A%2520in%2520vivo%2520imaging%2520and%2520precise%2520cancer%2520treatment%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D17836%26epage%3D17843%26doi%3D10.1021%2Fja510421q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peiró
Cadahía, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bondebjerg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Previtali, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andresen, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clausen, M. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of hydrogen peroxide sensitive prodrugs of methotrexate and aminopterin for the treatment of rheumatoid arthritis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3503</span>– <span class="NLM_lpage">3515</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01775</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01775" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmslGqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3503-3515&author=J.+Peir%C3%B3%0ACadah%C3%ADaauthor=J.+Bondebjergauthor=C.+A.+Hansenauthor=V.+Previtaliauthor=A.+E.+Hansenauthor=T.+L.+Andresenauthor=M.+H.+Clausen&title=Synthesis+and+evaluation+of+hydrogen+peroxide+sensitive+prodrugs+of+methotrexate+and+aminopterin+for+the+treatment+of+rheumatoid+arthritis&doi=10.1021%2Facs.jmedchem.7b01775"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Hydrogen Peroxide Sensitive Prodrugs of Methotrexate and Aminopterin for the Treatment of Rheumatoid Arthritis</span></div><div class="casAuthors">Peiro Cadahia, Jorge; Bondebjerg, Jon; Hansen, Christian A.; Previtali, Viola; Hansen, Anders E.; Andresen, Thomas L.; Clausen, Mads H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3503-3515</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of novel hydrogen peroxide sensitive prodrugs I (11-13; R = H, Me, F) of methotrexate (MTX) and aminopterin (AMT) were synthesized and evaluated for therapeutic efficacy in mice with collagen induced arthritis (CIA) as a model of chronic rheumatoid arthritis (RA).  The prodrug strategy selected is based on ROS-labile 4-methylphenylboronic acid promoieties linked to the drugs via a carbamate linkage or a direct C-N bond.  Activation under pathophysiol. concns. of H2O2 proved to be effective, and prodrug candidates were selected in agreement with relevant in vitro physicochem. and pharmacokinetic assays.  Selected candidates showed moderate to good soly., high chem. and enzymic stability, and therapeutic efficacy comparable to the parent drugs in the CIA model.  Importantly, the prodrugs displayed the expected safer toxicity profile and increased therapeutic window compared to MTX and AMT while maintaining a comparable therapeutic efficacy, which is highly encouraging for future use in RA patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdXtNA0_tY-LVg90H21EOLACvtfcHk0li0shmn4zbonQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmslGqs7s%253D&md5=8b58908d30a5092afa61d67856d9ecbb</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01775%26sid%3Dliteratum%253Aachs%26aulast%3DPeir%25C3%25B3%2BCadah%25C3%25ADa%26aufirst%3DJ.%26aulast%3DBondebjerg%26aufirst%3DJ.%26aulast%3DHansen%26aufirst%3DC.%2BA.%26aulast%3DPrevitali%26aufirst%3DV.%26aulast%3DHansen%26aufirst%3DA.%2BE.%26aulast%3DAndresen%26aufirst%3DT.%2BL.%26aulast%3DClausen%26aufirst%3DM.%2BH.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520hydrogen%2520peroxide%2520sensitive%2520prodrugs%2520of%2520methotrexate%2520and%2520aminopterin%2520for%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3503%26epage%3D3515%26doi%3D10.1021%2Facs.jmedchem.7b01775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McInnes, I. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schett, G.</span></span> <span> </span><span class="NLM_article-title">The pathogenesis of rheumatoid arthritis</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>365</i></span>,  <span class="NLM_fpage">2205</span>– <span class="NLM_lpage">2219</span>, <span class="refDoi"> DOI: 10.1056/NEJMra1004965</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1056%2FNEJMra1004965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=22150039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ajsrrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2011&pages=2205-2219&author=I.+B.+McInnesauthor=G.+Schett&title=The+pathogenesis+of+rheumatoid+arthritis&doi=10.1056%2FNEJMra1004965"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">The pathogenesis of rheumatoid arthritis</span></div><div class="casAuthors">McInnes, Lain B.; Schett, Georg</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2205-2219</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review discusses key pathogenic advances in rheumatoid arthritis, genetics, environmental factors, immunol. processes, inflammation, and structural damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJslDVaG7MxbVg90H21EOLACvtfcHk0li0shmn4zbonQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ajsrrM&md5=31a79ccb05bca03f207b15f934b2d52d</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1056%2FNEJMra1004965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra1004965%26sid%3Dliteratum%253Aachs%26aulast%3DMcInnes%26aufirst%3DI.%2BB.%26aulast%3DSchett%26aufirst%3DG.%26atitle%3DThe%2520pathogenesis%2520of%2520rheumatoid%2520arthritis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2011%26volume%3D365%26spage%3D2205%26epage%3D2219%26doi%3D10.1056%2FNEJMra1004965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weinblatt, M.</span></span> <span> </span><span class="NLM_article-title">Methotrexate in rheumatoid arthritis: a quarter century of development</span>. <i>Trans. Am. Clin. Climatol. Assoc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">16</span>– <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=23874006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A280%3ADC%252BC3sfislanuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2013&pages=16-25&author=M.+Weinblatt&title=Methotrexate+in+rheumatoid+arthritis%3A+a+quarter+century+of+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Methotrexate in rheumatoid arthritis: a quarter century of development</span></div><div class="casAuthors">Weinblatt Michael E</div><div class="citationInfo"><span class="NLM_cas:title">Transactions of the American Clinical and Climatological Association</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16-25</span>
        ISSN:<span class="NLM_cas:issn">0065-7778</span>.
    </div><div class="casAbstract">Methotrexate (MTX) is now the most popular drug worldwide for the treatment of rheumatoid arthritis.  Low-dose, weekly MTX (10 to 25 mg/wk) used as either monotherapy or in combination with other drugs has a superior efficacy profile as defined in placebo-controlled trials and comparable efficacy to other drugs including anti-TNF therapy.  At 1 year, one third of patients on MTX have no radiographic progression and even greater effects are seen when combined with targeted biological therapies.  MTX is well tolerated; gastrointestinal toxicity is the most common toxicity with rarely bone marrow, lung, or liver toxicity.  MTX therapy has been a major advance in the treatment of rheumatoid arthritis and is now the cornerstone of therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRqArOx8qswLjEwO064Z95rfW6udTcc2ebn8g62P0O6rLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfislanuw%253D%253D&md5=2133803c36109fff27f4680d108331d6</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeinblatt%26aufirst%3DM.%26atitle%3DMethotrexate%2520in%2520rheumatoid%2520arthritis%253A%2520a%2520quarter%2520century%2520of%2520development%26jtitle%3DTrans.%2520Am.%2520Clin.%2520Climatol.%2520Assoc.%26date%3D2013%26volume%3D124%26spage%3D16%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cronstein, B. N.</span></span> <span> </span><span class="NLM_article-title">Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis</span>. <i>Bull. NYU Hosp. Jt. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">168</span>– <span class="NLM_lpage">173</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=17922664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A280%3ADC%252BD2sngtVGitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2007&pages=168-173&author=H.+Tianauthor=B.+N.+Cronstein&title=Understanding+the+mechanisms+of+action+of+methotrexate%3A+implications+for+the+treatment+of+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis</span></div><div class="casAuthors">Tian Henghe; Cronstein Bruce N</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of the NYU hospital for joint diseases</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">168-73</span>
        ISSN:<span class="NLM_cas:issn">1936-9719</span>.
    </div><div class="casAbstract">Methotrexate has been widely used for the treatment of rheumatoid arthritis (RA).  The mechanisms of action of methotrexate are complex.  Developed as a folic acid analogue, methotrexate inhibits purine and pyrimidine synthesis, which accounts for its efficacy in the therapy of cancer as well as for some of its toxicities.  Recently, many studies have focused on the adenosine-mediated antiinflammatory effects of methotrexate.  Certain aspects of methotrexate toxicities are also attributed to adenosine release.  A better understanding of the mechanisms of action and toxicities of methotrexate will direct clinicians in their treatment approach and toxicity monitoring.  Toward that objective, the latest developments in the pharmacokinetics, mechanism of action, pharmacogenetics, and toxicity of methotrexate are herein discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKpjpRCjFMtdHxxy173TfNfW6udTcc2ebg5H-KINDNybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sngtVGitQ%253D%253D&md5=b4d433ad29e80faaa489a0dcda426d27</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DH.%26aulast%3DCronstein%26aufirst%3DB.%2BN.%26atitle%3DUnderstanding%2520the%2520mechanisms%2520of%2520action%2520of%2520methotrexate%253A%2520implications%2520for%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DBull.%2520NYU%2520Hosp.%2520Jt.%2520Dis.%26date%3D2007%26volume%3D65%26spage%3D168%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khanna, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulus, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elashoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emery, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorrier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furst, D.</span></span> <span> </span><span class="NLM_article-title">Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">3030</span>– <span class="NLM_lpage">3038</span>, <span class="refDoi"> DOI: 10.1002/art.21295</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2Fart.21295" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=16200612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtF2msrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2005&pages=3030-3038&author=D.+Khannaauthor=G.+Parkauthor=H.+Paulusauthor=K.+Simpsonauthor=D.+Elashoffauthor=S.+Cohenauthor=P.+Emeryauthor=C.+Dorrierauthor=D.+Furst&title=Reduction+of+the+efficacy+of+methotrexate+by+the+use+of+folic+acid%3A+post+hoc+analysis+from+two+randomized+controlled+studies&doi=10.1002%2Fart.21295"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies</span></div><div class="casAuthors">Khanna, Dinesh; Park, Grace S.; Paulus, Harold E.; Simpson, Karen M.; Elashoff, David; Cohen, Stanley B.; Emery, Paul; Dorrier, Catharine; Furst, Daniel E.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3030-3038</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective. To examine the effect of folic acid on the efficacy of methotrexate (MTX) treatment in rheumatoid arthritis (RA) at 12 mo in 2 phase III randomized controlled trials (RCTs) of leflunomide in which MTX was used as a comparator.  Methods. Analyses were restricted to patients randomized to receive MTX who had rheumatoid factor data.  The US study recruited 482 patients with active RA; 179 received at least 1 dose of MTX, and all were mandated to receive 1 mg of oral folic acid once or twice daily.  The multinational European study recruited 999 patients with active RA; 489 received at least 1 dose of MTX, and oral folic acid was not required, although 50 received folate after developing an adverse event.  Because of similar entry criteria for both studies, the data for patients with available primary outcome data at week 52 were pooled (n = 668), and the patients were grouped by folic acid use (n = 225) and nonuse (n = 443).  To account for the significant between-study differences in the MTX groups, baseline covariates were adjusted using propensity scores so that folic acid users could be matched with nonusers.  This allowed for a comparison of differences in American College of Rheumatol. (ACR) 20% improvement criteria at week 52.  Results. At study entry, non-folic acid users had a significantly lower mean body wt., shorter mean RA duration, and higher mean disease activity (measured by joint counts, patient's and physician's global assessments, and acute-phase reactant levels).  The mean MTX dosage at week 52 was similar in the 2 RCTs.  Using propensity score matching techniques, the proportion of patients achieving an ACR 20% response at week 52 averaged 17% higher in the non-folic acid group than in the folic acid group (range 15-21%).  Similarly, the proportion of patients achieving ACR 50% and ACR 70% responses averaged 14% (range 12-16%) and 12% (range 9-14%) higher, resp., in the non-folic acid group.  Adverse events were reported in 93% of US study patients and 94% of the multinational study patients.  Elevated liver transaminase levels (above the upper limit of normal) were reported in 29% of the US study patients (majority receiving folic acid) and 62% of the multinational study patients (majority not receiving folic acid).  Conclusion. After using propensity scores to adjust for differences in the baseline characteristics of folic acid users and non-folic acid users, 9-21% fewer MTX-treated RA patients taking folic acid had ACR 20%, 50%, or 70% improvement at 52 wk compared with those who did not receive folic acid in the 2 phase III RA clin. trials.  As a post hoc anal., the results of this data anal. should be considered "hypothesis generating" and an impetus for future studies regarding the effects of folic acid on the efficacy of MTX in RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEPs1GWs8UY7Vg90H21EOLACvtfcHk0lh7M_Ms-aa5HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtF2msrrN&md5=5d4e8bfac44bd3e29995b3498aaf8458</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1002%2Fart.21295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.21295%26sid%3Dliteratum%253Aachs%26aulast%3DKhanna%26aufirst%3DD.%26aulast%3DPark%26aufirst%3DG.%26aulast%3DPaulus%26aufirst%3DH.%26aulast%3DSimpson%26aufirst%3DK.%26aulast%3DElashoff%26aufirst%3DD.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DEmery%26aufirst%3DP.%26aulast%3DDorrier%26aufirst%3DC.%26aulast%3DFurst%26aufirst%3DD.%26atitle%3DReduction%2520of%2520the%2520efficacy%2520of%2520methotrexate%2520by%2520the%2520use%2520of%2520folic%2520acid%253A%2520post%2520hoc%2520analysis%2520from%2520two%2520randomized%2520controlled%2520studies%26jtitle%3DArthritis%2520Rheum.%26date%3D2005%26volume%3D52%26spage%3D3030%26epage%3D3038%26doi%3D10.1002%2Fart.21295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rautio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumpulainen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heimbach, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliyai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Järvinen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savolainen, J.</span></span> <span> </span><span class="NLM_article-title">Prodrugs: design and clinical applications</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">270</span>, <span class="refDoi"> DOI: 10.1038/nrd2468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1038%2Fnrd2468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=18219308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFOrs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=255-270&author=J.+Rautioauthor=H.+Kumpulainenauthor=T.+Heimbachauthor=R.+Oliyaiauthor=D.+Ohauthor=T.+J%C3%A4rvinenauthor=J.+Savolainen&title=Prodrugs%3A+design+and+clinical+applications&doi=10.1038%2Fnrd2468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Prodrugs: design and clinical applications</span></div><div class="casAuthors">Rautio, Jarkko; Kumpulainen, Hanna; Heimbach, Tycho; Oliyai, Reza; Oh, Dooman; Jaervinen, Tomi; Savolainen, Jouko</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">255-270</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Prodrugs are bioreversible derivs. of drug mols. that undergo an enzymic and/or chem. transformation in vivo to release the active parent drug, which can then exert the desired pharmacol. effect.  In both drug discovery and development, prodrugs have become an established tool for improving physicochem., biopharmaceutical or pharmacokinetic properties of pharmacol. active agents.  About 5-7% of drugs approved worldwide can be classified as prodrugs, and the implementation of a prodrug approach in the early stages of drug discovery is a growing trend.  To illustrate the applicability of the prodrug strategy, this article describes the most common functional groups that are amenable to prodrug design, and highlights examples of prodrugs that are either launched or are undergoing human trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxnlEXYMLCVbVg90H21EOLACvtfcHk0ljHl9Z1ARFdxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFOrs7w%253D&md5=481a088ad2ee4da062779b5b28a33cbb</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1038%2Fnrd2468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2468%26sid%3Dliteratum%253Aachs%26aulast%3DRautio%26aufirst%3DJ.%26aulast%3DKumpulainen%26aufirst%3DH.%26aulast%3DHeimbach%26aufirst%3DT.%26aulast%3DOliyai%26aufirst%3DR.%26aulast%3DOh%26aufirst%3DD.%26aulast%3DJ%25C3%25A4rvinen%26aufirst%3DT.%26aulast%3DSavolainen%26aufirst%3DJ.%26atitle%3DProdrugs%253A%2520design%2520and%2520clinical%2520applications%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D255%26epage%3D270%26doi%3D10.1038%2Fnrd2468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liederer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borchardt, R.</span></span> <span> </span><span class="NLM_article-title">Enzymes involved in the bioconversion of ester-based prodrugs</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">1177</span>– <span class="NLM_lpage">1195</span>, <span class="refDoi"> DOI: 10.1002/jps.20542</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2Fjps.20542" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=16639719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsFWmu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2006&pages=1177-1195&author=B.+Liedererauthor=R.+Borchardt&title=Enzymes+involved+in+the+bioconversion+of+ester-based+prodrugs&doi=10.1002%2Fjps.20542"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Enzymes involved in the bioconversion of ester-based prodrugs</span></div><div class="casAuthors">Liederer, Bianca M.; Borchardt, Ronald T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1177-1195</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Enzymes are essential for the activation of many prodrugs.  In this review, the most important enzymes (e.g., paraoxonase, carboxylesterase, acetylcholinesterase, cholinesterase) involved in the bioconversion of ester-based prodrugs will be discussed in terms of their biol. and biochem.  Most of these enzymes fall into the category of hydrolytic enzymes.  However, nonhydrolytic enzymes, including cytochrome P450s, can also catalyze the bioconversion of ester prodrugs and thus will be discussed here.  Other factors influencing the ability of these enzymes to catalyze the bioconversion of ester-based prodrugs, particularly species and interindividual differences and stereochem. and structural features of the prodrugs, will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0llDjMqFZU7Vg90H21EOLACvtfcHk0ljHl9Z1ARFdxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsFWmu7Y%253D&md5=c4bb34d8918f2b4de099a0502c5bdb00</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1002%2Fjps.20542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.20542%26sid%3Dliteratum%253Aachs%26aulast%3DLiederer%26aufirst%3DB.%26aulast%3DBorchardt%26aufirst%3DR.%26atitle%3DEnzymes%2520involved%2520in%2520the%2520bioconversion%2520of%2520ester-based%2520prodrugs%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2006%26volume%3D95%26spage%3D1177%26epage%3D1195%26doi%3D10.1002%2Fjps.20542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Previtali, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrovic, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peiró
Cadahía, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troelsen, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clausen, M. H.</span></span> <span> </span><span class="NLM_article-title">Auxiliary in vitro and <i>in vivo</i> biological evaluation of hydrogen peroxide sensitive prodrugs of methotrexate and aminopterin for the treatment of rheumatoid arthritis</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">115247</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2019.115247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.bmc.2019.115247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=31843461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVSlu73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2020&pages=115247&author=V.+Previtaliauthor=K.+Petrovicauthor=J.+Peir%C3%B3%0ACadah%C3%ADaauthor=N.+S.+Troelsenauthor=M.+H.+Clausen&title=Auxiliary+in+vitro+and+in+vivo+biological+evaluation+of+hydrogen+peroxide+sensitive+prodrugs+of+methotrexate+and+aminopterin+for+the+treatment+of+rheumatoid+arthritis&doi=10.1016%2Fj.bmc.2019.115247"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Auxiliary in vitro and in vivo biological evaluation of hydrogen peroxide sensitive prodrugs of methotrexate and aminopterin for the treatment of rheumatoid arthritis</span></div><div class="casAuthors">Previtali, Viola; Petrovic, Katarina; Peiro Cadahia, Jorge; Troelsen, Nikolaj Sten; Clausen, Mads H.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">115247</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Rheumatoid arthritis (RA) is a chronic inflammatory disease that causes severe joints damage and other extra-articular alterations.  Despite the efficacy of low-dose methotrexate (LD-MTX) in RA treatment, adverse effects are the predominant reasons for discontinuation of therapy.  As a therapeutic targeting strategy, the presence of increased concns. of reactive oxygen species (ROS) in the inflammatory environment can serve as the stimulus for prodrug activation in site-selective drug delivery systems.  Our group has previously reported novel ROS sensitive prodrugs (1-3) of MTX and aminopterin (AMT) for site-selective delivery to inflammatory tissue assocd. with RA, with the aim of reducing side effects in RA therapy.  Herein, we investigate the effect and toxicity of the same prodrugs in a rat CIA (collagen-induced arthritis) model of RA.  We find that prodrug 1, an arylboronic acid ROS-sensitive MTX-prodrug, displays similar in vivo efficacy as MTX at an equimolar dose, while avoiding adverse effects known to restrict MTX treatment.  To further characterize prodrug 1 and its ROS mediated activation, we synthesized compd. 4, a neg. control lacking the boronic acid moiety.  We then investigated the effect of mols. on cell proliferation and cytotoxicity in the presence of the ROS scavenger pyruvate, as well as their stability in buffer and cell media, demonstrating a direct correlation between ROS concn. and the prodrug activity.  Moreover, the in vitro ADME properties were investigated, including permeability, rat plasma and microsomal stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosrlyZon7p3LVg90H21EOLACvtfcHk0ljHl9Z1ARFdxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVSlu73J&md5=d070f26cea05af53ba8334cab7a499f8</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2019.115247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2019.115247%26sid%3Dliteratum%253Aachs%26aulast%3DPrevitali%26aufirst%3DV.%26aulast%3DPetrovic%26aufirst%3DK.%26aulast%3DPeir%25C3%25B3%2BCadah%25C3%25ADa%26aufirst%3DJ.%26aulast%3DTroelsen%26aufirst%3DN.%2BS.%26aulast%3DClausen%26aufirst%3DM.%2BH.%26atitle%3DAuxiliary%2520in%2520vitro%2520and%2520in%2520vivo%2520biological%2520evaluation%2520of%2520hydrogen%2520peroxide%2520sensitive%2520prodrugs%2520of%2520methotrexate%2520and%2520aminopterin%2520for%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2020%26volume%3D28%26spage%3D115247%26doi%3D10.1016%2Fj.bmc.2019.115247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haorah, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramirez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Persidsky, Y.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">566</span>– <span class="NLM_lpage">576</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2006.04393.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1111%2Fj.1471-4159.2006.04393.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=17250680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltVKitLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=566-576&author=J.+Haorahauthor=S.+Ramirezauthor=K.+Schallauthor=D.+Smithauthor=R.+Pandyaauthor=Y.+Persidsky&title=Oxidative+stress+activates+protein+tyrosine+kinase+and+matrix+metalloproteinases+leading+to+blood-brain+barrier+dysfunction&doi=10.1111%2Fj.1471-4159.2006.04393.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction</span></div><div class="casAuthors">Haorah, James; Ramirez, Servio H.; Schall, Kathy; Smith, Daniel; Pandya, Rita; Persidsky, Yuri</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">566-576</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The blood-brain barrier (BBB) formed by brain microvascular endothelial cells (BMVEC) regulates the passage of mols. and leukocytes in and out of the brain.  Oxidative stress is a major underlying cause of neurodegenerative and neuroinflammatory disorders and BBB injury assocd. with them.  Using human BMVEC grown on porous membranes covered with basement membrane (BM) matrix (BBB models), we demonstrated that reactive oxygen species (ROS) augmented permeability and monocyte migration across BBB.  ROS activated matrix metalloproteinases (MMP-1, -2, and -9) and decreased tissue inhibitors of MMPs (TIMP-1 and -2) in a protein tyrosine kinase (PTK)-dependent manner.  Increase in MMPs and PTK activities paralleled degrdn. of BM protein and enhanced tyrosine phosphorylation of tight junction (TJ) protein.  These effects and enhanced permeability/monocyte migration were prevented by inhibitors of MMPs, PTKs, or antioxidant suggesting that oxidative stress caused BBB injury via degrdn. of BM protein by activated MMPs and by PTK-mediated TJ protein phosphorylation.  These findings point to new therapeutic interventions ameliorating BBB dysfunction in neurol. disorders such as stroke or neuroinflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoptQU8PhSIn7Vg90H21EOLACvtfcHk0liyFTX01xcSUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltVKitLY%253D&md5=86600b946b8670c5df874e8abedcb751</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04393.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04393.x%26sid%3Dliteratum%253Aachs%26aulast%3DHaorah%26aufirst%3DJ.%26aulast%3DRamirez%26aufirst%3DS.%26aulast%3DSchall%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DPandya%26aufirst%3DR.%26aulast%3DPersidsky%26aufirst%3DY.%26atitle%3DOxidative%2520stress%2520activates%2520protein%2520tyrosine%2520kinase%2520and%2520matrix%2520metalloproteinases%2520leading%2520to%2520blood-brain%2520barrier%2520dysfunction%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D101%26spage%3D566%26epage%3D576%26doi%3D10.1111%2Fj.1471-4159.2006.04393.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaczmarek, L.</span></span> <span> </span><span class="NLM_article-title">Mmp-9 inhibition: a therapeutic strategy in ischemic stroke</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">563</span>– <span class="NLM_lpage">573</span>, <span class="refDoi"> DOI: 10.1007/s12035-013-8538-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1007%2Fs12035-013-8538-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=24026771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVCitrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2014&pages=563-573&author=M.+Chaturvediauthor=L.+Kaczmarek&title=Mmp-9+inhibition%3A+a+therapeutic+strategy+in+ischemic+stroke&doi=10.1007%2Fs12035-013-8538-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">MMP-9 Inhibition: a Therapeutic Strategy in Ischemic Stroke</span></div><div class="casAuthors">Chaturvedi, Mayank; Kaczmarek, Leszek</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">563-573</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Ischemic stroke is a leading cause of disability worldwide.  In cerebral ischemia there is an enhanced expression of matrix metallo-proteinase-9 (MMP-9), which has been assocd. with various complications including excitotoxicity, neuronal damage, apoptosis, blood-brain barrier (BBB) opening leading to cerebral edema, and hemorrhagic transformation.  Moreover, the tissue plasminogen activator (tPA), which is the only US-FDA approved treatment of ischemic stroke, has a brief 3 to 4 h time window and it has been proposed that detrimental effects of tPA beyond the 3 h since the onset of stroke are derived from its ability to activate MMP-9 that in turn contributes to the breakdown of BBB.  Therefore, the available literature suggests that MMP-9 inhibition can be of therapeutic importance in ischemic stroke.  Hence, combination therapies of MMP-9 inhibitor along with tPA can be beneficial in ischemic stroke.  In this review we will discuss the current status of various strategies which have shown neuroprotection and extension of thrombolytic window by directly or indirectly inhibiting MMP-9 activity.  In the introductory part of the review, we briefly provide an overview on ischemic stroke, commonly used models of ischemic stroke and a role of MMP-9 in ischemia.  In next part, the literature is organized as various approaches which have proven neuroprotective effects through direct or indirect decrease in MMP-9 activity, namely, using biotherapeutics, involving MMP-9 gene inhibition using viral vectors; using endogenous inhibitor of MMP-9, repurposing of old drugs such as minocycline, new chem. entities like DP-b99, and finally other approaches like therapeutic hypothermia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2kGS9IvaXvrVg90H21EOLACvtfcHk0liyFTX01xcSUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVCitrvP&md5=21828bf3861b708e60c7d90e367aff33</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1007%2Fs12035-013-8538-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-013-8538-z%26sid%3Dliteratum%253Aachs%26aulast%3DChaturvedi%26aufirst%3DM.%26aulast%3DKaczmarek%26aufirst%3DL.%26atitle%3DMmp-9%2520inhibition%253A%2520a%2520therapeutic%2520strategy%2520in%2520ischemic%2520stroke%26jtitle%3DMol.%2520Neurobiol.%26date%3D2014%26volume%3D49%26spage%3D563%26epage%3D573%26doi%3D10.1007%2Fs12035-013-8538-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fields, G. B.</span></span> <span> </span><span class="NLM_article-title">The rebirth of matrix metalloproteinase inhibitors: moving beyond the dogma</span>. <i>Cells</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">984</span>, <span class="refDoi"> DOI: 10.3390/cells8090984</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.3390%2Fcells8090984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmtVSltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=984&author=G.+B.+Fields&title=The+rebirth+of+matrix+metalloproteinase+inhibitors%3A+moving+beyond+the+dogma&doi=10.3390%2Fcells8090984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">The rebirth of matrix metalloproteinase inhibitors: moving beyond the dogma</span></div><div class="casAuthors">Fields, Gregg B.</div><div class="citationInfo"><span class="NLM_cas:title">Cells</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">984</span>CODEN:
                <span class="NLM_cas:coden">CELLC6</span>;
        ISSN:<span class="NLM_cas:issn">2073-4409</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The pursuit of matrix metalloproteinase (MMP) inhibitors began in earnest over three decades ago.  Initial clin. trials were disappointing, resulting in a neg. view of MMPs as therapeutic targets.  As a better understanding of MMP biol. and inhibitor pharmacokinetic properties emerged, it became clear that initial MMP inhibitor clin. trials were held prematurely.  Further complicating matters were problematic conclusions drawn from animal model studies.  The most recent generation of MMP inhibitors have desirable selectivities and improved pharmacokinetics, resulting in improved toxicity profiles.  Application of selective MMP inhibitors led to the conclusion that MMP-2, MMP-9, MMP-13, and MT1-MMP are not involved in musculoskeletal syndrome, a common side effect obsd. with broad spectrum MMP inhibitors.  Specific activities within a single MMP can now be inhibited.  Better definition of the roles of MMPs in immunol. responses and inflammation will help inform clinic trials, and multiple studies indicate that modulating MMP activity can improve immunotherapy.  There is a U.S.  Food and Drug Administration (FDA)-approved MMP inhibitor for periodontal disease, and several MMP inhibitors are in clinic trials, targeting a variety of maladies including gastric cancer, diabetic foot ulcers, and multiple sclerosis.  It is clearly time to move on from the dogma of viewing MMP inhibition as intractable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY8YcT4Rj5RLVg90H21EOLACvtfcHk0liyFTX01xcSUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmtVSltrY%253D&md5=4ff4b435717c123cd5043df32587c853</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.3390%2Fcells8090984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcells8090984%26sid%3Dliteratum%253Aachs%26aulast%3DFields%26aufirst%3DG.%2BB.%26atitle%3DThe%2520rebirth%2520of%2520matrix%2520metalloproteinase%2520inhibitors%253A%2520moving%2520beyond%2520the%2520dogma%26jtitle%3DCells%26date%3D2019%26volume%3D8%26spage%3D984%26doi%3D10.3390%2Fcells8090984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Major Jourden, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S. M.</span></span> <span> </span><span class="NLM_article-title">Hydrogen peroxide activated matrix metalloproteinase inhibitors: a prodrug approach</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6795</span>– <span class="NLM_lpage">6797</span>, <span class="refDoi"> DOI: 10.1002/anie.201003819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2Fanie.201003819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFGnsbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=6795-6797&author=J.+L.+Major+Jourdenauthor=S.+M.+Cohen&title=Hydrogen+peroxide+activated+matrix+metalloproteinase+inhibitors%3A+a+prodrug+approach&doi=10.1002%2Fanie.201003819"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrogen Peroxide Activated Matrix Metalloproteinase Inhibitors: a Prodrug Approach</span></div><div class="casAuthors">Major Jourden, Jody L.; Cohen, Seth M.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">6795-6797, S6795/1-S6795/12</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The proinhibitors e.g. I, introduced in this work demonstrate an effective means to passivate matrix metalloproteinases inhibitors (MMPi) and activate them in the presence of H2O2.  Through addn. of a boronic ester protecting group to the metal-binding moiety of MMPi via a self-immolative linker, proinhibitors based on two different zinc-binding groups (ZBGs) were developed.  These compds. were found to be sufficiently stable in buffer and were found to have high rates of cleavage allowing for efficient activation with H2O2.  These compds. should display a dual mode of action in the prevention of reperfusion injury, by neutralizing reactive oxygen species and generating an active MMPi.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi0oYNvHaGTbVg90H21EOLACvtfcHk0liyFTX01xcSUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFGnsbfN&md5=190822c841539f2cb7b6514e61cac13f</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1002%2Fanie.201003819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201003819%26sid%3Dliteratum%253Aachs%26aulast%3DMajor%2BJourden%26aufirst%3DJ.%2BL.%26aulast%3DCohen%26aufirst%3DS.%2BM.%26atitle%3DHydrogen%2520peroxide%2520activated%2520matrix%2520metalloproteinase%2520inhibitors%253A%2520a%2520prodrug%2520approach%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2010%26volume%3D49%26spage%3D6795%26epage%3D6797%26doi%3D10.1002%2Fanie.201003819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Staurengo-Ferrari, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badaro-Garcia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hohmann, M. S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manchope, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaninelli, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casagrande, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verri, W. A.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Contribution of Nrf2 modulation to the mechanism of action of analgesic and anti-inflammatory drugs in pre-clinical and clinical stages</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1536</span>, <span class="refDoi"> DOI: 10.3389/fphar.2018.01536</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.3389%2Ffphar.2018.01536" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=30687097" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=1536&author=L.+Staurengo-Ferrariauthor=S.+Badaro-Garciaauthor=M.+S.+N.+Hohmannauthor=M.+F.+Manchopeauthor=T.+H.+Zaninelliauthor=R.+Casagrandeauthor=W.+A.+Verri&title=Contribution+of+Nrf2+modulation+to+the+mechanism+of+action+of+analgesic+and+anti-inflammatory+drugs+in+pre-clinical+and+clinical+stages&doi=10.3389%2Ffphar.2018.01536"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2018.01536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2018.01536%26sid%3Dliteratum%253Aachs%26aulast%3DStaurengo-Ferrari%26aufirst%3DL.%26aulast%3DBadaro-Garcia%26aufirst%3DS.%26aulast%3DHohmann%26aufirst%3DM.%2BS.%2BN.%26aulast%3DManchope%26aufirst%3DM.%2BF.%26aulast%3DZaninelli%26aufirst%3DT.%2BH.%26aulast%3DCasagrande%26aufirst%3DR.%26aulast%3DVerri%26aufirst%3DW.%2BA.%26atitle%3DContribution%2520of%2520Nrf2%2520modulation%2520to%2520the%2520mechanism%2520of%2520action%2520of%2520analgesic%2520and%2520anti-inflammatory%2520drugs%2520in%2520pre-clinical%2520and%2520clinical%2520stages%26jtitle%3DFront.%2520Pharmacol.%26date%3D2019%26volume%3D9%26spage%3D1536%26doi%3D10.3389%2Ffphar.2018.01536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span> <span> </span><span class="NLM_article-title">A hydrogen peroxide responsive prodrug of keap1-Nrf2 inhibitor for improving oral absorption and selective activation in inflammatory conditions</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">101565</span>, <span class="refDoi"> DOI: 10.1016/j.redox.2020.101565</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.redox.2020.101565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=32422540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BB3cXpsl2ht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2020&pages=101565&author=M.+Luauthor=X.+Zhangauthor=J.+Zhaoauthor=Q.+Youauthor=Z.+Jiang&title=A+hydrogen+peroxide+responsive+prodrug+of+keap1-Nrf2+inhibitor+for+improving+oral+absorption+and+selective+activation+in+inflammatory+conditions&doi=10.1016%2Fj.redox.2020.101565"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">A hydrogen peroxide responsive prodrug of Keap1-Nrf2 inhibitor for improving oral absorption and selective activation in inflammatory conditions</span></div><div class="casAuthors">Lu, Mengchen; Zhang, Xian; Zhao, Jing; You, Qidong; Jiang, Zhengyu</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101565</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Transcription factor Nuclear factor erythroid 2-related factor 2 (Nrf2) and its neg. regulator, the E3 ligase adaptor Kelch-like ECH-assocd. protein 1 (Keap1), control the redox and metabolic homeostasis and oxidative stress.  Inhibitors of Keap1-Nrf2 interaction are promising in oxidative stress related inflammatory diseases but now hit hurdles.  By utilizing thiazolidinone moiety to shield the key carboxyl pharmacophore in Keap1-Nrf2 inhibitor, a hydrogen peroxide (H2O2)-responsive prodrug pro2 was developed.  The prodrug modification improved the physicochem. properties and cell membrane permeability of the parent drug.  Pro2 was stable and stayed inactive under various physiol. conditions, while became active by stimulation of H2O2 or inflammation derived reactive oxygen species.  Moreover, pro2 exhibited proper pharmacokinetic profile suitable for oral administration and enhanced anti-inflammatory efficiency in vivo.  Thus, this novel prodrug approach may not only provide an important advance in the therapy of chronic inflammatory diseases with high level of H2O2, but also offer a fresh soln. to improve the drug-like and selectivity issues of Keap1-Nrf2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox6NmI2hfYILVg90H21EOLACvtfcHk0ljmz_OtMhC9Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXpsl2ht7o%253D&md5=f110f0d0005af7265e0fde632eca1e88</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2020.101565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2020.101565%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DZ.%26atitle%3DA%2520hydrogen%2520peroxide%2520responsive%2520prodrug%2520of%2520keap1-Nrf2%2520inhibitor%2520for%2520improving%2520oral%2520absorption%2520and%2520selective%2520activation%2520in%2520inflammatory%2520conditions%26jtitle%3DRedox%2520Biol.%26date%3D2020%26volume%3D34%26spage%3D101565%26doi%3D10.1016%2Fj.redox.2020.101565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carden, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granger, D. N.</span></span> <span> </span><span class="NLM_article-title">Pathophysiology of ischaemia-reperfusion injury</span>. <i>J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>190</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">266</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C255%3A%3AAID-PATH526%3E3.0.CO%3B2-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10685060" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitFyiu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=2000&pages=255-266&author=D.+L.+Cardenauthor=D.+N.+Granger&title=Pathophysiology+of+ischaemia-reperfusion+injury&doi=10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C255%3A%3AAID-PATH526%3E3.0.CO%3B2-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Pathophysiology of ischemia-reperfusion injury</span></div><div class="casAuthors">Carden, Donna L.; Granger, D. Neil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pathology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">190</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">255-266</span>CODEN:
                <span class="NLM_cas:coden">JPTLAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-3417</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review with 97 refs.  Reperfusion of ischemic tissues is often assocd. with microvascular dysfunction that is manifested as impaired endothelium-dependent dilation in arterioles, enhanced fluid filtration and leukocyte plugging in capillaries, and the trafficking of leukocytes and plasma protein extravasation in postcapillary venules.  Activated endothelial cells in all segments of the microcirculation produce more oxygen radicals, but less nitric oxide, in the initial period following reperfusion.  The resulting imbalance between superoxide and nitric oxide in endothelial cells leads to the prodn. and release of inflammatory mediators (e.g. platelet-activating factor, tumor necrosis factor) and enhances the biosynthesis of adhesion mols. that mediate leukocyte-endothelial cell adhesion.  Some of the known risk factors for cardiovascular disease (hypercholesterolemia, hypertension, and diabetes) appear to exaggerate many of the microvascular alterations elicited by ischemia and reperfusion (I/R).  The inflammatory mediators released as a consequence of reperfusion also appear to activate endothelial cells in remote organs that are not exposed to the initial ischemic insult.  This distant response to I/R can result in leukocyte-dependent microvascular injury that is characteristic of the multiple organ dysfunction syndrome.  Adaptational responses to I/R injury have been demonstrated that allow for protection of briefly ischemic tissues against the harmful effects of subsequent, prolonged ischemia, a phenomenon called ischemic preconditioning.  There are two temporally and mechanistically distinct types of protection afforded by this adaptational response, i.e. acute and delayed preconditioning.  The factors (e.g. protein kinase C activation) that initiate the acute and delayed preconditioning responses appear to be similar; however the protective effects of acute preconditioning are protein synthesis-independent, while the effects of delayed preconditioning require protein synthesis.  The published literature in this field of investigation suggests that there are several potential targets for therapeutic intervention against I/R-induced microvascular injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYkKxsOvH-vrVg90H21EOLACvtfcHk0ljmz_OtMhC9Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitFyiu7s%253D&md5=1886c207f935ac2b011d0caea179005a</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C255%3A%3AAID-PATH526%3E3.0.CO%3B2-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-9896%2528200002%2529190%253A3%253C255%253A%253AAID-PATH526%253E3.0.CO%253B2-6%26sid%3Dliteratum%253Aachs%26aulast%3DCarden%26aufirst%3DD.%2BL.%26aulast%3DGranger%26aufirst%3DD.%2BN.%26atitle%3DPathophysiology%2520of%2520ischaemia-reperfusion%2520injury%26jtitle%3DJ.%2520Pathol.%26date%3D2000%26volume%3D190%26spage%3D255%26epage%3D266%26doi%3D10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C255%3A%3AAID-PATH526%3E3.0.CO%3B2-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brietske, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bate, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackwood, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glembotski, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooley, C. B.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species (ROS)-activatable prodrug strategy for selective activation of ATF6 following ischemia-reperfusion injury</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">292</span>– <span class="NLM_lpage">297</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.9b00299</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.9b00299" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFWgs7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=292-297&author=J.+E.+Palmerauthor=B.+M.+Brietskeauthor=T.+C.+Bateauthor=E.+A.+Blackwoodauthor=M.+Gargauthor=C.+C.+Glembotskiauthor=C.+B.+Cooley&title=Reactive+oxygen+species+%28ROS%29-activatable+prodrug+strategy+for+selective+activation+of+ATF6+following+ischemia-reperfusion+injury&doi=10.1021%2Facsmedchemlett.9b00299"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive Oxygen Species (ROS)-Activatable Prodrug for Selective Activation of ATF6 after Ischemia/Reperfusion Injury</span></div><div class="casAuthors">Palmer, Jonathan E.; Brietske, Breanna M.; Bate, Tyler C.; Blackwood, Erik A.; Garg, Manasa; Glembotski, Christopher C.; Cooley, Christina B.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">292-297</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors describe here the design, synthesis, and biol. evaluation of a reactive oxygen species (ROS)-activatable prodrug for the selective delivery of 147, a small mol. ATF6 activator, for ischemia/reperfusion injury.  ROS-activatable prodrug 1 and a neg. control unable to release free drug were synthesized and examd. for peroxide-mediated activation.  Prodrug 1 blocks activity of 147 by its inability to undergo metabolic oxidn. by ER-resident cytochrome P 450 enzymes such as Cyp1A2, probed directly here for the first time.  Biol. evaluation of ROS-activatable prodrug 1 in primary cardiomyocytes demonstrates protection against peroxide-mediated toxicity and enhances viability following simulated I/R injury.  The ability to selectively target ATF6 activation under diseased conditions establishes the potential for localized stress-responsive signaling pathway activation as a therapeutic approach for I/R injury and related protein misfolding maladies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqavcfgb7at0LVg90H21EOLACvtfcHk0liAtbPMisnwdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFWgs7fF&md5=12b806d46bc76c1f857f3c1e053c1557</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.9b00299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.9b00299%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DJ.%2BE.%26aulast%3DBrietske%26aufirst%3DB.%2BM.%26aulast%3DBate%26aufirst%3DT.%2BC.%26aulast%3DBlackwood%26aufirst%3DE.%2BA.%26aulast%3DGarg%26aufirst%3DM.%26aulast%3DGlembotski%26aufirst%3DC.%2BC.%26aulast%3DCooley%26aufirst%3DC.%2BB.%26atitle%3DReactive%2520oxygen%2520species%2520%2528ROS%2529-activatable%2520prodrug%2520strategy%2520for%2520selective%2520activation%2520of%2520ATF6%2520following%2520ischemia-reperfusion%2520injury%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26volume%3D11%26spage%3D292%26epage%3D297%26doi%3D10.1021%2Facsmedchemlett.9b00299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samad, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, P. M.</span></span> <span> </span><span class="NLM_article-title">Hydrogen peroxide-activatable antioxidant prodrug as a targeted therapeutic agent for ischemia-reperfusion injury</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">16592</span>, <span class="refDoi"> DOI: 10.1038/srep16592</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1038%2Fsrep16592" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=26563741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A280%3ADC%252BC28visVGhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=16592&author=D.+Leeauthor=S.+Parkauthor=S.+Baeauthor=D.+Jeongauthor=M.+Parkauthor=C.+Kangauthor=W.+Yooauthor=M.+A.+Samadauthor=Q.+Keauthor=G.+Khangauthor=P.+M.+Kang&title=Hydrogen+peroxide-activatable+antioxidant+prodrug+as+a+targeted+therapeutic+agent+for+ischemia-reperfusion+injury&doi=10.1038%2Fsrep16592"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrogen peroxide-activatable antioxidant prodrug as a targeted therapeutic agent for ischemia-reperfusion injury</span></div><div class="casAuthors">Lee Dongwon; Park Seunggyu; Jeong Dahee; Park Minhyung; Kang Changsun; Yoo Wooyoung; Samad Mohammed A; Khang Gilson; Lee Dongwon; Khang Gilson; Bae Soochan; Samad Mohammed A; Ke Qingen; Kang Peter M</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16592</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Overproduction of hydrogen peroxide (H2O2) causes oxidative stress and is the main culprit in the pathogenesis of ischemia/reperfusion (I/R) injury.  Suppression of oxidative stress is therefore critical in the treatment of I/R injury.  Here, we report H2O2-activatable antioxidant prodrug (BRAP) that is capable of specifically targeting the site of oxidative stress and exerting anti-inflammatory and anti-apoptotic activities.  BRAP with a self-immolative boronic ester protecting group was designed to scavenge H2O2 and release HBA (p-hydroxybenzyl alcohol) with antioxidant and anti-inflammatory activities.  BRAP exerted potent antioxidant and anti-inflammatory activity in lipopolysaccharide (LPS)- and H2O2-stimulated cells by suppressing the generation of ROS and pro-inflammatory cytokines.  In mouse models of hepatic I/R and cardiac I/R, BRAP exerted potent antioxidant, anti-inflammatory and anti-apoptotic activities due to the synergistic effects of H2O2-scavenging boronic esters and therapeutic HBA.  In addition, administration of high doses of BRAP daily for 7 days showed no renal or hepatic function abnormalities.  Therefore BRAP has tremendous therapeutic potential as H2O2-activatable antioxidant prodrug for the treatment of I/R injuries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQX6Ce5-kyI5XwOGIfWJ7-GfW6udTcc2eZV8zR9QiTjsLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28visVGhsQ%253D%253D&md5=cdc73f3cd6fb3b1513b402932a410054</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1038%2Fsrep16592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep16592%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DD.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DBae%26aufirst%3DS.%26aulast%3DJeong%26aufirst%3DD.%26aulast%3DPark%26aufirst%3DM.%26aulast%3DKang%26aufirst%3DC.%26aulast%3DYoo%26aufirst%3DW.%26aulast%3DSamad%26aufirst%3DM.%2BA.%26aulast%3DKe%26aufirst%3DQ.%26aulast%3DKhang%26aufirst%3DG.%26aulast%3DKang%26aufirst%3DP.%2BM.%26atitle%3DHydrogen%2520peroxide-activatable%2520antioxidant%2520prodrug%2520as%2520a%2520targeted%2520therapeutic%2520agent%2520for%2520ischemia-reperfusion%2520injury%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D16592%26doi%3D10.1038%2Fsrep16592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M. C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pralle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isacoff, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. J.</span></span> <span> </span><span class="NLM_article-title">A selective, cell-permeable optical probe for hydrogen peroxide in living cells</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">15392</span>– <span class="NLM_lpage">15393</span>, <span class="refDoi"> DOI: 10.1021/ja0441716</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0441716" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptlSju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=15392-15393&author=M.+C.+Y.+Changauthor=A.+Pralleauthor=E.+Y.+Isacoffauthor=C.+J.+Chang&title=A+selective%2C+cell-permeable+optical+probe+for+hydrogen+peroxide+in+living+cells&doi=10.1021%2Fja0441716"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">A selective, cell-permeable optical probe for hydrogen peroxide in living cells</span></div><div class="casAuthors">Chang, Michelle C. Y.; Pralle, Arnd; Isacoff, Ehud Y.; Chang, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">15392-15393</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present the synthesis, properties, and biol. applications of Peroxyfluor-1 (PF1), a new type of optical probe for intracellular imaging of hydrogen peroxide in living biol. samples.  PF1 utilizes a boronate deprotection mechanism to provide unprecedented selectivity and optical dynamic range for detecting H2O2 in aq. soln. over similar reactive oxygen species including superoxide, nitric oxide, tert-Bu hydroperoxide, and hydroxyl radical.  We further demonstrate the value of this reagent for biol. applications by imaging changes in [H2O2] in living mammalian cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZF0Gn9N0dPLVg90H21EOLACvtfcHk0liAtbPMisnwdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptlSju7g%253D&md5=34e25dc64f085d0c3ee8006f15acaa53</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1021%2Fja0441716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0441716%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DM.%2BC.%2BY.%26aulast%3DPralle%26aufirst%3DA.%26aulast%3DIsacoff%26aufirst%3DE.%2BY.%26aulast%3DChang%26aufirst%3DC.%2BJ.%26atitle%3DA%2520selective%252C%2520cell-permeable%2520optical%2520probe%2520for%2520hydrogen%2520peroxide%2520in%2520living%2520cells%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26spage%3D15392%26epage%3D15393%26doi%3D10.1021%2Fja0441716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albers, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pralle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isacoff, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. J.</span></span> <span> </span><span class="NLM_article-title">Boronate-based fluorescent probes for imaging cellular hydrogenperoxide</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">16652</span>– <span class="NLM_lpage">16659</span>, <span class="refDoi"> DOI: 10.1021/ja054474f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja054474f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFynurjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=16652-16659&author=E.+W.+Millerauthor=A.+E.+Albersauthor=A.+Pralleauthor=E.+Y.+Isacoffauthor=C.+J.+Chang&title=Boronate-based+fluorescent+probes+for+imaging+cellular+hydrogenperoxide&doi=10.1021%2Fja054474f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Boronate-Based Fluorescent Probes for Imaging Cellular Hydrogen Peroxide</span></div><div class="casAuthors">Miller, Evan W.; Albers, Aaron E.; Pralle, Arnd; Isacoff, Ehud Y.; Chang, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">16652-16659</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The syntheses, properties, and biol. applications of the Peroxysensor family, a new class of fluorescent probes for hydrogen peroxide, are presented.  These reagents utilize a boronate deprotection mechanism to provide high selectivity and optical dynamic range for detecting H2O2 in aq. soln. over similar reactive oxygen species (ROS) including superoxide, nitric oxide, tert-Bu hydroperoxide, hypochlorite, singlet oxygen, ozone, and hydroxyl radical.  Peroxyresorufin-1 (PR1), Peroxyfluor-1 (PF1), and Peroxyxanthone-1 (PX1) are first-generation probes that respond to H2O2 by an increase in red, green, and blue fluorescence, resp.  The boronate dyes are cell-permeable and can detect micromolar changes in H2O2 concns. in living cells, including hippocampal neurons, using confocal microscopy and two-photon microscopy.  The unique combination of ROS selectivity, membrane permeability, and a range of available excitation/emission colors establishes the potential value of PR1, PF1, PX1, and related probes for interrogating the physiol. and pathol. of cellular H2O2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9KOzj_MCKJrVg90H21EOLACvtfcHk0liXTA8zJkmfqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFynurjL&md5=14aed1a610be89ae600a6daa27931cc5</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1021%2Fja054474f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja054474f%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DE.%2BW.%26aulast%3DAlbers%26aufirst%3DA.%2BE.%26aulast%3DPralle%26aufirst%3DA.%26aulast%3DIsacoff%26aufirst%3DE.%2BY.%26aulast%3DChang%26aufirst%3DC.%2BJ.%26atitle%3DBoronate-based%2520fluorescent%2520probes%2520for%2520imaging%2520cellular%2520hydrogenperoxide%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D16652%26epage%3D16659%26doi%3D10.1021%2Fja054474f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tulyathan, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isacoff, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. J.</span></span> <span> </span><span class="NLM_article-title">Molecular imaging of hydrogen peroxide produced for cell signaling</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">267</span>, <span class="refDoi"> DOI: 10.1038/nchembio871</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1038%2Fnchembio871" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=17401379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkt1Gqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=263-267&author=E.+W.+Millerauthor=O.+Tulyathanauthor=E.+Y.+Isacoffauthor=C.+J.+Chang&title=Molecular+imaging+of+hydrogen+peroxide+produced+for+cell+signaling&doi=10.1038%2Fnchembio871"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular imaging of hydrogen peroxide produced for cell signaling</span></div><div class="casAuthors">Miller, Evan W.; Tulyanthan, Orapim; Isacoff, Ehud Y.; Chang, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">263-267</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hydrogen peroxide (H2O2) is emerging as a newly recognized messenger in cellular signal transduction.  However, a substantial challenge in elucidating its diverse roles in complex biol. environments is the lack of methods for probing this reactive oxygen metabolite in living systems with mol. specificity.  Here the authors report the synthesis and application of Peroxy Green 1 (PG1) and Peroxy Crimson 1 (PC1), two new fluorescent probes that show high selectivity for H2O2 and are capable of visualizing endogenous H2O2 produced in living cells by growth factor stimulation, including the first direct imaging of peroxide produced for brain cell signaling.  The combined features of reactive oxygen species selectivity, sensitivity to signaling levels of H2O2, and live-cell compatibility presage many new opportunities for PG1, PC1 and related synthetic reagents for exploring the physiol. roles of H2O2 in living systems with mol. imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxJrTop8-yYLVg90H21EOLACvtfcHk0liXTA8zJkmfqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkt1Gqu7c%253D&md5=ae003fc21a8a456bebc9c4337ab057c5</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1038%2Fnchembio871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio871%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DE.%2BW.%26aulast%3DTulyathan%26aufirst%3DO.%26aulast%3DIsacoff%26aufirst%3DE.%2BY.%26aulast%3DChang%26aufirst%3DC.%2BJ.%26atitle%3DMolecular%2520imaging%2520of%2520hydrogen%2520peroxide%2520produced%2520for%2520cell%2520signaling%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2007%26volume%3D3%26spage%3D263%26epage%3D267%26doi%3D10.1038%2Fnchembio871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avshalumov, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, M. E.</span></span> <span> </span><span class="NLM_article-title">Mitochondria are the source of hydrogen peroxide for dynamic brain-cell signaling</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">9002</span>– <span class="NLM_lpage">9010</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.1706-09.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1523%2FJNEUROSCI.1706-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=19605638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovFegur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=9002-9010&author=L.+Baoauthor=M.+V.+Avshalumovauthor=J.+C.+Patelauthor=C.+R.+Leeauthor=E.+W.+Millerauthor=C.+J.+Changauthor=M.+E.+Rice&title=Mitochondria+are+the+source+of+hydrogen+peroxide+for+dynamic+brain-cell+signaling&doi=10.1523%2FJNEUROSCI.1706-09.2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria are the source of hydrogen peroxide for dynamic brain-cell signaling</span></div><div class="casAuthors">Bao, Li; Avshalumov, Marat V.; Patel, Jyoti C.; Lee, Christian R.; Miller, Evan W.; Chang, Christopher J.; Rice, Margaret E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">9002-9010</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Hydrogen peroxide (H2O2) is emerging as a ubiquitous small-mol. messenger in biol., particularly in the brain, but underlying mechanisms of peroxide signaling remain an open frontier for study.  For example, dynamic dopamine transmission in dorsolateral striatum is regulated on a subsecond timescale by glutamate via H2O2 signaling, which activates ATP-sensitive potassium (KATP) channels to inhibit dopamine release.  However, the origin of this modulatory H2O2 has been elusive.  Here we addressed three possible sources of H2O2 produced for rapid neuronal signaling in striatum: mitochondrial respiration, monoamine oxidase (MAO), and NADPH oxidase (Nox).  Evoked dopamine release in guinea-pig striatal slices was monitored with carbon-fiber microelectrodes and fast-scan cyclic voltammetry.  Using direct fluorescence imaging of H2O2 and tissue anal. of ATP, we found that coapplication of rotenone (50 nM), a mitochondrial complex I inhibitor, and succinate (5 mM), a complex II substrate, limited H2O2 prodn., but maintained tissue ATP content.  Strikingly, coapplication of rotenone and succinate also prevented glutamate-dependent regulation of dopamine release, implicating mitochondrial H2O2 in release modulation.  In contrast, inhibitors of MAO or Nox had no effect on dopamine release, suggesting a limited role for these metabolic enzymes in rapid H2O2 prodn. in the striatum.  These data provide the first demonstration that respiring mitochondria are the primary source of H2O2 generation for dynamic neuronal signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraJ4IEc8DCy7Vg90H21EOLACvtfcHk0liXTA8zJkmfqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovFegur0%253D&md5=c31380b2054d2a848b7f3543ee563310</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1706-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1706-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DBao%26aufirst%3DL.%26aulast%3DAvshalumov%26aufirst%3DM.%2BV.%26aulast%3DPatel%26aufirst%3DJ.%2BC.%26aulast%3DLee%26aufirst%3DC.%2BR.%26aulast%3DMiller%26aufirst%3DE.%2BW.%26aulast%3DChang%26aufirst%3DC.%2BJ.%26aulast%3DRice%26aufirst%3DM.%2BE.%26atitle%3DMitochondria%2520are%2520the%2520source%2520of%2520hydrogen%2520peroxide%2520for%2520dynamic%2520brain-cell%2520signaling%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D9002%26epage%3D9010%26doi%3D10.1523%2FJNEUROSCI.1706-09.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dickinson, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srikun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. J.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial-targeted fluorescent probes for reactive oxygen species</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2009.10.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.cbpa.2009.10.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=19910238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht12qt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2010&pages=50-56&author=B.+C.+Dickinsonauthor=D.+Srikunauthor=C.+J.+Chang&title=Mitochondrial-targeted+fluorescent+probes+for+reactive+oxygen+species&doi=10.1016%2Fj.cbpa.2009.10.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial-targeted fluorescent probes for reactive oxygen species</span></div><div class="casAuthors">Dickinson, Bryan C.; Srikun, Duangkhae; Chang, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-56</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  As the primary consumers of oxygen within all aerobic organisms, mitochondria are a major source of cellular reactive oxygen species (ROS) derived from the in vivo chem. of oxygen metab.  Mitochondrial ROS were traditionally implicated in aging and in a variety of pathologies, including cancer, neurodegeneration, and diabetes, but recent studies also link controlled mitochondrial ROS fluxes to cell regulation and signaling events.  Progress in the development of mitochondrial-targeted fluorescent small-mol. indicators that detect specific ROS with high selectivity offers a promising approach for interrogating mitochondrial ROS prodn., trafficking, and downstream biol. effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD9WekX1XZ1rVg90H21EOLACvtfcHk0liXTA8zJkmfqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht12qt7c%253D&md5=940b9fc2993ab0fcf1d7070c65ca73dd</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2009.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2009.10.014%26sid%3Dliteratum%253Aachs%26aulast%3DDickinson%26aufirst%3DB.%2BC.%26aulast%3DSrikun%26aufirst%3DD.%26aulast%3DChang%26aufirst%3DC.%2BJ.%26atitle%3DMitochondrial-targeted%2520fluorescent%2520probes%2520for%2520reactive%2520oxygen%2520species%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D14%26spage%3D50%26epage%3D56%26doi%3D10.1016%2Fj.cbpa.2009.10.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Modica-Napolitano, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aprille, J. R.</span></span> <span> </span><span class="NLM_article-title">Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1016/S0169-409X(01)00125-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2FS0169-409X%2801%2900125-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=11377803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjslSmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2001&pages=63-70&author=J.+S.+Modica-Napolitanoauthor=J.+R.+Aprille&title=Delocalized+lipophilic+cations+selectively+target+the+mitochondria+of+carcinoma+cells&doi=10.1016%2FS0169-409X%2801%2900125-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells</span></div><div class="casAuthors">Modica-Napolitano, J. S.; Aprille, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">63-70</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 65 refs.  Traditional chemotherapies, aimed at DNA replication in rapidly dividing cells, have achieved only limited success in the treatment of carcinomas due largely to their lack of specificity for cells of tumorigenic origin.  It is important, therefore, to investigate treatment strategies aimed at novel cellular targets that are sufficiently different between normal cells and cancer cells so as to provide a basis for selective tumor cell killing.  Delocalized lipophilic cations (DLCs) are concd. by cells and into mitochondria in response to neg. inside transmembrane potentials.  The higher plasma and/or mitochondrial membrane potentials of carcinoma cells compared to normal epithelial cells account for the selective accumulation of DLCs in carcinoma mitochondria.  Since most DLCs are toxic to mitochondria at high concns., their selective accumulation in carcinoma mitochondria and consequent mitochondrial toxicity provide a basis for selective carcinoma cell killing.  Several of these compds. have already displayed some degree of efficacy as chemotherapeutic agents in vitro and in vivo.  The effectiveness of DLCs can also be enhanced by their use in photochemotherapy or combination drug therapy.  Discovery of the biochem. differences that account for the higher membrane potentials in carcinoma cells is expected to lead to the design of new DLCs targeted specifically to those differences, resulting in even greater selectivity and efficacy for tumor cell killing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGsWwMDH5OBLVg90H21EOLACvtfcHk0lhtuVM1K3suHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjslSmtLk%253D&md5=47f1fea1d9ede2b916903e36e9bbff66</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2801%2900125-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252801%252900125-9%26sid%3Dliteratum%253Aachs%26aulast%3DModica-Napolitano%26aufirst%3DJ.%2BS.%26aulast%3DAprille%26aufirst%3DJ.%2BR.%26atitle%3DDelocalized%2520lipophilic%2520cations%2520selectively%2520target%2520the%2520mitochondria%2520of%2520carcinoma%2520cells%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2001%26volume%3D49%26spage%3D63%26epage%3D70%26doi%3D10.1016%2FS0169-409X%2801%2900125-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dickinson, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. J.</span></span> <span> </span><span class="NLM_article-title">A targetable fluorescent probe for imaging hydrogen peroxide in the mitochondria of living cells</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">9638</span>– <span class="NLM_lpage">9639</span>, <span class="refDoi"> DOI: 10.1021/ja802355u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja802355u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD1cXot1ahs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=9638-9639&author=B.+C.+Dickinsonauthor=C.+J.+Chang&title=A+targetable+fluorescent+probe+for+imaging+hydrogen+peroxide+in+the+mitochondria+of+living+cells&doi=10.1021%2Fja802355u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">A Targetable Fluorescent Probe for Imaging Hydrogen Peroxide in the Mitochondria of Living Cells</span></div><div class="casAuthors">Dickinson, Bryan C.; Chang, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">9638-9639</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors present the design, synthesis, and biol. applications of mitochondria peroxy yellow 1 (MitoPY1), a new type of bifunctional fluorescent probe for imaging hydrogen peroxide levels within the mitochondria of living cells.  MitoPY1 combines a chemoselective boronate-based switch and a mitochondrial-targeting phosphonium moiety for detection of hydrogen peroxide localized to cellular mitochondria.  Confocal microscopy and flow cytometry expts. in a variety of mammalian cell types show that MitoPY1 can visualize localized changes in mitochondrial hydrogen peroxide concns. generated by situations of oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou7Tz0cd9NKbVg90H21EOLACvtfcHk0lhtuVM1K3suHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXot1ahs74%253D&md5=3f5c82fa985bb525238691160b6c8ecc</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1021%2Fja802355u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja802355u%26sid%3Dliteratum%253Aachs%26aulast%3DDickinson%26aufirst%3DB.%2BC.%26aulast%3DChang%26aufirst%3DC.%2BJ.%26atitle%3DA%2520targetable%2520fluorescent%2520probe%2520for%2520imaging%2520hydrogen%2520peroxide%2520in%2520the%2520mitochondria%2520of%2520living%2520cells%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D9638%26epage%3D9639%26doi%3D10.1021%2Fja802355u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masanta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heo, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. M.</span></span> <span> </span><span class="NLM_article-title">A mitochondria-localized two-photon fluorescent probe for ratiometric imaging of hydrogen peroxide in live tissue</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">3518</span>– <span class="NLM_lpage">3520</span>, <span class="refDoi"> DOI: 10.1039/c2cc00034b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1039%2Fc2cc00034b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=22382302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Wkt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2012&pages=3518-3520&author=G.+Masantaauthor=C.+H.+Heoauthor=C.+S.+Limauthor=S.+K.+Baeauthor=B.+R.+Choauthor=H.+M.+Kim&title=A+mitochondria-localized+two-photon+fluorescent+probe+for+ratiometric+imaging+of+hydrogen+peroxide+in+live+tissue&doi=10.1039%2Fc2cc00034b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">A mitochondria-localized two-photon fluorescent probe for ratiometric imaging of hydrogen peroxide in live tissue</span></div><div class="casAuthors">Masanta, Goutam; Heo, Cheol Ho; Lim, Chang Su; Bae, Sung Keun; Cho, Bong Rae; Kim, Hwan Myung</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">3518-3520</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The authors report a two-photon fluorescent probe (SHP-Mito) which can ratiometrically detect mitochondrial H2O2 in live cells and intact tissues at >100 μm depth through the use of two-photon microscopy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6yA-LCzPEBrVg90H21EOLACvtfcHk0lhtuVM1K3suHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Wkt7s%253D&md5=ffbcf82155f83ebf45e773bb494f2510</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1039%2Fc2cc00034b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2cc00034b%26sid%3Dliteratum%253Aachs%26aulast%3DMasanta%26aufirst%3DG.%26aulast%3DHeo%26aufirst%3DC.%2BH.%26aulast%3DLim%26aufirst%3DC.%2BS.%26aulast%3DBae%26aufirst%3DS.%2BK.%26aulast%3DCho%26aufirst%3DB.%2BR.%26aulast%3DKim%26aufirst%3DH.%2BM.%26atitle%3DA%2520mitochondria-localized%2520two-photon%2520fluorescent%2520probe%2520for%2520ratiometric%2520imaging%2520of%2520hydrogen%2520peroxide%2520in%2520live%2520tissue%26jtitle%3DChem.%2520Commun.%26date%3D2012%26volume%3D48%26spage%3D3518%26epage%3D3520%26doi%3D10.1039%2Fc2cc00034b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span> <span> </span><span class="NLM_article-title">A NIR fluorescent probe: imaging endogenous hydrogen peroxide during an autophagy process induced by rapamycin</span>. <i>J. Mater. Chem. B</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">7363</span>– <span class="NLM_lpage">7367</span>, <span class="refDoi"> DOI: 10.1039/C6TB02463G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1039%2FC6TB02463G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=32263736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslaltLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2016&pages=7363-7367&author=F.+Xuauthor=H.+Liauthor=Q.+Yaoauthor=J.+Fanauthor=J.+Wangauthor=X.+Peng&title=A+NIR+fluorescent+probe%3A+imaging+endogenous+hydrogen+peroxide+during+an+autophagy+process+induced+by+rapamycin&doi=10.1039%2FC6TB02463G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">A NIR fluorescent probe: imaging endogenous hydrogen peroxide during an autophagy process induced by rapamycin</span></div><div class="casAuthors">Xu, Feng; Li, Haidong; Yao, Qichao; Fan, Jiangli; Wang, Jingyun; Peng, Xiaojun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Materials Chemistry B: Materials for Biology and Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">7363-7367</span>CODEN:
                <span class="NLM_cas:coden">JMCBDV</span>;
        ISSN:<span class="NLM_cas:issn">2050-7518</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A near-IR probe (Cy-B) with high sensitivity, and good specificity as well as photo-stability has been developed for monitoring both exogenous and endogenous H2O2 in living cells.  To the best of the authors' knowledge, it was applied successfully for the first time to monitor spontaneous hydrogen peroxide in an autophagy process induced by the stimulation of rapamycin.  The mice imaging expts. indicate that the probe has a good potential to be employed in the imaging of living biol. systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQOUHBMGVkLrVg90H21EOLACvtfcHk0lhtuVM1K3suHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslaltLvL&md5=0c8f9f964a286b66d6fd52526c2a44e9</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1039%2FC6TB02463G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6TB02463G%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DYao%26aufirst%3DQ.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPeng%26aufirst%3DX.%26atitle%3DA%2520NIR%2520fluorescent%2520probe%253A%2520imaging%2520endogenous%2520hydrogen%2520peroxide%2520during%2520an%2520autophagy%2520process%2520induced%2520by%2520rapamycin%26jtitle%3DJ.%2520Mater.%2520Chem.%2520B%26date%3D2016%26volume%3D4%26spage%3D7363%26epage%3D7367%26doi%3D10.1039%2FC6TB02463G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, Y.</span></span> <span> </span><span class="NLM_article-title">An ESIPT-based mitochondria-targeted ratiometric and NIR-emitting fluorescent probe for hydrogen peroxide and its bioimaging in living cells</span>. <i>Dyes Pigm.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>158</i></span>,  <span class="NLM_fpage">482</span>– <span class="NLM_lpage">489</span>, <span class="refDoi"> DOI: 10.1016/j.dyepig.2017.12.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.dyepig.2017.12.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVaqu77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2018&pages=482-489&author=L.+Tangauthor=M.+Tianauthor=H.+Chenauthor=X.+Yanauthor=K.+Zhongauthor=Y.+Bian&title=An+ESIPT-based+mitochondria-targeted+ratiometric+and+NIR-emitting+fluorescent+probe+for+hydrogen+peroxide+and+its+bioimaging+in+living+cells&doi=10.1016%2Fj.dyepig.2017.12.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">An ESIPT-based mitochondria-targeted ratiometric and NIR-emitting fluorescent probe for hydrogen peroxide and its bioimaging in living cells</span></div><div class="casAuthors">Tang, Lijun; Tian, Mingyu; Chen, Haibo; Yan, Xiaomei; Zhong, Keli; Bian, Yanjiang</div><div class="citationInfo"><span class="NLM_cas:title">Dyes and Pigments</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">482-489</span>CODEN:
                <span class="NLM_cas:coden">DYPIDX</span>;
        ISSN:<span class="NLM_cas:issn">0143-7208</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A mitochondria-targetable ratiometric fluorescent probe, HBTPB, has been developed for the detection of H2O2 with a near IR (NIR) emission and a large Stokes shift (357 nm).  Probe HBTPB displays high selectivity toward H2O2 over other reactive oxygen/nitrogen species (ROS/RNS), biol. thiols and anions.  The detection limit of this probe is as low as 5.9 × 10-7 M.  The sensing process confirmed by NMR and mass spectral anal. shows that the addn. of H2O2 to the soln. of HBTPB triggers an oxidative hydrolysis and a subsequent elimination reaction undergoes to release an ESIPT (excited-state intramol. proton transfer) featured fluorescent dye.  Probe HBTPB is cell permeable and has been applied to sense exogenous and endogenous H2O2 in living A549 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUraQUkUQb67Vg90H21EOLACvtfcHk0li99laiYnwkZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVaqu77N&md5=5551b71907554fd52418e6dbd7124a1d</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1016%2Fj.dyepig.2017.12.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dyepig.2017.12.028%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DL.%26aulast%3DTian%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DZhong%26aufirst%3DK.%26aulast%3DBian%26aufirst%3DY.%26atitle%3DAn%2520ESIPT-based%2520mitochondria-targeted%2520ratiometric%2520and%2520NIR-emitting%2520fluorescent%2520probe%2520for%2520hydrogen%2520peroxide%2520and%2520its%2520bioimaging%2520in%2520living%2520cells%26jtitle%3DDyes%2520Pigm.%26date%3D2018%26volume%3D158%26spage%3D482%26epage%3D489%26doi%3D10.1016%2Fj.dyepig.2017.12.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span> <span> </span><span class="NLM_article-title">A mitochondria-targeted colorimetric and ratiometric fluorescent probe for hydrogen peroxide with a large emission shift and bio-imaging in living cells</span>. <i>Sens. Actuators, B</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>255</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1016/j.snb.2017.08.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.snb.2017.08.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlartbfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=255&publication_year=2018&pages=42-48&author=Y.+Shenauthor=X.+Zhangauthor=Y.+Zhangauthor=Y.+Wuauthor=C.+Zhangauthor=Y.+Chenauthor=J.+Jinauthor=H.+Li&title=A+mitochondria-targeted+colorimetric+and+ratiometric+fluorescent+probe+for+hydrogen+peroxide+with+a+large+emission+shift+and+bio-imaging+in+living+cells&doi=10.1016%2Fj.snb.2017.08.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">A mitochondria-targeted colorimetric and ratiometric fluorescent probe for hydrogen peroxide with a large emission shift and bio-imaging in living cells</span></div><div class="casAuthors">Shen, Youming; Zhang, Xiangyang; Zhang, Youyu; Wu, Yanyang; Zhang, Chunxiang; Chen, Yuandao; Jin, Junling; Li, Haitao</div><div class="citationInfo"><span class="NLM_cas:title">Sensors and Actuators, B: Chemical</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">255</span>
        (<span class="NLM_cas:issue">Part_1</span>),
    <span class="NLM_cas:pages">42-48</span>CODEN:
                <span class="NLM_cas:coden">SABCEB</span>;
        ISSN:<span class="NLM_cas:issn">0925-4005</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel mitochondria-targeted fluorescent probe compd. 1 for H2O2 has constructed based on a coumarin as the fluorophore and a boronate moiety as the reaction site, which showed colorimetric and ratiometric fluorescence dual response to H2O2.  This probe displayed a large blue-shifted in emission wavelength (105 nm) with two well-resolved emission bands toward hydrogen peroxide.  The compd. 1 can be quant., good selective and sensitive recognition to H2O2 with low detection limit (10 nM).  The sensing mechanism was confirmed by H NMR and HRMS spectroscopy.  The mechanism regarding the optical responses of the compd. 1 toward H2O2 was also detd. by d. function theory (DFT) calcns.  Moreover, the probe could be used for detg. H2O2 in living cells by ratiometric fluorescence imaging with excellent mitochondrial targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopV7AsavHjaLVg90H21EOLACvtfcHk0li99laiYnwkZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlartbfI&md5=5752421b91b079da1ec047d129f7da00</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2Fj.snb.2017.08.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.snb.2017.08.020%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DH.%26atitle%3DA%2520mitochondria-targeted%2520colorimetric%2520and%2520ratiometric%2520fluorescent%2520probe%2520for%2520hydrogen%2520peroxide%2520with%2520a%2520large%2520emission%2520shift%2520and%2520bio-imaging%2520in%2520living%2520cells%26jtitle%3DSens.%2520Actuators%252C%2520B%26date%3D2018%26volume%3D255%26spage%3D42%26epage%3D48%26doi%3D10.1016%2Fj.snb.2017.08.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span> <span> </span><span class="NLM_article-title">A mitochondria-targeting ratiometric fluorescent probe for imaging hydrogen peroxide with long-wavelength emission and large stokes shift</span>. <i>Sens. Actuators, B</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">253</span>, <span class="refDoi"> DOI: 10.1016/j.snb.2018.08.119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.snb.2018.08.119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1Cgsr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2018&pages=247-253&author=L.+Heauthor=X.+Liuauthor=Y.+Zhangauthor=L.+Yangauthor=Q.+Fangauthor=Y.+Gengauthor=W.+Chenauthor=X.+Song&title=A+mitochondria-targeting+ratiometric+fluorescent+probe+for+imaging+hydrogen+peroxide+with+long-wavelength+emission+and+large+stokes+shift&doi=10.1016%2Fj.snb.2018.08.119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">A mitochondria-targeting ratiometric fluorescent probe for imaging hydrogen peroxide with long-wavelength emission and large Stokes shift</span></div><div class="casAuthors">He, Long; Liu, Xingjiang; Zhang, Yun; Yang, Lei; Fang, Qian; Geng, Yani; Chen, Wenqiang; Song, Xiangzhi</div><div class="citationInfo"><span class="NLM_cas:title">Sensors and Actuators, B: Chemical</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">247-253</span>CODEN:
                <span class="NLM_cas:coden">SABCEB</span>;
        ISSN:<span class="NLM_cas:issn">0925-4005</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hydrogen peroxide, one of the curial reactive oxygen species, is believed to involve in a wide range of physiol. processes.  In this work, we designed and synthesized a new fluorescent probe, HKB, for the detection of hydrogen peroxide, by taking advantage of the combination of ICT and ESIPT mechanisms.  Different from other benzothiazole-based ratiometric probes, the intramol. ESIPT process is preserved in probe HKB and the large Stokes shift is remained.  Probe HKB displayed significant ratiometric fluorescence variations (I594nm/ I666nm) upon the addn. of 50 equiv. of hydrogen peroxide under a single-wavelength excitation at 440 nm in PBS buffer (pH = 7.0, 10 mM, 30% CH3CN) and showed a large Stokes shift change from 102 nm to 254 nm.  Moreover, this probe exhibited excellent mitochondria targeting property with a 0.94 Pearson's colocalization coeff. using Rh123 as a ref.  Gratifyingly, preliminary biol. expts. indicated that probe HKB could sense both the exogenous and endogenous hydrogen peroxide in living HeLa cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsrfQ_wpvmUbVg90H21EOLACvtfcHk0li99laiYnwkZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1Cgsr3E&md5=8b2b6956268c08afe229170745fcd8d9</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1016%2Fj.snb.2018.08.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.snb.2018.08.119%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DFang%26aufirst%3DQ.%26aulast%3DGeng%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DSong%26aufirst%3DX.%26atitle%3DA%2520mitochondria-targeting%2520ratiometric%2520fluorescent%2520probe%2520for%2520imaging%2520hydrogen%2520peroxide%2520with%2520long-wavelength%2520emission%2520and%2520large%2520stokes%2520shift%26jtitle%3DSens.%2520Actuators%252C%2520B%26date%3D2018%26volume%3D276%26spage%3D247%26epage%3D253%26doi%3D10.1016%2Fj.snb.2018.08.119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span> <span> </span><span class="NLM_article-title">A doubly-quenched fluorescent probe for low-background detection of mitochondrial H<sub>2</sub>O<sub>2</sub></span>. <i>Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">6902</span>– <span class="NLM_lpage">6909</span>, <span class="refDoi"> DOI: 10.1021/acs.analchem.9b01294</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.analchem.9b01294" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1MXot1yjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2019&pages=6902-6909&author=J.+Liuauthor=J.+Liangauthor=C.+Wuauthor=Y.+Zhao&title=A+doubly-quenched+fluorescent+probe+for+low-background+detection+of+mitochondrial+H2O2&doi=10.1021%2Facs.analchem.9b01294"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">A Doubly-Quenched Fluorescent Probe for Low-Background Detection of Mitochondrial H2O2</span></div><div class="casAuthors">Liu, Jun; Liang, Jingjing; Wu, Chuanliu; Zhao, Yibing</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">6902-6909</span>CODEN:
                <span class="NLM_cas:coden">ANCHAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2700</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hydrogen peroxide (H2O2) is an important product of oxygen metab. which plays a crucial role in regulating a variety of cellular functions.  Fluorescent probes have made a great contribution to the understanding of the biol. role of endogenous H2O2.  However, while the first-generation fluorescent probes for H2O2 featuring dual aryl boronates show large turn-on fluorescence responses but slow response kinetics, the second-generation probes featuring monoboronate, on the contrary, show rapid response kinetics but moderate turn-on fluorescence responses.  A general strategy that can reduce the background fluorescence of these boronate-masked probes would significantly improve the sensitivity of the endogenous H2O2 detection.  In this work, the authors proposed a general and reliable double-quenching concept for the design of fluorescent probes with low-background fluorescence.  A new fluorescent probe was developed for the detection of endogenous H2O2 in mitochondria of live cancer cells.  This probe exploits a boronate-driven lactam formation and an eliminable quenching moiety simultaneously (i.e., the doubly-quenching effect) to reduce the background fluorescence, which ultimately results in the achievement of a >50-fold fluorescence turn-on.  This study not only presents a highly sensitive fluorescent probe for the detection of H2O2, but provides a new concept for the design of fluorescent probes with a previously unachievable fluorescence off-on response ratio for other types of ROS and many other biol. relevant analytes.  The authors believe that this work would greatly benefit the development of new-generation fluorescent probes with large turn-on responses and the reliable application of these probes in complex living systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFlMGcbVU9jrVg90H21EOLACvtfcHk0ljhi8_gCIMAwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXot1yjtLo%253D&md5=08982a5c89fcf7996eb35d2878a6b0cc</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1021%2Facs.analchem.9b01294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.analchem.9b01294%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DY.%26atitle%3DA%2520doubly-quenched%2520fluorescent%2520probe%2520for%2520low-background%2520detection%2520of%2520mitochondrial%2520H2O2%26jtitle%3DAnal.%2520Chem.%26date%3D2019%26volume%3D91%26spage%3D6902%26epage%3D6909%26doi%3D10.1021%2Facs.analchem.9b01294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jing, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">A mitochondria-targeting highly specific fluorescent probe for fast sensing of endogenous peroxynitrite in living cells</span>. <i>Sens. Actuators, B</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>303</i></span>,  <span class="NLM_fpage">127284</span>, <span class="refDoi"> DOI: 10.1016/j.snb.2019.127284</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.snb.2019.127284" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvF2ltL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2020&pages=127284&author=W.+Shuauthor=Y.+Wuauthor=S.+Zangauthor=S.+Suauthor=H.+Kangauthor=J.+Jingauthor=X.+Zhang&title=A+mitochondria-targeting+highly+specific+fluorescent+probe+for+fast+sensing+of+endogenous+peroxynitrite+in+living+cells&doi=10.1016%2Fj.snb.2019.127284"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">A mitochondria-targeting highly specific fluorescent probe for fast sensing of endogenous peroxynitrite in living cells</span></div><div class="casAuthors">Shu, Wei; Wu, Yulong; Zang, Shunping; Su, Sa; Kang, Hao; Jing, Jing; Zhang, Xiaoling</div><div class="citationInfo"><span class="NLM_cas:title">Sensors and Actuators, B: Chemical</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">127284</span>CODEN:
                <span class="NLM_cas:coden">SABCEB</span>;
        ISSN:<span class="NLM_cas:issn">0925-4005</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Peroxynitrite (ONOO-), an endogenous reactive oxygen species, acts an important role in various physiol. and pathol. processes.  Herein, we designed a mitochondria targeting fluorescent probe MBTBE for sensitive detn. of ONOO-.  MBTBE exhibits rapid response (less than 1 min) and high selectivity towards peroxynitrite with distinct color changing (colorless to orange).  The fluorescence intensity at 569 nm was linearly correlated with the concn. of ONOO- (0-10μM) with a detection limit of 16 nM.  Addnl., MBTBE possesses good biocompatibility and mitochondria-targeting.  Furthermore, MBTBE was successfully applied to monitor fluctuations in ONOO-levels and H2S-induced ONOO- clearing in HeLa cells, indicating excellent potential applications in bioanal. anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobh2udv3fexLVg90H21EOLACvtfcHk0ljhi8_gCIMAwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvF2ltL3P&md5=b924a78f73e70525a4b15d4fbc690903</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2Fj.snb.2019.127284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.snb.2019.127284%26sid%3Dliteratum%253Aachs%26aulast%3DShu%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZang%26aufirst%3DS.%26aulast%3DSu%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DJing%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DA%2520mitochondria-targeting%2520highly%2520specific%2520fluorescent%2520probe%2520for%2520fast%2520sensing%2520of%2520endogenous%2520peroxynitrite%2520in%2520living%2520cells%26jtitle%3DSens.%2520Actuators%252C%2520B%26date%3D2020%26volume%3D303%26spage%3D127284%26doi%3D10.1016%2Fj.snb.2019.127284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dielschneider, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henson, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, S. B.</span></span> <span> </span><span class="NLM_article-title">Lysosomes as oxidative targets for cancer therapy</span>. <i>Oxid. Med. Cell. Longevity</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2017</i></span>,  <span class="NLM_fpage">3749157</span>, <span class="refDoi"> DOI: 10.1155/2017/3749157</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1155%2F2017%2F3749157" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=28757908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A280%3ADC%252BC1cfisFKhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2017&publication_year=2017&pages=3749157&author=D.+F.+Dielschneiderauthor=E.+S.+Hensonauthor=S.+B.+Gibson&title=Lysosomes+as+oxidative+targets+for+cancer+therapy&doi=10.1155%2F2017%2F3749157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosomes as Oxidative Targets for Cancer Therapy</span></div><div class="casAuthors">Dielschneider Rebecca F; Henson Elizabeth S; Gibson Spencer B</div><div class="citationInfo"><span class="NLM_cas:title">Oxidative medicine and cellular longevity</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">2017</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3749157</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Lysosomes are membrane-bound vesicles that contain hydrolases for the degradation and recycling of essential nutrients to maintain homeostasis within cells.  Cancer cells have increased lysosomal function to proliferate, metabolize, and adapt to stressful environments.  This has made cancer cells susceptible to lysosomal membrane permeabilization (LMP).  There are many factors that mediate LMP such as Bcl-2 family member, p53; sphingosine; and oxidative stress which are often altered in cancer.  Upon lysosomal disruption, reactive oxygen species (ROS) levels increase leading to lipid peroxidation, mitochondrial dysfunction, autophagy, and reactive iron.  Cathepsins are also released causing degradation of macromolecules and cellular structures.  This ultimately kills the cancer cell through different types of cell death (apoptosis, autosis, or ferroptosis).  In this review, we will explore the contributions lysosomes play in inducing cell death, how this is regulated by ROS in cancer, and how lysosomotropic agents might be utilized to treat cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSYuVDJjxZ6HthSDZx9hyjKfW6udTcc2ebLZaql4Vommbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfisFKhtw%253D%253D&md5=bf3ccf14c0170fed6177cf86567d2684</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1155%2F2017%2F3749157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2017%252F3749157%26sid%3Dliteratum%253Aachs%26aulast%3DDielschneider%26aufirst%3DD.%2BF.%26aulast%3DHenson%26aufirst%3DE.%2BS.%26aulast%3DGibson%26aufirst%3DS.%2BB.%26atitle%3DLysosomes%2520as%2520oxidative%2520targets%2520for%2520cancer%2520therapy%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longevity%26date%3D2017%26volume%3D2017%26spage%3D3749157%26doi%3D10.1155%2F2017%2F3749157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minakaki, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krainc, D.</span></span> <span> </span><span class="NLM_article-title">Perserving lysosomal function in the aging brain: insights from neurodegeneration</span>. <i>Neurotherapeutics</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">611</span>– <span class="NLM_lpage">634</span>, <span class="refDoi"> DOI: 10.1007/s13311-019-00742-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1007%2Fs13311-019-00742-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=31183763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A280%3ADC%252BB3M3lt1egtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=611-634&author=W.+Pengauthor=G.+Minakakiauthor=M.+Nguyenauthor=D.+Krainc&title=Perserving+lysosomal+function+in+the+aging+brain%3A+insights+from+neurodegeneration&doi=10.1007%2Fs13311-019-00742-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Preserving Lysosomal Function in the Aging Brain: Insights from Neurodegeneration</span></div><div class="casAuthors">Peng Wesley; Minakaki Georgia; Nguyen Maria; Krainc Dimitri</div><div class="citationInfo"><span class="NLM_cas:title">Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">611-634</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Lysosomes are acidic, membrane-bound organelles that serve as the primary catabolic compartment of the cell.  They are crucial to a variety of cellular processes from nutrient storage to autophagy.  Given the diversity of lysosomal functions, it is unsurprising that lysosomes are also emerging as important players in aging.  Lysosomal dysfunction is implicated in several aging-related neurodegenerative diseases including Alzheimer's, Parkinson's, amyotrophic lateral sclerosis/frontotemporal dementia, and Huntington's.  Although the precise role of lysosomes in the aging brain is not well-elucidated, some insight into their function has been gained from our understanding of the pathophysiology of age-dependent neurodegenerative diseases.  Therapeutic strategies targeting lysosomes and autophagic machinery have already been tested in several of these diseases with promising results, suggesting that improving lysosomal function could be similarly beneficial in preserving function in the aging brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSewpaPNT8MbJggzHGM8X5CfW6udTcc2eaMWJFaDU7dXbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M3lt1egtg%253D%253D&md5=232b65b45813b4450c8844ca78e826a4</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1007%2Fs13311-019-00742-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13311-019-00742-3%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DW.%26aulast%3DMinakaki%26aufirst%3DG.%26aulast%3DNguyen%26aufirst%3DM.%26aulast%3DKrainc%26aufirst%3DD.%26atitle%3DPerserving%2520lysosomal%2520function%2520in%2520the%2520aging%2520brain%253A%2520insights%2520from%2520neurodegeneration%26jtitle%3DNeurotherapeutics%26date%3D2019%26volume%3D16%26spage%3D611%26epage%3D634%26doi%3D10.1007%2Fs13311-019-00742-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, J.</span></span> <span> </span><span class="NLM_article-title">Visualization of endogenous and exogenous hydrogen peroxide using a lysosome-targetable fluorescent probe</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">8488</span>, <span class="refDoi"> DOI: 10.1038/srep08488</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1038%2Fsrep08488" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=25684681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFKhtbnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=8488&author=D.+Kimauthor=G.+Kimauthor=S.-J.+Namauthor=J.+Yinauthor=J.+Yoon&title=Visualization+of+endogenous+and+exogenous+hydrogen+peroxide+using+a+lysosome-targetable+fluorescent+probe&doi=10.1038%2Fsrep08488"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Visualization of Endogenous and Exogenous Hydrogen Peroxide Using A Lysosome-Targetable Fluorescent Probe</span></div><div class="casAuthors">Kim, Dabin; Kim, Gyoungmi; Nam, Sang-Jip; Yin, Jun; Yoon, Juyoung</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8488</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS) play crucial roles in diverse physiol. processes; therefore, the efficient detection of ROS is very crucial.  In this study, we report a boronate-based hydrogen peroxide (H2O2) probe having naphthalimide fluorophore.  This probe also contained a morpholine moiety as a directing group for lysosome.  The recognition property indicated that the probe exhibited high selectivity towards H2O2 not only in the soln. but also in the living cells.  Furthermore, it was used to monitor the level of endogenous and exogenous H2O2.  These results support that the probe can function as an efficient indicator to detect H2O2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6QqLSmSHr1rVg90H21EOLACvtfcHk0liY24r_6ZmFJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFKhtbnE&md5=a765526d4c401b5a907ae39319c6ec74</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1038%2Fsrep08488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep08488%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DG.%26aulast%3DNam%26aufirst%3DS.-J.%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DYoon%26aufirst%3DJ.%26atitle%3DVisualization%2520of%2520endogenous%2520and%2520exogenous%2520hydrogen%2520peroxide%2520using%2520a%2520lysosome-targetable%2520fluorescent%2520probe%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D8488%26doi%3D10.1038%2Fsrep08488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span> <span> </span><span class="NLM_article-title">A lysosome-locating and acidic pH-activatable fluorescent probe for visualizing endogenous H<sub>2</sub>O<sub>2</sub> in lysosomes</span>. <i>Analyst</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>142</i></span>,  <span class="NLM_fpage">4522</span>– <span class="NLM_lpage">4528</span>, <span class="refDoi"> DOI: 10.1039/C7AN01280B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1039%2FC7AN01280B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=29099141" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslGqsrbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2017&pages=4522-4528&author=J.+Liuauthor=S.+Zhouauthor=J.+Renauthor=C.+Wuauthor=Y.+Zhao&title=A+lysosome-locating+and+acidic+pH-activatable+fluorescent+probe+for+visualizing+endogenous+H2O2+in+lysosomes&doi=10.1039%2FC7AN01280B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">A lysosome-locating and acidic pH-activatable fluorescent probe for visualizing endogenous H2O2 in lysosomes</span></div><div class="casAuthors">Liu, Jun; Zhou, Shunqing; Ren, Jing; Wu, Chuanliu; Zhao, Yibing</div><div class="citationInfo"><span class="NLM_cas:title">Analyst (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4522-4528</span>CODEN:
                <span class="NLM_cas:coden">ANALAO</span>;
        ISSN:<span class="NLM_cas:issn">0003-2654</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">There is increasing evidence indicating that lysosomal H2O2 is closely related to autophagy and apoptotic pathways under both physiol. and pathol. conditions.  Therefore, fluorescent probes that can be exploited to visualize H2O2 in lysosomes are potential tools for exploring diverse roles of H2O2 in cells.  However, functional exploration of lysosomal H2O2 is limited by the lack of fluorescent probes capable of compatibly sensing H2O2 under weak acidic conditions (pH = 4.5) of lysosomes.  Lower spatial resoln. of the fluorescent visualization of lysosomal H2O2 might be caused by the interference of signals from cytosolic and mitochondrial H2O2, as well as the non-specific distribution of the probes in cells.  In this work, we developed a lysosome-locating and acidic-pH-activatable fluorescent probe for the detection and visualization of H2O2 in lysosomes, which consists of a H2O2-responsive boronate unit, a lysosome-locating morpholine group, and a pH-activatable benzorhodol fluorophore.  The response of the fluorescent probe to H2O2 is significantly more pronounced under acidic pH conditions than that under neutral pH conditions.  Notably, the present probe enables the fluorescence sensing of endogenous lysosomal H2O2 in living cells without external stimulations, with signal interference from the cytoplasm and other intracellular organelles being negligible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMmo2YVu0e67Vg90H21EOLACvtfcHk0liY24r_6ZmFJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslGqsrbF&md5=0e3500bde5921b3c50ced8c9cead34d7</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1039%2FC7AN01280B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7AN01280B%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DY.%26atitle%3DA%2520lysosome-locating%2520and%2520acidic%2520pH-activatable%2520fluorescent%2520probe%2520for%2520visualizing%2520endogenous%2520H2O2%2520in%2520lysosomes%26jtitle%3DAnalyst%26date%3D2017%26volume%3D142%26spage%3D4522%26epage%3D4528%26doi%3D10.1039%2FC7AN01280B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span> <span> </span><span class="NLM_article-title">pH-switchable fluorescent probe for spatially-confined visualization of intracellular hydrogen peroxide</span>. <i>Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">5865</span>– <span class="NLM_lpage">5870</span>, <span class="refDoi"> DOI: 10.1021/acs.analchem.6b00654</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.analchem.6b00654" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsVWjs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2016&pages=5865-5870&author=J.+Liuauthor=J.+Renauthor=X.+Baoauthor=W.+Gaoauthor=C.+Wuauthor=Y.+Zhao&title=pH-switchable+fluorescent+probe+for+spatially-confined+visualization+of+intracellular+hydrogen+peroxide&doi=10.1021%2Facs.analchem.6b00654"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">pH-Switchable Fluorescent Probe for Spatially-Confined Visualization of Intracellular Hydrogen Peroxide</span></div><div class="casAuthors">Liu, Jun; Ren, Jing; Bao, Xiaojia; Gao, Wei; Wu, Chuanliu; Zhao, Yibing</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5865-5870</span>CODEN:
                <span class="NLM_cas:coden">ANCHAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2700</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Intracellular H2O2 plays an important role in regulating a variety of cellular functions.  Fluorescent probes that can make response to intracellular levels of H2O2 would provide valuable tools for revealing the functions of H2O2 in living organisms.  However, traditional pH-insensitive probes and lysosome-targetable probes can only provide spatially nonspecific visualization of intracellular H2O2 and specific sensing of lysosomal H2O2, resp.  In this work, we developed a H2O2-responsive and pH-switchable fluorescent probe (HP-L1) which can make response sequentially to intracellular H2O2 and lysosomal pH.  The fluorescent probe is comprised of a H2O2-responsive boronate moiety and a pH-switchable spirobenzopyran fluorophore.  When the probe was applied for intracellular H2O2 sensing, only fluorescent emission from lysosomes is visible, and the fluorescence from other regions is not able to be obviously detected, which is due to the pH-switchable property of the spirobenzopyran fluorophore.  Thus, the developed fluorescence probe enables the spatially confined (i.e., lysosome-specific) visualization of the intracellular H2O2.  We envisioned that this kind of fluorescent probe (or the proposed sensing strategy) would allow the visualization of the overall levels of intracellular H2O2 without interferences of possible fluorescent signals from other sources (e.g., dyes for cellular staining and multiplex anal.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob0lZaMtFVNbVg90H21EOLACvtfcHk0liY24r_6ZmFJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsVWjs7c%253D&md5=f1061e0d88120b308199f259dd1355df</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1021%2Facs.analchem.6b00654&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.analchem.6b00654%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DBao%26aufirst%3DX.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DY.%26atitle%3DpH-switchable%2520fluorescent%2520probe%2520for%2520spatially-confined%2520visualization%2520of%2520intracellular%2520hydrogen%2520peroxide%26jtitle%3DAnal.%2520Chem.%26date%3D2016%26volume%3D88%26spage%3D5865%26epage%3D5870%26doi%3D10.1021%2Facs.analchem.6b00654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chittiboyina, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lelievre, S. A.</span></span> <span> </span><span class="NLM_article-title">Microenvironment-cell nucleus relationship in the context of oxidative</span>. <i>Front. Cell Dev. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">23</span>, <span class="refDoi"> DOI: 10.3389/fcell.2018.00023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.3389%2Ffcell.2018.00023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=29594114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A280%3ADC%252BC1MnmsF2muw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2018&pages=23&author=S.+Chittiboyinaauthor=Y.+Baiauthor=S.+A.+Lelievre&title=Microenvironment-cell+nucleus+relationship+in+the+context+of+oxidative&doi=10.3389%2Ffcell.2018.00023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Microenvironment-Cell Nucleus Relationship in the Context of Oxidative Stress</span></div><div class="casAuthors">Chittiboyina Shirisha; Bai Yunfeng; Lelievre Sophie A; Chittiboyina Shirisha; Lelievre Sophie A; Lelievre Sophie A</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in cell and developmental biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">23</span>
        ISSN:<span class="NLM_cas:issn">2296-634X</span>.
    </div><div class="casAbstract">The microenvironment is a source of reactive oxygen species (ROS) that influence cell phenotype and tissue homeostasis.  The impact of ROS on redox pathways as well as directly on epigenetic mechanisms and the DNA illustrate communication with the cell nucleus.  Changes in gene transcription related to redox conditions also influence the content and structure of the extracellular matrix.  However, the importance of microenvironmental ROS for normal progression through life and disease development still needs to be thoroughly understood.  We illustrate how different ROS concentration levels trigger various intracellular pathways linked to nuclear functions and determine processes necessary for the differentiation of stem cells.  The abnormal predominance of ROS that leads to oxidative stress is emphasized in light of its impact on aging and diseases related to aging.  These phenomena are discussed in the context of the possible contribution of extracellular ROS via direct diffusion into cells responsible for organ function, but also via an impact on stromal cells that triggers extracellular modifications and influences mechanotransduction.  Finally, we argue that organs-on-a-chip with controlled microenvironmental conditions can help thoroughly grasp whether ROS production is readily a cause or a consequence of certain disorders, and better understand the concentration levels of extracellular ROS that are necessary to induce a switch in phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSuDJC-Kpybg4xhnOQkIHOxfW6udTcc2ea0fNW95oX_ALntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MnmsF2muw%253D%253D&md5=8482e331ee4149af06038ef1d095d8b5</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.3389%2Ffcell.2018.00023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffcell.2018.00023%26sid%3Dliteratum%253Aachs%26aulast%3DChittiboyina%26aufirst%3DS.%26aulast%3DBai%26aufirst%3DY.%26aulast%3DLelievre%26aufirst%3DS.%2BA.%26atitle%3DMicroenvironment-cell%2520nucleus%2520relationship%2520in%2520the%2520context%2520of%2520oxidative%26jtitle%3DFront.%2520Cell%2520Dev.%2520Biol.%26date%3D2018%26volume%3D6%26spage%3D23%26doi%3D10.3389%2Ffcell.2018.00023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Srikun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albers, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iavarone, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. J.</span></span> <span> </span><span class="NLM_article-title">Organelle-targetable fluorescent probes for imaging hydrogen peroxide in living cells via SNAP-Tag protein labeling</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">4455</span>– <span class="NLM_lpage">4465</span>, <span class="refDoi"> DOI: 10.1021/ja100117u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja100117u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3cXislKhsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=4455-4465&author=D.+Srikunauthor=A.+E.+Albersauthor=C.+I.+Namauthor=A.+T.+Iavaroneauthor=C.+J.+Chang&title=Organelle-targetable+fluorescent+probes+for+imaging+hydrogen+peroxide+in+living+cells+via+SNAP-Tag+protein+labeling&doi=10.1021%2Fja100117u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Organelle-Targetable Fluorescent Probes for Imaging Hydrogen Peroxide in Living Cells via SNAP-Tag Protein Labeling</span></div><div class="casAuthors">Srikun, Duangkhae; Albers, Aaron E.; Nam, Christine I.; Iavarone, Anthony T.; Chang, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4455-4465</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hydrogen peroxide (H2O2) is a potent small-mol. oxidant that can exert a diverse array of physiol. and/or pathol. effects within living systems depending on the timing and location of its prodn., accumulation, trafficking, and consumption.  To help study the chem. and biol. of this reactive oxygen species (ROS) in its native cellular context, the authors now present a new method for monitoring local, subcellular changes in H2O2 levels by fluorescence imaging.  Specifically, the authors have exploited the versatility of the SNAP-tag technol. for site-specific protein labeling with small mols. on the surface or interior of living cells with the use of boronate-capped dyes to selectively visualize H2O2.  The resulting SNAP-Peroxy-Green (SNAP-PG) probes consist of appropriately derivatized boronates bioconjugated to SNAP-tag fusion proteins.  Spectroscopic measurements of the SNAP-PG constructs confirm their ability to detect H2O2 with specificity over other biol. relevant ROS.  Moreover, these hybrid small-mol./protein reporters can be used in live mammalian cells expressing SNAP-tag fusion proteins directed to the plasma membrane, nucleus, mitochondria, and endoplasmic reticulum.  Imaging expts. using scanning confocal microscopy establish organelle-specific localization of the SNAP-tag probes and their fluorescence turn-on in response to changes in local H2O2 levels.  This work provides a general mol. imaging platform for assaying H2O2 chem. in living cells with subcellular resoln.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7GCq2ZhrcnrVg90H21EOLACvtfcHk0ljjBdnzGqdS3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXislKhsbc%253D&md5=97a3adf7127933650337cd556c96cc6d</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1021%2Fja100117u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja100117u%26sid%3Dliteratum%253Aachs%26aulast%3DSrikun%26aufirst%3DD.%26aulast%3DAlbers%26aufirst%3DA.%2BE.%26aulast%3DNam%26aufirst%3DC.%2BI.%26aulast%3DIavarone%26aufirst%3DA.%2BT.%26aulast%3DChang%26aufirst%3DC.%2BJ.%26atitle%3DOrganelle-targetable%2520fluorescent%2520probes%2520for%2520imaging%2520hydrogen%2520peroxide%2520in%2520living%2520cells%2520via%2520SNAP-Tag%2520protein%2520labeling%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D4455%26epage%3D4465%26doi%3D10.1021%2Fja100117u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ronningen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oldenburg, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vekterud, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delbarre, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moskaug, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collas, P.</span></span> <span> </span><span class="NLM_article-title">Prepatterning of differentiation-driven nuclear lamin A/C-associated chromatin domains by GlcNAcylated histone H2B</span>. <i>Genome Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1825</span>– <span class="NLM_lpage">1835</span>, <span class="refDoi"> DOI: 10.1101/gr.193748.115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1101%2Fgr.193748.115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=26359231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A280%3ADC%252BC283htFaguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=1825-1835&author=T.+Ronningenauthor=A.+Shahauthor=A.+R.+Oldenburgauthor=K.+Vekterudauthor=E.+Delbarreauthor=J.+O.+Moskaugauthor=P.+Collas&title=Prepatterning+of+differentiation-driven+nuclear+lamin+A%2FC-associated+chromatin+domains+by+GlcNAcylated+histone+H2B&doi=10.1101%2Fgr.193748.115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Prepatterning of differentiation-driven nuclear lamin A/C-associated chromatin domains by GlcNAcylated histone H2B</span></div><div class="casAuthors">Ronningen Torunn; Shah Akshay; Vekterud Kristin; Delbarre Erwan; Oldenburg Anja R; Moskaug Jan Oivind; Collas Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Genome research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1825-35</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dynamic interactions of nuclear lamins with chromatin through lamin-associated domains (LADs) contribute to spatial arrangement of the genome.  Here, we provide evidence for prepatterning of differentiation-driven formation of lamin A/C LADs by domains of histone H2B modified on serine 112 by the nutrient sensor O-linked N-acetylglucosamine (H2BS112GlcNAc), which we term GADs.  We demonstrate a two-step process of lamin A/C LAD formation during in vitro adipogenesis, involving spreading of lamin A/C-chromatin interactions in the transition from progenitor cell proliferation to cell-cycle arrest, and genome-scale redistribution of these interactions through a process of LAD exchange within hours of adipogenic induction.  Lamin A/C LADs are found both in active and repressive chromatin contexts that can be influenced by cell differentiation status.  De novo formation of adipogenic lamin A/C LADs occurs nonrandomly on GADs, which consist of megabase-size intergenic and repressive chromatin domains.  Accordingly, whereas predifferentiation lamin A/C LADs are gene-rich, post-differentiation LADs harbor repressive features reminiscent of lamin B1 LADs.  Release of lamin A/C from genes directly involved in glycolysis concurs with their transcriptional up-regulation after adipogenic induction, and with downstream elevations in H2BS112GlcNAc levels and O-GlcNAc cycling.  Our results unveil an epigenetic prepatterning of adipogenic LADs by GADs, suggesting a coupling of developmentally regulated lamin A/C-genome interactions to a metabolically sensitive chromatin modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQAcwMJAE2LJIxhnOQkIHOxfW6udTcc2ea4lD09fNhHJ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC283htFaguw%253D%253D&md5=fa360f547bfdd9c213338a623d4845bb</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1101%2Fgr.193748.115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgr.193748.115%26sid%3Dliteratum%253Aachs%26aulast%3DRonningen%26aufirst%3DT.%26aulast%3DShah%26aufirst%3DA.%26aulast%3DOldenburg%26aufirst%3DA.%2BR.%26aulast%3DVekterud%26aufirst%3DK.%26aulast%3DDelbarre%26aufirst%3DE.%26aulast%3DMoskaug%26aufirst%3DJ.%2BO.%26aulast%3DCollas%26aufirst%3DP.%26atitle%3DPrepatterning%2520of%2520differentiation-driven%2520nuclear%2520lamin%2520A%252FC-associated%2520chromatin%2520domains%2520by%2520GlcNAcylated%2520histone%2520H2B%26jtitle%3DGenome%2520Res.%26date%3D2015%26volume%3D25%26spage%3D1825%26epage%3D1835%26doi%3D10.1101%2Fgr.193748.115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, T.</span></span> <span> </span><span class="NLM_article-title">A highly sensitive ratiometric fluorescent probe for the detection of cytoplasmic and nuclear hydrogen peroxide</span>. <i>Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">9970</span>– <span class="NLM_lpage">9976</span>, <span class="refDoi"> DOI: 10.1021/ac502909c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ac502909c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFSqtbzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=9970-9976&author=Y.+Wenauthor=K.+Liuauthor=H.+Yangauthor=Y.+Liauthor=H.+Lanauthor=Y.+Liuauthor=X.+Zhangauthor=T.+Yi&title=A+highly+sensitive+ratiometric+fluorescent+probe+for+the+detection+of+cytoplasmic+and+nuclear+hydrogen+peroxide&doi=10.1021%2Fac502909c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">A Highly Sensitive Ratiometric Fluorescent Probe for the Detection of Cytoplasmic and Nuclear Hydrogen Peroxide</span></div><div class="casAuthors">Wen, Ying; Liu, Keyin; Yang, Huiran; Li, Yi; Lan, Haichuang; Liu, Yi; Zhang, Xinyu; Yi, Tao</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">9970-9976</span>CODEN:
                <span class="NLM_cas:coden">ANCHAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2700</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As a marker for oxidative stress and a second messenger in signal transduction, hydrogen peroxide (H2O2) plays an important role in living systems.  It is thus crit. to monitor the changes in H2O2 in cells and tissues.  Here, the authors developed a highly sensitive and versatile ratiometric H2O2 fluorescent probe (NP1) based on 1,8-naphthalimide and boric acid ester.  In response to H2O2, the ratio of its fluorescent intensities at 555 and 403 nm changed 1020-fold within 200 min.  The detecting limit of NP1 toward H2O2 is estd. as 0.17 μM.  It was capable of imaging endogenous H2O2 generated in live RAW 264.7 macrophages as a cellular inflammation response, and esp., it was able to detect H2O2 produced as a signaling mol. in A431 human epidermoid carcinoma cells through stimulation by epidermal growth factor.  This probe contains an azide group and thus has the potential to be linked to various mols. via the click reaction.  After binding to a Nuclear Localization Signal peptide, the peptide-based combination probe (pep-NP1) was successfully targeted to nuclei and was capable of ratiometrically detecting nuclear H2O2 in living cells.  NP1 was a highly sensitive ratiometric H2O2 dye with promising biol. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHqdfx_mDfWLVg90H21EOLACvtfcHk0lh8wLhhJwFVEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFSqtbzK&md5=225dd0810c49549f6a57cdad0a748f14</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Fac502909c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fac502909c%26sid%3Dliteratum%253Aachs%26aulast%3DWen%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLan%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYi%26aufirst%3DT.%26atitle%3DA%2520highly%2520sensitive%2520ratiometric%2520fluorescent%2520probe%2520for%2520the%2520detection%2520of%2520cytoplasmic%2520and%2520nuclear%2520hydrogen%2520peroxide%26jtitle%3DAnal.%2520Chem.%26date%3D2014%26volume%3D86%26spage%3D9970%26epage%3D9976%26doi%3D10.1021%2Fac502909c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
de Bittner, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubikovskaya, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. J.</span></span> <span> </span><span class="NLM_article-title">In vivo imaging of hydrogen peroxide production in a murine tumor model with a chemoselective bioluminescent reporter</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">21316</span>– <span class="NLM_lpage">21321</span>, <span class="refDoi"> DOI: 10.1073/pnas.1012864107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1073%2Fpnas.1012864107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=21115844" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Wis7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=21316-21321&author=G.+C.+Van%0Ade+Bittnerauthor=E.+A.+Dubikovskayaauthor=C.+R.+Bertozziauthor=C.+J.+Chang&title=In+vivo+imaging+of+hydrogen+peroxide+production+in+a+murine+tumor+model+with+a+chemoselective+bioluminescent+reporter&doi=10.1073%2Fpnas.1012864107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo imaging of hydrogen peroxide production in a murine tumor model with a chemoselective bioluminescent reporter</span></div><div class="casAuthors">Van de Bittner, Genevieve C.; Dubikovskaya, Elena a; Bertozzi, Carolyn R.; Chang, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">21316-21321, S21316/1-S21316/5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Living organisms produce hydrogen peroxide (H2O2) to kill invading pathogens and for cellular signaling, but aberrant generation of this reactive oxygen species is a hallmark of oxidative stress and inflammation in aging, injury, and disease.  The effects of H2O2 on the overall health of living animals remain elusive, in part owing to a dearth of methods for studying this transient small mol. in vivo.  Here we report the design, synthesis, and in vivo applications of Peroxy Caged Luciferin-1 (PCL-1), a chemoselective bioluminescent probe for the real-time detection of H2O2 within living animals.  PCL-1 is a boronic acid-caged firefly luciferin mol. that selectively reacts with H2O2 to release firefly luciferin, which triggers a bioluminescent response in the presence of firefly luciferase.  The high sensitivity and selectivity of PCL-1 for H2O2, combined with the favorable properties of bioluminescence for in vivo imaging, afford a unique technol. for real-time detection of basal levels of H2O2 generated in healthy, living mice.  Moreover, we demonstrate the efficacy of PCL-1 for monitoring physiol. fluctuations in H2O2 levels by directly imaging elevations in H2O2 within testosterone-stimulated tumor xenografts in vivo.  The ability to chemoselectively monitor H2O2 fluxes in real time in living animals offers opportunities to dissect H2O2's disparate contributions to health, aging, and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNPErZ3dr_Y7Vg90H21EOLACvtfcHk0lh8wLhhJwFVEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Wis7bF&md5=a7b520f852bd565114effc7d26ef4cbb</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1012864107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1012864107%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bde%2BBittner%26aufirst%3DG.%2BC.%26aulast%3DDubikovskaya%26aufirst%3DE.%2BA.%26aulast%3DBertozzi%26aufirst%3DC.%2BR.%26aulast%3DChang%26aufirst%3DC.%2BJ.%26atitle%3DIn%2520vivo%2520imaging%2520of%2520hydrogen%2520peroxide%2520production%2520in%2520a%2520murine%2520tumor%2520model%2520with%2520a%2520chemoselective%2520bioluminescent%2520reporter%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D21316%26epage%3D21321%26doi%3D10.1073%2Fpnas.1012864107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, G.</span></span> <span> </span><span class="NLM_article-title">Bioluminescent turn-on probe for sensing hypochlorite in vitro and in tumors</span>. <i>Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">5693</span>– <span class="NLM_lpage">5696</span>, <span class="refDoi"> DOI: 10.1021/acs.analchem.7b01103</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.analchem.7b01103" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntlWjtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2017&pages=5693-5696&author=P.+Chenauthor=Z.+Zhengauthor=Y.+Zhuauthor=Y.+Dongauthor=F.+Wangauthor=G.+Liang&title=Bioluminescent+turn-on+probe+for+sensing+hypochlorite+in+vitro+and+in+tumors&doi=10.1021%2Facs.analchem.7b01103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Bioluminescent Turn-On Probe for Sensing Hypochlorite in Vitro and in Tumors</span></div><div class="casAuthors">Chen, Peiyao; Zheng, Zhen; Zhu, Yunxia; Dong, Yu; Wang, Fuqiang; Liang, Gaolin</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5693-5696</span>CODEN:
                <span class="NLM_cas:coden">ANCHAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2700</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hypochlorite (ClO-) is one of the most important reactive oxygen species but using a BL probe for its selective detection (or imaging) still remains challenging.  Herein, we report a latent BL probe benzoylhydrazine luciferin (1) for highly selective detection of ClO-in vitro and imaging ClO- in living cells and tumors.  In vitro tests indicated that 1 could be applied for highly selective detection of ClO- within the range of 0-62.5 μM with a limit of detection of 0.705 μM.  Using these unique features of 1, we successfully applied it to image ClO- in living cells and tumors.  We envision that probe 1 might be applied to elucidate the biol. roles of ClO- in wider physiol. and pathol. processes in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraHym4ZjDAhbVg90H21EOLACvtfcHk0lhqrbUhrp53bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntlWjtb0%253D&md5=e6e55df6c0a5601a0cf2d7b269234314</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1021%2Facs.analchem.7b01103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.analchem.7b01103%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%26aulast%3DZheng%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DLiang%26aufirst%3DG.%26atitle%3DBioluminescent%2520turn-on%2520probe%2520for%2520sensing%2520hypochlorite%2520in%2520vitro%2520and%2520in%2520tumors%26jtitle%3DAnal.%2520Chem.%26date%3D2017%26volume%3D89%26spage%3D5693%26epage%3D5696%26doi%3D10.1021%2Facs.analchem.7b01103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, I.</span></span> <span> </span><span class="NLM_article-title">Preparation of a multiple-targeting NIR-based fluorogenic probe and its application for selective cancer cell imaging</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">4628</span>– <span class="NLM_lpage">4631</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.9b01530</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.9b01530" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVOntr3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2019&pages=4628-4631&author=H.+Liauthor=C.-H.+Leeauthor=I.+Shin&title=Preparation+of+a+multiple-targeting+NIR-based+fluorogenic+probe+and+its+application+for+selective+cancer+cell+imaging&doi=10.1021%2Facs.orglett.9b01530"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of a Multiple-Targeting NIR-Based Fluorogenic Probe and Its Application for Selective Cancer Cell Imaging</span></div><div class="casAuthors">Li, Hui; Lee, Chang-Hee; Shin, Injae</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4628-4631</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To improve cancer selectivity of imaging agents, we synthesized the triple-targeting, near-IR (NIR) based fluorogenic probe, Oct-FK(PBA)-NIR.  The new probe consists of (1) octreotide as a synthetic ligand of somatostatin receptors, (2) a H2O2-responsive phenylboronic acid, (3) a dipeptide substrate for cathepsin B, and (4) a NIR fluorophore.  The results of cell studies show that the probe can be used for selective imaging of cancer cells in the NIR range without interference with normal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3QxvVLmL8LbVg90H21EOLACvtfcHk0lhqrbUhrp53bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVOntr3O&md5=5ca9d5bb09d4281219f02295121a431c</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.9b01530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.9b01530%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DC.-H.%26aulast%3DShin%26aufirst%3DI.%26atitle%3DPreparation%2520of%2520a%2520multiple-targeting%2520NIR-based%2520fluorogenic%2520probe%2520and%2520its%2520application%2520for%2520selective%2520cancer%2520cell%2520imaging%26jtitle%3DOrg.%2520Lett.%26date%3D2019%26volume%3D21%26spage%3D4628%26epage%3D4631%26doi%3D10.1021%2Facs.orglett.9b01530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span> <span> </span><span class="NLM_article-title">A near-infrared ratiometric/turn-on fluorescent probe for <i>in vivo</i> imaging of hydrogen peroxide in a murine model of acute inflammation</span>. <i>Anal. Chim. Acta</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1024</i></span>,  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">176</span>, <span class="refDoi"> DOI: 10.1016/j.aca.2018.03.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.aca.2018.03.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=29776543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotlClt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1024&publication_year=2018&pages=169-176&author=J.+Houauthor=M.+Qianauthor=H.+Zhaoauthor=Y.+Liauthor=Y.+Liaoauthor=G.+Hanauthor=Z.+Xuauthor=F.+Wangauthor=Y.+Songauthor=Y.+Liu&title=A+near-infrared+ratiometric%2Fturn-on+fluorescent+probe+for+in+vivo+imaging+of+hydrogen+peroxide+in+a+murine+model+of+acute+inflammation&doi=10.1016%2Fj.aca.2018.03.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">A near-infrared ratiometric/turn-on fluorescent probe for in vivo imaging of hydrogen peroxide in a murine model of acute inflammation</span></div><div class="casAuthors">Hou, Jingli; Qian, Meng; Zhao, Huanhuan; Li, Yingchun; Liao, Yongfang; Han, Guifang; Xu, Zhelong; Wang, Feng; Song, Yuguang; Liu, Yangping</div><div class="citationInfo"><span class="NLM_cas:title">Analytica Chimica Acta</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">1024</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">169-176</span>CODEN:
                <span class="NLM_cas:coden">ACACAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2670</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Much attention has been paid to develop optical probes for noninvasive, quant., in vivo monitoring of hydrogen peroxide (H2O2) due to its important roles in the initiation and development of numerous diseases.  Motivated to meet this need, we herein report the synthesis of a near-IR (NIR) fluorescent probe (AB1) for H2O2 by modulating intramol. charge transfer (ICT) process of the dye 9H-1,3-Dichloro-7-hydroxy-9,9-dimethylacridine-2-one (DDAO).  The probe AB1 exhibits both a large NIR fluorescence turn-on and a ratiometric response to H2O2 with high sensitivity and specificity.  The fluorescence response of AB1 has a good linear relationship with H2O2 over a wide concn. range from 1 μM to 100 μM, thus affording a detection limit of 0.42 μM.  Confocal microscopic expts. demonstrated that AB1 could ratiometrically detect exogenous and endogenous H2O2 in living cells.  Moreover, owing to the NIR emission of DDAO, the probe was also utilized to image endogenous H2O2 from the peritoneal cavity in a mouse model of lipopolysaccharide-induced acute inflammation, based on the fluorescence turn-on mode.  This new probe shows great potential as a reliable chem. tool to study the development and progression of H2O2-assocd. diseases in living animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRG7L2e-Qmc7Vg90H21EOLACvtfcHk0lhqrbUhrp53bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotlClt70%253D&md5=a2d5e4dbbb8910a6456ad6d558f578bd</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2Fj.aca.2018.03.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.aca.2018.03.028%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLiao%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26atitle%3DA%2520near-infrared%2520ratiometric%252Fturn-on%2520fluorescent%2520probe%2520for%2520in%2520vivo%2520imaging%2520of%2520hydrogen%2520peroxide%2520in%2520a%2520murine%2520model%2520of%2520acute%2520inflammation%26jtitle%3DAnal.%2520Chim.%2520Acta%26date%3D2018%26volume%3D1024%26spage%3D169%26epage%3D176%26doi%3D10.1016%2Fj.aca.2018.03.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D.</span></span> <span> </span><span class="NLM_article-title">Resolving controversies on the path to Alzheimer’s therapeutics</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1060</span>– <span class="NLM_lpage">1065</span>, <span class="refDoi"> DOI: 10.1038/nm.2460</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1038%2Fnm.2460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=21900936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFCntL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=1060-1065&author=D.+Selkoe&title=Resolving+controversies+on+the+path+to+Alzheimer%E2%80%99s+therapeutics&doi=10.1038%2Fnm.2460"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Resolving controversies on the path to Alzheimer's therapeutics</span></div><div class="casAuthors">Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1060-1065</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease constitutes a personal and societal tragedy of immense proportions.  Since 1960, research in labs. and clinics worldwide has elucidated many features of this insidious and ultimately fatal syndrome, and this progress has led to initial human trials of potentially disease-modifying agents.  However, some of these agents have already failed.  Gnawing controversies and important gaps in our knowledge seem to cast addnl. doubt on the ability of the field to move forward effectively.  Here I discuss some of these looming concerns and offer possible explanations for the major trial failures that suggest they are not predictive of the future.  Rigorous preclin. validation of mechanism-based therapeutic agents followed by meticulously designed trials that focus on the cardinal cognitive symptoms and their assocd. biomarkers in the mild or presymptomatic phases of Alzheimer's disease are likely to lead to success, perhaps in the not-too-distant future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9e3VIkcVvWrVg90H21EOLACvtfcHk0lhqrbUhrp53bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFCntL7E&md5=501720027a4b1e4fd2a838f94aecd667</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1038%2Fnm.2460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2460%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%26atitle%3DResolving%2520controversies%2520on%2520the%2520path%2520to%2520Alzheimer%25E2%2580%2599s%2520therapeutics%26jtitle%3DNat.%2520Med.%26date%3D2011%26volume%3D17%26spage%3D1060%26epage%3D1065%26doi%3D10.1038%2Fnm.2460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tramutola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanzillotta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perluigi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butterfield, D. A.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress, protein modification and Alzheimer disease</span>. <i>Brain Res. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">88</span>– <span class="NLM_lpage">96</span>, <span class="refDoi"> DOI: 10.1016/j.brainresbull.2016.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.brainresbull.2016.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=27316747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtV2gt73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2017&pages=88-96&author=A.+Tramutolaauthor=C.+Lanzillottaauthor=M.+Perluigiauthor=D.+A.+Butterfield&title=Oxidative+stress%2C+protein+modification+and+Alzheimer+disease&doi=10.1016%2Fj.brainresbull.2016.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress, protein modification and Alzheimer disease</span></div><div class="casAuthors">Tramutola, A.; Lanzillotta, C.; Perluigi, M.; Butterfield, D. Allan</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Bulletin</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">88-96</span>CODEN:
                <span class="NLM_cas:coden">BRBUDU</span>;
        ISSN:<span class="NLM_cas:issn">0361-9230</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Alzheimer disease (AD) is a progressive neurodegenerative disease that affects the elderly population with complex etiol.  Many hypotheses have been proposed to explain different causes of AD, but the exact mechanisms remain unclear.  In this review, we focus attention on the oxidative-stress hypothesis of neurodegeneration and we discuss redox proteomics approaches to analyze post-mortem human brain from AD brain.  Collectively, these studies have provided valuable insights into the mol. mechanisms involved both in the pathogenesis and progression of AD, demonstrating the impairment of numerous cellular processes such as energy prodn., cellular structure, signal transduction, synaptic function, mitochondrial function, cell cycle progression, and degradative systems.  Each of these cellular functions normally contributes to maintain healthy neuronal homeostasis, so the deregulation of one or more of these functions could contribute to the pathol. and clin. presentation of AD.  In particular, we discuss the evidence demonstrating the oxidn./dysfunction of a no. of enzymes specifically involved in energy metab. that support the view that reduced glucose metab. and loss of ATP are crucial events triggering neurodegeneration and progression of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol1I_1jee1TrVg90H21EOLACvtfcHk0ljgMLfvTzepmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtV2gt73E&md5=c7872dbeaf579e65064223a33e18450d</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1016%2Fj.brainresbull.2016.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainresbull.2016.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DTramutola%26aufirst%3DA.%26aulast%3DLanzillotta%26aufirst%3DC.%26aulast%3DPerluigi%26aufirst%3DM.%26aulast%3DButterfield%26aufirst%3DD.%2BA.%26atitle%3DOxidative%2520stress%252C%2520protein%2520modification%2520and%2520Alzheimer%2520disease%26jtitle%3DBrain%2520Res.%2520Bull.%26date%3D2017%26volume%3D133%26spage%3D88%26epage%3D96%26doi%3D10.1016%2Fj.brainresbull.2016.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ran, C.</span></span> <span> </span><span class="NLM_article-title">Imaging hydrogen peroxide in Alzheimer’s disease via cascade signal amplification</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">35613</span>, <span class="refDoi"> DOI: 10.1038/srep35613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1038%2Fsrep35613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=27762326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslGrtLjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=35613&author=J.+Yangauthor=J.+Yangauthor=S.+H.+Liangauthor=Y.+Xuauthor=A.+Mooreauthor=C.+Ran&title=Imaging+hydrogen+peroxide+in+Alzheimer%E2%80%99s+disease+via+cascade+signal+amplification&doi=10.1038%2Fsrep35613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging hydrogen peroxide in Alzheimer's disease via cascade signal amplification</span></div><div class="casAuthors">Yang, Jian; Yang, Jing; Liang, Steven H.; Xu, Yungen; Moore, Anna; Ran, Chongzhao</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">35613</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">In brains of Alzheimer's disease (AD), reactive oxygen species (ROS) levels are significantly higher than that of healthy brains.  Evidence suggests that, during AD onset and progression, a vicious cycle revolves around amyloid beta (Aβ) prodn., aggregation, plaque formation, microglia/immunol. responses, inflammation, and ROS prodn.  In this cycle, ROS species play a central role, and H2O2 is one of the most important ROS species.  In this report, we have designed a fluorescent imaging probe CRANAD-88, which is capable of cascade amplifying near IR fluorescence (NIRF) signals at three levels upon interacting with H2O2 in AD brains.  We demonstrated that the amplification was feasible in vitro and in vivo.  Remarkably, we showed that, for the first time, it was feasible to monitor the changes of H2O2 concns. in AD brains before and after treatment with an H2O2 scavenger.  Our method opens new revenues to investigate H2O2 in AD brains and can be very instructive for drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNXjcUvExESrVg90H21EOLACvtfcHk0ljgMLfvTzepmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslGrtLjP&md5=9cb6630329308b0b47d28b6dc0254107</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1038%2Fsrep35613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep35613%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DS.%2BH.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DMoore%26aufirst%3DA.%26aulast%3DRan%26aufirst%3DC.%26atitle%3DImaging%2520hydrogen%2520peroxide%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520via%2520cascade%2520signal%2520amplification%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D35613%26doi%3D10.1038%2Fsrep35613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span> <span> </span><span class="NLM_article-title">A novel pyrimidine based deep-red fluorogenic probe for detecting hydrogen peroxide in Parkinson’s disease models</span>. <i>Talanta</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>199</i></span>,  <span class="NLM_fpage">628</span>– <span class="NLM_lpage">633</span>, <span class="refDoi"> DOI: 10.1016/j.talanta.2019.03.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.talanta.2019.03.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=30952307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1MXks12ju7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=199&publication_year=2019&pages=628-633&author=X.+Qiuauthor=C.+Xinauthor=W.+Qinauthor=Z.+Liauthor=D.+Zhangauthor=G.+Zhangauthor=B.+Pengauthor=X.+Hanauthor=C.+Yuauthor=L.+Liauthor=W.+Huang&title=A+novel+pyrimidine+based+deep-red+fluorogenic+probe+for+detecting+hydrogen+peroxide+in+Parkinson%E2%80%99s+disease+models&doi=10.1016%2Fj.talanta.2019.03.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">A novel pyrimidine based deep-red fluorogenic probe for detecting hydrogen peroxide in Parkinson's disease models</span></div><div class="casAuthors">Qiu, Xinghan; Xin, Chenqi; Qin, Wenjing; Li, Zheng; Zhang, Duoteng; Zhang, Gaobin; Peng, Bo; Han, Xu; Yu, Changmin; Li, Lin; Huang, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Talanta</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">199</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">628-633</span>CODEN:
                <span class="NLM_cas:coden">TLNTA2</span>;
        ISSN:<span class="NLM_cas:issn">0039-9140</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Parkinson's disease (PD) severely affects life quality of patients and has brought huge economic burden to health system worldwide.  Previous studies showed that the abnormal expression of hydrogen peroxide (H2O2) in the brain is closely related to the development of neurodegenerative diseases such as PD.  Herein, the authors designed a novel deep-red H2O2 fluorogenic probe PB1 to detect the level of H2O2 in vivo.  PB1 showed a highly selectivity response to H2O2 over other reactants such as reactive oxygen/nitrogen species, biothiols and various ions in aq. soln. at physiol. pH.  PB1 possesses an excellent response to H2O2 in the cells and in the brain tissue of drosophila from confocal fluorescence imaging.  These results suggested that PB1 holds great potential in the study of the relation between H2O2 overexpression and PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCkeZMBlw5J7Vg90H21EOLACvtfcHk0ljgMLfvTzepmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXks12ju7k%253D&md5=1f55f64277f5de72d078fafc5132007f</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1016%2Fj.talanta.2019.03.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.talanta.2019.03.017%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DXin%26aufirst%3DC.%26aulast%3DQin%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DW.%26atitle%3DA%2520novel%2520pyrimidine%2520based%2520deep-red%2520fluorogenic%2520probe%2520for%2520detecting%2520hydrogen%2520peroxide%2520in%2520Parkinson%25E2%2580%2599s%2520disease%2520models%26jtitle%3DTalanta%26date%3D2019%26volume%3D199%26spage%3D628%26epage%3D633%26doi%3D10.1016%2Fj.talanta.2019.03.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paira, P.</span></span> <span> </span><span class="NLM_article-title">Theranostic aspects: treatment of cancer by nanotechnology</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">969</span>– <span class="NLM_lpage">975</span>, <span class="refDoi"> DOI: 10.2174/1389557518666171129214336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.2174%2F1389557518666171129214336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=29189149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFGgtrbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=969-975&author=B.+Sarkarauthor=P.+Paira&title=Theranostic+aspects%3A+treatment+of+cancer+by+nanotechnology&doi=10.2174%2F1389557518666171129214336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Theranostic Aspects: Treatment of Cancer by Nanotechnology</span></div><div class="casAuthors">Sarkar, Bidisha; Paira, Priyankar</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">969-975</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Theranostic agents or theranostic imaging as its name suggests is a combination of two terms-diagnosis & therapy.  Efforts are being made to combine both the terms into clin. formulations.  This theranostic imaging is found to be very much significant to complex diseases like cancer and proliferative tumors esp. because accurate photocopy for every tumor can be obtained by genomic and proteomic profiling and using such informations in theranostic agents can be constructed or modeled in such a way that it is specific in its action and selective towards the cancer cells only, without causing any adverse effects on the normal tissue cells.  By means of nanoplatforms, we can conveniently deliver cancer cell specific targeting ligand or peptide inside the human body.  Primary delivery approach comprises of nanoparticles, liposomes, dendrimers, prodrugs, polymersomes, carbon nanotubes and polymeric micelles.  Theranostic agents, i.e., therapeutic and diagnostic agents can be phys. bound or else they can be bound with polymers which are exclusively designed and this together forms nanocarriers.  Hence, the review highlights the advances of nanotechnol. that has given us a platform for cancer detection and treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk08KQmitAfLVg90H21EOLACvtfcHk0lgrSK1Wk03Pkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFGgtrbK&md5=3e6d8cd2d82a7f32c5899e386012bfd2</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.2174%2F1389557518666171129214336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557518666171129214336%26sid%3Dliteratum%253Aachs%26aulast%3DSarkar%26aufirst%3DB.%26aulast%3DPaira%26aufirst%3DP.%26atitle%3DTheranostic%2520aspects%253A%2520treatment%2520of%2520cancer%2520by%2520nanotechnology%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2018%26volume%3D18%26spage%3D969%26epage%3D975%26doi%3D10.2174%2F1389557518666171129214336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, W. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. S.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial induced and self-monitored intrinsic apoptosis by antitumor theranostic prodrug: <i>In Vivo</i> imaging and precise cancer treatment</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">17836</span>– <span class="NLM_lpage">17843</span>, <span class="refDoi"> DOI: 10.1021/ja510421q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja510421q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFOjsL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=17836-17843&author=R.+Kumarauthor=J.+Hanauthor=H.-J.+Limauthor=W.+X.+Renauthor=J.-Y.+Limauthor=J.-H.+Kimauthor=J.+S.+Kim&title=Mitochondrial+induced+and+self-monitored+intrinsic+apoptosis+by+antitumor+theranostic+prodrug%3A+In+Vivo+imaging+and+precise+cancer+treatment&doi=10.1021%2Fja510421q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial Induced and Self-Monitored Intrinsic Apoptosis by Antitumor Theranostic Prodrug: In Vivo Imaging and Precise Cancer Treatment</span></div><div class="casAuthors">Kumar, Rajesh; Han, Jiyou; Lim, Hee-Joung; Ren, Wen Xiu; Lim, Ja-Yun; Kim, Jong-Hoon; Kim, Jong Seung</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">17836-17843</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activation of apoptosis, the cell death machinery, in tumor cells by organelle-specific delivery of antitumor theranostic agent is the utmost challenge in cancer therapy.  Herein, we developed a highly efficient mitochondria-targeting antitumor theranostic prodrug 7 that contained two mols. of drug 5'-deoxy-5-fluorouridine and an apoptotic marker ethidium for self-monitoring intrinsic (mitochondrial) apoptosis after its activation in tumor cells.  Theranostic 7 was activated by endogenously produced mitochondrial-overexpressed H2O2 and released drug 5'-deoxy-5-fluorouridine and apoptotic marker ethidium to the tumor cells.  The in vitro and in vivo drug release was monitored by observing the fluorescence changes of ethidium.  Theranostic 7 exhibited an enhanced cytotoxicity over com. 5-fluorouracil (an active drug of 5'-deoxy-5-fluorouridine) leading to intrinsic apoptosis monitored by in situ generated ethidium.  Enhanced expression of mitochondria-mediated apoptotic genes (NOXA, PUMA, BID, BAX, and BAK), Cyt C, Caspase-3 and -9, and cell surface death receptors was obsd. after theranostic 7 activation in tumor cells.  In vivo and ex vivo xenografts revealed that theranostic 7 significantly inhibited tumor progression and cured the tumor-bearing mice.  Such organelle-specific theranostic strategies have great potential for the early diagnosis and precise treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdxDp1xuNvfLVg90H21EOLACvtfcHk0lgrSK1Wk03Pkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFOjsL3O&md5=0e80b2f99a1054f9da8570c3ceb84783</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1021%2Fja510421q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja510421q%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DH.-J.%26aulast%3DRen%26aufirst%3DW.%2BX.%26aulast%3DLim%26aufirst%3DJ.-Y.%26aulast%3DKim%26aufirst%3DJ.-H.%26aulast%3DKim%26aufirst%3DJ.%2BS.%26atitle%3DMitochondrial%2520induced%2520and%2520self-monitored%2520intrinsic%2520apoptosis%2520by%2520antitumor%2520theranostic%2520prodrug%253A%2520In%2520Vivo%2520imaging%2520and%2520precise%2520cancer%2520treatment%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D17836%26epage%3D17843%26doi%3D10.1021%2Fja510421q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhuniya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maiti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. S.</span></span> <span> </span><span class="NLM_article-title">An activatable prodrug for the treatment of metastatic tumors</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">13888</span>– <span class="NLM_lpage">13894</span>, <span class="refDoi"> DOI: 10.1021/ja5077684</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja5077684" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFamsL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=13888-13894&author=E.-J.+Kimauthor=S.+Bhuniyaauthor=H.+Leeauthor=H.+M.+Kimauthor=C.+Cheongauthor=S.+Maitiauthor=K.+S.+Hongauthor=J.+S.+Kim&title=An+activatable+prodrug+for+the+treatment+of+metastatic+tumors&doi=10.1021%2Fja5077684"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">An Activatable Prodrug for the Treatment of Metastatic Tumors</span></div><div class="casAuthors">Kim, Eun-Joong; Bhuniya, Sankarprasad; Lee, Hyunseung; Kim, Hyun Min; Cheong, Chaejoon; Maiti, Sukhendu; Hong, Kwan Soo; Kim, Jong Seung</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">13888-13894</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Metastatic cancers have historically been difficult to treat.  However, metastatic tumors have been found to have high levels of reactive oxygen species such as hydrogen peroxide (H2O2), supporting the hypothesis that a prodrug could be activated by intracellular H2O2 and lead to a potential antimetastatic therapy.  In this study, prodrug 7 was designed to be activated by H2O2-mediated boronate oxidn., resulting in activation of the fluorophore for detection and release of the therapeutic agent, SN-38.  Drug release from prodrug 7 was investigated by monitoring fluorescence after addn. of H2O2 to the cancer cells.  Prodrug 7 activated by H2O2, selectively inhibited tumor cell growth.  Furthermore, intratracheally administered prodrug 7 showed effective antitumor activity in a mouse model of metastatic lung disease.  Thus, this H2O2-responsive prodrug has therapeutic potential as a novel treatment for metastatic cancer via cellular imaging with fluorescence as well as selective release of the anticancer drug, SN-38.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX5gk0YqDa5rVg90H21EOLACvtfcHk0lgrSK1Wk03Pkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFamsL%252FK&md5=35fc515aa6940c7b7946bb5638ed4e19</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1021%2Fja5077684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja5077684%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DE.-J.%26aulast%3DBhuniya%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DH.%2BM.%26aulast%3DCheong%26aufirst%3DC.%26aulast%3DMaiti%26aufirst%3DS.%26aulast%3DHong%26aufirst%3DK.%2BS.%26aulast%3DKim%26aufirst%3DJ.%2BS.%26atitle%3DAn%2520activatable%2520prodrug%2520for%2520the%2520treatment%2520of%2520metastatic%2520tumors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D13888%26epage%3D13894%26doi%3D10.1021%2Fja5077684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takagi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toshima, K.</span></span> <span> </span><span class="NLM_article-title">Target-selective fluorescence imaging and photocytotoxicity against H<sub>2</sub>O<sub>2</sub> high-expressing cancer cells using a photoactivatable theranostic agent</span>. <i>Chem. - Asian J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">2656</span>– <span class="NLM_lpage">2659</span>, <span class="refDoi"> DOI: 10.1002/asia.201701004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2Fasia.201701004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=28834271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFClurjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=2656-2659&author=R.+Takagiauthor=A.+Takedaauthor=D.+Takahashiauthor=K.+Toshima&title=Target-selective+fluorescence+imaging+and+photocytotoxicity+against+H2O2+high-expressing+cancer+cells+using+a+photoactivatable+theranostic+agent&doi=10.1002%2Fasia.201701004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Target-Selective Fluorescence Imaging and Photocytotoxicity against H2O2 High-Expressing Cancer Cells Using a Photoactivatable Theranostic Agent</span></div><div class="casAuthors">Takagi, Ryoma; Takeda, Ayano; Takahashi, Daisuke; Toshima, Kazunobu</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - An Asian Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2656-2659</span>CODEN:
                <span class="NLM_cas:coden">CAAJBI</span>;
        ISSN:<span class="NLM_cas:issn">1861-4728</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A purpose-designed and synthesized H2O2-reactive and photoactivatable theranostic agent I consisting of 1) an arylboronic acid moiety, 2) pro-fluorophore moiety, and 3) photoactivatable moiety (photosensitizer), selectively and effectively reacted with H2O2 while simultaneously releasing resorufin for fluorescence detection under neutral aq. conditions.  In addn., I was cell-permeable, and exhibited effective photocytotoxicity against fluorescently visualized cells only upon photoirradn.  The results also showed that I produced a selective fluorescence response to H2O2, even in living cultured cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCEYz_3D5SSLVg90H21EOLACvtfcHk0lgrSK1Wk03Pkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFClurjF&md5=a80997cdb9b24d4d84bee9887964eb68</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1002%2Fasia.201701004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fasia.201701004%26sid%3Dliteratum%253Aachs%26aulast%3DTakagi%26aufirst%3DR.%26aulast%3DTakeda%26aufirst%3DA.%26aulast%3DTakahashi%26aufirst%3DD.%26aulast%3DToshima%26aufirst%3DK.%26atitle%3DTarget-selective%2520fluorescence%2520imaging%2520and%2520photocytotoxicity%2520against%2520H2O2%2520high-expressing%2520cancer%2520cells%2520using%2520a%2520photoactivatable%2520theranostic%2520agent%26jtitle%3DChem.%2520-%2520Asian%2520J.%26date%3D2017%26volume%3D12%26spage%3D2656%26epage%3D2659%26doi%3D10.1002%2Fasia.201701004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ravikumar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagheri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saini, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakrapani, H.</span></span> <span> </span><span class="NLM_article-title">A small molecule for theranostic targeting of cancer cells</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">13352</span>– <span class="NLM_lpage">13355</span>, <span class="refDoi"> DOI: 10.1039/C7CC08526E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1039%2FC7CC08526E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=29192700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVaqsLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2017&pages=13352-13355&author=G.+Ravikumarauthor=M.+Bagheriauthor=D.+K.+Sainiauthor=H.+Chakrapani&title=A+small+molecule+for+theranostic+targeting+of+cancer+cells&doi=10.1039%2FC7CC08526E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule for theraNOstic targeting of cancer cells</span></div><div class="casAuthors">Ravikumar, Govindan; Bagheri, Meisam; Saini, Deepak Kumar; Chakrapani, Harinath</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">100</span>),
    <span class="NLM_cas:pages">13352-13355</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Thera/NO - a small mol. that is activated by hydrogen peroxide to generate nitric oxide (NO) and a fluorescence signal is reported.  Using cancer and primary cells, we show that Thera/NO preferentially releases NO in cancer cells, which can trigger DNA damage and cell death in them.  The coupled fluorescence signal facilitated tracking the NO release in living cells without collateral consumption of NO.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT2i6nC8L4ULVg90H21EOLACvtfcHk0lgidYGkdifS4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVaqsLzE&md5=163f505253e0daa9063c7499ac15ebff</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1039%2FC7CC08526E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7CC08526E%26sid%3Dliteratum%253Aachs%26aulast%3DRavikumar%26aufirst%3DG.%26aulast%3DBagheri%26aufirst%3DM.%26aulast%3DSaini%26aufirst%3DD.%2BK.%26aulast%3DChakrapani%26aufirst%3DH.%26atitle%3DA%2520small%2520molecule%2520for%2520theranostic%2520targeting%2520of%2520cancer%2520cells%26jtitle%3DChem.%2520Commun.%26date%3D2017%26volume%3D53%26spage%3D13352%26epage%3D13355%26doi%3D10.1039%2FC7CC08526E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, C.</span></span> <span> </span><span class="NLM_article-title">A simple and effective “elimination” approach for selective cancer therapy to reveal the role of H<sub>2</sub>O<sub>2</sub></span>. <i>ACS Omega.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">22157</span>– <span class="NLM_lpage">22162</span>, <span class="refDoi"> DOI: 10.1021/acsomega.0c02240</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.0c02240" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A280%3ADC%252BB38bot1Grug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2020&pages=22157-22162&author=J.+Liuauthor=C.+Cao&title=A+simple+and+effective+%E2%80%9Celimination%E2%80%9D+approach+for+selective+cancer+therapy+to+reveal+the+role+of+H2O2&doi=10.1021%2Facsomega.0c02240"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">A Simple and Effective "Elimination" Approach for Selective Cancer Therapy to Reveal the Role of H2O2</span></div><div class="casAuthors">Liu Jun; Cao Cheng</div><div class="citationInfo"><span class="NLM_cas:title">ACS omega</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">22157-22162</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Fluorescence imaging capability for visualizing tumor microenvironments can play a role in advancing drug discovery efforts, exploring therapeutic efficacy, and thus significantly improving the prognosis.  Specifically, we present the design, synthesis, spectroscopic properties, and the targeting diagnosis of a single boronate-appended benzorhodol.  Drug release from the prodrug LHX-B-CPT was detected by tackling the fluorescent signal after the addition of H2O2 to the target cancer cells.  The prodrug entered the cells via endocytosis mechanisms due to the folate unit, highlighting that the final delivery locations can minutely influence drug efficacy.  Thus, this theranostic system is a new therapeutic agent, based on the reasoning that the depletion of H2O2 would be readily detected at the subcellular level by the fluorescence changes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQPNxkcQIngLLBItaL1WaVAfW6udTcc2eZbI-Fb162A2rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB38bot1Grug%253D%253D&md5=9d3182c41b79ea701ecac36dfce4560e</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1021%2Facsomega.0c02240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.0c02240%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DC.%26atitle%3DA%2520simple%2520and%2520effective%2520%25E2%2580%259Celimination%25E2%2580%259D%2520approach%2520for%2520selective%2520cancer%2520therapy%2520to%2520reveal%2520the%2520role%2520of%2520H2O2%26jtitle%3DACS%2520Omega.%26date%3D2020%26volume%3D5%26spage%3D22157%26epage%3D22162%26doi%3D10.1021%2Facsomega.0c02240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span> <span> </span><span class="NLM_article-title">Two decades under the influence of the rule of five and the changing properties of approved oral drugs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1701</span>– <span class="NLM_lpage">1714</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00686</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00686" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslait73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=1701-1714&author=M.+D.+Shultz&title=Two+decades+under+the+influence+of+the+rule+of+five+and+the+changing+properties+of+approved+oral+drugs&doi=10.1021%2Facs.jmedchem.8b00686"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Two Decades under the Influence of the Rule of Five and the Changing Properties of Approved Oral Drugs</span></div><div class="casAuthors">Shultz, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1701-1714</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two decades have passed since the rule of five ushered in the concept of "drug-like" properties.  Attempts to quantify, correlate, and categorize mols. based on Ro5 parameters evolved into the introduction of efficiency metrics with far reaching consequences in decision making by industry leaders and scientists seeking to discover new medicines.  Examn. of oral drug parameters approved before and after the original Ro5 anal. demonstrates that some parameters such as clogP and HBD remained const. while the cutoffs for parameters such as mol. wt. and HBA have increased substantially over the past 20 years.  The time dependent increase in the mol. wt. of oral drugs during the past 20 years provides compelling evidence to disprove the hypothesis that mol. wt. is a "drug-like" property.  This anal. does not validate parameters that have not changed as being "drug-like" but instead calls into question the entire hypothesis that "drug-like" properties exist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAnoxpQsv2kbVg90H21EOLACvtfcHk0lgidYGkdifS4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslait73K&md5=d3c8b1107133dc0b7b277d22fa029597</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00686%26sid%3Dliteratum%253Aachs%26aulast%3DShultz%26aufirst%3DM.%2BD.%26atitle%3DTwo%2520decades%2520under%2520the%2520influence%2520of%2520the%2520rule%2520of%2520five%2520and%2520the%2520changing%2520properties%2520of%2520approved%2520oral%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D1701%26epage%3D1714%26doi%3D10.1021%2Facs.jmedchem.8b00686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raymer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, B. K.</span></span> <span> </span><span class="NLM_article-title">Lead-like drugs: a perspective</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">10375</span>– <span class="NLM_lpage">10384</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00407</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00407" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtl2is73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=10375-10384&author=B.+Raymerauthor=B.+K.+Bhattacharya&title=Lead-like+drugs%3A+a+perspective&doi=10.1021%2Facs.jmedchem.8b00407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Lead-like Drugs: A Perspective</span></div><div class="casAuthors">Raymer, Brian; Bhattacharya, Samit K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10375-10384</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lead-like drugs, or drugs below mol. wt. 300, are an important and sometimes overlooked component of the current pharmacopeia and contemporary medicinal chem. practice.  To examine the recent state-of-the-art in lead-like drug discovery, we surveyed recent drug approvals from 2011 to 2017 and top 200 prescribed medications, as well as provide case studies on recently approved lead-like drugs.  Many of these recent drugs are close analogs of previously known drugs or natural substrates, with a key focus of their medicinal chem. optimization being the choice of a low mol. wt. starting point and maintaining low mol. wt. during the optimization.  However, the identification of low mol. wt. starting points may be limited by the availability of suitable low mol. wt. screening sets.  To increase the discovery rate of lead-like drugs, we suggest an increased focus on inclusion and prosecution of lead-like starting points in screening libraries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqDUrWKytt_7Vg90H21EOLACvtfcHk0ljdn0U5pDcEpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtl2is73O&md5=e9fc17d69c7d671459fdaf77d6721829</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00407%26sid%3Dliteratum%253Aachs%26aulast%3DRaymer%26aufirst%3DB.%26aulast%3DBhattacharya%26aufirst%3DB.%2BK.%26atitle%3DLead-like%2520drugs%253A%2520a%2520perspective%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D10375%26epage%3D10384%26doi%3D10.1021%2Facs.jmedchem.8b00407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 5 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Wei Liu, Zuhao Li, Yanqing Qiu, Jun Li, Jinfeng Yang, <span class="NLM_string-name hlFld-ContribAuthor">Jishan Li</span>. </span><span class="cited-content_cbyCitation_article-title">Biomineralization of Aggregation-Induced Emission-Active Photosensitizers for pH-Mediated Tumor Imaging and Photodynamic Therapy. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Bio Materials</span><span> <strong>2021,</strong> <em>4 </em>
                                    (7)
                                     , 5566-5574. <a href="https://doi.org/10.1021/acsabm.1c00298" title="DOI URL">https://doi.org/10.1021/acsabm.1c00298</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsabm.1c00298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsabm.1c00298%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Bio%2520Materials%26atitle%3DBiomineralization%252Bof%252BAggregation-Induced%252BEmission-Active%252BPhotosensitizers%252Bfor%252BpH-Mediated%252BTumor%252BImaging%252Band%252BPhotodynamic%252BTherapy%26aulast%3DLiu%26aufirst%3DWei%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D01042021%26date%3D10062021%26date%3D17062021%26volume%3D4%26issue%3D7%26spage%3D5566%26epage%3D5574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hanxi  Yi</span>, <span class="hlFld-ContribAuthor ">Wangxing  Lu</span>, <span class="hlFld-ContribAuthor ">Fan  Liu</span>, <span class="hlFld-ContribAuthor ">Guoqing  Zhang</span>, <span class="hlFld-ContribAuthor ">Feifan  Xie</span>, <span class="hlFld-ContribAuthor ">Wenjie  Liu</span>, <span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Wenhu  Zhou</span>, <span class="hlFld-ContribAuthor ">Zeneng  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">ROS-responsive liposomes with NIR light-triggered doxorubicin release for combinatorial therapy of breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nanobiotechnology</span><span> <strong>2021,</strong> <em>19 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12951-021-00877-6" title="DOI URL">https://doi.org/10.1186/s12951-021-00877-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12951-021-00877-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12951-021-00877-6%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nanobiotechnology%26atitle%3DROS-responsive%252Bliposomes%252Bwith%252BNIR%252Blight-triggered%252Bdoxorubicin%252Brelease%252Bfor%252Bcombinatorial%252Btherapy%252Bof%252Bbreast%252Bcancer%26aulast%3DYi%26aufirst%3DHanxi%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao-Jie  Wang</span>, <span class="hlFld-ContribAuthor ">Xinxin  Guo</span>, <span class="hlFld-ContribAuthor ">Rui-Qin  Zhai</span>, <span class="hlFld-ContribAuthor ">Changning  Sun</span>, <span class="hlFld-ContribAuthor ">Guokai  Xiao</span>, <span class="hlFld-ContribAuthor ">Jin  Chen</span>, <span class="hlFld-ContribAuthor ">Mei-Yan  Wei</span>, <span class="hlFld-ContribAuthor ">Chang-Lun  Shao</span>, <span class="hlFld-ContribAuthor ">Yuchao  Gu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of penipanoid C-inspired 2-(3,4,5-trimethoxybenzoyl)quinazolin-4(3H)-one derivatives as potential anticancer agents by inhibiting cell proliferation and inducing apoptosis in hepatocellular carcinoma cells. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>224 </em>, 113671. <a href="https://doi.org/10.1016/j.ejmech.2021.113671" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113671</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113671%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bpenipanoid%252BC-inspired%252B2-%2525283%25252C4%25252C5-trimethoxybenzoyl%252529quinazolin-4%2525283H%252529-one%252Bderivatives%252Bas%252Bpotential%252Banticancer%252Bagents%252Bby%252Binhibiting%252Bcell%252Bproliferation%252Band%252Binducing%252Bapoptosis%252Bin%252Bhepatocellular%252Bcarcinoma%252Bcells%26aulast%3DWang%26aufirst%3DChao-Jie%26date%3D2021%26volume%3D224%26spage%3D113671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xianglian  Liao</span>, <span class="hlFld-ContribAuthor ">Chunxiu  Yang</span>, <span class="hlFld-ContribAuthor ">Huiyun  Lin</span>, <span class="hlFld-ContribAuthor ">Buhong  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Quenching effects of (-)-Epigallocatechin gallate for singlet oxygen production and its protection against oxidative damage induced by Ce6-mediated photodynamic therapy in vitro. </span><span class="cited-content_cbyCitation_journal-name">Photodiagnosis and Photodynamic Therapy</span><span> <strong>2021,</strong> <em>700 </em>, 102467. <a href="https://doi.org/10.1016/j.pdpdt.2021.102467" title="DOI URL">https://doi.org/10.1016/j.pdpdt.2021.102467</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pdpdt.2021.102467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pdpdt.2021.102467%26sid%3Dliteratum%253Aachs%26jtitle%3DPhotodiagnosis%2520and%2520Photodynamic%2520Therapy%26atitle%3DQuenching%252Beffects%252Bof%252B%252528-%252529-Epigallocatechin%252Bgallate%252Bfor%252Bsinglet%252Boxygen%252Bproduction%252Band%252Bits%252Bprotection%252Bagainst%252Boxidative%252Bdamage%252Binduced%252Bby%252BCe6-mediated%252Bphotodynamic%252Btherapy%252Bin%252Bvitro%26aulast%3DLiao%26aufirst%3DXianglian%26date%3D2021%26volume%3D700%26spage%3D102467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simona  Braccini</span>, <span class="hlFld-ContribAuthor ">Giacomo  Provinciali</span>, <span class="hlFld-ContribAuthor ">Lorenzo  Biancalana</span>, <span class="hlFld-ContribAuthor ">Guido  Pampaloni</span>, <span class="hlFld-ContribAuthor ">Federica  Chiellini</span>, <span class="hlFld-ContribAuthor ">Fabio  Marchetti</span>. </span><span class="cited-content_cbyCitation_article-title">The Cytotoxic Activity of Diiron Bis-Cyclopentadienyl Complexes with Bridging C3-Ligands. </span><span class="cited-content_cbyCitation_journal-name">Applied Sciences</span><span> <strong>2021,</strong> <em>11 </em>
                                    (10)
                                     , 4351. <a href="https://doi.org/10.3390/app11104351" title="DOI URL">https://doi.org/10.3390/app11104351</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/app11104351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fapp11104351%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Sciences%26atitle%3DThe%252BCytotoxic%252BActivity%252Bof%252BDiiron%252BBis-Cyclopentadienyl%252BComplexes%252Bwith%252BBridging%252BC3-Ligands%26aulast%3DBraccini%26aufirst%3DSimona%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D10%26spage%3D4351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0032.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Drug release mechanism for arylboronate-containing ROS-responsive prodrugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Various linking strategies for designing the arylboronate-containing ROS-responsive prodrugs based on parent drugs with different functional groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Drug release mechanism for the thiazolidinone-containing ROS-responsive prodrugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Drug release mechanism for the selenium- or sulfur-containing ROS-responsive prodrugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structures of ICL-inducing prodrugs <b>5</b>–<b>8</b> and mechanisms of ICL formation induced by H<sub>2</sub>O<sub>2</sub> activation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures of ROS-responsive anticancer prodrugs <b>9</b>–<b>17</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Anticancer mechanism of the ROS-responsive prodrug <b>18</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. ROS-responsive prodrug (<b>19</b>) of an anticancer protein RNase A and its ROS-triggered drug release.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. <i>N</i>-Alkylaminoferrocene prodrugs (<b>20</b>) and the mechanism of the ROS-responsive drug release for <b>20</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Monophenylboronate- or bisphenylboronate-containing ROS-responsive prodrugs (<b>22</b>–<b>24</b>) of aminoferrocene with various substituents at the amino group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. ROS-responsive platinum-based prodrugs (<b>25</b>–<b>27</b>) and the possible mechanism of activation responsive to ROS in cancer cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Structures of ROS-responsive anticancer prodrugs <b>28</b>–<b>32</b> with Se, Te, or S atoms as the ROS-responsive trigger groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Structures of MTX and its prodrugs <b>33</b>–<b>35</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Structures of anti-inflammatory prodrugs <b>36</b>–<b>40</b> and their corresponding parent agents.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Structures of the H<sub>2</sub>O<sub>2</sub>-targeting fluorescent ROS probes <b>41</b>–<b>45</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Structures of the mitochondrial-targeting fluorescent ROS probes <b>46</b>–<b>53</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Mechanism of the ROS-responsive and mitochondrial-targeting probe <b>52</b> by a double-quenching strategy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Structures of the lysosome-targeting fluorescent ROS probes <b>54</b>–<b>56</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0019.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Mechanism of the lysosome-targeting H<sub>2</sub>O<sub>2</sub> probe <b>54</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0020.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Mechanism of fluorescence response of <b>56</b> to H<sub>2</sub>O<sub>2</sub> at different pH conditions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0021.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Structures of the nucleus-targeting fluorescent ROS probes <b>58</b> and <b>59</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0022.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Structures of cancer-cell-targetable fluorescent probes <b>60</b>–<b>62</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0023.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Mechanism of probe <b>63</b> responsiveness to H<sub>2</sub>O<sub>2</sub> in an animal model of acute inflammation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0024.jpeg" id="rightTab-gr24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Structure of the AD-targetable fluorescent probe <b>64</b> (CRANAD-88).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0025.jpeg" id="rightTab-gr25" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Structure of the PD-targetable fluorescent probe <b>65</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0026.jpeg" id="rightTab-gr26" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Structure of the ROS-responsive theranostic prodrug <b>66</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig27" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0027.jpeg" id="rightTab-gr27" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. Structures of the ROS-responsive theranostic prodrugs <b>67</b>–<b>69</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig28" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0028.jpeg" id="rightTab-gr28" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. Activation mechanism of the theranostic prodrug <b>67</b> to release the parent drug SN-38 and fluorophore in cancer cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig29" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Figure 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0029.jpeg" id="rightTab-gr29" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 29. Structure of the ROS-responsive theranostic prodrug <b>70</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig29"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig30" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Figure 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/medium/jm0c01704_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0030.jpeg" id="rightTab-gr30" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 30. Anticancer mechanism of the ROS-responsive theranostic prodrug <b>71</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01704/20210107/images/large/jm0c01704_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01704&amp;id=fig30"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i25">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78226" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78226" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 164 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmgren, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, N.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halliwell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalyanaraman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhee, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornalley, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Partridge, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gems, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyström, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belousov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacker, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winterbourn, C. C.</span></span> <span> </span><span class="NLM_article-title">Unraveling the biological roles of reactive oxygen species</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">361</span>– <span class="NLM_lpage">366</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2011.03.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.cmet.2011.03.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=21459321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktF2nsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=361-366&author=M.+P.+Murphyauthor=A.+Holmgrenauthor=N.-G.+Larssonauthor=B.+Halliwellauthor=C.+J.+Changauthor=B.+Kalyanaramanauthor=S.+G.+Rheeauthor=P.+J.+Thornalleyauthor=L.+Partridgeauthor=D.+Gemsauthor=T.+Nystr%C3%B6mauthor=V.+Belousovauthor=P.+T.+Schumackerauthor=C.+C.+Winterbourn&title=Unraveling+the+biological+roles+of+reactive+oxygen+species&doi=10.1016%2Fj.cmet.2011.03.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Unraveling the Biological Roles of Reactive Oxygen Species</span></div><div class="casAuthors">Murphy, Michael P.; Holmgren, Arne; Larsson, Nils-Goeran; Halliwell, Barry; Chang, Christopher J.; Kalyanaraman, Balaraman; Rhee, Sue Goo; Thornalley, Paul J.; Partridge, Linda; Gems, David; Nystroem, Thomas; Belousov, Vsevolod; Schumacker, Paul T.; Winterbourn, Christine C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">361-366</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Reactive oxygen species are not only harmful agents that cause oxidative damage in pathologies, they also have important roles as regulatory agents in a range of biol. phenomena.  The relatively recent development of this more nuanced view presents a challenge to the biomedical research community on how best to assess the significance of reactive oxygen species and oxidative damage in biol. systems.  Considerable progress is being made in addressing these issues, and here we survey some recent developments for those contemplating research in this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKbT56CVsbG7Vg90H21EOLACvtfcHk0lhIjhuLS9wrxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktF2nsL4%253D&md5=f08569bc26aee0e8093983bfde841211</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2011.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2011.03.010%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26aulast%3DHolmgren%26aufirst%3DA.%26aulast%3DLarsson%26aufirst%3DN.-G.%26aulast%3DHalliwell%26aufirst%3DB.%26aulast%3DChang%26aufirst%3DC.%2BJ.%26aulast%3DKalyanaraman%26aufirst%3DB.%26aulast%3DRhee%26aufirst%3DS.%2BG.%26aulast%3DThornalley%26aufirst%3DP.%2BJ.%26aulast%3DPartridge%26aufirst%3DL.%26aulast%3DGems%26aufirst%3DD.%26aulast%3DNystr%25C3%25B6m%26aufirst%3DT.%26aulast%3DBelousov%26aufirst%3DV.%26aulast%3DSchumacker%26aufirst%3DP.%2BT.%26aulast%3DWinterbourn%26aufirst%3DC.%2BC.%26atitle%3DUnraveling%2520the%2520biological%2520roles%2520of%2520reactive%2520oxygen%2520species%26jtitle%3DCell%2520Metab.%26date%3D2011%26volume%3D13%26spage%3D361%26epage%3D366%26doi%3D10.1016%2Fj.cmet.2011.03.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finkel, T.</span></span> <span> </span><span class="NLM_article-title">Oxidant signals and oxidative stress</span>. <i>Curr. Opin. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1016/S0955-0674(03)00002-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2FS0955-0674%2803%2900002-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=12648682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitV2msLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2003&pages=247-254&author=T.+Finkel&title=Oxidant+signals+and+oxidative+stress&doi=10.1016%2FS0955-0674%2803%2900002-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidant signals and oxidative stress</span></div><div class="casAuthors">Finkel, Toren</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">247-254</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Although oxidants clearly possess the capacity to behave in a random and destructive fashion, growing evidence suggests that in many instances the prodn. of reactive oxygen species is tightly regulated and their downstream targets exquisitely specific.  This past year, several notable advances have been made in defining the specific redox-dependent targets of intracellular oxidants, as well as the myriad pathways that appear to employ oxidants as effector mols.  These new studies have significantly altered our understanding of how reactive oxygen species participate in diverse processes from tumorigenesis to aging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAh8RKELmCErVg90H21EOLACvtfcHk0ljGrPlEZ1txXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitV2msLo%253D&md5=89ef7bdb5b3f4f99d22e2239cbe2c9a7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0955-0674%2803%2900002-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0955-0674%252803%252900002-4%26sid%3Dliteratum%253Aachs%26aulast%3DFinkel%26aufirst%3DT.%26atitle%3DOxidant%2520signals%2520and%2520oxidative%2520stress%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2003%26volume%3D15%26spage%3D247%26epage%3D254%26doi%3D10.1016%2FS0955-0674%2803%2900002-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rhee, S. G.</span></span> <span> </span><span class="NLM_article-title">Cell signaling. H<sub>2</sub>O<sub>2</sub>, a necessary evil for cell signaling</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>312</i></span>,  <span class="NLM_fpage">1882</span>– <span class="NLM_lpage">1883</span>, <span class="refDoi"> DOI: 10.1126/science.1130481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1126%2Fscience.1130481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=16809515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A280%3ADC%252BD28zpt1Oiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=2006&pages=1882-1883&author=S.+G.+Rhee&title=Cell+signaling.+H2O2%2C+a+necessary+evil+for+cell+signaling&doi=10.1126%2Fscience.1130481"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Cell signaling. H2O2, a necessary evil for cell signaling</span></div><div class="casAuthors">Rhee Sue Goo</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">312</span>
        (<span class="NLM_cas:issue">5782</span>),
    <span class="NLM_cas:pages">1882-3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT5jW4yY2PH7u98rul4nhSdfW6udTcc2eYqjHqMigIEzrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28zpt1Oiug%253D%253D&md5=2942e179a4630f55507999873367c240</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscience.1130481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1130481%26sid%3Dliteratum%253Aachs%26aulast%3DRhee%26aufirst%3DS.%2BG.%26atitle%3DCell%2520signaling.%2520H2O2%252C%2520a%2520necessary%2520evil%2520for%2520cell%2520signaling%26jtitle%3DScience%26date%3D2006%26volume%3D312%26spage%3D1882%26epage%3D1883%26doi%3D10.1126%2Fscience.1130481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, J.</span></span> <span> </span><span class="NLM_article-title">Fluorescent and luminescent probes for detection of reactive oxygen and nitrogen species</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">4783</span>– <span class="NLM_lpage">4804</span>, <span class="refDoi"> DOI: 10.1039/c1cs15037e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1039%2Fc1cs15037e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=21629957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVeitbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2011&pages=4783-4804&author=X.+Chenauthor=X.+Tianauthor=I.+Shinauthor=J.+Yoon&title=Fluorescent+and+luminescent+probes+for+detection+of+reactive+oxygen+and+nitrogen+species&doi=10.1039%2Fc1cs15037e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescent and luminescent probes for detection of reactive oxygen and nitrogen species</span></div><div class="casAuthors">Chen, Xiaoqiang; Tian, Xizhe; Shin, Injae; Yoon, Juyoung</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4783-4804</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Oxidative and nitrosative stress induced by ROS/RNS play crucial roles in a wide range of physiol. processes and are also implicated in various diseases, including cancer and neurodegenerative disorders.  Sensitive and selective methods for the detection of ROS/RNS based on fluorescent and luminescent probes are of great use in monitoring the in vivo prodn. of these species and elucidating their biol. functions.  This crit. review highlights recent advances that were made in the development of fluorescent and luminescent probes employed to monitor various ROS/RNS (132 refs.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQZZWhDY-Sl7Vg90H21EOLACvtfcHk0ljGrPlEZ1txXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVeitbfN&md5=c5d039ab805a21f3845f6b3919039a42</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1039%2Fc1cs15037e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1cs15037e%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DShin%26aufirst%3DI.%26aulast%3DYoon%26aufirst%3DJ.%26atitle%3DFluorescent%2520and%2520luminescent%2520probes%2520for%2520detection%2520of%2520reactive%2520oxygen%2520and%2520nitrogen%2520species%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2011%26volume%3D40%26spage%3D4783%26epage%3D4804%26doi%3D10.1039%2Fc1cs15037e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trachootham, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span> <span> </span><span class="NLM_article-title">Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">579</span>– <span class="NLM_lpage">591</span>, <span class="refDoi"> DOI: 10.1038/nrd2803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1038%2Fnrd2803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=19478820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsFWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=579-591&author=D.+Trachoothamauthor=J.+Alexandreauthor=P.+Huang&title=Targeting+cancer+cells+by+ROS-mediated+mechanisms%3A+a+radical+therapeutic+approach%3F&doi=10.1038%2Fnrd2803"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?</span></div><div class="casAuthors">Trachootham, Dunyaporn; Alexandre, Jerome; Huang, Peng</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">579-591</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Increased generation of reactive oxygen species (ROS) and an altered redox status have long been obsd. in cancer cells, and recent studies suggest that this biochem. property of cancer cells can be exploited for therapeutic benefits.  Cancer cells in advanced stage tumors frequently exhibit multiple genetic alterations and high oxidative stress, suggesting that it might be possible to preferentially eliminate these cells by pharmacol. ROS insults.  However, the upregulation of antioxidant capacity in adaptation to intrinsic oxidative stress in cancer cells can confer drug resistance.  Abrogation of such drug-resistant mechanisms by redox modulation could have significant therapeutic implications.  We argue that modulating the unique redox regulatory mechanisms of cancer cells might be an effective strategy to eliminate these cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobgIa2fgBPBrVg90H21EOLACvtfcHk0ljw8h80MrL-lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsFWqsLk%253D&md5=d50931b8de8bcab62d376becc768a71c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd2803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2803%26sid%3Dliteratum%253Aachs%26aulast%3DTrachootham%26aufirst%3DD.%26aulast%3DAlexandre%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DP.%26atitle%3DTargeting%2520cancer%2520cells%2520by%2520ROS-mediated%2520mechanisms%253A%2520a%2520radical%2520therapeutic%2520approach%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D579%26epage%3D591%26doi%3D10.1038%2Fnrd2803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">D’Autreaux, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toledano, M. B.</span></span> <span> </span><span class="NLM_article-title">ROS as signaling molecules: mechanisms that generate specificity in ROS homeostasis</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">813</span>– <span class="NLM_lpage">824</span>, <span class="refDoi"> DOI: 10.1038/nrm2256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1038%2Fnrm2256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=17848967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKmt7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=813-824&author=B.+D%E2%80%99Autreauxauthor=M.+B.+Toledano&title=ROS+as+signaling+molecules%3A+mechanisms+that+generate+specificity+in+ROS+homeostasis&doi=10.1038%2Fnrm2256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">ROS as signaling molecules: mechanisms that generate specificity in ROS homeostasis</span></div><div class="casAuthors">D'Autreaux, Benoit; Toledano, Michel B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">813-824</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Reactive O species (ROS) have been shown to be toxic but also to function as signaling mols.  This biol. paradox underlies mechanisms that are important for the integrity and fitness of living organisms and their aging.  The pathways that regulate ROS homeostasis are crucial for mitigating the toxicity of ROS and provide strong evidence about specificity in ROS signaling.  By taking advantage of the chem. of ROS, highly specific mechanisms have evolved that form the basis of oxidant scavenging and ROS signaling systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR5hZl87z2WLVg90H21EOLACvtfcHk0ljw8h80MrL-lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKmt7rF&md5=5302fd59fdfaf8636793ea768f188219</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrm2256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2256%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Autreaux%26aufirst%3DB.%26aulast%3DToledano%26aufirst%3DM.%2BB.%26atitle%3DROS%2520as%2520signaling%2520molecules%253A%2520mechanisms%2520that%2520generate%2520specificity%2520in%2520ROS%2520homeostasis%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2007%26volume%3D8%26spage%3D813%26epage%3D824%26doi%3D10.1038%2Fnrm2256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schumacker, P. T.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species in cancer cells: live by the sword, die by the sword</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">175</span>– <span class="NLM_lpage">176</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2006.08.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.ccr.2006.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=16959608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVSlu73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=175-176&author=P.+T.+Schumacker&title=Reactive+oxygen+species+in+cancer+cells%3A+live+by+the+sword%2C+die+by+the+sword&doi=10.1016%2Fj.ccr.2006.08.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species in cancer cells: live by the sword, die by the sword</span></div><div class="casAuthors">Schumacker, Paul T.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">175-176</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Reactive oxygen species and tumor biol. are intertwined in a complex web, making it difficult to understand which came first, whether oxidants are required for tumor cell growth, and whether oxidant stress can be exploited therapeutically.  Evidence suggests that transformed cells use ROS signals to drive proliferation and other events required for tumor progression.  This confers a state of increased basal oxidative stress, making them vulnerable to chemotherapeutic agents that further augment ROS generation or that weaken antioxidant defenses of the cell.  In this respect, it appears that tumor cells may die by the same systems they require.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE87Ik9Nnb2bVg90H21EOLACvtfcHk0ljw8h80MrL-lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVSlu73M&md5=aa7c8ed4524ce0392d478c53090925d1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2006.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2006.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DSchumacker%26aufirst%3DP.%2BT.%26atitle%3DReactive%2520oxygen%2520species%2520in%2520cancer%2520cells%253A%2520live%2520by%2520the%2520sword%252C%2520die%2520by%2520the%2520sword%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D10%26spage%3D175%26epage%3D176%26doi%3D10.1016%2Fj.ccr.2006.08.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suh, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lassegue, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorescu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griendling, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambeth, J. D.</span></span> <span> </span><span class="NLM_article-title">Cell transformation by the superoxide-generating oxidase Mox1</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>401</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">82</span>, <span class="refDoi"> DOI: 10.1038/43459</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1038%2F43459" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10485709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADyaK1MXlvVGmsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=401&publication_year=1999&pages=79-82&author=Y.+A.+Suhauthor=R.+S.+Arnoldauthor=B.+Lassegueauthor=J.+Shiauthor=X.+Xuauthor=D.+Sorescuauthor=A.+B.+Chungauthor=K.+K.+Griendlingauthor=J.+D.+Lambeth&title=Cell+transformation+by+the+superoxide-generating+oxidase+Mox1&doi=10.1038%2F43459"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cell transformation by the superoxide-generating oxidase Mox1</span></div><div class="casAuthors">Suh, Young-Ah; Arnold, Rebecca S.; Lassegue, Bernard; Shi, Jing; Xu, Xlangxi; Sorescu, Dan; Chung, Andrew B.; Griendling, Kathy K.; Lambeth, J. David</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">401</span>
        (<span class="NLM_cas:issue">6748</span>),
    <span class="NLM_cas:pages">79-82</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS) generated in some non-phagocytic cells are implicated in mitogenic signaling and cancer.  Many cancer cells show increased prodn. of ROS, and normal cells exposed to hydrogen peroxide or superoxide show increased proliferation and express growth-related genes.  ROS are generated in response to growth factors, and may affect cell growth, for example in vascular smooth-muscle cells.  Increased ROS in Ras-transformed fibroblasts correlates with increased mitogenic rate.  Here the authors describe the cloning of mox1, which encodes a homolog of the catalytic subunit of the superoxide-generating NADPH oxidase of phagocytes, gp91phox.  Mox1 mRNA is expressed in colon, prostate, uterus and vascular smooth muscle, but not in peripheral blood leukocytes.  In smooth-muscle cells, platelet-derived growth factor induces mox1 mRNA prodn., while antisense mox1 mRNA decreases superoxide generation and serum-stimulated growth.  Overexpression of mox1 in NIH3T3 cells increases superoxide generation and cell growth.  Cells expressing mox1 have a transformed appearance, show anchorage-independent growth and produce tumors in athymic mice.  These data link ROS prodn. by Mox1 to growth control in non-phagocytic cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbUPMilVZ4P7Vg90H21EOLACvtfcHk0ljw8h80MrL-lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvVGmsbg%253D&md5=6e25d37a6cfc28f9c53e798fa928382e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F43459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F43459%26sid%3Dliteratum%253Aachs%26aulast%3DSuh%26aufirst%3DY.%2BA.%26aulast%3DArnold%26aufirst%3DR.%2BS.%26aulast%3DLassegue%26aufirst%3DB.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DSorescu%26aufirst%3DD.%26aulast%3DChung%26aufirst%3DA.%2BB.%26aulast%3DGriendling%26aufirst%3DK.%2BK.%26aulast%3DLambeth%26aufirst%3DJ.%2BD.%26atitle%3DCell%2520transformation%2520by%2520the%2520superoxide-generating%2520oxidase%2520Mox1%26jtitle%3DNature%26date%3D1999%26volume%3D401%26spage%3D79%26epage%3D82%26doi%3D10.1038%2F43459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koh, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halliwell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenner, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laughton, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beart, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, N. S.</span></span> <span> </span><span class="NLM_article-title">Chronic exposure to U18666A is associated with oxidative stress in cultured murine cortical neurons</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">1278</span>– <span class="NLM_lpage">1289</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2006.03958.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1111%2Fj.1471-4159.2006.03958.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=16771828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFemu7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2006&pages=1278-1289&author=C.+H.+Kohauthor=M.+Whitemanauthor=Q.+X.+Liauthor=B.+Halliwellauthor=A.+M.+Jennerauthor=B.+S.+Wongauthor=K.+M.+Laughtonauthor=M.+Wenkauthor=C.+L.+Mastersauthor=P.+M.+Beartauthor=O.+Bernardauthor=N.+S.+Cheung&title=Chronic+exposure+to+U18666A+is+associated+with+oxidative+stress+in+cultured+murine+cortical+neurons&doi=10.1111%2Fj.1471-4159.2006.03958.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic exposure to U18666A is associated with oxidative stress in cultured murine cortical neurons</span></div><div class="casAuthors">Koh, Chor Hui Vivien; Whiteman, Matthew; Li, Qiao-Xin; Halliwell, Barry; Jenner, Andrew M.; Wong, Boon Seng; Laughton, Katrina M.; Wenk, Markus; Masters, Colin L.; Beart, Philip M.; Bernard, Ora; Cheung, Nam Sang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1278-1289</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Findings that antioxidant treatment may be beneficial in Alzheimer's disease indicate that oxidative stress is an important factor in its pathogenesis.  Studies have also suggested that cholesterol imbalance in the brain might be related to the development of neurol. disorders.  Previously, we have reported that U18666A, a cholesterol transport-inhibiting agent, leads to apoptosis and intracellular cholesterol accumulation in primary cortical neurons.  In this study, we found that neuronal apoptosis mediated by U18666A is assocd. with oxidative stress in the treated cortical neurons.  Cortical neurons treated with U18666A also showed decreased secretion and increased intraneuronal accumulation of β-amyloid.  The assocn. of neuronal apoptosis with oxidative stress and Aβ accumulation may provide clues to the pathogenesis of Alzheimer's disease, as well as the role oxidative stress plays in other neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSmp0_cKwoA7Vg90H21EOLACvtfcHk0lhICl1WwXyiQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFemu7bK&md5=9f460d08ee51c0d1ac1fb1f1a0ccc4d1</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.03958.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.03958.x%26sid%3Dliteratum%253Aachs%26aulast%3DKoh%26aufirst%3DC.%2BH.%26aulast%3DWhiteman%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DQ.%2BX.%26aulast%3DHalliwell%26aufirst%3DB.%26aulast%3DJenner%26aufirst%3DA.%2BM.%26aulast%3DWong%26aufirst%3DB.%2BS.%26aulast%3DLaughton%26aufirst%3DK.%2BM.%26aulast%3DWenk%26aufirst%3DM.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DBeart%26aufirst%3DP.%2BM.%26aulast%3DBernard%26aufirst%3DO.%26aulast%3DCheung%26aufirst%3DN.%2BS.%26atitle%3DChronic%2520exposure%2520to%2520U18666A%2520is%2520associated%2520with%2520oxidative%2520stress%2520in%2520cultured%2520murine%2520cortical%2520neurons%26jtitle%3DJ.%2520Neurochem.%26date%3D2006%26volume%3D98%26spage%3D1278%26epage%3D1289%26doi%3D10.1111%2Fj.1471-4159.2006.03958.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mittal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malik, A. B.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species in inflammation and tissue injury</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1126</span>– <span class="NLM_lpage">1167</span>, <span class="refDoi"> DOI: 10.1089/ars.2012.5149</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1089%2Fars.2012.5149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=23991888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2cXit12qtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=1126-1167&author=M.+Mittalauthor=M.+R.+Siddiquiauthor=K.+Tranauthor=S.+P.+Reddyauthor=A.+B.+Malik&title=Reactive+oxygen+species+in+inflammation+and+tissue+injury&doi=10.1089%2Fars.2012.5149"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive Oxygen Species in Inflammation and Tissue Injury</span></div><div class="casAuthors">Mittal, Manish; Siddiqui, Mohammad Rizwan; Tran, Khiem; Reddy, Sekhar P.; Malik, Asrar B.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1126-1167</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Reactive oxygen species (ROS) are key signaling mols. that play an important role in the progression of inflammatory disorders.  An enhanced ROS generation by polymorphonuclear neutrophils (PMNs) at the site of inflammation causes endothelial dysfunction and tissue injury.  The vascular endothelium plays an important role in passage of macromols. and inflammatory cells from the blood to tissue.  Under the inflammatory conditions, oxidative stress produced by PMNs leads to the opening of inter-endothelial junctions and promotes the migration of inflammatory cells across the endothelial barrier.  The migrated inflammatory cells not only help in the clearance of pathogens and foreign particles but also lead to tissue injury.  The current review compiles the past and current research in the area of inflammation with particular emphasis on oxidative stress-mediated signaling mechanisms that are involved in inflammation and tissue injury.  Antioxid. Redox Signal. 20, 1126-1167.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot8O-h45Zi6LVg90H21EOLACvtfcHk0lhICl1WwXyiQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXit12qtbg%253D&md5=324f08a1e66b88576526690cb6583cf5</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1089%2Fars.2012.5149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2012.5149%26sid%3Dliteratum%253Aachs%26aulast%3DMittal%26aufirst%3DM.%26aulast%3DSiddiqui%26aufirst%3DM.%2BR.%26aulast%3DTran%26aufirst%3DK.%26aulast%3DReddy%26aufirst%3DS.%2BP.%26aulast%3DMalik%26aufirst%3DA.%2BB.%26atitle%3DReactive%2520oxygen%2520species%2520in%2520inflammation%2520and%2520tissue%2520injury%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2014%26volume%3D20%26spage%3D1126%26epage%3D1167%26doi%3D10.1089%2Fars.2012.5149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barnham, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, A. I.</span></span> <span> </span><span class="NLM_article-title">Neurodegenerative diseases and oxidative stress</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">214</span>, <span class="refDoi"> DOI: 10.1038/nrd1330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1038%2Fnrd1330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=15031734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD2cXit12nsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=205-214&author=K.+J.+Barnhamauthor=C.+L.+Mastersauthor=A.+I.+Bush&title=Neurodegenerative+diseases+and+oxidative+stress&doi=10.1038%2Fnrd1330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Neurodegenerative diseases and oxidative stress</span></div><div class="casAuthors">Barnham, Kevin J.; Masters, Colin L.; Bush, Ashley I.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">205-214</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Oxidative stress has been implicated in the progression of Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.  Oxygen is vital for life but is also potentially dangerous, and a complex system of checks and balances exists for utilizing this essential element.  Oxidative stress is the result of an imbalance in pro-oxidant/antioxidant homeostasis that leads to the generation of toxic reactive oxygen species.  The systems in place to cope with the biochem. of oxygen are complex, and many questions about the mechanisms of oxygen regulation remain unanswered.  However, this same complexity provides a no. of therapeutic targets, and different strategies, including novel metal-protein attenuating compds., aimed at a variety of targets have shown promise in clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPqGR8Vlz1hLVg90H21EOLACvtfcHk0lhICl1WwXyiQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXit12nsL4%253D&md5=73a09223923e8b895ebee89405e5c7fd</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnrd1330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1330%26sid%3Dliteratum%253Aachs%26aulast%3DBarnham%26aufirst%3DK.%2BJ.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DBush%26aufirst%3DA.%2BI.%26atitle%3DNeurodegenerative%2520diseases%2520and%2520oxidative%2520stress%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D205%26epage%3D214%26doi%3D10.1038%2Fnrd1330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, M. P.</span></span> <span> </span><span class="NLM_article-title">Pathways towards and away from Alzheimer’s disease</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>430</i></span>,  <span class="NLM_fpage">631</span>– <span class="NLM_lpage">639</span>, <span class="refDoi"> DOI: 10.1038/nature02621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1038%2Fnature02621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=15295589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmt1Gis7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=430&publication_year=2004&pages=631-639&author=M.+P.+Mattson&title=Pathways+towards+and+away+from+Alzheimer%E2%80%99s+disease&doi=10.1038%2Fnature02621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Pathways towards and away from Alzheimer's disease</span></div><div class="casAuthors">Mattson, Mark P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">430</span>
        (<span class="NLM_cas:issue">7000</span>),
    <span class="NLM_cas:pages">631-639</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Slowly but surely, Alzheimer's disease (AD) patients lose their memory and their cognitive abilities, and even their personalities may change dramatically.  These changes are due to the progressive dysfunction and death of nerve cells that are responsible for the storage and processing of information.  Although drugs can temporarily improve memory, at present there are no treatments that can stop or reverse the inexorable neurodegenerative process.  But rapid progress towards understanding the cellular and mol. alterations that are responsible for the neuron's demise may soon help in developing effective preventative and therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQHWKtbjr0cLVg90H21EOLACvtfcHk0lhsYeBX8FsEFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmt1Gis7o%253D&md5=796c7f13ce37cf041c62266bad2f7218</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnature02621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02621%26sid%3Dliteratum%253Aachs%26aulast%3DMattson%26aufirst%3DM.%2BP.%26atitle%3DPathways%2520towards%2520and%2520away%2520from%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D2004%26volume%3D430%26spage%3D631%26epage%3D639%26doi%3D10.1038%2Fnature02621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wersinger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidhu, A.</span></span> <span> </span><span class="NLM_article-title">Differential cytotoxicity of dopamine and H<sub>2</sub>O<sub>2</sub> in a human neuroblastoma divided cell line transfected with α-synuclein and its familial Parkinson’s disease-linked mutants</span>. <i>Neurosci. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>342</i></span>,  <span class="NLM_fpage">124</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1016/S0304-3940(03)00212-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2FS0304-3940%2803%2900212-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=12727333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjt1Ohsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2003&pages=124-128&author=C.+Wersingerauthor=A.+Sidhu&title=Differential+cytotoxicity+of+dopamine+and+H2O2+in+a+human+neuroblastoma+divided+cell+line+transfected+with+%CE%B1-synuclein+and+its+familial+Parkinson%E2%80%99s+disease-linked+mutants&doi=10.1016%2FS0304-3940%2803%2900212-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Differential cytotoxicity of dopamine and H2O2 in a human neuroblastoma divided cell line transfected with α-synuclein and its familial Parkinson's disease-linked mutants</span></div><div class="casAuthors">Wersinger, Christophe; Sidhu, Anita</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">342</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">124-128</span>CODEN:
                <span class="NLM_cas:coden">NELED5</span>;
        ISSN:<span class="NLM_cas:issn">0304-3940</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">α-Synuclein accumulates in Lewy bodies and two missense mutations, A30P and A53T, have been linked to familial Parkinson's disease.  Neither the normal function of α-synuclein nor the pathomechanism of α-synuclein-induced neuropathy are known.  SK-N-MC neuroblastoma cells were transiently transfected with either wt α-synuclein, or its mutants, and their abilities to protect against oxidative stress were assessed.  At low expression levels (1 μg cDNA/105 cells), all three synuclein variants were devoid of any effect on dopamine-induced cytotoxicity and nitrite prodn., whereas at higher expression (5 μg cDNA/105 cells), the variants enhanced dopamine-mediated effects.  Low levels of wt α-synuclein blocked H2O2-induced cytotoxicity and nitrite prodn., a protective effect that was partly decreased upon higher expression.  Both A30P and A53T increased in a dose-dependent manner H2O2-induced nitrite prodn. and cell death.  These results show an absence of protective effects for the A30P/A53T mutants, and a differential cytoprotective role of α-synuclein against oxidants, which varies according to expression levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzzgw5lWoTMbVg90H21EOLACvtfcHk0lhsYeBX8FsEFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjt1Ohsbk%253D&md5=4355895cf8a1ba0ba6542e9f68f4e03a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0304-3940%2803%2900212-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3940%252803%252900212-X%26sid%3Dliteratum%253Aachs%26aulast%3DWersinger%26aufirst%3DC.%26aulast%3DSidhu%26aufirst%3DA.%26atitle%3DDifferential%2520cytotoxicity%2520of%2520dopamine%2520and%2520H2O2%2520in%2520a%2520human%2520neuroblastoma%2520divided%2520cell%2520line%2520transfected%2520with%2520%25CE%25B1-synuclein%2520and%2520its%2520familial%2520Parkinson%25E2%2580%2599s%2520disease-linked%2520mutants%26jtitle%3DNeurosci.%2520Lett.%26date%3D2003%26volume%3D342%26spage%3D124%26epage%3D128%26doi%3D10.1016%2FS0304-3940%2803%2900212-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Serrano, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feito, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Mayorga, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diez-Orejas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matesanz, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portolés, M. T.</span></span> <span> </span><span class="NLM_article-title">Response of macrophages and neural cells in contact with reduced graphene oxide microfibers</span>. <i>Biomater. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">2987</span>– <span class="NLM_lpage">2997</span>, <span class="refDoi"> DOI: 10.1039/C8BM00902C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1039%2FC8BM00902C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=30255874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslGnu7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2018&pages=2987-2997&author=M.+C.+Serranoauthor=M.+J.+Feitoauthor=A.+Gonz%C3%A1lez-Mayorgaauthor=R.+Diez-Orejasauthor=M.+C.+Matesanzauthor=M.+T.+Portol%C3%A9s&title=Response+of+macrophages+and+neural+cells+in+contact+with+reduced+graphene+oxide+microfibers&doi=10.1039%2FC8BM00902C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Response of macrophages and neural cells in contact with reduced graphene oxide microfibers</span></div><div class="casAuthors">Serrano, M. C.; Feito, M. J.; Gonzalez-Mayorga, A.; Diez-Orejas, R.; Matesanz, M. C.; Portoles, M. T.</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2987-2997</span>CODEN:
                <span class="NLM_cas:coden">BSICCH</span>;
        ISSN:<span class="NLM_cas:issn">2047-4849</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Graphene-based materials are revealing a great promise for biomedical applications and demonstrating attractiveness for neural repair.  In the context of neural tissue damage, the dialogue between neural and immune cells appears crit. for driving regeneration, thus making the understanding of their relations pivotal.  Herein, the acute response of RAW-264.7 macrophages on nanostructured reduced graphene oxide (rGO) microfibers has been evaluated through the anal. of cell parameters including proliferation, viability, intracellular content of reactive oxygen species, cell cycle, apoptosis, and cell size and complexity.  The influence of the direct contact of rGO microfibers on their polarization towards M1 and M2 phenotypes has been studied by analyses of both M1 (CD80) and M2 (CD163) markers and the secretion of the inflammatory cytokines TNF-α and IL-6.  Finally, the capability of these rGO microfibers to regulate neural stem cell differentiation has been also evaluated.  Findings reveal that rGO microfibers inhibit the proliferation of RAW-264.7 macrophages without affecting their viability and cell cycle profiles.  The presence of M1 and M2 macrophages on these microfibers was confirmed after 24 and 48 h, resp., accompanied by a decrease in TNF-α and an increase in IL-6 cytokine secretion.  These rGO microfibers were also able to support the formation of a highly interconnected neural culture composed of both neurons (map2+ cells) and glial cells (vimentin+ cells).  These findings encourage further investigation of these microfibers as attractive biomaterials to interact with immune and neural cells, attempting to support wound healing and tissue repair after implantation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrihdOMvYqE5rVg90H21EOLACvtfcHk0lhsYeBX8FsEFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslGnu7zO&md5=8a2a3f27337d2e75299e0e8f49cf6cda</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1039%2FC8BM00902C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8BM00902C%26sid%3Dliteratum%253Aachs%26aulast%3DSerrano%26aufirst%3DM.%2BC.%26aulast%3DFeito%26aufirst%3DM.%2BJ.%26aulast%3DGonz%25C3%25A1lez-Mayorga%26aufirst%3DA.%26aulast%3DDiez-Orejas%26aufirst%3DR.%26aulast%3DMatesanz%26aufirst%3DM.%2BC.%26aulast%3DPortol%25C3%25A9s%26aufirst%3DM.%2BT.%26atitle%3DResponse%2520of%2520macrophages%2520and%2520neural%2520cells%2520in%2520contact%2520with%2520reduced%2520graphene%2520oxide%2520microfibers%26jtitle%3DBiomater.%2520Sci.%26date%3D2018%26volume%3D6%26spage%3D2987%26epage%3D2997%26doi%3D10.1039%2FC8BM00902C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turrens, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boveris, A.</span></span> <span> </span><span class="NLM_article-title">Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>191</i></span>,  <span class="NLM_fpage">421</span>– <span class="NLM_lpage">427</span>, <span class="refDoi"> DOI: 10.1042/bj1910421</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1042%2Fbj1910421" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=6263247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADyaL3MXlvF2mtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=1980&pages=421-427&author=J.+F.+Turrensauthor=A.+Boveris&title=Generation+of+superoxide+anion+by+the+NADH+dehydrogenase+of+bovine+heart+mitochondria&doi=10.1042%2Fbj1910421"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria</span></div><div class="casAuthors">Turrens, Julio F.; Boveris, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">421-7</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    </div><div class="casAbstract">Submitochondrial particles from bovine heart in which NADH dehydrogenase (I) was reduced by addn. of NADH and rotenone or by reversed electron transfer generated ∼0.9 nmol O2-/min/mg protein at pH 7.4 and 30°.  With NADH as substrate, rotenone, antimycin, and cyanide increased O2- prodn.  In NADH- and antimycin-supplemented submitochondrial particles, rotenone had a biphasic effect: it stimulated and inhibited O2- prodn. at the I and the ubiquinone-cytochrome b (II) sites, resp.  Generation of O2- by I supported by reversed electron transfer was inhibited by rotenone, an uncoupler, and oligomycin at concns. inhibitory to energy-dependent succinate-NAD reductase.  Cyanide did not affect and inhibited O2- generation at I and the II site, resp.  Prodn. of O2- at I was ∼50% of that at the II area.  Activity of these 2 O2--producing sites occurred over the pH range 7.0-8.8.  An O2--dependent autocatalytic process requiring NADH, submitochondrial particles, and adrenaline is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPMJIBopl-ZrVg90H21EOLACvtfcHk0liXp-PUoY3z0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXlvF2mtg%253D%253D&md5=c2afbcbafe1c4a3e951e7bc67660a112</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1042%2Fbj1910421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj1910421%26sid%3Dliteratum%253Aachs%26aulast%3DTurrens%26aufirst%3DJ.%2BF.%26aulast%3DBoveris%26aufirst%3DA.%26atitle%3DGeneration%2520of%2520superoxide%2520anion%2520by%2520the%2520NADH%2520dehydrogenase%2520of%2520bovine%2520heart%2520mitochondria%26jtitle%3DBiochem.%2520J.%26date%3D1980%26volume%3D191%26spage%3D421%26epage%3D427%26doi%3D10.1042%2Fbj1910421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cullen, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinfeld, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, X. C.</span></span> <span> </span><span class="NLM_article-title">Arsenic binding to proteins</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">7769</span>– <span class="NLM_lpage">7792</span>, <span class="refDoi"> DOI: 10.1021/cr300015c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr300015c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVals7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2013&pages=7769-7792&author=S.+Shenauthor=X.-F.+Liauthor=W.+R.+Cullenauthor=M.+Weinfeldauthor=X.+C.+Le&title=Arsenic+binding+to+proteins&doi=10.1021%2Fcr300015c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Arsenic binding to proteins</span></div><div class="casAuthors">Shen, Shengwen; Li, Xing-Fang; Cullen, William R.; Weinfeld, Michael; Le, X. Chris</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">7769-7792</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The chem. basis and biol. implications and consequences of As binding to proteins are discussed.  Anal. techniques and the characteristics of As binding, including binding affinity, kinetics, and speciation are also described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCuo8emKPDRrVg90H21EOLACvtfcHk0liXp-PUoY3z0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVals7fO&md5=e7b8feb6cfc2faa2cf0e9c68666a04d4</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fcr300015c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr300015c%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.-F.%26aulast%3DCullen%26aufirst%3DW.%2BR.%26aulast%3DWeinfeld%26aufirst%3DM.%26aulast%3DLe%26aufirst%3DX.%2BC.%26atitle%3DArsenic%2520binding%2520to%2520proteins%26jtitle%3DChem.%2520Rev.%26date%3D2013%26volume%3D113%26spage%3D7769%26epage%3D7792%26doi%3D10.1021%2Fcr300015c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woods, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolthoff, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meehan, E. J.</span></span> <span> </span><span class="NLM_article-title">Arsenic (IV) as an intermediate in the induced oxidation of arsenic (III) by the iron (II)-hydrogen peroxide reaction</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1964</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">1698</span>– <span class="NLM_lpage">1700</span>, <span class="refDoi"> DOI: 10.1021/ja01063a011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01063a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADyaF2cXovVehtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1964&pages=1698-1700&author=R.+Woodsauthor=I.+M.+Kolthoffauthor=E.+J.+Meehan&title=Arsenic+%28IV%29+as+an+intermediate+in+the+induced+oxidation+of+arsenic+%28III%29+by+the+iron+%28II%29-hydrogen+peroxide+reaction&doi=10.1021%2Fja01063a011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Arsenic(IV) as an intermediate in the induced oxidation of arsenic(III) by the iron(II)-hydrogen peroxide reaction</span></div><div class="casAuthors">Woods, R.; Kolthoff, I. M.; Meehan, E. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1964</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1698-1700</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The Fe(II)-H2O2 couple induces the oxidn. of As(III).  The mechanism involving the intermediate formation of As(IV), is similar to that in the induced oxidn. of As (III) by the Fe(II)- peroxydisulfate couple and the photoredn. of Fe(III).  From a study of the induced oxidn. of As(III) at 25° the ratio of the rate consts. of the reactions of the hydroxyl free radical with As(III) and Fe(II) was calcd. to be 4, in satisfactory agreement with a value of 2 from the photoinduced oxidn. of As(III) by Fe(III).  This ratio for the active intermediate formed in the peroxydisulfate-Fe(II) reaction is 21.  In the Fe(II)-peroxydisulfate inducing reaction, SO4•- oxidizes As(III) to As(IV).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlhlq7XC-AmbVg90H21EOLACvtfcHk0liXp-PUoY3z0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2cXovVehtA%253D%253D&md5=28433794fae19f2059143db86b8e7b96</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fja01063a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01063a011%26sid%3Dliteratum%253Aachs%26aulast%3DWoods%26aufirst%3DR.%26aulast%3DKolthoff%26aufirst%3DI.%2BM.%26aulast%3DMeehan%26aufirst%3DE.%2BJ.%26atitle%3DArsenic%2520%2528IV%2529%2520as%2520an%2520intermediate%2520in%2520the%2520induced%2520oxidation%2520of%2520arsenic%2520%2528III%2529%2520by%2520the%2520iron%2520%2528II%2529-hydrogen%2520peroxide%2520reaction%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1964%26volume%3D86%26spage%3D1698%26epage%3D1700%26doi%3D10.1021%2Fja01063a011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Samikkannu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yih, L.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A. S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jan, K.-Y.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species are involved in arsenic trioxide inhibition of pyruvate dehydrogenase activity</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">409</span>– <span class="NLM_lpage">414</span>, <span class="refDoi"> DOI: 10.1021/tx025615j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx025615j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD3sXht1Snsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2003&pages=409-414&author=T.+Samikkannuauthor=C.-H.+Chenauthor=L.-H.+Yihauthor=A.+S.+S.+Wangauthor=S.-Y.+Linauthor=T.-C.+Chenauthor=K.-Y.+Jan&title=Reactive+oxygen+species+are+involved+in+arsenic+trioxide+inhibition+of+pyruvate+dehydrogenase+activity&doi=10.1021%2Ftx025615j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive Oxygen Species Are Involved in Arsenic Trioxide Inhibition of Pyruvate Dehydrogenase Activity</span></div><div class="casAuthors">Samikkannu, Thangavel; Chen, Chien-Hung; Yih, Ling-Huei; Wang, Alexander S. S.; Lin, Shu-Yu; Chen, Tsen-Chien; Jan, Kun-Yan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">409-414</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Arsenite was shown to inhibit pyruvate dehydrogenase (PDH) activity through binding to vicinal dithiols in pure enzyme and tissue ext. However, no data are available on how arsenite inhibits PDH activity in human cells.  The IC50 values for arsenic trioxide (As2O3) to inhibit the PDH activity in porcine heart pure enzyme prepn. and in human leukemia cell line HL60 cells were estd. to be 182 and 2 μM, resp.  Thus, As2O3 inactivation of PDH activity was about 90 times more potent in HL60 cells than in purified enzyme prepn.  The IC50 values for As2O3 and phenylarsine oxide to reduce the vicinal thiol content in HL60 cells were estd. to be 81.7 and 1.9 μM, resp.  Thus, As2O3 is a potent PDH inhibitor but a weak vicinal thiol reacting agent in HL60 cells.  Antioxidants but not dithiol compds. suppressed As2O3 inhibition of PDH activity in HL60 cells.  Conversely, dithiol compds. but not antioxidants suppressed the inhibition of PDH activity by phenylarsine oxide.  As2O3 increased H2O2 level in HL60 cells, but this was not obsd. for phenylarsine oxide.  Mitochondrial respiration inhibitors suppressed the As2O3-induced H2O2 prodn. and As2O3 inhibition of PDH activity.  Moreover, metal chelators ameliorated whereas Fenton metals aggravated As2O3 inhibition of PDH activity.  Treatment with H2O2 plus Fenton metals also decreased the PDH activity in HL60 cells. Therefore, it seems that As2O3 elevates H2O2 prodn. in mitochondria and this may produce hydroxyl through the Fenton reaction and result in oxidative damage to the protein of PDH.  The present results suggest that arsenite may cause protein oxidn. to inactivate an enzyme and this can occur at a much lower concn. than arsenite binding directly to the crit. thiols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3WDxekjR7SbVg90H21EOLACvtfcHk0liXp-PUoY3z0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXht1Snsbc%253D&md5=acc83a4bbd5f02152132470230736a3d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Ftx025615j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx025615j%26sid%3Dliteratum%253Aachs%26aulast%3DSamikkannu%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DC.-H.%26aulast%3DYih%26aufirst%3DL.-H.%26aulast%3DWang%26aufirst%3DA.%2BS.%2BS.%26aulast%3DLin%26aufirst%3DS.-Y.%26aulast%3DChen%26aufirst%3DT.-C.%26aulast%3DJan%26aufirst%3DK.-Y.%26atitle%3DReactive%2520oxygen%2520species%2520are%2520involved%2520in%2520arsenic%2520trioxide%2520inhibition%2520of%2520pyruvate%2520dehydrogenase%2520activity%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2003%26volume%3D16%26spage%3D409%26epage%3D414%26doi%3D10.1021%2Ftx025615j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imlay, J. A.</span></span> <span> </span><span class="NLM_article-title">The molecular mechanisms and physiological consequences of oxidative stress: lessons from a model bacterium</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">443</span>– <span class="NLM_lpage">454</span>, <span class="refDoi"> DOI: 10.1038/nrmicro3032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1038%2Fnrmicro3032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=23712352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3sXot1Cntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=443-454&author=J.+A.+Imlay&title=The+molecular+mechanisms+and+physiological+consequences+of+oxidative+stress%3A+lessons+from+a+model+bacterium&doi=10.1038%2Fnrmicro3032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular mechanisms and physiological consequences of oxidative stress: lessons from a model bacterium</span></div><div class="casAuthors">Imlay, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">443-454</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Oxic environments are hazardous.  Mol. oxygen adventitiously abstrs. electrons from many redox enzymes, continuously forming intracellular superoxide and hydrogen peroxide.  These species can destroy the activities of metalloenzymes and the integrity of DNA, forcing organisms to protect themselves with scavenging enzymes and repair systems.  Nevertheless, elevated levels of oxidants quickly poison bacteria, and both microbial competitors and hostile eukaryotic hosts exploit this vulnerability by assaulting these bacteria with peroxides or superoxide-forming antibiotics.  In response, bacteria activate elegant adaptive strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9r4YH3uuc_7Vg90H21EOLACvtfcHk0lj0OMKAZuiFrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXot1Cntbw%253D&md5=781f5ceb7a2ffc72b902952df5f2c39e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro3032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro3032%26sid%3Dliteratum%253Aachs%26aulast%3DImlay%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520molecular%2520mechanisms%2520and%2520physiological%2520consequences%2520of%2520oxidative%2520stress%253A%2520lessons%2520from%2520a%2520model%2520bacterium%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2013%26volume%3D11%26spage%3D443%26epage%3D454%26doi%3D10.1038%2Fnrmicro3032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winterbourn, C. C.</span></span> <span> </span><span class="NLM_article-title">Reconciling the chemistry and biology of reactive oxygen species</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">278</span>– <span class="NLM_lpage">286</span>, <span class="refDoi"> DOI: 10.1038/nchembio.85</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1038%2Fnchembio.85" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=18421291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvVSmtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=278-286&author=C.+C.+Winterbourn&title=Reconciling+the+chemistry+and+biology+of+reactive+oxygen+species&doi=10.1038%2Fnchembio.85"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Reconciling the chemistry and biology of reactive oxygen species</span></div><div class="casAuthors">Winterbourn, Christine C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">278-286</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There is a vast literature on the generation and effects of reactive oxygen species in biol. systems, both in relation to damage they cause and their involvement in cell regulatory and signaling pathways.  The biol. chem. of different oxidants is becoming well understood, but it is often unclear how this translates into cellular mechanisms where redox changes have been demonstrated.  This review addresses this gap.  It examines how target selectivity and antioxidant effectiveness vary for different oxidants.  Kinetic considerations of reactivity are used to assess likely targets in cells and how reactions might be influenced by restricted diffusion and compartmentalization.  It also highlights areas where greater understanding is required on the fate of oxidants generated by cellular NADPH oxidases and on the identification of oxidant sensors in cell signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwwgXqt-zxS7Vg90H21EOLACvtfcHk0lj0OMKAZuiFrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvVSmtLo%253D&md5=c3752b90c8da55d7144dce6cfabbf836</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.85&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.85%26sid%3Dliteratum%253Aachs%26aulast%3DWinterbourn%26aufirst%3DC.%2BC.%26atitle%3DReconciling%2520the%2520chemistry%2520and%2520biology%2520of%2520reactive%2520oxygen%2520species%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D4%26spage%3D278%26epage%3D286%26doi%3D10.1038%2Fnchembio.85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Szatrowski, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nathan, C. F.</span></span> <span> </span><span class="NLM_article-title">Production of large amounts of hydrogen peroxide by human tumor cells</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">794</span>– <span class="NLM_lpage">798</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1846317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADyaK3MXpvFagsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1991&pages=794-798&author=T.+P.+Szatrowskiauthor=C.+F.+Nathan&title=Production+of+large+amounts+of+hydrogen+peroxide+by+human+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Production of large amounts of hydrogen peroxide by human tumor cells</span></div><div class="casAuthors">Szatrowski, Ted P.; Nathan, Carl F.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">794-8</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">Few nonphagocytic cells are known to generate reactive oxygen intermediates.  Based on horseradish peroxidase-dependent, catalase-inhibitable oxidn. of fluorescent scopoletin, seven human tumor cell lines constitutively elaborated H2O2 at rates (up to 0.5 nmol/104) cells/h) large enough that cumulative amts. at 4 h were comparable to the amt. of H2O2 produced by phorbol ester-triggered neutrophils.  Superoxide dismutase-inhibitable ferricytochrome c redn. was detectable at much lower rates.  H2O2 prodn. was inhibited by diphenyleneiodonium, a flavoprotein binder (concn. producing 50% inhibition, 0.3 μM), and diethyldithiocarbamate, a divalent cation chelator (concn. producing 50% inhibition, 3 μM), but not by cyanide or azide, inhibitors of electron transport, or by agents that inhibit xanthine oxidase, polyamine oxidase, or cytochrome P 450.  Cytochrome b559, present in human phagocytes and lymphocytes, was undetectable in these tumor cells by a sensitive spectrophotometric method.  Mouse fibroblasts transfected with human tyrosinase cDNA made melanin, but not H2O2.  Constitutive generation of large amts. of reactive oxygen intermediates, if it occurs in vivo, might contribute to the ability of some tumors to mutate, inhibit antiproteases, injure local tissues, and therefore promote tumor heterogeneity, invasion, and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_BGOBNQut4bVg90H21EOLACvtfcHk0lj0OMKAZuiFrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXpvFagsw%253D%253D&md5=d3efc9540319fa746cbafcef8fd4a2d5</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSzatrowski%26aufirst%3DT.%2BP.%26aulast%3DNathan%26aufirst%3DC.%2BF.%26atitle%3DProduction%2520of%2520large%2520amounts%2520of%2520hydrogen%2520peroxide%2520by%2520human%2520tumor%2520cells%26jtitle%3DCancer%2520Res.%26date%3D1991%26volume%3D51%26spage%3D794%26epage%3D798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of nonquinone substrates for NAD(P)H: quinone oxidoreductase 1 (NQO1) as Effective Intracellular ROS generators for the treatment of drug-resistant non-small-cell lung cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">11280</span>– <span class="NLM_lpage">11297</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01424</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01424" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVSgs7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=11280-11297&author=X.+Wuauthor=X.+Liauthor=Z.+Liauthor=Y.+Yuauthor=Q.+Youauthor=X.+Zhang&title=Discovery+of+nonquinone+substrates+for+NAD%28P%29H%3A+quinone+oxidoreductase+1+%28NQO1%29+as+Effective+Intracellular+ROS+generators+for+the+treatment+of+drug-resistant+non-small-cell+lung+cancer&doi=10.1021%2Facs.jmedchem.8b01424"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Nonquinone Substrates for NAD(P)H: Quinone Oxidoreductase 1 (NQO1) as Effective Intracellular ROS Generators for the Treatment of Drug-Resistant Non-Small-Cell Lung Cancer</span></div><div class="casAuthors">Wu, Xingsen; Li, Xiang; Li, Zhihong; Yu, Yancheng; You, Qidong; Zhang, Xiaojin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11280-11297</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The elevation of oxidative stress preferentially in cancer cells by efficient NQO1 substrates, which promote ROS generation through redox cycling, has emerged as an effective strategy for cancer therapy, even for treating drug-resistant cancers.  Here, we described the identification and structural optimization studies of the hit compd. 1, a new chemotype of nonquinone substrate for NQO1 as an efficient ROS generator.  Further structure-activity relationship studies resulted in the most active compd. 20k, a tricyclic 2,3-dicyano indenopyrazinone, which selectively inhibited the proliferation of NQO1-overexpressing A549 and A549/Taxol cancer cells.  Furthermore, 20k dramatically elevated the intracellular ROS levels through NQO1-catalyzed redox cycling and induced PARP-1-mediated cell apoptosis in A549/Taxol cells.  In addn., 20k significantly suppressed the growth of A549/Taxol xenograft tumors in mice with no apparent toxicity obsd. in vivo.  Together, 20k acts as an efficient NQO1 substrate and may be a new option for the treatment of NQO1-overexpresssing drug-resistant NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2n_XSHF05XLVg90H21EOLACvtfcHk0ljyahzKJQdJUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVSgs7rJ&md5=2d7ed264c0d24f7ac7e6ea3a474f3601</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01424%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520nonquinone%2520substrates%2520for%2520NAD%2528P%2529H%253A%2520quinone%2520oxidoreductase%25201%2520%2528NQO1%2529%2520as%2520Effective%2520Intracellular%2520ROS%2520generators%2520for%2520the%2520treatment%2520of%2520drug-resistant%2520non-small-cell%2520lung%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D11280%26epage%3D11297%26doi%3D10.1021%2Facs.jmedchem.8b01424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dharmaraja, A. T.</span></span> <span> </span><span class="NLM_article-title">Role of reactive oxygen species (ROS) in therapeutics and drug resistance in cancer and bacteria</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3221</span>– <span class="NLM_lpage">3240</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01243</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01243" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVSjsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3221-3240&author=A.+T.+Dharmaraja&title=Role+of+reactive+oxygen+species+%28ROS%29+in+therapeutics+and+drug+resistance+in+cancer+and+bacteria&doi=10.1021%2Facs.jmedchem.6b01243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Reactive Oxygen Species (ROS) in Therapeutics and Drug Resistance in Cancer and Bacteria</span></div><div class="casAuthors">Dharmaraja, Allimuthu T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3221-3240</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Evading persistent drug resistance in cancer and bacteria to most of the com. used drugs is necessary to restore the human health settings.  A distinct property of cancer phenotype is enhanced glucose metab. and oxidative stress from normal cells.  Reactive oxygen species (ROS) are metabolic byproducts of aerobic respiration and are responsible for maintaining redox homeostasis in cells.  Maintaining the redox balance in cancerous cells are found to be crit. for their survival, which is modulated by reduced thiols and reducing cofactors NAD(P)H.  Thus altering the levels reducing equiv. were found to enhance intracellular ROS and sensitize cancer cells to therapeutics.  Similarly, Escherichia coli and life threatening infectious pathogens such as Staphylococcus aureus and Mycobacterium tuberculosis were found to be more sensitive to modulation of intracellular oxidative environment.  Combination drug strategies were successfully employed in attenuating the effects of drug resistant cancer and bacterial.  Here, a collection of some ROS modulation based cancer and bacterial therapeutics is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoshDBtCrwl5LVg90H21EOLACvtfcHk0ljyahzKJQdJUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVSjsrY%253D&md5=71bfb8f37ab75364fedcb07de262fc2c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01243%26sid%3Dliteratum%253Aachs%26aulast%3DDharmaraja%26aufirst%3DA.%2BT.%26atitle%3DRole%2520of%2520reactive%2520oxygen%2520species%2520%2528ROS%2529%2520in%2520therapeutics%2520and%2520drug%2520resistance%2520in%2520cancer%2520and%2520bacteria%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3221%26epage%3D3240%26doi%3D10.1021%2Facs.jmedchem.6b01243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Current development of ROS-modulating agents as novel antitumor therapy</span>. <i>Curr. Cancer Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">122</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.2174/1568009616666160216125833</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.2174%2F1568009616666160216125833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=26881931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1eksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=122-136&author=N.+Wangauthor=Y.+Wuauthor=J.+Bianauthor=X.+Qianauthor=H.+Linauthor=H.+Sunauthor=Q.+Youauthor=X.+Zhang&title=Current+development+of+ROS-modulating+agents+as+novel+antitumor+therapy&doi=10.2174%2F1568009616666160216125833"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Current Development of ROS-Modulating Agents as Novel Antitumor Therapy</span></div><div class="casAuthors">Wang, Nan; Wu, Yue; Bian, Jinlei; Qian, Xue; Lin, Hongzhi; Sun, Haopeng; You, Qidong; Zhang, Xiaojin</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">122-136</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Compared to normal cells, usually cancer cells are under higher oxidative stress.  Elevating intracellular levels of reactive oxygen species (ROS) by introducing excessive ROS or inhibiting antioxidant system may enhance selectively of cancer cell killing by ROS-modulating agents through stress sensitization or stress overload.  Meanwhile due to the adaptive response, normal cells may be capable of maintaining redox homeostasis under exogenous ROS.  Here we review ROS-modulating agents in different mechanisms and classify them into groups by various targets for illustrating more clearly.  At last, we discuss their side effects and the potential troubles of developing these agents and argue that might be an effective strategy for further exploring to modulate the unique redox regulatory mechanisms of cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGiT3Tj48T9bVg90H21EOLACvtfcHk0ljyahzKJQdJUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1eksbo%253D&md5=02ac2a93c914054fad81a62f98d6214f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2174%2F1568009616666160216125833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009616666160216125833%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DCurrent%2520development%2520of%2520ROS-modulating%2520agents%2520as%2520novel%2520antitumor%2520therapy%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2017%26volume%3D17%26spage%3D122%26epage%3D136%26doi%3D10.2174%2F1568009616666160216125833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span> <span> </span><span class="NLM_article-title">Bioinspired polydopamine-coated hemoglobin as potential oxygen carrier with antioxidant properties</span>. <i>Biomacromolecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1333</span>– <span class="NLM_lpage">1341</span>, <span class="refDoi"> DOI: 10.1021/acs.biomac.7b00077</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biomac.7b00077" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXksFalu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=1333-1341&author=Q.+Wangauthor=R.+Zhangauthor=M.+Luauthor=G.+Youauthor=Y.+Wangauthor=G.+Chenauthor=C.+Zhaoauthor=Z.+Wangauthor=X.+Songauthor=Y.+Wuauthor=L.+Zhaoauthor=H.+Zhou&title=Bioinspired+polydopamine-coated+hemoglobin+as+potential+oxygen+carrier+with+antioxidant+properties&doi=10.1021%2Facs.biomac.7b00077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Bioinspired Polydopamine-Coated Hemoglobin as Potential Oxygen Carrier with Antioxidant Properties</span></div><div class="casAuthors">Wang, Quan; Zhang, Ruirui; Lu, Mingzi; You, Guoxing; Wang, Ying; Chen, Gan; Zhao, Caiyan; Wang, Zhen; Song, Xiang; Wu, Yan; Zhao, Lian; Zhou, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Biomacromolecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1333-1341</span>CODEN:
                <span class="NLM_cas:coden">BOMAF6</span>;
        ISSN:<span class="NLM_cas:issn">1525-7797</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oxidative side reaction is one of the major factors hindering the development of Hb-based oxygen carriers (HBOCs).  To avoid the oxidative toxicity, we designed and synthesized polydopamine-coated Hb (Hb-PDA) nanoparticles via simple one-step assemblage without any toxic reagent.  Hb-PDA nanoparticles showed oxidative protection of Hb by inhibiting the generation of metHb (MetHb) and ferryl (Fe IV) Hb, as well as excellent antioxidant properties by scavenging free radicals and reactive oxygen species (ROS).  Interestingly, the scavenging rate of Hb-PDA nanoparticles for ABTS+ radical is at most 89%, while for DPPH radical it reaches 49%.  In addn., Hb-PDA efficiently reduced the intracellular H2O2-induced ROS generation.  Moreover, Hb-PDA nanoparticles exhibited high oxygen affinity, low effect on blood constituents, and low cytotoxicity.  The results indicate that polydopamine-coated Hb might be a promising approach for constructing novel oxygen carriers with the capacity to reduce oxidative side reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBO_fIOaqWdbVg90H21EOLACvtfcHk0lgkrbFhd6eMHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXksFalu70%253D&md5=72e546fc6d5cead2fa95fde72bac5926</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.biomac.7b00077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biomac.7b00077%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DYou%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DH.%26atitle%3DBioinspired%2520polydopamine-coated%2520hemoglobin%2520as%2520potential%2520oxygen%2520carrier%2520with%2520antioxidant%2520properties%26jtitle%3DBiomacromolecules%26date%3D2017%26volume%3D18%26spage%3D1333%26epage%3D1341%26doi%3D10.1021%2Facs.biomac.7b00077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giorgio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trinei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Migliaccio, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelicci, P. G.</span></span> <span> </span><span class="NLM_article-title">Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals?</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">722</span>– <span class="NLM_lpage">728</span>, <span class="refDoi"> DOI: 10.1038/nrm2240</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1038%2Fnrm2240" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=17700625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsVartbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=722-728&author=M.+Giorgioauthor=M.+Trineiauthor=E.+Migliaccioauthor=P.+G.+Pelicci&title=Hydrogen+peroxide%3A+a+metabolic+by-product+or+a+common+mediator+of+ageing+signals%3F&doi=10.1038%2Fnrm2240"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals?</span></div><div class="casAuthors">Giorgio, Marco; Trinei, Mirella; Migliaccio, Enrica; Pelicci, Pier Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">722-728</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The reactive oxygen species that are generated by mitochondrial respiration, including hydrogen peroxide (H2O2), are potent inducers of oxidative damage and mediators of aging.  It is not clear, however, whether oxidative stress is the result of a genetic program or the byproduct of physiol. processes.  Recent findings demonstrate that a fraction of mitochondrial H2O2, produced by a specialized enzyme as a signaling mol. in the pathway of apoptosis, induces intracellular oxidative stress and accelerates aging.  We propose that genes that control H2O2 prodn. are selected determinants of lifespan.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDrDSwJY70j7Vg90H21EOLACvtfcHk0lgkrbFhd6eMHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsVartbw%253D&md5=73d82a630334210de966bd03a2efe428</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnrm2240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2240%26sid%3Dliteratum%253Aachs%26aulast%3DGiorgio%26aufirst%3DM.%26aulast%3DTrinei%26aufirst%3DM.%26aulast%3DMigliaccio%26aufirst%3DE.%26aulast%3DPelicci%26aufirst%3DP.%2BG.%26atitle%3DHydrogen%2520peroxide%253A%2520a%2520metabolic%2520by-product%2520or%2520a%2520common%2520mediator%2520of%2520ageing%2520signals%253F%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2007%26volume%3D8%26spage%3D722%26epage%3D728%26doi%3D10.1038%2Fnrm2240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nohl, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gille, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staniek, K.</span></span> <span> </span><span class="NLM_article-title">Intracellular generation of reactive oxygen species by mitochondria</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">719</span>– <span class="NLM_lpage">723</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2004.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.bcp.2004.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=15710349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlCrsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2005&pages=719-723&author=H.+Nohlauthor=L.+Gilleauthor=K.+Staniek&title=Intracellular+generation+of+reactive+oxygen+species+by+mitochondria&doi=10.1016%2Fj.bcp.2004.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular generation of reactive oxygen species by mitochondria</span></div><div class="casAuthors">Nohl, Hans; Gille, Lars; Staniek, Katrin</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">719-723</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Mitochondria have bioenergetic properties that strongly suggest their involvement in the cellular formation of reactive oxygen species (ROS).  Apparent confirmation of this process has come from work with isolated mitochondria, which have been shown to produce H2O2 from dismutating superoxide radicals.  Two different sites were reported to shuttle single electrons to oxygen out of the normal respiratory sequence.  However, the mechanisms for ROS formation at these two sites are controversial.  Arguments against mitochondrial ROS formation in the living cell are based on the fact that bioenergetic alterations may result from the mech. removal of mitochondria from their natural environment.  Furthermore, the invasive detection methods that are generally used may be inappropriate because of the possible interaction of the detection system with mitochondrial constituents.  The use of non-invasive detection methods has proved that ROS formation does not occur unless changes in the phys. state of the membrane are established.  The aim of this commentary is to discuss critically the arguments in favor of mitochondria as the main intracellular source of ROS.  The pros and cons of working with isolated mitochondria, as well as the detection methodol. are carefully analyzed to judge whether or not the above assumption is correct.  The conclusion that mitochondria are the main ROS generators in the cell contradicts the fact that ROS release was not obsd.  However, if electron flow from ubiquinol to the bc1 complex is hindered due to changes in lipid fluidity, single electrons may transfer to dioxygen and produce H2O2 via superoxide radicals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsr722uOiHHbVg90H21EOLACvtfcHk0lgkrbFhd6eMHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlCrsLo%253D&md5=c914297a48790bf23147bf21793a1049</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2004.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2004.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DNohl%26aufirst%3DH.%26aulast%3DGille%26aufirst%3DL.%26aulast%3DStaniek%26aufirst%3DK.%26atitle%3DIntracellular%2520generation%2520of%2520reactive%2520oxygen%2520species%2520by%2520mitochondria%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2005%26volume%3D69%26spage%3D719%26epage%3D723%26doi%3D10.1016%2Fj.bcp.2004.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Veal, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, B.</span></span> <span> </span><span class="NLM_article-title">Hydrogen peroxide sensing and signaling</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2007.03.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.molcel.2007.03.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=17434122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkvFSrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=1-14&author=E.+Vealauthor=A.+Dayauthor=B.+Morgan&title=Hydrogen+peroxide+sensing+and+signaling&doi=10.1016%2Fj.molcel.2007.03.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrogen peroxide sensing and signaling</span></div><div class="casAuthors">Veal, Elizabeth A.; Day, Alison M.; Morgan, Brian A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-14</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  It is well established that oxidative stress is an important cause of cell damage assocd. with the initiation and progression of many diseases.  Consequently, all air-living organisms contain antioxidant enzymes that limit oxidative stress by detoxifying reactive oxygen species, including hydrogen peroxide.  However, in eukaryotes, hydrogen peroxide also has important roles as a signaling mol. in the regulation of a variety of biol. processes.  Here, we will discuss the mol. mechanisms by which hydrogen peroxide is sensed and the increasing evidence that antioxidant enzymes play multiple, key roles as sensors and regulators of signal transduction in response to hydrogen peroxide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWVi5MYuUMYrVg90H21EOLACvtfcHk0liXa4Nn9ulfwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkvFSrtr4%253D&md5=de089e276a6cbd7e58d3e92279eeae1d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2007.03.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2007.03.016%26sid%3Dliteratum%253Aachs%26aulast%3DVeal%26aufirst%3DE.%26aulast%3DDay%26aufirst%3DA.%26aulast%3DMorgan%26aufirst%3DB.%26atitle%3DHydrogen%2520peroxide%2520sensing%2520and%2520signaling%26jtitle%3DMol.%2520Cell%26date%3D2007%26volume%3D26%26spage%3D1%26epage%3D14%26doi%3D10.1016%2Fj.molcel.2007.03.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minakami, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamiya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumimoto, H.</span></span> <span> </span><span class="NLM_article-title">Visualization of phagosomal hydrogen peroxide production by a novel fluorescent probe that is localized via SNAP-Tag labeling</span>. <i>Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">5983</span>– <span class="NLM_lpage">5990</span>, <span class="refDoi"> DOI: 10.1021/ac501041w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ac501041w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2cXos1Wru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=5983-5990&author=M.+Aboauthor=R.+Minakamiauthor=K.+Miyanoauthor=M.+Kamiyaauthor=T.+Naganoauthor=Y.+Uranoauthor=H.+Sumimoto&title=Visualization+of+phagosomal+hydrogen+peroxide+production+by+a+novel+fluorescent+probe+that+is+localized+via+SNAP-Tag+labeling&doi=10.1021%2Fac501041w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Visualization of Phagosomal Hydrogen Peroxide Production by a Novel Fluorescent Probe That Is Localized via SNAP-tag Labeling</span></div><div class="casAuthors">Abo, Masahiro; Minakami, Reiko; Miyano, Kei; Kamiya, Mako; Nagano, Tetsuo; Urano, Yasuteru; Sumimoto, Hideki</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5983-5990</span>CODEN:
                <span class="NLM_cas:coden">ANCHAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2700</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hydrogen peroxide (H2O2), a member of reactive oxygen species (ROS), plays diverse physiol. roles including host defense and cellular signal transduction.  During ingestion of invading microorganisms, professional phagocytes such as macrophages release H2O2 specifically into the phagosome to direct toxic ROS toward engulfed microbes.  Although H2O2 is considered to exert discrete effects in living systems depending on location of its prodn., accumulation, and consumption, there have been limitations of techniques for probing this oxygen metabolite with high mol. specificity at the subcellular resoln.  Here the authors describe the development of an O6-benzylguanine deriv. of 5-(4-nitrobenzoyl)carbonylfluorescein (NBzF-BG), a novel H2O2-specific fluorescent probe; NBzF-BG is covalently and selectively conjugated with the SNAP-tag protein, giving the fluorophore-protein conjugate (SNAP-NBzF).  SNAP-NBzF rapidly reacts with H2O2 and thereby shows a 9-fold enhancement in fluorescence.  When SNAP-tag is expressed in HEK293T cells and RAW264.7 macrophages as a protein C-terminally fused to the transmembrane domain of platelet-derived growth factor receptor (PDGFR), the tag is presented on the outside of the plasma membrane; conjugation of NBzF-BG with the cell surface SNAP-tag enables detection of H2O2 added exogenously.  The authors also demonstrate mol. imaging of H2O2 that is endogenously produced in phagosomes of macrophages ingesting IgG-coated latex beads.  Thus, NBzF-BG, combined with the SNAP-tag technol., should be useful as a tool to measure local prodn. of H2O2 in living cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-cSshzkJ8gLVg90H21EOLACvtfcHk0liXa4Nn9ulfwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXos1Wru74%253D&md5=981c12edf0a5379d8be7ebd818be2902</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fac501041w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fac501041w%26sid%3Dliteratum%253Aachs%26aulast%3DAbo%26aufirst%3DM.%26aulast%3DMinakami%26aufirst%3DR.%26aulast%3DMiyano%26aufirst%3DK.%26aulast%3DKamiya%26aufirst%3DM.%26aulast%3DNagano%26aufirst%3DT.%26aulast%3DUrano%26aufirst%3DY.%26aulast%3DSumimoto%26aufirst%3DH.%26atitle%3DVisualization%2520of%2520phagosomal%2520hydrogen%2520peroxide%2520production%2520by%2520a%2520novel%2520fluorescent%2520probe%2520that%2520is%2520localized%2520via%2520SNAP-Tag%2520labeling%26jtitle%3DAnal.%2520Chem.%26date%3D2014%26volume%3D86%26spage%3D5983%26epage%3D5990%26doi%3D10.1021%2Fac501041w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lippert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van de Bittner, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span> <span> </span><span class="NLM_article-title">Boronate oxidation as a bioorthogonal reaction approach for studying the chemistry of hydrogen peroxide in living systems</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">793</span>– <span class="NLM_lpage">804</span>, <span class="refDoi"> DOI: 10.1021/ar200126t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ar200126t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVWhu7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2011&pages=793-804&author=A.+Lippertauthor=G.+Van+de+Bittnerauthor=C.+Chang&title=Boronate+oxidation+as+a+bioorthogonal+reaction+approach+for+studying+the+chemistry+of+hydrogen+peroxide+in+living+systems&doi=10.1021%2Far200126t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Boronate Oxidation as a Bioorthogonal Reaction Approach for Studying the Chemistry of Hydrogen Peroxide in Living Systems</span></div><div class="casAuthors">Lippert, Alexander R.; Van de Bittner, Genevieve C.; Chang, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">793-804</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Reactive oxygen species (ROS), such as hydrogen peroxide, are important products of oxygen metab. that, when misregulated, can accumulate and cause oxidative stress inside cells.  Accordingly, organisms have evolved mol. systems, including antioxidant metalloenzymes (such as superoxide dismutase and catalase) and an array of thiol-based redox couples, to neutralize this threat to the cell when it occurs.  On the other hand, emerging evidence shows that the controlled generation of ROS, particularly H2O2, is necessary to maintain cellular fitness.  The identification of NADPH oxidase enzymes, which generate specific ROS and reside in virtually all cell types throughout the body, is a prime example.  Indeed, a growing body of work shows that H2O2 and other ROS have essential functions in healthy physiol. signaling pathways.  The signal-stress dichotomy of H2O2 serves as a source of motivation for disentangling its beneficial from its detrimental effects on living systems.  Mol. imaging of this oxygen metabolite with reaction-based probes is a powerful approach for real-time, noninvasive monitoring of H2O2 chem. in biol. specimens, but two key challenges to studying H2O2 in this way are chemoselectivity and bioorthogonality of probe mols.  Chemoselectivity is problematic because traditional methods for ROS detection suffer from nonspecific reactivity with other ROS.  Moreover, some methods require enzymic additives not compatible with live-cell or live-animal specimens.  Addnl., bioorthogonality requires that the reactions must not compete with or disturb intrinsic cellular chem.; this requirement is particularly crit. with thiol- or metal-based couples mediating the major redox events within the cell.  Chemoselective bioorthogonal reactions, such as alkyne-azide cycloaddns. and related click reactions, the Staudinger-Bertozzi ligation, and the transformations used in various reaction-based mol. probes, have found widespread application in the modification, labeling, and detection of biol. mols. and processes.  In this Account, we summarize H2O2 studies from our lab. using the H2O2-mediated oxidn. of aryl boronates to phenols as a bioorthogonal approach to detect fluxes of this important ROS in living systems.  We have installed this versatile switch onto org. and inorg. scaffolds to serve as "turn-on" probes for visible and near-IR (NIR) fluorescence, ratiometric fluorescence, time-gated lanthanide luminescence, and in vivo bioluminescence detection of H2O2 in living cells and animals.  Further chem. and genetic manipulations target these probes to specific organelles and other subcellular locales and can also allow them to be trapped intracellularly, enhancing their sensitivity.  These novel chem. tools have revealed fundamental new biol. insights into the prodn., localization, trafficking, and in vivo roles of H2O2 in a wide variety of living systems, including immune, cancer, stem, and neural cell models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphrbStUZBTbLVg90H21EOLACvtfcHk0liXa4Nn9ulfwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVWhu7rL&md5=4a9adb2c4dc443679cb4ea4ee0eee648</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Far200126t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far200126t%26sid%3Dliteratum%253Aachs%26aulast%3DLippert%26aufirst%3DA.%26aulast%3DVan%2Bde%2BBittner%26aufirst%3DG.%26aulast%3DChang%26aufirst%3DC.%26atitle%3DBoronate%2520oxidation%2520as%2520a%2520bioorthogonal%2520reaction%2520approach%2520for%2520studying%2520the%2520chemistry%2520of%2520hydrogen%2520peroxide%2520in%2520living%2520systems%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2011%26volume%3D44%26spage%3D793%26epage%3D804%26doi%3D10.1021%2Far200126t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dickinson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span> <span> </span><span class="NLM_article-title">Chemistry and biology of reactive oxygen species in signaling or stress responses</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">504</span>– <span class="NLM_lpage">511</span>, <span class="refDoi"> DOI: 10.1038/nchembio.607</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1038%2Fnchembio.607" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=21769097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFyhsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=504-511&author=B.+Dickinsonauthor=C.+Chang&title=Chemistry+and+biology+of+reactive+oxygen+species+in+signaling+or+stress+responses&doi=10.1038%2Fnchembio.607"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry and biology of reactive oxygen species in signaling or stress responses</span></div><div class="casAuthors">Dickinson, Bryan C.; Chang, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">504-511</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Reactive O species (ROS) are a family of mols. that are continuously generated, transformed and consumed in all living organisms as a consequence of aerobic life.  The traditional view of these reactive O metabolites is one of oxidative stress and damage that leads to decline of tissue and organ systems in aging and disease.  However, emerging data show that ROS produced in certain situations can also contribute to physiol. and increased fitness.  Here, the authors provide a focused discussion on what factors lead ROS mols. to become signal and/or stress agents, highlighting how increasing knowledge of the underlying chem. of ROS can lead to advances in understanding their disparate contributions to biol.  An important facet of this emerging area at the chem.-biol. interface is the development of new tools to study these small mols. and their reactivity in complex biol. systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8yowqTyr7O7Vg90H21EOLACvtfcHk0lh4-RNFKhDCzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFyhsL4%253D&md5=320823c1c7f9013a7c8f3d6c2f3f6952</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.607%26sid%3Dliteratum%253Aachs%26aulast%3DDickinson%26aufirst%3DB.%26aulast%3DChang%26aufirst%3DC.%26atitle%3DChemistry%2520and%2520biology%2520of%2520reactive%2520oxygen%2520species%2520in%2520signaling%2520or%2520stress%2520responses%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D504%26epage%3D511%26doi%3D10.1038%2Fnchembio.607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishna, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corpe, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buettner, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shacter, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, M.</span></span> <span> </span><span class="NLM_article-title">Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">13604</span>– <span class="NLM_lpage">13609</span>, <span class="refDoi"> DOI: 10.1073/pnas.0506390102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1073%2Fpnas.0506390102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=16157892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVygtr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=13604-13609&author=Q.+Chenauthor=M.+Espeyauthor=M.+Krishnaauthor=J.+Mitchellauthor=C.+Corpeauthor=G.+Buettnerauthor=E.+Shacterauthor=M.+Levine&title=Pharmacologic+ascorbic+acid+concentrations+selectively+kill+cancer+cells%3A+action+as+a+pro-drug+to+deliver+hydrogen+peroxide+to+tissues&doi=10.1073%2Fpnas.0506390102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues</span></div><div class="casAuthors">Chen, Qi; Espey, Michael Graham; Krishna, Murali C.; Mitchell, James B.; Corpe, Christopher P.; Buettner, Garry R.; Shacter, Emily; Levine, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">13604-13609</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Human pharmacokinetics data indicate that i.v. ascorbic acid (ascorbate) in pharmacol. concns. could have an unanticipated role in cancer treatment.  Our goals here were to test whether ascorbate killed cancer cells selectively, and if so, to det. mechanisms, using clin. relevant conditions.  Cell death in 10 cancer and 4 normal cell types was measured by using 1-h exposures.  Normal cells were unaffected by 20 mM ascorbate, whereas 5 cancer lines had EC50 values of <4 mM, a concn. easily achievable i.v.  Human lymphoma cells were studied in detail because of their sensitivity to ascorbate (EC50 of 0.5 mM) and suitability for addressing mechanisms.  Extracellular but not intracellular ascorbate mediated cell death, which occurred by apoptosis and pyknosis/necrosis.  Cell death was independent of metal chelators and absolutely dependent on H2O2 formation.  Cell death from H2O2 added to cells was identical to that found when H2O2 was generated by ascorbate treatment.  H2O2 generation was dependent on ascorbate concn., incubation time, and the presence of 0.5-10% serum, and displayed a linear relationship with ascorbate radical formation.  Although ascorbate addn. to medium generated H2O2, ascorbate addn. to blood generated no detectable H2O2 and only trace detectable ascorbate radical.  Taken together, these data indicate that ascorbate at concns. achieved only by i.v. administration may be a pro-drug for formation of H2O2, and that blood can be a delivery system of the pro-drug to tissues.  These findings give plausibility to i.v. ascorbic acid in cancer treatment, and have unexpected implications for treatment of infections where H2O2 may be beneficial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEa-_5UqwnK7Vg90H21EOLACvtfcHk0lh4-RNFKhDCzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVygtr%252FP&md5=3cbc688e2cc0df9dc3357f47b87a16f9</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0506390102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0506390102%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DEspey%26aufirst%3DM.%26aulast%3DKrishna%26aufirst%3DM.%26aulast%3DMitchell%26aufirst%3DJ.%26aulast%3DCorpe%26aufirst%3DC.%26aulast%3DBuettner%26aufirst%3DG.%26aulast%3DShacter%26aufirst%3DE.%26aulast%3DLevine%26aufirst%3DM.%26atitle%3DPharmacologic%2520ascorbic%2520acid%2520concentrations%2520selectively%2520kill%2520cancer%2520cells%253A%2520action%2520as%2520a%2520pro-drug%2520to%2520deliver%2520hydrogen%2520peroxide%2520to%2520tissues%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D13604%26epage%3D13609%26doi%3D10.1073%2Fpnas.0506390102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beal, M. F.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>443</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">795</span>, <span class="refDoi"> DOI: 10.1038/nature05292</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1038%2Fnature05292" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=17051205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVyktbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=443&publication_year=2006&pages=787-795&author=M.+T.+Linauthor=M.+F.+Beal&title=Mitochondrial+dysfunction+and+oxidative+stress+in+neurodegenerative+diseases&doi=10.1038%2Fnature05292"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases</span></div><div class="casAuthors">Lin, Michael T.; Beal, M. Flint</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">443</span>
        (<span class="NLM_cas:issue">7113</span>),
    <span class="NLM_cas:pages">787-795</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Many lines of evidence suggest that mitochondria have a central role in aging-related neurodegenerative diseases.  Mitochondria are crit. regulators of cell death, a key feature of neurodegeneration.  Mutations in mitochondrial DNA and oxidative stress both contribute to aging, which is the greatest risk factor for neurodegenerative diseases.  In all major examples of these diseases there is strong evidence that mitochondrial dysfunction occurs early and acts causally in disease pathogenesis.  Moreover, an impressive no. of disease-specific proteins interact with mitochondria.  Thus, therapies targeting basic mitochondrial processes, such as energy metab. or free-radical generation, or specific interactions of disease-related proteins with mitochondria, hold great promise.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ_a_kJVRRZbVg90H21EOLACvtfcHk0lh4-RNFKhDCzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVyktbbO&md5=f1f1e0773f62373232ff10156e630cae</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnature05292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05292%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DM.%2BT.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26atitle%3DMitochondrial%2520dysfunction%2520and%2520oxidative%2520stress%2520in%2520neurodegenerative%2520diseases%26jtitle%3DNature%26date%3D2006%26volume%3D443%26spage%3D787%26epage%3D795%26doi%3D10.1038%2Fnature05292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenmoku, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, T.</span></span> <span> </span><span class="NLM_article-title">Development of a highly specific rhodamine-based fluorescence probe for hypochlorous acid and its application to real-time imaging of phagocytosis</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">7313</span>– <span class="NLM_lpage">7318</span>, <span class="refDoi"> DOI: 10.1021/ja068740g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja068740g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1yktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=7313-7318&author=S.+Kenmokuauthor=Y.+Uranoauthor=H.+Kojimaauthor=T.+Nagano&title=Development+of+a+highly+specific+rhodamine-based+fluorescence+probe+for+hypochlorous+acid+and+its+application+to+real-time+imaging+of+phagocytosis&doi=10.1021%2Fja068740g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Highly Specific Rhodamine-Based Fluorescence Probe for Hypochlorous Acid and Its Application to Real-Time Imaging of Phagocytosis</span></div><div class="casAuthors">Kenmoku, Suguru; Urano, Yasuteru; Kojima, Hirotatsu; Nagano, Tetsuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7313-7318</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The tetramethylrhodamine (TMR) fluorophore is a useful platform for fluorescence probes, being applicable, for example, to biol. investigations utilizing fluorescence microscopy, owing to its excellent photochem. properties in aq. media.  The authors have developed new TMR derivs. that show different dependences of their behavior upon the environment.  Among them, HMTMR showed unique characteristics, and its putative spirocyclic structure was confirmed by x-ray crystallog.  Utilizing this discovery, the authors have established a strategy to modulate the fluorescence of TMR by regulating the spirocyclization, and the authors have obtained a new fluorescence probe that can detect hypochlorous acid specifically.  This probe, HySOx, can work in 99.9% aq. soln. at pH 7.4 and was confirmed to be able to detect hypochlorous acid being generated inside phagosomes in real time.  HySOx is tolerant to autoxidn. and photobleaching under bioimaging conditions.  Regulation of the spirocyclization of rhodamines, as the authors describe here, provides a new approach to the rational development of novel fluorescence probes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAmmqQG_GeaLVg90H21EOLACvtfcHk0li-dDyJacvBvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1yktro%253D&md5=eef6ccd5811ebb92f459e8c3e33a65af</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fja068740g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja068740g%26sid%3Dliteratum%253Aachs%26aulast%3DKenmoku%26aufirst%3DS.%26aulast%3DUrano%26aufirst%3DY.%26aulast%3DKojima%26aufirst%3DH.%26aulast%3DNagano%26aufirst%3DT.%26atitle%3DDevelopment%2520of%2520a%2520highly%2520specific%2520rhodamine-based%2520fluorescence%2520probe%2520for%2520hypochlorous%2520acid%2520and%2520its%2520application%2520to%2520real-time%2520imaging%2520of%2520phagocytosis%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D7313%26epage%3D7318%26doi%3D10.1021%2Fja068740g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hyman, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franz, K. J.</span></span> <span> </span><span class="NLM_article-title">Probing oxidative stress: Small molecule fluorescent sensors of metal ions, reactive oxygen species, and thiols</span>. <i>Coord. Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>256</i></span>,  <span class="NLM_fpage">2333</span>– <span class="NLM_lpage">2356</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2012.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.ccr.2012.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=23440254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVyiurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=2012&pages=2333-2356&author=L.+M.+Hymanauthor=K.+J.+Franz&title=Probing+oxidative+stress%3A+Small+molecule+fluorescent+sensors+of+metal+ions%2C+reactive+oxygen+species%2C+and+thiols&doi=10.1016%2Fj.ccr.2012.03.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Probing oxidative stress: Small molecule fluorescent sensors of metal ions, reactive oxygen species, and thiols</span></div><div class="casAuthors">Hyman, Lynne M.; Franz, Katherine J.</div><div class="citationInfo"><span class="NLM_cas:title">Coordination Chemistry Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">256</span>
        (<span class="NLM_cas:issue">19-20</span>),
    <span class="NLM_cas:pages">2333-2356</span>CODEN:
                <span class="NLM_cas:coden">CCHRAM</span>;
        ISSN:<span class="NLM_cas:issn">0010-8545</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Oxidative stress is a common feature shared by many diseases, including neurodegenerative diseases.  Factors that contribute to cellular oxidative stress include elevated levels of reactive oxygen species, diminished availability of detoxifying thiols, and the misregulation of metal ions (both redox-active iron and copper as well as non-redox active calcium and zinc).  Deciphering how each of these components interacts to contribute to oxidative stress presents an interesting challenge.  Fluorescent sensors can be powerful tools for detecting specific analytes within a complicated cellular environment.  Reviewed here are several classes of small mol. fluorescent sensors designed to detect several mol. participants of oxidative stress.  The authors focus the review on describing the design, function and application of probes to detect metal cations, reactive oxygen species, and intracellular thiol-contg. compds.  In addn., the authors highlight the intricacies and complications that are often faced in sensor design and implementation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx4daU-JzbsrVg90H21EOLACvtfcHk0li-dDyJacvBvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVyiurs%253D&md5=3b2603a7f2fb5946e36c1c61645c7dd4</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2012.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2012.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DHyman%26aufirst%3DL.%2BM.%26aulast%3DFranz%26aufirst%3DK.%2BJ.%26atitle%3DProbing%2520oxidative%2520stress%253A%2520Small%2520molecule%2520fluorescent%2520sensors%2520of%2520metal%2520ions%252C%2520reactive%2520oxygen%2520species%252C%2520and%2520thiols%26jtitle%3DCoord.%2520Chem.%2520Rev.%26date%3D2012%26volume%3D256%26spage%3D2333%26epage%3D2356%26doi%3D10.1016%2Fj.ccr.2012.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farfán-García, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo-Mendieta, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciprés-Flores, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padilla-Martínez, I. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trujillo-Ferrara, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soriano-Ursúa, M. A.</span></span> <span> </span><span class="NLM_article-title">Current data regarding the structure-toxicity relationship of boron-containing compounds</span>. <i>Toxicol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>258</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1016/j.toxlet.2016.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.toxlet.2016.06.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=27329537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtV2msLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=2016&pages=115-125&author=E.+D.+Farf%C3%A1n-Garc%C3%ADaauthor=N.+T.+Castillo-Mendietaauthor=F.+J.+Cipr%C3%A9s-Floresauthor=I.+I.+Padilla-Mart%C3%ADnezauthor=J.+G.+Trujillo-Ferraraauthor=M.+A.+Soriano-Urs%C3%BAa&title=Current+data+regarding+the+structure-toxicity+relationship+of+boron-containing+compounds&doi=10.1016%2Fj.toxlet.2016.06.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Current data regarding the structure-toxicity relationship of boron-containing compounds</span></div><div class="casAuthors">Farfan-Garcia, E. D.; Castillo-Mendieta, N. T.; Cipres-Flores, F. J.; Padilla-Martinez, I. I.; Trujillo-Ferrara, J. G.; Soriano-Ursua, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">258</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">115-125</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Boron is ubiquitous in nature, being an essential element of diverse cells.  As a result, humans have had contact with boron contg. compds. (BCCs) for a long time.  During the 20th century, BCCs were developed as antiseptics, antibiotics, cosmetics and insecticides.  Boric acid was freely used in the nosocomial environment as an antiseptic and sedative salt, leading to the death of patients and an important discovery about its crit. toxicol. for humans.  Since then the many toxicol. studies done in relation to BCCs have helped to establish the proper limits of their use.  During the last 15 years, there has been a boom of research on the design and use of new, potent and efficient boron contg. drugs, finding that the addn. of boron to some known drugs increases their affinity and selectivity.  This mini-review summarizes two aspects of BCCs: toxicol. data found with exptl. models, and the scarce but increasing data about the structure-activity relationship for toxicity and therapeutic use.  As is the case with boron-free compds., the biol. activity of BCCs is related to their chem. structure.  The authors discuss the use of new technol. to discover potent and efficient BCCs for medicinal therapy by avoiding toxic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCkpve6O1MabVg90H21EOLACvtfcHk0li-dDyJacvBvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtV2msLrM&md5=448678512af76a1bd04f1d157a462b3e</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.toxlet.2016.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxlet.2016.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DFarf%25C3%25A1n-Garc%25C3%25ADa%26aufirst%3DE.%2BD.%26aulast%3DCastillo-Mendieta%26aufirst%3DN.%2BT.%26aulast%3DCipr%25C3%25A9s-Flores%26aufirst%3DF.%2BJ.%26aulast%3DPadilla-Mart%25C3%25ADnez%26aufirst%3DI.%2BI.%26aulast%3DTrujillo-Ferrara%26aufirst%3DJ.%2BG.%26aulast%3DSoriano-Urs%25C3%25BAa%26aufirst%3DM.%2BA.%26atitle%3DCurrent%2520data%2520regarding%2520the%2520structure-toxicity%2520relationship%2520of%2520boron-containing%2520compounds%26jtitle%3DToxicol.%2520Lett.%26date%3D2016%26volume%3D258%26spage%3D115%26epage%3D125%26doi%3D10.1016%2Fj.toxlet.2016.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis of biologically active boron-containing compounds</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">201</span>– <span class="NLM_lpage">211</span>, <span class="refDoi"> DOI: 10.1039/C7MD00552K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1039%2FC7MD00552K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=30108914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVOrt7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=201-211&author=F.+Yangauthor=M.+Zhuauthor=J.+Zhangauthor=H.+Zhou&title=Synthesis+of+biologically+active+boron-containing+compounds&doi=10.1039%2FC7MD00552K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of biologically active boron-containing compounds</span></div><div class="casAuthors">Yang, Fei; Zhu, Mingyan; Zhang, Jinyi; Zhou, Huchen</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">201-211</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Boron-contg. compds. which possess unique and attractive properties have received increasing attention from the pharmaceutical industry and academia recently.  They have shown interesting and useful biol. activities, including antibacterial, antifungal, antiparasitic, antiviral, and anti-inflammatory activities.  In this review, the synthetic strategies for various boron-contg. compds., including peptidyl boronic acids, benzoxaboroles, benzoxaborines, benzodiazaborines, amine carboxyboranes, and amine cyanoboranes are summarized.  Representative structures of each structural class and recently developed biol. active boron-contg. compds. are used as examples in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoknvFRHlSSVbVg90H21EOLACvtfcHk0li-dDyJacvBvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVOrt7jN&md5=11018b19779619600cdb63d60ae07407</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1039%2FC7MD00552K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7MD00552K%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DF.%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DH.%26atitle%3DSynthesis%2520of%2520biologically%2520active%2520boron-containing%2520compounds%26jtitle%3DMedChemComm%26date%3D2018%26volume%3D9%26spage%3D201%26epage%3D211%26doi%3D10.1039%2FC7MD00552K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ban, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, H.</span></span> <span> </span><span class="NLM_article-title">Boron-based drug design</span>. <i>Chem. Rec.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">616</span>– <span class="NLM_lpage">635</span>, <span class="refDoi"> DOI: 10.1002/tcr.201402100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2Ftcr.201402100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=25800654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltFWisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=616-635&author=H.+S.+Banauthor=H.+Nakamura&title=Boron-based+drug+design&doi=10.1002%2Ftcr.201402100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Boron-Based Drug Design</span></div><div class="casAuthors">Ban, Hyun Seung; Nakamura, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Record</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">616-635</span>CODEN:
                <span class="NLM_cas:coden">CRHEAK</span>;
        ISSN:<span class="NLM_cas:issn">1528-0691</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The use of the element boron, which is not generally obsd. in a living body, possesses a high potential for the discovery of new biol. activity in pharmaceutical drug design.  In this account, the authors describe the recent developments in boron-based drug design, including boronic acid contg. protein tyrosine kinase inhibitors, proteasome inhibitors, and tubulin polymn. inhibitors, and ortho-carborane-contg. proteasome activators, hypoxia-inducible factor 1 inhibitors, and topoisomerase inhibitors.  Furthermore, the authors applied a closo-dodecaborate as a water-sol. moiety as well as a boron-10 source for the design of boron carriers in boron neutron capture therapy, such as boronated porphyrins and boron lipids for a liposomal boron delivery system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaf96EHiagY7Vg90H21EOLACvtfcHk0lh2MuGCYXM1dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltFWisrY%253D&md5=2274f1fbd3ec933c9874fe38834e41dd</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2Ftcr.201402100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Ftcr.201402100%26sid%3Dliteratum%253Aachs%26aulast%3DBan%26aufirst%3DH.%2BS.%26aulast%3DNakamura%26aufirst%3DH.%26atitle%3DBoron-based%2520drug%2520design%26jtitle%3DChem.%2520Rec.%26date%3D2015%26volume%3D15%26spage%3D616%26epage%3D635%26doi%3D10.1002%2Ftcr.201402100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stubelius, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almutairi, A.</span></span> <span> </span><span class="NLM_article-title">The chemistry of boronic acids in nanomaterials for drug delivery</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">3108</span>– <span class="NLM_lpage">3119</span>, <span class="refDoi"> DOI: 10.1021/acs.accounts.9b00292</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.accounts.9b00292" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFarsrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2019&pages=3108-3119&author=A.+Stubeliusauthor=S.+Leeauthor=A.+Almutairi&title=The+chemistry+of+boronic+acids+in+nanomaterials+for+drug+delivery&doi=10.1021%2Facs.accounts.9b00292"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The Chemistry of Boronic Acids in Nanomaterials for Drug Delivery</span></div><div class="casAuthors">Stubelius, Alexandra; Lee, Sangeun; Almutairi, Adah</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3108-3119</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Conspectus: Interest in increasing drug delivery efficiency has risen over the past decade both as a means to improve efficacy of already clin. available drugs and due to the increased difficulties of approving new drugs.  As a functional group for targeted drug delivery, boronic acids (BAs) have been incorporated in polymeric particles both as a stimuli-responsive functional group and as a targeting ligand.  Here, BA chem. presents a wealth of opportunities for biol. applications.  It not only reacts with several chem. markers of disease such as reactive oxygen species (ROS), ATP (ATP), glucose, and reduced pH, but it also acts as ligands for diols such as sialic acid.  These stimuli-responsive drug delivery systems optimize delivery of therapeutics based on rational design and precise mol. engineering.  When designing materials contg. BA, the unique chem. properties are important to take into consideration such as its vacant p-orbital, its mol. geometry, and the designed acid's pKa.  Instead of behaving as most carboxylic acids that donate protons, BAs instead primarily act as Lewis acids that accept electrons.  In aq. soln., most polymers contg. BA exist in an equil. between their triangular hydrophobic form and a tetrahedral hydrophilic form.  The most common pKa's are in the nonphysiol. range of 8-10, and much ongoing research focuses on modifying BAs into materials sensitive to a more physiol. relevant pH range.  So far, BA moieties have been incorporated into a stunning array of materials, ranging from small mols. that can self-assemble into higher order structures such as micelles and polymeric micelles, via larger polymeric assemblies, to large scale hydrogels.  With the abundance of biol. mols. contg. diols and polyhydroxy motifs, BA-contg. materials have proven valuable in several biomedical applications such as treatment of cancer, diabetes, obesity, and bacterial infections.  Both materials functionalized with BA and boronic esters display good safety profiles in vitro and in vivo; thus, BA-contg. materials represent promising carriers for responsive delivery systems with great potential for clin. translation.  The intention of this Account is to showcase the versatility of BA for biomedical applications.  We first discuss the chem. of BA and what to consider when designing BA-contg. materials.  Further, we review how its chem. recently has been applied to nanomaterials for enhanced delivery efficiency, both as a stimuli-responsive group and as a targeting ligand.  Lastly, we discuss the current limitations and further perspectives of BA in biomaterials, based on the great benefits that can come from utilizing the unique BA chem. to enhance drug delivery efficiency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFV0Gj9y1rcLVg90H21EOLACvtfcHk0lh2MuGCYXM1dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFarsrnK&md5=751da858ff3ee4ce67f87ed261c1f3f7</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facs.accounts.9b00292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.accounts.9b00292%26sid%3Dliteratum%253Aachs%26aulast%3DStubelius%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DAlmutairi%26aufirst%3DA.%26atitle%3DThe%2520chemistry%2520of%2520boronic%2520acids%2520in%2520nanomaterials%2520for%2520drug%2520delivery%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2019%26volume%3D52%26spage%3D3108%26epage%3D3119%26doi%3D10.1021%2Facs.accounts.9b00292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span> <span> </span><span class="NLM_article-title">Boronic acid compounds as potential pharmaceutical agents</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">346</span>– <span class="NLM_lpage">368</span>, <span class="refDoi"> DOI: 10.1002/med.10043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2Fmed.10043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=12647314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjsVWitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=346-368&author=W.+Yangauthor=X.+Gaoauthor=B.+Wang&title=Boronic+acid+compounds+as+potential+pharmaceutical+agents&doi=10.1002%2Fmed.10043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Boronic acid compounds as potential pharmaceutical agents</span></div><div class="casAuthors">Yang, Wenqian; Gao, Xingming; Wang, Binghe</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">346-368</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Boronic acid compds. have been used, because of their unique structural features, for the development of potent enzyme inhibitors, boron neutron capture agents for cancer therapy, and as antibody mimics that recognize biol. important saccharides.  Consequently, there has been a surge of interests in boronic acid compds.  This study reviews the recent development in this area during the last six years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB0CvJjV10BbVg90H21EOLACvtfcHk0lh2MuGCYXM1dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjsVWitb8%253D&md5=0b841477e2113218d55991e23133bd60</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fmed.10043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.10043%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DB.%26atitle%3DBoronic%2520acid%2520compounds%2520as%2520potential%2520pharmaceutical%2520agents%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2003%26volume%3D23%26spage%3D346%26epage%3D368%26doi%3D10.1002%2Fmed.10043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, G. F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dos Santos, J. L.</span></span> <span> </span><span class="NLM_article-title">Boron in drug design: recent advances in the development of new therapeutic agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>179</i></span>,  <span class="NLM_fpage">791</span>– <span class="NLM_lpage">804</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.06.092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.ejmech.2019.06.092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=31288128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtleju7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2019&pages=791-804&author=G.+F.+S.+Fernandesauthor=W.+A.+Dennyauthor=J.+L.+Dos+Santos&title=Boron+in+drug+design%3A+recent+advances+in+the+development+of+new+therapeutic+agents&doi=10.1016%2Fj.ejmech.2019.06.092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Boron in drug design: Recent advances in the development of new therapeutic agents</span></div><div class="casAuthors">Fernandes, Guilherme Felipe Santos; Denny, William Alexander; Dos Santos, Jean Leandro</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">791-804</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Advances in the field of boron chem. have expanded the application of this element in Medicinal Chem.  Boron-contg. compds. represent a new class for medicinal chemists to use in their drug designs.  Bortezomib, a dipeptide boronic acid approved by the FDA in 2003 for treatment of multiple myeloma, paved the way for the discovery of new boron-contg. compds. After its approval, two other boron-contg. compds. have been approved, tavaborole for the treatment of onychomycosis and crisaborole for the treatment of mild to moderate atopic dermatitis.  A no. of boron-contg. compds. have been described and evaluated for a plethora of therapeutic applications.  The present review is intended to highlight the recent advances related to boron-contg. compds. and their therapeutic applications.  Here, we focused only in those most biol. active compds. with proven in vitro and/or in vivo efficacy in the therapeutic area published in the last years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNneApZtw8C7Vg90H21EOLACvtfcHk0liFbJpf0dxilw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtleju7fE&md5=52c7677a4b6213be8a03b48c3981bba4</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.06.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.06.092%26sid%3Dliteratum%253Aachs%26aulast%3DFernandes%26aufirst%3DG.%2BF.%2BS.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DDos%2BSantos%26aufirst%3DJ.%2BL.%26atitle%3DBoron%2520in%2520drug%2520design%253A%2520recent%2520advances%2520in%2520the%2520development%2520of%2520new%2520therapeutic%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D179%26spage%3D791%26epage%3D804%26doi%3D10.1016%2Fj.ejmech.2019.06.092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biswas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao Pinninti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maiti, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N. D. P.</span></span> <span> </span><span class="NLM_article-title">Environment activatable nanoprodrug: two-step surveillance in the anticancer drug release</span>. <i>ACS Appl. Mater. Interfaces</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">28180</span>– <span class="NLM_lpage">28184</span>, <span class="refDoi"> DOI: 10.1021/acsami.7b05132</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsami.7b05132" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht12mt7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=28180-28184&author=S.+Biswasauthor=J.+Dasauthor=S.+Barmanauthor=B.+Rao+Pinnintiauthor=T.+K.+Maitiauthor=N.+D.+P.+Singh&title=Environment+activatable+nanoprodrug%3A+two-step+surveillance+in+the+anticancer+drug+release&doi=10.1021%2Facsami.7b05132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Environment Activatable Nanoprodrug: Two-Step Surveillance in the Anticancer Drug Release</span></div><div class="casAuthors">Biswas, Sandipan; Das, Joyjyoti; Barman, Shrabani; Rao Pinninti, Bhaskara; K. Maiti, Tapas; Singh, N. D. Pradeep</div><div class="citationInfo"><span class="NLM_cas:title">ACS Applied Materials & Interfaces</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">28180-28184</span>CODEN:
                <span class="NLM_cas:coden">AAMICK</span>;
        ISSN:<span class="NLM_cas:issn">1944-8244</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Remedial cancer therapy deals with a large no. of theranostic applications.  However, systems, so far known, are only capable of single surveillance for both diagnostic and therapeutic modes of action.  A nanosystem, which can be localized to the cancer and deliver the chemotherapeutic agent on demand, will provide effective therapeutic activity.  Herein, we designed a single component nanoprodrug ANPD-X (Activatable Nano Pro-Drug-X) which identified the tumor sites by fluorescent color change (signal 1, blue to green fluorescence) using H2O2-mediated oxidn. of boronate fluorophore.  In the next step, precise spatiotemporal irradn. of light only on identified tumor sites resulted in the release of anticancer drug chlorambucil.  The real time information on drug release was achieved by a second fluorescence color change (signal 2, green to blue fluorescence).  Thus, nanoprodrug ANPD-X provided overall two-step surveillance in the anticancer drug delivery.  Activation of the ANPD-X after addn. of H2O2 and drug release upon photoirradn. was investigated in vitro by monitoring its fluorescence in the HeLa cell line.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJb4u4U95f6rVg90H21EOLACvtfcHk0liFbJpf0dxilw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht12mt7nF&md5=ae616cc6d9ff68288b597b8186fd5459</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facsami.7b05132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsami.7b05132%26sid%3Dliteratum%253Aachs%26aulast%3DBiswas%26aufirst%3DS.%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DBarman%26aufirst%3DS.%26aulast%3DRao%2BPinninti%26aufirst%3DB.%26aulast%3DMaiti%26aufirst%3DT.%2BK.%26aulast%3DSingh%26aufirst%3DN.%2BD.%2BP.%26atitle%3DEnvironment%2520activatable%2520nanoprodrug%253A%2520two-step%2520surveillance%2520in%2520the%2520anticancer%2520drug%2520release%26jtitle%3DACS%2520Appl.%2520Mater.%2520Interfaces%26date%3D2017%26volume%3D9%26spage%3D28180%26epage%3D28184%26doi%3D10.1021%2Facsami.7b05132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bedini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraternale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crinelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolucci, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarantini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spadoni, G.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological activity of hydrogen peroxide responsive arylboronate melatonin hybrids</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">100</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrestox.8b00216</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrestox.8b00216" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFehurbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2019&pages=100-112&author=A.+Bediniauthor=A.+Fraternaleauthor=R.+Crinelliauthor=M.+Mariauthor=S.+Bartolucciauthor=L.+Chiarantiniauthor=G.+Spadoni&title=Design%2C+synthesis%2C+and+biological+activity+of+hydrogen+peroxide+responsive+arylboronate+melatonin+hybrids&doi=10.1021%2Facs.chemrestox.8b00216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Activity of Hydrogen Peroxide Responsive Arylboronate Melatonin Hybrids</span></div><div class="casAuthors">Bedini, Annalida; Fraternale, Alessandra; Crinelli, Rita; Mari, Michele; Bartolucci, Silvia; Chiarantini, Laura; Spadoni, Gilberto</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">100-112</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Stimulus-responsive cleavage reactions have found broad use to direct drug release at a particular target disease area.  Increased levels of reactive oxygen species (ROS) have been assocd. with the development and progression of cancer and several other disease states, motivating the development of drug conjugates that can undergo a chemoselective ROS-triggered release.  Melatonin (MLT) and the reactive electrophile p-benzoquinone methide (p-QM) have evidenced either cytoprotective or cytotoxic effects in biol. systems, depending on the dose, cellular targets, and time of exposure.  In this study, the authors report the synthesis and biol. activity of two MLT derivs. linked to ROS-responsive arylboronate triggers (P1 and P2), which can be activated by endogenously generated hydrogen peroxide (H2O2) to release MLT, or 5-methoxytryptamine (5-MeOT), and p-QM-intermediates.  Their H2O2-induced activation mechanism was studied by HPLC-DAD-MS.  P1, which rapidly releases MLT and p-QM, was able to strongly induce the Nrf2 antioxidant signaling pathway, but was ineffective to provide protection against H2O2-mediated oxidative damage.  By contrast, P1 exhibited strong toxic effects in HeLa cancer cells, without causing significant toxicity to normal NCTC-2544 cells.  Similar, although more limited, effects were exerted by P2.  In both cases, cytotoxicity was accompanied by depletion of cellular glutathione (GSH), probably as a consequence of p-QM release, and increased ROS levels.  A role for MLT in toxicity was also obsd., suggesting that the P1 released products, MLT and p-QM, contributed additively to promote cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAvVcvY9LON7Vg90H21EOLACvtfcHk0liFbJpf0dxilw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFehurbF&md5=dd2fe6ed6ea40a9334fec58a3ea47f7d</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrestox.8b00216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrestox.8b00216%26sid%3Dliteratum%253Aachs%26aulast%3DBedini%26aufirst%3DA.%26aulast%3DFraternale%26aufirst%3DA.%26aulast%3DCrinelli%26aufirst%3DR.%26aulast%3DMari%26aufirst%3DM.%26aulast%3DBartolucci%26aufirst%3DS.%26aulast%3DChiarantini%26aufirst%3DL.%26aulast%3DSpadoni%26aufirst%3DG.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520activity%2520of%2520hydrogen%2520peroxide%2520responsive%2520arylboronate%2520melatonin%2520hybrids%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2019%26volume%3D32%26spage%3D100%26epage%3D112%26doi%3D10.1021%2Facs.chemrestox.8b00216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span> <span> </span><span class="NLM_article-title">Biocompatible boron-containing prodrugs of belinostat for the potential treatment of solid tumors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">149</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00504</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00504" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlvVertg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=149-154&author=S.+Zhengauthor=S.+Guoauthor=Q.+Zhongauthor=C.+Zhangauthor=J.+Liuauthor=L.+Yangauthor=Q.+Zhangauthor=G.+Wang&title=Biocompatible+boron-containing+prodrugs+of+belinostat+for+the+potential+treatment+of+solid+tumors&doi=10.1021%2Facsmedchemlett.7b00504"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Biocompatible Boron-Containing Prodrugs of Belinostat for the Potential Treatment of Solid Tumors</span></div><div class="casAuthors">Zheng, Shilong; Guo, Shanchun; Zhong, Qiu; Zhang, Changde; Liu, Jiawang; Yang, Lin; Zhang, Qiang; Wang, Guangdi</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">149-154</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Despite promising therapeutic utilities for treatment of hematol. malignancies, histone deacetylase inhibitor (HDACi) drugs have not proven as effective in the treatment of solid tumors.  To expand the clin. indications of HDACi drugs, we developed novel boron-contg. prodrugs of belinostat (2), one of which efficiently releases active 2 through a cascade of reactions in cell culture and demonstrates activities comparable to 2 against a panel of cancer cell lines.  Importantly, prodrug I is more efficacious than belinostat in vivo, not only inhibiting the growth of tumor but also reducing tumor vols. in an MCF-7 xenograft tumor model owing to its superior biocompatibility, which suggests its clin. potential in the treatment of solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjIOQIgps2KrVg90H21EOLACvtfcHk0liFbJpf0dxilw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlvVertg%253D%253D&md5=96d56396fbcd0a6192f277ffb13fb423</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00504%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DS.%26aulast%3DZhong%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DG.%26atitle%3DBiocompatible%2520boron-containing%2520prodrugs%2520of%2520belinostat%2520for%2520the%2520potential%2520treatment%2520of%2520solid%2520tumors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D149%26epage%3D154%26doi%3D10.1021%2Facsmedchemlett.7b00504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jourden, J. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniel, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S. M.</span></span> <span> </span><span class="NLM_article-title">Investigation of self-immolative linkers in the design of hydrogen peroxide activated metalloprotein inhibitors</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">7968</span>– <span class="NLM_lpage">7970</span>, <span class="refDoi"> DOI: 10.1039/c1cc12526e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1039%2Fc1cc12526e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=21677985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotl2jsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2011&pages=7968-7970&author=J.+L.+M.+Jourdenauthor=K.+B.+Danielauthor=S.+M.+Cohen&title=Investigation+of+self-immolative+linkers+in+the+design+of+hydrogen+peroxide+activated+metalloprotein+inhibitors&doi=10.1039%2Fc1cc12526e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of self-immolative linkers in the design of hydrogen peroxide activated metalloprotein inhibitors</span></div><div class="casAuthors">Jourden, Jody L. Major; Daniel, Kevin B.; Cohen, Seth M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">7968-7970</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A series of self-immolative boronic ester protected Me salicylates and metal-binding groups with various linking strategies have been investigated for their use in the design of matrix metalloproteinase proinhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvVE1PCZf15rVg90H21EOLACvtfcHk0ljQ9ceNlMp11A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotl2jsbY%253D&md5=8857bc5ca7ac12b8ee5eb419892a6a2c</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1039%2Fc1cc12526e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1cc12526e%26sid%3Dliteratum%253Aachs%26aulast%3DJourden%26aufirst%3DJ.%2BL.%2BM.%26aulast%3DDaniel%26aufirst%3DK.%2BB.%26aulast%3DCohen%26aufirst%3DS.%2BM.%26atitle%3DInvestigation%2520of%2520self-immolative%2520linkers%2520in%2520the%2520design%2520of%2520hydrogen%2520peroxide%2520activated%2520metalloprotein%2520inhibitors%26jtitle%3DChem.%2520Commun.%26date%3D2011%26volume%3D47%26spage%3D7968%26epage%3D7970%26doi%3D10.1039%2Fc1cc12526e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neufeld, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Ramirez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species-responsive protein modification and its intracellular delivery for targeted cancer therapy</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">13444</span>– <span class="NLM_lpage">13448</span>, <span class="refDoi"> DOI: 10.1002/anie.201407234</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2Fanie.201407234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVCit73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=13444-13448&author=M.+Wangauthor=S.+Sunauthor=C.+I.+Neufeldauthor=B.+Perez-Ramirezauthor=Q.+Xu&title=Reactive+oxygen+species-responsive+protein+modification+and+its+intracellular+delivery+for+targeted+cancer+therapy&doi=10.1002%2Fanie.201407234"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive Oxygen Species-Responsive Protein Modification and Its Intracellular Delivery for Targeted Cancer Therapy</span></div><div class="casAuthors">Wang, Ming; Sun, Shuo; Neufeld, Caleb I.; Perez-Ramirez, Bernardo; Xu, Qiaobing</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">13444-13448</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Herein we report a convenient chem. approach to reversibly modulate protein (RNase A) function and develop a protein that is responsive to reactive oxygen species (ROS) for targeted cancer therapy.  The conjugation of RNase A with 4-nitrophenyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) benzyl carbonate (NBC) blocks protein lysine and temporarily deactivates the protein.  However, the treatment of RNase A-NBC with hydrogen peroxide (one major intracellular ROS) efficiently cleaves the NBC conjugation and restores the RNase A activity.  Thus, RNase A-NBC can be reactivated inside tumor cells by high levels of intracellular ROS, thereby restoring the cytotoxicity of RNase A for cancer therapy.  Due to higher ROS levels inside tumor cells compared to healthy cells, and the resulting different levels of RNase A-NBC reactivation, RNase A-NBC shows a significant specific cytotoxicity against tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3uxwUOg3LNrVg90H21EOLACvtfcHk0ljQ9ceNlMp11A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVCit73F&md5=d0e6ebdc36e6915f5cbd851544914e70</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2Fanie.201407234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201407234%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DNeufeld%26aufirst%3DC.%2BI.%26aulast%3DPerez-Ramirez%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DQ.%26atitle%3DReactive%2520oxygen%2520species-responsive%2520protein%2520modification%2520and%2520its%2520intracellular%2520delivery%2520for%2520targeted%2520cancer%2520therapy%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D13444%26epage%3D13448%26doi%3D10.1002%2Fanie.201407234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peiró Cadahía, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Previtali, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bondebjerg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andresen, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clausen, M. H.</span></span> <span> </span><span class="NLM_article-title">Methotrexate prodrugs sensitive to reactive oxygen species for the improved treatment of rheumatoid arthritis</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">738</span>– <span class="NLM_lpage">746</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.07.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.ejmech.2018.07.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=30048923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlOit7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2018&pages=738-746&author=N.+S.+Andersenauthor=J.+Peir%C3%B3+Cadah%C3%ADaauthor=V.+Previtaliauthor=J.+Bondebjergauthor=C.+A.+Hansenauthor=A.+E.+Hansenauthor=T.+L.+Andresenauthor=M.+H.+Clausen&title=Methotrexate+prodrugs+sensitive+to+reactive+oxygen+species+for+the+improved+treatment+of+rheumatoid+arthritis&doi=10.1016%2Fj.ejmech.2018.07.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Methotrexate prodrugs sensitive to reactive oxygen species for the improved treatment of rheumatoid arthritis</span></div><div class="casAuthors">Andersen, Nikolaj S.; Peiro Cadahia, Jorge; Previtali, Viola; Bondebjerg, Jon; Hansen, Christian A.; Hansen, Anders E.; Andresen, Thomas L.; Clausen, Mads H.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">738-746</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Methotrexate (MTX) is the std. of care in the treatment of rheumatoid arthritis (RA), a common autoimmune disease that is characterized by chronic inflammation in the synovial membrane of joints.  Unfortunately, MTX suffers from high discontinuation rates due to a large variability in efficacy and, in particular, adverse effects.  As inflammation is assocd. with elevated levels of reactive oxygen species (ROS) like H2O2, we propose to improve treatment through site-selective delivery of MTX to inflammatory tissue by use of a H2O2 sensitive MTX prodrug.  To establish proof proof-of-concept, two novel H2O2 sensitive, thiazolidinone-based MTX prodrugs were synthesized and evaluated for this purpose.  MTX-γ-thiazolidinone (MTX-γ-TZ) exhibited the most promising properties - good to high chem. and metabolic stability, excellent aq. soly., while being activated when subjected to patho-physiol. concns. of H2O2.  In vivo, MTX-γ-TZ exhibited comparable efficacy to MTX in a murine collagen type II-induced arthritis (CIA) model while treated mice showed indications of reduced toxicity as their body wt. decreased less towards the end of the study, compared to the MTX-treated group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe-StPKO8IgLVg90H21EOLACvtfcHk0ljQ9ceNlMp11A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlOit7vM&md5=82b56b143cf51ce9b1441b5e2fbf41af</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.07.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.07.045%26sid%3Dliteratum%253Aachs%26aulast%3DAndersen%26aufirst%3DN.%2BS.%26aulast%3DPeir%25C3%25B3%2BCadah%25C3%25ADa%26aufirst%3DJ.%26aulast%3DPrevitali%26aufirst%3DV.%26aulast%3DBondebjerg%26aufirst%3DJ.%26aulast%3DHansen%26aufirst%3DC.%2BA.%26aulast%3DHansen%26aufirst%3DA.%2BE.%26aulast%3DAndresen%26aufirst%3DT.%2BL.%26aulast%3DClausen%26aufirst%3DM.%2BH.%26atitle%3DMethotrexate%2520prodrugs%2520sensitive%2520to%2520reactive%2520oxygen%2520species%2520for%2520the%2520improved%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D156%26spage%3D738%26epage%3D746%26doi%3D10.1016%2Fj.ejmech.2018.07.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monserrat, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S. M.</span></span> <span> </span><span class="NLM_article-title">Exploring hydrogen peroxide responsive thiazolidinone-based prodrugs</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">7116</span>– <span class="NLM_lpage">7119</span>, <span class="refDoi"> DOI: 10.1039/C4CC09921D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1039%2FC4CC09921D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=25811298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltFWjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2015&pages=7116-7119&author=C.+Perezauthor=J.-P.+Monserratauthor=Y.+Chenauthor=S.+M.+Cohen&title=Exploring+hydrogen+peroxide+responsive+thiazolidinone-based+prodrugs&doi=10.1039%2FC4CC09921D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring hydrogen peroxide responsive thiazolidinone-based prodrugs</span></div><div class="casAuthors">Perez, Christian; Monserrat, Jean-Philippe; Chen, Yao; Cohen, Seth M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">7116-7119</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A novel approach for developing prodrugs based on masked carboxylic acids is described.  Rather than using conventional esterase-based activation, thiazolidinone protecting groups have been identified that can reveal carboxylic acid groups upon activation by hydrogen peroxide.  This may prove valuable in the continuing development of prodrug strategies that rely on reactive oxygen species as a trigger.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtp4dvzuXJCbVg90H21EOLACvtfcHk0lgKKTN1TP6mGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltFWjtrs%253D&md5=47fae789e2adf3691d3a2fc840e76d62</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1039%2FC4CC09921D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4CC09921D%26sid%3Dliteratum%253Aachs%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DMonserrat%26aufirst%3DJ.-P.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DCohen%26aufirst%3DS.%2BM.%26atitle%3DExploring%2520hydrogen%2520peroxide%2520responsive%2520thiazolidinone-based%2520prodrugs%26jtitle%3DChem.%2520Commun.%26date%3D2015%26volume%3D51%26spage%3D7116%26epage%3D7119%26doi%3D10.1039%2FC4CC09921D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chittavong, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span> <span> </span><span class="NLM_article-title">Organic CO prodrugs activated by endogenous ROS</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">8</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.7b02775</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.7b02775" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslKltLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2018&pages=8-11&author=Z.+Panauthor=J.+Zhangauthor=K.+Jiauthor=V.+Chittavongauthor=X.+Jiauthor=B.+Wang&title=Organic+CO+prodrugs+activated+by+endogenous+ROS&doi=10.1021%2Facs.orglett.7b02775"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Organic CO Prodrugs Activated by Endogenous ROS</span></div><div class="casAuthors">Pan, Zhixiang; Zhang, Jun; Ji, Kaili; Chittavong, Vayou; Ji, Xingyue; Wang, Binghe</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8-11</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CO prodrugs with triggered release mechanisms are highly desirable for targeted delivery.  Herein described are org. CO prodrugs that are activated by ROS and thus can be used to selectively deliver CO to cells with elevated ROS levels.  Such CO prodrugs can serve as powerful tools for targeted delivery to disease sites with elevated ROS levels and to explore the therapeutic applications of CO.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSFhtEB9mJwbVg90H21EOLACvtfcHk0lgKKTN1TP6mGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslKltLfL&md5=daba27bc927026160ad549b5288f573a</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.7b02775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.7b02775%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DK.%26aulast%3DChittavong%26aufirst%3DV.%26aulast%3DJi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DB.%26atitle%3DOrganic%2520CO%2520prodrugs%2520activated%2520by%2520endogenous%2520ROS%26jtitle%3DOrg.%2520Lett.%26date%3D2018%26volume%3D20%26spage%3D8%26epage%3D11%26doi%3D10.1021%2Facs.orglett.7b02775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oddone, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pederzoli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duskey, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Benedictis, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabrucker, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angela Vandelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruozi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tosi, G.</span></span> <span> </span><span class="NLM_article-title">ROS-responsive “smart” polymeric conjugate: synthesis, characterization and proof-of-concept study</span>. <i>Int. J. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>570</i></span>,  <span class="NLM_fpage">118655</span>, <span class="refDoi"> DOI: 10.1016/j.ijpharm.2019.118655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.ijpharm.2019.118655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=31479731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs12qs7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=570&publication_year=2019&pages=118655&author=N.+Oddoneauthor=F.+Pederzoliauthor=J.+T.+Duskeyauthor=C.+A.+De+Benedictisauthor=A.+M.+Grabruckerauthor=F.+Forniauthor=M.+Angela+Vandelliauthor=B.+Ruoziauthor=G.+Tosi&title=ROS-responsive+%E2%80%9Csmart%E2%80%9D+polymeric+conjugate%3A+synthesis%2C+characterization+and+proof-of-concept+study&doi=10.1016%2Fj.ijpharm.2019.118655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">ROS-responsive "smart" polymeric conjugate: Synthesis, characterization and proof-of-concept study</span></div><div class="casAuthors">Oddone, Natalia; Pederzoli, Francesca; Duskey, Jason T.; De Benedictis, Chiara A.; Grabrucker, Andreas M.; Forni, Flavio; Vandelli, Maria Angela; Ruozi, Barbara; Tosi, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">570</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">118655</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">New approaches integrating stimuli-responsive linkers into prodrugs are currently emerging.  These "smart" prodrugs can enhance the effectivity of conventional prodrugs with promising clin. applicability.  Oxidative stress is central to several diseases, including cancer.  Therefore, the design of prodrugs that respond to ROS stimulus, allowing a selective drug release in this condition, is fairly encouraging.  Aiming to investigate the ROS-responsiveness of prodrugs contg. the ROS-cleavable moiety, Thioketal (TK), we performed proof-of-concept studies by synthesizing ROS-responsive conjugate, namely mPEG-TK-Cy5, through exploiting Cy5 fluorescent dye.  We demonstrated that, differently to non-ROS-responsive control conjugate (mPEG-Cy5), mPEG-TK-Cy5 shows a selective release of Cy5 in response to ROS in both, ROS-simulated conditions and in vitro on glioblastoma cells.  Our results confirm the applicability of TK-technol. in the design of ROS-responsive prodrugs, which constitutes a promising approach in cancer treatment.  The translatability of this technol. for other diseases treatment makes this a highly relevant and promising approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLVScAWaLeErVg90H21EOLACvtfcHk0lgKKTN1TP6mGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs12qs7%252FL&md5=5d0d5f9f96f01b80efde2b8ff7c6ee34</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2019.118655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2019.118655%26sid%3Dliteratum%253Aachs%26aulast%3DOddone%26aufirst%3DN.%26aulast%3DPederzoli%26aufirst%3DF.%26aulast%3DDuskey%26aufirst%3DJ.%2BT.%26aulast%3DDe%2BBenedictis%26aufirst%3DC.%2BA.%26aulast%3DGrabrucker%26aufirst%3DA.%2BM.%26aulast%3DForni%26aufirst%3DF.%26aulast%3DAngela%2BVandelli%26aufirst%3DM.%26aulast%3DRuozi%26aufirst%3DB.%26aulast%3DTosi%26aufirst%3DG.%26atitle%3DROS-responsive%2520%25E2%2580%259Csmart%25E2%2580%259D%2520polymeric%2520conjugate%253A%2520synthesis%252C%2520characterization%2520and%2520proof-of-concept%2520study%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2019%26volume%3D570%26spage%3D118655%26doi%3D10.1016%2Fj.ijpharm.2019.118655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, D. A.</span>; <span class="NLM_string-name">Najera, C.</span></span> <span> </span><span class="NLM_article-title">Desulfonylation reactions</span>. In  <i>Organic Reactions</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denmark, S. E.</span></span>, Ed.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2009</span>; Vol.  <span class="NLM_volume">72</span>, pp  <span class="NLM_fpage">367</span>– <span class="NLM_lpage">656</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2F0471264180.or072.02" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=367-656&author=D.+A.+Alonso&author=C.+Najeraauthor=S.+E.+Denmark&title=Organic+Reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1002%2F0471264180.or072.02&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0471264180.or072.02%26sid%3Dliteratum%253Aachs%26aulast%3DAlonso%26aufirst%3DD.%2BA.%26atitle%3DDesulfonylation%2520reactions%26btitle%3DOrganic%2520Reactions%26aulast%3DDenmark%26aufirst%3DS.%2BE.%26pub%3DWiley%26date%3D2009%26volume%3D72%26spage%3D367%26epage%3D656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oddone, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boury, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcion, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabrucker, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da Ros, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janaszewska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandelli, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tosi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruozi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duskey, J. T.</span></span> <span> </span><span class="NLM_article-title">Synthesis, characterization, and in vitro studies of an reactive oxygen species (ROS)-responsive methoxy polyethylene glycol-thioketal-melphalan prodrug for glioblastoma treatment</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">574</span>, <span class="refDoi"> DOI: 10.3389/fphar.2020.00574</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.3389%2Ffphar.2020.00574" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=32425795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvFKksbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=574&author=N.+Oddoneauthor=F.+Bouryauthor=E.+Garcionauthor=A.+M.+Grabruckerauthor=M.+C.+Martinezauthor=F.+Da+Rosauthor=A.+Janaszewskaauthor=F.+Forniauthor=M.+A.+Vandelliauthor=G.+Tosiauthor=B.+Ruoziauthor=J.+T.+Duskey&title=Synthesis%2C+characterization%2C+and+in+vitro+studies+of+an+reactive+oxygen+species+%28ROS%29-responsive+methoxy+polyethylene+glycol-thioketal-melphalan+prodrug+for+glioblastoma+treatment&doi=10.3389%2Ffphar.2020.00574"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, characterization, and in vitro studies of an reactive oxygen species (ROS)-responsive methoxy polyethylene glycol-thioketal-melphalan prodrug for glioblastoma treatment</span></div><div class="casAuthors">Oddone, Natalia; Boury, Frank; Garcion, Emmanuel; Grabrucker, Andreas M.; Martinez, M. Carmen; Da Ros, Federica; Janaszewska, Anna; Forni, Flavio; Vandelli, Maria Angela; Tosi, Giovanni; Ruozi, Barbara; Duskey, Jason T.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">574</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Glioblastoma (GBM) is the most frequent and aggressive primary tumor of the brain and avs. a life expectancy in diagnosed patients of only 15 mo.  Hence, more effective therapies against this malignancy are urgently needed.  Several diseases, including cancer, are featured by high levels of reactive oxygen species (ROS), which are possible GBM hallmarks to target or benefit from.  Therefore, the covalent linkage of drugs to ROS-responsive mols. can be exploited aiming for a selective drug release within relevant pathol. environments.  In this work, we designed a new ROS-responsive prodrug by using Melphalan (MPH) covalently coupled with methoxy polyethylene glycol (mPEG) through a ROS-cleavable group thioketal (TK), demonstrating the capacity to self-assembly into nanosized micelles.  Full chem.-phys. characterization was conducted on the polymeric-prodrug and proper controls, along with in vitro cytotoxicity assayed on different GBM cell lines and "healthy" astrocyte cells confirming the absence of any cytotoxicity of the prodrug on healthy cells (i.e. astrocytes).  These results were compared with the non-ROS responsive counterpart, underlining the anti-tumoral activity of ROS-responsive compared to the non-ROS-responsive prodrug on GBM cells expressing high levels of ROS.  On the other hand, the combination treatment with this ROS-responsive prodrug and X-ray irradn. on human GBM cells resulted in an increase of the antitumoral effect, and this might be connected to radiotherapy.  Hence, these results represent a starting point for a rationale design of innovative and tailored ROS-responsive prodrugs to be used in GBM therapy and in combination with radiotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpICDqYbD3ndLVg90H21EOLACvtfcHk0ljs-GReIROE-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvFKksbbF&md5=c4b662c914a47331ddc2873113c8580b</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2020.00574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2020.00574%26sid%3Dliteratum%253Aachs%26aulast%3DOddone%26aufirst%3DN.%26aulast%3DBoury%26aufirst%3DF.%26aulast%3DGarcion%26aufirst%3DE.%26aulast%3DGrabrucker%26aufirst%3DA.%2BM.%26aulast%3DMartinez%26aufirst%3DM.%2BC.%26aulast%3DDa%2BRos%26aufirst%3DF.%26aulast%3DJanaszewska%26aufirst%3DA.%26aulast%3DForni%26aufirst%3DF.%26aulast%3DVandelli%26aufirst%3DM.%2BA.%26aulast%3DTosi%26aufirst%3DG.%26aulast%3DRuozi%26aufirst%3DB.%26aulast%3DDuskey%26aufirst%3DJ.%2BT.%26atitle%3DSynthesis%252C%2520characterization%252C%2520and%2520in%2520vitro%2520studies%2520of%2520an%2520reactive%2520oxygen%2520species%2520%2528ROS%2529-responsive%2520methoxy%2520polyethylene%2520glycol-thioketal-melphalan%2520prodrug%2520for%2520glioblastoma%2520treatment%26jtitle%3DFront.%2520Pharmacol.%26date%3D2020%26volume%3D11%26spage%3D574%26doi%3D10.3389%2Ffphar.2020.00574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span> <span> </span><span class="NLM_article-title">Self-luminescing theranostic nanoreactors with intraparticle relayed energy transfer for tumor microenvironment activated imaging and photodynamic therapy</span>. <i>Theranostics</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">20</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.7150/thno.28857</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.7150%2Fthno.28857" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=30662551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtV2nsbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=20-33&author=M.+Wuauthor=L.+Wuauthor=J.+Liauthor=D.+Zhangauthor=S.+Lanauthor=X.+Zhangauthor=X.+Linauthor=G.+Liuauthor=X.+Liuauthor=J.+Liu&title=Self-luminescing+theranostic+nanoreactors+with+intraparticle+relayed+energy+transfer+for+tumor+microenvironment+activated+imaging+and+photodynamic+therapy&doi=10.7150%2Fthno.28857"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Self-luminescing theranostic nanoreactors with intraparticle relayed energy transfer for tumor microenvironment activated imaging and photodynamic therapy</span></div><div class="casAuthors">Wu, Ming; Wu, Lingjie; Li, Jiong; Zhang, Da; Lan, Shanyou; Zhang, Xiaolong; Lin, Xinyi; Liu, Gang; Liu, Xiaolong; Liu, Jingfeng</div><div class="citationInfo"><span class="NLM_cas:title">Theranostics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">20-33</span>CODEN:
                <span class="NLM_cas:coden">THERDS</span>;
        ISSN:<span class="NLM_cas:issn">1838-7640</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">The low tissue penetration depth of external excitation light severely hinders the sensitivity of fluorescence imaging (FL) and the efficacy of photodynamic therapy (PDT) in vivo; thus, rational theranostic platforms that overcome the light penetration depth limit are urgently needed.  To overcome this crucial problem, we designed a self-luminescing nanosystem (denoted POCL) with near-IR (NIR) light emission and singlet oxygen (1O2) generation abilities utilizing an intraparticle relayed resonance energy transfer strategy.  Bis[3,4,6-trichloro-2-(pentyloxycarbonyl) phenyl] oxalate (CPPO) as a chem. energy source with high reactivity toward H2O2, poly[(9,9'-dioctyl-2,7-divinylene-fluorenylene)-alt-2-methoxy-5-(2-ethyl-hexyloxy)-1,4-phenylene] (PFPV) as a highly efficient chemiluminescence converter, and tetraphenylporphyrin (TPP) as a photosensitizer with NIR emission and 1O2 generation abilities were coencapsulated by self-assembly with poly(ethyleneglycol)-co-poly(caprolactone) (PEG-PCL) and folate-PEG-cholesterol to form the POCL nanoreactor, with folate as the targeting group.  A series of in vitro and in vivo analyses, including phys. and chem. characterizations, tumor targeting ability, tumor microenvironment activated imaging and photodynamic therapy, as well as biosafety, were systematically investigated to characterize the POCL.  The POCL displayed excellent NIR luminescence and 1O2 generation abilities in response to H2O2.  Therefore, it could serve as a specific H2O2 probe to identify tumors through chemiluminescence imaging and as a chemiluminescence-driven PDT agent for inducing tumor cell apoptosis to inhibit tumor growth due to the abnormal overprodn. of H2O2 in the tumor microenvironment.  Moreover, the folate ligand on the POCL surface can further improve the accumulation at the tumor site via a receptor-mediated mechanism, thus enhancing tumor imaging and the therapeutic effects both in vitro and in vivo but without any observable systemic toxicity.  The nanosystem reported here might serve as a targeted, smart, precise, and noninvasive strategy triggered by the tumor microenvironment rather than by an outside light source for cancer NIR imaging and PDT treatment without limitations on penetration depth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoybC75JFkvsrVg90H21EOLACvtfcHk0ljs-GReIROE-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtV2nsbbP&md5=3315fc09a7d9d552aaf3b446934c9cd8</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.7150%2Fthno.28857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.28857%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DLan%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DJ.%26atitle%3DSelf-luminescing%2520theranostic%2520nanoreactors%2520with%2520intraparticle%2520relayed%2520energy%2520transfer%2520for%2520tumor%2520microenvironment%2520activated%2520imaging%2520and%2520photodynamic%2520therapy%26jtitle%3DTheranostics%26date%3D2019%26volume%3D9%26spage%3D20%26epage%3D33%26doi%3D10.7150%2Fthno.28857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span> <span> </span><span class="NLM_article-title">Self-strengthened oxidation-responsive bioactivating prodrug nanosystem with sequential and synergistically facilitated drug release for treatment of breast cancer</span>. <i>ACS Appl. Mater. Interfaces</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">18914</span>– <span class="NLM_lpage">18922</span>, <span class="refDoi"> DOI: 10.1021/acsami.9b03056</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsami.9b03056" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1MXovVKgtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=18914-18922&author=K.+Wangauthor=B.+Yangauthor=H.+Yeauthor=X.+Zhangauthor=H.+Songauthor=X.+Wangauthor=N.+Liauthor=L.+Weiauthor=Y.+Wangauthor=H.+Zhangauthor=Q.+Kanauthor=Z.+Heauthor=D.+Wangauthor=J.+Sun&title=Self-strengthened+oxidation-responsive+bioactivating+prodrug+nanosystem+with+sequential+and+synergistically+facilitated+drug+release+for+treatment+of+breast+cancer&doi=10.1021%2Facsami.9b03056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Self-Strengthened Oxidation-Responsive Bioactivating Prodrug Nanosystem with Sequential and Synergistically Facilitated Drug Release for Treatment of Breast Cancer</span></div><div class="casAuthors">Wang, Kaiyuan; Yang, Bin; Ye, Hao; Zhang, Xuanbo; Song, Hang; Wang, Xia; Li, Na; Wei, Lin; Wang, Yu; Zhang, Haotian; Kan, Qiming; He, Zhonggui; Wang, Dun; Sun, Jin</div><div class="citationInfo"><span class="NLM_cas:title">ACS Applied Materials & Interfaces</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">18914-18922</span>CODEN:
                <span class="NLM_cas:coden">AAMICK</span>;
        ISSN:<span class="NLM_cas:issn">1944-8244</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Although environment-sensitive prodrug-based nanoparticles (NPs) have developed rapidly, lots of prodrug NPs still show poor selectivity and efficiency of parent drug bioactivation because of tumor heterogeneity.  Herein, self-strengthened bioactivating prodrug-based NPs are fabricated via co-encapsulation of oxidn.-responsive thioether-linked linoleic acid-paclitaxel conjugates (PTX-S-LA) and β-lapachone (LPC) into polymeric micelles (PMs).  Following cellular uptake, PMs first release LPC to significantly elevate the reactive oxidative species (ROS) level through NAD(P)H: quinone oxidoreductase-1 (NQO1) catalysis.  Then, NQO1-generated ROS in combination with endogenous high ROS levels in tumor cells could synergistically facilitate PTX-S-LA to release the active cytotoxic agent PTX.  Such a novel prodrug nanosystem exhibits self-strengthened prodrug bioactivation, ultraselective release, and cytotoxicity between cancer and normal cells, prolonged circulation time, and enhanced tumor accumulation, leading to high antitumor efficiency and superior biosafety.  Our findings pave the new way for the rational design of oxidn.-responsive prodrug NPs for high-efficacy cancer chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2h6AMn7XRQbVg90H21EOLACvtfcHk0ljs-GReIROE-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXovVKgtL4%253D&md5=3814c1236dd14cf44643ffa59a723ca0</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Facsami.9b03056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsami.9b03056%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DSong%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DWei%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DKan%26aufirst%3DQ.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DJ.%26atitle%3DSelf-strengthened%2520oxidation-responsive%2520bioactivating%2520prodrug%2520nanosystem%2520with%2520sequential%2520and%2520synergistically%2520facilitated%2520drug%2520release%2520for%2520treatment%2520of%2520breast%2520cancer%26jtitle%3DACS%2520Appl.%2520Mater.%2520Interfaces%26date%3D2019%26volume%3D11%26spage%3D18914%26epage%3D18922%26doi%3D10.1021%2Facsami.9b03056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span> <span> </span><span class="NLM_article-title">Gamma radiation-responsive side-chain tellurium-containing polymer for cancer therapy</span>. <i>Mater. Chem. Front.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">2109</span>– <span class="NLM_lpage">2115</span>, <span class="refDoi"> DOI: 10.1039/C8QM00321A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1039%2FC8QM00321A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslequ7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2018&pages=2109-2115&author=F.+Fanauthor=S.+Gaoauthor=S.+Jiauthor=Y.+Fuauthor=P.+Zhangauthor=H.+Xu&title=Gamma+radiation-responsive+side-chain+tellurium-containing+polymer+for+cancer+therapy&doi=10.1039%2FC8QM00321A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Gamma radiation-responsive side-chain tellurium-containing polymer for cancer therapy</span></div><div class="casAuthors">Fan, Fuqiang; Gao, Shiqian; Ji, Shaobo; Fu, Yu; Zhang, Pengpeng; Xu, Huaping</div><div class="citationInfo"><span class="NLM_cas:title">Materials Chemistry Frontiers</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2109-2115</span>CODEN:
                <span class="NLM_cas:coden">MCFAC5</span>;
        ISSN:<span class="NLM_cas:issn">2052-1537</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The combination of chemotherapy and radiotherapy could not only enhance cancer treatment efficacy, but also shorten the period of the overall treatment and relieve the anxiety of the patients during the remedy.  Herein, we present a novel strategy for coordinating the chemotherapy drug CDDP with a tellurium-contg. polymer, which restrained the tumor cytotoxicity of these two portions.  After a low dose of gamma radiation, CDDP departed from the coordination complexes, and the tumor cytotoxicity of both was restored.  In contrast to conventional chemotherapy, this radiation responsive system possesses specific anticancer effects and less toxicity in the non-radiation therapy.  In addn., with regard to the premise of therapeutic efficiency, this system effectively lowered the radiated dosage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOVvS00MHEc7Vg90H21EOLACvtfcHk0li-g8hySrgryw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslequ7vO&md5=7961bc9f0d455be65b00620847ca8036</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1039%2FC8QM00321A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8QM00321A%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DF.%26aulast%3DGao%26aufirst%3DS.%26aulast%3DJi%26aufirst%3DS.%26aulast%3DFu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DXu%26aufirst%3DH.%26atitle%3DGamma%2520radiation-responsive%2520side-chain%2520tellurium-containing%2520polymer%2520for%2520cancer%2520therapy%26jtitle%3DMater.%2520Chem.%2520Front.%26date%3D2018%26volume%3D2%26spage%3D2109%26epage%3D2115%26doi%3D10.1039%2FC8QM00321A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boire, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zachman, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rath, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sung, H.-J.</span></span> <span> </span><span class="NLM_article-title">ROS-cleavable proline oligomer crosslinking of polycaprolactone for pro-angiogenic host response</span>. <i>J. Mater. Chem. B</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">7109</span>– <span class="NLM_lpage">7113</span>, <span class="refDoi"> DOI: 10.1039/C4TB01094A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1039%2FC4TB01094A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=25343029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Siu7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=7109-7113&author=S.+H.+Leeauthor=T.+C.+Boireauthor=J.+B.+Leeauthor=M.+K.+Guptaauthor=A.+L.+Zachmanauthor=R.+Rathauthor=H.-J.+Sung&title=ROS-cleavable+proline+oligomer+crosslinking+of+polycaprolactone+for+pro-angiogenic+host+response&doi=10.1039%2FC4TB01094A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">ROS-cleavable proline oligomer crosslinking of polycaprolactone for pro-angiogenic host response</span></div><div class="casAuthors">Lee, Sue Hyun; Boire, Timothy C.; Lee, Jung Bok; Gupta, Mukesh K.; Zachman, Angela L.; Rath, Rutwik; Sung, Hak-Joon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Materials Chemistry B: Materials for Biology and Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">7109-7113</span>CODEN:
                <span class="NLM_cas:coden">JMCBDV</span>;
        ISSN:<span class="NLM_cas:issn">2050-7518</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A reactive oxygen species (ROS)-degradable scaffold is fabricated by crosslinking biocompatible, hydrolytically-degradable poly(ε-caprolactone) (PCL) with a ROS-degradable oligoproline peptide, KP7K.  The ROS-mediated degradability triggers favorable host responses of the scaffold including improved cell infiltration and angiogenesis in vivo, indicating its unique advantages for tissue engineering applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKHHa70ibZzbVg90H21EOLACvtfcHk0li-g8hySrgryw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Siu7%252FF&md5=27047a2b4a51a0a1662a7b7122711f0a</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1039%2FC4TB01094A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4TB01094A%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DBoire%26aufirst%3DT.%2BC.%26aulast%3DLee%26aufirst%3DJ.%2BB.%26aulast%3DGupta%26aufirst%3DM.%2BK.%26aulast%3DZachman%26aufirst%3DA.%2BL.%26aulast%3DRath%26aufirst%3DR.%26aulast%3DSung%26aufirst%3DH.-J.%26atitle%3DROS-cleavable%2520proline%2520oligomer%2520crosslinking%2520of%2520polycaprolactone%2520for%2520pro-angiogenic%2520host%2520response%26jtitle%3DJ.%2520Mater.%2520Chem.%2520B%26date%3D2014%26volume%3D2%26spage%3D7109%26epage%3D7113%26doi%3D10.1039%2FC4TB01094A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amici, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stadtman, E. R.</span></span> <span> </span><span class="NLM_article-title">Conversion of amino acid residues in proteins and amino acid homopolymers to carbonyl derivatives by metal-catalyzed oxidation reactions</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>264</i></span>,  <span class="NLM_fpage">3341</span>– <span class="NLM_lpage">3346</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2FS0021-9258%2818%2994071-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=2563380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADyaL1MXhvVygsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=1989&pages=3341-3346&author=A.+Amiciauthor=R.+L.+Levineauthor=L.+Tsaiauthor=E.+R.+Stadtman&title=Conversion+of+amino+acid+residues+in+proteins+and+amino+acid+homopolymers+to+carbonyl+derivatives+by+metal-catalyzed+oxidation+reactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Conversion of amino acid residues in proteins and amino acid homopolymers to carbonyl derivatives by metal-catalyzed oxidation reactions</span></div><div class="casAuthors">Amici, Adolfo; Levine, Rodney L.; Tsai, Lin; Stadtman, Earl R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">264</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3341-6</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">A no. of metal-catalyzed oxidn. (MCO) systems mediate the oxidative inactivation of enzymes.  This oxidn. is accompanied by conversion of the side chains of some amino acid residues to carbonyl derivs.  To identify the amino acid residues which are sensitive to MCO oxidn., several enzymes/proteins and amino acid homopolymers were exposed to various MCO systems.  The carbonyl groups which were formed were converted to their corresponding 3H-labeled hydroxy derivs.  After acid hydrolysis, the labeled free amino acids were sepd. by ion-exchange chromatog.  Each protein or polymer gave rise to several different labeled amino acids.  The elution profiles of labeled amino acid obtained from prepns. of Escherichia coli glutamine synthetase which had been oxidized by MCO systems comprised of either Fe(II)/O2 or ascorbate/Fe(II)O2 both in the presence and absence of EDTA were qual. the same.  From a comparison of the elution profiles of labeled amino acids from various proteins with those obtained from homopolymers, it is evident that the side chains of histidine, arginine, lysine, and proline are particularly sensitive to oxidn. by the MCO systems.  This conclusion is supported also by direct amino acid anal. of acid hydrolyzates which shows that the oxidn. of glutamine synthetase, enolase, and phosphoglycerate kinase is assocd. with the loss of ≥1 histidine residue per subunit.  From the results of studies with homopolymers, it is apparent that glutamic semialdehyde is a major product of both proline and arginine residues.  In addn., hydroxyproline and unlabeled glutamic acid were identified among the hydrolysis products of oxidized poly-L-proline, and unlabeled aspartic acid was identified as a product of poly-L-histidine oxidn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlOhx7IIfor7Vg90H21EOLACvtfcHk0li-g8hySrgryw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhvVygsbk%253D&md5=fc4ef7de0901f164e7c82328288bcc8f</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2994071-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252994071-8%26sid%3Dliteratum%253Aachs%26aulast%3DAmici%26aufirst%3DA.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DTsai%26aufirst%3DL.%26aulast%3DStadtman%26aufirst%3DE.%2BR.%26atitle%3DConversion%2520of%2520amino%2520acid%2520residues%2520in%2520proteins%2520and%2520amino%2520acid%2520homopolymers%2520to%2520carbonyl%2520derivatives%2520by%2520metal-catalyzed%2520oxidation%2520reactions%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1989%26volume%3D264%26spage%3D3341%26epage%3D3346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koblin, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zachman, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrien, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmeister, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giorgio, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sung, H.-J.</span></span> <span> </span><span class="NLM_article-title">Physiologically relevant oxidative degradation of oligo (proline) cross-linked polymeric scaffolds</span>. <i>Biomacromolecules</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">4357</span>– <span class="NLM_lpage">4366</span>, <span class="refDoi"> DOI: 10.1021/bm201328k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bm201328k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlGjtrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=4357-4366&author=S.+S.+Yuauthor=R.+L.+Koblinauthor=A.+L.+Zachmanauthor=D.+S.+Perrienauthor=L.+H.+Hofmeisterauthor=T.+D.+Giorgioauthor=H.-J.+Sung&title=Physiologically+relevant+oxidative+degradation+of+oligo+%28proline%29+cross-linked+polymeric+scaffolds&doi=10.1021%2Fbm201328k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Physiologically Relevant Oxidative Degradation of Oligo(proline) Cross-Linked Polymeric Scaffolds</span></div><div class="casAuthors">Yu, Shann S.; Koblin, Rachel L.; Zacherman, Angela L.; Perrien, Daniel S.; Hofmeister, Lucas H.; Giorgio, Todd D.; Sung, Hak-Joon</div><div class="citationInfo"><span class="NLM_cas:title">Biomacromolecules</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4357-4366</span>CODEN:
                <span class="NLM_cas:coden">BOMAF6</span>;
        ISSN:<span class="NLM_cas:issn">1525-7797</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chronic inflammation-mediated oxidative stress is a common mechanism of implant rejection and failure.  Therefore, polymer scaffolds that can degrade slowly in response to this environment may provide a viable platform for implant site-specific, sustained release of immunomodulatory agents over a long time period.  In this work, proline oligomers of varying lengths (Pn) were synthesized and exposed to oxidative environments, and their accelerated degrdn. under oxidative conditions was verified via high performance liq. chromatog. and gel permeation chromatog.  Next, diblock copolymers of poly(ethylene glycol) (PEG) and poly(ε-caprolactone) (PCL) were carboxylated to form 100 kDa terpolymers of 4%PEG-86%PCL-10%cPCL (cPCL = poly(carboxyl-ε-caprolactone); i% indicates molar ratio).  The polymers were then crosslinked with biaminated PEG-Pn-PEG chains, where Pn indicates the length of the proline oligomer flanked by PEG chains.  Salt-leaching of the polymeric matrixes created scaffolds of macroporous and microporous architecture, as obsd. by SEM.  The degrdn. of scaffolds was accelerated under oxidative conditions, as evidenced by mass loss and differential scanning calorimetry measurements.  Immortalized murine bone-marrow-derived macrophages were then seeded on the scaffolds and activated through the addn. of γ-interferon and lipopolysaccharide throughout the 9-day study period.  This treatment promoted the release of H2O2 by the macrophages and the degrdn. of proline-contg. scaffolds compared to the control scaffolds.  The accelerated degrdn. was evidenced by increased scaffold porosity, as visualized through SEM and X-ray microtomog. imaging.  The current study provides insight into the development of scaffolds that respond to oxidative environments through gradual degrdn. for the controlled release of therapeutics targeted to diseases that feature chronic inflammation and oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq46vPmOWHuN7Vg90H21EOLACvtfcHk0lh3THJ_BGzCzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlGjtrfP&md5=789c136f7146937cb70a53643f2a53af</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fbm201328k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbm201328k%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DS.%2BS.%26aulast%3DKoblin%26aufirst%3DR.%2BL.%26aulast%3DZachman%26aufirst%3DA.%2BL.%26aulast%3DPerrien%26aufirst%3DD.%2BS.%26aulast%3DHofmeister%26aufirst%3DL.%2BH.%26aulast%3DGiorgio%26aufirst%3DT.%2BD.%26aulast%3DSung%26aufirst%3DH.-J.%26atitle%3DPhysiologically%2520relevant%2520oxidative%2520degradation%2520of%2520oligo%2520%2528proline%2529%2520cross-linked%2520polymeric%2520scaffolds%26jtitle%3DBiomacromolecules%26date%3D2011%26volume%3D12%26spage%3D4357%26epage%3D4366%26doi%3D10.1021%2Fbm201328k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Noll, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, P. S.</span></span> <span> </span><span class="NLM_article-title">Formation and repair of interstrand cross-links in DNA</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">301</span>, <span class="refDoi"> DOI: 10.1021/cr040478b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr040478b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlars73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2006&pages=277-301&author=D.+M.+Nollauthor=T.+M.+Masonauthor=P.+S.+Miller&title=Formation+and+repair+of+interstrand+cross-links+in+DNA&doi=10.1021%2Fcr040478b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Formation and Repair of Interstrand Cross-Links in DNA</span></div><div class="casAuthors">Noll, David M.; McGregor Mason, Tracey; Miller, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">277-301</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This review will focus primarily on DNA interstrand crosslinks for which there is a substantial body of information about their repair.  These include interstrand crosslinks produced by nitrogen mustards, mitomycin C, platinum compds. and psoralen.  The formation and structures of these crosslinks will first be briefly reviewed.  The mechanism of repair of these crosslinks as derived from both genetic studies and expts. in cellfree systems will then be described as they occur in both prokaryotic and eukaryotic organisms.  It will become apparent from the following discussion that the understanding of interstrand crosslink repair is at best incomplete both at the genetic and certainly at the mol. levels.  Nevertheless, an examn. of the literature from the past decade suggests that a consensus is emerging on the broader if not the detailed mechanistic aspects of the process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_YwWKX2eI9rVg90H21EOLACvtfcHk0lh3THJ_BGzCzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlars73L&md5=78f3f6f9c3634d6e9e67cba3b9ee9386</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fcr040478b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr040478b%26sid%3Dliteratum%253Aachs%26aulast%3DNoll%26aufirst%3DD.%2BM.%26aulast%3DMason%26aufirst%3DT.%2BM.%26aulast%3DMiller%26aufirst%3DP.%2BS.%26atitle%3DFormation%2520and%2520repair%2520of%2520interstrand%2520cross-links%2520in%2520DNA%26jtitle%3DChem.%2520Rev.%26date%3D2006%26volume%3D106%26spage%3D277%26epage%3D301%26doi%3D10.1021%2Fcr040478b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balakrishnan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandhi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span> <span> </span><span class="NLM_article-title">Hydrogen peroxide inducible DNA cross-linking agents: targeted anticancer prodrugs</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">19278</span>– <span class="NLM_lpage">19281</span>, <span class="refDoi"> DOI: 10.1021/ja2073824</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja2073824" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyqsLvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=19278-19281&author=Y.+Kuangauthor=K.+Balakrishnanauthor=V.+Gandhiauthor=X.+Peng&title=Hydrogen+peroxide+inducible+DNA+cross-linking+agents%3A+targeted+anticancer+prodrugs&doi=10.1021%2Fja2073824"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrogen Peroxide Inducible DNA Cross-Linking Agents: Targeted Anticancer Prodrugs</span></div><div class="casAuthors">Kuang, Yunyan; Balakrishnan, Kumudha; Gandhi, Varsha; Peng, Xiaohua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">19278-19281</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The major concern for anticancer chemotherapeutic agents is the host toxicity.  The development of anticancer prodrugs targeting the unique biochem. alterations in cancer cells is an attractive approach to achieve therapeutic activity and selectivity.  We designed and synthesized a new type of nitrogen mustard prodrug that can be activated by high level of reactive oxygen species (ROS) found in cancer cells to release the active chemotherapy agent.  The activation mechanism was detd. by NMR anal.  The activity and selectivity of these prodrugs toward ROS was detd. by measuring DNA interstrand cross-links and/or DNA alkylations.  These compds. showed 60-90% inhibition toward various cancer cells, while normal lymphocytes were not affected.  To the best of our knowledge, this is the first example of H2O2-activated anticancer prodrugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY5EVvl5gaabVg90H21EOLACvtfcHk0lh3THJ_BGzCzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyqsLvE&md5=d907a75fa0e9c33185187cdfb85fda29</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fja2073824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja2073824%26sid%3Dliteratum%253Aachs%26aulast%3DKuang%26aufirst%3DY.%26aulast%3DBalakrishnan%26aufirst%3DK.%26aulast%3DGandhi%26aufirst%3DV.%26aulast%3DPeng%26aufirst%3DX.%26atitle%3DHydrogen%2520peroxide%2520inducible%2520DNA%2520cross-linking%2520agents%253A%2520targeted%2520anticancer%2520prodrugs%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D19278%26epage%3D19281%26doi%3D10.1021%2Fja2073824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span> <span> </span><span class="NLM_article-title">Aromatic nitrogen mustard-based prodrugs: activity, selectivity, and the mechanism of DNA cross-linking</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">7410</span>– <span class="NLM_lpage">7418</span>, <span class="refDoi"> DOI: 10.1002/chem.201400090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2Fchem.201400090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=24806710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnslWlu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=7410-7418&author=W.+Chenauthor=Y.+Hanauthor=X.+Peng&title=Aromatic+nitrogen+mustard-based+prodrugs%3A+activity%2C+selectivity%2C+and+the+mechanism+of+DNA+cross-linking&doi=10.1002%2Fchem.201400090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Aromatic Nitrogen Mustard-Based Prodrugs: Activity, Selectivity, and the Mechanism of DNA Cross-Linking</span></div><div class="casAuthors">Chen, Wenbing; Han, Yanyan; Peng, Xiaohua</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7410-7418</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Three novel H2O2-activated arom. nitrogen mustard prodrugs (6-8) are reported.  These compds. contain a DNA alkylating agent connected to a H2O2-responsive trigger by different electron-withdrawing linkers so that they are inactive towards DNA but can be triggered by H2O2 to release active species.  The activity and selectivity of these compds. towards DNA were investigated by measuring DNA interstrand cross-link (ICL) formation in the presence or absence of H2O2.  An electron-withdrawing linker unit, such as a quaternary ammonia salt (6), a carboxyamide (7), and a carbonate group (8), is sufficient to deactivate the arom. nitrogen mustard resulting in less than 1.5 % crosslinking formation.  However, H2O2 can restore the activity of the effectors by converting a withdrawing group to a donating group, therefore increasing the crosslinking efficiency (>20 %).  The stability and reaction sites of the ICL products were detd., which revealed that alkylation induced by 7 and 8 not only occurred at the purine sites but also at the pyrimidine site.  For the first time, we isolated and characterized the monomer adducts formed between the canonical nucleosides and the arom. nitrogen mustard (15) which supported that nitrogen mustards reacted with dG, dA, and dC.  The activation mechanism was studied by NMR spectroscopic anal.  An in vitro cytotoxicity assay demonstrated that compd. 7 with a carboxyamide linker dramatically inhibited the growth of various cancer cells with a GI50 of less than 1 μM, whereas compd. 6 with a charged linker did not show any obvious toxicity in all cell lines tested.  These data indicated that a neutral carboxyamide linker is preferable for developing nitrogen mustard prodrugs.  Our results showed that 7 is a potent anticancer prodrug that can serve as a model compd. for further development.  We believe these novel arom. nitrogen mustards will inspire further and effective applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM6P1tNGeK57Vg90H21EOLACvtfcHk0lh3THJ_BGzCzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnslWlu7Y%253D&md5=64c7a2f00767b697da1a635be060e49a</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1002%2Fchem.201400090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201400090%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DX.%26atitle%3DAromatic%2520nitrogen%2520mustard-based%2520prodrugs%253A%2520activity%252C%2520selectivity%252C%2520and%2520the%2520mechanism%2520of%2520DNA%2520cross-linking%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2014%26volume%3D20%26spage%3D7410%26epage%3D7418%26doi%3D10.1002%2Fchem.201400090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balakrishnan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandhi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species (ROS) inducible DNA cross-linking agents and their effect on cancer cells and normal lymphocytes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4498</span>– <span class="NLM_lpage">4510</span>, <span class="refDoi"> DOI: 10.1021/jm401349g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401349g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2cXns1Ciu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4498-4510&author=W.+Chenauthor=K.+Balakrishnanauthor=Y.+Kuangauthor=Y.+Hanauthor=M.+Fuauthor=V.+Gandhiauthor=X.+Peng&title=Reactive+oxygen+species+%28ROS%29+inducible+DNA+cross-linking+agents+and+their+effect+on+cancer+cells+and+normal+lymphocytes&doi=10.1021%2Fjm401349g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive Oxygen Species (ROS) Inducible DNA Cross-Linking Agents and Their Effect on Cancer Cells and Normal Lymphocytes</span></div><div class="casAuthors">Chen, Wenbing; Balakrishnan, Kumudha; Kuang, Yunyan; Han, Yanyan; Fu, Min; Gandhi, Varsha; Peng, Xiaohua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4498-4510</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Reducing host toxicity is one of the main challenges of cancer chemotherapy.  Many tumor cells contain high levels of ROS that make them distinctively different from normal cells.  The authors report a series of ROS-activated arom. nitrogen mustards that selectively kill chronic lymphocytic leukemia (CLL) over normal lymphocytes.  These agents showed powerful DNA crosslinking abilities when coupled with H2O2, one of the most common ROS in cancer cells, whereas little DNA crosslinking was detected without H2O2.  Consistent with chem. observation, in vitro cytotoxicity assay demonstrated that these agents induced 40-80% apoptosis in primary leukemic lymphocytes isolated from CLL patients but less than 25% cell death to normal lymphocytes from healthy donors.  The IC50 for the most potent compd. (2) was ∼5 μM in CLL cells, while the IC50 was not achieved in normal lymphocytes.  Collectively, these data provide utility and selectivity of these agents that will inspire further and effective applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmV7B5XHuPHbVg90H21EOLACvtfcHk0lgi2IKBG3EIwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXns1Ciu7k%253D&md5=a5871a2d6b2909c485b4dd7c9e1cf5fe</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjm401349g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401349g%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DBalakrishnan%26aufirst%3DK.%26aulast%3DKuang%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DFu%26aufirst%3DM.%26aulast%3DGandhi%26aufirst%3DV.%26aulast%3DPeng%26aufirst%3DX.%26atitle%3DReactive%2520oxygen%2520species%2520%2528ROS%2529%2520inducible%2520DNA%2520cross-linking%2520agents%2520and%2520their%2520effect%2520on%2520cancer%2520cells%2520and%2520normal%2520lymphocytes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4498%26epage%3D4510%26doi%3D10.1021%2Fjm401349g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zu, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span> <span> </span><span class="NLM_article-title">Cytotoxicity and topo I targeting activity of substituted 10--nitrogenous heterocyclic aromatic group derivatives of SN-38</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">3200</span>– <span class="NLM_lpage">3206</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2010.03.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.ejmech.2010.03.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=20392545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtF2jtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=3200-3206&author=Q.+Y.+Liauthor=X.+Q.+Dengauthor=Y.+G.+Zuauthor=H.+Lvauthor=L.+Suauthor=L.+Yaoauthor=Y.+Zhangauthor=L.+Li&title=Cytotoxicity+and+topo+I+targeting+activity+of+substituted+10%2D%2Dnitrogenous+heterocyclic+aromatic+group+derivatives+of+SN-38&doi=10.1016%2Fj.ejmech.2010.03.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxicity and Topo I targeting activity of substituted 10--nitrogenous heterocyclic aromatic group derivatives of SN-38</span></div><div class="casAuthors">Li, Qing-yong; Deng, Xiao-qiu; Zu, Yuan-gang; Lv, Hongyan; Su, Lin; Yao, Liping; Zhang, Yu; Li, Lei</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3200-3206</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of nitrogenous heterocyclic arom. group-substituted derivs. of SN-38 were prepd.  The SN-38 derivs. were evaluated for cytotoxic activity in three cancer cell lines with many of the compds., e.g. I, displaying potency similar to topotecan.  All of the pyridine salt derivs., e.g. II, revealed comparable or superior topoisomerase I inhibitory activity compared to camptothecin (CPT).  Compared to the corresponding CPT derivs., e.g., III, the SN-38 pyridine salts, which possess an addnl. Et group, demonstrate increased cytotoxicity and topoisomerase I inhibition and good water soly.  These results are consistent with the structure activity relationship of CPT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh9ou--4j4j7Vg90H21EOLACvtfcHk0lgi2IKBG3EIwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtF2jtrg%253D&md5=fea1f37ba6f3989b7da35e77987e5140</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2010.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2010.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DQ.%2BY.%26aulast%3DDeng%26aufirst%3DX.%2BQ.%26aulast%3DZu%26aufirst%3DY.%2BG.%26aulast%3DLv%26aufirst%3DH.%26aulast%3DSu%26aufirst%3DL.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26atitle%3DCytotoxicity%2520and%2520topo%2520I%2520targeting%2520activity%2520of%2520substituted%252010--nitrogenous%2520heterocyclic%2520aromatic%2520group%2520derivatives%2520of%2520SN-38%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D3200%26epage%3D3206%26doi%3D10.1016%2Fj.ejmech.2010.03.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">A new strategy to improve the metabolic stability of lactone: discovery of (20S,21S)-21-fluorocamptothecins as novel, hydrolytically stable topoisomerase I inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">7902</span>– <span class="NLM_lpage">7910</span>, <span class="refDoi"> DOI: 10.1021/jm400906z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400906z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFarsrzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7902-7910&author=Z.+Miaoauthor=L.+Zhuauthor=G.+Dongauthor=C.+Zhuangauthor=Y.+Wuauthor=S.+Wangauthor=Z.+Guoauthor=Y.+Liuauthor=S.+Wuauthor=S.+Zhuauthor=K.+Fangauthor=J.+Yaoauthor=J.+Liauthor=C.+Shengauthor=W.+Zhang&title=A+new+strategy+to+improve+the+metabolic+stability+of+lactone%3A+discovery+of+%2820S%2C21S%29-21-fluorocamptothecins+as+novel%2C+hydrolytically+stable+topoisomerase+I+inhibitors&doi=10.1021%2Fjm400906z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">A New Strategy To Improve the Metabolic Stability of Lactone: Discovery of (20S,21S) 21-Fluorocamptothecins as Novel, Hydrolytically Stable Topoisomerase I Inhibitors</span></div><div class="casAuthors">Miao, Zhenyuan; Zhu, Lingjian; Dong, Guoqiang; Zhuang, Chunlin; Wu, Yuelin; Wang, Shengzheng; Guo, Zizao; Liu, Yang; Wu, Shanchao; Zhu, Shiping; Fang, Kun; Yao, Jianzhong; Li, Jian; Sheng, Chunquan; Zhang, Wannian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7902-7910</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lactone is a common structural motif in biol. active natural products.  However, the metabolic instability of lactone significantly reduces their in vivo potency.  In the present investigation, a new strategy to improve the metabolic stability of lactone was provided by the design of α-fluoro ether as a novel bioisostere of lactone.  The effectiveness of the α-fluoro ether/lactone replacement was validated by the discovery of (20S,21S)-21-fluorocamptothecins as hydrolytically stable topoisomerase I inhibitors.  A highly potent camptothecin deriv., (20S,21S)-7-Cyclohexyluorocamptothecin, was successfully identified, which showed excellent in vitro and in vivo antitumor activities and represents a promising lead for the discovery of novel antitumor agents.  Interestingly, this study also provided a new structure-activity relationship for the C21-carbonyl group of camptothecin, which has been regarded as an essential pharmacophore.  The authors' results revealed that the conserved C21-carbonyl group can be replaced by a fluorine substituent. α-Fluoro ether may have general application in improving the metabolic stability of lactone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvIv8t6UZLVbVg90H21EOLACvtfcHk0lgi2IKBG3EIwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFarsrzE&md5=c99ef47778bdea1041e131efdb8fdbfa</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjm400906z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400906z%26sid%3Dliteratum%253Aachs%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DZhuang%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DK.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DA%2520new%2520strategy%2520to%2520improve%2520the%2520metabolic%2520stability%2520of%2520lactone%253A%2520discovery%2520of%2520%252820S%252C21S%2529-21-fluorocamptothecins%2520as%2520novel%252C%2520hydrolytically%2520stable%2520topoisomerase%2520I%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7902%26epage%3D7910%26doi%3D10.1021%2Fjm400906z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhuniya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maiti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. S.</span></span> <span> </span><span class="NLM_article-title">An activatable prodrug for the treatment of metastatic tumors</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">13888</span>– <span class="NLM_lpage">13894</span>, <span class="refDoi"> DOI: 10.1021/ja5077684</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja5077684" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFamsL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=13888-13894&author=E.+J.+Kimauthor=S.+Bhuniyaauthor=H.+Leeauthor=H.+M.+Kimauthor=C.+Cheongauthor=S.+Maitiauthor=K.+S.+Hongauthor=J.+S.+Kim&title=An+activatable+prodrug+for+the+treatment+of+metastatic+tumors&doi=10.1021%2Fja5077684"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">An Activatable Prodrug for the Treatment of Metastatic Tumors</span></div><div class="casAuthors">Kim, Eun-Joong; Bhuniya, Sankarprasad; Lee, Hyunseung; Kim, Hyun Min; Cheong, Chaejoon; Maiti, Sukhendu; Hong, Kwan Soo; Kim, Jong Seung</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">13888-13894</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Metastatic cancers have historically been difficult to treat.  However, metastatic tumors have been found to have high levels of reactive oxygen species such as hydrogen peroxide (H2O2), supporting the hypothesis that a prodrug could be activated by intracellular H2O2 and lead to a potential antimetastatic therapy.  In this study, prodrug 7 was designed to be activated by H2O2-mediated boronate oxidn., resulting in activation of the fluorophore for detection and release of the therapeutic agent, SN-38.  Drug release from prodrug 7 was investigated by monitoring fluorescence after addn. of H2O2 to the cancer cells.  Prodrug 7 activated by H2O2, selectively inhibited tumor cell growth.  Furthermore, intratracheally administered prodrug 7 showed effective antitumor activity in a mouse model of metastatic lung disease.  Thus, this H2O2-responsive prodrug has therapeutic potential as a novel treatment for metastatic cancer via cellular imaging with fluorescence as well as selective release of the anticancer drug, SN-38.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX5gk0YqDa5rVg90H21EOLACvtfcHk0ljZKyoiYTplOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFamsL%252FK&md5=35fc515aa6940c7b7946bb5638ed4e19</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fja5077684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja5077684%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DE.%2BJ.%26aulast%3DBhuniya%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DH.%2BM.%26aulast%3DCheong%26aufirst%3DC.%26aulast%3DMaiti%26aufirst%3DS.%26aulast%3DHong%26aufirst%3DK.%2BS.%26aulast%3DKim%26aufirst%3DJ.%2BS.%26atitle%3DAn%2520activatable%2520prodrug%2520for%2520the%2520treatment%2520of%2520metastatic%2520tumors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D13888%26epage%3D13894%26doi%3D10.1021%2Fja5077684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span> <span> </span><span class="NLM_article-title">10-Boronic acid substituted camptothecin as prodrug of SN-38</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">84</span>– <span class="NLM_lpage">89</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.03.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.ejmech.2016.03.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=27060760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlsl2htbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=84-89&author=L.+Wangauthor=S.+Xieauthor=L.+Maauthor=Y.+Chenauthor=W.+Lu&title=10-Boronic+acid+substituted+camptothecin+as+prodrug+of+SN-38&doi=10.1016%2Fj.ejmech.2016.03.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">10-Boronic acid substituted camptothecin as prodrug of SN-38</span></div><div class="casAuthors">Wang, Lei; Xie, Shao; Ma, Longjun; Chen, Yi; Lu, Wei</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">84-89</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Malignant tumor cells have been found to have high levels of reactive oxygen species such as hydrogen peroxide (H2O2), supporting the hypothesis that a prodrug could be activated by intracellular H2O2 and lead to a potential antitumor therapy.  In this study, the 7-ethyl-10-boronic acid camptothecin (B1) was synthesized for the first time as prodrug of SN-38, by linking a cleavable aryl carbon-boron bond to the SN-38.  Prodrug B1 selectively activated by H2O2, converted rapidly to the active form SN-38 under favorable oxidative conditions in cancer cells with elevated levels of H2O2.  The cell survival assay showed that prodrug B1 was equally or more effective in inhibiting the growth of six different cancer cells, as compared to SN-38.  Unexpectedly, prodrug B1 displayed even more potent Topo I inhibitory activity than SN-38, suggesting that it was not only a prodrug of SN-38 but also a typical Topo I inhibitor.  Prodrug B1 also demonstrated a significant antitumor activity at 2.0 mg/kg in a xenograft model using human brain star glioblastoma cell lines U87MG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbS7sNf3ZRmbVg90H21EOLACvtfcHk0ljZKyoiYTplOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlsl2htbo%253D&md5=39c3592513770a0017e7a80993848eaf</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.03.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.03.063%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DXie%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DW.%26atitle%3D10-Boronic%2520acid%2520substituted%2520camptothecin%2520as%2520prodrug%2520of%2520SN-38%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D116%26spage%3D84%26epage%3D89%26doi%3D10.1016%2Fj.ejmech.2016.03.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Natural product evodiamine with borate trigger unit: discovery of potent antitumor agents against colon cancer</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">439</span>– <span class="NLM_lpage">444</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.9b00513</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.9b00513" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BB3cXktlOhtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=439-444&author=X.+Liauthor=S.+Wuauthor=G.+Dongauthor=S.+Chenauthor=Z.+Maauthor=D.+Liuauthor=C.+Sheng&title=Natural+product+evodiamine+with+borate+trigger+unit%3A+discovery+of+potent+antitumor+agents+against+colon+cancer&doi=10.1021%2Facsmedchemlett.9b00513"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Product Evodiamine with Borate Trigger Unit: Discovery of Potent Antitumor Agents against Colon Cancer</span></div><div class="casAuthors">Li, Xinglin; Wu, Shanchao; Dong, Guoqiang; Chen, Shuqiang; Ma, Zonglin; Liu, Dan; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">439-444</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In order to improve the antitumor potency of the natural product evodiamine, novel boron-contg. evodiamine derivs. were designed by incorporating boronic acid and boronate as trigger units.  Boronate deriv. 13a could be triggered by reactive oxygen species (ROS) in the HCT116 colon cancer cell line and showed excellent antitumor activity in vitro and in vivo.  It induced apoptosis in HCT116 cancer cells in a dose-dependent manner and cell growth arrest at the G2 phase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkwOrWtBZTF7Vg90H21EOLACvtfcHk0ljZKyoiYTplOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXktlOhtr4%253D&md5=2bd0bc1c240bcb2faab29458ae230195</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.9b00513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.9b00513%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DNatural%2520product%2520evodiamine%2520with%2520borate%2520trigger%2520unit%253A%2520discovery%2520of%2520potent%2520antitumor%2520agents%2520against%2520colon%2520cancer%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26volume%3D11%26spage%3D439%26epage%3D444%26doi%3D10.1021%2Facsmedchemlett.9b00513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barneda-Zahonero, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parra, M.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylases and cancer</span>. <i>Mol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">579</span>– <span class="NLM_lpage">589</span>, <span class="refDoi"> DOI: 10.1016/j.molonc.2012.07.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.molonc.2012.07.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=22963873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs12gt7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2012&pages=579-589&author=B.+Barneda-Zahoneroauthor=M.+Parra&title=Histone+deacetylases+and+cancer&doi=10.1016%2Fj.molonc.2012.07.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylases and cancer</span></div><div class="casAuthors">Barneda-Zahonero, Bruna; Parra, Maribel</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Oncology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">579-589</span>CODEN:
                <span class="NLM_cas:coden">MOONC3</span>;
        ISSN:<span class="NLM_cas:issn">1574-7891</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Reversible acetylation of histone and non-histone proteins is one of the most abundant post-translational modifications in eukaryotic cells.  Protein acetylation and deacetylation are achieved by the antagonistic actions of two families of enzymes, histone acetyltransferases (HATs) and histone deacetylases (HDACs).  Aberrant protein acetylation, particularly on histones, has been related to cancer while abnormal expression of HDACs has been found in a broad range of cancer types.  Therefore, HDACs have emerged as promising targets in cancer therapeutics, and the development of HDAC inhibitors (HDIs), a rapidly evolving area of clin. research.  However, the contributions of specific HDACs to a given cancer type remain incompletely understood.  The aim of this review is to summarize the current knowledge concerning the role of HDACs in cancer with special emphasis on what we have learned from the anal. of patient samples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOl-qXEsP2IrVg90H21EOLACvtfcHk0ljn8J2p4Oz8IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs12gt7%252FK&md5=7c294b40669bf079b1319391ee456642</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.molonc.2012.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molonc.2012.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DBarneda-Zahonero%26aufirst%3DB.%26aulast%3DParra%26aufirst%3DM.%26atitle%3DHistone%2520deacetylases%2520and%2520cancer%26jtitle%3DMol.%2520Oncol.%26date%3D2012%26volume%3D6%26spage%3D579%26epage%3D589%26doi%3D10.1016%2Fj.molonc.2012.07.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moskowitz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horwitz, S.</span></span> <span> </span><span class="NLM_article-title">Targeting histone deacetylases in T-cell lymphoma</span>. <i>Leuk. Lymphoma</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1306</span>– <span class="NLM_lpage">1319</span>, <span class="refDoi"> DOI: 10.1080/10428194.2016.1247956</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1080%2F10428194.2016.1247956" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=27813438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVCjur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2017&pages=1306-1319&author=A.+Moskowitzauthor=S.+Horwitz&title=Targeting+histone+deacetylases+in+T-cell+lymphoma&doi=10.1080%2F10428194.2016.1247956"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting histone deacetylases in T-cell lymphoma</span></div><div class="casAuthors">Moskowitz, Alison J.; Horwitz, Steven M.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia & Lymphoma</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1306-1319</span>CODEN:
                <span class="NLM_cas:coden">LELYEA</span>;
        ISSN:<span class="NLM_cas:issn">1029-2403</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Histone deacetylase inhibitors (HDACi) are epigenetic modifiers with single-agent activity in patients with cutaneous and peripheral T-cell lymphoma (CTCL, PTCL).  The mechanisms for this preferential activity remain unclear, and although some would term this as 'class effect,' there are differences in efficacy and safety, likely a result of the varying chem. structures/classes, histone and non-histone targets, potencies, and clin. dosing for each.  Three HDACi have single-agent approval in relapsed/refractory TCL in the United States: romidepsin in CTCL and PTCL, vorinostat in CTCL, and belinostat in PTCL.  Although comparison of these agents is difficult due to differences in patient populations, through this review we aimed to provide a detailed overview of the clin. data for HDACi in TCL and their use in clin. practice.  Despite early concerns, data demonstrate the cardiac safety of HDACi, while highlighting the need to maintain electrolytes in the normal range and monitor QT interval when initially co-administering antiemetics or other drugs that prolong QT.  To further improve response rates and durability of responses, HDACi are under clin. investigation in combination with chemotherapy regimens and various novel agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriCACWFrwWGLVg90H21EOLACvtfcHk0ljn8J2p4Oz8IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVCjur3O&md5=bf630a355f4521ac0246ec9470aaca92</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1080%2F10428194.2016.1247956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10428194.2016.1247956%26sid%3Dliteratum%253Aachs%26aulast%3DMoskowitz%26aufirst%3DA.%26aulast%3DHorwitz%26aufirst%3DS.%26atitle%3DTargeting%2520histone%2520deacetylases%2520in%2520T-cell%2520lymphoma%26jtitle%3DLeuk.%2520Lymphoma%26date%3D2017%26volume%3D58%26spage%3D1306%26epage%3D1319%26doi%3D10.1080%2F10428194.2016.1247956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eom, G.</span></span> <span> </span><span class="NLM_article-title">HDAC and HDAC inhibitor: from cancer to cardiovascular diseases</span>. <i>Chonnam Med. J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.4068/cmj.2016.52.1.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.4068%2Fcmj.2016.52.1.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=26865995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmtFKms70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2016&pages=1-11&author=S.+Yoonauthor=G.+Eom&title=HDAC+and+HDAC+inhibitor%3A+from+cancer+to+cardiovascular+diseases&doi=10.4068%2Fcmj.2016.52.1.1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC and HDAC inhibitor: from cancer to cardiovascular diseases</span></div><div class="casAuthors">Yoon, Somy; Eom, Gwang Hyeon</div><div class="citationInfo"><span class="NLM_cas:title">Chonnam Medical Journal</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">CMJHA4</span>;
        ISSN:<span class="NLM_cas:issn">2233-7385</span>.
    
            (<span class="NLM_cas:orgname">Chonnam National University Medical School</span>)
        </div><div class="casAbstract">A review.  Histone deacetylases (HDACs) are epigenetic regulators that regulate the histone tail, chromatin conformation, protein-DNA interaction, and even transcription.  HDACs are also post-transcriptional modifiers that regulate the protein acetylation implicated in several pathophysiol. states.  HDAC inhibitors have been highlighted as a novel category of anti-cancer drugs.  To date, four HDAC inhibitors, Vorinostat, Romidepsin, Panobinostat, and Belinostat, have been approved by the United States Food and Drug Administration.  Principally, these HDAC inhibitors are used for hematol. cancers in clinic with less severe side effects.  Clin. trials are continuously expanding to address other types of cancer and also nonmalignant diseases.  HDAC inhibition also results in beneficial outcomes in various types of neurodegenerative diseases, inflammation disorders, and cardiovascular diseases.  In this review, we will briefly discuss 1) the roles of HDACs in the acquisition of a cancer's phenotype and the general outcome of the HDAC inhibitors in cancer, 2) the functional relevance of HDACs in cardiovascular diseases and the possible therapeutic implications of HDAC inhibitors in cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSsxE7tiGIdbVg90H21EOLACvtfcHk0ljn8J2p4Oz8IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmtFKms70%253D&md5=fb9a3b8c88dcf36789b7813d458eb139</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.4068%2Fcmj.2016.52.1.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4068%252Fcmj.2016.52.1.1%26sid%3Dliteratum%253Aachs%26aulast%3DYoon%26aufirst%3DS.%26aulast%3DEom%26aufirst%3DG.%26atitle%3DHDAC%2520and%2520HDAC%2520inhibitor%253A%2520from%2520cancer%2520to%2520cardiovascular%2520diseases%26jtitle%3DChonnam%2520Med.%2520J.%26date%3D2016%26volume%3D52%26spage%3D1%26epage%3D11%26doi%3D10.4068%2Fcmj.2016.52.1.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balliet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallagher, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dellinger, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazarus, P.</span></span> <span> </span><span class="NLM_article-title">Characterization of UGTs active against SAHA and association between SAHA glucuronidation activity phenotype with UGT genotype</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">2981</span>– <span class="NLM_lpage">2989</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-4143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1158%2F0008-5472.CAN-08-4143" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=19318555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvVWisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=2981-2989&author=R.+Ballietauthor=G.+Chenauthor=C.+Gallagherauthor=R.+Dellingerauthor=D.+Sunauthor=P.+Lazarus&title=Characterization+of+UGTs+active+against+SAHA+and+association+between+SAHA+glucuronidation+activity+phenotype+with+UGT+genotype&doi=10.1158%2F0008-5472.CAN-08-4143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of UGTs Active against SAHA and Association between SAHA Glucuronidation Activity Phenotype with UGT Genotype</span></div><div class="casAuthors">Balliet, Renee M.; Chen, Gang; Gallagher, Carla J.; Dellinger, Ryan W.; Sun, Dongxiao; Lazarus, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2981-2989</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Suberoylanilide hydroxamic acid (SAHA) is a histone deacetylase inhibitor used in the treatment of cutaneous T-cell lymphoma and in clin. trials for treatment of multiple other cancers.  A major mode of SAHA metab. is by glucuronidation via the UDP-glucuronosyltransferase (UGT) family of enzymes.  To characterize the UGTs active against SAHA, homogenates from HEK293 cell lines overexpressing UGT wild-type or variant UGT were used.  The hepatic UGTs 2B17 and 1A9 and the extrahepatic UGTs 1A8 and 1A10 exhibited the highest overall activity against SAHA as detd. by Vmax/KM (16 ± 6.5, 7.1 ± 2.2, 33 ± 6.3, and 24 ± 2.4 nL/min-1/μg UGT protein-1, resp.), with UGT2B17 exhibiting the lowest KM (300 μmol/L) against SAHA of any UGT in vitro.  Whereas the UGT1A8p.Ala173Gly variant exhibited a 3-fold (P < 0.005) decrease in glucuronidation activity against SAHA compared with wild-type UGT1A8, the UGT1A8p.Cys277Tyr variant exhibited no detectable glucuronidation activity; a similar lack of detectable glucuronidation activity was obsd. for the UGT1A10p.Gly139Lys variant.  To analyze the effects of the UGT2B17 gene deletion variant (UGT2B17*2) on SAHA glucuronidation phenotype, human liver microsomes (HLM) were analyzed for glucuronidation activity against SAHA and compared with UGT2B17 genotype.  HLM from subjects homozygous for UGT2B17*2 exhibited a 45% (P < 0.01) decrease in glucuronidation activity and a 75% (P < 0.002) increase in KM compared with HLMs from subjects homozygous for the wild-type UGT2B17*1 allele.  Overall, these results suggest that several UGTs play an important role in the metab. of SAHA and that UGT2B17-null individuals could potentially exhibit altered SAHA clearance rates with differences in overall response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYTm-1gtyYyrVg90H21EOLACvtfcHk0ljn8J2p4Oz8IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvVWisb4%253D&md5=de9beb1be7a46b1dfdf1a338f12c77dd</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-4143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-4143%26sid%3Dliteratum%253Aachs%26aulast%3DBalliet%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DGallagher%26aufirst%3DC.%26aulast%3DDellinger%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DLazarus%26aufirst%3DP.%26atitle%3DCharacterization%2520of%2520UGTs%2520active%2520against%2520SAHA%2520and%2520association%2520between%2520SAHA%2520glucuronidation%2520activity%2520phenotype%2520with%2520UGT%2520genotype%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D2981%26epage%3D2989%26doi%3D10.1158%2F0008-5472.CAN-08-4143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flipo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocine, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dassonneville, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Déprez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deprez-Poulain, R.</span></span> <span> </span><span class="NLM_article-title">Hydroxamates: relationships between structure and plasma stability</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">6790</span>– <span class="NLM_lpage">6802</span>, <span class="refDoi"> DOI: 10.1021/jm900648x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900648x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GgsbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6790-6802&author=M.+Flipoauthor=J.+Chartonauthor=A.+Hocineauthor=S.+Dassonnevilleauthor=B.+D%C3%A9prezauthor=R.+Deprez-Poulain&title=Hydroxamates%3A+relationships+between+structure+and+plasma+stability&doi=10.1021%2Fjm900648x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroxamates: Relationships between Structure and Plasma Stability</span></div><div class="casAuthors">Flipo, Marion; Charton, Julie; Hocine, Akila; Dassonneville, Sandrine; Deprez, Benoit; Deprez-Poulain, Rebecca</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6790-6802</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hydroxamates are valuable tools for chem. biol. as well as interesting leads for medicinal chem.  Although many hydroxamates display nanomolar activities against metalloproteases, only three hydroxamates have reached the market, among which is the HDAC inhibitor vorinostat.  Failures in development are generally attributed to lack of selectivity, toxicity, or poor stability.  To help medicinal chemists with respect to plasma stability, the authors have performed the first and preliminary study on structure-plasma stability for hydroxamates.  The authors define some structural rules to predict or improve the plasma stability in the preclin. stage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk66ooWU1NhbVg90H21EOLACvtfcHk0lilZ6NrK5b2Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GgsbnJ&md5=069a87988fbeb68a248d006c7f6307a0</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm900648x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900648x%26sid%3Dliteratum%253Aachs%26aulast%3DFlipo%26aufirst%3DM.%26aulast%3DCharton%26aufirst%3DJ.%26aulast%3DHocine%26aufirst%3DA.%26aulast%3DDassonneville%26aufirst%3DS.%26aulast%3DD%25C3%25A9prez%26aufirst%3DB.%26aulast%3DDeprez-Poulain%26aufirst%3DR.%26atitle%3DHydroxamates%253A%2520relationships%2520between%2520structure%2520and%2520plasma%2520stability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6790%26epage%3D6802%26doi%3D10.1021%2Fjm900648x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schlimme, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauser, A.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carafa, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kannan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stolfa, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cellamare, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altucci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sippl, W.</span></span> <span> </span><span class="NLM_article-title">Carbamate prodrug concept for hydroxamate HDAC inhibitors</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1193</span>– <span class="NLM_lpage">1198</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201100007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2Fcmdc.201100007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=21416613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotVCnsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1193-1198&author=S.+Schlimmeauthor=A.-T.+Hauserauthor=V.+Carafaauthor=R.+Heinkeauthor=S.+Kannanauthor=D.+A.+Stolfaauthor=S.+Cellamareauthor=A.+Carottiauthor=L.+Altucciauthor=M.+Jungauthor=W.+Sippl&title=Carbamate+prodrug+concept+for+hydroxamate+HDAC+inhibitors&doi=10.1002%2Fcmdc.201100007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Carbamate Prodrug Concept for Hydroxamate HDAC Inhibitors</span></div><div class="casAuthors">Schlimme, Sonja; Hauser, Alexander-Thomas; Carafa, Vincenzo; Heinke, Ralf; Kannan, Srinivasaraghavan; Stolfa, Diana A.; Cellamare, Saverio; Carotti, Angelo; Altucci, Lucia; Jung, Manfred; Sippl, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1193-1198</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Virtual screening against a HDAC6 homol. model has led to the indentification of a new HDAC6-selective inhibitor I and a carbamate deriv. that acts as a prodrug in cell culture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5mxc5jtnXe7Vg90H21EOLACvtfcHk0lilZ6NrK5b2Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotVCnsbs%253D&md5=21fdb2c7de1ca402e9cf370cd3607eeb</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100007%26sid%3Dliteratum%253Aachs%26aulast%3DSchlimme%26aufirst%3DS.%26aulast%3DHauser%26aufirst%3DA.-T.%26aulast%3DCarafa%26aufirst%3DV.%26aulast%3DHeinke%26aufirst%3DR.%26aulast%3DKannan%26aufirst%3DS.%26aulast%3DStolfa%26aufirst%3DD.%2BA.%26aulast%3DCellamare%26aufirst%3DS.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DAltucci%26aufirst%3DL.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DSippl%26aufirst%3DW.%26atitle%3DCarbamate%2520prodrug%2520concept%2520for%2520hydroxamate%2520HDAC%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D1193%26epage%3D1198%26doi%3D10.1002%2Fcmdc.201100007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhagat, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, A.</span></span> <span> </span><span class="NLM_article-title">An endogenous reactive oxygen species (ROS)-activated histone deacetylase inhibitor prodrug for cancer chemotherapy</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2073</span>– <span class="NLM_lpage">2079</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201800367</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2Fcmdc.201800367" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=30070768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFKqu7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=2073-2079&author=S.+D.+Bhagatauthor=U.+Singhauthor=R.+K.+Mishraauthor=A.+Srivastava&title=An+endogenous+reactive+oxygen+species+%28ROS%29-activated+histone+deacetylase+inhibitor+prodrug+for+cancer+chemotherapy&doi=10.1002%2Fcmdc.201800367"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">An Endogenous Reactive Oxygen Species (ROS)-Activated Histone Deacetylase Inhibitor Prodrug for Cancer Chemotherapy</span></div><div class="casAuthors">Bhagat, Somnath D.; Singh, Usha; Mishra, Ram Kumar; Srivastava, Aasheesh</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2073-2079</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Suberoylanilide hydroxamic acid (SAHA, vorinostat) is a potent small-mol. pan-inhibitor of histone deacetylases (HDACs) approved for treatment of cutaneous T-cell lymphoma (CTCL).  However, SAHA exhibits poor selectivity for cancer cells over noncancer cells.  With an aim to improving its selectivity for cancer cells, the authors generated a novel SAHA prodrug (SAHA-OBP) that is activated in the presence of hydrogen peroxide, a reactive oxygen species (ROS) known to be overexpressed in cancer cells.  The high endogenous ROS content in cancer cells triggers rapid removal of the 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl carbonyl (OBP) cap to release active SAHA.  The SAHA-OBP prodrug demonstrates selective activity against multiple cancer cell lines such as HeLa, MCF-7, MDA-MB-231, and B16-F10, while remaining benign toward noncancer cells.  The downstream effects of SAHA released from SAHA-OBP in cancer cells is the induction of apoptosis.  SAHA-OBP was also found to be effective on multicellular tumor spheroids (MCTS).  The SAHA prodrug designed in this study undergoes rapid ROS-dependent activation and imparts much-needed selectivity to SAHA for cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQpWFPXO5SS7Vg90H21EOLACvtfcHk0lilZ6NrK5b2Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFKqu7%252FJ&md5=194b433548a5ca7806ead22ac9a8b7a9</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201800367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201800367%26sid%3Dliteratum%253Aachs%26aulast%3DBhagat%26aufirst%3DS.%2BD.%26aulast%3DSingh%26aufirst%3DU.%26aulast%3DMishra%26aufirst%3DR.%2BK.%26aulast%3DSrivastava%26aufirst%3DA.%26atitle%3DAn%2520endogenous%2520reactive%2520oxygen%2520species%2520%2528ROS%2529-activated%2520histone%2520deacetylase%2520inhibitor%2520prodrug%2520for%2520cancer%2520chemotherapy%26jtitle%3DChemMedChem%26date%3D2018%26volume%3D13%26spage%3D2073%26epage%3D2079%26doi%3D10.1002%2Fcmdc.201800367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedtke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Z.</span></span> <span> </span><span class="NLM_article-title">H<sub>2</sub>O<sub>2</sub>/peroxynitrite-activated hydroxamic acid HDAC inhibitor prodrugs show antileukemic activities against AML cells</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">635</span>– <span class="NLM_lpage">640</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.8b00057</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00057" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFentbjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=635-640&author=Y.+Liaoauthor=L.+Xuauthor=S.+Ouauthor=H.+Edwardsauthor=D.+Luedtkeauthor=Y.+Geauthor=Z.+Qin&title=H2O2%2Fperoxynitrite-activated+hydroxamic+acid+HDAC+inhibitor+prodrugs+show+antileukemic+activities+against+AML+cells&doi=10.1021%2Facsmedchemlett.8b00057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">H2O2/Peroxynitrite-Activated Hydroxamic Acid HDAC Inhibitor Prodrugs Show Antileukemic Activities against AML Cells</span></div><div class="casAuthors">Liao, Yi; Xu, Liping; Ou, Siyu; Edwards, Holly; Luedtke, Daniel; Ge, Yubin; Qin, Zhihui</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">635-640</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Occurrence of acute myeloid leukemia (AML) results in abundant endogenous reactive oxygen species (ROS)/reactive nitrogen species (RNS) in AML cells and in disease-relevant microenvironments.  Histone deacetylase inhibitor (HDACi) prodrug approach was designed accordingly by masking the hydroxamic acid zinc binding group with hydrogen peroxide (H2O2)/peroxynitrite (PNT)-sensitive, self-immolative aryl boronic acid moiety.  Model prodrugs 5-82 (I) and 5-23 (II) were activated in AML cells to release cytotoxic HDACis, evidenced by inducing acetylation markers and reducing viability of AML cells.  Intracellular activation and antileukemic activities of prodrug were increased or decreased by ROS/PNT inducers and scavengers, resp.  Prodrugs 5-82 (I) and 5-23 (II) also enhanced the potency of chemotherapy drug cytarabine, supporting the potentials of this prodrug class in combinatorial treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtVLyTA7Ynr7Vg90H21EOLACvtfcHk0lihX3VHYoky7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFentbjK&md5=923d6234d9827e3abf1c729969221ce1</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00057%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DOu%26aufirst%3DS.%26aulast%3DEdwards%26aufirst%3DH.%26aulast%3DLuedtke%26aufirst%3DD.%26aulast%3DGe%26aufirst%3DY.%26aulast%3DQin%26aufirst%3DZ.%26atitle%3DH2O2%252Fperoxynitrite-activated%2520hydroxamic%2520acid%2520HDAC%2520inhibitor%2520prodrugs%2520show%2520antileukemic%2520activities%2520against%2520AML%2520cells%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D635%26epage%3D640%26doi%3D10.1021%2Facsmedchemlett.8b00057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span> <span> </span><span class="NLM_article-title">Biocompatible boron-containing prodrugs of belinostat for the potential treatment of solid tumors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">149</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00504</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00504" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlvVertg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=149-154&author=S.+Zhengauthor=S.+Guoauthor=Q.+Zhongauthor=C.+Zhangauthor=J.+Liuauthor=L.+Yangauthor=Q.+Zhangauthor=G.+Wang&title=Biocompatible+boron-containing+prodrugs+of+belinostat+for+the+potential+treatment+of+solid+tumors&doi=10.1021%2Facsmedchemlett.7b00504"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Biocompatible Boron-Containing Prodrugs of Belinostat for the Potential Treatment of Solid Tumors</span></div><div class="casAuthors">Zheng, Shilong; Guo, Shanchun; Zhong, Qiu; Zhang, Changde; Liu, Jiawang; Yang, Lin; Zhang, Qiang; Wang, Guangdi</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">149-154</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Despite promising therapeutic utilities for treatment of hematol. malignancies, histone deacetylase inhibitor (HDACi) drugs have not proven as effective in the treatment of solid tumors.  To expand the clin. indications of HDACi drugs, we developed novel boron-contg. prodrugs of belinostat (2), one of which efficiently releases active 2 through a cascade of reactions in cell culture and demonstrates activities comparable to 2 against a panel of cancer cell lines.  Importantly, prodrug I is more efficacious than belinostat in vivo, not only inhibiting the growth of tumor but also reducing tumor vols. in an MCF-7 xenograft tumor model owing to its superior biocompatibility, which suggests its clin. potential in the treatment of solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjIOQIgps2KrVg90H21EOLACvtfcHk0lihX3VHYoky7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlvVertg%253D%253D&md5=96d56396fbcd0a6192f277ffb13fb423</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00504%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DS.%26aulast%3DZhong%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DG.%26atitle%3DBiocompatible%2520boron-containing%2520prodrugs%2520of%2520belinostat%2520for%2520the%2520potential%2520treatment%2520of%2520solid%2520tumors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D149%26epage%3D154%26doi%3D10.1021%2Facsmedchemlett.7b00504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geller, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barzily-Rokni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonas, O. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shental, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nejman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavert, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thaiss, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reuben, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avraham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederick, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligorio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosher, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuks, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurbatri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gopalakrishnan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurd, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skalak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaud, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trauger, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barshack, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandbank, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flaherty, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandinova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrett, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thayer, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrone, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huttenhower, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhatia, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gevers, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wargo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straussman, R.</span></span> <span> </span><span class="NLM_article-title">Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>357</i></span>,  <span class="NLM_fpage">1156</span>– <span class="NLM_lpage">1160</span>, <span class="refDoi"> DOI: 10.1126/science.aah5043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1126%2Fscience.aah5043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=28912244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVOitbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2017&pages=1156-1160&author=L.+T.+Gellerauthor=M.+Barzily-Rokniauthor=T.+Daninoauthor=O.+H.+Jonasauthor=N.+Shentalauthor=D.+Nejmanauthor=N.+Gavertauthor=Y.+Zwangauthor=Z.+A.+Cooperauthor=K.+Sheeauthor=C.+A.+Thaissauthor=A.+Reubenauthor=J.+Livnyauthor=R.+Avrahamauthor=D.+T.+Frederickauthor=M.+Ligorioauthor=K.+Chatmanauthor=S.+E.+Johnstonauthor=C.+M.+Mosherauthor=A.+Brandisauthor=G.+Fuksauthor=C.+Gurbatriauthor=V.+Gopalakrishnanauthor=M.+Kimauthor=M.+W.+Hurdauthor=M.+Katzauthor=J.+Flemingauthor=A.+Maitraauthor=D.+A.+Smithauthor=M.+Skalakauthor=J.+Buauthor=M.+Michaudauthor=S.+A.+Traugerauthor=I.+Barshackauthor=T.+Golanauthor=J.+Sandbankauthor=K.+T.+Flahertyauthor=A.+Mandinovaauthor=W.+S.+Garrettauthor=S.+P.+Thayerauthor=C.+R.+Ferroneauthor=C.+Huttenhowerauthor=S.+N.+Bhatiaauthor=D.+Geversauthor=J.+A.+Wargoauthor=T.+R.+Golubauthor=R.+Straussman&title=Potential+role+of+intratumor+bacteria+in+mediating+tumor+resistance+to+the+chemotherapeutic+drug+gemcitabine&doi=10.1126%2Fscience.aah5043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine</span></div><div class="casAuthors">Geller, Leore T.; Barzily-Rokni, Michal; Danino, Tal; Jonas, Oliver H.; Shental, Noam; Nejman, Deborah; Gavert, Nancy; Zwang, Yaara; Cooper, Zachary A.; Shee, Kevin; Thaiss, Christoph A.; Reuben, Alexandre; Livny, Jonathan; Avraham, Roi; Frederick, Dennie T.; Ligorio, Matteo; Chatman, Kelly; Johnston, Stephen E.; Mosher, Carrie M.; Brandis, Alexander; Fuks, Garold; Gurbatri, Candice; Gopalakrishnan, Vancheswaran; Kim, Michael; Hurd, Mark W.; Katz, Matthew; Fleming, Jason; Maitra, Anirban; Smith, David A.; Skalak, Matt; Bu, Jeffrey; Michaud, Monia; Trauger, Sunia A.; Barshack, Iris; Golan, Talia; Sandbank, Judith; Flaherty, Keith T.; Mandinova, Anna; Garrett, Wendy S.; Thayer, Sarah P.; Ferrone, Cristina R.; Huttenhower, Curtis; Bhatia, Sangeeta N.; Gevers, Dirk; Wargo, Jennifer A.; Golub, Todd R.; Straussman, Ravid</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">6356</span>),
    <span class="NLM_cas:pages">1156-1160</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Growing evidence suggests that microbes can influence the efficacy of cancer therapies.  By studying colon cancer models, we found that bacteria can metabolize the chemotherapeutic drug gemcitabine (2',2'-difluorodeoxycytidine) into its inactive form, 2',2'-difluorodeoxyuridine.  Metab. was dependent on the expression of a long isoform of the bacterial enzyme cytidine deaminase (CDDL), seen primarily in Gammaproteobacteria.  In a colon cancer mouse model, gemcitabine resistance was induced by intratumor Gammaproteobacteria, dependent on bacterial CDDL expression, and abrogated by cotreatment with the antibiotic ciprofloxacin.  Gemcitabine is commonly used to treat pancreatic ductal adenocarcinoma (PDAC), and we hypothesized that intratumor bacteria might contribute to drug resistance of these tumors.  Consistent with this possibility, we found that of the 113 human PDACs that were tested, 86 (76%) were pos. for bacteria, mainly Gammaproteobacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosNU1tWwuHBrVg90H21EOLACvtfcHk0lihX3VHYoky7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVOitbfM&md5=c362091ae8c56c0cc5dead46b4f6c96e</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1126%2Fscience.aah5043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aah5043%26sid%3Dliteratum%253Aachs%26aulast%3DGeller%26aufirst%3DL.%2BT.%26aulast%3DBarzily-Rokni%26aufirst%3DM.%26aulast%3DDanino%26aufirst%3DT.%26aulast%3DJonas%26aufirst%3DO.%2BH.%26aulast%3DShental%26aufirst%3DN.%26aulast%3DNejman%26aufirst%3DD.%26aulast%3DGavert%26aufirst%3DN.%26aulast%3DZwang%26aufirst%3DY.%26aulast%3DCooper%26aufirst%3DZ.%2BA.%26aulast%3DShee%26aufirst%3DK.%26aulast%3DThaiss%26aufirst%3DC.%2BA.%26aulast%3DReuben%26aufirst%3DA.%26aulast%3DLivny%26aufirst%3DJ.%26aulast%3DAvraham%26aufirst%3DR.%26aulast%3DFrederick%26aufirst%3DD.%2BT.%26aulast%3DLigorio%26aufirst%3DM.%26aulast%3DChatman%26aufirst%3DK.%26aulast%3DJohnston%26aufirst%3DS.%2BE.%26aulast%3DMosher%26aufirst%3DC.%2BM.%26aulast%3DBrandis%26aufirst%3DA.%26aulast%3DFuks%26aufirst%3DG.%26aulast%3DGurbatri%26aufirst%3DC.%26aulast%3DGopalakrishnan%26aufirst%3DV.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DHurd%26aufirst%3DM.%2BW.%26aulast%3DKatz%26aufirst%3DM.%26aulast%3DFleming%26aufirst%3DJ.%26aulast%3DMaitra%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DSkalak%26aufirst%3DM.%26aulast%3DBu%26aufirst%3DJ.%26aulast%3DMichaud%26aufirst%3DM.%26aulast%3DTrauger%26aufirst%3DS.%2BA.%26aulast%3DBarshack%26aufirst%3DI.%26aulast%3DGolan%26aufirst%3DT.%26aulast%3DSandbank%26aufirst%3DJ.%26aulast%3DFlaherty%26aufirst%3DK.%2BT.%26aulast%3DMandinova%26aufirst%3DA.%26aulast%3DGarrett%26aufirst%3DW.%2BS.%26aulast%3DThayer%26aufirst%3DS.%2BP.%26aulast%3DFerrone%26aufirst%3DC.%2BR.%26aulast%3DHuttenhower%26aufirst%3DC.%26aulast%3DBhatia%26aufirst%3DS.%2BN.%26aulast%3DGevers%26aufirst%3DD.%26aulast%3DWargo%26aufirst%3DJ.%2BA.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DStraussman%26aufirst%3DR.%26atitle%3DPotential%2520role%2520of%2520intratumor%2520bacteria%2520in%2520mediating%2520tumor%2520resistance%2520to%2520the%2520chemotherapeutic%2520drug%2520gemcitabine%26jtitle%3DScience%26date%3D2017%26volume%3D357%26spage%3D1156%26epage%3D1160%26doi%3D10.1126%2Fscience.aah5043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsushita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eguchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koseki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwagami, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asaoka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotoh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasahara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morihiro, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satoh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obika, S.</span></span> <span> </span><span class="NLM_article-title">A hydrogen peroxide activatable gemcitabine prodrug for the selective treatment of pancreatic ductal adenocarcinoma</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1384</span>– <span class="NLM_lpage">1391</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201900324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2Fcmdc.201900324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=31207139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlSmtb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&pages=1384-1391&author=K.+Matsushitaauthor=T.+Okudaauthor=S.+Moriauthor=M.+Konnoauthor=H.+Eguchiauthor=A.+Asaiauthor=J.+Kosekiauthor=Y.+Iwagamiauthor=D.+Yamadaauthor=H.+Akitaauthor=T.+Asaokaauthor=T.+Nodaauthor=K.+Kawamotoauthor=K.+Gotohauthor=S.+Kobayashiauthor=Y.+Kasaharaauthor=K.+Morihiroauthor=T.+Satohauthor=Y.+Dokiauthor=M.+Moriauthor=H.+Ishiiauthor=S.+Obika&title=A+hydrogen+peroxide+activatable+gemcitabine+prodrug+for+the+selective+treatment+of+pancreatic+ductal+adenocarcinoma&doi=10.1002%2Fcmdc.201900324"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">A Hydrogen Peroxide Activatable Gemcitabine Prodrug for the Selective Treatment of Pancreatic Ductal Adenocarcinoma</span></div><div class="casAuthors">Matsushita, Katsunori; Okuda, Takumi; Mori, Shohei; Konno, Masamitsu; Eguchi, Hidetoshi; Asai, Ayumu; Koseki, Jun; Iwagami, Yoshifumi; Yamada, Daisaku; Akita, Hirofumi; Asaoka, Tadafumi; Noda, Takehiro; Kawamoto, Koichi; Gotoh, Kunihito; Kobayashi, Shogo; Kasahara, Yuuya; Morihiro, Kunihiko; Satoh, Taroh; Doki, Yuichiro; Mori, Masaki; Ishii, Hideshi; Obika, Satoshi</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1384-1391</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The main concern in the use of anticancer chemotherapeutic drugs is host toxicity.  Patients need to interrupt or change chemotherapy due to adverse effects.  In this study, we aimed to decrease adverse events with gemcitabine (GEM) in the treatment of pancreatic ductal adenocarcinoma and focused on the difference of hydrogen peroxide levels in normal vs. cancer cells.  We designed and synthesized a novel boronate-ester-caged prodrug that is activated by the high H2O2 concns. found in cancer cells to release GEM.  An H2O2-activatable GEM (A-GEM) has higher selectivity for H2O2 over other reactive oxygen species (ROS) and cytotoxic effects corresponding to the H2O2 concn. in vitro.  A xenograft model of immunodeficient mice indicated that the effect of A-GEM was not inferior to that of GEM when administered in vivo.  In particular, myelosuppression was significantly decreased following A-GEM treatment compared with that following GEM treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg1DX6Qb4J5LVg90H21EOLACvtfcHk0lglzsMomN7-Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlSmtb3N&md5=d923b63f507752e11d1a96b5481adaab</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201900324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201900324%26sid%3Dliteratum%253Aachs%26aulast%3DMatsushita%26aufirst%3DK.%26aulast%3DOkuda%26aufirst%3DT.%26aulast%3DMori%26aufirst%3DS.%26aulast%3DKonno%26aufirst%3DM.%26aulast%3DEguchi%26aufirst%3DH.%26aulast%3DAsai%26aufirst%3DA.%26aulast%3DKoseki%26aufirst%3DJ.%26aulast%3DIwagami%26aufirst%3DY.%26aulast%3DYamada%26aufirst%3DD.%26aulast%3DAkita%26aufirst%3DH.%26aulast%3DAsaoka%26aufirst%3DT.%26aulast%3DNoda%26aufirst%3DT.%26aulast%3DKawamoto%26aufirst%3DK.%26aulast%3DGotoh%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DKasahara%26aufirst%3DY.%26aulast%3DMorihiro%26aufirst%3DK.%26aulast%3DSatoh%26aufirst%3DT.%26aulast%3DDoki%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DM.%26aulast%3DIshii%26aufirst%3DH.%26aulast%3DObika%26aufirst%3DS.%26atitle%3DA%2520hydrogen%2520peroxide%2520activatable%2520gemcitabine%2520prodrug%2520for%2520the%2520selective%2520treatment%2520of%2520pancreatic%2520ductal%2520adenocarcinoma%26jtitle%3DChemMedChem%26date%3D2019%26volume%3D14%26spage%3D1384%26epage%3D1391%26doi%3D10.1002%2Fcmdc.201900324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skarbek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maslah, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rascol, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labruère, R.</span></span> <span> </span><span class="NLM_article-title">Arylboronate prodrugs of doxorubicin as promising chemotherapy for pancreatic cancer</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">103158</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2019.103158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.bioorg.2019.103158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=31376782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFWmtL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2019&pages=103158&author=C.+Skarbekauthor=S.+Serraauthor=H.+Maslahauthor=E.+Rascolauthor=R.+Labru%C3%A8re&title=Arylboronate+prodrugs+of+doxorubicin+as+promising+chemotherapy+for+pancreatic+cancer&doi=10.1016%2Fj.bioorg.2019.103158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Arylboronate prodrugs of doxorubicin as promising chemotherapy for pancreatic cancer</span></div><div class="casAuthors">Skarbek, Charles; Serra, Silvia; Maslah, Hichem; Rascol, Estelle; Labruere, Raphael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103158</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This study describes the synthesis of arylboronate-based ROS-responsive prodrugs of doxorubicin and their biol. evaluation as anticancer agents.  The detn. of the most sensitive cancer type toward arylboronate prodrugs is crucial for further consideration of these mols. in clin. phase.  To address this goal, an arylboronate-based profluorescent probe was used to compare the capacity of various cancer cell lines to efficiently convert the precursor into the free fluorophore.  On the selected MiaPaCa-2 pancreatic cancer cells, a benzeneboronate prodrug exhibited 67% of the cytotoxicity obtained with the free doxorubicin.  The prodrug was also able to induce tumor regression on MiaPaCa-2 pancreatic tumor model in ovo.  Using this model, the amt. of free doxorubicin liberated from this prodrug into the tumor was equiv. to the quantity measured after direct intratumoral injection of the same concn. of doxorubicin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYPZWNykgG4LVg90H21EOLACvtfcHk0lglzsMomN7-Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFWmtL%252FE&md5=b5da3a39022df3cb3ddcf9a93669d5bb</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2019.103158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2019.103158%26sid%3Dliteratum%253Aachs%26aulast%3DSkarbek%26aufirst%3DC.%26aulast%3DSerra%26aufirst%3DS.%26aulast%3DMaslah%26aufirst%3DH.%26aulast%3DRascol%26aufirst%3DE.%26aulast%3DLabru%25C3%25A8re%26aufirst%3DR.%26atitle%3DArylboronate%2520prodrugs%2520of%2520doxorubicin%2520as%2520promising%2520chemotherapy%2520for%2520pancreatic%2520cancer%26jtitle%3DBioorg.%2520Chem.%26date%3D2019%26volume%3D91%26spage%3D103158%26doi%3D10.1016%2Fj.bioorg.2019.103158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obianom, O. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, F.</span></span> <span> </span><span class="NLM_article-title">Enhanced tumor selectivity of 5-fluorouracil using a reactive oxygen species-activated prodrug approach</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">131</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.8b00539</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00539" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVSgsL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=127-131&author=Y.+Aiauthor=O.+N.+Obianomauthor=M.+Kuserauthor=Y.+Liauthor=Y.+Shuauthor=F.+Xue&title=Enhanced+tumor+selectivity+of+5-fluorouracil+using+a+reactive+oxygen+species-activated+prodrug+approach&doi=10.1021%2Facsmedchemlett.8b00539"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced tumor selectivity of 5-fluorouracil using a reactive oxygen species-activated prodrug approach</span></div><div class="casAuthors">Ai, Yong; Obianom, Obinna N.; Kuser, Meredith; Li, Yue; Shu, Yan; Xue, Fengtian</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-131</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the design, synthesis, and evaluation of novel 5-fluorouracil (5FU) prodrugs 1a, 1b that are efficiently activated by the high level of reactive oxygen species (ROS) in cancer cells.  Prodrugs 1a, 1b selectively kill cancer cells over normal cells and are well-tolerated in mice.  The strategy described herein can extend application of chemotherapeutic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGVNAPjFsTbLVg90H21EOLACvtfcHk0li83FjmuQS-hA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVSgsL7P&md5=7c4d13a40d52838bbaddcc9f4d4c5537</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00539%26sid%3Dliteratum%253Aachs%26aulast%3DAi%26aufirst%3DY.%26aulast%3DObianom%26aufirst%3DO.%2BN.%26aulast%3DKuser%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DShu%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DF.%26atitle%3DEnhanced%2520tumor%2520selectivity%2520of%25205-fluorouracil%2520using%2520a%2520reactive%2520oxygen%2520species-activated%2520prodrug%2520approach%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D10%26spage%3D127%26epage%3D131%26doi%3D10.1021%2Facsmedchemlett.8b00539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gatti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dugnani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calastretti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spadoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scaglione, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bevilacqua, A.</span></span> <span> </span><span class="NLM_article-title">Antiproliferative and pro-apoptotic activity of melatonin analogues on melanoma and breast cancer cells</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">68338</span>– <span class="NLM_lpage">68353</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.20124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.18632%2Foncotarget.20124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=28978121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A280%3ADC%252BC1M%252FltlWlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=68338-68353&author=G.+Gattiauthor=V.+Luciniauthor=S.+Dugnaniauthor=A.+Calastrettiauthor=G.+Spadoniauthor=A.+Bediniauthor=S.+Rivaraauthor=M.+Morauthor=G.+Cantiauthor=F.+Scaglioneauthor=A.+Bevilacqua&title=Antiproliferative+and+pro-apoptotic+activity+of+melatonin+analogues+on+melanoma+and+breast+cancer+cells&doi=10.18632%2Foncotarget.20124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Antiproliferative and pro-apoptotic activity of melatonin analogues on melanoma and breast cancer cells</span></div><div class="casAuthors">Gatti Giuliana; Calastretti Angela; Canti Gianfranco; Bevilacqua Annamaria; Lucini Valeria; Dugnani Silvana; Scaglione Francesco; Spadoni Gilberto; Bedini Annalida; Rivara Silvia; Mor Marco</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">68338-68353</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Melatonin plays different physiological functions ranging from the regulation of circadian rhythms to tumor inhibition, owing to its antioxidant, immunomodulatory and anti-aging properties.  Due to its pleiotropic functions, melatonin has been shown to elicit cytoprotective processes in normal cells and trigger pro-apoptotic signals in cancer cells.  The therapeutic potential of melatonin analogues prompted us to investigate the in vitro and in vivo antitumor activity of new melatonin derivatives and explore the underlying molecular mechanisms.  The experiments revealed that the new melatonin analogues inhibited the growth of melanoma and breast cancer cells in a dose- and time-dependent manner.  In addition, our results indicated that melatonin derivative UCM 1037 could induce apoptosis in melanoma and breast cancer cells, as well as cell necrosis, in MCF-7.  Together, apoptosis and necrosis could be two possible mechanisms to explain the cytotoxic effect of the melatonin analogue against cancer cells.  The suppression of tumor growth by the melatonin analogues was further demonstrated in vivo in a xenograft mice model.  A decrease in the activation of MAPK pathway was observed in all cancer cells following UCM 1037 treatment.  Overall, this study describes a promising antitumor compound showing antiproliferative and cytotoxic activity in melanoma and breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRLwCRKT7Pe3b0AGQpJZWpJfW6udTcc2ealBZ20A_3-uLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M%252FltlWlsw%253D%253D&md5=985a60350efbda8d1c366dd07f5d2f94</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.20124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.20124%26sid%3Dliteratum%253Aachs%26aulast%3DGatti%26aufirst%3DG.%26aulast%3DLucini%26aufirst%3DV.%26aulast%3DDugnani%26aufirst%3DS.%26aulast%3DCalastretti%26aufirst%3DA.%26aulast%3DSpadoni%26aufirst%3DG.%26aulast%3DBedini%26aufirst%3DA.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DCanti%26aufirst%3DG.%26aulast%3DScaglione%26aufirst%3DF.%26aulast%3DBevilacqua%26aufirst%3DA.%26atitle%3DAntiproliferative%2520and%2520pro-apoptotic%2520activity%2520of%2520melatonin%2520analogues%2520on%2520melanoma%2520and%2520breast%2520cancer%2520cells%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D68338%26epage%3D68353%26doi%3D10.18632%2Foncotarget.20124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daum, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reshetnikov, M. S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sisa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumych, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lootsik, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilyy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bila, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janko, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexiou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellner, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokhir, A.</span></span> <span> </span><span class="NLM_article-title">Lysosome-targeting amplifiers of reactive oxygen species as anticancer prodrugs</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">15545</span>– <span class="NLM_lpage">15549</span>, <span class="refDoi"> DOI: 10.1002/anie.201706585</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2Fanie.201706585" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslygtb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=15545-15549&author=S.+Daumauthor=M.+S.+V.+Reshetnikovauthor=M.+Sisaauthor=T.+Dumychauthor=M.+D.+Lootsikauthor=R.+Bilyyauthor=E.+Bilaauthor=C.+Jankoauthor=C.+Alexiouauthor=M.+Herrmannauthor=L.+Sellnerauthor=A.+Mokhir&title=Lysosome-targeting+amplifiers+of+reactive+oxygen+species+as+anticancer+prodrugs&doi=10.1002%2Fanie.201706585"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosome-Targeting Amplifiers of Reactive Oxygen Species as Anticancer Prodrugs</span></div><div class="casAuthors">Daum, Steffen; Reshetnikov, M. S. Viktor; Sisa, Miroslav; Dumych, Tetyana; Lootsik, Maxim D.; Bilyy, Rostyslav; Bila, Evgenia; Janko, Christina; Alexiou, Christoph; Herrmann, Martin; Sellner, Leopold; Mokhir, Andriy</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">15545-15549</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Cancer cells produce elevated levels of reactive oxygen species, which has been used to design cancer specific prodrugs.  Their activation relies on at least a bimol. process, in which a prodrug reacts with ROS.  However, at low micromolar concns. of the prodrugs and ROS, the activation is usually inefficient.  Herein, the authors propose and validate a potentially general approach for solving this intrinsic problem of ROS-dependent prodrugs.  In particular, known prodrug 4-(N-ferrocenyl-N-benzylaminocarbonyloxymethyl)phenylboronic acid pinacol ester was converted into its lysosome-specific analog.  Since lysosomes contain a higher concn. of active ROS than the cytoplasm, activation of the prodrug was facilitated with respect to the parent compd.  Moreover, it was found to exhibit high anticancer activity in a variety of cancer cell lines (IC50=3.5-7.2 μM) and in vivo (40 mg kg-1, NK/Ly murine model) but remained weakly toxic towards non-malignant cells (IC50=15-30 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwRXSpEQwuabVg90H21EOLACvtfcHk0li83FjmuQS-hA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslygtb3N&md5=6e9cfccec2f511cf647cff6e72044dfe</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1002%2Fanie.201706585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201706585%26sid%3Dliteratum%253Aachs%26aulast%3DDaum%26aufirst%3DS.%26aulast%3DReshetnikov%26aufirst%3DM.%2BS.%2BV.%26aulast%3DSisa%26aufirst%3DM.%26aulast%3DDumych%26aufirst%3DT.%26aulast%3DLootsik%26aufirst%3DM.%2BD.%26aulast%3DBilyy%26aufirst%3DR.%26aulast%3DBila%26aufirst%3DE.%26aulast%3DJanko%26aufirst%3DC.%26aulast%3DAlexiou%26aufirst%3DC.%26aulast%3DHerrmann%26aufirst%3DM.%26aulast%3DSellner%26aufirst%3DL.%26aulast%3DMokhir%26aufirst%3DA.%26atitle%3DLysosome-targeting%2520amplifiers%2520of%2520reactive%2520oxygen%2520species%2520as%2520anticancer%2520prodrugs%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2017%26volume%3D56%26spage%3D15545%26epage%3D15549%26doi%3D10.1002%2Fanie.201706585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bair, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palchaudhuri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hergenrother, P. J.</span></span> <span> </span><span class="NLM_article-title">Chemistry and biology of deoxynyboquinone, a potent inducer of cancer cell death</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">5469</span>– <span class="NLM_lpage">5478</span>, <span class="refDoi"> DOI: 10.1021/ja100610m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja100610m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvFKjsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=5469-5478&author=J.+S.+Bairauthor=R.+Palchaudhuriauthor=P.+J.+Hergenrother&title=Chemistry+and+biology+of+deoxynyboquinone%2C+a+potent+inducer+of+cancer+cell+death&doi=10.1021%2Fja100610m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry and Biology of Deoxynyboquinone, a Potent Inducer of Cancer Cell Death</span></div><div class="casAuthors">Bair, Joseph S.; Palchaudhuri, Rahul; Hergenrother, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5469-5478</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Deoxynyboquinone (DNQ)(I) is a potent antineoplastic agent with an unknown mechanism of action.  Here we describe a facile synthetic route to this anthraquinone, and we use this material to det. the mechanism by which DNQ induces death in cancer cells.  DNQ was synthesized in seven linear steps through a route employing three palladium-mediated coupling reactions.  Expts. performed on cancer cells grown in hypoxia and normoxia strongly suggest that DNQ undergoes bioredn. to its semiquinone, which then is re-oxidized by mol. oxygen, forming superoxide that induces cell death.  Furthermore, global transcript profiling of cells treated with DNQ shows elevation of transcripts related to oxidative stress, a result confirmed at the protein level by Western blotting.  In contrast to most other antineoplastic agents that generate reactive oxygen species (ROS), DNQ potently induces death of cancer cells in culture, with IC50 values between 16 and 210 nM.  In addn., unlike the exptl. therapeutic elesclomol, DNQ is still able to induce cancer cell death under hypoxic conditions.  This mechanistic understanding of DNQ will allow for a more comprehensive evaluation of the potential of direct ROS generation as an anticancer strategy, and DNQ itself has potential as a novel anticancer agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZNDU7HSiqTrVg90H21EOLACvtfcHk0lgMAs0DWCzYTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvFKjsbg%253D&md5=743039ba174407d5bdff005502830d81</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fja100610m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja100610m%26sid%3Dliteratum%253Aachs%26aulast%3DBair%26aufirst%3DJ.%2BS.%26aulast%3DPalchaudhuri%26aufirst%3DR.%26aulast%3DHergenrother%26aufirst%3DP.%2BJ.%26atitle%3DChemistry%2520and%2520biology%2520of%2520deoxynyboquinone%252C%2520a%2520potent%2520inducer%2520of%2520cancer%2520cell%2520death%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D5469%26epage%3D5478%26doi%3D10.1021%2Fja100610m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bao, X.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, X.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, B.</span></span> <span> </span><span class="NLM_article-title">A hydrogen peroxide-activated Cu (II) pro-ionophore strategy for modifying naphthazarin as a promising anticancer agent with high selectivity for generating ROS in HepG2 cells over in L02 cells</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>152</i></span>,  <span class="NLM_fpage">597</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2019.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.freeradbiomed.2019.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=31805398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVSlu7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2020&pages=597-608&author=X.-Z.+Baoauthor=Q.+Wangauthor=X.-R.+Renauthor=F.+Daiauthor=B.+Zhou&title=A+hydrogen+peroxide-activated+Cu+%28II%29+pro-ionophore+strategy+for+modifying+naphthazarin+as+a+promising+anticancer+agent+with+high+selectivity+for+generating+ROS+in+HepG2+cells+over+in+L02+cells&doi=10.1016%2Fj.freeradbiomed.2019.12.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">A hydrogen peroxide-activated Cu(II) pro-ionophore strategy for modifying naphthazarin as a promising anticancer agent with high selectivity for generating ROS in HepG2 cells over in L02 cells</span></div><div class="casAuthors">Bao, Xia-Zhen; Wang, Qi; Ren, Xiao-Rong; Dai, Fang; Zhou, Bo</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">597-608</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Targeting redox vulnerability of cancer cells by pro-oxidants capable of generating reactive oxygen species (ROS) has surfaced as an important anticancer strategy.  Due to the intrinsic narrow therapeutic window and other dangerous side effects of ROS generation, it is highly needed and challenging to develop pro-oxidative anticancer agents (PAAs) with high selectivity for generating ROS in cancer cells.  Herein we report a hydrogen peroxide (H2O2)-activated Cu(II) pro-ionophore strategy to develop naphthazarin (Nap) as such type of PAAs based on the H2O2-mediated conversion of boronate to free phenol.  The boronate-protected Nap (PNap) can exploit increased levels of H2O2 in HepG2 cells to in situ release Nap followed by its efflux via conjugation with reduced glutathione (GSH), allowing that the Nap-GSH adduct works as a Cu(II) ionophore to induce continuously GSH depletion via a redn.-dependent releasing of Cu(I) by GSH.  This strategy endows PNap with the unprecedented ability to hit multi-redox characteristics (increased levels of H2O2, GSH and copper) of HepG2 cells, leading to ROS generation preferentially in HepG2 cells along with their selective death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnW5zVYLJv7LVg90H21EOLACvtfcHk0lgMAs0DWCzYTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVSlu7zO&md5=88be6b75365195744ab7de1d474d97df</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2019.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2019.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DBao%26aufirst%3DX.-Z.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DRen%26aufirst%3DX.-R.%26aulast%3DDai%26aufirst%3DF.%26aulast%3DZhou%26aufirst%3DB.%26atitle%3DA%2520hydrogen%2520peroxide-activated%2520Cu%2520%2528II%2529%2520pro-ionophore%2520strategy%2520for%2520modifying%2520naphthazarin%2520as%2520a%2520promising%2520anticancer%2520agent%2520with%2520high%2520selectivity%2520for%2520generating%2520ROS%2520in%2520HepG2%2520cells%2520over%2520in%2520L02%2520cells%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2020%26volume%3D152%26spage%3D597%26epage%3D608%26doi%3D10.1016%2Fj.freeradbiomed.2019.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shlyakhovenko, V. O.</span></span> <span> </span><span class="NLM_article-title">Ribonucleases. Possible new approach in cancer therapy</span>. <i>Exp. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">2</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.31768/2312-8852.2016.38(1):2-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.31768%2F2312-8852.2016.38%281%29%3A2-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=27031711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A280%3ADC%252BC28flslGrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2016&pages=2-8&author=V.+O.+Shlyakhovenko&title=Ribonucleases.+Possible+new+approach+in+cancer+therapy&doi=10.31768%2F2312-8852.2016.38%281%29%3A2-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Ribonucleases. Possible new approach in cancer therapy</span></div><div class="casAuthors">Shlyakhovenko V O</div><div class="citationInfo"><span class="NLM_cas:title">Experimental oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-8</span>
        ISSN:<span class="NLM_cas:issn">1812-9269</span>.
    </div><div class="casAbstract">In the review, the use of the ribonucleases for cancer therapy is discussed.  Using of epigenetic mechanisms of regulation--blocking protein synthesis without affecting the DNA structure--is a promising direction in the therapy.  The ribonucleases isolated from different sources, despite of similar mechanism of enzymatic reactions, have different biological effects.  The use of enzymes isolated from new sources, particularly from plants and fungi, shows promising results.  In this article we discuss the new approach for the use of enzymes resistant to inhibitors and ribozymes, that is aimed at the destruction of the oncogene specific mRNA and the induction of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQQNPQZtOWPYJggzHGM8X5CfW6udTcc2eaHuGyvHNovxrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28flslGrsA%253D%253D&md5=3967f02f02f497e53593099f2364ba92</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.31768%2F2312-8852.2016.38%281%29%3A2-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.31768%252F2312-8852.2016.38%25281%2529%253A2-8%26sid%3Dliteratum%253Aachs%26aulast%3DShlyakhovenko%26aufirst%3DV.%2BO.%26atitle%3DRibonucleases.%2520Possible%2520new%2520approach%2520in%2520cancer%2520therapy%26jtitle%3DExp.%2520Oncol.%26date%3D2016%26volume%3D38%26spage%3D2%26epage%3D8%26doi%3D10.31768%2F2312-8852.2016.38%281%29%3A2-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raines, R. T.</span></span> <span> </span><span class="NLM_article-title">Ribonucleases as novel chemotherapeutics: the ranpirnase example</span>. <i>BioDrugs</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">53</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.2165/00063030-200822010-00006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.2165%2F00063030-200822010-00006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=18215091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltl2rtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=53-58&author=J.+E.+Leeauthor=R.+T.+Raines&title=Ribonucleases+as+novel+chemotherapeutics%3A+the+ranpirnase+example&doi=10.2165%2F00063030-200822010-00006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Ribonucleases as novel chemotherapeutics: the ranpirnase example</span></div><div class="casAuthors">Lee, J. Eugene; Raines, Ronald T.</div><div class="citationInfo"><span class="NLM_cas:title">BioDrugs</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-58</span>CODEN:
                <span class="NLM_cas:coden">BIDRF4</span>;
        ISSN:<span class="NLM_cas:issn">1173-8804</span>.
    
            (<span class="NLM_cas:orgname">Wolters Kluwer Health</span>)
        </div><div class="casAbstract">A review.  Ranpirnase, a cytotoxic RNase from the frog Rana pipiens, is the archetype of a novel class of cancer chemotherapeutic agents based on homologs and variants of bovine pancreatic RNase (RNase A).  Ranpirnase in combination with doxorubicin is in clin. trials for the treatment of unresectable malignant mesothelioma and other cancers.  The putative mechanism for ranpirnase-mediated cytotoxicity involves binding to anionic components of the extracellular membrane, cytosolic internalization, and degrdn. of tRNA leading to apoptosis.  The maintenance of ribonucleolytic activity in the presence of the cytosolic RNase inhibitor protein is a key aspect of the cytotoxic activity of ranpirnase.  The basis for its specific toxicity for cancer cells is not known.  This review describes the development of ranpirnase as a cancer chemotherapeutic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3VOenFh_EXrVg90H21EOLACvtfcHk0lgMAs0DWCzYTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltl2rtrY%253D&md5=5ccb8937c9ca9e96fa1a08a9aaed7ffd</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.2165%2F00063030-200822010-00006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00063030-200822010-00006%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BE.%26aulast%3DRaines%26aufirst%3DR.%2BT.%26atitle%3DRibonucleases%2520as%2520novel%2520chemotherapeutics%253A%2520the%2520ranpirnase%2520example%26jtitle%3DBioDrugs%26date%3D2008%26volume%3D22%26spage%3D53%26epage%3D58%26doi%3D10.2165%2F00063030-200822010-00006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palte, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raines, R. T.</span></span> <span> </span><span class="NLM_article-title">Boronate-mediated biologic delivery</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">3631</span>– <span class="NLM_lpage">3634</span>, <span class="refDoi"> DOI: 10.1021/ja210719s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja210719s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhslals7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=3631-3634&author=G.+A.+Ellisauthor=M.+J.+Palteauthor=R.+T.+Raines&title=Boronate-mediated+biologic+delivery&doi=10.1021%2Fja210719s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Boronate-Mediated Biologic Delivery</span></div><div class="casAuthors">Ellis, Gregory A.; Palte, Michael J.; Raines, Ronald T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3631-3634</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inefficient cellular delivery limits the landscape of macromol. drugs.  Boronic acids readily form boronate esters with the 1,2- and 1,3-diols of saccharides, such as those that coat the surface of mammalian cells.  Here pendant boronic acids are shown to enhance the cytosolic delivery of a protein toxin.  Thus, boronates are a noncationic carrier that can deliver a polar macromol. into mammalian cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUQ1xdHeMzLbVg90H21EOLACvtfcHk0ljQNXP8nwjz7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhslals7k%253D&md5=9c17b7d03edf5a28a0bb226ef8035e7f</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1021%2Fja210719s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja210719s%26sid%3Dliteratum%253Aachs%26aulast%3DEllis%26aufirst%3DG.%2BA.%26aulast%3DPalte%26aufirst%3DM.%2BJ.%26aulast%3DRaines%26aufirst%3DR.%2BT.%26atitle%3DBoronate-mediated%2520biologic%2520delivery%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D3631%26epage%3D3634%26doi%3D10.1021%2Fja210719s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hagen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzenell, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jentzsch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veldwijk, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokhir, A.</span></span> <span> </span><span class="NLM_article-title">Aminoferrocene-based prodrugs activated by reactive oxygen species</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">924</span>– <span class="NLM_lpage">934</span>, <span class="refDoi"> DOI: 10.1021/jm2014937</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2014937" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ers7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=924-934&author=H.+Hagenauthor=P.+Marzenellauthor=E.+Jentzschauthor=F.+Wenzauthor=M.+R.+Veldwijkauthor=A.+Mokhir&title=Aminoferrocene-based+prodrugs+activated+by+reactive+oxygen+species&doi=10.1021%2Fjm2014937"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Aminoferrocene-Based Prodrugs Activated by Reactive Oxygen Species</span></div><div class="casAuthors">Hagen, Helen; Marzenell, Paul; Jentzsch, Elmar; Wenz, Frederik; Veldwijk, Marlon R.; Mokhir, Andriy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">924-934</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cancer cells generally generate higher amts. of reactive oxygen species than normal cells.  On the basis of this difference, prodrugs have been developed (e.g., hydroxyferrocifen), which remain inactive in normal cells, but become activated in cancer cells.  In this work we describe novel aminoferrocene-based prodrugs, which, in contrast to hydroxyferrocifen, after activation form not only quinone methides (QMs), but also catalysts (iron or ferrocenium ions).  The released products act in a concerted fashion.  In particular, QMs alkylate glutathione, thereby inhibiting the antioxidative system of the cell, whereas the iron species induce catalytic generation of hydroxyl radicals.  Since the catalysts are formed as products of the activation reaction, it proceeds autocatalytically.  The most potent prodrug described here is toxic toward cancer cells (human promyelocytic leukemia (HL-60), IC50 = 9 μM, and human glioblastoma-astrocytoma (U373), IC50 = 25 μM), but not toxic (up to 100 μM) toward representative nonmalignant cells (fibroblasts).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXZLxLfss0RrVg90H21EOLACvtfcHk0ljQNXP8nwjz7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ers7bI&md5=28894e8a8006c8b0ef91455aee76139d</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1021%2Fjm2014937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2014937%26sid%3Dliteratum%253Aachs%26aulast%3DHagen%26aufirst%3DH.%26aulast%3DMarzenell%26aufirst%3DP.%26aulast%3DJentzsch%26aufirst%3DE.%26aulast%3DWenz%26aufirst%3DF.%26aulast%3DVeldwijk%26aufirst%3DM.%2BR.%26aulast%3DMokhir%26aufirst%3DA.%26atitle%3DAminoferrocene-based%2520prodrugs%2520activated%2520by%2520reactive%2520oxygen%2520species%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D924%26epage%3D934%26doi%3D10.1021%2Fjm2014937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pigeon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Top, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vessieres, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huche, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gormen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Arbi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plamont, M.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGlinchey, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaouen, G.</span></span> <span> </span><span class="NLM_article-title">A new series of ferrocifen derivatives, bearing two aminoalkyl chains, with strong antiproliferative effects on breast cancer cells</span>. <i>New J. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">2212</span>– <span class="NLM_lpage">2218</span>, <span class="refDoi"> DOI: 10.1039/c1nj20192a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1039%2Fc1nj20192a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1ags7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2011&pages=2212-2218&author=P.+Pigeonauthor=S.+Topauthor=A.+Vessieresauthor=M.+Hucheauthor=M.+Gormenauthor=M.+El+Arbiauthor=M.-A.+Plamontauthor=M.+J.+McGlincheyauthor=G.+Jaouen&title=A+new+series+of+ferrocifen+derivatives%2C+bearing+two+aminoalkyl+chains%2C+with+strong+antiproliferative+effects+on+breast+cancer+cells&doi=10.1039%2Fc1nj20192a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">A new series of ferrocifen derivatives, bearing two aminoalkyl chains, with strong antiproliferative effects on breast cancer cells</span></div><div class="casAuthors">Pigeon, Pascal; Top, Siden; Vessieres, Anne; Huche, Michel; Goermen, Meral; El Arbi, Mehdi; Plamont, Marie-Aude; McGlinchey, Michael J.; Jaouen, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">New Journal of Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2212-2218</span>CODEN:
                <span class="NLM_cas:coden">NJCHE5</span>;
        ISSN:<span class="NLM_cas:issn">1144-0546</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">We have prepd. several organometallic systems whose structures are closely analogous to that of tamoxifen, the drug used in the treatment of hormone-dependent breast cancers, but which now possess two basic aminoalkyl chains: O(CH2)3NMe2.  Despite the absence of a phenolic functionality, these ferrocenyl compds. 3, 4 and their org. analog 5 recognize the estrogen receptor but in addn. exhibit strong antiproliferative effects on hormone-dependent breast cancer cells (MCF-7), and also on hormone-independent ones (MDA-MB-231) with, in this case, an IC50 value of about 0.4 μM.  The ferrocenyl moiety does not create a major effect here compared to a purely org. arom. group.  On the other hand, the presence within the mol. of two vicinal basic entities, potentially allowing complexation to metal ions such as Zn2+, could perhaps be the key to the antiproliferative effectiveness of this series which operates via a different mechanism to that of hydroxytamoxifen 1 and hydroxyferrocifen 2.  The behavior of these new species is discussed.  They possess the distinctive feature of combining a strong antiproliferative effect with intense antibacterial and antifungal activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppafGULcD4wbVg90H21EOLACvtfcHk0ljQNXP8nwjz7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1ags7fK&md5=16ee20ca7e95f9c5a3aa7e1f7a10c7da</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1039%2Fc1nj20192a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1nj20192a%26sid%3Dliteratum%253Aachs%26aulast%3DPigeon%26aufirst%3DP.%26aulast%3DTop%26aufirst%3DS.%26aulast%3DVessieres%26aufirst%3DA.%26aulast%3DHuche%26aufirst%3DM.%26aulast%3DGormen%26aufirst%3DM.%26aulast%3DEl%2BArbi%26aufirst%3DM.%26aulast%3DPlamont%26aufirst%3DM.-A.%26aulast%3DMcGlinchey%26aufirst%3DM.%2BJ.%26aulast%3DJaouen%26aufirst%3DG.%26atitle%3DA%2520new%2520series%2520of%2520ferrocifen%2520derivatives%252C%2520bearing%2520two%2520aminoalkyl%2520chains%252C%2520with%2520strong%2520antiproliferative%2520effects%2520on%2520breast%2520cancer%2520cells%26jtitle%3DNew%2520J.%2520Chem.%26date%3D2011%26volume%3D35%26spage%3D2212%26epage%3D2218%26doi%3D10.1039%2Fc1nj20192a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daum, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chekhun, V. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todor, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukianova, N. Yu.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shvets, Y. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellner, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Putzker, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Graaf, I. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groothuis, G. M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zozulia, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hampel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokhir, A.</span></span> <span> </span><span class="NLM_article-title">Improved synthesis of <i>N</i>-benzylaminoferrocene-based prodrugs and evaluation of their toxicity and antileukemic activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2015</span>– <span class="NLM_lpage">2024</span>, <span class="refDoi"> DOI: 10.1021/jm5019548</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5019548" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs12ltrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2015-2024&author=S.+Daumauthor=V.+F.+Chekhunauthor=I.+N.+Todorauthor=N.+Yu.+Lukianovaauthor=Y.+V.+Shvetsauthor=L.+Sellnerauthor=K.+Putzkerauthor=J.+Lewisauthor=T.+Zenzauthor=I.+A.+M.+de+Graafauthor=G.+M.+M.+Groothuisauthor=A.+Casiniauthor=O.+Zozuliaauthor=F.+Hampelauthor=A.+Mokhir&title=Improved+synthesis+of+N-benzylaminoferrocene-based+prodrugs+and+evaluation+of+their+toxicity+and+antileukemic+activity&doi=10.1021%2Fjm5019548"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Improved synthesis of N-benzylaminoferrocene-based prodrugs and evaluation of their toxicity and antileukemic activity</span></div><div class="casAuthors">Daum, Steffen; Chekhun, Vasiliy F.; Todor, Igor N.; Lukianova, Natalia Yu.; Shvets, Yulia V.; Sellner, Leopold; Putzker, Kerstin; Lewis, Joe; Zenz, Thorsten; de Graaf, Inge A. M.; Groothuis, Geny M. M.; Casini, Angela; Zozulia, Oleksii; Hampel, Frank; Mokhir, Andriy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2015-2024</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report on an improved method of synthesis of N-benzylaminoferrocene-based prodrugs and demonstrate its applicability by prepg. nine new aminoferrocenes.  Their effect on the viability of selected cancer cells having different p53 status was studied.  The obtained data are in agreement with the hypothesis that the toxicity of aminoferrocenes is not dependent upon p53 status.  Subsequently the toxicity of a selected prodrug (4) was investigated ex vivo using rat precision cut liver slices and in vivo on hybrid male mice BDF1.  In both expts. no toxicity was obsd.: ex vivo, up to 10 μM; in vivo, up to 6 mg/kg.  Finally, prodrug 4 was shown to extend the survival of BDF1 mice carrying L1210 leukemia from 13.7 ± 0.6 days to 17.5 ± 0.7 days when injected daily 6 times at a dose of 26 μg/kg starting from the second day after injection of L1210 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLDu6senrhSrVg90H21EOLACvtfcHk0ljuWO9KunAiQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs12ltrk%253D&md5=3ef143641864bf0c859a5edc63d49c8f</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Fjm5019548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5019548%26sid%3Dliteratum%253Aachs%26aulast%3DDaum%26aufirst%3DS.%26aulast%3DChekhun%26aufirst%3DV.%2BF.%26aulast%3DTodor%26aufirst%3DI.%2BN.%26aulast%3DLukianova%26aufirst%3DN.%2BYu.%26aulast%3DShvets%26aufirst%3DY.%2BV.%26aulast%3DSellner%26aufirst%3DL.%26aulast%3DPutzker%26aufirst%3DK.%26aulast%3DLewis%26aufirst%3DJ.%26aulast%3DZenz%26aufirst%3DT.%26aulast%3Dde%2BGraaf%26aufirst%3DI.%2BA.%2BM.%26aulast%3DGroothuis%26aufirst%3DG.%2BM.%2BM.%26aulast%3DCasini%26aufirst%3DA.%26aulast%3DZozulia%26aufirst%3DO.%26aulast%3DHampel%26aufirst%3DF.%26aulast%3DMokhir%26aufirst%3DA.%26atitle%3DImproved%2520synthesis%2520of%2520N-benzylaminoferrocene-based%2520prodrugs%2520and%2520evaluation%2520of%2520their%2520toxicity%2520and%2520antileukemic%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2015%26epage%3D2024%26doi%3D10.1021%2Fjm5019548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schikora, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reznikov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaykovskaya, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sachinska, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polyakova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokhir, A.</span></span> <span> </span><span class="NLM_article-title">Activity of aminoferrocene-based prodrugs against prostate cancer</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3447</span>– <span class="NLM_lpage">3450</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.07.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.bmcl.2015.07.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=26206503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFOmur3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=3447-3450&author=M.+Schikoraauthor=A.+Reznikovauthor=L.+Chaykovskayaauthor=O.+Sachinskaauthor=L.+Polyakovaauthor=A.+Mokhir&title=Activity+of+aminoferrocene-based+prodrugs+against+prostate+cancer&doi=10.1016%2Fj.bmcl.2015.07.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Activity of aminoferrocene-based prodrugs against prostate cancer</span></div><div class="casAuthors">Schikora, Margot; Reznikov, Alexander; Chaykovskaya, Liudmila; Sachinska, Olga; Polyakova, Lubov; Mokhir, Andriy</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3447-3450</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We tested cytotoxicity of aminoferrocene-based prodrugs towards human androgen-responsive and unresponsive prostate cancer cell lines LNCaP and DU-145 correspondingly.  Two prodrugs were selected, which are both activated at elevated concns. of ROS with generation of quinone methide (antioxidant system inhibitor) and iron-contg. compds. (N-benzylaminoferrocene (prodrug 1) and Fe salts (2)).  We obsd. that only prodrug 1 is active against the selected prostate cancer cells (IC50 = 11-27 μM) and its activity correlates with the high cell-membrane permeability and increased prodn. of intracellular ROS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGDdMGEI6tTbVg90H21EOLACvtfcHk0ljuWO9KunAiQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFOmur3J&md5=70400acb3f6622c5abeae6330efdfb0a</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.07.013%26sid%3Dliteratum%253Aachs%26aulast%3DSchikora%26aufirst%3DM.%26aulast%3DReznikov%26aufirst%3DA.%26aulast%3DChaykovskaya%26aufirst%3DL.%26aulast%3DSachinska%26aufirst%3DO.%26aulast%3DPolyakova%26aufirst%3DL.%26aulast%3DMokhir%26aufirst%3DA.%26atitle%3DActivity%2520of%2520aminoferrocene-based%2520prodrugs%2520against%2520prostate%2520cancer%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D3447%26epage%3D3450%26doi%3D10.1016%2Fj.bmcl.2015.07.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marzenell, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellner, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grinyte, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavlov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daum, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokhir, A.</span></span> <span> </span><span class="NLM_article-title">Aminoferrocene-based prodrugs and their effects on human normal and cancer cells as well as bacterial cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">6935</span>– <span class="NLM_lpage">6944</span>, <span class="refDoi"> DOI: 10.1021/jm400754c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400754c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1CltLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6935-6944&author=P.+Marzenellauthor=H.+Hagenauthor=L.+Sellnerauthor=T.+Zenzauthor=R.+Grinyteauthor=V.+Pavlovauthor=S.+Daumauthor=A.+Mokhir&title=Aminoferrocene-based+prodrugs+and+their+effects+on+human+normal+and+cancer+cells+as+well+as+bacterial+cells&doi=10.1021%2Fjm400754c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Aminoferrocene-Based Prodrugs and Their Effects on Human Normal and Cancer Cells as Well as Bacterial Cells</span></div><div class="casAuthors">Marzenell, Paul; Hagen, Helen; Sellner, Leopold; Zenz, Thorsten; Grinyte, Ruta; Pavlov, Valeri; Daum, Steffen; Mokhir, Andriy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6935-6944</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aminoferrocene-based prodrugs are activated under cancer-specific conditions (high concn. of reactive oxygen species, ROS) with the formation of glutathione scavengers (p-quinone methide) and ROS-generating iron complexes.  Herein, the authors explored three structural modifications of these prodrugs to improve their properties: (a) the attachment of a -COOH function to the ferrocene fragment leads to the improvement of water soly. and reactivity in vitro but also decreases cell-membrane permeability and biol. activity, (b) the alkylation of the N-benzyl residue does not show any significant affect, and (c) the attachment of the second arylboronic acid fragment improves the toxicity (IC50) of the prodrugs toward human promyelocytic leukemia cells (HL-60) from 52 to 12 μM.  Finally, the authors demonstrated that the prodrugs are active against primary chronic lymphocytic leukemia (CLL) cells, with the best compds. exhibiting an IC50 value of 1.5 μM.  The most active compds. were found to not affect mononuclear cells and representative bacterial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5D_up23GkYrVg90H21EOLACvtfcHk0ljuWO9KunAiQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1CltLrF&md5=cf2da987bcc5ba84d67d2827e73eff53</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1021%2Fjm400754c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400754c%26sid%3Dliteratum%253Aachs%26aulast%3DMarzenell%26aufirst%3DP.%26aulast%3DHagen%26aufirst%3DH.%26aulast%3DSellner%26aufirst%3DL.%26aulast%3DZenz%26aufirst%3DT.%26aulast%3DGrinyte%26aufirst%3DR.%26aulast%3DPavlov%26aufirst%3DV.%26aulast%3DDaum%26aufirst%3DS.%26aulast%3DMokhir%26aufirst%3DA.%26atitle%3DAminoferrocene-based%2520prodrugs%2520and%2520their%2520effects%2520on%2520human%2520normal%2520and%2520cancer%2520cells%2520as%2520well%2520as%2520bacterial%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6935%26epage%3D6944%26doi%3D10.1021%2Fjm400754c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daum, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babiy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konovalova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shtemenko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shtemenko, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janko, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexiou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokhir, A.</span></span> <span> </span><span class="NLM_article-title">Tuning the structure of aminoferrocene-based anticancer prodrugs to prevent their aggregation in aqueous solution</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>178</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2017.08.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.jinorgbio.2017.08.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=29028541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1elurzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2018&pages=9-17&author=S.+Daumauthor=S.+Babiyauthor=H.+Konovalovaauthor=W.+Hoferauthor=A.+Shtemenkoauthor=N.+Shtemenkoauthor=C.+Jankoauthor=C.+Alexiouauthor=A.+Mokhir&title=Tuning+the+structure+of+aminoferrocene-based+anticancer+prodrugs+to+prevent+their+aggregation+in+aqueous+solution&doi=10.1016%2Fj.jinorgbio.2017.08.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Tuning the structure of aminoferrocene-based anticancer prodrugs to prevent their aggregation in aqueous solution</span></div><div class="casAuthors">Daum, Steffen; Babiy, Svetlana; Konovalova, Helen; Hofer, Walter; Shtemenko, Alexander; Shtemenko, Natalia; Janko, Christina; Alexiou, Christoph; Mokhir, Andriy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9-17</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Aminoferrocene-based prodrugs are activated in cancer cells by reactive oxygen species (ROS).  They were shown to exhibit high cytotoxicity towards a variety of cancer cell lines and primary cancer cells, but remain not toxic towards non-malignant cells.  However, these prodrugs have rather high lipophilicity leading to relatively low water soly.  In particular, an n-octanol/water partition coeff. for the best aminoferrocene-based prodrug (2) was found to be 4.51 ± 0.03.  Though the approaches for decreasing lipophilicity are straightforward and include the addn. of polar residues to the drug structure, these modifications also lead to dramatic decrease of cell permeability and, correspondingly, lower the activity of the drug.  Therefore, a delicate balance of polar and unpolar groups should be found to reduce lipophilicity without compromising the useful drug properties.  In this study we optimized an N-alkyl substituent, which is a key element responsible for the stabilization of the aminoferrocene drug released in cancer cells from prodrug 2.  We found that an N-propargyl residue is an optimal replacement for the N-benzyl fragment.  In particular, such a substitution (prodrug 7a) leads to redn. of prodrug lipophilicity down to logP = 3.78 ± 0.05, improvement of its water soly., decrease of its propensity towards aggregation and dramatic increase of its ROS-generating properties.  Finally, we demonstrated that the optimized prodrug strongly suppresses growth of Guerin's carcinoma (T8) in vivo at the dose of 30 mg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuMK18Z4OtL7Vg90H21EOLACvtfcHk0ljVXY0jVzzueA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1elurzJ&md5=2450b73a50c1d8340ee2e5aabd062772</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2017.08.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2017.08.038%26sid%3Dliteratum%253Aachs%26aulast%3DDaum%26aufirst%3DS.%26aulast%3DBabiy%26aufirst%3DS.%26aulast%3DKonovalova%26aufirst%3DH.%26aulast%3DHofer%26aufirst%3DW.%26aulast%3DShtemenko%26aufirst%3DA.%26aulast%3DShtemenko%26aufirst%3DN.%26aulast%3DJanko%26aufirst%3DC.%26aulast%3DAlexiou%26aufirst%3DC.%26aulast%3DMokhir%26aufirst%3DA.%26atitle%3DTuning%2520the%2520structure%2520of%2520aminoferrocene-based%2520anticancer%2520prodrugs%2520to%2520prevent%2520their%2520aggregation%2520in%2520aqueous%2520solution%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2018%26volume%3D178%26spage%3D9%26epage%3D17%26doi%3D10.1016%2Fj.jinorgbio.2017.08.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daum, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reshetnikov, M. S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sisa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumych, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lootsik, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilyy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bila, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janko, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexiou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellner, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokhir, A.</span></span> <span> </span><span class="NLM_article-title">Lysosome-targeting amplifiers of reactive oxygen species as anticancer prodrugs</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">15545</span>– <span class="NLM_lpage">15549</span>, <span class="refDoi"> DOI: 10.1002/anie.201706585</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2Fanie.201706585" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslygtb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=15545-15549&author=S.+Daumauthor=M.+S.+V.+Reshetnikovauthor=M.+Sisaauthor=T.+Dumychauthor=M.+D.+Lootsikauthor=R.+Bilyyauthor=E.+Bilaauthor=C.+Jankoauthor=C.+Alexiouauthor=M.+Herrmannauthor=L.+Sellnerauthor=A.+Mokhir&title=Lysosome-targeting+amplifiers+of+reactive+oxygen+species+as+anticancer+prodrugs&doi=10.1002%2Fanie.201706585"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosome-Targeting Amplifiers of Reactive Oxygen Species as Anticancer Prodrugs</span></div><div class="casAuthors">Daum, Steffen; Reshetnikov, M. S. Viktor; Sisa, Miroslav; Dumych, Tetyana; Lootsik, Maxim D.; Bilyy, Rostyslav; Bila, Evgenia; Janko, Christina; Alexiou, Christoph; Herrmann, Martin; Sellner, Leopold; Mokhir, Andriy</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">15545-15549</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Cancer cells produce elevated levels of reactive oxygen species, which has been used to design cancer specific prodrugs.  Their activation relies on at least a bimol. process, in which a prodrug reacts with ROS.  However, at low micromolar concns. of the prodrugs and ROS, the activation is usually inefficient.  Herein, the authors propose and validate a potentially general approach for solving this intrinsic problem of ROS-dependent prodrugs.  In particular, known prodrug 4-(N-ferrocenyl-N-benzylaminocarbonyloxymethyl)phenylboronic acid pinacol ester was converted into its lysosome-specific analog.  Since lysosomes contain a higher concn. of active ROS than the cytoplasm, activation of the prodrug was facilitated with respect to the parent compd.  Moreover, it was found to exhibit high anticancer activity in a variety of cancer cell lines (IC50=3.5-7.2 μM) and in vivo (40 mg kg-1, NK/Ly murine model) but remained weakly toxic towards non-malignant cells (IC50=15-30 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwRXSpEQwuabVg90H21EOLACvtfcHk0ljVXY0jVzzueA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslygtb3N&md5=6e9cfccec2f511cf647cff6e72044dfe</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1002%2Fanie.201706585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201706585%26sid%3Dliteratum%253Aachs%26aulast%3DDaum%26aufirst%3DS.%26aulast%3DReshetnikov%26aufirst%3DM.%2BS.%2BV.%26aulast%3DSisa%26aufirst%3DM.%26aulast%3DDumych%26aufirst%3DT.%26aulast%3DLootsik%26aufirst%3DM.%2BD.%26aulast%3DBilyy%26aufirst%3DR.%26aulast%3DBila%26aufirst%3DE.%26aulast%3DJanko%26aufirst%3DC.%26aulast%3DAlexiou%26aufirst%3DC.%26aulast%3DHerrmann%26aufirst%3DM.%26aulast%3DSellner%26aufirst%3DL.%26aulast%3DMokhir%26aufirst%3DA.%26atitle%3DLysosome-targeting%2520amplifiers%2520of%2520reactive%2520oxygen%2520species%2520as%2520anticancer%2520prodrugs%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2017%26volume%3D56%26spage%3D15545%26epage%3D15549%26doi%3D10.1002%2Fanie.201706585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dilruba, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalayda, G. V.</span></span> <span> </span><span class="NLM_article-title">Platinum-based drugs: past, present and future</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">1103</span>– <span class="NLM_lpage">1124</span>, <span class="refDoi"> DOI: 10.1007/s00280-016-2976-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1007%2Fs00280-016-2976-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=26886018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC28XivFOqs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2016&pages=1103-1124&author=S.+Dilrubaauthor=G.+V.+Kalayda&title=Platinum-based+drugs%3A+past%2C+present+and+future&doi=10.1007%2Fs00280-016-2976-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Platinum-based drugs: past, present and future</span></div><div class="casAuthors">Dilruba, Shahana; Kalayda, Ganna V.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1103-1124</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Platinum-based drugs cisplatin, carboplatin and oxaliplatin are widely used in the therapy of human neoplasms.  Their clin. success is, however, limited due to severe side effects and intrinsic or acquired resistance to the treatment.  Much effort has been put into the development of new platinum anticancer complexes, but none of them has reached worldwide clin. application so far.  Nedaplatin, lobaplatin and heptaplatin received only regional approval.  Some new platinum complexes and platinum drug formulations are undergoing clin. trials.  Here, we review the main classes of new platinum drug candidates, such as sterically hindered complexes, monofunctional platinum drugs, complexes with biol. active ligands, trans-configured and polynuclear platinum complexes, platinum(IV) prodrugs and platinum-based drug delivery systems.  For each class of compds., a detailed overview of the mechanism of action is given, the cytotoxicity is compared to that of the clin. used platinum drugs, and the clin. perspectives are discussed.  A crit. anal. of lessons to be learned is presented.  Finally, a general outlook regarding future directions in the field of new platinum drugs is given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfV4v-5JjduLVg90H21EOLACvtfcHk0ljVXY0jVzzueA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivFOqs7k%253D&md5=1e1882f631ad56ef1a07b2075b1faa5e</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1007%2Fs00280-016-2976-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-016-2976-z%26sid%3Dliteratum%253Aachs%26aulast%3DDilruba%26aufirst%3DS.%26aulast%3DKalayda%26aufirst%3DG.%2BV.%26atitle%3DPlatinum-based%2520drugs%253A%2520past%252C%2520present%2520and%2520future%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2016%26volume%3D77%26spage%3D1103%26epage%3D1124%26doi%3D10.1007%2Fs00280-016-2976-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wheate, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craig, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oun, R.</span></span> <span> </span><span class="NLM_article-title">The status of platinum anticancer drugs in the clinic and in clinical trials</span>. <i>Dalton Trans. Camb. Engl.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">8113</span>– <span class="NLM_lpage">8127</span>, <span class="refDoi"> DOI: 10.1039/c0dt00292e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1039%2Fc0dt00292e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=20593091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A280%3ADC%252BC3cjntVOhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2010&pages=8113-8127&author=N.+Wheateauthor=S.+Walkerauthor=G.+Craigauthor=R.+Oun&title=The+status+of+platinum+anticancer+drugs+in+the+clinic+and+in+clinical+trials&doi=10.1039%2Fc0dt00292e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">The status of platinum anticancer drugs in the clinic and in clinical trials</span></div><div class="casAuthors">Wheate Nial J; Walker Shonagh; Craig Gemma E; Oun Rabbab</div><div class="citationInfo"><span class="NLM_cas:title">Dalton transactions (Cambridge, England : 2003)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">8113-27</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Since its approval in 1979 cisplatin has become an important component in chemotherapy regimes for the treatment of ovarian, testicular, lung and bladder cancers, as well as lymphomas, myelomas and melanoma.  Unfortunately its continued use is greatly limited by severe dose limiting side effects and intrinsic or acquired drug resistance.  Over the last 30 years, 23 other platinum-based drugs have entered clinical trials with only two (carboplatin and oxaliplatin) of these gaining international marketing approval, and another three (nedaplatin, lobaplatin and heptaplatin) gaining approval in individual nations.  During this time there have been more failures than successes with the development of 14 drugs being halted during clinical trials.  Currently there are four drugs in the various phases of clinical trial (satraplatin, picoplatin, Lipoplatin and ProLindac).  No new small molecule platinum drug has entered clinical trials since 1999 which is representative of a shift in focus away from drug design and towards drug delivery in the last decade.  In this perspective article we update the status of platinum anticancer drugs currently approved for use, those undergoing clinical trials and those discontinued during clinical trials, and discuss the results in the context of where we believe the field will develop over the next decade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSA_Z4lAike1oxhnOQkIHOxfW6udTcc2eYGyKcWC4C0Q7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjntVOhtQ%253D%253D&md5=7831999d7abf759476cc49a4cdaecb6f</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1039%2Fc0dt00292e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0dt00292e%26sid%3Dliteratum%253Aachs%26aulast%3DWheate%26aufirst%3DN.%26aulast%3DWalker%26aufirst%3DS.%26aulast%3DCraig%26aufirst%3DG.%26aulast%3DOun%26aufirst%3DR.%26atitle%3DThe%2520status%2520of%2520platinum%2520anticancer%2520drugs%2520in%2520the%2520clinic%2520and%2520in%2520clinical%2520trials%26jtitle%3DDalton%2520Trans.%2520Camb.%2520Engl.%26date%3D2010%26volume%3D39%26spage%3D8113%26epage%3D8127%26doi%3D10.1039%2Fc0dt00292e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loos, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eechoute, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verweij, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathijssen, R. H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiemer, E. A. C.</span></span> <span> </span><span class="NLM_article-title">Drug transporters of platinum-based anticancer agents and their clinical significance</span>. <i>Drug Resist. Updates</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1016/j.drup.2010.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.drup.2010.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=21251871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitFGgs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=22-34&author=H.+Burgerauthor=W.+J.+Loosauthor=K.+Eechouteauthor=J.+Verweijauthor=R.+H.+J.+Mathijssenauthor=E.+A.+C.+Wiemer&title=Drug+transporters+of+platinum-based+anticancer+agents+and+their+clinical+significance&doi=10.1016%2Fj.drup.2010.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Drug transporters of platinum-based anticancer agents and their clinical significance</span></div><div class="casAuthors">Burger, Herman; Loos, Walter J.; Eechoute, Karel; Verweij, Jaap; Mathijssen, Ron H. J.; Wiemer, Erik A. C.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Resistance Updates</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-34</span>CODEN:
                <span class="NLM_cas:coden">DRUPFW</span>;
        ISSN:<span class="NLM_cas:issn">1368-7646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Platinum-based drugs are among the most active anticancer agents and are successfully used in a wide variety of human malignancies.  However, acquired and/or intrinsic resistance still represent a major limitation.  Lately, in particular mechanisms leading to impaired uptake and/or decreased cellular accumulation of platinum compds. have attracted attention.  In this review, we focus on the role of active platinum uptake and efflux systems as determinants of platinum sensitivity and -resistance and their contribution to platinum pharmacokinetics (PK) and pharmacodynamics (PD).  First, the three mostly used platinum-based anticancer agents as well as the most promising novel platinum compds. in development are put into clin. perspective.  Next, we describe the presently known potential platinum transporters - with special emphasis on org. cation transporters (OCTs) - and discuss their role on clin. outcome (i.e. efficacy and adverse events) of platinum-based chemotherapy.  In addn., transporter-mediated tumor resistance, the impact of potential platinum transporter-mediated drug-drug interactions, and the role of drug transporters in the renal elimination of platinum compds. are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpSV0_w_vYMLVg90H21EOLACvtfcHk0lgV5XHiQx0yRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXitFGgs70%253D&md5=7c061553cd5b29e46af482de08442fb3</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2010.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2010.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DBurger%26aufirst%3DH.%26aulast%3DLoos%26aufirst%3DW.%2BJ.%26aulast%3DEechoute%26aufirst%3DK.%26aulast%3DVerweij%26aufirst%3DJ.%26aulast%3DMathijssen%26aufirst%3DR.%2BH.%2BJ.%26aulast%3DWiemer%26aufirst%3DE.%2BA.%2BC.%26atitle%3DDrug%2520transporters%2520of%2520platinum-based%2520anticancer%2520agents%2520and%2520their%2520clinical%2520significance%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2011%26volume%3D14%26spage%3D22%26epage%3D34%26doi%3D10.1016%2Fj.drup.2010.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moussa, Y. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheate, N. J.</span></span> <span> </span><span class="NLM_article-title">The side effects of platinum-based chemotherapy drugs: a review for chemists</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">6645</span>– <span class="NLM_lpage">6653</span>, <span class="refDoi"> DOI: 10.1039/C8DT00838H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1039%2FC8DT00838H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=29632935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmsF2gtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2018&pages=6645-6653&author=R.+Ounauthor=Y.+E.+Moussaauthor=N.+J.+Wheate&title=The+side+effects+of+platinum-based+chemotherapy+drugs%3A+a+review+for+chemists&doi=10.1039%2FC8DT00838H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">The side effects of platinum-based chemotherapy drugs: a review for chemists</span></div><div class="casAuthors">Oun, Rabbab; Moussa, Yvonne E.; Wheate, Nial J.</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6645-6653</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The platinum-based drugs cisplatin, carboplatin and oxaliplatin are regularly prescribed in the treatment of cancer and while they are effective, their use is limited by their severe, dose-limiting side effects (also referred to as adverse effects/events).  In total, a cancer patient can experience any combination of around 40 specific side effects.  The dose-limiting side effect for cisplatin is nephrotoxicity, for carboplatin it is myelosuppression, and for oxaliplatin it is neurotoxicity.  Other common side effects include anaphylaxis, cytopenias (including leukopenia and neutropenia, thrombocytopenia, and anemia), hepatotoxicity, ototoxicity, cardiotoxicity, nausea and vomiting, diarrhea, mucositis, stomatitis, pain, alopecia, anorexia, cachexia, and asthenia.  The side effects may require patients to be prescribed dose redns. in their platinum drugs of between 25 and 100%.  Furthermore, patients require extensive monitoring of their biochemistries, kidney and liver function, and depending on the drug, hearing tests.  Finally, patients are commonly co-prescribed addnl. non-chemotherapy based drugs to treat the side effects which can include antiemetics, antibiotics and myeloid growth factors, mannitol, propafenone, saline hyperhydration, magnesium supplements, monoclonal antibody cytokine blockers and antioxidants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ8seL8Vc3g7Vg90H21EOLACvtfcHk0lgV5XHiQx0yRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmsF2gtL0%253D&md5=7e23105fd5f01cd16855b01187ef3356</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1039%2FC8DT00838H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8DT00838H%26sid%3Dliteratum%253Aachs%26aulast%3DOun%26aufirst%3DR.%26aulast%3DMoussa%26aufirst%3DY.%2BE.%26aulast%3DWheate%26aufirst%3DN.%2BJ.%26atitle%3DThe%2520side%2520effects%2520of%2520platinum-based%2520chemotherapy%2520drugs%253A%2520a%2520review%2520for%2520chemists%26jtitle%3DDalton%2520Trans.%26date%3D2018%26volume%3D47%26spage%3D6645%26epage%3D6653%26doi%3D10.1039%2FC8DT00838H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reshetnikov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daum, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janko, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karawacka, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tietze, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexiou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paryzhak, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumych, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilyy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmisano, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokhir, A.</span></span> <span> </span><span class="NLM_article-title">ROS-responsive <i>N</i>-alkylaminoferrocenes for cancer-cell-specific targeting of mitochondria</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">11943</span>– <span class="NLM_lpage">11946</span>, <span class="refDoi"> DOI: 10.1002/anie.201805955</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2Fanie.201805955" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFCkt7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=11943-11946&author=V.+Reshetnikovauthor=S.+Daumauthor=C.+Jankoauthor=W.+Karawackaauthor=R.+Tietzeauthor=C.+Alexiouauthor=S.+Paryzhakauthor=T.+Dumychauthor=R.+Bilyyauthor=P.+Tripalauthor=B.+Schmidauthor=R.+Palmisanoauthor=A.+Mokhir&title=ROS-responsive+N-alkylaminoferrocenes+for+cancer-cell-specific+targeting+of+mitochondria&doi=10.1002%2Fanie.201805955"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">ROS-responsive N-alkylaminoferrocenes for cancer-cell-specific targeting of mitochondria</span></div><div class="casAuthors">Reshetnikov, Viktor; Daum, Steffen; Janko, Christina; Karawacka, Weronika; Tietze, Rainer; Alexiou, Christoph; Paryzhak, Solomiya; Dumych, Tetiana; Bilyy, Rostyslav; Tripal, Philipp; Schmid, Benjamin; Palmisano, Ralf; Mokhir, Andriy</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">11943-11946</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Mitochondrial membrane potential is more neg. in cancer cells than in normal cells, allowing cancer targeting by delocalized lipophilic cations (DLCs).  However, as the difference is rather small, these drugs affect also normal cells.  Now a concept of pro-DLCs is proposed based on an N-alkylaminoferrocene structure.  These prodrugs are activated by the reaction with reactive oxygen species (ROS) forming ferrocenium-based DLCs.  Since ROS are overproduced in cancer, the high-efficiency cancer-cell-specific targeting of mitochondria could be achieved as demonstrated by fluorescence microscopy in combination with two fluorogenic pro-DLCs in vitro and in vivo.  We prepd. a conjugate of another pro-DLC with a clin. approved drug carboplatin and confirmed that its accumulation in mitochondria was higher than that of the free drug.  This was reflected in the substantially higher anticancer effect of the conjugate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH3EjM-JLwJ7Vg90H21EOLACvtfcHk0liWLYNwSi0U0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFCkt7nP&md5=e19713f6a491ebb650a4c14774365707</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1002%2Fanie.201805955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201805955%26sid%3Dliteratum%253Aachs%26aulast%3DReshetnikov%26aufirst%3DV.%26aulast%3DDaum%26aufirst%3DS.%26aulast%3DJanko%26aufirst%3DC.%26aulast%3DKarawacka%26aufirst%3DW.%26aulast%3DTietze%26aufirst%3DR.%26aulast%3DAlexiou%26aufirst%3DC.%26aulast%3DParyzhak%26aufirst%3DS.%26aulast%3DDumych%26aufirst%3DT.%26aulast%3DBilyy%26aufirst%3DR.%26aulast%3DTripal%26aufirst%3DP.%26aulast%3DSchmid%26aufirst%3DB.%26aulast%3DPalmisano%26aufirst%3DR.%26aulast%3DMokhir%26aufirst%3DA.%26atitle%3DROS-responsive%2520N-alkylaminoferrocenes%2520for%2520cancer-cell-specific%2520targeting%2520of%2520mitochondria%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2018%26volume%3D57%26spage%3D11943%26epage%3D11946%26doi%3D10.1002%2Fanie.201805955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reshetnikov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daum, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokhir, A.</span></span> <span> </span><span class="NLM_article-title">Cancer-specific, intracellular, reductive activation of anticancer Pt (IV) prodrugs</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5678</span>– <span class="NLM_lpage">5681</span>, <span class="refDoi"> DOI: 10.1002/chem.201701192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2Fchem.201701192" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=28319647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsFSgtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=5678-5681&author=V.+Reshetnikovauthor=S.+Daumauthor=A.+Mokhir&title=Cancer-specific%2C+intracellular%2C+reductive+activation+of+anticancer+Pt+%28IV%29+prodrugs&doi=10.1002%2Fchem.201701192"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer-Specific, Intracellular, Reductive Activation of Anticancer PtIV Prodrugs</span></div><div class="casAuthors">Reshetnikov, Viktor; Daum, Steffen; Mokhir, Andriy</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5678-5681</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Because cellular uptake of anticancer PtII and PtIV drugs occurs by different mechanisms, the latter ones can exhibit substantial activity towards cells, which have either intrinsic or acquired resistance towards PtII drugs.  However, this pos. effect is diminished due to reductive activation of PtIV drugs in extracellular space that can be one of the reasons why they have not yet been approved for clin. use despite over 60 clin. trials conducted worldwide.  Herein, we suggest a soln. to this problem by achieving highly specific intracellular vs. extracellular prodrug redn.  In particular, we prepd. a hybrid PtIV prodrug contg. two pro-reductants.  This hybrid was uptaken by cells, the pro-reductants were activated in the cancer-specific microenvironment (high H2O2), and reduced PtIV by two one-electron transfers.  The drug formed in this way induced cell death both in cisplatin-sensitive and resistant cell lines, but remained nontoxic to normal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolk4Q2uk2fg7Vg90H21EOLACvtfcHk0liWLYNwSi0U0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsFSgtrw%253D&md5=ccc504f05d43ba419c208a57175a562e</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1002%2Fchem.201701192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201701192%26sid%3Dliteratum%253Aachs%26aulast%3DReshetnikov%26aufirst%3DV.%26aulast%3DDaum%26aufirst%3DS.%26aulast%3DMokhir%26aufirst%3DA.%26atitle%3DCancer-specific%252C%2520intracellular%252C%2520reductive%2520activation%2520of%2520anticancer%2520Pt%2520%2528IV%2529%2520prodrugs%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2017%26volume%3D23%26spage%3D5678%26epage%3D5681%26doi%3D10.1002%2Fchem.201701192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reshetnikov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkhypov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Julakanti, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokhir, A.</span></span> <span> </span><span class="NLM_article-title">A cancer specific oxaliplatin-releasing Pt (IV)-prodrug</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">6679</span>– <span class="NLM_lpage">6682</span>, <span class="refDoi"> DOI: 10.1039/C8DT01458B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1039%2FC8DT01458B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=29708261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotF2mur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2018&pages=6679-6682&author=V.+Reshetnikovauthor=A.+Arkhypovauthor=P.+R.+Julakantiauthor=A.+Mokhir&title=A+cancer+specific+oxaliplatin-releasing+Pt+%28IV%29-prodrug&doi=10.1039%2FC8DT01458B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">A cancer specific oxaliplatin-releasing Pt(IV)-prodrug</span></div><div class="casAuthors">Reshetnikov, Viktor; Arkhypov, Anton; Julakanti, Purushottam Reddy; Mokhir, Andriy</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6679-6682</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">We prepd. a Pt(IV)-prodrug, which under cancer specific conditions (elevated concn. of reactive oxygen species, ROS) releases a DNA-binding drug oxaliplatin as well as ROS-amplifying drugs p-quinone methide and N-alkylferrocenium.  Due to the concerted action of these components, an excellent anticancer effect was achieved: IC50 = 0.4 ± 0.1 μM for human ovarian carcinoma A2780 cells.  Importantly, the prodrug was found to be 45-fold less toxic to normal cells (HDFa).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUp2kLqbFK4rVg90H21EOLACvtfcHk0liWLYNwSi0U0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotF2mur4%253D&md5=b83ed431a5e3cdcd34f51bbec7f366da</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1039%2FC8DT01458B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8DT01458B%26sid%3Dliteratum%253Aachs%26aulast%3DReshetnikov%26aufirst%3DV.%26aulast%3DArkhypov%26aufirst%3DA.%26aulast%3DJulakanti%26aufirst%3DP.%2BR.%26aulast%3DMokhir%26aufirst%3DA.%26atitle%3DA%2520cancer%2520specific%2520oxaliplatin-releasing%2520Pt%2520%2528IV%2529-prodrug%26jtitle%3DDalton%2520Trans.%26date%3D2018%26volume%3D47%26spage%3D6679%26epage%3D6682%26doi%3D10.1039%2FC8DT01458B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wegiel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csizmadia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belcher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vercellotti, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penacho, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sukhatme, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandolfi, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helczynski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjartell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Persson, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otterbein, L. E.</span></span> <span> </span><span class="NLM_article-title">Carbon monoxide expedites metabolic exhaustion to inhibit tumor growth</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">7009</span>– <span class="NLM_lpage">7021</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-13-1075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1158%2F0008-5472.CAN-13-1075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=24121491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVKhu77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=7009-7021&author=B.+Wegielauthor=D.+Galloauthor=E.+Csizmadiaauthor=C.+Harrisauthor=J.+Belcherauthor=G.+M.+Vercellottiauthor=N.+Penachoauthor=P.+Sethauthor=V.+Sukhatmeauthor=A.+Ahmedauthor=P.+P.+Pandolfiauthor=L.+Helczynskiauthor=A.+Bjartellauthor=J.+L.+Perssonauthor=L.+E.+Otterbein&title=Carbon+monoxide+expedites+metabolic+exhaustion+to+inhibit+tumor+growth&doi=10.1158%2F0008-5472.CAN-13-1075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Carbon Monoxide Expedites Metabolic Exhaustion to Inhibit Tumor Growth</span></div><div class="casAuthors">Wegiel, Barbara; Gallo, David; Csizmadia, Eva; Harris, Clair; Belcher, John; Vercellotti, Gregory M.; Penacho, Nuno; Seth, Pankaj; Sukhatme, Vikas; Ahmed, Asif; Pandolfi, Pier Paolo; Helczynski, Leszek; Bjartell, Anders; Persson, Jenny Liao; Otterbein, Leo E.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7009-7021</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">One classical feature of cancer cells is their metabolic acquisition of a highly glycolytic phenotype.  Carbon monoxide (CO), one of the products of the cytoprotective mol. heme oxygenase-1 (HO-1) in cancer cells, has been implicated in carcinogenesis and therapeutic resistance.  However, the functional contributions of CO and HO-1 to these processes are poorly defined.  In human prostate cancers, we found that HO-1 was nuclear localized in malignant cells, with low enzymic activity in moderately differentiated tumors correlating with relatively worse clin. outcomes.  Exposure to CO sensitized prostate cancer cells but not normal cells to chemotherapy, with growth arrest and apoptosis induced in vivo in part through mitotic catastrophe.  CO targeted mitochondria activity in cancer cells as evidenced by higher oxygen consumption, free radical generation, and mitochondrial collapse.  Collectively, our findings indicated that CO transiently induces an anti-Warburg effect by rapidly fueling cancer cell bioenergetics, ultimately resulting in metabolic exhaustion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAf7Bqzr9K27Vg90H21EOLACvtfcHk0liWLYNwSi0U0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVKhu77I&md5=8af0a258c4388ec6fdd6c017a00d3a58</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-13-1075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-13-1075%26sid%3Dliteratum%253Aachs%26aulast%3DWegiel%26aufirst%3DB.%26aulast%3DGallo%26aufirst%3DD.%26aulast%3DCsizmadia%26aufirst%3DE.%26aulast%3DHarris%26aufirst%3DC.%26aulast%3DBelcher%26aufirst%3DJ.%26aulast%3DVercellotti%26aufirst%3DG.%2BM.%26aulast%3DPenacho%26aufirst%3DN.%26aulast%3DSeth%26aufirst%3DP.%26aulast%3DSukhatme%26aufirst%3DV.%26aulast%3DAhmed%26aufirst%3DA.%26aulast%3DPandolfi%26aufirst%3DP.%2BP.%26aulast%3DHelczynski%26aufirst%3DL.%26aulast%3DBjartell%26aufirst%3DA.%26aulast%3DPersson%26aufirst%3DJ.%2BL.%26aulast%3DOtterbein%26aufirst%3DL.%2BE.%26atitle%3DCarbon%2520monoxide%2520expedites%2520metabolic%2520exhaustion%2520to%2520inhibit%2520tumor%2520growth%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D7009%26epage%3D7021%26doi%3D10.1158%2F0008-5472.CAN-13-1075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Majewska, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioannidis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raza, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanna, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulbeck, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, M.</span></span> <span> </span><span class="NLM_article-title">Postprogression survival in patients with glioblastoma treated with concurrent chemoradiotherapy: a routine care cohort study</span>. <i>CNS Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">307</span>– <span class="NLM_lpage">313</span>, <span class="refDoi"> DOI: 10.2217/cns-2017-0001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.2217%2Fcns-2017-0001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=28990795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVars77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2017&pages=307-313&author=P.+Majewskaauthor=S.+Ioannidisauthor=M.+H.+Razaauthor=N.+Tannaauthor=H.+Bulbeckauthor=M.+Williams&title=Postprogression+survival+in+patients+with+glioblastoma+treated+with+concurrent+chemoradiotherapy%3A+a+routine+care+cohort+study&doi=10.2217%2Fcns-2017-0001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Postprogression survival in patients with glioblastoma treated with concurrent chemoradiotherapy: a routine care cohort study</span></div><div class="casAuthors">Majewska, Paulina; Ioannidis, Stefanos; Raza, Muhammad Hasan; Tanna, Nikhil; Bulbeck, Helen; Williams, Mathew</div><div class="citationInfo"><span class="NLM_cas:title">CNS Oncology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-313</span>CODEN:
                <span class="NLM_cas:coden">CONNCO</span>;
        ISSN:<span class="NLM_cas:issn">2045-0915</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">Glioblastoma is the commonest malignant brain tumor in adults.  Most patients develop progressive disease before they die.  However, survival after developing progressive disease is infrequently reported.  We identified patients with histol. proven disease who were treated with concurrent chemoradiotherapy during 2006-2013.  We analyzed overall survival (OS), progression-free survival and postprogression survival (PPS) in relation to age, O6-methylguanine-DNA methyltransferase promoter methylation and extent of surgical resection.  We identified 166 patients.  Median survival was 13.5 mo; 2-yr OS was 21.7%.  Median progression-free survival and PPS were 7.03 and 4.53 mo, resp.  Age and extent of surgical resection were correlated with OS.  Only the extent of surgical resection was assocd. with PPS.  Our work suggests that the established prognostic factors for glioblastoma do not appear to help predict PPS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0ceDwZob_IbVg90H21EOLACvtfcHk0ljfQpW1tKLASg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVars77K&md5=f6b3b39a98a1ae78381d0298a07f5984</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.2217%2Fcns-2017-0001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Fcns-2017-0001%26sid%3Dliteratum%253Aachs%26aulast%3DMajewska%26aufirst%3DP.%26aulast%3DIoannidis%26aufirst%3DS.%26aulast%3DRaza%26aufirst%3DM.%2BH.%26aulast%3DTanna%26aufirst%3DN.%26aulast%3DBulbeck%26aufirst%3DH.%26aulast%3DWilliams%26aufirst%3DM.%26atitle%3DPostprogression%2520survival%2520in%2520patients%2520with%2520glioblastoma%2520treated%2520with%2520concurrent%2520chemoradiotherapy%253A%2520a%2520routine%2520care%2520cohort%2520study%26jtitle%3DCNS%2520Oncol.%26date%3D2017%26volume%3D6%26spage%3D307%26epage%3D313%26doi%3D10.2217%2Fcns-2017-0001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ajazuddin</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amarji, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanaujia, P.</span></span> <span> </span><span class="NLM_article-title">Synthesis, characterization and in vitro studies of pegylated melphalan conjugates</span>. <i>Drug Dev. Ind. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1053</span>– <span class="NLM_lpage">1062</span>, <span class="refDoi"> DOI: 10.3109/03639045.2012.702346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.3109%2F03639045.2012.702346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=22779444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosl2lu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2013&pages=1053-1062&author=+Ajazuddinauthor=A.+Alexanderauthor=B.+Amarjiauthor=P.+Kanaujia&title=Synthesis%2C+characterization+and+in+vitro+studies+of+pegylated+melphalan+conjugates&doi=10.3109%2F03639045.2012.702346"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, characterization and in vitro studies of pegylated melphalan conjugates</span></div><div class="casAuthors">Ajazuddin; Alexander, Amit; Amarji, Basant; Kanaujia, Parijat</div><div class="citationInfo"><span class="NLM_cas:title">Drug Development and Industrial Pharmacy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1053-1062</span>CODEN:
                <span class="NLM_cas:coden">DDIPD8</span>;
        ISSN:<span class="NLM_cas:issn">0363-9045</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Melphalan, a drug used for the treatment of breast, ovaries and a certain type of cancer in the bone marrow, was conjugated to linear methoxy poly (ethylene glycol) (M-PEG) of 2000 and 5000, Da.  An ester linkage between polymer and drug was used in the coupling to yield a polymeric prodrug.  Purified esters were characterized by Maldi-Tof and IR spectroscopy methods.  The modification allowed overcoming the known melphalan aq. soly. problem (0.1 μg/mL) leading us to obtain a polymer-drug bioconjugate more suitable for oral and parenteral administration.  It was found that mol. wt. of M-PEG is crit. for the conjugates stability, aq. soly. (80 times and 123 times higher aq. soly. for M-PEG 2000 and M-PEG 5000, resp.), and hemolytic activity.  The melphalan caused 100% hemolysis above the concn. 3.5 μg/mL in 1 h. whereas conjugate of M-PEG 2000 and M-PEG 5000 shows 81.3 ± 0.5% and 48.8 ± 1.5% hemolysis, resp. at 32 μg/mL after 1 h.  Further in vitro anticancer activity of melphalan and its conjugates was performed with breast cancer MCF-7 cell lines.  It shows that LD50 concn. was higher 1.14 and 2 μm for M-PEG 2000 and M-PEG 5000, resp. in comparison to pure melphalan (0.74 μm).  Above studies revealed improved pharmacokinetics properties upon conjugation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYn9sQY9K0r7Vg90H21EOLACvtfcHk0ljfQpW1tKLASg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosl2lu7s%253D&md5=60c398a129b56ef9a04162a92eefccf0</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.3109%2F03639045.2012.702346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F03639045.2012.702346%26sid%3Dliteratum%253Aachs%26aulast%3DAjazuddin%26aulast%3DAlexander%26aufirst%3DA.%26aulast%3DAmarji%26aufirst%3DB.%26aulast%3DKanaujia%26aufirst%3DP.%26atitle%3DSynthesis%252C%2520characterization%2520and%2520in%2520vitro%2520studies%2520of%2520pegylated%2520melphalan%2520conjugates%26jtitle%3DDrug%2520Dev.%2520Ind.%2520Pharm.%26date%3D2013%26volume%3D39%26spage%3D1053%26epage%3D1062%26doi%3D10.3109%2F03639045.2012.702346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gutowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowalczyk, S.</span></span> <span> </span><span class="NLM_article-title">A study of free radical chemistry: their role and pathophysiological significance</span>. <i>Acta Biochim. Polym.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.18388/abp.2013_1944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.18388%2Fabp.2013_1944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=23513192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntFaku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2013&pages=1-16&author=M.+Gutowskiauthor=S.+Kowalczyk&title=A+study+of+free+radical+chemistry%3A+their+role+and+pathophysiological+significance&doi=10.18388%2Fabp.2013_1944"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">A study of free radical chemistry: their role and pathophysiological significance</span></div><div class="casAuthors">Gutowski, Mariusz; Kowalczyk, Slawomir</div><div class="citationInfo"><span class="NLM_cas:title">Acta Biochimica Polonica</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-16</span>CODEN:
                <span class="NLM_cas:coden">ABPLAF</span>;
        ISSN:<span class="NLM_cas:issn">1734-154X</span>.
    
            (<span class="NLM_cas:orgname">Polish Biochemical Society</span>)
        </div><div class="casAbstract">A review.  Oxygen is one of the most important mols. on Earth mainly because of the biochem. symmetry of oxygenic photosynthesis and aerobic respiration that can maintain homeostasis within our planet's biosphere.  Oxygen can also produce toxic mols., reactive oxygen species (ROS).  ROS play a dual role in biol. systems, since they can be either harmful or beneficial to living systems.  They can be considered a double-edged sword because at moderate concns., nitric oxide (NO•), superoxide anion, and related reactive oxygen species play an important role as regulatory mediators in signalling processes.  Many of the ROS-mediated responses actually protect the cells against oxidative stress and reestablish "redox homeostasis".  On the other hand, overprodn. of ROS has the potential to cause damage.  In the recent decades, ROS has become a focus of interest in most biomedical disciplines and many types of clin. research.  Increasing evidence from research on several diseases shows that oxidative stress is assocd. with the pathogenesis of diabetes mellitus, obesity, cancer, cardiovascular diseases, inflammation, ischemia/reperfusion injury, obstructive sleep apnea, neurodegenerative disorders, hypertension and ageing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkALfxIGCV6bVg90H21EOLACvtfcHk0ljfQpW1tKLASg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntFaku7c%253D&md5=a678b12e3a6f92a39c5875068053b79b</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.18388%2Fabp.2013_1944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18388%252Fabp.2013_1944%26sid%3Dliteratum%253Aachs%26aulast%3DGutowski%26aufirst%3DM.%26aulast%3DKowalczyk%26aufirst%3DS.%26atitle%3DA%2520study%2520of%2520free%2520radical%2520chemistry%253A%2520their%2520role%2520and%2520pathophysiological%2520significance%26jtitle%3DActa%2520Biochim.%2520Polym.%26date%3D2013%26volume%3D60%26spage%3D1%26epage%3D16%26doi%3D10.18388%2Fabp.2013_1944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wruck, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fragoulis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurzynski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandenburg, L.-O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassenpflug, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freitag-Wolf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varoga, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pufe, T.</span></span> <span> </span><span class="NLM_article-title">Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-Knockout mice</span>. <i>Ann. Rheum. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">844</span>– <span class="NLM_lpage">850</span>, <span class="refDoi"> DOI: 10.1136/ard.2010.132720</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1136%2Fard.2010.132720" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=21173018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnt1egsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2011&pages=844-850&author=C.+Wruckauthor=A.+Fragoulisauthor=A.+Gurzynskiauthor=L.-O.+Brandenburgauthor=Y.+Kanauthor=K.+Chanauthor=J.+Hassenpflugauthor=S.+Freitag-Wolfauthor=D.+Varogaauthor=S.+Lipprossauthor=T.+Pufe&title=Role+of+oxidative+stress+in+rheumatoid+arthritis%3A+insights+from+the+Nrf2-Knockout+mice&doi=10.1136%2Fard.2010.132720"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-knockout mice</span></div><div class="casAuthors">Wruck, Christoph Jan; Fragoulis, Athanassios; Gurzynski, Agata; Brandenburg, Lars-Ove; Kan, Yuet Wai; Chan, Kaimin; Hassenpflug, Joachim; Freitag-Wolf, Sandra; Varoga, Deike; Lippross, Sebastian; Pufe, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the Rheumatic Diseases</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">844-850</span>CODEN:
                <span class="NLM_cas:coden">ARDIAO</span>;
        ISSN:<span class="NLM_cas:issn">0003-4967</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Increasing evidence suggests that oxidative stress may play a key role in joint destruction due to rheumatoid arthritis (RA).  The aim of this study was to elucidate the role of nuclear factor erythroid 2-related factor 2 (Nrf2), a transcription factor that maintains the cellular defense against oxidative stress, in RA.  The activation status of Nrf2 was assessed in synovial tissue from patients with RA using immunohistochem.  Antibody-induced arthritis (AIA) was induced in Nrf2-knockout and Nrf2-wild-type control mice.  The severity of cartilage destruction was evaluated using a damage score.  The extent of oxidative stress, the activation state of Nrf2 and the expression level of Nrf2 target genes were analyzed by immunhistol. staining.  The expression of vascular endothelial growth factor (VEGF)-A was examd. on mRNA and protein using the Luminex technique.  A Xenogen imaging system was used to measure Nrf2 activity in an antioxidant response element-luciferase transgenic mouse during AIA.  Results Nrf2 was activated in the joints of arthritic mice and of patients with RA.  Nrf2-knockout mice had more severe cartilage injuries and more oxidative damage, and the expression of Nrf2 target genes was enhanced in Nrf2-wild-type but not in knockout mice during AIA.  Both VEGF-A mRNA and protein expression was upregulated in Nrf2-knockout mice during AIA.  An unexpected finding was the no. of spontaneously fractured bones in Nrf2-knockout mice with AIA.  These results provide strong evidence that oxidative stress is significantly involved in cartilage degrdn. in exptl. arthritis, and indicate that the presence of a functional Nrf2 gene is a major requirement for limiting cartilage destruction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVA53-Yyb-qLVg90H21EOLACvtfcHk0lj7KMl0WaPHSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnt1egsbk%253D&md5=a68710cc4197ac967802fd1d0631aef2</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1136%2Fard.2010.132720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fard.2010.132720%26sid%3Dliteratum%253Aachs%26aulast%3DWruck%26aufirst%3DC.%26aulast%3DFragoulis%26aufirst%3DA.%26aulast%3DGurzynski%26aufirst%3DA.%26aulast%3DBrandenburg%26aufirst%3DL.-O.%26aulast%3DKan%26aufirst%3DY.%26aulast%3DChan%26aufirst%3DK.%26aulast%3DHassenpflug%26aufirst%3DJ.%26aulast%3DFreitag-Wolf%26aufirst%3DS.%26aulast%3DVaroga%26aufirst%3DD.%26aulast%3DLippross%26aufirst%3DS.%26aulast%3DPufe%26aufirst%3DT.%26atitle%3DRole%2520of%2520oxidative%2520stress%2520in%2520rheumatoid%2520arthritis%253A%2520insights%2520from%2520the%2520Nrf2-Knockout%2520mice%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2011%26volume%3D70%26spage%3D844%26epage%3D850%26doi%3D10.1136%2Fard.2010.132720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weinstain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savariar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felsen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsien, R.</span></span> <span> </span><span class="NLM_article-title"><i>In vivo</i> targeting of hydrogen peroxide by activatable cell-penetrating peptides</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">874</span>– <span class="NLM_lpage">877</span>, <span class="refDoi"> DOI: 10.1021/ja411547j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja411547j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2cXksVGr" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=874-877&author=R.+Weinstainauthor=E.+Savariarauthor=C.+Felsenauthor=R.+Tsien&title=In+vivo+targeting+of+hydrogen+peroxide+by+activatable+cell-penetrating+peptides&doi=10.1021%2Fja411547j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">In Vivo Targeting of Hydrogen Peroxide by Activatable Cell-Penetrating Peptides</span></div><div class="casAuthors">Weinstain, Roy; Savariar, Elamprakash N.; Felsen, Csilla N.; Tsien, Roger Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">874-877</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A hydrogen peroxide (H2O2)-activated cell-penetrating peptide was developed through incorporation of a boronic acid-contg. cleavable linker between polycationic cell-penetrating peptide and polyanionic fragments.  Fluorescence labeling of the two ends of the mol. enabled monitoring its reaction with H2O2 through release of the highly adhesive cell-penetrating peptide and disruption of fluorescence resonance energy transfer.  The H2O2 sensor selectively reacts with endogenous H2O2 in cell culture to monitor the oxidative burst of promyelocytes and in vivo to image lung inflammation.  Targeting H2O2 has potential applications in imaging and therapy of diseases related to oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZU1pQtHtIALVg90H21EOLACvtfcHk0lj7KMl0WaPHSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXksVGr&md5=4a5fed53a10efd855720e6c83a7e0fbf</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1021%2Fja411547j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja411547j%26sid%3Dliteratum%253Aachs%26aulast%3DWeinstain%26aufirst%3DR.%26aulast%3DSavariar%26aufirst%3DE.%26aulast%3DFelsen%26aufirst%3DC.%26aulast%3DTsien%26aufirst%3DR.%26atitle%3DIn%2520vivo%2520targeting%2520of%2520hydrogen%2520peroxide%2520by%2520activatable%2520cell-penetrating%2520peptides%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D874%26epage%3D877%26doi%3D10.1021%2Fja411547j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial induced and self-monitored intrinsic apoptosis by antitumor theranostic prodrug: <i>in vivo</i> imaging and precise cancer treatment</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">17836</span>– <span class="NLM_lpage">17843</span>, <span class="refDoi"> DOI: 10.1021/ja510421q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja510421q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFOjsL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=17836-17843&author=R.+Kumarauthor=J.+Hanauthor=H.-J.+Limauthor=W.+Renauthor=J.-Y.+Limauthor=J.-H.+Kimauthor=J.+Kim&title=Mitochondrial+induced+and+self-monitored+intrinsic+apoptosis+by+antitumor+theranostic+prodrug%3A+in+vivo+imaging+and+precise+cancer+treatment&doi=10.1021%2Fja510421q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial Induced and Self-Monitored Intrinsic Apoptosis by Antitumor Theranostic Prodrug: In Vivo Imaging and Precise Cancer Treatment</span></div><div class="casAuthors">Kumar, Rajesh; Han, Jiyou; Lim, Hee-Joung; Ren, Wen Xiu; Lim, Ja-Yun; Kim, Jong-Hoon; Kim, Jong Seung</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">17836-17843</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activation of apoptosis, the cell death machinery, in tumor cells by organelle-specific delivery of antitumor theranostic agent is the utmost challenge in cancer therapy.  Herein, we developed a highly efficient mitochondria-targeting antitumor theranostic prodrug 7 that contained two mols. of drug 5'-deoxy-5-fluorouridine and an apoptotic marker ethidium for self-monitoring intrinsic (mitochondrial) apoptosis after its activation in tumor cells.  Theranostic 7 was activated by endogenously produced mitochondrial-overexpressed H2O2 and released drug 5'-deoxy-5-fluorouridine and apoptotic marker ethidium to the tumor cells.  The in vitro and in vivo drug release was monitored by observing the fluorescence changes of ethidium.  Theranostic 7 exhibited an enhanced cytotoxicity over com. 5-fluorouracil (an active drug of 5'-deoxy-5-fluorouridine) leading to intrinsic apoptosis monitored by in situ generated ethidium.  Enhanced expression of mitochondria-mediated apoptotic genes (NOXA, PUMA, BID, BAX, and BAK), Cyt C, Caspase-3 and -9, and cell surface death receptors was obsd. after theranostic 7 activation in tumor cells.  In vivo and ex vivo xenografts revealed that theranostic 7 significantly inhibited tumor progression and cured the tumor-bearing mice.  Such organelle-specific theranostic strategies have great potential for the early diagnosis and precise treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdxDp1xuNvfLVg90H21EOLACvtfcHk0lj7KMl0WaPHSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFOjsL3O&md5=0e80b2f99a1054f9da8570c3ceb84783</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1021%2Fja510421q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja510421q%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DH.-J.%26aulast%3DRen%26aufirst%3DW.%26aulast%3DLim%26aufirst%3DJ.-Y.%26aulast%3DKim%26aufirst%3DJ.-H.%26aulast%3DKim%26aufirst%3DJ.%26atitle%3DMitochondrial%2520induced%2520and%2520self-monitored%2520intrinsic%2520apoptosis%2520by%2520antitumor%2520theranostic%2520prodrug%253A%2520in%2520vivo%2520imaging%2520and%2520precise%2520cancer%2520treatment%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D17836%26epage%3D17843%26doi%3D10.1021%2Fja510421q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peiró
Cadahía, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bondebjerg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Previtali, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andresen, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clausen, M. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of hydrogen peroxide sensitive prodrugs of methotrexate and aminopterin for the treatment of rheumatoid arthritis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3503</span>– <span class="NLM_lpage">3515</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01775</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01775" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmslGqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3503-3515&author=J.+Peir%C3%B3%0ACadah%C3%ADaauthor=J.+Bondebjergauthor=C.+A.+Hansenauthor=V.+Previtaliauthor=A.+E.+Hansenauthor=T.+L.+Andresenauthor=M.+H.+Clausen&title=Synthesis+and+evaluation+of+hydrogen+peroxide+sensitive+prodrugs+of+methotrexate+and+aminopterin+for+the+treatment+of+rheumatoid+arthritis&doi=10.1021%2Facs.jmedchem.7b01775"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Hydrogen Peroxide Sensitive Prodrugs of Methotrexate and Aminopterin for the Treatment of Rheumatoid Arthritis</span></div><div class="casAuthors">Peiro Cadahia, Jorge; Bondebjerg, Jon; Hansen, Christian A.; Previtali, Viola; Hansen, Anders E.; Andresen, Thomas L.; Clausen, Mads H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3503-3515</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of novel hydrogen peroxide sensitive prodrugs I (11-13; R = H, Me, F) of methotrexate (MTX) and aminopterin (AMT) were synthesized and evaluated for therapeutic efficacy in mice with collagen induced arthritis (CIA) as a model of chronic rheumatoid arthritis (RA).  The prodrug strategy selected is based on ROS-labile 4-methylphenylboronic acid promoieties linked to the drugs via a carbamate linkage or a direct C-N bond.  Activation under pathophysiol. concns. of H2O2 proved to be effective, and prodrug candidates were selected in agreement with relevant in vitro physicochem. and pharmacokinetic assays.  Selected candidates showed moderate to good soly., high chem. and enzymic stability, and therapeutic efficacy comparable to the parent drugs in the CIA model.  Importantly, the prodrugs displayed the expected safer toxicity profile and increased therapeutic window compared to MTX and AMT while maintaining a comparable therapeutic efficacy, which is highly encouraging for future use in RA patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdXtNA0_tY-LVg90H21EOLACvtfcHk0lgEVvJJSf5ANA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmslGqs7s%253D&md5=8b58908d30a5092afa61d67856d9ecbb</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01775%26sid%3Dliteratum%253Aachs%26aulast%3DPeir%25C3%25B3%2BCadah%25C3%25ADa%26aufirst%3DJ.%26aulast%3DBondebjerg%26aufirst%3DJ.%26aulast%3DHansen%26aufirst%3DC.%2BA.%26aulast%3DPrevitali%26aufirst%3DV.%26aulast%3DHansen%26aufirst%3DA.%2BE.%26aulast%3DAndresen%26aufirst%3DT.%2BL.%26aulast%3DClausen%26aufirst%3DM.%2BH.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520hydrogen%2520peroxide%2520sensitive%2520prodrugs%2520of%2520methotrexate%2520and%2520aminopterin%2520for%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3503%26epage%3D3515%26doi%3D10.1021%2Facs.jmedchem.7b01775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McInnes, I. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schett, G.</span></span> <span> </span><span class="NLM_article-title">The pathogenesis of rheumatoid arthritis</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>365</i></span>,  <span class="NLM_fpage">2205</span>– <span class="NLM_lpage">2219</span>, <span class="refDoi"> DOI: 10.1056/NEJMra1004965</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1056%2FNEJMra1004965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=22150039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ajsrrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2011&pages=2205-2219&author=I.+B.+McInnesauthor=G.+Schett&title=The+pathogenesis+of+rheumatoid+arthritis&doi=10.1056%2FNEJMra1004965"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">The pathogenesis of rheumatoid arthritis</span></div><div class="casAuthors">McInnes, Lain B.; Schett, Georg</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2205-2219</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review discusses key pathogenic advances in rheumatoid arthritis, genetics, environmental factors, immunol. processes, inflammation, and structural damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJslDVaG7MxbVg90H21EOLACvtfcHk0lgEVvJJSf5ANA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ajsrrM&md5=31a79ccb05bca03f207b15f934b2d52d</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1056%2FNEJMra1004965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra1004965%26sid%3Dliteratum%253Aachs%26aulast%3DMcInnes%26aufirst%3DI.%2BB.%26aulast%3DSchett%26aufirst%3DG.%26atitle%3DThe%2520pathogenesis%2520of%2520rheumatoid%2520arthritis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2011%26volume%3D365%26spage%3D2205%26epage%3D2219%26doi%3D10.1056%2FNEJMra1004965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weinblatt, M.</span></span> <span> </span><span class="NLM_article-title">Methotrexate in rheumatoid arthritis: a quarter century of development</span>. <i>Trans. Am. Clin. Climatol. Assoc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">16</span>– <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=23874006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A280%3ADC%252BC3sfislanuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2013&pages=16-25&author=M.+Weinblatt&title=Methotrexate+in+rheumatoid+arthritis%3A+a+quarter+century+of+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Methotrexate in rheumatoid arthritis: a quarter century of development</span></div><div class="casAuthors">Weinblatt Michael E</div><div class="citationInfo"><span class="NLM_cas:title">Transactions of the American Clinical and Climatological Association</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16-25</span>
        ISSN:<span class="NLM_cas:issn">0065-7778</span>.
    </div><div class="casAbstract">Methotrexate (MTX) is now the most popular drug worldwide for the treatment of rheumatoid arthritis.  Low-dose, weekly MTX (10 to 25 mg/wk) used as either monotherapy or in combination with other drugs has a superior efficacy profile as defined in placebo-controlled trials and comparable efficacy to other drugs including anti-TNF therapy.  At 1 year, one third of patients on MTX have no radiographic progression and even greater effects are seen when combined with targeted biological therapies.  MTX is well tolerated; gastrointestinal toxicity is the most common toxicity with rarely bone marrow, lung, or liver toxicity.  MTX therapy has been a major advance in the treatment of rheumatoid arthritis and is now the cornerstone of therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRqArOx8qswLjEwO064Z95rfW6udTcc2eZHAIU3U28_cbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfislanuw%253D%253D&md5=2133803c36109fff27f4680d108331d6</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeinblatt%26aufirst%3DM.%26atitle%3DMethotrexate%2520in%2520rheumatoid%2520arthritis%253A%2520a%2520quarter%2520century%2520of%2520development%26jtitle%3DTrans.%2520Am.%2520Clin.%2520Climatol.%2520Assoc.%26date%3D2013%26volume%3D124%26spage%3D16%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cronstein, B. N.</span></span> <span> </span><span class="NLM_article-title">Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis</span>. <i>Bull. NYU Hosp. Jt. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">168</span>– <span class="NLM_lpage">173</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=17922664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A280%3ADC%252BD2sngtVGitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2007&pages=168-173&author=H.+Tianauthor=B.+N.+Cronstein&title=Understanding+the+mechanisms+of+action+of+methotrexate%3A+implications+for+the+treatment+of+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis</span></div><div class="casAuthors">Tian Henghe; Cronstein Bruce N</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of the NYU hospital for joint diseases</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">168-73</span>
        ISSN:<span class="NLM_cas:issn">1936-9719</span>.
    </div><div class="casAbstract">Methotrexate has been widely used for the treatment of rheumatoid arthritis (RA).  The mechanisms of action of methotrexate are complex.  Developed as a folic acid analogue, methotrexate inhibits purine and pyrimidine synthesis, which accounts for its efficacy in the therapy of cancer as well as for some of its toxicities.  Recently, many studies have focused on the adenosine-mediated antiinflammatory effects of methotrexate.  Certain aspects of methotrexate toxicities are also attributed to adenosine release.  A better understanding of the mechanisms of action and toxicities of methotrexate will direct clinicians in their treatment approach and toxicity monitoring.  Toward that objective, the latest developments in the pharmacokinetics, mechanism of action, pharmacogenetics, and toxicity of methotrexate are herein discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKpjpRCjFMtdHxxy173TfNfW6udTcc2ebD7oFhyMhKM7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sngtVGitQ%253D%253D&md5=b4d433ad29e80faaa489a0dcda426d27</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DH.%26aulast%3DCronstein%26aufirst%3DB.%2BN.%26atitle%3DUnderstanding%2520the%2520mechanisms%2520of%2520action%2520of%2520methotrexate%253A%2520implications%2520for%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DBull.%2520NYU%2520Hosp.%2520Jt.%2520Dis.%26date%3D2007%26volume%3D65%26spage%3D168%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khanna, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulus, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elashoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emery, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorrier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furst, D.</span></span> <span> </span><span class="NLM_article-title">Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">3030</span>– <span class="NLM_lpage">3038</span>, <span class="refDoi"> DOI: 10.1002/art.21295</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2Fart.21295" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=16200612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtF2msrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2005&pages=3030-3038&author=D.+Khannaauthor=G.+Parkauthor=H.+Paulusauthor=K.+Simpsonauthor=D.+Elashoffauthor=S.+Cohenauthor=P.+Emeryauthor=C.+Dorrierauthor=D.+Furst&title=Reduction+of+the+efficacy+of+methotrexate+by+the+use+of+folic+acid%3A+post+hoc+analysis+from+two+randomized+controlled+studies&doi=10.1002%2Fart.21295"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies</span></div><div class="casAuthors">Khanna, Dinesh; Park, Grace S.; Paulus, Harold E.; Simpson, Karen M.; Elashoff, David; Cohen, Stanley B.; Emery, Paul; Dorrier, Catharine; Furst, Daniel E.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3030-3038</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective. To examine the effect of folic acid on the efficacy of methotrexate (MTX) treatment in rheumatoid arthritis (RA) at 12 mo in 2 phase III randomized controlled trials (RCTs) of leflunomide in which MTX was used as a comparator.  Methods. Analyses were restricted to patients randomized to receive MTX who had rheumatoid factor data.  The US study recruited 482 patients with active RA; 179 received at least 1 dose of MTX, and all were mandated to receive 1 mg of oral folic acid once or twice daily.  The multinational European study recruited 999 patients with active RA; 489 received at least 1 dose of MTX, and oral folic acid was not required, although 50 received folate after developing an adverse event.  Because of similar entry criteria for both studies, the data for patients with available primary outcome data at week 52 were pooled (n = 668), and the patients were grouped by folic acid use (n = 225) and nonuse (n = 443).  To account for the significant between-study differences in the MTX groups, baseline covariates were adjusted using propensity scores so that folic acid users could be matched with nonusers.  This allowed for a comparison of differences in American College of Rheumatol. (ACR) 20% improvement criteria at week 52.  Results. At study entry, non-folic acid users had a significantly lower mean body wt., shorter mean RA duration, and higher mean disease activity (measured by joint counts, patient's and physician's global assessments, and acute-phase reactant levels).  The mean MTX dosage at week 52 was similar in the 2 RCTs.  Using propensity score matching techniques, the proportion of patients achieving an ACR 20% response at week 52 averaged 17% higher in the non-folic acid group than in the folic acid group (range 15-21%).  Similarly, the proportion of patients achieving ACR 50% and ACR 70% responses averaged 14% (range 12-16%) and 12% (range 9-14%) higher, resp., in the non-folic acid group.  Adverse events were reported in 93% of US study patients and 94% of the multinational study patients.  Elevated liver transaminase levels (above the upper limit of normal) were reported in 29% of the US study patients (majority receiving folic acid) and 62% of the multinational study patients (majority not receiving folic acid).  Conclusion. After using propensity scores to adjust for differences in the baseline characteristics of folic acid users and non-folic acid users, 9-21% fewer MTX-treated RA patients taking folic acid had ACR 20%, 50%, or 70% improvement at 52 wk compared with those who did not receive folic acid in the 2 phase III RA clin. trials.  As a post hoc anal., the results of this data anal. should be considered "hypothesis generating" and an impetus for future studies regarding the effects of folic acid on the efficacy of MTX in RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEPs1GWs8UY7Vg90H21EOLACvtfcHk0lhZ653jsYvj5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtF2msrrN&md5=5d4e8bfac44bd3e29995b3498aaf8458</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1002%2Fart.21295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.21295%26sid%3Dliteratum%253Aachs%26aulast%3DKhanna%26aufirst%3DD.%26aulast%3DPark%26aufirst%3DG.%26aulast%3DPaulus%26aufirst%3DH.%26aulast%3DSimpson%26aufirst%3DK.%26aulast%3DElashoff%26aufirst%3DD.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DEmery%26aufirst%3DP.%26aulast%3DDorrier%26aufirst%3DC.%26aulast%3DFurst%26aufirst%3DD.%26atitle%3DReduction%2520of%2520the%2520efficacy%2520of%2520methotrexate%2520by%2520the%2520use%2520of%2520folic%2520acid%253A%2520post%2520hoc%2520analysis%2520from%2520two%2520randomized%2520controlled%2520studies%26jtitle%3DArthritis%2520Rheum.%26date%3D2005%26volume%3D52%26spage%3D3030%26epage%3D3038%26doi%3D10.1002%2Fart.21295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rautio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumpulainen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heimbach, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliyai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Järvinen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savolainen, J.</span></span> <span> </span><span class="NLM_article-title">Prodrugs: design and clinical applications</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">270</span>, <span class="refDoi"> DOI: 10.1038/nrd2468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1038%2Fnrd2468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=18219308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFOrs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=255-270&author=J.+Rautioauthor=H.+Kumpulainenauthor=T.+Heimbachauthor=R.+Oliyaiauthor=D.+Ohauthor=T.+J%C3%A4rvinenauthor=J.+Savolainen&title=Prodrugs%3A+design+and+clinical+applications&doi=10.1038%2Fnrd2468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Prodrugs: design and clinical applications</span></div><div class="casAuthors">Rautio, Jarkko; Kumpulainen, Hanna; Heimbach, Tycho; Oliyai, Reza; Oh, Dooman; Jaervinen, Tomi; Savolainen, Jouko</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">255-270</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Prodrugs are bioreversible derivs. of drug mols. that undergo an enzymic and/or chem. transformation in vivo to release the active parent drug, which can then exert the desired pharmacol. effect.  In both drug discovery and development, prodrugs have become an established tool for improving physicochem., biopharmaceutical or pharmacokinetic properties of pharmacol. active agents.  About 5-7% of drugs approved worldwide can be classified as prodrugs, and the implementation of a prodrug approach in the early stages of drug discovery is a growing trend.  To illustrate the applicability of the prodrug strategy, this article describes the most common functional groups that are amenable to prodrug design, and highlights examples of prodrugs that are either launched or are undergoing human trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxnlEXYMLCVbVg90H21EOLACvtfcHk0lhZ653jsYvj5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFOrs7w%253D&md5=481a088ad2ee4da062779b5b28a33cbb</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1038%2Fnrd2468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2468%26sid%3Dliteratum%253Aachs%26aulast%3DRautio%26aufirst%3DJ.%26aulast%3DKumpulainen%26aufirst%3DH.%26aulast%3DHeimbach%26aufirst%3DT.%26aulast%3DOliyai%26aufirst%3DR.%26aulast%3DOh%26aufirst%3DD.%26aulast%3DJ%25C3%25A4rvinen%26aufirst%3DT.%26aulast%3DSavolainen%26aufirst%3DJ.%26atitle%3DProdrugs%253A%2520design%2520and%2520clinical%2520applications%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D255%26epage%3D270%26doi%3D10.1038%2Fnrd2468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liederer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borchardt, R.</span></span> <span> </span><span class="NLM_article-title">Enzymes involved in the bioconversion of ester-based prodrugs</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">1177</span>– <span class="NLM_lpage">1195</span>, <span class="refDoi"> DOI: 10.1002/jps.20542</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2Fjps.20542" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=16639719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsFWmu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2006&pages=1177-1195&author=B.+Liedererauthor=R.+Borchardt&title=Enzymes+involved+in+the+bioconversion+of+ester-based+prodrugs&doi=10.1002%2Fjps.20542"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Enzymes involved in the bioconversion of ester-based prodrugs</span></div><div class="casAuthors">Liederer, Bianca M.; Borchardt, Ronald T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1177-1195</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Enzymes are essential for the activation of many prodrugs.  In this review, the most important enzymes (e.g., paraoxonase, carboxylesterase, acetylcholinesterase, cholinesterase) involved in the bioconversion of ester-based prodrugs will be discussed in terms of their biol. and biochem.  Most of these enzymes fall into the category of hydrolytic enzymes.  However, nonhydrolytic enzymes, including cytochrome P450s, can also catalyze the bioconversion of ester prodrugs and thus will be discussed here.  Other factors influencing the ability of these enzymes to catalyze the bioconversion of ester-based prodrugs, particularly species and interindividual differences and stereochem. and structural features of the prodrugs, will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0llDjMqFZU7Vg90H21EOLACvtfcHk0lhZ653jsYvj5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsFWmu7Y%253D&md5=c4bb34d8918f2b4de099a0502c5bdb00</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1002%2Fjps.20542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.20542%26sid%3Dliteratum%253Aachs%26aulast%3DLiederer%26aufirst%3DB.%26aulast%3DBorchardt%26aufirst%3DR.%26atitle%3DEnzymes%2520involved%2520in%2520the%2520bioconversion%2520of%2520ester-based%2520prodrugs%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2006%26volume%3D95%26spage%3D1177%26epage%3D1195%26doi%3D10.1002%2Fjps.20542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Previtali, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrovic, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peiró
Cadahía, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troelsen, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clausen, M. H.</span></span> <span> </span><span class="NLM_article-title">Auxiliary in vitro and <i>in vivo</i> biological evaluation of hydrogen peroxide sensitive prodrugs of methotrexate and aminopterin for the treatment of rheumatoid arthritis</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">115247</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2019.115247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.bmc.2019.115247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=31843461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVSlu73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2020&pages=115247&author=V.+Previtaliauthor=K.+Petrovicauthor=J.+Peir%C3%B3%0ACadah%C3%ADaauthor=N.+S.+Troelsenauthor=M.+H.+Clausen&title=Auxiliary+in+vitro+and+in+vivo+biological+evaluation+of+hydrogen+peroxide+sensitive+prodrugs+of+methotrexate+and+aminopterin+for+the+treatment+of+rheumatoid+arthritis&doi=10.1016%2Fj.bmc.2019.115247"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Auxiliary in vitro and in vivo biological evaluation of hydrogen peroxide sensitive prodrugs of methotrexate and aminopterin for the treatment of rheumatoid arthritis</span></div><div class="casAuthors">Previtali, Viola; Petrovic, Katarina; Peiro Cadahia, Jorge; Troelsen, Nikolaj Sten; Clausen, Mads H.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">115247</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Rheumatoid arthritis (RA) is a chronic inflammatory disease that causes severe joints damage and other extra-articular alterations.  Despite the efficacy of low-dose methotrexate (LD-MTX) in RA treatment, adverse effects are the predominant reasons for discontinuation of therapy.  As a therapeutic targeting strategy, the presence of increased concns. of reactive oxygen species (ROS) in the inflammatory environment can serve as the stimulus for prodrug activation in site-selective drug delivery systems.  Our group has previously reported novel ROS sensitive prodrugs (1-3) of MTX and aminopterin (AMT) for site-selective delivery to inflammatory tissue assocd. with RA, with the aim of reducing side effects in RA therapy.  Herein, we investigate the effect and toxicity of the same prodrugs in a rat CIA (collagen-induced arthritis) model of RA.  We find that prodrug 1, an arylboronic acid ROS-sensitive MTX-prodrug, displays similar in vivo efficacy as MTX at an equimolar dose, while avoiding adverse effects known to restrict MTX treatment.  To further characterize prodrug 1 and its ROS mediated activation, we synthesized compd. 4, a neg. control lacking the boronic acid moiety.  We then investigated the effect of mols. on cell proliferation and cytotoxicity in the presence of the ROS scavenger pyruvate, as well as their stability in buffer and cell media, demonstrating a direct correlation between ROS concn. and the prodrug activity.  Moreover, the in vitro ADME properties were investigated, including permeability, rat plasma and microsomal stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosrlyZon7p3LVg90H21EOLACvtfcHk0lhUhZ0EsHfc5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVSlu73J&md5=d070f26cea05af53ba8334cab7a499f8</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2019.115247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2019.115247%26sid%3Dliteratum%253Aachs%26aulast%3DPrevitali%26aufirst%3DV.%26aulast%3DPetrovic%26aufirst%3DK.%26aulast%3DPeir%25C3%25B3%2BCadah%25C3%25ADa%26aufirst%3DJ.%26aulast%3DTroelsen%26aufirst%3DN.%2BS.%26aulast%3DClausen%26aufirst%3DM.%2BH.%26atitle%3DAuxiliary%2520in%2520vitro%2520and%2520in%2520vivo%2520biological%2520evaluation%2520of%2520hydrogen%2520peroxide%2520sensitive%2520prodrugs%2520of%2520methotrexate%2520and%2520aminopterin%2520for%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2020%26volume%3D28%26spage%3D115247%26doi%3D10.1016%2Fj.bmc.2019.115247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haorah, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramirez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Persidsky, Y.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">566</span>– <span class="NLM_lpage">576</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2006.04393.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1111%2Fj.1471-4159.2006.04393.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=17250680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltVKitLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=566-576&author=J.+Haorahauthor=S.+Ramirezauthor=K.+Schallauthor=D.+Smithauthor=R.+Pandyaauthor=Y.+Persidsky&title=Oxidative+stress+activates+protein+tyrosine+kinase+and+matrix+metalloproteinases+leading+to+blood-brain+barrier+dysfunction&doi=10.1111%2Fj.1471-4159.2006.04393.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction</span></div><div class="casAuthors">Haorah, James; Ramirez, Servio H.; Schall, Kathy; Smith, Daniel; Pandya, Rita; Persidsky, Yuri</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">566-576</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The blood-brain barrier (BBB) formed by brain microvascular endothelial cells (BMVEC) regulates the passage of mols. and leukocytes in and out of the brain.  Oxidative stress is a major underlying cause of neurodegenerative and neuroinflammatory disorders and BBB injury assocd. with them.  Using human BMVEC grown on porous membranes covered with basement membrane (BM) matrix (BBB models), we demonstrated that reactive oxygen species (ROS) augmented permeability and monocyte migration across BBB.  ROS activated matrix metalloproteinases (MMP-1, -2, and -9) and decreased tissue inhibitors of MMPs (TIMP-1 and -2) in a protein tyrosine kinase (PTK)-dependent manner.  Increase in MMPs and PTK activities paralleled degrdn. of BM protein and enhanced tyrosine phosphorylation of tight junction (TJ) protein.  These effects and enhanced permeability/monocyte migration were prevented by inhibitors of MMPs, PTKs, or antioxidant suggesting that oxidative stress caused BBB injury via degrdn. of BM protein by activated MMPs and by PTK-mediated TJ protein phosphorylation.  These findings point to new therapeutic interventions ameliorating BBB dysfunction in neurol. disorders such as stroke or neuroinflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoptQU8PhSIn7Vg90H21EOLACvtfcHk0lhUhZ0EsHfc5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltVKitLY%253D&md5=86600b946b8670c5df874e8abedcb751</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04393.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04393.x%26sid%3Dliteratum%253Aachs%26aulast%3DHaorah%26aufirst%3DJ.%26aulast%3DRamirez%26aufirst%3DS.%26aulast%3DSchall%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DPandya%26aufirst%3DR.%26aulast%3DPersidsky%26aufirst%3DY.%26atitle%3DOxidative%2520stress%2520activates%2520protein%2520tyrosine%2520kinase%2520and%2520matrix%2520metalloproteinases%2520leading%2520to%2520blood-brain%2520barrier%2520dysfunction%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D101%26spage%3D566%26epage%3D576%26doi%3D10.1111%2Fj.1471-4159.2006.04393.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaczmarek, L.</span></span> <span> </span><span class="NLM_article-title">Mmp-9 inhibition: a therapeutic strategy in ischemic stroke</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">563</span>– <span class="NLM_lpage">573</span>, <span class="refDoi"> DOI: 10.1007/s12035-013-8538-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1007%2Fs12035-013-8538-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=24026771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVCitrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2014&pages=563-573&author=M.+Chaturvediauthor=L.+Kaczmarek&title=Mmp-9+inhibition%3A+a+therapeutic+strategy+in+ischemic+stroke&doi=10.1007%2Fs12035-013-8538-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">MMP-9 Inhibition: a Therapeutic Strategy in Ischemic Stroke</span></div><div class="casAuthors">Chaturvedi, Mayank; Kaczmarek, Leszek</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">563-573</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Ischemic stroke is a leading cause of disability worldwide.  In cerebral ischemia there is an enhanced expression of matrix metallo-proteinase-9 (MMP-9), which has been assocd. with various complications including excitotoxicity, neuronal damage, apoptosis, blood-brain barrier (BBB) opening leading to cerebral edema, and hemorrhagic transformation.  Moreover, the tissue plasminogen activator (tPA), which is the only US-FDA approved treatment of ischemic stroke, has a brief 3 to 4 h time window and it has been proposed that detrimental effects of tPA beyond the 3 h since the onset of stroke are derived from its ability to activate MMP-9 that in turn contributes to the breakdown of BBB.  Therefore, the available literature suggests that MMP-9 inhibition can be of therapeutic importance in ischemic stroke.  Hence, combination therapies of MMP-9 inhibitor along with tPA can be beneficial in ischemic stroke.  In this review we will discuss the current status of various strategies which have shown neuroprotection and extension of thrombolytic window by directly or indirectly inhibiting MMP-9 activity.  In the introductory part of the review, we briefly provide an overview on ischemic stroke, commonly used models of ischemic stroke and a role of MMP-9 in ischemia.  In next part, the literature is organized as various approaches which have proven neuroprotective effects through direct or indirect decrease in MMP-9 activity, namely, using biotherapeutics, involving MMP-9 gene inhibition using viral vectors; using endogenous inhibitor of MMP-9, repurposing of old drugs such as minocycline, new chem. entities like DP-b99, and finally other approaches like therapeutic hypothermia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2kGS9IvaXvrVg90H21EOLACvtfcHk0lhUhZ0EsHfc5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVCitrvP&md5=21828bf3861b708e60c7d90e367aff33</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1007%2Fs12035-013-8538-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-013-8538-z%26sid%3Dliteratum%253Aachs%26aulast%3DChaturvedi%26aufirst%3DM.%26aulast%3DKaczmarek%26aufirst%3DL.%26atitle%3DMmp-9%2520inhibition%253A%2520a%2520therapeutic%2520strategy%2520in%2520ischemic%2520stroke%26jtitle%3DMol.%2520Neurobiol.%26date%3D2014%26volume%3D49%26spage%3D563%26epage%3D573%26doi%3D10.1007%2Fs12035-013-8538-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fields, G. B.</span></span> <span> </span><span class="NLM_article-title">The rebirth of matrix metalloproteinase inhibitors: moving beyond the dogma</span>. <i>Cells</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">984</span>, <span class="refDoi"> DOI: 10.3390/cells8090984</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.3390%2Fcells8090984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmtVSltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=984&author=G.+B.+Fields&title=The+rebirth+of+matrix+metalloproteinase+inhibitors%3A+moving+beyond+the+dogma&doi=10.3390%2Fcells8090984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">The rebirth of matrix metalloproteinase inhibitors: moving beyond the dogma</span></div><div class="casAuthors">Fields, Gregg B.</div><div class="citationInfo"><span class="NLM_cas:title">Cells</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">984</span>CODEN:
                <span class="NLM_cas:coden">CELLC6</span>;
        ISSN:<span class="NLM_cas:issn">2073-4409</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The pursuit of matrix metalloproteinase (MMP) inhibitors began in earnest over three decades ago.  Initial clin. trials were disappointing, resulting in a neg. view of MMPs as therapeutic targets.  As a better understanding of MMP biol. and inhibitor pharmacokinetic properties emerged, it became clear that initial MMP inhibitor clin. trials were held prematurely.  Further complicating matters were problematic conclusions drawn from animal model studies.  The most recent generation of MMP inhibitors have desirable selectivities and improved pharmacokinetics, resulting in improved toxicity profiles.  Application of selective MMP inhibitors led to the conclusion that MMP-2, MMP-9, MMP-13, and MT1-MMP are not involved in musculoskeletal syndrome, a common side effect obsd. with broad spectrum MMP inhibitors.  Specific activities within a single MMP can now be inhibited.  Better definition of the roles of MMPs in immunol. responses and inflammation will help inform clinic trials, and multiple studies indicate that modulating MMP activity can improve immunotherapy.  There is a U.S.  Food and Drug Administration (FDA)-approved MMP inhibitor for periodontal disease, and several MMP inhibitors are in clinic trials, targeting a variety of maladies including gastric cancer, diabetic foot ulcers, and multiple sclerosis.  It is clearly time to move on from the dogma of viewing MMP inhibition as intractable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY8YcT4Rj5RLVg90H21EOLACvtfcHk0ljAdSxMjYvKBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmtVSltrY%253D&md5=4ff4b435717c123cd5043df32587c853</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.3390%2Fcells8090984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcells8090984%26sid%3Dliteratum%253Aachs%26aulast%3DFields%26aufirst%3DG.%2BB.%26atitle%3DThe%2520rebirth%2520of%2520matrix%2520metalloproteinase%2520inhibitors%253A%2520moving%2520beyond%2520the%2520dogma%26jtitle%3DCells%26date%3D2019%26volume%3D8%26spage%3D984%26doi%3D10.3390%2Fcells8090984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Major Jourden, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S. M.</span></span> <span> </span><span class="NLM_article-title">Hydrogen peroxide activated matrix metalloproteinase inhibitors: a prodrug approach</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6795</span>– <span class="NLM_lpage">6797</span>, <span class="refDoi"> DOI: 10.1002/anie.201003819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2Fanie.201003819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFGnsbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=6795-6797&author=J.+L.+Major+Jourdenauthor=S.+M.+Cohen&title=Hydrogen+peroxide+activated+matrix+metalloproteinase+inhibitors%3A+a+prodrug+approach&doi=10.1002%2Fanie.201003819"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrogen Peroxide Activated Matrix Metalloproteinase Inhibitors: a Prodrug Approach</span></div><div class="casAuthors">Major Jourden, Jody L.; Cohen, Seth M.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">6795-6797, S6795/1-S6795/12</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The proinhibitors e.g. I, introduced in this work demonstrate an effective means to passivate matrix metalloproteinases inhibitors (MMPi) and activate them in the presence of H2O2.  Through addn. of a boronic ester protecting group to the metal-binding moiety of MMPi via a self-immolative linker, proinhibitors based on two different zinc-binding groups (ZBGs) were developed.  These compds. were found to be sufficiently stable in buffer and were found to have high rates of cleavage allowing for efficient activation with H2O2.  These compds. should display a dual mode of action in the prevention of reperfusion injury, by neutralizing reactive oxygen species and generating an active MMPi.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi0oYNvHaGTbVg90H21EOLACvtfcHk0ljAdSxMjYvKBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFGnsbfN&md5=190822c841539f2cb7b6514e61cac13f</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1002%2Fanie.201003819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201003819%26sid%3Dliteratum%253Aachs%26aulast%3DMajor%2BJourden%26aufirst%3DJ.%2BL.%26aulast%3DCohen%26aufirst%3DS.%2BM.%26atitle%3DHydrogen%2520peroxide%2520activated%2520matrix%2520metalloproteinase%2520inhibitors%253A%2520a%2520prodrug%2520approach%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2010%26volume%3D49%26spage%3D6795%26epage%3D6797%26doi%3D10.1002%2Fanie.201003819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Staurengo-Ferrari, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badaro-Garcia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hohmann, M. S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manchope, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaninelli, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casagrande, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verri, W. A.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Contribution of Nrf2 modulation to the mechanism of action of analgesic and anti-inflammatory drugs in pre-clinical and clinical stages</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1536</span>, <span class="refDoi"> DOI: 10.3389/fphar.2018.01536</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.3389%2Ffphar.2018.01536" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=30687097" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=1536&author=L.+Staurengo-Ferrariauthor=S.+Badaro-Garciaauthor=M.+S.+N.+Hohmannauthor=M.+F.+Manchopeauthor=T.+H.+Zaninelliauthor=R.+Casagrandeauthor=W.+A.+Verri&title=Contribution+of+Nrf2+modulation+to+the+mechanism+of+action+of+analgesic+and+anti-inflammatory+drugs+in+pre-clinical+and+clinical+stages&doi=10.3389%2Ffphar.2018.01536"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2018.01536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2018.01536%26sid%3Dliteratum%253Aachs%26aulast%3DStaurengo-Ferrari%26aufirst%3DL.%26aulast%3DBadaro-Garcia%26aufirst%3DS.%26aulast%3DHohmann%26aufirst%3DM.%2BS.%2BN.%26aulast%3DManchope%26aufirst%3DM.%2BF.%26aulast%3DZaninelli%26aufirst%3DT.%2BH.%26aulast%3DCasagrande%26aufirst%3DR.%26aulast%3DVerri%26aufirst%3DW.%2BA.%26atitle%3DContribution%2520of%2520Nrf2%2520modulation%2520to%2520the%2520mechanism%2520of%2520action%2520of%2520analgesic%2520and%2520anti-inflammatory%2520drugs%2520in%2520pre-clinical%2520and%2520clinical%2520stages%26jtitle%3DFront.%2520Pharmacol.%26date%3D2019%26volume%3D9%26spage%3D1536%26doi%3D10.3389%2Ffphar.2018.01536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span> <span> </span><span class="NLM_article-title">A hydrogen peroxide responsive prodrug of keap1-Nrf2 inhibitor for improving oral absorption and selective activation in inflammatory conditions</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">101565</span>, <span class="refDoi"> DOI: 10.1016/j.redox.2020.101565</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.redox.2020.101565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=32422540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BB3cXpsl2ht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2020&pages=101565&author=M.+Luauthor=X.+Zhangauthor=J.+Zhaoauthor=Q.+Youauthor=Z.+Jiang&title=A+hydrogen+peroxide+responsive+prodrug+of+keap1-Nrf2+inhibitor+for+improving+oral+absorption+and+selective+activation+in+inflammatory+conditions&doi=10.1016%2Fj.redox.2020.101565"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">A hydrogen peroxide responsive prodrug of Keap1-Nrf2 inhibitor for improving oral absorption and selective activation in inflammatory conditions</span></div><div class="casAuthors">Lu, Mengchen; Zhang, Xian; Zhao, Jing; You, Qidong; Jiang, Zhengyu</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101565</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Transcription factor Nuclear factor erythroid 2-related factor 2 (Nrf2) and its neg. regulator, the E3 ligase adaptor Kelch-like ECH-assocd. protein 1 (Keap1), control the redox and metabolic homeostasis and oxidative stress.  Inhibitors of Keap1-Nrf2 interaction are promising in oxidative stress related inflammatory diseases but now hit hurdles.  By utilizing thiazolidinone moiety to shield the key carboxyl pharmacophore in Keap1-Nrf2 inhibitor, a hydrogen peroxide (H2O2)-responsive prodrug pro2 was developed.  The prodrug modification improved the physicochem. properties and cell membrane permeability of the parent drug.  Pro2 was stable and stayed inactive under various physiol. conditions, while became active by stimulation of H2O2 or inflammation derived reactive oxygen species.  Moreover, pro2 exhibited proper pharmacokinetic profile suitable for oral administration and enhanced anti-inflammatory efficiency in vivo.  Thus, this novel prodrug approach may not only provide an important advance in the therapy of chronic inflammatory diseases with high level of H2O2, but also offer a fresh soln. to improve the drug-like and selectivity issues of Keap1-Nrf2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox6NmI2hfYILVg90H21EOLACvtfcHk0ljAdSxMjYvKBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXpsl2ht7o%253D&md5=f110f0d0005af7265e0fde632eca1e88</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2020.101565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2020.101565%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DZ.%26atitle%3DA%2520hydrogen%2520peroxide%2520responsive%2520prodrug%2520of%2520keap1-Nrf2%2520inhibitor%2520for%2520improving%2520oral%2520absorption%2520and%2520selective%2520activation%2520in%2520inflammatory%2520conditions%26jtitle%3DRedox%2520Biol.%26date%3D2020%26volume%3D34%26spage%3D101565%26doi%3D10.1016%2Fj.redox.2020.101565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carden, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granger, D. N.</span></span> <span> </span><span class="NLM_article-title">Pathophysiology of ischaemia-reperfusion injury</span>. <i>J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>190</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">266</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C255%3A%3AAID-PATH526%3E3.0.CO%3B2-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10685060" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitFyiu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=2000&pages=255-266&author=D.+L.+Cardenauthor=D.+N.+Granger&title=Pathophysiology+of+ischaemia-reperfusion+injury&doi=10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C255%3A%3AAID-PATH526%3E3.0.CO%3B2-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Pathophysiology of ischemia-reperfusion injury</span></div><div class="casAuthors">Carden, Donna L.; Granger, D. Neil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pathology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">190</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">255-266</span>CODEN:
                <span class="NLM_cas:coden">JPTLAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-3417</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review with 97 refs.  Reperfusion of ischemic tissues is often assocd. with microvascular dysfunction that is manifested as impaired endothelium-dependent dilation in arterioles, enhanced fluid filtration and leukocyte plugging in capillaries, and the trafficking of leukocytes and plasma protein extravasation in postcapillary venules.  Activated endothelial cells in all segments of the microcirculation produce more oxygen radicals, but less nitric oxide, in the initial period following reperfusion.  The resulting imbalance between superoxide and nitric oxide in endothelial cells leads to the prodn. and release of inflammatory mediators (e.g. platelet-activating factor, tumor necrosis factor) and enhances the biosynthesis of adhesion mols. that mediate leukocyte-endothelial cell adhesion.  Some of the known risk factors for cardiovascular disease (hypercholesterolemia, hypertension, and diabetes) appear to exaggerate many of the microvascular alterations elicited by ischemia and reperfusion (I/R).  The inflammatory mediators released as a consequence of reperfusion also appear to activate endothelial cells in remote organs that are not exposed to the initial ischemic insult.  This distant response to I/R can result in leukocyte-dependent microvascular injury that is characteristic of the multiple organ dysfunction syndrome.  Adaptational responses to I/R injury have been demonstrated that allow for protection of briefly ischemic tissues against the harmful effects of subsequent, prolonged ischemia, a phenomenon called ischemic preconditioning.  There are two temporally and mechanistically distinct types of protection afforded by this adaptational response, i.e. acute and delayed preconditioning.  The factors (e.g. protein kinase C activation) that initiate the acute and delayed preconditioning responses appear to be similar; however the protective effects of acute preconditioning are protein synthesis-independent, while the effects of delayed preconditioning require protein synthesis.  The published literature in this field of investigation suggests that there are several potential targets for therapeutic intervention against I/R-induced microvascular injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYkKxsOvH-vrVg90H21EOLACvtfcHk0liAT48PWKlMlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitFyiu7s%253D&md5=1886c207f935ac2b011d0caea179005a</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C255%3A%3AAID-PATH526%3E3.0.CO%3B2-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-9896%2528200002%2529190%253A3%253C255%253A%253AAID-PATH526%253E3.0.CO%253B2-6%26sid%3Dliteratum%253Aachs%26aulast%3DCarden%26aufirst%3DD.%2BL.%26aulast%3DGranger%26aufirst%3DD.%2BN.%26atitle%3DPathophysiology%2520of%2520ischaemia-reperfusion%2520injury%26jtitle%3DJ.%2520Pathol.%26date%3D2000%26volume%3D190%26spage%3D255%26epage%3D266%26doi%3D10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C255%3A%3AAID-PATH526%3E3.0.CO%3B2-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brietske, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bate, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackwood, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glembotski, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooley, C. B.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species (ROS)-activatable prodrug strategy for selective activation of ATF6 following ischemia-reperfusion injury</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">292</span>– <span class="NLM_lpage">297</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.9b00299</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.9b00299" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFWgs7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=292-297&author=J.+E.+Palmerauthor=B.+M.+Brietskeauthor=T.+C.+Bateauthor=E.+A.+Blackwoodauthor=M.+Gargauthor=C.+C.+Glembotskiauthor=C.+B.+Cooley&title=Reactive+oxygen+species+%28ROS%29-activatable+prodrug+strategy+for+selective+activation+of+ATF6+following+ischemia-reperfusion+injury&doi=10.1021%2Facsmedchemlett.9b00299"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive Oxygen Species (ROS)-Activatable Prodrug for Selective Activation of ATF6 after Ischemia/Reperfusion Injury</span></div><div class="casAuthors">Palmer, Jonathan E.; Brietske, Breanna M.; Bate, Tyler C.; Blackwood, Erik A.; Garg, Manasa; Glembotski, Christopher C.; Cooley, Christina B.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">292-297</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors describe here the design, synthesis, and biol. evaluation of a reactive oxygen species (ROS)-activatable prodrug for the selective delivery of 147, a small mol. ATF6 activator, for ischemia/reperfusion injury.  ROS-activatable prodrug 1 and a neg. control unable to release free drug were synthesized and examd. for peroxide-mediated activation.  Prodrug 1 blocks activity of 147 by its inability to undergo metabolic oxidn. by ER-resident cytochrome P 450 enzymes such as Cyp1A2, probed directly here for the first time.  Biol. evaluation of ROS-activatable prodrug 1 in primary cardiomyocytes demonstrates protection against peroxide-mediated toxicity and enhances viability following simulated I/R injury.  The ability to selectively target ATF6 activation under diseased conditions establishes the potential for localized stress-responsive signaling pathway activation as a therapeutic approach for I/R injury and related protein misfolding maladies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqavcfgb7at0LVg90H21EOLACvtfcHk0liAT48PWKlMlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFWgs7fF&md5=12b806d46bc76c1f857f3c1e053c1557</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.9b00299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.9b00299%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DJ.%2BE.%26aulast%3DBrietske%26aufirst%3DB.%2BM.%26aulast%3DBate%26aufirst%3DT.%2BC.%26aulast%3DBlackwood%26aufirst%3DE.%2BA.%26aulast%3DGarg%26aufirst%3DM.%26aulast%3DGlembotski%26aufirst%3DC.%2BC.%26aulast%3DCooley%26aufirst%3DC.%2BB.%26atitle%3DReactive%2520oxygen%2520species%2520%2528ROS%2529-activatable%2520prodrug%2520strategy%2520for%2520selective%2520activation%2520of%2520ATF6%2520following%2520ischemia-reperfusion%2520injury%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26volume%3D11%26spage%3D292%26epage%3D297%26doi%3D10.1021%2Facsmedchemlett.9b00299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samad, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, P. M.</span></span> <span> </span><span class="NLM_article-title">Hydrogen peroxide-activatable antioxidant prodrug as a targeted therapeutic agent for ischemia-reperfusion injury</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">16592</span>, <span class="refDoi"> DOI: 10.1038/srep16592</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1038%2Fsrep16592" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=26563741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A280%3ADC%252BC28visVGhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=16592&author=D.+Leeauthor=S.+Parkauthor=S.+Baeauthor=D.+Jeongauthor=M.+Parkauthor=C.+Kangauthor=W.+Yooauthor=M.+A.+Samadauthor=Q.+Keauthor=G.+Khangauthor=P.+M.+Kang&title=Hydrogen+peroxide-activatable+antioxidant+prodrug+as+a+targeted+therapeutic+agent+for+ischemia-reperfusion+injury&doi=10.1038%2Fsrep16592"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrogen peroxide-activatable antioxidant prodrug as a targeted therapeutic agent for ischemia-reperfusion injury</span></div><div class="casAuthors">Lee Dongwon; Park Seunggyu; Jeong Dahee; Park Minhyung; Kang Changsun; Yoo Wooyoung; Samad Mohammed A; Khang Gilson; Lee Dongwon; Khang Gilson; Bae Soochan; Samad Mohammed A; Ke Qingen; Kang Peter M</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16592</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Overproduction of hydrogen peroxide (H2O2) causes oxidative stress and is the main culprit in the pathogenesis of ischemia/reperfusion (I/R) injury.  Suppression of oxidative stress is therefore critical in the treatment of I/R injury.  Here, we report H2O2-activatable antioxidant prodrug (BRAP) that is capable of specifically targeting the site of oxidative stress and exerting anti-inflammatory and anti-apoptotic activities.  BRAP with a self-immolative boronic ester protecting group was designed to scavenge H2O2 and release HBA (p-hydroxybenzyl alcohol) with antioxidant and anti-inflammatory activities.  BRAP exerted potent antioxidant and anti-inflammatory activity in lipopolysaccharide (LPS)- and H2O2-stimulated cells by suppressing the generation of ROS and pro-inflammatory cytokines.  In mouse models of hepatic I/R and cardiac I/R, BRAP exerted potent antioxidant, anti-inflammatory and anti-apoptotic activities due to the synergistic effects of H2O2-scavenging boronic esters and therapeutic HBA.  In addition, administration of high doses of BRAP daily for 7 days showed no renal or hepatic function abnormalities.  Therefore BRAP has tremendous therapeutic potential as H2O2-activatable antioxidant prodrug for the treatment of I/R injuries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQX6Ce5-kyI5XwOGIfWJ7-GfW6udTcc2eaMXTvvg2xWQrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28visVGhsQ%253D%253D&md5=cdc73f3cd6fb3b1513b402932a410054</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1038%2Fsrep16592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep16592%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DD.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DBae%26aufirst%3DS.%26aulast%3DJeong%26aufirst%3DD.%26aulast%3DPark%26aufirst%3DM.%26aulast%3DKang%26aufirst%3DC.%26aulast%3DYoo%26aufirst%3DW.%26aulast%3DSamad%26aufirst%3DM.%2BA.%26aulast%3DKe%26aufirst%3DQ.%26aulast%3DKhang%26aufirst%3DG.%26aulast%3DKang%26aufirst%3DP.%2BM.%26atitle%3DHydrogen%2520peroxide-activatable%2520antioxidant%2520prodrug%2520as%2520a%2520targeted%2520therapeutic%2520agent%2520for%2520ischemia-reperfusion%2520injury%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D16592%26doi%3D10.1038%2Fsrep16592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M. C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pralle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isacoff, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. J.</span></span> <span> </span><span class="NLM_article-title">A selective, cell-permeable optical probe for hydrogen peroxide in living cells</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">15392</span>– <span class="NLM_lpage">15393</span>, <span class="refDoi"> DOI: 10.1021/ja0441716</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0441716" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptlSju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=15392-15393&author=M.+C.+Y.+Changauthor=A.+Pralleauthor=E.+Y.+Isacoffauthor=C.+J.+Chang&title=A+selective%2C+cell-permeable+optical+probe+for+hydrogen+peroxide+in+living+cells&doi=10.1021%2Fja0441716"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">A selective, cell-permeable optical probe for hydrogen peroxide in living cells</span></div><div class="casAuthors">Chang, Michelle C. Y.; Pralle, Arnd; Isacoff, Ehud Y.; Chang, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">15392-15393</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present the synthesis, properties, and biol. applications of Peroxyfluor-1 (PF1), a new type of optical probe for intracellular imaging of hydrogen peroxide in living biol. samples.  PF1 utilizes a boronate deprotection mechanism to provide unprecedented selectivity and optical dynamic range for detecting H2O2 in aq. soln. over similar reactive oxygen species including superoxide, nitric oxide, tert-Bu hydroperoxide, and hydroxyl radical.  We further demonstrate the value of this reagent for biol. applications by imaging changes in [H2O2] in living mammalian cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZF0Gn9N0dPLVg90H21EOLACvtfcHk0lg69vMvgvfQAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptlSju7g%253D&md5=34e25dc64f085d0c3ee8006f15acaa53</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1021%2Fja0441716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0441716%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DM.%2BC.%2BY.%26aulast%3DPralle%26aufirst%3DA.%26aulast%3DIsacoff%26aufirst%3DE.%2BY.%26aulast%3DChang%26aufirst%3DC.%2BJ.%26atitle%3DA%2520selective%252C%2520cell-permeable%2520optical%2520probe%2520for%2520hydrogen%2520peroxide%2520in%2520living%2520cells%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26spage%3D15392%26epage%3D15393%26doi%3D10.1021%2Fja0441716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albers, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pralle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isacoff, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. J.</span></span> <span> </span><span class="NLM_article-title">Boronate-based fluorescent probes for imaging cellular hydrogenperoxide</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">16652</span>– <span class="NLM_lpage">16659</span>, <span class="refDoi"> DOI: 10.1021/ja054474f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja054474f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFynurjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=16652-16659&author=E.+W.+Millerauthor=A.+E.+Albersauthor=A.+Pralleauthor=E.+Y.+Isacoffauthor=C.+J.+Chang&title=Boronate-based+fluorescent+probes+for+imaging+cellular+hydrogenperoxide&doi=10.1021%2Fja054474f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Boronate-Based Fluorescent Probes for Imaging Cellular Hydrogen Peroxide</span></div><div class="casAuthors">Miller, Evan W.; Albers, Aaron E.; Pralle, Arnd; Isacoff, Ehud Y.; Chang, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">16652-16659</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The syntheses, properties, and biol. applications of the Peroxysensor family, a new class of fluorescent probes for hydrogen peroxide, are presented.  These reagents utilize a boronate deprotection mechanism to provide high selectivity and optical dynamic range for detecting H2O2 in aq. soln. over similar reactive oxygen species (ROS) including superoxide, nitric oxide, tert-Bu hydroperoxide, hypochlorite, singlet oxygen, ozone, and hydroxyl radical.  Peroxyresorufin-1 (PR1), Peroxyfluor-1 (PF1), and Peroxyxanthone-1 (PX1) are first-generation probes that respond to H2O2 by an increase in red, green, and blue fluorescence, resp.  The boronate dyes are cell-permeable and can detect micromolar changes in H2O2 concns. in living cells, including hippocampal neurons, using confocal microscopy and two-photon microscopy.  The unique combination of ROS selectivity, membrane permeability, and a range of available excitation/emission colors establishes the potential value of PR1, PF1, PX1, and related probes for interrogating the physiol. and pathol. of cellular H2O2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9KOzj_MCKJrVg90H21EOLACvtfcHk0lgRf059oLhsvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFynurjL&md5=14aed1a610be89ae600a6daa27931cc5</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1021%2Fja054474f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja054474f%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DE.%2BW.%26aulast%3DAlbers%26aufirst%3DA.%2BE.%26aulast%3DPralle%26aufirst%3DA.%26aulast%3DIsacoff%26aufirst%3DE.%2BY.%26aulast%3DChang%26aufirst%3DC.%2BJ.%26atitle%3DBoronate-based%2520fluorescent%2520probes%2520for%2520imaging%2520cellular%2520hydrogenperoxide%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D16652%26epage%3D16659%26doi%3D10.1021%2Fja054474f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tulyathan, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isacoff, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. J.</span></span> <span> </span><span class="NLM_article-title">Molecular imaging of hydrogen peroxide produced for cell signaling</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">267</span>, <span class="refDoi"> DOI: 10.1038/nchembio871</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1038%2Fnchembio871" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=17401379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkt1Gqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=263-267&author=E.+W.+Millerauthor=O.+Tulyathanauthor=E.+Y.+Isacoffauthor=C.+J.+Chang&title=Molecular+imaging+of+hydrogen+peroxide+produced+for+cell+signaling&doi=10.1038%2Fnchembio871"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular imaging of hydrogen peroxide produced for cell signaling</span></div><div class="casAuthors">Miller, Evan W.; Tulyanthan, Orapim; Isacoff, Ehud Y.; Chang, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">263-267</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hydrogen peroxide (H2O2) is emerging as a newly recognized messenger in cellular signal transduction.  However, a substantial challenge in elucidating its diverse roles in complex biol. environments is the lack of methods for probing this reactive oxygen metabolite in living systems with mol. specificity.  Here the authors report the synthesis and application of Peroxy Green 1 (PG1) and Peroxy Crimson 1 (PC1), two new fluorescent probes that show high selectivity for H2O2 and are capable of visualizing endogenous H2O2 produced in living cells by growth factor stimulation, including the first direct imaging of peroxide produced for brain cell signaling.  The combined features of reactive oxygen species selectivity, sensitivity to signaling levels of H2O2, and live-cell compatibility presage many new opportunities for PG1, PC1 and related synthetic reagents for exploring the physiol. roles of H2O2 in living systems with mol. imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxJrTop8-yYLVg90H21EOLACvtfcHk0lgRf059oLhsvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkt1Gqu7c%253D&md5=ae003fc21a8a456bebc9c4337ab057c5</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1038%2Fnchembio871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio871%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DE.%2BW.%26aulast%3DTulyathan%26aufirst%3DO.%26aulast%3DIsacoff%26aufirst%3DE.%2BY.%26aulast%3DChang%26aufirst%3DC.%2BJ.%26atitle%3DMolecular%2520imaging%2520of%2520hydrogen%2520peroxide%2520produced%2520for%2520cell%2520signaling%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2007%26volume%3D3%26spage%3D263%26epage%3D267%26doi%3D10.1038%2Fnchembio871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avshalumov, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, M. E.</span></span> <span> </span><span class="NLM_article-title">Mitochondria are the source of hydrogen peroxide for dynamic brain-cell signaling</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">9002</span>– <span class="NLM_lpage">9010</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.1706-09.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1523%2FJNEUROSCI.1706-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=19605638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovFegur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=9002-9010&author=L.+Baoauthor=M.+V.+Avshalumovauthor=J.+C.+Patelauthor=C.+R.+Leeauthor=E.+W.+Millerauthor=C.+J.+Changauthor=M.+E.+Rice&title=Mitochondria+are+the+source+of+hydrogen+peroxide+for+dynamic+brain-cell+signaling&doi=10.1523%2FJNEUROSCI.1706-09.2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria are the source of hydrogen peroxide for dynamic brain-cell signaling</span></div><div class="casAuthors">Bao, Li; Avshalumov, Marat V.; Patel, Jyoti C.; Lee, Christian R.; Miller, Evan W.; Chang, Christopher J.; Rice, Margaret E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">9002-9010</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Hydrogen peroxide (H2O2) is emerging as a ubiquitous small-mol. messenger in biol., particularly in the brain, but underlying mechanisms of peroxide signaling remain an open frontier for study.  For example, dynamic dopamine transmission in dorsolateral striatum is regulated on a subsecond timescale by glutamate via H2O2 signaling, which activates ATP-sensitive potassium (KATP) channels to inhibit dopamine release.  However, the origin of this modulatory H2O2 has been elusive.  Here we addressed three possible sources of H2O2 produced for rapid neuronal signaling in striatum: mitochondrial respiration, monoamine oxidase (MAO), and NADPH oxidase (Nox).  Evoked dopamine release in guinea-pig striatal slices was monitored with carbon-fiber microelectrodes and fast-scan cyclic voltammetry.  Using direct fluorescence imaging of H2O2 and tissue anal. of ATP, we found that coapplication of rotenone (50 nM), a mitochondrial complex I inhibitor, and succinate (5 mM), a complex II substrate, limited H2O2 prodn., but maintained tissue ATP content.  Strikingly, coapplication of rotenone and succinate also prevented glutamate-dependent regulation of dopamine release, implicating mitochondrial H2O2 in release modulation.  In contrast, inhibitors of MAO or Nox had no effect on dopamine release, suggesting a limited role for these metabolic enzymes in rapid H2O2 prodn. in the striatum.  These data provide the first demonstration that respiring mitochondria are the primary source of H2O2 generation for dynamic neuronal signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraJ4IEc8DCy7Vg90H21EOLACvtfcHk0lgRf059oLhsvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovFegur0%253D&md5=c31380b2054d2a848b7f3543ee563310</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1706-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1706-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DBao%26aufirst%3DL.%26aulast%3DAvshalumov%26aufirst%3DM.%2BV.%26aulast%3DPatel%26aufirst%3DJ.%2BC.%26aulast%3DLee%26aufirst%3DC.%2BR.%26aulast%3DMiller%26aufirst%3DE.%2BW.%26aulast%3DChang%26aufirst%3DC.%2BJ.%26aulast%3DRice%26aufirst%3DM.%2BE.%26atitle%3DMitochondria%2520are%2520the%2520source%2520of%2520hydrogen%2520peroxide%2520for%2520dynamic%2520brain-cell%2520signaling%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D9002%26epage%3D9010%26doi%3D10.1523%2FJNEUROSCI.1706-09.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dickinson, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srikun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. J.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial-targeted fluorescent probes for reactive oxygen species</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2009.10.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.cbpa.2009.10.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=19910238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht12qt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2010&pages=50-56&author=B.+C.+Dickinsonauthor=D.+Srikunauthor=C.+J.+Chang&title=Mitochondrial-targeted+fluorescent+probes+for+reactive+oxygen+species&doi=10.1016%2Fj.cbpa.2009.10.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial-targeted fluorescent probes for reactive oxygen species</span></div><div class="casAuthors">Dickinson, Bryan C.; Srikun, Duangkhae; Chang, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-56</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  As the primary consumers of oxygen within all aerobic organisms, mitochondria are a major source of cellular reactive oxygen species (ROS) derived from the in vivo chem. of oxygen metab.  Mitochondrial ROS were traditionally implicated in aging and in a variety of pathologies, including cancer, neurodegeneration, and diabetes, but recent studies also link controlled mitochondrial ROS fluxes to cell regulation and signaling events.  Progress in the development of mitochondrial-targeted fluorescent small-mol. indicators that detect specific ROS with high selectivity offers a promising approach for interrogating mitochondrial ROS prodn., trafficking, and downstream biol. effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD9WekX1XZ1rVg90H21EOLACvtfcHk0ljIpBqxTjVU7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht12qt7c%253D&md5=940b9fc2993ab0fcf1d7070c65ca73dd</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2009.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2009.10.014%26sid%3Dliteratum%253Aachs%26aulast%3DDickinson%26aufirst%3DB.%2BC.%26aulast%3DSrikun%26aufirst%3DD.%26aulast%3DChang%26aufirst%3DC.%2BJ.%26atitle%3DMitochondrial-targeted%2520fluorescent%2520probes%2520for%2520reactive%2520oxygen%2520species%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D14%26spage%3D50%26epage%3D56%26doi%3D10.1016%2Fj.cbpa.2009.10.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Modica-Napolitano, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aprille, J. R.</span></span> <span> </span><span class="NLM_article-title">Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1016/S0169-409X(01)00125-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2FS0169-409X%2801%2900125-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=11377803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjslSmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2001&pages=63-70&author=J.+S.+Modica-Napolitanoauthor=J.+R.+Aprille&title=Delocalized+lipophilic+cations+selectively+target+the+mitochondria+of+carcinoma+cells&doi=10.1016%2FS0169-409X%2801%2900125-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells</span></div><div class="casAuthors">Modica-Napolitano, J. S.; Aprille, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">63-70</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 65 refs.  Traditional chemotherapies, aimed at DNA replication in rapidly dividing cells, have achieved only limited success in the treatment of carcinomas due largely to their lack of specificity for cells of tumorigenic origin.  It is important, therefore, to investigate treatment strategies aimed at novel cellular targets that are sufficiently different between normal cells and cancer cells so as to provide a basis for selective tumor cell killing.  Delocalized lipophilic cations (DLCs) are concd. by cells and into mitochondria in response to neg. inside transmembrane potentials.  The higher plasma and/or mitochondrial membrane potentials of carcinoma cells compared to normal epithelial cells account for the selective accumulation of DLCs in carcinoma mitochondria.  Since most DLCs are toxic to mitochondria at high concns., their selective accumulation in carcinoma mitochondria and consequent mitochondrial toxicity provide a basis for selective carcinoma cell killing.  Several of these compds. have already displayed some degree of efficacy as chemotherapeutic agents in vitro and in vivo.  The effectiveness of DLCs can also be enhanced by their use in photochemotherapy or combination drug therapy.  Discovery of the biochem. differences that account for the higher membrane potentials in carcinoma cells is expected to lead to the design of new DLCs targeted specifically to those differences, resulting in even greater selectivity and efficacy for tumor cell killing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGsWwMDH5OBLVg90H21EOLACvtfcHk0ljIpBqxTjVU7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjslSmtLk%253D&md5=47f1fea1d9ede2b916903e36e9bbff66</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2801%2900125-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252801%252900125-9%26sid%3Dliteratum%253Aachs%26aulast%3DModica-Napolitano%26aufirst%3DJ.%2BS.%26aulast%3DAprille%26aufirst%3DJ.%2BR.%26atitle%3DDelocalized%2520lipophilic%2520cations%2520selectively%2520target%2520the%2520mitochondria%2520of%2520carcinoma%2520cells%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2001%26volume%3D49%26spage%3D63%26epage%3D70%26doi%3D10.1016%2FS0169-409X%2801%2900125-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dickinson, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. J.</span></span> <span> </span><span class="NLM_article-title">A targetable fluorescent probe for imaging hydrogen peroxide in the mitochondria of living cells</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">9638</span>– <span class="NLM_lpage">9639</span>, <span class="refDoi"> DOI: 10.1021/ja802355u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja802355u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BD1cXot1ahs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=9638-9639&author=B.+C.+Dickinsonauthor=C.+J.+Chang&title=A+targetable+fluorescent+probe+for+imaging+hydrogen+peroxide+in+the+mitochondria+of+living+cells&doi=10.1021%2Fja802355u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">A Targetable Fluorescent Probe for Imaging Hydrogen Peroxide in the Mitochondria of Living Cells</span></div><div class="casAuthors">Dickinson, Bryan C.; Chang, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">9638-9639</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors present the design, synthesis, and biol. applications of mitochondria peroxy yellow 1 (MitoPY1), a new type of bifunctional fluorescent probe for imaging hydrogen peroxide levels within the mitochondria of living cells.  MitoPY1 combines a chemoselective boronate-based switch and a mitochondrial-targeting phosphonium moiety for detection of hydrogen peroxide localized to cellular mitochondria.  Confocal microscopy and flow cytometry expts. in a variety of mammalian cell types show that MitoPY1 can visualize localized changes in mitochondrial hydrogen peroxide concns. generated by situations of oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou7Tz0cd9NKbVg90H21EOLACvtfcHk0ljIpBqxTjVU7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXot1ahs74%253D&md5=3f5c82fa985bb525238691160b6c8ecc</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1021%2Fja802355u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja802355u%26sid%3Dliteratum%253Aachs%26aulast%3DDickinson%26aufirst%3DB.%2BC.%26aulast%3DChang%26aufirst%3DC.%2BJ.%26atitle%3DA%2520targetable%2520fluorescent%2520probe%2520for%2520imaging%2520hydrogen%2520peroxide%2520in%2520the%2520mitochondria%2520of%2520living%2520cells%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D9638%26epage%3D9639%26doi%3D10.1021%2Fja802355u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masanta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heo, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. M.</span></span> <span> </span><span class="NLM_article-title">A mitochondria-localized two-photon fluorescent probe for ratiometric imaging of hydrogen peroxide in live tissue</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">3518</span>– <span class="NLM_lpage">3520</span>, <span class="refDoi"> DOI: 10.1039/c2cc00034b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1039%2Fc2cc00034b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=22382302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Wkt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2012&pages=3518-3520&author=G.+Masantaauthor=C.+H.+Heoauthor=C.+S.+Limauthor=S.+K.+Baeauthor=B.+R.+Choauthor=H.+M.+Kim&title=A+mitochondria-localized+two-photon+fluorescent+probe+for+ratiometric+imaging+of+hydrogen+peroxide+in+live+tissue&doi=10.1039%2Fc2cc00034b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">A mitochondria-localized two-photon fluorescent probe for ratiometric imaging of hydrogen peroxide in live tissue</span></div><div class="casAuthors">Masanta, Goutam; Heo, Cheol Ho; Lim, Chang Su; Bae, Sung Keun; Cho, Bong Rae; Kim, Hwan Myung</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">3518-3520</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The authors report a two-photon fluorescent probe (SHP-Mito) which can ratiometrically detect mitochondrial H2O2 in live cells and intact tissues at >100 μm depth through the use of two-photon microscopy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6yA-LCzPEBrVg90H21EOLACvtfcHk0ljIpBqxTjVU7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Wkt7s%253D&md5=ffbcf82155f83ebf45e773bb494f2510</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1039%2Fc2cc00034b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2cc00034b%26sid%3Dliteratum%253Aachs%26aulast%3DMasanta%26aufirst%3DG.%26aulast%3DHeo%26aufirst%3DC.%2BH.%26aulast%3DLim%26aufirst%3DC.%2BS.%26aulast%3DBae%26aufirst%3DS.%2BK.%26aulast%3DCho%26aufirst%3DB.%2BR.%26aulast%3DKim%26aufirst%3DH.%2BM.%26atitle%3DA%2520mitochondria-localized%2520two-photon%2520fluorescent%2520probe%2520for%2520ratiometric%2520imaging%2520of%2520hydrogen%2520peroxide%2520in%2520live%2520tissue%26jtitle%3DChem.%2520Commun.%26date%3D2012%26volume%3D48%26spage%3D3518%26epage%3D3520%26doi%3D10.1039%2Fc2cc00034b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span> <span> </span><span class="NLM_article-title">A NIR fluorescent probe: imaging endogenous hydrogen peroxide during an autophagy process induced by rapamycin</span>. <i>J. Mater. Chem. B</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">7363</span>– <span class="NLM_lpage">7367</span>, <span class="refDoi"> DOI: 10.1039/C6TB02463G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1039%2FC6TB02463G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=32263736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslaltLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2016&pages=7363-7367&author=F.+Xuauthor=H.+Liauthor=Q.+Yaoauthor=J.+Fanauthor=J.+Wangauthor=X.+Peng&title=A+NIR+fluorescent+probe%3A+imaging+endogenous+hydrogen+peroxide+during+an+autophagy+process+induced+by+rapamycin&doi=10.1039%2FC6TB02463G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">A NIR fluorescent probe: imaging endogenous hydrogen peroxide during an autophagy process induced by rapamycin</span></div><div class="casAuthors">Xu, Feng; Li, Haidong; Yao, Qichao; Fan, Jiangli; Wang, Jingyun; Peng, Xiaojun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Materials Chemistry B: Materials for Biology and Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">7363-7367</span>CODEN:
                <span class="NLM_cas:coden">JMCBDV</span>;
        ISSN:<span class="NLM_cas:issn">2050-7518</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A near-IR probe (Cy-B) with high sensitivity, and good specificity as well as photo-stability has been developed for monitoring both exogenous and endogenous H2O2 in living cells.  To the best of the authors' knowledge, it was applied successfully for the first time to monitor spontaneous hydrogen peroxide in an autophagy process induced by the stimulation of rapamycin.  The mice imaging expts. indicate that the probe has a good potential to be employed in the imaging of living biol. systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQOUHBMGVkLrVg90H21EOLACvtfcHk0lj8T61gAxXOmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslaltLvL&md5=0c8f9f964a286b66d6fd52526c2a44e9</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1039%2FC6TB02463G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6TB02463G%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DYao%26aufirst%3DQ.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPeng%26aufirst%3DX.%26atitle%3DA%2520NIR%2520fluorescent%2520probe%253A%2520imaging%2520endogenous%2520hydrogen%2520peroxide%2520during%2520an%2520autophagy%2520process%2520induced%2520by%2520rapamycin%26jtitle%3DJ.%2520Mater.%2520Chem.%2520B%26date%3D2016%26volume%3D4%26spage%3D7363%26epage%3D7367%26doi%3D10.1039%2FC6TB02463G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, Y.</span></span> <span> </span><span class="NLM_article-title">An ESIPT-based mitochondria-targeted ratiometric and NIR-emitting fluorescent probe for hydrogen peroxide and its bioimaging in living cells</span>. <i>Dyes Pigm.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>158</i></span>,  <span class="NLM_fpage">482</span>– <span class="NLM_lpage">489</span>, <span class="refDoi"> DOI: 10.1016/j.dyepig.2017.12.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.dyepig.2017.12.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVaqu77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2018&pages=482-489&author=L.+Tangauthor=M.+Tianauthor=H.+Chenauthor=X.+Yanauthor=K.+Zhongauthor=Y.+Bian&title=An+ESIPT-based+mitochondria-targeted+ratiometric+and+NIR-emitting+fluorescent+probe+for+hydrogen+peroxide+and+its+bioimaging+in+living+cells&doi=10.1016%2Fj.dyepig.2017.12.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">An ESIPT-based mitochondria-targeted ratiometric and NIR-emitting fluorescent probe for hydrogen peroxide and its bioimaging in living cells</span></div><div class="casAuthors">Tang, Lijun; Tian, Mingyu; Chen, Haibo; Yan, Xiaomei; Zhong, Keli; Bian, Yanjiang</div><div class="citationInfo"><span class="NLM_cas:title">Dyes and Pigments</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">482-489</span>CODEN:
                <span class="NLM_cas:coden">DYPIDX</span>;
        ISSN:<span class="NLM_cas:issn">0143-7208</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A mitochondria-targetable ratiometric fluorescent probe, HBTPB, has been developed for the detection of H2O2 with a near IR (NIR) emission and a large Stokes shift (357 nm).  Probe HBTPB displays high selectivity toward H2O2 over other reactive oxygen/nitrogen species (ROS/RNS), biol. thiols and anions.  The detection limit of this probe is as low as 5.9 × 10-7 M.  The sensing process confirmed by NMR and mass spectral anal. shows that the addn. of H2O2 to the soln. of HBTPB triggers an oxidative hydrolysis and a subsequent elimination reaction undergoes to release an ESIPT (excited-state intramol. proton transfer) featured fluorescent dye.  Probe HBTPB is cell permeable and has been applied to sense exogenous and endogenous H2O2 in living A549 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUraQUkUQb67Vg90H21EOLACvtfcHk0lj8T61gAxXOmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVaqu77N&md5=5551b71907554fd52418e6dbd7124a1d</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1016%2Fj.dyepig.2017.12.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dyepig.2017.12.028%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DL.%26aulast%3DTian%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DZhong%26aufirst%3DK.%26aulast%3DBian%26aufirst%3DY.%26atitle%3DAn%2520ESIPT-based%2520mitochondria-targeted%2520ratiometric%2520and%2520NIR-emitting%2520fluorescent%2520probe%2520for%2520hydrogen%2520peroxide%2520and%2520its%2520bioimaging%2520in%2520living%2520cells%26jtitle%3DDyes%2520Pigm.%26date%3D2018%26volume%3D158%26spage%3D482%26epage%3D489%26doi%3D10.1016%2Fj.dyepig.2017.12.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span> <span> </span><span class="NLM_article-title">A mitochondria-targeted colorimetric and ratiometric fluorescent probe for hydrogen peroxide with a large emission shift and bio-imaging in living cells</span>. <i>Sens. Actuators, B</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>255</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1016/j.snb.2017.08.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.snb.2017.08.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlartbfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=255&publication_year=2018&pages=42-48&author=Y.+Shenauthor=X.+Zhangauthor=Y.+Zhangauthor=Y.+Wuauthor=C.+Zhangauthor=Y.+Chenauthor=J.+Jinauthor=H.+Li&title=A+mitochondria-targeted+colorimetric+and+ratiometric+fluorescent+probe+for+hydrogen+peroxide+with+a+large+emission+shift+and+bio-imaging+in+living+cells&doi=10.1016%2Fj.snb.2017.08.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">A mitochondria-targeted colorimetric and ratiometric fluorescent probe for hydrogen peroxide with a large emission shift and bio-imaging in living cells</span></div><div class="casAuthors">Shen, Youming; Zhang, Xiangyang; Zhang, Youyu; Wu, Yanyang; Zhang, Chunxiang; Chen, Yuandao; Jin, Junling; Li, Haitao</div><div class="citationInfo"><span class="NLM_cas:title">Sensors and Actuators, B: Chemical</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">255</span>
        (<span class="NLM_cas:issue">Part_1</span>),
    <span class="NLM_cas:pages">42-48</span>CODEN:
                <span class="NLM_cas:coden">SABCEB</span>;
        ISSN:<span class="NLM_cas:issn">0925-4005</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel mitochondria-targeted fluorescent probe compd. 1 for H2O2 has constructed based on a coumarin as the fluorophore and a boronate moiety as the reaction site, which showed colorimetric and ratiometric fluorescence dual response to H2O2.  This probe displayed a large blue-shifted in emission wavelength (105 nm) with two well-resolved emission bands toward hydrogen peroxide.  The compd. 1 can be quant., good selective and sensitive recognition to H2O2 with low detection limit (10 nM).  The sensing mechanism was confirmed by H NMR and HRMS spectroscopy.  The mechanism regarding the optical responses of the compd. 1 toward H2O2 was also detd. by d. function theory (DFT) calcns.  Moreover, the probe could be used for detg. H2O2 in living cells by ratiometric fluorescence imaging with excellent mitochondrial targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopV7AsavHjaLVg90H21EOLACvtfcHk0lj8T61gAxXOmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlartbfI&md5=5752421b91b079da1ec047d129f7da00</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2Fj.snb.2017.08.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.snb.2017.08.020%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DH.%26atitle%3DA%2520mitochondria-targeted%2520colorimetric%2520and%2520ratiometric%2520fluorescent%2520probe%2520for%2520hydrogen%2520peroxide%2520with%2520a%2520large%2520emission%2520shift%2520and%2520bio-imaging%2520in%2520living%2520cells%26jtitle%3DSens.%2520Actuators%252C%2520B%26date%3D2018%26volume%3D255%26spage%3D42%26epage%3D48%26doi%3D10.1016%2Fj.snb.2017.08.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span> <span> </span><span class="NLM_article-title">A mitochondria-targeting ratiometric fluorescent probe for imaging hydrogen peroxide with long-wavelength emission and large stokes shift</span>. <i>Sens. Actuators, B</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">253</span>, <span class="refDoi"> DOI: 10.1016/j.snb.2018.08.119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.snb.2018.08.119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1Cgsr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2018&pages=247-253&author=L.+Heauthor=X.+Liuauthor=Y.+Zhangauthor=L.+Yangauthor=Q.+Fangauthor=Y.+Gengauthor=W.+Chenauthor=X.+Song&title=A+mitochondria-targeting+ratiometric+fluorescent+probe+for+imaging+hydrogen+peroxide+with+long-wavelength+emission+and+large+stokes+shift&doi=10.1016%2Fj.snb.2018.08.119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">A mitochondria-targeting ratiometric fluorescent probe for imaging hydrogen peroxide with long-wavelength emission and large Stokes shift</span></div><div class="casAuthors">He, Long; Liu, Xingjiang; Zhang, Yun; Yang, Lei; Fang, Qian; Geng, Yani; Chen, Wenqiang; Song, Xiangzhi</div><div class="citationInfo"><span class="NLM_cas:title">Sensors and Actuators, B: Chemical</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">247-253</span>CODEN:
                <span class="NLM_cas:coden">SABCEB</span>;
        ISSN:<span class="NLM_cas:issn">0925-4005</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hydrogen peroxide, one of the curial reactive oxygen species, is believed to involve in a wide range of physiol. processes.  In this work, we designed and synthesized a new fluorescent probe, HKB, for the detection of hydrogen peroxide, by taking advantage of the combination of ICT and ESIPT mechanisms.  Different from other benzothiazole-based ratiometric probes, the intramol. ESIPT process is preserved in probe HKB and the large Stokes shift is remained.  Probe HKB displayed significant ratiometric fluorescence variations (I594nm/ I666nm) upon the addn. of 50 equiv. of hydrogen peroxide under a single-wavelength excitation at 440 nm in PBS buffer (pH = 7.0, 10 mM, 30% CH3CN) and showed a large Stokes shift change from 102 nm to 254 nm.  Moreover, this probe exhibited excellent mitochondria targeting property with a 0.94 Pearson's colocalization coeff. using Rh123 as a ref.  Gratifyingly, preliminary biol. expts. indicated that probe HKB could sense both the exogenous and endogenous hydrogen peroxide in living HeLa cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsrfQ_wpvmUbVg90H21EOLACvtfcHk0liuB_rLDVwJiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1Cgsr3E&md5=8b2b6956268c08afe229170745fcd8d9</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1016%2Fj.snb.2018.08.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.snb.2018.08.119%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DFang%26aufirst%3DQ.%26aulast%3DGeng%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DSong%26aufirst%3DX.%26atitle%3DA%2520mitochondria-targeting%2520ratiometric%2520fluorescent%2520probe%2520for%2520imaging%2520hydrogen%2520peroxide%2520with%2520long-wavelength%2520emission%2520and%2520large%2520stokes%2520shift%26jtitle%3DSens.%2520Actuators%252C%2520B%26date%3D2018%26volume%3D276%26spage%3D247%26epage%3D253%26doi%3D10.1016%2Fj.snb.2018.08.119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span> <span> </span><span class="NLM_article-title">A doubly-quenched fluorescent probe for low-background detection of mitochondrial H<sub>2</sub>O<sub>2</sub></span>. <i>Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">6902</span>– <span class="NLM_lpage">6909</span>, <span class="refDoi"> DOI: 10.1021/acs.analchem.9b01294</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.analchem.9b01294" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1MXot1yjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2019&pages=6902-6909&author=J.+Liuauthor=J.+Liangauthor=C.+Wuauthor=Y.+Zhao&title=A+doubly-quenched+fluorescent+probe+for+low-background+detection+of+mitochondrial+H2O2&doi=10.1021%2Facs.analchem.9b01294"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">A Doubly-Quenched Fluorescent Probe for Low-Background Detection of Mitochondrial H2O2</span></div><div class="casAuthors">Liu, Jun; Liang, Jingjing; Wu, Chuanliu; Zhao, Yibing</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">6902-6909</span>CODEN:
                <span class="NLM_cas:coden">ANCHAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2700</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hydrogen peroxide (H2O2) is an important product of oxygen metab. which plays a crucial role in regulating a variety of cellular functions.  Fluorescent probes have made a great contribution to the understanding of the biol. role of endogenous H2O2.  However, while the first-generation fluorescent probes for H2O2 featuring dual aryl boronates show large turn-on fluorescence responses but slow response kinetics, the second-generation probes featuring monoboronate, on the contrary, show rapid response kinetics but moderate turn-on fluorescence responses.  A general strategy that can reduce the background fluorescence of these boronate-masked probes would significantly improve the sensitivity of the endogenous H2O2 detection.  In this work, the authors proposed a general and reliable double-quenching concept for the design of fluorescent probes with low-background fluorescence.  A new fluorescent probe was developed for the detection of endogenous H2O2 in mitochondria of live cancer cells.  This probe exploits a boronate-driven lactam formation and an eliminable quenching moiety simultaneously (i.e., the doubly-quenching effect) to reduce the background fluorescence, which ultimately results in the achievement of a >50-fold fluorescence turn-on.  This study not only presents a highly sensitive fluorescent probe for the detection of H2O2, but provides a new concept for the design of fluorescent probes with a previously unachievable fluorescence off-on response ratio for other types of ROS and many other biol. relevant analytes.  The authors believe that this work would greatly benefit the development of new-generation fluorescent probes with large turn-on responses and the reliable application of these probes in complex living systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFlMGcbVU9jrVg90H21EOLACvtfcHk0liuB_rLDVwJiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXot1yjtLo%253D&md5=08982a5c89fcf7996eb35d2878a6b0cc</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1021%2Facs.analchem.9b01294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.analchem.9b01294%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DY.%26atitle%3DA%2520doubly-quenched%2520fluorescent%2520probe%2520for%2520low-background%2520detection%2520of%2520mitochondrial%2520H2O2%26jtitle%3DAnal.%2520Chem.%26date%3D2019%26volume%3D91%26spage%3D6902%26epage%3D6909%26doi%3D10.1021%2Facs.analchem.9b01294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jing, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">A mitochondria-targeting highly specific fluorescent probe for fast sensing of endogenous peroxynitrite in living cells</span>. <i>Sens. Actuators, B</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>303</i></span>,  <span class="NLM_fpage">127284</span>, <span class="refDoi"> DOI: 10.1016/j.snb.2019.127284</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.snb.2019.127284" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvF2ltL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2020&pages=127284&author=W.+Shuauthor=Y.+Wuauthor=S.+Zangauthor=S.+Suauthor=H.+Kangauthor=J.+Jingauthor=X.+Zhang&title=A+mitochondria-targeting+highly+specific+fluorescent+probe+for+fast+sensing+of+endogenous+peroxynitrite+in+living+cells&doi=10.1016%2Fj.snb.2019.127284"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">A mitochondria-targeting highly specific fluorescent probe for fast sensing of endogenous peroxynitrite in living cells</span></div><div class="casAuthors">Shu, Wei; Wu, Yulong; Zang, Shunping; Su, Sa; Kang, Hao; Jing, Jing; Zhang, Xiaoling</div><div class="citationInfo"><span class="NLM_cas:title">Sensors and Actuators, B: Chemical</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">127284</span>CODEN:
                <span class="NLM_cas:coden">SABCEB</span>;
        ISSN:<span class="NLM_cas:issn">0925-4005</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Peroxynitrite (ONOO-), an endogenous reactive oxygen species, acts an important role in various physiol. and pathol. processes.  Herein, we designed a mitochondria targeting fluorescent probe MBTBE for sensitive detn. of ONOO-.  MBTBE exhibits rapid response (less than 1 min) and high selectivity towards peroxynitrite with distinct color changing (colorless to orange).  The fluorescence intensity at 569 nm was linearly correlated with the concn. of ONOO- (0-10μM) with a detection limit of 16 nM.  Addnl., MBTBE possesses good biocompatibility and mitochondria-targeting.  Furthermore, MBTBE was successfully applied to monitor fluctuations in ONOO-levels and H2S-induced ONOO- clearing in HeLa cells, indicating excellent potential applications in bioanal. anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobh2udv3fexLVg90H21EOLACvtfcHk0liuB_rLDVwJiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvF2ltL3P&md5=b924a78f73e70525a4b15d4fbc690903</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2Fj.snb.2019.127284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.snb.2019.127284%26sid%3Dliteratum%253Aachs%26aulast%3DShu%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZang%26aufirst%3DS.%26aulast%3DSu%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DJing%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DA%2520mitochondria-targeting%2520highly%2520specific%2520fluorescent%2520probe%2520for%2520fast%2520sensing%2520of%2520endogenous%2520peroxynitrite%2520in%2520living%2520cells%26jtitle%3DSens.%2520Actuators%252C%2520B%26date%3D2020%26volume%3D303%26spage%3D127284%26doi%3D10.1016%2Fj.snb.2019.127284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dielschneider, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henson, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, S. B.</span></span> <span> </span><span class="NLM_article-title">Lysosomes as oxidative targets for cancer therapy</span>. <i>Oxid. Med. Cell. Longevity</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2017</i></span>,  <span class="NLM_fpage">3749157</span>, <span class="refDoi"> DOI: 10.1155/2017/3749157</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1155%2F2017%2F3749157" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=28757908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A280%3ADC%252BC1cfisFKhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2017&publication_year=2017&pages=3749157&author=D.+F.+Dielschneiderauthor=E.+S.+Hensonauthor=S.+B.+Gibson&title=Lysosomes+as+oxidative+targets+for+cancer+therapy&doi=10.1155%2F2017%2F3749157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosomes as Oxidative Targets for Cancer Therapy</span></div><div class="casAuthors">Dielschneider Rebecca F; Henson Elizabeth S; Gibson Spencer B</div><div class="citationInfo"><span class="NLM_cas:title">Oxidative medicine and cellular longevity</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">2017</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3749157</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Lysosomes are membrane-bound vesicles that contain hydrolases for the degradation and recycling of essential nutrients to maintain homeostasis within cells.  Cancer cells have increased lysosomal function to proliferate, metabolize, and adapt to stressful environments.  This has made cancer cells susceptible to lysosomal membrane permeabilization (LMP).  There are many factors that mediate LMP such as Bcl-2 family member, p53; sphingosine; and oxidative stress which are often altered in cancer.  Upon lysosomal disruption, reactive oxygen species (ROS) levels increase leading to lipid peroxidation, mitochondrial dysfunction, autophagy, and reactive iron.  Cathepsins are also released causing degradation of macromolecules and cellular structures.  This ultimately kills the cancer cell through different types of cell death (apoptosis, autosis, or ferroptosis).  In this review, we will explore the contributions lysosomes play in inducing cell death, how this is regulated by ROS in cancer, and how lysosomotropic agents might be utilized to treat cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSYuVDJjxZ6HthSDZx9hyjKfW6udTcc2eb5uo6oaubJq7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfisFKhtw%253D%253D&md5=bf3ccf14c0170fed6177cf86567d2684</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1155%2F2017%2F3749157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2017%252F3749157%26sid%3Dliteratum%253Aachs%26aulast%3DDielschneider%26aufirst%3DD.%2BF.%26aulast%3DHenson%26aufirst%3DE.%2BS.%26aulast%3DGibson%26aufirst%3DS.%2BB.%26atitle%3DLysosomes%2520as%2520oxidative%2520targets%2520for%2520cancer%2520therapy%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longevity%26date%3D2017%26volume%3D2017%26spage%3D3749157%26doi%3D10.1155%2F2017%2F3749157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minakaki, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krainc, D.</span></span> <span> </span><span class="NLM_article-title">Perserving lysosomal function in the aging brain: insights from neurodegeneration</span>. <i>Neurotherapeutics</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">611</span>– <span class="NLM_lpage">634</span>, <span class="refDoi"> DOI: 10.1007/s13311-019-00742-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1007%2Fs13311-019-00742-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=31183763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A280%3ADC%252BB3M3lt1egtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=611-634&author=W.+Pengauthor=G.+Minakakiauthor=M.+Nguyenauthor=D.+Krainc&title=Perserving+lysosomal+function+in+the+aging+brain%3A+insights+from+neurodegeneration&doi=10.1007%2Fs13311-019-00742-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Preserving Lysosomal Function in the Aging Brain: Insights from Neurodegeneration</span></div><div class="casAuthors">Peng Wesley; Minakaki Georgia; Nguyen Maria; Krainc Dimitri</div><div class="citationInfo"><span class="NLM_cas:title">Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">611-634</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Lysosomes are acidic, membrane-bound organelles that serve as the primary catabolic compartment of the cell.  They are crucial to a variety of cellular processes from nutrient storage to autophagy.  Given the diversity of lysosomal functions, it is unsurprising that lysosomes are also emerging as important players in aging.  Lysosomal dysfunction is implicated in several aging-related neurodegenerative diseases including Alzheimer's, Parkinson's, amyotrophic lateral sclerosis/frontotemporal dementia, and Huntington's.  Although the precise role of lysosomes in the aging brain is not well-elucidated, some insight into their function has been gained from our understanding of the pathophysiology of age-dependent neurodegenerative diseases.  Therapeutic strategies targeting lysosomes and autophagic machinery have already been tested in several of these diseases with promising results, suggesting that improving lysosomal function could be similarly beneficial in preserving function in the aging brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSewpaPNT8MbJggzHGM8X5CfW6udTcc2eb5uo6oaubJq7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M3lt1egtg%253D%253D&md5=232b65b45813b4450c8844ca78e826a4</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1007%2Fs13311-019-00742-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13311-019-00742-3%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DW.%26aulast%3DMinakaki%26aufirst%3DG.%26aulast%3DNguyen%26aufirst%3DM.%26aulast%3DKrainc%26aufirst%3DD.%26atitle%3DPerserving%2520lysosomal%2520function%2520in%2520the%2520aging%2520brain%253A%2520insights%2520from%2520neurodegeneration%26jtitle%3DNeurotherapeutics%26date%3D2019%26volume%3D16%26spage%3D611%26epage%3D634%26doi%3D10.1007%2Fs13311-019-00742-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, J.</span></span> <span> </span><span class="NLM_article-title">Visualization of endogenous and exogenous hydrogen peroxide using a lysosome-targetable fluorescent probe</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">8488</span>, <span class="refDoi"> DOI: 10.1038/srep08488</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1038%2Fsrep08488" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=25684681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFKhtbnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=8488&author=D.+Kimauthor=G.+Kimauthor=S.-J.+Namauthor=J.+Yinauthor=J.+Yoon&title=Visualization+of+endogenous+and+exogenous+hydrogen+peroxide+using+a+lysosome-targetable+fluorescent+probe&doi=10.1038%2Fsrep08488"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Visualization of Endogenous and Exogenous Hydrogen Peroxide Using A Lysosome-Targetable Fluorescent Probe</span></div><div class="casAuthors">Kim, Dabin; Kim, Gyoungmi; Nam, Sang-Jip; Yin, Jun; Yoon, Juyoung</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8488</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS) play crucial roles in diverse physiol. processes; therefore, the efficient detection of ROS is very crucial.  In this study, we report a boronate-based hydrogen peroxide (H2O2) probe having naphthalimide fluorophore.  This probe also contained a morpholine moiety as a directing group for lysosome.  The recognition property indicated that the probe exhibited high selectivity towards H2O2 not only in the soln. but also in the living cells.  Furthermore, it was used to monitor the level of endogenous and exogenous H2O2.  These results support that the probe can function as an efficient indicator to detect H2O2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6QqLSmSHr1rVg90H21EOLACvtfcHk0lgNSccvs4RN8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFKhtbnE&md5=a765526d4c401b5a907ae39319c6ec74</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1038%2Fsrep08488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep08488%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DG.%26aulast%3DNam%26aufirst%3DS.-J.%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DYoon%26aufirst%3DJ.%26atitle%3DVisualization%2520of%2520endogenous%2520and%2520exogenous%2520hydrogen%2520peroxide%2520using%2520a%2520lysosome-targetable%2520fluorescent%2520probe%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D8488%26doi%3D10.1038%2Fsrep08488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span> <span> </span><span class="NLM_article-title">A lysosome-locating and acidic pH-activatable fluorescent probe for visualizing endogenous H<sub>2</sub>O<sub>2</sub> in lysosomes</span>. <i>Analyst</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>142</i></span>,  <span class="NLM_fpage">4522</span>– <span class="NLM_lpage">4528</span>, <span class="refDoi"> DOI: 10.1039/C7AN01280B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1039%2FC7AN01280B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=29099141" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslGqsrbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2017&pages=4522-4528&author=J.+Liuauthor=S.+Zhouauthor=J.+Renauthor=C.+Wuauthor=Y.+Zhao&title=A+lysosome-locating+and+acidic+pH-activatable+fluorescent+probe+for+visualizing+endogenous+H2O2+in+lysosomes&doi=10.1039%2FC7AN01280B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">A lysosome-locating and acidic pH-activatable fluorescent probe for visualizing endogenous H2O2 in lysosomes</span></div><div class="casAuthors">Liu, Jun; Zhou, Shunqing; Ren, Jing; Wu, Chuanliu; Zhao, Yibing</div><div class="citationInfo"><span class="NLM_cas:title">Analyst (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4522-4528</span>CODEN:
                <span class="NLM_cas:coden">ANALAO</span>;
        ISSN:<span class="NLM_cas:issn">0003-2654</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">There is increasing evidence indicating that lysosomal H2O2 is closely related to autophagy and apoptotic pathways under both physiol. and pathol. conditions.  Therefore, fluorescent probes that can be exploited to visualize H2O2 in lysosomes are potential tools for exploring diverse roles of H2O2 in cells.  However, functional exploration of lysosomal H2O2 is limited by the lack of fluorescent probes capable of compatibly sensing H2O2 under weak acidic conditions (pH = 4.5) of lysosomes.  Lower spatial resoln. of the fluorescent visualization of lysosomal H2O2 might be caused by the interference of signals from cytosolic and mitochondrial H2O2, as well as the non-specific distribution of the probes in cells.  In this work, we developed a lysosome-locating and acidic-pH-activatable fluorescent probe for the detection and visualization of H2O2 in lysosomes, which consists of a H2O2-responsive boronate unit, a lysosome-locating morpholine group, and a pH-activatable benzorhodol fluorophore.  The response of the fluorescent probe to H2O2 is significantly more pronounced under acidic pH conditions than that under neutral pH conditions.  Notably, the present probe enables the fluorescence sensing of endogenous lysosomal H2O2 in living cells without external stimulations, with signal interference from the cytoplasm and other intracellular organelles being negligible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMmo2YVu0e67Vg90H21EOLACvtfcHk0lgfTzvEb2aJDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslGqsrbF&md5=0e3500bde5921b3c50ced8c9cead34d7</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1039%2FC7AN01280B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7AN01280B%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DY.%26atitle%3DA%2520lysosome-locating%2520and%2520acidic%2520pH-activatable%2520fluorescent%2520probe%2520for%2520visualizing%2520endogenous%2520H2O2%2520in%2520lysosomes%26jtitle%3DAnalyst%26date%3D2017%26volume%3D142%26spage%3D4522%26epage%3D4528%26doi%3D10.1039%2FC7AN01280B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span> <span> </span><span class="NLM_article-title">pH-switchable fluorescent probe for spatially-confined visualization of intracellular hydrogen peroxide</span>. <i>Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">5865</span>– <span class="NLM_lpage">5870</span>, <span class="refDoi"> DOI: 10.1021/acs.analchem.6b00654</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.analchem.6b00654" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsVWjs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2016&pages=5865-5870&author=J.+Liuauthor=J.+Renauthor=X.+Baoauthor=W.+Gaoauthor=C.+Wuauthor=Y.+Zhao&title=pH-switchable+fluorescent+probe+for+spatially-confined+visualization+of+intracellular+hydrogen+peroxide&doi=10.1021%2Facs.analchem.6b00654"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">pH-Switchable Fluorescent Probe for Spatially-Confined Visualization of Intracellular Hydrogen Peroxide</span></div><div class="casAuthors">Liu, Jun; Ren, Jing; Bao, Xiaojia; Gao, Wei; Wu, Chuanliu; Zhao, Yibing</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5865-5870</span>CODEN:
                <span class="NLM_cas:coden">ANCHAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2700</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Intracellular H2O2 plays an important role in regulating a variety of cellular functions.  Fluorescent probes that can make response to intracellular levels of H2O2 would provide valuable tools for revealing the functions of H2O2 in living organisms.  However, traditional pH-insensitive probes and lysosome-targetable probes can only provide spatially nonspecific visualization of intracellular H2O2 and specific sensing of lysosomal H2O2, resp.  In this work, we developed a H2O2-responsive and pH-switchable fluorescent probe (HP-L1) which can make response sequentially to intracellular H2O2 and lysosomal pH.  The fluorescent probe is comprised of a H2O2-responsive boronate moiety and a pH-switchable spirobenzopyran fluorophore.  When the probe was applied for intracellular H2O2 sensing, only fluorescent emission from lysosomes is visible, and the fluorescence from other regions is not able to be obviously detected, which is due to the pH-switchable property of the spirobenzopyran fluorophore.  Thus, the developed fluorescence probe enables the spatially confined (i.e., lysosome-specific) visualization of the intracellular H2O2.  We envisioned that this kind of fluorescent probe (or the proposed sensing strategy) would allow the visualization of the overall levels of intracellular H2O2 without interferences of possible fluorescent signals from other sources (e.g., dyes for cellular staining and multiplex anal.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob0lZaMtFVNbVg90H21EOLACvtfcHk0lgfTzvEb2aJDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsVWjs7c%253D&md5=f1061e0d88120b308199f259dd1355df</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1021%2Facs.analchem.6b00654&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.analchem.6b00654%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DBao%26aufirst%3DX.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DY.%26atitle%3DpH-switchable%2520fluorescent%2520probe%2520for%2520spatially-confined%2520visualization%2520of%2520intracellular%2520hydrogen%2520peroxide%26jtitle%3DAnal.%2520Chem.%26date%3D2016%26volume%3D88%26spage%3D5865%26epage%3D5870%26doi%3D10.1021%2Facs.analchem.6b00654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chittiboyina, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lelievre, S. A.</span></span> <span> </span><span class="NLM_article-title">Microenvironment-cell nucleus relationship in the context of oxidative</span>. <i>Front. Cell Dev. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">23</span>, <span class="refDoi"> DOI: 10.3389/fcell.2018.00023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.3389%2Ffcell.2018.00023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=29594114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A280%3ADC%252BC1MnmsF2muw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2018&pages=23&author=S.+Chittiboyinaauthor=Y.+Baiauthor=S.+A.+Lelievre&title=Microenvironment-cell+nucleus+relationship+in+the+context+of+oxidative&doi=10.3389%2Ffcell.2018.00023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Microenvironment-Cell Nucleus Relationship in the Context of Oxidative Stress</span></div><div class="casAuthors">Chittiboyina Shirisha; Bai Yunfeng; Lelievre Sophie A; Chittiboyina Shirisha; Lelievre Sophie A; Lelievre Sophie A</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in cell and developmental biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">23</span>
        ISSN:<span class="NLM_cas:issn">2296-634X</span>.
    </div><div class="casAbstract">The microenvironment is a source of reactive oxygen species (ROS) that influence cell phenotype and tissue homeostasis.  The impact of ROS on redox pathways as well as directly on epigenetic mechanisms and the DNA illustrate communication with the cell nucleus.  Changes in gene transcription related to redox conditions also influence the content and structure of the extracellular matrix.  However, the importance of microenvironmental ROS for normal progression through life and disease development still needs to be thoroughly understood.  We illustrate how different ROS concentration levels trigger various intracellular pathways linked to nuclear functions and determine processes necessary for the differentiation of stem cells.  The abnormal predominance of ROS that leads to oxidative stress is emphasized in light of its impact on aging and diseases related to aging.  These phenomena are discussed in the context of the possible contribution of extracellular ROS via direct diffusion into cells responsible for organ function, but also via an impact on stromal cells that triggers extracellular modifications and influences mechanotransduction.  Finally, we argue that organs-on-a-chip with controlled microenvironmental conditions can help thoroughly grasp whether ROS production is readily a cause or a consequence of certain disorders, and better understand the concentration levels of extracellular ROS that are necessary to induce a switch in phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSuDJC-Kpybg4xhnOQkIHOxfW6udTcc2eb2TtTNe7T0dLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MnmsF2muw%253D%253D&md5=8482e331ee4149af06038ef1d095d8b5</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.3389%2Ffcell.2018.00023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffcell.2018.00023%26sid%3Dliteratum%253Aachs%26aulast%3DChittiboyina%26aufirst%3DS.%26aulast%3DBai%26aufirst%3DY.%26aulast%3DLelievre%26aufirst%3DS.%2BA.%26atitle%3DMicroenvironment-cell%2520nucleus%2520relationship%2520in%2520the%2520context%2520of%2520oxidative%26jtitle%3DFront.%2520Cell%2520Dev.%2520Biol.%26date%3D2018%26volume%3D6%26spage%3D23%26doi%3D10.3389%2Ffcell.2018.00023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Srikun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albers, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iavarone, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. J.</span></span> <span> </span><span class="NLM_article-title">Organelle-targetable fluorescent probes for imaging hydrogen peroxide in living cells via SNAP-Tag protein labeling</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">4455</span>– <span class="NLM_lpage">4465</span>, <span class="refDoi"> DOI: 10.1021/ja100117u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja100117u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3cXislKhsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=4455-4465&author=D.+Srikunauthor=A.+E.+Albersauthor=C.+I.+Namauthor=A.+T.+Iavaroneauthor=C.+J.+Chang&title=Organelle-targetable+fluorescent+probes+for+imaging+hydrogen+peroxide+in+living+cells+via+SNAP-Tag+protein+labeling&doi=10.1021%2Fja100117u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Organelle-Targetable Fluorescent Probes for Imaging Hydrogen Peroxide in Living Cells via SNAP-Tag Protein Labeling</span></div><div class="casAuthors">Srikun, Duangkhae; Albers, Aaron E.; Nam, Christine I.; Iavarone, Anthony T.; Chang, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4455-4465</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hydrogen peroxide (H2O2) is a potent small-mol. oxidant that can exert a diverse array of physiol. and/or pathol. effects within living systems depending on the timing and location of its prodn., accumulation, trafficking, and consumption.  To help study the chem. and biol. of this reactive oxygen species (ROS) in its native cellular context, the authors now present a new method for monitoring local, subcellular changes in H2O2 levels by fluorescence imaging.  Specifically, the authors have exploited the versatility of the SNAP-tag technol. for site-specific protein labeling with small mols. on the surface or interior of living cells with the use of boronate-capped dyes to selectively visualize H2O2.  The resulting SNAP-Peroxy-Green (SNAP-PG) probes consist of appropriately derivatized boronates bioconjugated to SNAP-tag fusion proteins.  Spectroscopic measurements of the SNAP-PG constructs confirm their ability to detect H2O2 with specificity over other biol. relevant ROS.  Moreover, these hybrid small-mol./protein reporters can be used in live mammalian cells expressing SNAP-tag fusion proteins directed to the plasma membrane, nucleus, mitochondria, and endoplasmic reticulum.  Imaging expts. using scanning confocal microscopy establish organelle-specific localization of the SNAP-tag probes and their fluorescence turn-on in response to changes in local H2O2 levels.  This work provides a general mol. imaging platform for assaying H2O2 chem. in living cells with subcellular resoln.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7GCq2ZhrcnrVg90H21EOLACvtfcHk0liT-P1ufNVkPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXislKhsbc%253D&md5=97a3adf7127933650337cd556c96cc6d</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1021%2Fja100117u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja100117u%26sid%3Dliteratum%253Aachs%26aulast%3DSrikun%26aufirst%3DD.%26aulast%3DAlbers%26aufirst%3DA.%2BE.%26aulast%3DNam%26aufirst%3DC.%2BI.%26aulast%3DIavarone%26aufirst%3DA.%2BT.%26aulast%3DChang%26aufirst%3DC.%2BJ.%26atitle%3DOrganelle-targetable%2520fluorescent%2520probes%2520for%2520imaging%2520hydrogen%2520peroxide%2520in%2520living%2520cells%2520via%2520SNAP-Tag%2520protein%2520labeling%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D4455%26epage%3D4465%26doi%3D10.1021%2Fja100117u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ronningen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oldenburg, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vekterud, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delbarre, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moskaug, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collas, P.</span></span> <span> </span><span class="NLM_article-title">Prepatterning of differentiation-driven nuclear lamin A/C-associated chromatin domains by GlcNAcylated histone H2B</span>. <i>Genome Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1825</span>– <span class="NLM_lpage">1835</span>, <span class="refDoi"> DOI: 10.1101/gr.193748.115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1101%2Fgr.193748.115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=26359231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A280%3ADC%252BC283htFaguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=1825-1835&author=T.+Ronningenauthor=A.+Shahauthor=A.+R.+Oldenburgauthor=K.+Vekterudauthor=E.+Delbarreauthor=J.+O.+Moskaugauthor=P.+Collas&title=Prepatterning+of+differentiation-driven+nuclear+lamin+A%2FC-associated+chromatin+domains+by+GlcNAcylated+histone+H2B&doi=10.1101%2Fgr.193748.115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Prepatterning of differentiation-driven nuclear lamin A/C-associated chromatin domains by GlcNAcylated histone H2B</span></div><div class="casAuthors">Ronningen Torunn; Shah Akshay; Vekterud Kristin; Delbarre Erwan; Oldenburg Anja R; Moskaug Jan Oivind; Collas Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Genome research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1825-35</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dynamic interactions of nuclear lamins with chromatin through lamin-associated domains (LADs) contribute to spatial arrangement of the genome.  Here, we provide evidence for prepatterning of differentiation-driven formation of lamin A/C LADs by domains of histone H2B modified on serine 112 by the nutrient sensor O-linked N-acetylglucosamine (H2BS112GlcNAc), which we term GADs.  We demonstrate a two-step process of lamin A/C LAD formation during in vitro adipogenesis, involving spreading of lamin A/C-chromatin interactions in the transition from progenitor cell proliferation to cell-cycle arrest, and genome-scale redistribution of these interactions through a process of LAD exchange within hours of adipogenic induction.  Lamin A/C LADs are found both in active and repressive chromatin contexts that can be influenced by cell differentiation status.  De novo formation of adipogenic lamin A/C LADs occurs nonrandomly on GADs, which consist of megabase-size intergenic and repressive chromatin domains.  Accordingly, whereas predifferentiation lamin A/C LADs are gene-rich, post-differentiation LADs harbor repressive features reminiscent of lamin B1 LADs.  Release of lamin A/C from genes directly involved in glycolysis concurs with their transcriptional up-regulation after adipogenic induction, and with downstream elevations in H2BS112GlcNAc levels and O-GlcNAc cycling.  Our results unveil an epigenetic prepatterning of adipogenic LADs by GADs, suggesting a coupling of developmentally regulated lamin A/C-genome interactions to a metabolically sensitive chromatin modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQAcwMJAE2LJIxhnOQkIHOxfW6udTcc2eaQdAmx13kVe7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC283htFaguw%253D%253D&md5=fa360f547bfdd9c213338a623d4845bb</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1101%2Fgr.193748.115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgr.193748.115%26sid%3Dliteratum%253Aachs%26aulast%3DRonningen%26aufirst%3DT.%26aulast%3DShah%26aufirst%3DA.%26aulast%3DOldenburg%26aufirst%3DA.%2BR.%26aulast%3DVekterud%26aufirst%3DK.%26aulast%3DDelbarre%26aufirst%3DE.%26aulast%3DMoskaug%26aufirst%3DJ.%2BO.%26aulast%3DCollas%26aufirst%3DP.%26atitle%3DPrepatterning%2520of%2520differentiation-driven%2520nuclear%2520lamin%2520A%252FC-associated%2520chromatin%2520domains%2520by%2520GlcNAcylated%2520histone%2520H2B%26jtitle%3DGenome%2520Res.%26date%3D2015%26volume%3D25%26spage%3D1825%26epage%3D1835%26doi%3D10.1101%2Fgr.193748.115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, T.</span></span> <span> </span><span class="NLM_article-title">A highly sensitive ratiometric fluorescent probe for the detection of cytoplasmic and nuclear hydrogen peroxide</span>. <i>Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">9970</span>– <span class="NLM_lpage">9976</span>, <span class="refDoi"> DOI: 10.1021/ac502909c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ac502909c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFSqtbzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=9970-9976&author=Y.+Wenauthor=K.+Liuauthor=H.+Yangauthor=Y.+Liauthor=H.+Lanauthor=Y.+Liuauthor=X.+Zhangauthor=T.+Yi&title=A+highly+sensitive+ratiometric+fluorescent+probe+for+the+detection+of+cytoplasmic+and+nuclear+hydrogen+peroxide&doi=10.1021%2Fac502909c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">A Highly Sensitive Ratiometric Fluorescent Probe for the Detection of Cytoplasmic and Nuclear Hydrogen Peroxide</span></div><div class="casAuthors">Wen, Ying; Liu, Keyin; Yang, Huiran; Li, Yi; Lan, Haichuang; Liu, Yi; Zhang, Xinyu; Yi, Tao</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">9970-9976</span>CODEN:
                <span class="NLM_cas:coden">ANCHAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2700</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As a marker for oxidative stress and a second messenger in signal transduction, hydrogen peroxide (H2O2) plays an important role in living systems.  It is thus crit. to monitor the changes in H2O2 in cells and tissues.  Here, the authors developed a highly sensitive and versatile ratiometric H2O2 fluorescent probe (NP1) based on 1,8-naphthalimide and boric acid ester.  In response to H2O2, the ratio of its fluorescent intensities at 555 and 403 nm changed 1020-fold within 200 min.  The detecting limit of NP1 toward H2O2 is estd. as 0.17 μM.  It was capable of imaging endogenous H2O2 generated in live RAW 264.7 macrophages as a cellular inflammation response, and esp., it was able to detect H2O2 produced as a signaling mol. in A431 human epidermoid carcinoma cells through stimulation by epidermal growth factor.  This probe contains an azide group and thus has the potential to be linked to various mols. via the click reaction.  After binding to a Nuclear Localization Signal peptide, the peptide-based combination probe (pep-NP1) was successfully targeted to nuclei and was capable of ratiometrically detecting nuclear H2O2 in living cells.  NP1 was a highly sensitive ratiometric H2O2 dye with promising biol. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHqdfx_mDfWLVg90H21EOLACvtfcHk0liT-P1ufNVkPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFSqtbzK&md5=225dd0810c49549f6a57cdad0a748f14</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Fac502909c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fac502909c%26sid%3Dliteratum%253Aachs%26aulast%3DWen%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLan%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYi%26aufirst%3DT.%26atitle%3DA%2520highly%2520sensitive%2520ratiometric%2520fluorescent%2520probe%2520for%2520the%2520detection%2520of%2520cytoplasmic%2520and%2520nuclear%2520hydrogen%2520peroxide%26jtitle%3DAnal.%2520Chem.%26date%3D2014%26volume%3D86%26spage%3D9970%26epage%3D9976%26doi%3D10.1021%2Fac502909c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
de Bittner, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubikovskaya, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. J.</span></span> <span> </span><span class="NLM_article-title">In vivo imaging of hydrogen peroxide production in a murine tumor model with a chemoselective bioluminescent reporter</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">21316</span>– <span class="NLM_lpage">21321</span>, <span class="refDoi"> DOI: 10.1073/pnas.1012864107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1073%2Fpnas.1012864107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=21115844" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Wis7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=21316-21321&author=G.+C.+Van%0Ade+Bittnerauthor=E.+A.+Dubikovskayaauthor=C.+R.+Bertozziauthor=C.+J.+Chang&title=In+vivo+imaging+of+hydrogen+peroxide+production+in+a+murine+tumor+model+with+a+chemoselective+bioluminescent+reporter&doi=10.1073%2Fpnas.1012864107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo imaging of hydrogen peroxide production in a murine tumor model with a chemoselective bioluminescent reporter</span></div><div class="casAuthors">Van de Bittner, Genevieve C.; Dubikovskaya, Elena a; Bertozzi, Carolyn R.; Chang, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">21316-21321, S21316/1-S21316/5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Living organisms produce hydrogen peroxide (H2O2) to kill invading pathogens and for cellular signaling, but aberrant generation of this reactive oxygen species is a hallmark of oxidative stress and inflammation in aging, injury, and disease.  The effects of H2O2 on the overall health of living animals remain elusive, in part owing to a dearth of methods for studying this transient small mol. in vivo.  Here we report the design, synthesis, and in vivo applications of Peroxy Caged Luciferin-1 (PCL-1), a chemoselective bioluminescent probe for the real-time detection of H2O2 within living animals.  PCL-1 is a boronic acid-caged firefly luciferin mol. that selectively reacts with H2O2 to release firefly luciferin, which triggers a bioluminescent response in the presence of firefly luciferase.  The high sensitivity and selectivity of PCL-1 for H2O2, combined with the favorable properties of bioluminescence for in vivo imaging, afford a unique technol. for real-time detection of basal levels of H2O2 generated in healthy, living mice.  Moreover, we demonstrate the efficacy of PCL-1 for monitoring physiol. fluctuations in H2O2 levels by directly imaging elevations in H2O2 within testosterone-stimulated tumor xenografts in vivo.  The ability to chemoselectively monitor H2O2 fluxes in real time in living animals offers opportunities to dissect H2O2's disparate contributions to health, aging, and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNPErZ3dr_Y7Vg90H21EOLACvtfcHk0liT-P1ufNVkPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Wis7bF&md5=a7b520f852bd565114effc7d26ef4cbb</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1012864107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1012864107%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bde%2BBittner%26aufirst%3DG.%2BC.%26aulast%3DDubikovskaya%26aufirst%3DE.%2BA.%26aulast%3DBertozzi%26aufirst%3DC.%2BR.%26aulast%3DChang%26aufirst%3DC.%2BJ.%26atitle%3DIn%2520vivo%2520imaging%2520of%2520hydrogen%2520peroxide%2520production%2520in%2520a%2520murine%2520tumor%2520model%2520with%2520a%2520chemoselective%2520bioluminescent%2520reporter%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D21316%26epage%3D21321%26doi%3D10.1073%2Fpnas.1012864107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, G.</span></span> <span> </span><span class="NLM_article-title">Bioluminescent turn-on probe for sensing hypochlorite in vitro and in tumors</span>. <i>Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">5693</span>– <span class="NLM_lpage">5696</span>, <span class="refDoi"> DOI: 10.1021/acs.analchem.7b01103</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.analchem.7b01103" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntlWjtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2017&pages=5693-5696&author=P.+Chenauthor=Z.+Zhengauthor=Y.+Zhuauthor=Y.+Dongauthor=F.+Wangauthor=G.+Liang&title=Bioluminescent+turn-on+probe+for+sensing+hypochlorite+in+vitro+and+in+tumors&doi=10.1021%2Facs.analchem.7b01103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Bioluminescent Turn-On Probe for Sensing Hypochlorite in Vitro and in Tumors</span></div><div class="casAuthors">Chen, Peiyao; Zheng, Zhen; Zhu, Yunxia; Dong, Yu; Wang, Fuqiang; Liang, Gaolin</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5693-5696</span>CODEN:
                <span class="NLM_cas:coden">ANCHAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2700</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hypochlorite (ClO-) is one of the most important reactive oxygen species but using a BL probe for its selective detection (or imaging) still remains challenging.  Herein, we report a latent BL probe benzoylhydrazine luciferin (1) for highly selective detection of ClO-in vitro and imaging ClO- in living cells and tumors.  In vitro tests indicated that 1 could be applied for highly selective detection of ClO- within the range of 0-62.5 μM with a limit of detection of 0.705 μM.  Using these unique features of 1, we successfully applied it to image ClO- in living cells and tumors.  We envision that probe 1 might be applied to elucidate the biol. roles of ClO- in wider physiol. and pathol. processes in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraHym4ZjDAhbVg90H21EOLACvtfcHk0lgAj5KOIoTjHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntlWjtb0%253D&md5=e6e55df6c0a5601a0cf2d7b269234314</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1021%2Facs.analchem.7b01103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.analchem.7b01103%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%26aulast%3DZheng%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DLiang%26aufirst%3DG.%26atitle%3DBioluminescent%2520turn-on%2520probe%2520for%2520sensing%2520hypochlorite%2520in%2520vitro%2520and%2520in%2520tumors%26jtitle%3DAnal.%2520Chem.%26date%3D2017%26volume%3D89%26spage%3D5693%26epage%3D5696%26doi%3D10.1021%2Facs.analchem.7b01103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, I.</span></span> <span> </span><span class="NLM_article-title">Preparation of a multiple-targeting NIR-based fluorogenic probe and its application for selective cancer cell imaging</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">4628</span>– <span class="NLM_lpage">4631</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.9b01530</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.9b01530" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVOntr3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2019&pages=4628-4631&author=H.+Liauthor=C.-H.+Leeauthor=I.+Shin&title=Preparation+of+a+multiple-targeting+NIR-based+fluorogenic+probe+and+its+application+for+selective+cancer+cell+imaging&doi=10.1021%2Facs.orglett.9b01530"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of a Multiple-Targeting NIR-Based Fluorogenic Probe and Its Application for Selective Cancer Cell Imaging</span></div><div class="casAuthors">Li, Hui; Lee, Chang-Hee; Shin, Injae</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4628-4631</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To improve cancer selectivity of imaging agents, we synthesized the triple-targeting, near-IR (NIR) based fluorogenic probe, Oct-FK(PBA)-NIR.  The new probe consists of (1) octreotide as a synthetic ligand of somatostatin receptors, (2) a H2O2-responsive phenylboronic acid, (3) a dipeptide substrate for cathepsin B, and (4) a NIR fluorophore.  The results of cell studies show that the probe can be used for selective imaging of cancer cells in the NIR range without interference with normal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3QxvVLmL8LbVg90H21EOLACvtfcHk0lgAj5KOIoTjHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVOntr3O&md5=5ca9d5bb09d4281219f02295121a431c</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.9b01530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.9b01530%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DC.-H.%26aulast%3DShin%26aufirst%3DI.%26atitle%3DPreparation%2520of%2520a%2520multiple-targeting%2520NIR-based%2520fluorogenic%2520probe%2520and%2520its%2520application%2520for%2520selective%2520cancer%2520cell%2520imaging%26jtitle%3DOrg.%2520Lett.%26date%3D2019%26volume%3D21%26spage%3D4628%26epage%3D4631%26doi%3D10.1021%2Facs.orglett.9b01530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span> <span> </span><span class="NLM_article-title">A near-infrared ratiometric/turn-on fluorescent probe for <i>in vivo</i> imaging of hydrogen peroxide in a murine model of acute inflammation</span>. <i>Anal. Chim. Acta</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1024</i></span>,  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">176</span>, <span class="refDoi"> DOI: 10.1016/j.aca.2018.03.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.aca.2018.03.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=29776543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotlClt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1024&publication_year=2018&pages=169-176&author=J.+Houauthor=M.+Qianauthor=H.+Zhaoauthor=Y.+Liauthor=Y.+Liaoauthor=G.+Hanauthor=Z.+Xuauthor=F.+Wangauthor=Y.+Songauthor=Y.+Liu&title=A+near-infrared+ratiometric%2Fturn-on+fluorescent+probe+for+in+vivo+imaging+of+hydrogen+peroxide+in+a+murine+model+of+acute+inflammation&doi=10.1016%2Fj.aca.2018.03.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">A near-infrared ratiometric/turn-on fluorescent probe for in vivo imaging of hydrogen peroxide in a murine model of acute inflammation</span></div><div class="casAuthors">Hou, Jingli; Qian, Meng; Zhao, Huanhuan; Li, Yingchun; Liao, Yongfang; Han, Guifang; Xu, Zhelong; Wang, Feng; Song, Yuguang; Liu, Yangping</div><div class="citationInfo"><span class="NLM_cas:title">Analytica Chimica Acta</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">1024</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">169-176</span>CODEN:
                <span class="NLM_cas:coden">ACACAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2670</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Much attention has been paid to develop optical probes for noninvasive, quant., in vivo monitoring of hydrogen peroxide (H2O2) due to its important roles in the initiation and development of numerous diseases.  Motivated to meet this need, we herein report the synthesis of a near-IR (NIR) fluorescent probe (AB1) for H2O2 by modulating intramol. charge transfer (ICT) process of the dye 9H-1,3-Dichloro-7-hydroxy-9,9-dimethylacridine-2-one (DDAO).  The probe AB1 exhibits both a large NIR fluorescence turn-on and a ratiometric response to H2O2 with high sensitivity and specificity.  The fluorescence response of AB1 has a good linear relationship with H2O2 over a wide concn. range from 1 μM to 100 μM, thus affording a detection limit of 0.42 μM.  Confocal microscopic expts. demonstrated that AB1 could ratiometrically detect exogenous and endogenous H2O2 in living cells.  Moreover, owing to the NIR emission of DDAO, the probe was also utilized to image endogenous H2O2 from the peritoneal cavity in a mouse model of lipopolysaccharide-induced acute inflammation, based on the fluorescence turn-on mode.  This new probe shows great potential as a reliable chem. tool to study the development and progression of H2O2-assocd. diseases in living animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRG7L2e-Qmc7Vg90H21EOLACvtfcHk0lgAj5KOIoTjHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotlClt70%253D&md5=a2d5e4dbbb8910a6456ad6d558f578bd</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2Fj.aca.2018.03.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.aca.2018.03.028%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLiao%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26atitle%3DA%2520near-infrared%2520ratiometric%252Fturn-on%2520fluorescent%2520probe%2520for%2520in%2520vivo%2520imaging%2520of%2520hydrogen%2520peroxide%2520in%2520a%2520murine%2520model%2520of%2520acute%2520inflammation%26jtitle%3DAnal.%2520Chim.%2520Acta%26date%3D2018%26volume%3D1024%26spage%3D169%26epage%3D176%26doi%3D10.1016%2Fj.aca.2018.03.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D.</span></span> <span> </span><span class="NLM_article-title">Resolving controversies on the path to Alzheimer’s therapeutics</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1060</span>– <span class="NLM_lpage">1065</span>, <span class="refDoi"> DOI: 10.1038/nm.2460</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1038%2Fnm.2460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=21900936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFCntL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=1060-1065&author=D.+Selkoe&title=Resolving+controversies+on+the+path+to+Alzheimer%E2%80%99s+therapeutics&doi=10.1038%2Fnm.2460"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Resolving controversies on the path to Alzheimer's therapeutics</span></div><div class="casAuthors">Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1060-1065</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease constitutes a personal and societal tragedy of immense proportions.  Since 1960, research in labs. and clinics worldwide has elucidated many features of this insidious and ultimately fatal syndrome, and this progress has led to initial human trials of potentially disease-modifying agents.  However, some of these agents have already failed.  Gnawing controversies and important gaps in our knowledge seem to cast addnl. doubt on the ability of the field to move forward effectively.  Here I discuss some of these looming concerns and offer possible explanations for the major trial failures that suggest they are not predictive of the future.  Rigorous preclin. validation of mechanism-based therapeutic agents followed by meticulously designed trials that focus on the cardinal cognitive symptoms and their assocd. biomarkers in the mild or presymptomatic phases of Alzheimer's disease are likely to lead to success, perhaps in the not-too-distant future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9e3VIkcVvWrVg90H21EOLACvtfcHk0lhSxNjFgSjNFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFCntL7E&md5=501720027a4b1e4fd2a838f94aecd667</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1038%2Fnm.2460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2460%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%26atitle%3DResolving%2520controversies%2520on%2520the%2520path%2520to%2520Alzheimer%25E2%2580%2599s%2520therapeutics%26jtitle%3DNat.%2520Med.%26date%3D2011%26volume%3D17%26spage%3D1060%26epage%3D1065%26doi%3D10.1038%2Fnm.2460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tramutola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanzillotta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perluigi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butterfield, D. A.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress, protein modification and Alzheimer disease</span>. <i>Brain Res. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">88</span>– <span class="NLM_lpage">96</span>, <span class="refDoi"> DOI: 10.1016/j.brainresbull.2016.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.brainresbull.2016.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=27316747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtV2gt73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2017&pages=88-96&author=A.+Tramutolaauthor=C.+Lanzillottaauthor=M.+Perluigiauthor=D.+A.+Butterfield&title=Oxidative+stress%2C+protein+modification+and+Alzheimer+disease&doi=10.1016%2Fj.brainresbull.2016.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress, protein modification and Alzheimer disease</span></div><div class="casAuthors">Tramutola, A.; Lanzillotta, C.; Perluigi, M.; Butterfield, D. Allan</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Bulletin</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">88-96</span>CODEN:
                <span class="NLM_cas:coden">BRBUDU</span>;
        ISSN:<span class="NLM_cas:issn">0361-9230</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Alzheimer disease (AD) is a progressive neurodegenerative disease that affects the elderly population with complex etiol.  Many hypotheses have been proposed to explain different causes of AD, but the exact mechanisms remain unclear.  In this review, we focus attention on the oxidative-stress hypothesis of neurodegeneration and we discuss redox proteomics approaches to analyze post-mortem human brain from AD brain.  Collectively, these studies have provided valuable insights into the mol. mechanisms involved both in the pathogenesis and progression of AD, demonstrating the impairment of numerous cellular processes such as energy prodn., cellular structure, signal transduction, synaptic function, mitochondrial function, cell cycle progression, and degradative systems.  Each of these cellular functions normally contributes to maintain healthy neuronal homeostasis, so the deregulation of one or more of these functions could contribute to the pathol. and clin. presentation of AD.  In particular, we discuss the evidence demonstrating the oxidn./dysfunction of a no. of enzymes specifically involved in energy metab. that support the view that reduced glucose metab. and loss of ATP are crucial events triggering neurodegeneration and progression of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol1I_1jee1TrVg90H21EOLACvtfcHk0lhSxNjFgSjNFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtV2gt73E&md5=c7872dbeaf579e65064223a33e18450d</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1016%2Fj.brainresbull.2016.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainresbull.2016.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DTramutola%26aufirst%3DA.%26aulast%3DLanzillotta%26aufirst%3DC.%26aulast%3DPerluigi%26aufirst%3DM.%26aulast%3DButterfield%26aufirst%3DD.%2BA.%26atitle%3DOxidative%2520stress%252C%2520protein%2520modification%2520and%2520Alzheimer%2520disease%26jtitle%3DBrain%2520Res.%2520Bull.%26date%3D2017%26volume%3D133%26spage%3D88%26epage%3D96%26doi%3D10.1016%2Fj.brainresbull.2016.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ran, C.</span></span> <span> </span><span class="NLM_article-title">Imaging hydrogen peroxide in Alzheimer’s disease via cascade signal amplification</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">35613</span>, <span class="refDoi"> DOI: 10.1038/srep35613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1038%2Fsrep35613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=27762326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslGrtLjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=35613&author=J.+Yangauthor=J.+Yangauthor=S.+H.+Liangauthor=Y.+Xuauthor=A.+Mooreauthor=C.+Ran&title=Imaging+hydrogen+peroxide+in+Alzheimer%E2%80%99s+disease+via+cascade+signal+amplification&doi=10.1038%2Fsrep35613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging hydrogen peroxide in Alzheimer's disease via cascade signal amplification</span></div><div class="casAuthors">Yang, Jian; Yang, Jing; Liang, Steven H.; Xu, Yungen; Moore, Anna; Ran, Chongzhao</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">35613</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">In brains of Alzheimer's disease (AD), reactive oxygen species (ROS) levels are significantly higher than that of healthy brains.  Evidence suggests that, during AD onset and progression, a vicious cycle revolves around amyloid beta (Aβ) prodn., aggregation, plaque formation, microglia/immunol. responses, inflammation, and ROS prodn.  In this cycle, ROS species play a central role, and H2O2 is one of the most important ROS species.  In this report, we have designed a fluorescent imaging probe CRANAD-88, which is capable of cascade amplifying near IR fluorescence (NIRF) signals at three levels upon interacting with H2O2 in AD brains.  We demonstrated that the amplification was feasible in vitro and in vivo.  Remarkably, we showed that, for the first time, it was feasible to monitor the changes of H2O2 concns. in AD brains before and after treatment with an H2O2 scavenger.  Our method opens new revenues to investigate H2O2 in AD brains and can be very instructive for drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNXjcUvExESrVg90H21EOLACvtfcHk0lhSxNjFgSjNFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslGrtLjP&md5=9cb6630329308b0b47d28b6dc0254107</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1038%2Fsrep35613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep35613%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DS.%2BH.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DMoore%26aufirst%3DA.%26aulast%3DRan%26aufirst%3DC.%26atitle%3DImaging%2520hydrogen%2520peroxide%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520via%2520cascade%2520signal%2520amplification%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D35613%26doi%3D10.1038%2Fsrep35613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span> <span> </span><span class="NLM_article-title">A novel pyrimidine based deep-red fluorogenic probe for detecting hydrogen peroxide in Parkinson’s disease models</span>. <i>Talanta</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>199</i></span>,  <span class="NLM_fpage">628</span>– <span class="NLM_lpage">633</span>, <span class="refDoi"> DOI: 10.1016/j.talanta.2019.03.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1016%2Fj.talanta.2019.03.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=30952307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1MXks12ju7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=199&publication_year=2019&pages=628-633&author=X.+Qiuauthor=C.+Xinauthor=W.+Qinauthor=Z.+Liauthor=D.+Zhangauthor=G.+Zhangauthor=B.+Pengauthor=X.+Hanauthor=C.+Yuauthor=L.+Liauthor=W.+Huang&title=A+novel+pyrimidine+based+deep-red+fluorogenic+probe+for+detecting+hydrogen+peroxide+in+Parkinson%E2%80%99s+disease+models&doi=10.1016%2Fj.talanta.2019.03.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">A novel pyrimidine based deep-red fluorogenic probe for detecting hydrogen peroxide in Parkinson's disease models</span></div><div class="casAuthors">Qiu, Xinghan; Xin, Chenqi; Qin, Wenjing; Li, Zheng; Zhang, Duoteng; Zhang, Gaobin; Peng, Bo; Han, Xu; Yu, Changmin; Li, Lin; Huang, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Talanta</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">199</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">628-633</span>CODEN:
                <span class="NLM_cas:coden">TLNTA2</span>;
        ISSN:<span class="NLM_cas:issn">0039-9140</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Parkinson's disease (PD) severely affects life quality of patients and has brought huge economic burden to health system worldwide.  Previous studies showed that the abnormal expression of hydrogen peroxide (H2O2) in the brain is closely related to the development of neurodegenerative diseases such as PD.  Herein, the authors designed a novel deep-red H2O2 fluorogenic probe PB1 to detect the level of H2O2 in vivo.  PB1 showed a highly selectivity response to H2O2 over other reactants such as reactive oxygen/nitrogen species, biothiols and various ions in aq. soln. at physiol. pH.  PB1 possesses an excellent response to H2O2 in the cells and in the brain tissue of drosophila from confocal fluorescence imaging.  These results suggested that PB1 holds great potential in the study of the relation between H2O2 overexpression and PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCkeZMBlw5J7Vg90H21EOLACvtfcHk0lgMNPVR0PECpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXks12ju7k%253D&md5=1f55f64277f5de72d078fafc5132007f</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1016%2Fj.talanta.2019.03.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.talanta.2019.03.017%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DXin%26aufirst%3DC.%26aulast%3DQin%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DW.%26atitle%3DA%2520novel%2520pyrimidine%2520based%2520deep-red%2520fluorogenic%2520probe%2520for%2520detecting%2520hydrogen%2520peroxide%2520in%2520Parkinson%25E2%2580%2599s%2520disease%2520models%26jtitle%3DTalanta%26date%3D2019%26volume%3D199%26spage%3D628%26epage%3D633%26doi%3D10.1016%2Fj.talanta.2019.03.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paira, P.</span></span> <span> </span><span class="NLM_article-title">Theranostic aspects: treatment of cancer by nanotechnology</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">969</span>– <span class="NLM_lpage">975</span>, <span class="refDoi"> DOI: 10.2174/1389557518666171129214336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.2174%2F1389557518666171129214336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=29189149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFGgtrbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=969-975&author=B.+Sarkarauthor=P.+Paira&title=Theranostic+aspects%3A+treatment+of+cancer+by+nanotechnology&doi=10.2174%2F1389557518666171129214336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Theranostic Aspects: Treatment of Cancer by Nanotechnology</span></div><div class="casAuthors">Sarkar, Bidisha; Paira, Priyankar</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">969-975</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Theranostic agents or theranostic imaging as its name suggests is a combination of two terms-diagnosis & therapy.  Efforts are being made to combine both the terms into clin. formulations.  This theranostic imaging is found to be very much significant to complex diseases like cancer and proliferative tumors esp. because accurate photocopy for every tumor can be obtained by genomic and proteomic profiling and using such informations in theranostic agents can be constructed or modeled in such a way that it is specific in its action and selective towards the cancer cells only, without causing any adverse effects on the normal tissue cells.  By means of nanoplatforms, we can conveniently deliver cancer cell specific targeting ligand or peptide inside the human body.  Primary delivery approach comprises of nanoparticles, liposomes, dendrimers, prodrugs, polymersomes, carbon nanotubes and polymeric micelles.  Theranostic agents, i.e., therapeutic and diagnostic agents can be phys. bound or else they can be bound with polymers which are exclusively designed and this together forms nanocarriers.  Hence, the review highlights the advances of nanotechnol. that has given us a platform for cancer detection and treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk08KQmitAfLVg90H21EOLACvtfcHk0lgMNPVR0PECpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFGgtrbK&md5=3e6d8cd2d82a7f32c5899e386012bfd2</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.2174%2F1389557518666171129214336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557518666171129214336%26sid%3Dliteratum%253Aachs%26aulast%3DSarkar%26aufirst%3DB.%26aulast%3DPaira%26aufirst%3DP.%26atitle%3DTheranostic%2520aspects%253A%2520treatment%2520of%2520cancer%2520by%2520nanotechnology%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2018%26volume%3D18%26spage%3D969%26epage%3D975%26doi%3D10.2174%2F1389557518666171129214336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, W. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. S.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial induced and self-monitored intrinsic apoptosis by antitumor theranostic prodrug: <i>In Vivo</i> imaging and precise cancer treatment</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">17836</span>– <span class="NLM_lpage">17843</span>, <span class="refDoi"> DOI: 10.1021/ja510421q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja510421q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFOjsL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=17836-17843&author=R.+Kumarauthor=J.+Hanauthor=H.-J.+Limauthor=W.+X.+Renauthor=J.-Y.+Limauthor=J.-H.+Kimauthor=J.+S.+Kim&title=Mitochondrial+induced+and+self-monitored+intrinsic+apoptosis+by+antitumor+theranostic+prodrug%3A+In+Vivo+imaging+and+precise+cancer+treatment&doi=10.1021%2Fja510421q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial Induced and Self-Monitored Intrinsic Apoptosis by Antitumor Theranostic Prodrug: In Vivo Imaging and Precise Cancer Treatment</span></div><div class="casAuthors">Kumar, Rajesh; Han, Jiyou; Lim, Hee-Joung; Ren, Wen Xiu; Lim, Ja-Yun; Kim, Jong-Hoon; Kim, Jong Seung</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">17836-17843</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activation of apoptosis, the cell death machinery, in tumor cells by organelle-specific delivery of antitumor theranostic agent is the utmost challenge in cancer therapy.  Herein, we developed a highly efficient mitochondria-targeting antitumor theranostic prodrug 7 that contained two mols. of drug 5'-deoxy-5-fluorouridine and an apoptotic marker ethidium for self-monitoring intrinsic (mitochondrial) apoptosis after its activation in tumor cells.  Theranostic 7 was activated by endogenously produced mitochondrial-overexpressed H2O2 and released drug 5'-deoxy-5-fluorouridine and apoptotic marker ethidium to the tumor cells.  The in vitro and in vivo drug release was monitored by observing the fluorescence changes of ethidium.  Theranostic 7 exhibited an enhanced cytotoxicity over com. 5-fluorouracil (an active drug of 5'-deoxy-5-fluorouridine) leading to intrinsic apoptosis monitored by in situ generated ethidium.  Enhanced expression of mitochondria-mediated apoptotic genes (NOXA, PUMA, BID, BAX, and BAK), Cyt C, Caspase-3 and -9, and cell surface death receptors was obsd. after theranostic 7 activation in tumor cells.  In vivo and ex vivo xenografts revealed that theranostic 7 significantly inhibited tumor progression and cured the tumor-bearing mice.  Such organelle-specific theranostic strategies have great potential for the early diagnosis and precise treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdxDp1xuNvfLVg90H21EOLACvtfcHk0lgMNPVR0PECpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFOjsL3O&md5=0e80b2f99a1054f9da8570c3ceb84783</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1021%2Fja510421q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja510421q%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DH.-J.%26aulast%3DRen%26aufirst%3DW.%2BX.%26aulast%3DLim%26aufirst%3DJ.-Y.%26aulast%3DKim%26aufirst%3DJ.-H.%26aulast%3DKim%26aufirst%3DJ.%2BS.%26atitle%3DMitochondrial%2520induced%2520and%2520self-monitored%2520intrinsic%2520apoptosis%2520by%2520antitumor%2520theranostic%2520prodrug%253A%2520In%2520Vivo%2520imaging%2520and%2520precise%2520cancer%2520treatment%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D17836%26epage%3D17843%26doi%3D10.1021%2Fja510421q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhuniya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maiti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. S.</span></span> <span> </span><span class="NLM_article-title">An activatable prodrug for the treatment of metastatic tumors</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">13888</span>– <span class="NLM_lpage">13894</span>, <span class="refDoi"> DOI: 10.1021/ja5077684</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja5077684" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFamsL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=13888-13894&author=E.-J.+Kimauthor=S.+Bhuniyaauthor=H.+Leeauthor=H.+M.+Kimauthor=C.+Cheongauthor=S.+Maitiauthor=K.+S.+Hongauthor=J.+S.+Kim&title=An+activatable+prodrug+for+the+treatment+of+metastatic+tumors&doi=10.1021%2Fja5077684"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">An Activatable Prodrug for the Treatment of Metastatic Tumors</span></div><div class="casAuthors">Kim, Eun-Joong; Bhuniya, Sankarprasad; Lee, Hyunseung; Kim, Hyun Min; Cheong, Chaejoon; Maiti, Sukhendu; Hong, Kwan Soo; Kim, Jong Seung</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">13888-13894</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Metastatic cancers have historically been difficult to treat.  However, metastatic tumors have been found to have high levels of reactive oxygen species such as hydrogen peroxide (H2O2), supporting the hypothesis that a prodrug could be activated by intracellular H2O2 and lead to a potential antimetastatic therapy.  In this study, prodrug 7 was designed to be activated by H2O2-mediated boronate oxidn., resulting in activation of the fluorophore for detection and release of the therapeutic agent, SN-38.  Drug release from prodrug 7 was investigated by monitoring fluorescence after addn. of H2O2 to the cancer cells.  Prodrug 7 activated by H2O2, selectively inhibited tumor cell growth.  Furthermore, intratracheally administered prodrug 7 showed effective antitumor activity in a mouse model of metastatic lung disease.  Thus, this H2O2-responsive prodrug has therapeutic potential as a novel treatment for metastatic cancer via cellular imaging with fluorescence as well as selective release of the anticancer drug, SN-38.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX5gk0YqDa5rVg90H21EOLACvtfcHk0li-b25UFtRzcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFamsL%252FK&md5=35fc515aa6940c7b7946bb5638ed4e19</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1021%2Fja5077684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja5077684%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DE.-J.%26aulast%3DBhuniya%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DH.%2BM.%26aulast%3DCheong%26aufirst%3DC.%26aulast%3DMaiti%26aufirst%3DS.%26aulast%3DHong%26aufirst%3DK.%2BS.%26aulast%3DKim%26aufirst%3DJ.%2BS.%26atitle%3DAn%2520activatable%2520prodrug%2520for%2520the%2520treatment%2520of%2520metastatic%2520tumors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D13888%26epage%3D13894%26doi%3D10.1021%2Fja5077684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takagi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toshima, K.</span></span> <span> </span><span class="NLM_article-title">Target-selective fluorescence imaging and photocytotoxicity against H<sub>2</sub>O<sub>2</sub> high-expressing cancer cells using a photoactivatable theranostic agent</span>. <i>Chem. - Asian J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">2656</span>– <span class="NLM_lpage">2659</span>, <span class="refDoi"> DOI: 10.1002/asia.201701004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1002%2Fasia.201701004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=28834271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFClurjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=2656-2659&author=R.+Takagiauthor=A.+Takedaauthor=D.+Takahashiauthor=K.+Toshima&title=Target-selective+fluorescence+imaging+and+photocytotoxicity+against+H2O2+high-expressing+cancer+cells+using+a+photoactivatable+theranostic+agent&doi=10.1002%2Fasia.201701004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Target-Selective Fluorescence Imaging and Photocytotoxicity against H2O2 High-Expressing Cancer Cells Using a Photoactivatable Theranostic Agent</span></div><div class="casAuthors">Takagi, Ryoma; Takeda, Ayano; Takahashi, Daisuke; Toshima, Kazunobu</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - An Asian Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2656-2659</span>CODEN:
                <span class="NLM_cas:coden">CAAJBI</span>;
        ISSN:<span class="NLM_cas:issn">1861-4728</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A purpose-designed and synthesized H2O2-reactive and photoactivatable theranostic agent I consisting of 1) an arylboronic acid moiety, 2) pro-fluorophore moiety, and 3) photoactivatable moiety (photosensitizer), selectively and effectively reacted with H2O2 while simultaneously releasing resorufin for fluorescence detection under neutral aq. conditions.  In addn., I was cell-permeable, and exhibited effective photocytotoxicity against fluorescently visualized cells only upon photoirradn.  The results also showed that I produced a selective fluorescence response to H2O2, even in living cultured cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCEYz_3D5SSLVg90H21EOLACvtfcHk0li-b25UFtRzcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFClurjF&md5=a80997cdb9b24d4d84bee9887964eb68</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1002%2Fasia.201701004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fasia.201701004%26sid%3Dliteratum%253Aachs%26aulast%3DTakagi%26aufirst%3DR.%26aulast%3DTakeda%26aufirst%3DA.%26aulast%3DTakahashi%26aufirst%3DD.%26aulast%3DToshima%26aufirst%3DK.%26atitle%3DTarget-selective%2520fluorescence%2520imaging%2520and%2520photocytotoxicity%2520against%2520H2O2%2520high-expressing%2520cancer%2520cells%2520using%2520a%2520photoactivatable%2520theranostic%2520agent%26jtitle%3DChem.%2520-%2520Asian%2520J.%26date%3D2017%26volume%3D12%26spage%3D2656%26epage%3D2659%26doi%3D10.1002%2Fasia.201701004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ravikumar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagheri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saini, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakrapani, H.</span></span> <span> </span><span class="NLM_article-title">A small molecule for theranostic targeting of cancer cells</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">13352</span>– <span class="NLM_lpage">13355</span>, <span class="refDoi"> DOI: 10.1039/C7CC08526E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=10.1039%2FC7CC08526E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=29192700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVaqsLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2017&pages=13352-13355&author=G.+Ravikumarauthor=M.+Bagheriauthor=D.+K.+Sainiauthor=H.+Chakrapani&title=A+small+molecule+for+theranostic+targeting+of+cancer+cells&doi=10.1039%2FC7CC08526E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule for theraNOstic targeting of cancer cells</span></div><div class="casAuthors">Ravikumar, Govindan; Bagheri, Meisam; Saini, Deepak Kumar; Chakrapani, Harinath</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">100</span>),
    <span class="NLM_cas:pages">13352-13355</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Thera/NO - a small mol. that is activated by hydrogen peroxide to generate nitric oxide (NO) and a fluorescence signal is reported.  Using cancer and primary cells, we show that Thera/NO preferentially releases NO in cancer cells, which can trigger DNA damage and cell death in them.  The coupled fluorescence signal facilitated tracking the NO release in living cells without collateral consumption of NO.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT2i6nC8L4ULVg90H21EOLACvtfcHk0li-b25UFtRzcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVaqsLzE&md5=163f505253e0daa9063c7499ac15ebff</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1039%2FC7CC08526E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7CC08526E%26sid%3Dliteratum%253Aachs%26aulast%3DRavikumar%26aufirst%3DG.%26aulast%3DBagheri%26aufirst%3DM.%26aulast%3DSaini%26aufirst%3DD.%2BK.%26aulast%3DChakrapani%26aufirst%3DH.%26atitle%3DA%2520small%2520molecule%2520for%2520theranostic%2520targeting%2520of%2520cancer%2520cells%26jtitle%3DChem.%2520Commun.%26date%3D2017%26volume%3D53%26spage%3D13352%26epage%3D13355%26doi%3D10.1039%2FC7CC08526E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, C.</span></span> <span> </span><span class="NLM_article-title">A simple and effective “elimination” approach for selective cancer therapy to reveal the role of H<sub>2</sub>O<sub>2</sub></span>. <i>ACS Omega.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">22157</span>– <span class="NLM_lpage">22162</span>, <span class="refDoi"> DOI: 10.1021/acsomega.0c02240</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.0c02240" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A280%3ADC%252BB38bot1Grug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2020&pages=22157-22162&author=J.+Liuauthor=C.+Cao&title=A+simple+and+effective+%E2%80%9Celimination%E2%80%9D+approach+for+selective+cancer+therapy+to+reveal+the+role+of+H2O2&doi=10.1021%2Facsomega.0c02240"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">A Simple and Effective "Elimination" Approach for Selective Cancer Therapy to Reveal the Role of H2O2</span></div><div class="casAuthors">Liu Jun; Cao Cheng</div><div class="citationInfo"><span class="NLM_cas:title">ACS omega</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">22157-22162</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Fluorescence imaging capability for visualizing tumor microenvironments can play a role in advancing drug discovery efforts, exploring therapeutic efficacy, and thus significantly improving the prognosis.  Specifically, we present the design, synthesis, spectroscopic properties, and the targeting diagnosis of a single boronate-appended benzorhodol.  Drug release from the prodrug LHX-B-CPT was detected by tackling the fluorescent signal after the addition of H2O2 to the target cancer cells.  The prodrug entered the cells via endocytosis mechanisms due to the folate unit, highlighting that the final delivery locations can minutely influence drug efficacy.  Thus, this theranostic system is a new therapeutic agent, based on the reasoning that the depletion of H2O2 would be readily detected at the subcellular level by the fluorescence changes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQPNxkcQIngLLBItaL1WaVAfW6udTcc2eZMZlKSw9ihGLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB38bot1Grug%253D%253D&md5=9d3182c41b79ea701ecac36dfce4560e</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1021%2Facsomega.0c02240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.0c02240%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DC.%26atitle%3DA%2520simple%2520and%2520effective%2520%25E2%2580%259Celimination%25E2%2580%259D%2520approach%2520for%2520selective%2520cancer%2520therapy%2520to%2520reveal%2520the%2520role%2520of%2520H2O2%26jtitle%3DACS%2520Omega.%26date%3D2020%26volume%3D5%26spage%3D22157%26epage%3D22162%26doi%3D10.1021%2Facsomega.0c02240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span> <span> </span><span class="NLM_article-title">Two decades under the influence of the rule of five and the changing properties of approved oral drugs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1701</span>– <span class="NLM_lpage">1714</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00686</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00686" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslait73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=1701-1714&author=M.+D.+Shultz&title=Two+decades+under+the+influence+of+the+rule+of+five+and+the+changing+properties+of+approved+oral+drugs&doi=10.1021%2Facs.jmedchem.8b00686"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Two Decades under the Influence of the Rule of Five and the Changing Properties of Approved Oral Drugs</span></div><div class="casAuthors">Shultz, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1701-1714</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two decades have passed since the rule of five ushered in the concept of "drug-like" properties.  Attempts to quantify, correlate, and categorize mols. based on Ro5 parameters evolved into the introduction of efficiency metrics with far reaching consequences in decision making by industry leaders and scientists seeking to discover new medicines.  Examn. of oral drug parameters approved before and after the original Ro5 anal. demonstrates that some parameters such as clogP and HBD remained const. while the cutoffs for parameters such as mol. wt. and HBA have increased substantially over the past 20 years.  The time dependent increase in the mol. wt. of oral drugs during the past 20 years provides compelling evidence to disprove the hypothesis that mol. wt. is a "drug-like" property.  This anal. does not validate parameters that have not changed as being "drug-like" but instead calls into question the entire hypothesis that "drug-like" properties exist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAnoxpQsv2kbVg90H21EOLACvtfcHk0lhjN_6WTZXgJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslait73K&md5=d3c8b1107133dc0b7b277d22fa029597</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00686%26sid%3Dliteratum%253Aachs%26aulast%3DShultz%26aufirst%3DM.%2BD.%26atitle%3DTwo%2520decades%2520under%2520the%2520influence%2520of%2520the%2520rule%2520of%2520five%2520and%2520the%2520changing%2520properties%2520of%2520approved%2520oral%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D1701%26epage%3D1714%26doi%3D10.1021%2Facs.jmedchem.8b00686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raymer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, B. K.</span></span> <span> </span><span class="NLM_article-title">Lead-like drugs: a perspective</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">10375</span>– <span class="NLM_lpage">10384</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00407</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00407" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtl2is73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=10375-10384&author=B.+Raymerauthor=B.+K.+Bhattacharya&title=Lead-like+drugs%3A+a+perspective&doi=10.1021%2Facs.jmedchem.8b00407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Lead-like Drugs: A Perspective</span></div><div class="casAuthors">Raymer, Brian; Bhattacharya, Samit K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10375-10384</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lead-like drugs, or drugs below mol. wt. 300, are an important and sometimes overlooked component of the current pharmacopeia and contemporary medicinal chem. practice.  To examine the recent state-of-the-art in lead-like drug discovery, we surveyed recent drug approvals from 2011 to 2017 and top 200 prescribed medications, as well as provide case studies on recently approved lead-like drugs.  Many of these recent drugs are close analogs of previously known drugs or natural substrates, with a key focus of their medicinal chem. optimization being the choice of a low mol. wt. starting point and maintaining low mol. wt. during the optimization.  However, the identification of low mol. wt. starting points may be limited by the availability of suitable low mol. wt. screening sets.  To increase the discovery rate of lead-like drugs, we suggest an increased focus on inclusion and prosecution of lead-like starting points in screening libraries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqDUrWKytt_7Vg90H21EOLACvtfcHk0lhjN_6WTZXgJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtl2is73O&md5=e9fc17d69c7d671459fdaf77d6721829</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00407%26sid%3Dliteratum%253Aachs%26aulast%3DRaymer%26aufirst%3DB.%26aulast%3DBhattacharya%26aufirst%3DB.%2BK.%26atitle%3DLead-like%2520drugs%253A%2520a%2520perspective%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D10375%26epage%3D10384%26doi%3D10.1021%2Facs.jmedchem.8b00407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01704&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01704%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-1%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01704" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679980508cb53cfa","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
